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DISEASES OF BLOOD 
ANAEMIAS 
 
Anaemia is defined as a haemoglobin and/ or erythrocytes concentra- 
tion in blood below the lower limit of the normal range for the age and sex of 
the individual. In adults, the lower extreme of the normal haemoglobin is tak- 
en as 13.0 g/dl for males and 11.5 g/dl for females. 
Classification  of  anaemias:  Depending  upon  the  pathophysiologic 
mechanism, anaemias are classified into 3 groups: 
I. Anaemias due to blood loss. 
1. Acute post-haemorrhagic anaemia.
2. Chronic post-haemorrhagic anaemia.
II. Anaemia due to impaired red cell production. A disturbance due
to impaired red cell production from various causes may produce anaemia. 
These are as under: 
A. Cytoplasmic maturation defects 
1. Deficient haem synthesis: iron deficiency anaemia
2. Deficient globin synthesis: thalassaemic syndromes
B. Nuclear maturation defects 
Vitamin B12 and/or folic acid deficiency: megaloblastic anaemia 
C. Haematopoietic stem cell proliferation and differentiation abnormal- 
ity e.g. 
1. Aplastic anaemia
2. Pure red cell aplasia
D. Bone marrow failure due to systemic diseases (anaemia of chronic 
disorders) e.g. 
1. Anaemia of infections
2. Anaemia in renal disease
3. Anaemia in liver disease
4. Disseminated malignancy
5. Endocrinopathies





F. Congenital anaemia e.g. 
1. Sideroblastic anaemia
2. Congenital dyserythropoietic anaemia
III. Anaemia  due  to  increased  red  cell  destruction  (haemolytic









2. Haemolytic anaemias due to exravascular haemolysis mainly 
(Hereditary, intracorpusculae). 
a) abnormalities of red cell membrane, 
b) red cell enzyme defects, 
c)  disorders of haemoglobin. 
 
MORPHOLOGIC CLASSIFICATION. Based on the red cell size, haemo- 
globin content and red cell indices, anaemias are classified into 3 types: 
1. Microcytic, hypochromic: MCV, MCH, MCHC are all reduced e.g. 
in iron deficiency anaemia and in certain non-iron deficient anaemias 
(sideroblastic anaemia, thalassaemia, anaemia of chronic disorders). 
2. Normocytic, normochromic: MCV, MCH, MCHC are all normal 
e.g. after acute blood loss, haemolytic anaemias, bone marrow failure, anae- 
mia of chronic disorders. 
3. Macrocytic: MCV is raised e.g. in megaloblastic anaemia due to 
deficiency of vitamin B12 or folic acid. 
ANAEMIA OF BLOOD LOSS 
Depending upon the rate of blood loss due to haemorrhage, the effects 
of post-haemorrhagic anaemia appear. 
ACUTE BLOOD LOSS. When the loss of blood occurs suddenly, the fol- 
lowing events take place: 
i) Immediate threat to life due to hypovolaemia which may result in 
shock and death. 
ii) If the patient survives, shifting of interstitial fluid to intravascular 
compartment with consequent haemodilution with low haematocrit. 
iii) Hypoxia stimulates production of erythropoietin resulting in in- 
creased marrow erythropoiesis. 
CHRONIC BLOOD LOSS develops in slow but continuous blood loss (in 
bleeding from hemorrhoidal vein, uterine bleeding, and hemophilia). Skin 
becomes pale, bone marrow hyperplasia and extra medullary haemopoiesis 
are also seen. Metaplasia of yellow bone marrow into red bone marrow oc- 
curs in tube bones. Due to hypoxia fat dystrophy develops in parenchymatous 
organs (heart, liver). 
When the loss of blood is slow and insidious, the effects of anaemia 




tion and the iron stores are depleted. This results in iron deficiency anaemia 
as seen in other clinical conditions discussed below. 
 
HYPOCHROMIC ANAEMIA 
Hypochromic anaemiasare classified into 2 groups: 
I. Hypochromic anaemia due to iron deficiency. 
II. Hypochromic anaemias other than iron deficiency. The latter cate- 
gory includes 3 groups of disorders sideroblastic anaemia, thalassaemia and 
anaemia of chronic disorders. 
IRON DEFICIENCY ANAEMIA 
The commonest nutritional deficiency disorder present throughout the 
world is iron deficiency but its prevalence is higher in the developing countries. 
Iron Metabolism 
The amount of iron obtained from the diet should replace the losses from the skin, 
bowel and genitourinary tract. These losses together are about 1 mg daily in an adult male 
or in a non-menstruating female, while in a menstruating woman there is an additional 
iron loss of 0.5-1 mg daily. The iron required for haemoglobin synthesis is derived from 2 
primary sources - ingestion of foods containing iron (e.g. leafy vegetables, beans, meats, 
liver etc) and recycling of iron from senescent red cells. 
Absorption. Iron is absorbed mainly in the duodenum and proximal jejunum. Iron 
from diet containing haem is better absorbed than non-haem iron. Absorption of non-haem 
iron is enhanced by factors such as ascorbic acid (vitamin C), citric acid, amino acids, 
sugars, gastric secretions and hydrochloric acid. Iron absorption is impaired by factors like 
medicinal antacids, milk, pancreatic secretions, phytates, phosphates, ethylene diamine 
tetra-acetic acid (EDTA) and tannates contained in tea. 
Non-haem iron is released as ferrous or ferric form but is absorbed almost exclusively as 
ferrous form. Iron balance in the body is maintained largely by regulating the absorptive intake 
by intestinal mucosal cells, so called mucosal block. The factors which determine this mucosal 
intelligence are unknown. When the demand for iron is increased (e.g. during pregnancy, men- 
struation, periods of growth and various diseases), there is increased iron absorption, while ex- 
cessive body stores of iron cause reduced intestinal iron absorption. 
Distribution. In an adult, iron is distributed in the body as under: 
1. Haemoglobin – present in the red cells, contains most of the body iron (65%). 
2. Myoglobin – comprises a small amount of iron in the muscles (3.5%). 
3. Haem and non-haem enzymes – e.g. cytochrome, catalase, peroxidases, suc- 
cinic dehydrogenase and flavoproteins constitute a fraction of total body iron (0.5%). 
4. Transferrin-bound iron – circulates in the plasma and constitutes another frac- 
tion of total body iron (0.5%). 
All these forms of iron are in functional form. 
5. Ferritin and haemosiderin – are the storage forms of excess iron (30%). They 
are stored in the mononuclear-phagocyte cells of the spleen, liver and bone marrow and in 
the parenchymal cells of the liver. 
Transport. Iron is transported in plasma bound to a (3-globulin, transferrin, syn- 
thesised in the liver. Transferrin-bound iron is made available to the marrow where the im- 
mature red cell precursors utilise iron for haemoglobin synthesis. Transferrin is reutilised after 
iron is released from it. A small amount of transferrin iron is delivered to other sites such as 
parenchymal cells of the liver. Normally, transferrin is about one-third saturated. But in condi- 
tions where transferrin-iron saturation is increased, parenchymal iron uptake is increased. Vir- 
tually, no iron is deposited in the mononuclear-phagocyte cells (RE cells) from the plasma 




red cells. Storage form of iron (ferritin and haemosiderin) in RE cells is normally not func- 
tional but can be readily mobilised in response to increased demands for erythropoiesis. How- 
ever, conditions such as malignancy, infection and inflammation interfere with the release of 
iron from iron stores causing ineffective erythropoiesis. 
Excretion. The body is unable to regulate its iron content by excretion alone. The 
amount of iron lost per day is 0.5-1 mg which is independent of iron intake. This loss is 
nearly twice more (i.e. 1-2 mg/day) in menstruating women. Iron is lost from the body as a 
result of desquamation of epithelial cells from the gastrointestinal tract, from excretion in 
the urine and sweat, and loss via hair and nails. Iron excreted in the faeces mainly consists 
of unabsorbed iron and desquamated mucosal cells. 
Pathogenesis. Iron deficiency anaemia develops when the supply of iron 
is inadequate for the requirement of haemoglobin synthesis. Initially, the nega- 
tive iron balance is made good by mobilisation from the tissue stores so as to 
maintain haemoglobin synthesis. It is only after the tissue stores of iron are ex- 
hausted that the supply of iron to the marrow becomes insufficient for haemo- 
globin formation so that a state of iron deficiency anaemia develops. The devel- 
opment of iron deficiency depends upon one or more of the following factors: 
1. Increased blood loss, 
2. Increased requirements, 
3. Inadequate dietary intake, 
4. Decreased intestinal absorption. 
The relative significance of these factors varies with the age and sex of 
the patient. Accordingly, certain groups of individuals at increased risk of de- 
veloping iron deficiency can be identified (see below). In general, in developed 
countries the mechanism of iron deficiency is usually due to chronic occult 
blood loss, while in the underdeveloped countries poor intake of iron or defec- 
tive absorption are responsible for iron deficiency anaemia. 
Etiology. Iron deficiency anaemia is always secondary to an underly- 
ing disorder. Based on the above mentioned pathogenetic mechanisms, the 
following etiologic factors are involved in development of iron deficiency 
anaemia at different age and sex: 
1. Females in reproductive period of life. The highest incidence of 
iron deficiency anaemia is in women during their reproductive period of life. 
It may be from one or more of the following causes: 
i) Blood loss. This is the most important cause of anaemia in women 
during child-bearing age group. Commonly, it is due to persistent and heavy 
menstrual blood loss such as occurs in various pathological states and due to 
insertion of ILJCDs. Young girls at the onset of menstruation may develop 
mild anaemia due to blood loss. Significant blood loss may occur as a result 
of repeated miscarriages. 
ii) Inadequate intake. Inadequate intake of iron is prevalent in women 




anorexia, impaired absorption and diminished bioavailability may act as con- 
tributory factors. 
iii) Increased requirements. During pregnancy and adolescence, the de- 
mand of body for iron is increased. During a normal pregnancy, about 750 mg of 
iron may be siphoned off from the mother - about 400 mg to the foetus, 150 mg to 
the placenta, and 200 mg is lost at parturition and lactation. If several pregnancies 
occur at short intervals, iron deficiency anaemia certainly follows. 
2. Post-menopausal females. Though the physiological demand for 
iron decreases after cessation of menstruation, iron deficiency anaemia may 
develop in post-menopausal women due to chronic blood loss. Among the 
important causes are: 
i) Post-menopausal uterine bleeding due to carcinoma of the uterus. 
ii) Bleeding from the alimentary tract such as due to carcinoma of 
stomach and large bowel and hiatus hernia. 
3. Adult males. It is uncommon for adult males to develop iron defi- 
ciency anaemia in the presence of normal dietary iron content and iron ab- 
sorption. The vast majority of cases of iron deficiency anaemia in adult males 
are due to chronic blood loss. The cause for chronic haemorrhage may lie at 
one of the following sites: 
i) Gastrointestinal tract is the usual source of bleeding which may be 
due to peptic ulcer, haemorrhoids, hookworm infestation, carcinoma of stom- 
ach and large bowel, oesophageal varices, hiatus hernia, chronic aspirin in- 
gestion and ulcerative colitis. Other causes in the GIT are malabsorption and 
following gastrointestinal surgery. 
ii) Urinary tract e.g. due to haematuria and haemoglobinuria. 
iii) Nose e.g. in repeated epistaxis. 
iv) Lungs e.g. in haemoptysis from various causes. 
4. Infants and children. Iron deficiency anaemia is fairly common 
during infancy and childhood with a peak incidence at 1-2 years of age. The 
principal cause for anaemia at this age is increased demand of iron which is 
not met by the inadequate intake of iron in the diet. The normal full-term in- 
fant has sufficient iron stores for the first 4-6 months of life, while premature 
infants have inadequate reserves because iron stores from the mother are 
mainly laid down during the last trimester of pregnancy. Therefore, unless 
the infant is given supplemental feeding of iron or iron-containing foods, iron 
deficiency anaemia develops. 
 
SIDEROBLASTIC ANAEMIA 
The sideroblastic anaemias comprise a group of disorders of diverse 
etiology in which the nucleated erythroid precursors in the bone marrow, 




TYPES OF SIDEROBLASTIC ANAEMIAS 
Based on etiology, sideroblastic anaemias are classified into hereditary 
and acquired types. The acquired type is further divided into primary and 
secondary forms. 
I. Hereditary sideroblastic anaemia. This is a rare X-linked disorder 
associated with defective enzyme activity of aminolevulinic acid (ALA) syn- 
thetase required for haem synthesis. The affected males have moderate to 
marked anaemia while the females are carriers of the disorder and do not de- 
velop anaemia. The condition manifests in childhood or in early adult life. 
II. Acquired sideroblastic anaemia. The acquired sideroblastic 
anaemias are classified into primary and secondary types. 
A. Primary acquired sideroblastic anaemia. Primary, idiopathic, or 
refractory acquired sideroblastic anaemia occurs spontaneously in middle- 
aged and older individuals of both sexes. The disorder has its pathogenesis in 
disturbed growth and maturation of erythroid precursors at the level of haem- 
atopoietic stem cell, possibly due to reduced activity of the enzyme, ALA 
synthetase. The anaemia is of moderate to severe degree and appears insidi- 
ously. The bone marrow cells commonly show chromosomal abnormalities, 
neutropenia and thrombocytopenia with associated bleeding diathesis. The 
spleen and liver may be either normal or mildly enlarged, while the lymph 
nodes are not enlarged. Unlike other types of sideroblastic anaemia, this type 
is regarded as a myelodysplastic disorder in the FAB (French-American- 
British) classification and thus, can be a preleukaemic disorder. About 10% 
of individuals with refractory acquired sideroblastic anaemia develop acute 
myelogenous leukaemia. 
B. Secondary acquired sideroblastic anaemia. Acquired 
sideroblastic anaemia may develop secondary to a variety of drugs, chemi- 
cals, toxins, haematological and various other diseases. 
1. Drugs, chemicals and toxins: Isoniazid, an antituberculous drug and 
a pyfidoxine antagonist, is most commonly associated with development of 
sideroblastic anaemia by producing abnormalities in pyridoxine metabolism. 
Other drugs occasionally causing acquired sideroblastic anaemia are: cyclo- 
serine, chloramphenicol and alkylating agents (e.g. cyclophosphamide). Al- 
cohol and lead also cause sideroblastic anaemia. All these agents cause re- 
versible sideroblastic anaemia which usually resolves following removal of 
the offending agent. 
2. Haematological disorders: These include myelofibrosis, polycythaemia 




3. Miscellaneous: Occasionally, secondary sideroblastic anaemia may oc- 
cur in association with a variety of inflammatory, neoplastic and autoimmune 
diseases such as carcinoma, myxoedema, rheumatoid arthritis and SLE. 
 
ANAEMIA OF CHRONIC DISORDERS 
One of the commonly encountered anaemia is in patients of a variety of 
chronic systemic diseases in which anaemia develops secondary to disease pro- 
cess but there is no actual invasion of the bone marrow. In general, the anaemia 
in chronic disorders is usually normocytic normochromic but can have mild de- 
gree of microcytosis and hypochromia unrelated to iron deficiency. The severity 
of anaemia is usually directly related to the primary disease process. The anae- 
mia is corrected only if the primary disease is alleviated. 
Pathogenesis. A number of factors may contribute to the development 
of anaemia in chronic systemic disorders, and in many conditions, the anae- 
mia is complicated by other causes such as iron, B12 and folate deficiency, 
hypersplenism, renal failure with consequent reduced erythropoietic activity, 
endocrine abnormalities etc. However, in general, 2 factors appear to play 
significant role in the pathogenesis of anaemia in chronic disorders. These 
are: defective red cell production and reduced red cell life-span. 
 
MEGALOBLASTIC ANAEMIA 
The megaloblastic anaemias are disorders caused by impaired DNA 
synthesis and are characterised by a distinctive abnormality in the haemato- 
poietic precursors in the bone marrow in which the maturation of the nucleus 
is delayed relative to that of the cytoplasm. Since cell division is slow but cy- 
toplasmic development progresses normally, the nucleated red cell precusors 
tend to be larger which Ehrlich in 1880 termed megaloblasts. Megaloblasts 
are both morphologically and functionally abnormal with the result that the 
mature red cells formed from them and released into the peripheral blood are 
also abnormal in shape and size, the most prominent abnormality being mac- 
rocytosis. 
The underlying defect for the asynchronous maturation of the nucleus 
is defective DNA synthesis due to deficiency of vitamin B12 (cobalamin) 
and/or folic acid (folate). Less common causes are interference with DNA 
synthesis by congenital or acquired abnormalities of vitamin B12 or folic acid 
metabolism. Before considering the megaloblastic anaemia, a brief account 
of vitamin B12 and folic acid metabolism is considered in order. 
 
VITAMIN B12 METABOLISM 
Biochemistry. Vitamin B12 or cobalamin is a complex organometallic compound 
having a cobalt atom situated within a corrin ring, similar to the structure of porphyrin 




min — methyl-cobalamin and adenosyl-cobalamin, which act as coenzymes. The thera- 
peutic vitamin B12 preparation is called cyanocobalamin. 
Sources. The only dietary sources of vitamin B12 are foods of animal protein 
origin such as kidney, liver, heart, muscle meats, fish, eggs, cheese and milk. In contrast to 
folate, vegetables contain practically no vitamin B12. Cooking has little effect on its activi- 
ty. Vitamin B12 is synthesized in the human large bowel by microorganisms but is not ab- 
sorbed from this site and, thus, the humans are entirely dependent upon dietary sources. 
The 'average daily requirement for vitamin B12 is 2-4 μg. 
Absorption. After ingestion, vitamin B12 in food is released and forms a stable com- 
plex with gastric R-binder. R-binder is a form of glycoprotein found in various secretions (e.g. 
saliva, milk, gastric juice, bile), phagocytes and plasma. On entering the duodenum, the vita- 
min B12-R-binder complex is digested releasing vitamin B12 which then binds to intrinsic fac- 
tor (IF). The IF is a glycoprotein of molecular weight 50,000 produced by the parietal cells of 
the stomach and its secretion roughly parallels that of hydrochloric acid. The vitamin B12-IF 
complex, on reaching the distal ileum, binds to the specific receptors on the mucosal brush bor- 
der, thereby enabling the vitamin to be absorbed. The IF, therefore, acts as cell-directed carrier 
protein similar to transferrin. The receptor-bound vitamin B12-IF complex is taken into the ileal 
mucosal cells where after several hours the IF is destroyed, vitamin B12 released and is trans- 
ferred to another transport protein, transcobalamin (TC) II. The vitamin B12-TC II complex is 
finally secreted into the portal circulation from where it is taken by the liver, bone marrow and 
other cells. There are 2 major vitamin B12 binding proteins — TC I and TC II, and a minor pro- 
tein TC III. TC I is not essential for vitamin B12 transport but functions primarily as a storage 
protein while TC III is similar to TC II and binds a small amount of vitamin B12. 
Tissue stores. Normally, the liver is the principal storage site of vitamin B12 and stores 
about 2 mg of the vitamin, while other tissues like kidney, heart and brain together store about 
2 mg. The body stores of vitamin B12 are adequate for 2-4 years. Major source of loss is via 
bile and shedding of intestinal epithelial cells. A major part of the excreted vitamin B12 is re- 
absorbed in the ileum by the IF resulting in enterohepatic circulation. 
Functions. Vitamin B12 plays an important role in general cell metabolism, particu- 
lary essential for normal haematopoiesis and for maintenance of integrity of the nervous sys- 
tem. Vitamin B12 acts as a co-enzyme for 2 main biochemical reactions in the body: 
• Firstly, as methyl cobalamin (methyl B12) in the methylation of homocysteine to me- 
thionine by methyl tetrahydrofolate (THF). The homocysteine-methionine reaction is closely 
linked to folate metabolism: when this reaction is impaired, folate metabolism is deranged and 
results in defective DNA synthesis responsible for megaloblastic maturation. 
• Secondly, as adenosyl cobalamin (adenosyl B12) in propionate metabolism for the 
conversion of methyl malonyl co-enzyme A to succinyl co-enzyme A: lack of adenosyl 
B12 leads to large increase in the level of methyl malonyl CoA and its precursor, propionyl 
CoA. This results in synthesis of certain fatty acids which are incorporated into the neu- 
ronal lipids. This biochemical abnormality may contribute to the neurologic complications 
of vitamin B12 deficiency. 
 
FOLATE METABOLISM 
Biochemistry. Folate or folic acid, a yellow compound, is a member of water- 
soluble B complex vitamins with the chemical name of pteroyi glutamic acid (PGA). Folic 
acid does not exist as such in nature but exists as folates in polyglutamate form (conjugat- 
ed folates). For its metabolic action as co-enzyme, poly-glutamates must be reduced to 
dihydro- and tetrahydrofolate forms. 
Sources. Folate exists in different plants, bacteria and animal tissues. Its main dietary 
sources are fresh green leafy vegetables, fruits, liver, kidney, and to a lesser extent, muscle 
meats, cereals and milk. Folate is labile and is largely destroyed by cooking and canning. 




body since its absorption takes place in the small intestine. Thus, humans are mainly depend- 
ent upon diet for its supply. The average daily requirement is 100-200 μg. 
Absorption and transport. Folate is normally absorbed from the duodenum and 
upper jejunum and to a lesser extent, from the lower jejunum and ileum. However, absorp- 
tion depends upon the form of folate in the diet. Polyglutamate form in the foodstuffs is 
first cleaved by the enzyme, folate conjugase, in the mucosal cells to mono- and digluta- 
mates which are readily assimilated. Synthetic folic acid preparations in poly-glutamate 
form are also absorbed as rapidly as mono-and diglutamate form because of the absence of 
natural inhibitors. Mono- and diglutamates undergo further reduction in the mucosal cells 
to form tetrahydrofolate (THF), a monoglutamate. THF circulates in the plasma as meth- 
ylated compound, methyl THF, bound to a protein. Once methyl THF is transported into 
the cell by a carrier protein, it is reconverted to polyglutamate. 
Tissue stores. The liver and red cells are the main storage sites of folate, largely as 
methyl THF polyglutamate form. The total body stores of folate are about 10-12 mg enough 
for about 4 months. Normally, folate is lost from the sweat, saliva, urine and faeces. 
Functions. Folate plays an essential role in cellular metabolism. It acts as a co- 
enzyme for 2 important biochemical reactions involving transfer of 1-carbon units (viz. 
methyl and formyl groups) to various other compounds. These reactions are as under: 
• Thymidylate synthetase reaction. Formation of deoxy thymidylate monophos- 
phate (dTMP) from its precursor form, deoxy uridylate monophosphate (dUMP). 
• Methylation of homocysteine to methionine. This reaction is linked to vitamin 
B12 metabolism. 
These biochemical reactions are considered in detail below together with biochem- 
ical basis of the megaloblastic anaemia. 
 
Biochemical Basis of Megaloblastic Anaemia. The basic biochemical 
abnormality common to both vitamin B12 and folate deficiency is a block in 
the DNA synthesis pathway and that there is an inter-relationship between 
vitamin B12 and folate metabolism in the methylation reaction of homocyste- 
ine to methionine. 
Deficiency of folate from any cause results in reduced supply of the coen- 
zyme, methylene-THF, and thus interferes with the synthesis of DNA. Deficiency 
of vitamin B12 traps folate as its transport form, methyl-THF, thereby resulting in 
reduced formation of the active form, methylene-THF, needed for DNA synthe- 
sis. This is referred to as methyl-folate trap hypothesis. An alternative hypothesis 
of inter-relationship of B12 and folate is the formate-saturation hypothesis. Ac- 
cording to this hypothesis, the active substrate is formyl-THF. Vitamin B12 defi- 
ciency results in reduced supply of formate to THF causing reduced generation of 
the active compound, formyl THF. 
Etiology and Classification of Megaloblastic Anaemia. The etiology 
of megaloblastic anaemia varies in different parts of the world. 
1. Vitamin B12 deficiency. In Western countries, the deficiency of vit- 
amin B12 is usually due to pernicious (Addisonian) anaemia. True vegetarians 
like in India and breast-fed infants have dietary lack of vitamin B12. Gastrec- 
tomy by lack of intrinsic factor, and small intestinal lesions involving distal 




vitamin. Deficiency of vitamin B12 takes at least 2 years to develop when the 
body stores are totally depleted. 
2. Folate deficiency. Folate deficiency is more often due to poor die- 
tary intake. Other causes include malabsorption, excess folate utilisation such 
as in pregnancy and in various disease states, alcoholism, and excess urinary 
folate loss. Folate deficiency arises more rapidly than vitamin B12 deficiency 
since the body's stores of folate are relatively low which can last for up to 4 
months only. 
Patients with tropical sprue are often deficient in both vitamin B12 and 
folate. Combined deficiency of vitamin B12 and folate may occur from severe 
deficiency of vitamin B12 because of the biochemical interrelationship with 
folate metabolism. 
3. Other causes. In addition to deficiency of vitamin B12 and folate, 
megaloblastic anaemias may occasionally be induced by other factors unre- 
lated to vitamin deficiency. These include many drugs which interfere with 
DNA synthesis, acquired defects of haematopoietic stem cells, and rarely, 
congenital enzyme deficiencies. 
Clinical Features. Deficiency of vitamin B]2 and folate may cause the 
following clinical manifestations which may be present singly or in combina- 
tion and in varying severity: 
1. Anaemia. Macrocytic megaloblastic anaemia is the cardinal feature 
of deficiency of vitamin B12 and/or folate. The onset of anaemia is usually 
insidious and gradually progressive. 
2. Glossitis. Typically, the patient has a smooth, beefy, red tongue. 
3. Neurologic manifestations. Vitamin B12 deficiency, particularly in 
patients of pernicious anaemia, is associated with significant neurological 
manifestations in the form of subacute combined, degeneration of the spinal 
cord and peripheral neuropathy, while folate deficiency may occasionally de- 
velop neuropathy only. The underlying pathologic process consists of demye- 
lination of the peripheral nerves, the spinal cord and the cerebrum. Signs and 
symptoms include numbness, paraesthesia, weakness, ataxia, poor finger co- 
ordination and diminished reflexes. 
4. Others. In addition to the cardinal features mentioned above, pa- 
tients may have various other symptoms. These include: mild jaundice, angu- 
lar stomatitis, purpura, melanin pigmentation, symptoms of malabsorption, 
weight loss and anorexia. 
Significant findings of marrow examination are as under: 
i) Marrow cellularity. The marrow is hypercefluiar with a decreased 
myeloid-erythroid ratio. 
ii) Erythropoiesis. The erythroid hyperplasia is due to characteristic 




erythroid precursors, having nuclear-cytoplasmic asynchrony i.e. the nuclei 
are less mature than the development of cytoplasm. The nuclei are large, hav- 
ing fine, reticular and open chromatin that stains lightly, while the haemoglo- 
binisation of the cytoplasm proceeds normally or at a faster rate i.e. nuclear 
maturation lags behind that of cytoplasm. Megaloblasts with abnormal mi- 
toses may be seen. 
Features of ineffective erythropoiesis such as presence of degenerated 
erythroid precursors may be present. 
iii) Other cells. Granulocyte precursors are also affected to some ex- 
tent. Giant forms of metamyelocytes and band cells may be present in the 
marrow. Megakaryocytes are usually present in normal number but may oc- 
casionally be decreased and show abnormal morphology such as hyperseg- 
mented nuclei and agranular cytoplasm. 
iv) Marrow iron. Prussian blue staining for iron in the marrow shows an 
increase in the number and size of iron granules in the erythroid precursors. Ring 
sideroblasts are, however, rare. Iron in the reticulum cells is increased. 
PERNICIOUS ANAEMIA 
(PA) was first described by Addison in 1855 as a chronic disorder of 
middle-aged and elderly individual of either sex in which intrinsic factor 
secretion ceases owing to atrophy of the gastric mucosa. The condition is, 
therefore, also termed Addisonian megaloblastic anaemia. The average age 
at presentation is 60 years but rarely it can be seen in children under 10 
years of age (juvenile pernicious anaemia). 
Pathogenesis. There is evidence to suggest that the atrophy of gastric 
mucosa in PA is caused by an against gastric parietal cells. The immunologi- 
cal abnormalities in pernicious anaemia are as under: 
1. The incidence of PA is high in patients with other autoimmune dis- 
eases such as Graves' disease, myxoedema, thyroiditis, vitiligo, diabetes and 
idiopathic adrenocortical insufficiency. 
2. Patients with PA have abnormal circulating auto-antibodies such as 
anti-parietal cell antibody (90% cases) and anti-intrinsic factor  antibody 
(50% cases). 
3. Relatives of patients with PA have an increased incidence of the dis- 
ease or increased presence of auto-antibodies. 
4. Corticosteroids have been reported to be beneficial in curing the dis- 
ease both pathologically and clinically. 
5. PA is more common in patients with agarrtrnaglo-bulinaemia sup- 
porting the role of cellular immune system in destruction of parietal cells. 
Pathologic changes. The most characteristic pathologic finding in PA 




ach and sparing the antrum. Gastric epithelium may show cellular atypia. 
About 2-3% cases of PA develop carcinoma of the stomach. Other pathologic 
changes are secondary to vitamin B12 deficiency and include megaloblastoid 
alterations in the gastric and intestinal epithelium and neurologic abnormalities 
such as peripheral neuropathy and spinal cord damage. 
Clinical Features. The disease has insidious onset and progresses slowly. 
The clinical manifestations are mainly due to vitamin B12 deficiency. These in- 
clude anaemia, glossitis, neurological abnormalities (neuropathy, subacute com- 
bined degeneration of the spinal cord, retrobulbar neuritis), gastrointestinal mani- 
festations (diarrhoea, anorexia, weight loss, dyspepsia), hepatosplenomegaly, 
congestive heart failure and haemorrhagic manifestations. 
 
 
HAEMOLYTIC ANAEMIAS GENERAL ASPECTS 
Definition and Classification. Haemolytic anaemias are defined as 
anaemias resulting from an increase in the rate of red cell destruction. 
The premature destruction of red cells in haemolytic anaemia may oc- 
cur by 2 mechanisms: 
• First, the red cells undergo lysis in the circulation and release their 
contents into plasma (intravascular haemolysis). In these cases the plasma 
haemoglobin rises substantially and part of it may be excreted in the urine 
(haemoglobinuria). 
• Second, the red cells are taken up by cells of the RE system where 
they are destroyed and digested (extra-vascular haemolysis). In extravascular 
haemolysis, plasma haemoglobin level is, therefore, barely raised. 
Extravascular haemolysis is more common than the former. One or more 
factors may be involved in the pathogenesis of various haemolytic anaemias. 
Haemolytic anaemias are broadly classified into 2 main categories: 
I. Acquired haemolytic anaemias caused by a variety of extrinsic envi- 
ronmental factors (extra-corpuscular). 
II. Hereditary haemolytic anaemias are usually the result of intrinsic 
red cell defects (intra-corpuscular). 
Features of Haemolysis. A number of clinical and laboratory features 
are shared by various types of haemolytic anaemias. 
General clinical features. Some of the general clinical features com- 
mon to most congenital and acquired haemolytic anaemias are as under: 
1. Presence of pallor of mucous membranes. 
2. Positive family history with life-long anaemia in patients with con- 
genital haemolytic anaemia. 




4. Urine turns dark on standing due to excess of urobilinogen in urine. 
5. Splenomegaly is found in most chronic haemolytic anaemias, both 
congenital and acquired. 
6. Pigment gallstones are found in some cases. 
 
ACQUIRED (EXTRACORPUSCULAR) HAEMOLYTIC ANAEMIAS 
These anaemias are caused by a variety of extrinsic factors, namely: 
antibody (immunohaemolytic anaemia), mechanical factors (microangio- 
pathic haemolytic anaemia), direct toxic effect (in malaria, clostridial infec- 
tion etc), splenomegaly, and certain acquired membrane abnormalities (par- 
oxysmal nocturnal haemoglobinuria). These are discussed below: 
A. IMMUNOHAEMOLYTIC ANAEMIAS 
Immunohaemolytic anaemias are a group of anaemias occurring due to 
antibody production by the body against its own red cells. Immune haemolysis in 
these cases may be induced by one of the following three types of antibodies: 
1. Autoimmune haemolytic anaemia (AIHA) characterised by for- 
mation of autoantibodies against patient's own red cells. Depending upon the 
reactivity of autoantibody, AIHA is further divided into 2 types: 
i) 'Warm' antibody AIHA in which the autoantibodies are reactive at 
body temperature (37°C). 
ii) 'Cold' antibody AIHA in which the autoantibodies react better with 
patient's own red cells at 4°C. 
2. Drug-induced immunohaemolytic anaemia. 
3. Isoimmune haemolytic anaemia in which the antibodies are acquired 
by blood transfusions, pregnancies and haemolytic disease of the newborn. 
An important diagnostic tool in all cases of immunohaemolytic anae- 
mias is Coombs' antiglobulin test for detection of incomplete Rh-antibodies 
in saline directly (direct Coombs') or after addition of albumin (indirect 
Coombs'). 
B. MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 
Microangiopathic haemolytic anaemia is caused by mechanical trauma 
to the red cells in circulation. This type of haemolysis is characterised by red 
cell fragmentation (schistocytosis). There are 3 different ways by which mi- 
croangiopathic haemolytic anaemia results: 
1. External impact. Direct external trauma to red blood cells when they 
pass through microcirculation, especially over the bony prominences, may 
cause haemolysis during various activities e.g. in prolonged marchers, jog- 
gers, karate players etc. These patients develop haemoglobinaemia, haemo- 
globinuria (march haemoglobinuria), and sometimes myoglobinuria as a re- 




2. Cardiac haemolysis. A small proportion of patients who received 
prosthetic cardiac valves or artificial grafts develop haemolysis. This has 
been attributed to direct mechanical trauma to the red cells or shear stress 
from turbulent blood flow. 
3. Fibrin deposit in microvasculature. Deposition of fibrin in the mi- 
crovasculature exposes the red cells to physical obstruction and eventual 
fragmentation of red cells and trapping of the platelets. Fibrin deposits in the 
small vessels may occur in the following conditions: 
i) Abnormalities of the vessel wall e.g. in hypertension, eclampsia, dis- 
seminated cancers, transplant rejection, haemangioma etc. 
ii) Thrombotic thrombocytopenic purpura. 
iii) Haemolytic-uraemic syndrome, 
iv) Disseminated intravascular coagulation (DIC). 
v) Vasculitis in collagen diseases. 
C. HAEMOLYTIC ANAEMIA FROM DIRECT TOXIC EFFECTS 
Haemolysis  may  result  from  direct  toxic  effects  of  certain  agents. 
These include the following examples: 
1. Malaria by direct parasitisation of red cells (black-water fever). 
2. Bartonellosis by direct infection of red cells by the microorganisms. 
3. Septicaemia with Clostridium welchii by damaging the red cells. 
4. Other  microorganisms  such  as  pneumococci,  staphylococci  and 
Escherichia coli. 
5. Copper by direct haemolytic effect on red cells in Wilson's disease 
and patients on haemodialysis. 
6. Lead poisoning shows basophilic stippling of red blood cells. 
7. Snake and spider bites cause haemolysis by their venoms. 
8. Extensive burns. 
D. HAEMOLYTIC ANAEMIA IN SPLENOMEGALY 
Haemolytic anaemia is common in splenic enlargement from any cause. 
Normally, the spleen acts as a filter and traps the damaged red blood cells, de- 
stroys them and the splenic macrophages phagocytose the damaged red cells. A 
normal spleen poses no risk to normal red blood cells. But splenomegaly exag- 
gerates the damaging effect to which the red cells are exposed. Besides haemo- 
lytic anaemia, splenomegaly is usually associated with pancytopenia. Splenec- 
tomy or reduction in size of spleen by appropriate therapy relieves the anaemia 
as well as improves the leucocyte and platelet counts. 
E. PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH) 
PNH is a rare acquired disorder of red cell membrane in which there is 
chronic intravascular haemolysis due to undue sensitivity of red blood cells 




defect affects all the cells of myeloid progenitor lineage (RBCs, WBCs, 
platelets) suggesting a defect at the level of stem cell. The disorder generally 
presents in adult life. 
Clinical and laboratory findings. Clinical and laboratory findings are 
as under: 
i) Haemolytic anaemia. 
ii) Pancytopenia (mild granulocytopenia and thrombocytopenia fre- 
quent). 
iii) Intermittent clinical haemoglobinuria; acute haemolytic episodes 
occur at night identified by passage of brown urine in the morning. 
iv) Haemosiderinuria very common. 
v) Venous thrombosis common complication. 
The presence of inordinate sensitivity of red blood cells, leucocytes 
and platelets to complement in PNH can be demonstrated in vitro by Ham's 
test using red cell lysis at acidic pH or by sucrose haemolysis test. 
About 20% cases of PNH may develop myeloproliferative or myelo- 
dysplastic disorder and some even develop acute myeloid leukaemia. 
 
 
II. HEREDITARY (INTRACORPUSCULAR) HAEMOLYTIC ANAEMIA 
Hereditary haemolytic anaemias are usually the result of intracorpuscu- 
lar defects. Accordingly, they are broadly classified into 2 groups: 
• Those due to hereditary abnormalities of red cell membrane; and 
• Second are those with hereditay disorders of the interior of the red cells. 
A. HEREDITARY ABNORMALITIES OF RED CELL MEMBRANE 
There are 2 important types of inherited red cell membrane defects: he- 
reditary spherocytosis and hereditary elliptocytosis (hereditary ovalocytosis). 
Hereditary Spherocytosis is a common type of hereditary haemolytic 
anaemia of autosomal dominant inheritance in which the red cell membrane 
is abnormal. 
Pathogenesis. The molecular abnormality in hereditary spherocytosis 
is a deficiency in the structural protein of the red cell membrane, spectrin. 
Deficiency of spectrin correlates with the severity of anaemia. This abnor- 
mality results in spheroidal contour and smaller size of red blood cells. These 
microspherocytes are not flexible, unlike normal biconcave red cells. These 
rigid red cells are unable to pass through the spleen and in the process lose 
their surface membrane further. This produces a subpopulation of hy- 
perspheroidal red cells in the peripheral blood which are subsequently de- 




Clinical features. The disorder may be clinically apparent at any age 
from infancy to old age and has equal sex incidence. The family history may 
be present. The major clinical features are as under: 
1. Anaemia is usually mild to moderate. 
2. Splenomegaly is a constant feature. 
3. Jaundice occurs due to increased concentration of unconjugated (indi- 
rect) bilirubin in the plasma (also termed congenital haemolytic jaundice). 
4. Pigment gallstones are frequent due to increased bile pigment pro- 
duction. Splenectomy offers the only reliable mode of treatment. 
Hereditary Elliptocytosis (Hereditary Ovalocytosis) 
Hereditary elliptocytosis or hereditary ovalocytosis is another autoso- 
mal dominant disorder involving red cell membrane protein spectrin. The 
disorder is similar in all respects to hereditary spherocytosis except that the 
blood film shows oval or elliptical red cells and is clinically a milder disorder 
than hereditary spherocytosis. 
Acquired cases of elliptocytosis include iron deficiency and myelopro- 
liferative disorders. 
B. HEREDITARY DISORDERS OF RED CELL INTERIOR 
Inherited disorders involving the interior of the red blood cells are 
classified into 2 groups: 
1. Red cell enzyme defects: These cause defective red cell metabolism 
involving 2 pathways: 
i) Defects in the hexose monophosphate shunt: Common example is 
glucose-6-phosphate dehydrogenase. (G6PD) deficiency. 
ii) Defects in the Embden-Meyerhof (glycolytic) pathway: Example is 
pyruvate kinase (PK) deficiency. 
2. Disorders of haemoglobin: These are divided into 2 subgroups: 
i) Abnormal haemoglobins (haemoglobinopathies): Examples are sick- 
le syndromes and other haemoglobinopathies. 
ii) Reduced globin chain synthesis: Common examples are various 
types of thalassaemias. 
These disorders are discussed below. 
RED CELL ENZYME DEFECTS G6PD DEFICIENCY 
Among the defects in hexose monophosphate shunt, the most common is 
G6PD deficiency. It affects millions of people throughout the world. The G6PD 
gene is located on the X chromosome and its deficiency is, therefore, a sex (X)- 
linked trait affecting males, while the females are carriers and are asymptomatic. 




ignated as type B but blacks have normally A+ (positive) type G6PD variant. The 
most common and significant clinical variant is A-(negative) type found in black 
males. Like the HbS gene, the A-type G6PD variant confers protection against 
malaria. Individuals with A-G6PD variant have shortened red cell life-span but 
without anaemia. However, these individuals develop haemolytic episodes on ex- 
posure to oxidant stress such as viral and bacterial infections, certain drugs (anti- 
malarials, sulfonamides, nitrofurantoin, aspirin, vitamin K), metabolic acidosis 
and on ingestion of fava beans (favism). 
Pathogenesis. Normally, the red blood cells are well protected against 
oxidant stress because of adequate generation of reduced glutathione via the 
hexose monophosphate shunt. Individuals with inherited deficiency of G6PD, 
an enzyme required for hexose monophosphate shunt for glucose metabo- 
lism, fail to develop adequate levels of reduced glutathione in their red cells. 
This results in oxidation and precipitation of haemoglobin within the red cells 
forming Heinz bodies. Besides G6PD deficiency, deficiency of various other 
enzymes involved in the hexose monophosphate shunt may also infrequently 
cause clinical problems. 
Clinical features. The clinical manifestations are those of an acute 
haemolytic anaemia within hours of exposure to oxidant stress. The haemoly- 
sis is, however, self-limiting even if the exposure to the oxidant is continued 
since it affects the older red cells only. Haemoglobin level may return to 
normal when the older population of red cells has been destroyed and only 
younger cells remain. Some patients may have only darkening of the urine 
from haemoglobinuria but more severely affected ones develop constitutional 
symptoms including jaundice. Treatment is directed towards the prevention 
of haemolytic episodes such as stoppage of offending drug. Blood transfu- 
sions are rarely indicated. 
The diagnosis of G6PD enzyme deficiency is made by one of the screen- 
ing tests (e.g. methaemoglobin reduction test, fluorescent screening test, ascor- 
bate cyanide screening test) or by direct enzyme assay on red cells. 
PYRUVATE KINASE DEFICIENCY 
Pyruvate kinase (PK) deficiency is the only significant enzymopathy of 
the Embden-Meyerhof glycolytic pathway. The disorder is inherited as an au- 
tosomal recessive pattern. Heterozygote state is entirely asymptomatic, while 
the homozygous individual presents during early childhood with anaemia, 
jaundice and splenomegaly. 
DISORDERS OF HAEMOGLOBIN 
These geographic disorders are described below under 2 main head- 





Abnormal haemoglobins (haemoglobinopathies) 
Sickle syndromes 
The most important and widely prevalent type of haemoglobinopathy 
is due to the presence of sickle haemoglobin (HbS) in the red blood cells. The 
red cells with HbS develop 'sickling' when they are exposed to low oxygen 
tension. Sickle syndromes have the highest frequency in black race and in 
Central Africa where falciparum malaria is endemic. Patients with HbS are 
relatively protected against falciparum malaria. Sickle syndromes occur in 3 
different forms: 
1. As heterozygous state for HbS: sickle cell trait (AS). 
2. As homozygous state for HbS: sickle cell anaemia (SS). 
3. As double heterozygous states e.g. sickle β-thalassaemia, sickle-C 
disease (SC), sickle-D disease (SD). 
Heterozygous State: Sickle Cell Trait 
Sickle cell trait is a benign heterozygous state of HbS in which only 
one abnormal gene is inherited. Patients with AS develop no significant clini- 
cal problems except when they become severely hypoxic and may develop 
sickle cell crises. 
Homozygous State: Sickle Cell Anaemia 
Sickle cell anaemia (SS) is a homozygous state of HbS in the red cells 
in which an abnormal gene is inherited from each parent. SS is a severely 
malignant disorder associated with protean clinical manifestations and de- 
creased life expectancy. 
Pathogenesis. The basic molecular lesion in HbS is the substitution of 
valine for glutamic acid at the 6 residue position of the (5-globin, producing 
Hb a2βs  . 
The red cells in patients of SS have predominance of HbS and a small 
part consists of non-HbS haemoglobins, chiefly HbF (2-20% of the total hae- 
moglobin). During deoxygenation, the red cells containing HbS change from 
biconcave disc shape to an elongated crescent-shaped or sickle-shaped cell. This 
process termed sickling occurs both within the intact red cells and in vitro in 
free solution. The mechanism responsible for sickling upon deoxygenation of 
HbS-containing red cells is the polymerisation of deoxygenated HbS which ag- 
gregates to form elongated rod-like polymers. These elongated fibres align and 
distort the red cell into classic sickle shape. 
Clinical features. The clinical manifestations of homozygous sickle cell 
disease are widespread. The symptoms begin to appear after 6th month of life 
when most of the HbF is replaced by FIbS. Infection and folic acid deficiency 




1. Anaemia. There is usually severe haemolytic anaemia (primarily ex- 
travascular) with onset of aplastic crisis in between. The symptoms of anae- 
mia are generally mild since HbS gives up oxygen more readily than HbA to 
the tissues. 
2. Vaso-occlusive phenomena. Patients of SS develop recurrent vaso- 
occlusive episodes throughout their lives due to obstruction to capillary - 
blood flow by sickled red cells upon deoxygenation or dehydration. Vaso- 
obstruction affecting different organs and tissues results in infarcts which 
may be of 2 types: 
i) Microinfarcts affecting particularly the abdomen, chest, back and 
joints and are the cause of recurrent painful crises in SS. 
ii) Macroinfarcts involving most commonly the spleen, bones, lungs, 
kidneys, liver and skin, and result in anatomic and functional damage to these 
organs. 
3. Constitutional symptoms. In addition to the features of anaemia and 
infarction, patients with SS have impaired growth and development and in- 
creased susceptibility to infection due to markedly impaired splenic function. 
Double Heterozygous States 
Double heterozygous conditions involving combination of HbS with oth- 
er haemoglobinopathies may occur. Most common among these are sickle-β- 
thalassaemia, sickle C disease (SC), and sickle D disease (SD). All these disor- 
ders behave like mild form of sickle cell disease. Their diagnosis is made by 
haemoglobin electrophoresis and separating the different haemoglobins. 
OTHER HAEMOGLOBINOPATHIES 
Besides sickle haemoglobin, about 400 structurally different abnormal 
human haemoglobins have been discovered in different parts of the world. 
Some of them are associated with clinical manifestations, while others are of 
no consequence. 
HbC Haemoglobinopathy is prevalent in West Africa and in Ameri- 
can blacks. The molecular lesion in HbC is substitution of lysine for glutamic 
acid at β-6 globin chain position. The disorder of HbC may occur as benign 
homozygous HbC disease, or as asymptomatic heterozygous HbC trait, or as 
double heterozygous combinations such as sickle-HbC disease and HbC-β 
thalassaemia. 
HbD Haemoglobinopathy occurs in North-West India, Pakistan and 
Iran. About 3% of Sikhs living in Punjab are affected with HbD haemoglobi- 
nopathy (called HbD Punjab, also known as Hb-Los Angeles). HbD Punjab 





HbE Haemoglobinopathy is predominantly found in South-East Asia, 
India, Burma and Sri Lanka. HbE arises from the substitution of lysine for 
glutamic acid at β-26 globin chain position. Like other abnormal haemoglo- 
bins, HbE haemoglobinopathy may also occur as asymptomatic heterozygous 
HbE trait, compensated haemolytic homozygous HbE disease, or as double 
heterozygous states in combination with other haemoglobinopathies such as 
HbE-β thalassaemia and HbE-cx thalassaemia. 
Haemoglobin O-Arab Disease was first identified in an Arab family 
but has now been detected in American blacks too. The homozygous form of 
the disease appears as mild haemolytic anaemia with splenomegaly. 
Unstable-Hb Haemoglobinopathy. The unstable haemoglobins are 
those haemoglobin variants which undergo denaturation and precipitation 
within the red cells as Heinz bodies. These give rise to what is known as con- 
genital non-spherocytic haemolytic anaemia or congenital Heinz body haemo- 
lytic anaemia. These disorders have either autosomal dominant inheritance or 
develop from spontaneous mutations. The unstable haemoglobins arise from ei- 
ther a single amino acid substitution in the globin chain or due to deletion of one 
or more amino acids within the β-globin chain so that the firm bonding of the 
haem group within the molecule is disturbed leading to formation of methaemo- 
globin and precipitation of globin chains as Heinz bodies. 
Over 100 unstable haemoglobins have been described. They are named 
according to the place where they are encountered. For instance: Hb-Koln, 
Hb-Hammersmith, Hb-Zurich, Hb-Sydney, and so on. The diagnosis of un- 
stable Hb disease is made by test for Heinz bodies and by haemoglobin elec- 
trophoresis. 
THALASSAEMIA 
The thalassaemias are a diverse group of hereditary disorders in which 
there is reduced rate of synthesis of one or more of the globin polypeptide 
chains. Thus, thalassaemias, unlike haemoglobinopathies which are quantita- 
tive disorders of haemoglobin, are quantitative abnormalities of polypeptide 
globin chain synthesis. Thalassaemias were first described in people of Medi- 
terranean countries (North Africa, Southern Europe) from where it derives its 
name 'Mediterranean anaemia.' The Word 'thalassa' in Greek means 'the sea' 
since the condition was found commonly in regions around the Mediterrane- 
an basin. It also occurs in the Middle East, India, South-East Asia and, in 
general in blacks. 
Thalassaemias are genetically transmitted disorders. Normally, an in- 
dividual inherits two β-globin genes located one each on two chromosomes 
11, and two a-globin genes one each on two chromosomes 16, from each par- 




the genetic defect or deletion lies in transmission of α- or β-globin chain 
genes, thalassaemias are classified into α- and β- thalassaemias. Thus, pa- 
tients with α-thalassaemia have structurally normal α-globin chains but their 
production is impaired. Similarly, in β-thalassaemia, β-globin chains are 
structurally normal but their production is decreased. Each of the two main 
types of thalassaemias may occur as heterozygous (called α- and β- 
thalassaemia minor or trait), or as homogygous state (termed α- and β-thalas- 
saemia major). The former is generally asymptomatic, while the latter is a se- 
vere congenital haemolytic anaemia. 
Pathophysiology of anaemia in thalassaemia 
A constant feature of all forms of thalassaemia is the presence of 
anaemia. 
α-Thalassaemia: In a-thalassaemia major, the obvious cause of anae- 
mia is the inability to synthesise adult haemoglobin, while in a-thalassaemia 
trait there is reduced production of normal adult haemoglobin. Accordingly, 
a-thalassaemias are classified into 4 types: 
1. Four α-gene deletion: Hb Bart's hydrops foetalis. 
2. Three α-gene deletion: HbH disease. 
3. Two α-gene deletion: α-thalassaemia trait. 
4. One α-gene deletion: α-thalassaemia trait (carrier). 
β-Thalassaemia: In β-thalassaemia major, the most important cause of 
anaemia is premature red cell destruction brought about by erythrocyte mem- 
brane damage caused by the precipitated α-globin chains. Other contributory 
factors are: shortened red cell life-span, ineffective erythropoiesis, and hae- 
modilution due to increased plasma volume. A deficiency of β-globin chains 
in P-thalassaemia leads to large excess of α-chains within the developing red 
cells. Part of these excessive α-chains are removed by pairing with γ-globin 
chains as HbF, while the remainder unaccompanied α-chains precipitate rap- 
idly within the red cell as Heinz bodies. The precipitated α-chains cause cell 
membrane damage. During their passage through the splenic sinusoids, these 
red cells are further damaged and develop pitting due to removal of the pre- 
cipitated aggregates. Thus, such red cells are irreparably damaged and are 
phagocytosed by the RE cells of the spleen and liver causing anaemia, hepato- 
splenomegaly, and excess of tissue iron stores. Patients with β-thalassaemia mi- 
nor, on the other hand, have very mild ineffective erythropoiesis, haemolysis 
and shortening of red cell life-span. 
Depending upon the extent of reduction in β-chain synthesis, there are 
3 types of β-thalassaemia: 
1. Homozygous form: β-Thalassaemia major. It is the most severe 




i) β° thalassaemia major characterised by complete absence of β-chain 
synthesis. 
ii) β+  thalassaemia major having incomplete suppression of β-chain 
synthesis. 
2. β-Thalassaemia intermedia: It is β-thalassaemia of intermediate de- 
gree of severity that does not require regular blood transfusions. These cases 
are genetically heterozygous (β°/β or β+/β). 
3. Heterozygous form: β-Thalassaemia minor (trait). 
 
APLASTIC ANAEMIA AND OTHER PRIMARY BONE MARROW 
DISORDERS 
'Bone marrow failure' is the term used for primary disorders of the 
bone marrow which result in impaired formation of the erythropoietic precur- 
sors and consequent anaemia. It includes the following disorders: 
1. Aplastic anaemia, most importantly. 
2. Other primary bone marrow disroders such as: myelophthisic anae- 
mia, pure red cell aplasia, and myelodysplastic syndromes. 
APLASTIC ANAEMIA 
Aplastic anaemia is defined as pancytopenia (i.e. simultaneous pres- 
ence of anaemia, leucopenia and thrombocytopenia) resulting from aplasia of 
the bone marrow. The underlying defect in all cases appears to be sufficient 
reduction in the number of haematopoietic pluripotent stem cells  which 
makes them unable to divide and differentiate. 
Etiology and classification. Based on the etiology, aplastic anaemia is 
classified into 2 main types: primary and secondary. 
A. Primary aplastic anaemia. Primary type of aplastic anaemia in- 
cludes 2 entities: a congenital form called Fanconi's anaemia and an immuno- 
logically-mediated acquired form. 
1. Fanconi's anaemia. This has an autosomal recessive inheritance and 
is often associated with other congenital anomalies such as skeletal and renal 
abnormalities, and sometimes mental retardation. 
2. Immune causes. In many cases, suppression of haematopoietic stem 
cells by immunologic mechanisms may cause aplastic anaemia. The observa- 
tions in support of autoimmune mechanisms are the clinical response to immu- 
nosupppressive therapy and in vitro marrow culture experiments. 
B. Secondary aplastic anaemia. Aplastic anaemia may occur secondary 
to a variety of industrial, physical, chemical, iatrogenic and infectious causes. 
1. Drugs. A number of drugs are cytotoxic to the marrow and cause 
aplastic anaemia. The association of a drug with aplastic anaemia may be ei- 




• Dose-related aplasia of the bone marrow occurs with antimetabolites 
(e.g. methotrexate), mitotic inhibitors (e.g. daunorubicin), alkylating agents 
(e.g. busulfan), nitrosourea and anthracyclines. In such cases, withdrawal of 
the drug usually allows recovery of the marrow elements. 
• Idiosyncratic aplasia is depression of the bone marrow due to quali- 
tatively abnormal reaction of an individual to a drug when first administered. 
The most serious and most common example of idiosyncratic aplasia is asso- 
ciated with chloramphenicol. Other such common drugs are: sulfa drugs, ox- 
yphenbutazone, phenylbutazone, chlorpromazine, gold salts etc. 
2. Toxic chemicals. These include examples of industrial, domestic and 
accidental use of substances such as benzene derivatives, insecticides, arseni- 
cals etc. 
3. Infections. Aplastic anaemia may occur following viral hepatitis, 
Epstein-Barr virus infection, AIDS and other viral illnesses. 
4. Miscellaneous. Lastly, aplastic anaemia has been reported in associa- 
tion with certain other illnesses such as SLE, and with therapeutic X-rays. 
Clinical features. The onset of aplastic anaemia may occur at any age 
and is usually insidious. The clinical manifestations include the following: 
1. Anaemia and its symptoms like mild progressive weakness and fa- 
tigue.  
2. Haemorrhage from various sites due to thrombocytopenia such as 
from the skin, nose, gums, vagina, bowel, and occasionally in the CNS and 
retina. 
3. Infections of the mouth and throat are commonly present. 
4. The lymph nodes, liver and spleen are generally not enlarged. 
MYELOPHTHISIC ANAEMIA 
Development of severe anaemia may result from infiltration of the 
marrow termed as myelophthisic anaemia. The causes for marrow infiltra- 
tions include: 
• Haematologic malignancies (e.g. leukaemia, lymphoma, myeloma), 
• Metastatic deposits from non-haematologic malignancies (e.g. cancer 
breast, stomach, prostate, lung, thyroid), 
• Advanced tuberculosis, 
• Primary lipid storage diseases (Gaucher's and Niemann-Pick's disease). 
• Osteopetrosis and myelofibrosis may rarely cause myelophthisis. 
The type of anaemia in myelophthisis is generally normocytic normo- 
chromic with some fragmented red cells, basophilic stippling and normo- 
blasts in the peripheral blood. Thrombocytopenia is usually present but the 
leucocyte count is increased with slight shift-to-left of myeloid cells i.e. a 




and normoblasts is seen in the peripheral blood. Treatment consists of revers- 
ing the underlying pathologic process. 
PURE RED CELL APLASIA 
This is a rare syndrome involving a selective failure in the production 
of erythroid elements in the bone marrow but with normal granulopoiesis and 
megakaryocytopoiesis. Patients have normocytic normochromic anaemia 
with normal granulocyte and platelet count. Reticulocytes are markedly de- 
creased or are absent. 
Pure red cell aplasia exists in two forms: congenital and acquired. 
• Congenital red cell aplasia (Blackfan-Diamond syndrome) is a rare 
chronic disorder of unknown etiology. The disorder is corrected by glucocor- 
ticoids and marrow transplantation. 
• Acquired red cell aplasia is seen in middle-aged adults in association 
with some other diseases, most commonly thymoma; others are SLE, lym- 
phoma, T-cell chronic lymphocytic leukaemia or even without any precipitat- 
ing factor. The condition probably results from selective cytotoxicity of mar- 









Atherosclerosis is a specific form of arteriosclerosis affecting primarily 
the intima of large and medium-sized muscular arteries and is characterised 
by fibrofatty plaques or atheromas. The term atherosclerosis is derived from 
athero–(meaning porridge) referring to the soft lipid-rich material in the cen- 
tre of atheroma, and sclerosis (scarring) referring to connective tissue in the 
plaques. Atherosclerosis is the commonest and the most important of the arte- 
rial diseases. Though any large and medium-sized artery may be involved in 
atherosclerosis, the most commonly affected are the aorta, the coronary and 
the cerebral arterial systems. Therefore, the major clinical syndromes result- 
ing from ischaemia due to atherosclerosis are the myocardial infarcts (heart 
attacks) and the cerebral infarcts (strokes); other less common sequelae are 
peripheral vascular disease, aneurysmal dilatation due to weakened arterial 
wall, chronic ischaemic heart disease, ischaemic encephalopathy and mesen- 
teric occlusion. 
Etiology. Atherosclerosis is widely prevalent in industrialised coun- 
tries. However, majority of the incidences quoted in the literature are based 
on the major clinical syndromes produced by it, the most important interpre- 
tation being that death from myocardial infarction is related to underlying 
atherosclerosis. Cardiovascular disease, mostly related to atherosclerotic cor- 
onary heart disease or ischaemic heart disease (IHD) is the most common 
cause of death in the developed countries of the world. 
These risk factors are divided into three groups: 
I. Major constitutional risk factors: age, sex, genetic factors. 
II. Major acquired risk factors: hyperlipidaemia, hypertension, diabetes 
mellitus, smoking. 
III. Minor risk factors. 
I. Major constitutional risk factors 
Age, sex and genetic influences do affect the appearance of lesions of 
atherosclerosis. 
1. Age. Atherosclerosis is an age-related disease. Though early lesions 
of atherosclerosis may be present in childhood, clinically significant lesions 
are found with increasing age. Fully-developed atheromatous plaques usually 
appear in the 4th decade and beyond. Evidence in support comes from the 
high death rate from IHD in this age group. 
2. Sex. The incidence and severity of atherosclerosis are more in men 
than in women. The prevalence of atherosclerotic IHD is about three times 




clines with age but remains higher at all ages in men. The lower incidence of 
IHD in women, especially in premenopausal age, is probably due to high lev- 
els of oestrogen and high-density lipoproteins, both of which have anti- 
atherogenic influence. 
3. Genetic factors. Genetic factors play a significant role in atherogene- 
sis. Hereditary genetic derangements of lipoprotein metabolism predispose the 
individual to high blood lipid level and familial hypercholesterolaemia. 
4. Familial and racial factors: The familial predisposition to athero- 
sclerosis may be related to other risk factors like diabetes, hypertension and 
hyper-lipoproteinaemia. Racial differences too exist; Blacks have generally 
less severe atherosclerosis than Whites. 
II. Major acquired risk factors 
There are four major acquired risk factors in atherogenesis – hyperlipi- 
daemia, hypertension, cigarette smoking and diabetes mellitus. 
1. Hyperlipidaemia. Virchow in 19th century first identified choles- 
terol crystals in the atherosclerotic lesions. Since then, extensive information 
on lipoproteins and their role in atherosclerotic lesions has been gathered. It 
is now well established that hypercholesterolaemia has directly proportionate 
relationship with atherosclerosis and IHD. 
The main lipids in blood are cholesterol (normal 140-240 mg/dl) and 
triglycerides (below 160 mg/dl). An elevation of serum cholesterol levels 
above 260 mg/ dl in men and women between 30 and 50 years of age has 
three times higher risk of developing IHD as compared with people with se- 
rum cholesterol levels within normal limits. The concentration of cholesterol 
in the serum reflects the concentrations of different lipoproteins in the serum. 
The lipoproteins are divided into classes according to the density of solvent 
in which they remain suspended on centrifugation at high speed. The major 
classes of lipoprotein particles are chylomicrons, very-low density lipopro- 
teins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins 
(HDL). Each of these lipid particles contain lipid core and associated pro- 
teins, apolipoproteins, which are designated by a letter and/or a number. The 
major fractions of lipoproteins and their varying effects on atherosclerosis 
and IHD are as under: 
• Low-density lipoprotein (LDL) is richest in cholesterol and has the 
maximum association with atherosclerosis. 
• Very-low-density lipoprotein (VLDL) carries much of the triglycer- 
ides and has less marked effect than LDL. 
• High-density lipoprotein (HDL) is protective against atherosclerosis. 
Many studies have demonstrated the harmful effect of diet containing 
larger quantities of saturated fats (e.g. in eggs, meat, milk etc) which raise the 




2. Hypertension. Hypertension is the other major risk factor in the de- 
velopment of atherosclerotic IHD and cerebrovascular disease. It acts probably 
by mechanical injury to the arterial wall due to increased blood pressure. A sys- 
tolic pressure of over 160 mmHg or a diastolic pressure of over 95 mmHg is as- 
sociated with five times higher risk of developing IHD than in people with 
blood pressure within normal range (140/90 mmHg or less). 
3. Smoking. The extent and severity of atherosclerosis are much great- 
er in smokers than in non-smokers. Cigarette smoking is associated with 
higher risk of atherosclerotic IHD and sudden cardiac death. Men who smoke 
a pack of cigarettes a day are 3-5 times more likely to die of IHD than non- 
smokers. The increased risk and severity of atherosclerosis in smokers is due 
to reduced level of HDL and accumulation of carbon monoxide in the blood 
that produces carboxy-haemoglobin and eventually hypoxia in the arterial 
wall favouring atherosclerosis. 
4. Diabetes mellitus. Clinical manifestations of atherosclerosis are far 
more common and develop at an early age in people with both insulin- 
dependent and non-insulin dependent diabetes mellitus. The risk of develop- 
ing IHD is doubled, tendency to develop cerebrovascular disease is high, and 
frequency to develop gangrene of foot is about 100 times increased. The 
causes of increased severity of atherosclerosis are complex and numerous 
which include increased aggregation of platelets, increased LDL and de- 
creased HDL. 
III. Minor risk factors 
There are a number of less important and minor risk factors having 
some role in the etiology of atherosclerosis. These are as under: 
i) Higher incidence of atherosclerosis in developed countries and low 
prevalence in underdeveloped countries, suggesting the role of environmental 
influences, 
ii) Obesity, if the person is overweight by 20% or more, is associated 
with increased risk, 
iii) Use of oral contraceptives by women has been shown to have in- 
creased risk of developing myocardial infarction or stroke. 
iv) Lack of exercise is associated with the risk of developing athero- 
sclerosis and its complications, 
v) Type A behaviour pattern or stress characterised by aggressiveness, 
competitive drive, ambitiousness and a sense of urgency, is associated with 
enhanced risk of IHD compared with type B behaviour of relaxed and happy- 
go-lucky type. 
vi) Moderate consumption of alcohol appears to have slightly benefi- 




vii) Role of viruses in atherogenesis has been implicated recently. In 
chickens, avian herpesvirus (Marek disease virus), besides producing lym- 
phoid tumour, also produces intimal cell proliferation of muscular arteries 
and alters the metabolism of lipid and cholesterol in these cells. Although a 
conclusive role of viral infection in pathogenesis of human atherosclerosis is 
as yet unproven, viral infection would explain intimal cell proliferation and 
monoclonal cell proliferation in atheromatous lesion. 
 
Pathogenesis. As stated above, atherosclerosis is not caused by a sin- 
gle etiologic factor but is a multifactorial disease whose exact pathogenesis is 
still not known. A number of theories have been proposed since the times of 
Virchow. 
• Insudation hypothesis. The concept hypothesised by Virchow in 
1856 that atherosclerosis is a form of cellular proliferation of the intimal cells 
resulting from increased imbibing of lipids from the blood came to be called 
the 'lipid theory', currently known as 'response to injury hypothesis' and is 
nowadays the most widely accepted theory. 
• Encrustation hypothesis. The proposal put forth by Rokitansky in 
1852 that atheroma represented a form of encrustation on the arterial wall from 
the components in the blood forming thrombi composed of platelets, fibrin and 
leucocytes, was named as 'encrustation theory' or 'thrombogenic theory'. Since 
currently it is believed that encrustation or thrombosis is not the sole factor in 
atherogenesis but the components of thrombus (platelets, fibrin and leucocytes) 
have a role in atheromatous lesions, this theory has now been incorporated into 
the foregoing recent theory of response to injury. 
Thus, there is no consensus regarding the origin and progression of le- 
sion of atherosclerosis. The role of four key factors – arterial smooth muscle 
cells, endothelial cells, blood monocytes and hyperlipidaemia, is accepted by 
all. However, the areas of disagreement exist in the mechanism and sequence 
of events involving these factors in initiation, progression and complications 
of disease. Currently, pathogenesis of atherosclerosis is explained on the ba- 
sis of the following two theories: 
• Response-to-injury hypothesis, first described in 1973, and modified 
in 1986 and 1993 by Ross. 
• Monoclonal theory, postulated by Benditt and Benditt in 1973. 
1. Response-to-injury hypothesis. This theory is most widely accept- 
ed and incorporates aspects of two older historical theories of atherosclerosis 
– the lipid theory of Virchow and thrombogenic (encrustation) theory of 
Rokitansky. 
• The original response to injury theory was first described in 1973 ac- 




lial injury followed by smooth muscle cell proliferation so that the early lesions, 
according to this theory, consist of smooth muscle cells mainly. 
• The modified response-to-injury hypothesis described subsequently in 
1993 implicates lipoprotein entry into the intima as the initial event followed by 
lipid accumulation in the macrophages (foam cells now) which according to 
modified theory, are believed to be the dominant cells in early lesions. 
i) Endothelial injury. It has been known for many years that endotheli- 
al injury is the initial triggering event in the development of lesions of ather- 
osclerosis. Actual endothelial denudation is not an essential requirement, but 
endothelial dysfunction may initiate the sequence of events. Endothelial inju- 
ry can be induced in experimental animals by mechanical trauma, haemody- 
namic forces, immunological and chemical mechanisms, chronic hyperlipidae- 
mia, bacterial endotoxins, viruses, hypoxia and by carbon monoxide and tobac- 
co products. In man, risk factors such as hypertension, cigarette smoking and 
chronic hyperlipidaemia can cause endothelial damage or alter endothelial func- 
tion. The role of haemodynamic forces in causing endothelial injury is further 
supported by the distribution of atheromatous plaques at points of bifurcation or 
branching of blood vessels which are under greatest shear stress. 
ii) Intimal smooth muscle cell proliferation. Endothelial injury causes 
adherence, aggregation and platelet release reaction at the site of exposed sub- 
endothelial connective tissue. Proliferation of intimal smooth muscle cells is 
stimulated by various mitogens, the most important of which is platelet-derived 
growth factor (PDGF); others are fibroblast growth factor, epidermal growth 
factor, and transforming growth factor-alpha (TGF-α). Proliferation can also be 
facilitated by loss of growth inhibitors such as TGF-β and heparin-like sub- 
stances. Intimal proliferation of smooth muscle cells is accompanied by synthe- 
sis of matrix proteins — collagen, elastic fibre proteins and proteoglycans. 
iii) Role of blood monocytes. Though blood monocytes do not possess 
receptors for normal LDL, LDL does appear in the monocyte cytoplasm to form 
foam cell by mechanism. Plasma LDL on entry into the intima undergoes oxida- 
tion. The 'oxidised LDL' so formed in the intima performs the following all- 
important functions on monocytes and endothelium: 
• For monocytes, oxidised LDL acts to attract, proliferate, immobilise 
and activate them as well as is readily taken up by scavenger receptor on the 
monocyte to transform it to a lipid-laden foam cell. 
• For endothelium, oxidised LDL is cytotoxic. 
Death of foam cell by apoptosis releases lipid to form lipid core of 
plaque. 
iv) Role of hyperlipidaemia. As stated already, chronic hyperlipidae- 





Secondly, increased serum concentration of LDL and VLDL promotes 
formation of foam cells, while high serum concentration of HDL has anti- 
atherogenic effect. 
v) Thrombosis. As apparent from the foregoing, endothelial injury ex- 
poses subendothelial connective tissue resulting in formation of small platelet 
aggregates at the site and causing proliferation of smooth muscle cells. This 
causes mild inflammatory reaction which together with foam cells is incorpo- 
rated into the atheromatous plaque. The lesions enlarge by attaching fibrin and 
cells from the blood so that thrombus becomes a part of atheromatous plaque. 
2. Monoclonal hypothesis. This hypothesis is based on the postulate 
that proliferation of smooth muscle cells is the primary event and that this 
proliferation is monoclonal in origin similar to cellular proliferation in neo- 
plasms (e.g. in uterine leiomyoma). The evidence cited in support of mono- 
clonal hypothesis is the observation on proliferated smooth muscle cells in 
atheromatous plaques which have only one of the two forms of glucose-6- 
phosphate dehydro-genase (G6PD) isoenzymes, suggesting monoclonality in 
origin. The monoclonal proliferation of smooth muscle cells in atherosclero- 
sis may be initiated by mutation caused by exogenous chemicals (e.g. ciga- 
rette smoke), endogenous metabolites (e.g. lipoproteins) and some viruses 
(e.g. Marek's disease virus in chickens, herpesvirus). 
 
CLASSIFICAION OF АTHEROSCLEROSIS 
Localization of the process: 1. Atherosclerosis of aorta. 2. Atheroscle- 
rosis of coronary arteries. 3. Atherosclerosis of cerebral arteries. 4. Athero- 
sclerosis of renal arteries. 5. Atherosclerosis of mesenteric arteries. 6. Ather- 
osclerosis of lower limbs arteries. 
Clinical aspects: 
I period (preclinical): а) vasomotor disturbances; b) complex of labor- 
atory disturbances; 
II period (clinical): а) ischemic; b) trombonecrotic; c) sclerotic. 
 
Fazes of course: 1. Progression of atherosclerosis. 2. Stabilization of 
process. 3. Regression of atherosclerosis. 
 
Pathologic changes: 
Microscopic stages of atherosclerosis: 
1. Prelipid stage – is characterized by general metabolism impairment 
and increase of endothelium permeability. 
2. Lipidosis – it means infiltration of tunica intima with lipoproteins 




3. Lyposclerosis is characterized by growth of connective tissue 
around lipoproteins (corresponds to stage of fibrous plaques). 
4. Atheromatosis is characterized by degradation of lipoprotein 
plaques. 
5. Ulcerative stage is characterized by formation of atheromatous ul- 
cer on vascular surface usually with thrombus formation. 
6. Atherocalcinosis – deposition of Ca2+ salts (dystrophic calcification). 
Macroscopic stages of atherosclerosis: 
1. Fatty streaks and dots, 
2. Gelatinous lesions, 
3. Atheromatous plaques, 
4. Complicated plaques (plaques with ulceration, haemorrhages and 
thrombosis). 
5. Calcification, or atherocalcification. 
The clinical disease states due to luminal narrowing in atherosclerosis 
are caused by fully developed atheromatous plaques and complicated 
plaques. However, early lesions in the form of diffuse intimal thickening, fat- 
ty streaks and gelatinous lesions are often the forerunners in the evolution of 
atherosclerotic lesions. 
1. Fatty streaks and dots. Fatty streaks and dots on the intima by them- 
selves are harmless but may be the precursor lesions of atheromatous plaques. 
They are seen in all races of the world and begin to appear in the first year of 
life. However, they are uncommon in older persons and are probably absorbed. 
They are especially prominent in the aorta and other major arteries, more often 
on the posterior wall than the anterior wall. Grossly, the lesions may appear as 
flat or slightly elevated and yellow. They may be either in the form of small, 
multiple dots, about 1 mm in size, or in the form of elongated, beaded streaks. 
Microscopically, fatty streaks lying under the endo-thelium are composed of 
closely-packed foam cells, lipid-containing elongated smooth muscle cells and a 
few lymphoid cells. Small amount of extracellular lipid, collagen and proteogly- 
cans are also present. 
2. Gelatinous lesions. Gelatinous lesions develop in the intima of the 
aorta and other major arteries in the first few months of life. Like fatty 
streaks, they may also be precursors of plaques. They are round or oval, cir- 
cumscribed grey elevations, about 1 cm in diameter. 
Microscopically, gelatinous lesions are foci of increased ground sub- 
stance in the intima with thinned overlying endothelium. 
3. Atheromatous plaques. A fully developed atherosclerotic lesion is 
called atheromatous plaque, also called fibrous plaque, fibrofatty plaque or ath- 




graphic locations and races and are seen in advanced age. These lesions may 
develop from progression of early lesions of the atherosclerosis described 
above. Most often and most severely affected is the abdominal aorta, though 
smaller lesions, may be seen in descending thoracic aorta and aortic arch. The 
major branches of the aorta around the ostia are often severely involved, espe- 
cially the iliac, femoral, carotid, coronary, and cerebral arteries. 
Grossly, atheromatous plaques are white to yellowish-white lesions, var- 
ying in diameter from 1-2 cm and raised on the surface by a few millimeters to a 
centrimeter in thickness. Cut section of the plaque reveals the luminal surface as 
a firm, white fibrous cap and a central core composed of yellow to yellow- 
white, soft, porridge-like material and hence the name atheroma. 
Microscopically, the appearance of plaque varies depending upon the 
age of the lesion. However, the following features are invariably present: 
• The superficial luminal part of fibrous cap is covered by endotheli- 
um, and is composed of smooth muscle cells, dense connective tissue and ex- 
tracellular matrix containing proteoglycans and collagen. 
• The cellular area under the fibrous cap is comprised by a mixture of 
macrophages, foam cells, lymphocytes and a few smooth muscle cells which 
may contain lipid. 
• The deeper central soft core consists of extracellular lipid material, 
cholesterol clefts, fibrin, necrotic debris and lipid-laden foam cells. 
• In older and more advanced lesions, the collagen in the fibrous cap 
may be dense and hyalinised, smooth muscle cells may be atrophic and foam 
cells are fewer. 
4. Complicated plaques. Various pathologic changes that occur in ful- 
ly-developed atheromatous plaques are called the complicated lesions. These 
account for the most serious and aneurysmal dilatation. It is not uncommon 
to see more than one form of complication in a plaque. 
i) Calcification. Calcification occurs more commonly in advanced 
atheromatous plaques, especially in the aorta and coronaries. The diseased 
intima cracks like an egg-shell when the vessel is incised and opened. 
Microscopically, the calcium salts are deposited in the vicinity of ne- 
crotic area and in the soft lipid pool deep in the thickened intima. This form 
of atherosclerotic intimal calcification differs from Monckeberg's medial cal- 
cific arteriosclerosis that affects only the tunica media. 
ii) Ulceration. The layers covering the soft pultaceous material of an 
atheroma may ulcerate as a result of haemodynamic forces or mechanical 
trauma. This results in discharge of emboli composed of lipid material and 
debris into the blood stream, leaving a shallow, ragged ulcer with yellow li- 




coronary artery may suddenly rupture into the arterial lumen forcibly and 
cause thromboembolic occlusion. 
iii) Thrombosis. The ulcerated plaque and the areas of endothelial 
damage are vulnerable sites for formation of superimposed thrombi. These 
thrombi may get dislodged to become emboli and lodge elsewhere in the cir- 
culation, or may get organised and incorporated into the arterial wall as mural 
thrombi. Mural thrombi may become occlusive thrombi which may subse- 
quently recanalise. 
iv) Haemorrhage. Intimal haemorrhage may occur in an atheromatous 
plaque either from the blood in the vascular lumen through an ulcerated 
plaque, or from rupture of thin-walled capillaries that vascularise the athero- 
ma from adventitial vasa vasorum. Haemorrhage is particularly a common 
complication in coronary arteries. The haematoma formed at the site contains 
numerous haemosiderin-laden macrophages. 
v) Aneurysm formation. Though atherosclerosis is primarily an inti- 
mal disease, advanced lesions are associated with secondary changes in the 
media and adventitia. The changes in media include atrophy and thinning of 
the media and fragmentation of internal elastic lamina. The adventitia under- 
goes fibrosis and some inflammatory changes. These changes cause weaken- 
ing in the arterial wall resulting in aneurysmal dilatation. 
Clinical Effects 
The clinical effects of atherosclerosis depend upon the size and type of 
arteries affected. In general, the clinical effects result from the following: 
1. Slow luminal narrowing causing ischaemia and atrophy. 
2. Sudden luminal occlusion causing infarction necrosis. 
3. Propagation of plaque by formation of thrombi and emboli. 
4. Formation of aneurysmal dilatation and eventual rupture. 
Large arteries affected most often are the aorta, renal, mesenteric and 
carotids, whereas the medium- and small-sized arteries frequently involved 
are the coronaries, cerebrals and arteries of the lower limbs. Accordingly, the 
symptomatic atherosclerotic disease involves most often the heart, brain, kid- 
neys, small intestine and lower extremities. The effects pertaining to these 
organs are described in relevant chapters later. Some of the important effects 
are listed below: 
i) Aorta – Aneurysm formation, thrombosis and embolisation to other 
organs. 
ii) Heart – Myocardial infarction, ischaemic heart disease. 
iii) ) Brain – Chronic ischaemic brain damage, cerebral infarction. 
iv) Small intestine – Ischaemic bowel disease, infarction. 




HYPERTENSIVE VASCULAR DESIASE 
 
An elevated arterial blood pressure is a major health problem, particu- 
larly in developed countries. A persistent and sustained high blood pressure 
has damaging effects on the heart, brain and kidneys (benign and malignant 
nephrosclerosis). 
Definition and Classification 
Arterial or systemic hypertension in a patient is defined clinically as 
'borderline' if the systolic blood pressure is 140 – 149 mm Hg, and diastolic 
pressure is 90 - 94 mm Hg, and 'hypertensive'. 
Table 1. Classification of Blood Pressure for Adults Aged ≥ 18 Years: JNC 7 vs JNC 6 
 
JNC 7 Blood 
Pressure Category 
JNC 6 Blood 
Pressure Categor y 
SBP (mm Hg) and/or DBP (mm 
Hg) 
Normal Optimal < 120 and < 80 
Prehypertension  120-139 or 80-89 
 Normal < 130 and < 85 
 High-normal 130-139 or 85-89 
Hypertension: Hypertension    
Stage 1 Stage 1 140-159 or 90-99 
Stage 2  ≥ 160 or ≥ 100 
 Stage 2 160-179 or 100-109 
 Stage 3 ≥ 180 or ≥ 110 
 
The diastolic pressure is often considered more significant. However, 
blood pressure varies with many factors such as age of the patient, exercise, 
emotional disturbances like fear and anxiety. Therefore, it is important to 
measure blood pressure at least twice during two separate examinations under 
least stressful conditions. A clinically useful classification of hypertension 
has been recently described by the Joint National Committee of the 
WHO/International Society of Hypertension. By means of these criteria, the 
prevalence of hypertension is observed in about 25% of population. Hyper- 
tension is generally classified into 2 types: 
1. Primary or essential hypertension in which the cause of increase 
in blood pressure is unknown. Essential hypertension constitutes about 90- 
95% patients of hypertension. 
2. Secondary hypertension, in which the increase in blood pressure is 
caused by diseases of the kidneys, endocrines or some other organs. Second- 
ary hypertension comprises 5-10% cases of hypertension. 
According to the clinical course, both essential and secondary hyper- 
tension may be benign or malignant. 
• Benign hypertension is moderate elevation of blood pressure and the 
rise is slow over the years. 




• Malignant hypertension is marked and rapid increase of blood pres- 
sure to 200/140 mm Hg or more and the patients have papilloedema, retinal 
haemorrhages and hypertensive encephalopathy. Less than 5% of hyperten- 
sive patients develop malignant hypertension and life expectancy after diag- 
nosis in these patients is generally less than 2 years if not treated effectively. 
Etiology and Pathogenesis 
The etiology and pathogenesis of secondary hypertension that com- 
prises less than 10% cases has been better understood, whereas the mecha- 
nism of essential hypertension that constitutes about 90% of cases remains 
largely obscure. In general, normal blood pressure is regulated by 2 haemo- 
dynamic forces – cardiac output and total peripheral vascular resistance. 
Factors which alter these two factors result in hypertension. The role of kid- 
ney in hypertension, particularly in secondary hypertension, by elaboration of 
renin and subsequent formation of angiotensin II, is well established (renin- 
angiotensin system). 
With this background knowledge, we next turn to the mechanisms in- 
volved in the two forms of hypertension. 
ESSENTIAL (PRIMARY) HYPERTENSION. By definition, the cause of es- 
sential hypertension is unknown but a number of factors are related to its de- 
velopment. These are as under: 
1. Genetic factors. The role of heredity in the etiology of essential hy- 
pertension has long been suspected. The evidences in support are the familial 
aggregation, occurrence of hypertension in twins, epidemiologic data, exper- 
imental animal studies and identification of hypertension susceptibility gene 
(angiotensinogen gene). 
2. Racial and environmental factors. Surveys in the US have revealed 
higher incidence of essential hypertension in blacks than in whites. A number 
of environmental factors have been implicated in the development of hyper- 
tension including salt intake, obesity, skilled occupation, higher living stand- 
ards and patients in high stress. 
3. Risk factors modifying the course of essential hypertension. There is 
sufficient evidence to show that the course of essential hypertension that begins 
in middle life is modified by a number of factors. These are as under: 
i) Age. Younger the age at which hypertension is first noted but left un- 
treated, lower the life expectancy. 
ii) Sex. Females with hypertension appear to fare better than males. 
iii) Atherosclerosis. Accelerated atherosclerosis invariably accompa- 
nies essential hypertension. This could be due to contributory role of other 
independent factors like cigarette smoking, elevated serum cholesterol, glu- 




iv) Other risk factors. Other factors which alter the prognosis in hyper- 
tension include: smoking, excess of alcohol intake, diabetes mellitus, persis- 
tently high diastolic pressure above 115 mm Hg and evidence of end-organ 
damage (i.e. heart, eyes, kidney and nervous system). 
The pathogenetic mechanism in essential hypertension is explained by 
many theories. These are: 
1. High plasma level of catecholamines. 
2. Increase in blood volume i.e. arterial overfilling (volume hyperten- 
sion) and arteriolar constriction (vasoconstrictor hypertension). 
3. Increased cardiac output. 
4. Low-renin essential hypertension found in approximately 20% pa- 
tients due to altered responsiveness to renin release. 
5. High renin essential hypertension seen in about 15% cases due to 
decreased adrenal responsiveness to angiotensin II. 
SECONDARY HYPERTENSION. Mechanisms underlying hypertension 
with identifiable cause have been studied more extensively. Based on the eti- 
ology, these are described under four headings: renal hypertension, endocrine 
hypertension, hypertension associated with coarctation of aorta and neuro- 
genic causes. 
1. Renal Hypertension. Hypertension produced by renal diseases is 
called renal hypertension. Renal hypertension is subdivided into 2 groups: 
i) Renal vascular hypertension e.g. in occlusion of a major renal artery, 
pre-eclampsia, eclampsia, polyarteritis nodosa and fibromuscular dysplasia of 
renal artery. 
ii) Renal parenchymal hypertension e.g. in various types of glomerulo- 
nephritis, pyelonephritis, interstitial nephritis, diabetic nephropathy, amyloi- 
dosis, polycystic kidney disease and renin-producing tumours. 
In either case, renal hypertension can be produced by one of the 3 in- 
ter-related pathogenetic mechanisms: 
• activation of renin-angiotensin system, 
• sodium and water retention, and 
• decreased release of vasodepressor materials. 
a) Activation of renin-angiotensin system. Renin is a proteolytic en- 
zyme produced and stored in the granules of the juxtaglomerular cells surround- 
ing the afferent arterioles of glomerulus. The release of renin is stimulated by 
renal ischaemia, sympathetic nervous system stimulation, depressed sodium 
concentration, fluid depletion and decreased potassium intake. Released renin is 
transported through blood stream to the liver where it acts upon substrate angio- 
tensinogen, an a2-globulin synthesised in the liver, to form angiotensin I, a 
decapeptide. Angiotensin I is converted into angiotensin II, an octapeptide, by 




occurring vasoconstrictor substance and its pressor action is mainly attributed to 
peripheral arteriolar vasoconstriction. The other main effect of angiotensin II is 
to stimulate the adrenal cortex to secrete aldosterone that promotes reabsorption 
of sodium and water. 
Thus, the renin-angiotensin system is concerned mainly with 3 func- 
tions:  
i) Control of blood pressure by altering plasma concentration of angio- 
tensin II and aldosterone. 
ii) Regulation of sodium and water content, 
iii) ) Regulation of potassium balance. 
b) Sodium and water retention. Blood volume and cardiac output, 
both of which have a bearing on blood pressure, are regulated by blood levels 
of sodium which is significant for maintaining extracellular fluid volume. 
Blood concentration of sodium is regulated by 3 mechanisms: 
i) Release of aldosterone from activation of renin-angiotensin system, 
as already explained, 
ii) Reduction in GFR due to reduced blood flow as occurs in reduced 
renal mass or renal artery stenosis. This results in proximal tubular reabsorp- 
tion of sodium, 
iii) Release of atriopeptin hormone from atria of the heart in response 
to volume expansion. These peptides cause increased GFR and inhibit sodi- 
um reabsorption. 
c) Release of vasodepressor material. A number of vasodepressor 
materials and antihypertensives counterbalance the vasopressor effect of an- 
giotensin II. These substances include: prostaglandins (PGE2, PGF2, PGA or 
medullin) released from interstitial cells of the medulla, urinary kallikrein- 
kinin system and platelet-activating factor. 
2. Endocrine hypertension. A number of hormonal secretions may 
produce secondary hypertension. These are: 
i) Adrenal gland – e.g. in primary aldosteronism, Cushing's syndrome, 
adrenal virilism and pheochromocytoma. 
ii) Parathyroid gland – e.g. hypercalcaemia in hyperparathyroidism. 
iii) Oral contraceptives – Oestrogen component in the oral contracep- 
tives stimulates hepatic synthesis of renin substrate. 
3. Coarctation of aorta. Coarctation of the aorta causes systolic hy- 
pertension in the upper part of the body due to constriction itself. Diastolic 
hypertension results from changes in circulation. 
4. Neurogenic. Psychogenic, polyneuritis, increased intracranial pres- 





EFFECTS OF HYPERTENSION 
Systemic hypertension causes major effects in three main organs – 
heart and its blood vessels, nervous system, and kidneys. The renal effects in 
the form of benign and malignant nephrosclerosis are discussed below, 
whereas hypertensive effects on other organs are described elsewhere in the 
respective chapters. 
Benign Nephrosclerosis is the term used to describe the kidney of be- 
nign phase of hypertension. Mild benign nephrosclerosis is the most common 
form of renal disease in persons over 60 years of age but its severity increases 
in the presence of hypertension and diabetes mellitus. 
Pathologic changes. Grossly, both the kidneys are affected equally and 
are reduced in size and weight, often weighing about 100 gm or less. The 
capsule is often adherent to the cortical surface. The surface of the kidney is 
finely granular and shows V-shaped areas of scarring. The cut surface shows 
firm kidney and narrowed cortex. Microscopically, there are primarily diffuse 
vascular changes which produce parenchymal changes secondarily as a result 
of ischaemia. The histologic changes are, thus, described as vascular and 
parenchymal: 
i) Vascular changes: Changes in blood vessels involve arterioles and 
arteries up to the size of arcuate arteries. There are 2 types of changes in 
these blood vessels: 
a) Hyaline arteriolosclerosis that results in homogeneous and eosino- 
philic thickening of the wall of small blood vessels. 
b) Intimal thickening due to proliferation of smooth muscle cells in the 
intima. 
ii) Parenchymal changes: As a consequence of ischaemia, there is var- 
iable degree of atrophy of parenchyma. This includes: glomerular shrinkage, 
deposition of collagen in Bowman's space, periglomerular fibrosis, tubular 
atrophy and fine interstitial fibrosis. 
Clinical features. There is variable elevation of the blood pressure with headache, 
dizziness, palpitation and nervousness. Eye ground changes may be found but papilloede- 
ma is absent. Renal function tests and urine examination are normal in early stage. But in 
long-standing cases, there may be mild proteinuria with some hyaline or granular casts. 
Rarely, renal failure and uraemia may occur. 
Malignant Nephrosclerosis is the form of renal disease that occurs in 
malignant or accelerated hypertension. Malignant nephrosclerosis is uncom- 
mon and usually occurs as a superimposed complication in 5% cases of pre- 
existing benign essential hypertension or in those having secondary hyperten- 
sion with identifiable cause such as in chronic renal diseases. However, the 
pure form of disease also occurs, particularly at younger age with preponder- 




Pathologic changes. Grossly, the appearance of the kidney varies. In a 
case of malignant hypertension superimposed on pre-existing benign nephro- 
sclerosis, the kidneys are small in size, shrunken and reduced in weight and 
have finely granular surface. However, the kidneys of a patient who develops 
malignant hypertension in pure form are enlarged, oedematous and have pe- 
techial haemorrhages on the surface producing so called 'flea-bitten kidney'. 
Cut surface shows red and yellow mottled appearance. 
Microscopically, most commonly the changes are superimposed on 
benign nephrosclerosis. These changes are as under: 
i) Vascular changes: These are more severe and involve the arterioles. 
The two characteristic vascular changes seen are as under: 
a) Necrotising arteriolitis develops on hyaline arteriolosclerosis. The 
vessel wall shows fibrinoid necrosis, a few acute inflammatory cells and 
small haemorrhages. 
b) Hyperplastic intimal sclerosis or onionskin proliferation is charac- 
terised by concentric laminae of proliferated smooth muscle cells, collagen 
and basement membranes. 
ii) Ischaemic changes: The effects of vascular narrowing on the paren- 
chyma include tubular loss, fine interstitial fibrosis and foci of infarction ne- 
crosis. 
Clinical features. The patients of malignant nephrosclerosis have malignant or ac- 
celerated hypertension with blood pressure of 200/140 mm Hg or higher. Headache, dizzi- 
ness and impaired vision are commonly found. The presence of papilloedema distin- 
guishes malignant from benign phase of hypertension. The urine frequently shows haema- 
turia and proteinuria. Renal function tests show deterioration during the course of the ill- 
ness. Azotaemia (high BUN and serum creatinine) and uraemia develop soon if malignant 
hypertension is not treated aggressively. Approximately 90% of patients die within one 




Cerebrovascular diseases include a variety of medical conditions that 
affect the blood vessels of the brain and the cerebral circulation. Arteries 
supplying oxygen and nutrients to the brain are often damaged by atheroscle- 
rosis or arterial hypertension or deformed in these disorders. The most com- 
mon presentations of cerebrovascular diseases are a stroke (ischemic and 
hemorrhagic), transitory ischemia of the brain, discirculatory encephalopathy 
and vertebro-basilar insufficiency. 
 
TRANSITORY ISCHEMIA OF BRAIN, OR TRANSIENT ISCHEMIC 
ATTACK (TIA) 
TIA (also called a mini-stroke) is a condition in which the blood flow 




brain tissue can fully recover. The symptoms are only transient, leaving no 
sequelae or long-term deficits. In order to diagnose this entity, all neurologic 
signs and symptoms must have been resolved within 24 hrs without evidence 
of brain infarction on brain imaging. 
Morphologically TIA is characterized by vascular disturbances (spasm 
of arteriols, serum imbibitions of their walls, perivascular edema and single 
small haemorrhages) and local changes of brain tissue (edema, dystrophic 
changes of neurons). 
Sometimes perivascular accumulation of haemosiderin is revealed at 
the place of former small haemorrhages. 
 
STROKE 
There are two main variants of strokes: ischemic and hemorrhagic. Is- 
chemic stroke means decreased blood supply to the brain regions, while 
hemorrhagic stroke is bleeding into or around the brain. 
Signs and symptoms of a stroke may include an inability to move or 
feel on one side of the body (hemiplegia), problems of speech understanding 
or speaking, dizziness, loss of vision, etc. Signs and symptoms often appear 
soon after the stroke has occurred. A hemorrhagic stroke may also be associ- 
ated with a severe headache. 
Ischemic stroke, the most common is caused by a blockage of a blood 
vessel in the brain usually due thrombosis or emboli from the proximal arter- 
ies or from the heart, that leads to the brain ischemia. The neurologic signs 
and symptoms last longer than 24 hours and the brain infarction is demon- 
strated by imaging techniques. 
Morphologically ischemic stroke is characterized by cerebral infarction 
development or grey malacia of the brain matter. 
Haemorrhagic stroke. 
There are two main types of hemorrhagic stroke: 
Intracerebral hemorrhage, which is basically bleeding within the brain 
itself (when an artery in the brain bursts, flooding the surrounding tissue with 
blood), due to either intraparenchymal hemorrhage (bleeding within the brain 
tissue) or intraventricular hemorrhage (bleeding within the brain's ventricular 
system). 
Subarachnoid hemorrhage, which is basically bleeding that occurs 
outside of the brain tissue but still within the skull, and precisely between the 
arachnoid mater and pia mater (the delicate innermost layer of the three lay- 
ers of the meninges that surround the brain). 
The above two main types of hemorrhagic stroke are also two different 
forms of intracranial hemorrhage, which is the accumulation of blood any- 




rhage, such as epidural hematoma (bleeding between the skull and the dura 
mater, which is the thick outermost layer of the meninges that surround the 
brain) and subdural hematoma (bleeding in the subdural space), are not con- 
sidered "hemorrhagic strokes". 
Hemorrhagic strokes may occur on the background of alterations to the 
blood vessels in the brain, such as hyalinosis, cerebral amyloid angiopathy, 
cerebral arteriovenous malformation and an intracranial aneurysm, which can 
cause intraparenchymal or subarachnoid hemorrhage. 
In addition to neurological impairment, hemorrhagic strokes usually 
cause specific symptoms (for instance, subarachnoid hemorrhage classically 
causes a severe headache known as a thunderclap headache) or reveal evi- 
dence of a previous head injury. 
Inflammation contributes to the secondary brain injury after hemorrhage. 
The outcomes of stroke vary widely depending on size and location of 
the lesion. Disfunctions depend on the brain areas that have been damaged. 
Some of the physical disabilities that can result from stroke include 
muscle weakness, numbness, pressure sores, pneumonia, incontinence, aprax- 
ia (inability to perform learned movements), difficulties to carry out the daily 
activities, appetite loss, speech loss, vision loss and pain. 
Emotional problems following a stroke can be due to direct damage of 
emotional centers in the brain or from frustration and difficulty of adapting to 
new limitations. 
If the stroke is severe enough, or in a certain location such as parts of 
the brainstem, coma or death can result. 
 
VERTEBROBASILAR INSUFFICIENCY (VBI) 
Vertebrobasilar insufficiency (VBI), or vertebral-basilar ischemia, also 
called beauty parlor syndrome (BPS), is a temporary set of symptoms due to 
decreased blood flow (ischemia) in the posterior circulation of the brain. The 
posterior circulation supplies blood to the medulla, cerebellum, pons, mid- 
brain, thalamus, and occipital cortex (responsible for vision). Therefore, the 
symptoms due to VBI vary according to which portions of the brain experi- 
ence significantly decreased blood flow. In the United States, 25% of strokes 
and transient ischemic attacks occur in the vertebrobasilar distribution. These 
must be separated from strokes arising from the anterior circulation, which 
involves the carotid arteries. 
Main causes of vascular disorders in the VB-system are: 
1. Occlusive damages (atherosclerotic stenosis and thrombosis, embo- 
lisms, arteriitis of different etiology, fibromuscular dysplasia and other); 
2. Extravascular compressions (compression by osteophytes, articular 




3. Deformation (pathological crimpiness, thrombosis); 
4. Abnormalities (hypoplasia, abnormalities of beginning, localization, 
topography and other). 
 
DYSCIRCULATORY ENCEPHALOPATHY (DEP) 
Dyscirculatory encephalopathy is a slowly progressive brain dysfunc- 
tion that has arisen as a result of diffuse and / or small-focal damage to the 
brain tissue in conditions of long-term insufficiency of the cerebral blood 
supply 
Dyscirculatory encephalopathy is the most common diagnosis in clini- 
cal practice. The term was proposed by G.A. Maksudov and V.M. Kogan in 
1958 (according to other sources - E. Schmidt and G. Maksudov in the 70-s 
of the last century), and is traditionally used in the CIS countries, despite the 
fact that is not represented in the ICD-10. In English literature, especially in 
the United States, this state corresponds as subcortical arteriosclerotic en- 
cephalopathy (SAE), Binswanger's encephalopathy, multi-infarct dementia 
(Binswanger's type), subcortical dementia, vascular dementia (Binswanger's 
type), subcortical ischemic vascular disease and others (chronic cerebrovas- 
cular insufficiency, chronic cerebrovascular insufficiency, ischemic disease 
of the brain, etc).The vast majority (96%) was chronic ischemic – DEP. 
DEP is the result of a slowly progressive blood supply due to stenosis 
or obliteration of small intracranial atherosclerotic arteries. This process leads 
to the development of primary (acute, recurrent) and secondary changes in 
the brain substance. 
On the main reasons there are the following types of discirculatory en- 
cephalopathy: 1) atherosclerotic (often suffer great vessels of the head), 2) 
hypertensive, 3) mixed, and 4) venous. In general, it could be a specific dis- 
ease or a combination thereof (vegetative dystonia, rheumatism, vascular le- 
sions with vasculitis and trauma, systemic hemodynamic disorders, blood 
disorders, etc.). Damage in the white matter of nerve fibers leads to dissocia- 
tion of the functions of the cortex and underlying structures, which results in 
the clinical manifestations of DEP. 
 
ISHAEMIC HEART DISEASE 
 
Ischaemic heart disease (IHD) is defined as acute or chronic form of 
cardiac disability arising from imbalance between the myocardial supply and 
demand for oxygenated blood. Since narrowing or obstruction of the coronary 
arterial system is the most common cause of myocardial anoxia, the alternate 
term 'coronary artery disease (CAD)' is used synonymously with IHD. IHD or 
CAD is the leading cause of death in most industrialised countries (about one- 




countries. Men develop IHD earlier than women and death rates are also slightly 
higher for men than for women until the menopause. 
Etiopathogenesis. IHD is invariably caused by disease affecting the 
coronary arteries, the most prevalent being atherosclerosis accounting for 
more than 90% cases, while other causes are responsible for less than 10% 
cases of IHD. Therefore, it is convenient to consider the etiology of IHD un- 
der three broad headings: 
i) coronary atherosclerosis; 
ii) superadded changes in coronary atherosclerosis; and 
iii) non-atherosclerotic causes. 
I. Coronary Atherosclerosis 
Coronary atherosclerosis resulting in 'fixed' obstruction is the major 
cause of IHD in more than 90% cases. Here, a brief account of the pathology 
of lesions in atherosclerotic coronary artery disease is presented. 
1. Distribution. Atherosclerotic lesions in coronary arteries are distribut- 
ed in one or more of the three major coronary arterial trunks, the highest inci- 
dence being in the anterior descending branch of the left coronary, followed in 
decreasing frequency, by the right coronary artery and still less in circumflex 
branch of the left coronary. About one-third of cases have single-vessel disease, 
most often left anterior descending arterial involvement; another one-third have 
two-vessel disease, and the remainder have three major vessel disease. 
2. Location. Almost all adults show atherosclerotic plaques scattered 
throughout the coronary arterial system. However, significant stenotic lesions 
that may produce chronic myocardial ischaemia show more than 75% (three- 
fourth) reduction in the cross-sectional area of a coronary artery or its branch. 
The area of severest involvement is about 3 to 4 cm from the coronary ostia, 
more often at or near the bifurcation of the arteries, suggesting the role of 
haemodynamic forces in atherogenesis. 
3. Fixed atherosclerotic plaques. The atherosclerotic plaques in the 
coronaries are more often eccentrically located bulging into the lumen from 
one side. Occasionally, there may be concentric thickening of the wall of the 
artery. Atherosclerosis produces gradual luminal narrowing that may eventu- 
ally lead to 'fixed' coronary obstruction. The general features of atheromas of 
coronary arteries are similar to those affecting elsewhere in the body and may 
develop similar complications like calcification, coronary thrombosis, ulcera- 
tion, haemorrhage, rupture and aneurysm formation. 
II. Superadded Changes in Coronary Atherosclerosis 
The attacks of acute coronary syndromes, namely acute myocardial in- 




tain changes superimposed on a pre-existing fixed coronary atheromatous 
plaque. These are as under: 
1. Acute changes in chronic atheromatous plaque. 
Though chronic fixed obstructions are the most frequent cause of IHD, 
acute coronary episodes are often precipitated by sudden changes in chronic 
plaques such as plaque haemorrhage, fissuring, or ulceration that results in 
embolisation of atheromatous debris. Acute plaque changes are brought about 
by factors such as sudden coronary artery spasm, tachycardia, intraplaque 
haemorrhage and hypercholesterolaemia. 
2. Coronary artery thrombosis. Transmural acute myocardial infarc- 
tion is often precipitated by partial or complete coronary thrombosis. The ini- 
tiation of thrombus occurs due to surface ulceration of fixed chronic ather- 
omatous plaque, ultimately causing complete luminal occlusion. The lipid 
core of plaque, in particular, is highly thrombogenic. Small fragments of 
thrombotic material are then dislodged which are embolised to terminal coro- 
nary branches and cause microinfarcts of the myocardium. 
3. Local platelet aggregation and coronary artery spasm. Some cas- 
es of acute coronary episodes are caused by local aggregates of platelets on the 
atheromatous plaque, short of forming a thrombus. The aggregated platelets re- 
lease vasospasmic mediators such as thromboxane A2 which may probably be 
responsible for coronary vasospasm in the already atherosclerotic vessel. 
III. Non-Atherosclerotic Causes 
A number of other lesions may cause IHD in less than 10% of cases. 
These are as under: 
1. Vasospasm. It has been possible to document vasospasm of one of the 
major coronary arterial trunks in patients with no significant atherosclerotic cor- 
onary narrowing which may cause angina or myocardial infarction. 
2. Stenosis of coronary ostia. Coronary ostial narrowing may result 
from extension of syphilitic aortitis or from aortic atherosclerotic plaques en- 
croaching on the opening. 
3. Arteritis. Various types of inflammatory involvements of coronary 
arteries or small branches like in rheumatic arteritis, polyarteriitis nodosa, 
thromboangiitis obliterans (Buerger's disease), Takayasu's disease, Kawasa- 
ki's disease, tuberculosis and other bacterial infections may contribute to my- 
ocardial damage. 
4. Embolism. Rarely, emboli originating from elsewhere in the body 
may occlude the left coronary artery and its branches and produce IHD. The 
emboli may originate from bland thrombi, or from vegetations of bacterial 





5. Thrombotic diseases. Another infrequent cause of coronary occlu- 
sion is from hypercoagulability of the blood such as in shock, polycythaemia 
vera, sickle cell anaemia and thrombotic thrombocytopenic purpura. 
6. Trauma. Contusion of a coronary artery from penetrating injuries 
may produce thrombotic occlusion. 
7. Aneurysms. Extension of dissecting aneurysm of the aorta into the 
coronary artery may produce thrombotic coronary occlusion. Rarely, congen- 
ital, mycotic and syphilitic aneurysms may occur in coronary arteries and 
produce similar occlusive effects. 
8. Compression. Compression of a coronary from outside by a prima- 
ry or secondary tumour of the heart may result in coronary occlusion. 
 
EFFECTS OF MYOCARDIAL ISCHAEMIA 
Development of lesions in the coronaries is not always accompanied 
by cardiac disease. Depending upon the suddenness of onset, duration, de- 
gree, location and extent of the area affected by myocardial ischaemia, there 
can be two types of ischaemic manifestations: 
A. Myocardial infarction 
B. Non-infarct effects of myocardial ischaemia which include the fol- 
lowing: 
1. Angina pectoris 
2. Chronic ischaemic heart disease 
3. Sudden cardiac death 
Acute coronary syndromes include: acute myocardial infarction, unsta- 
ble angina and sudden ischaemic death. 
 
MYOCARDIAL INFARCTION 
Myocardial infarction (MI) is the most important consequence of coro- 
nary artery disease. Many patients may die within the first few hours of the 
onset, while remainder suffer from effects of impaired cardiac function. A 
significant factor that may prevent or diminish the myocardial damage is the 
development of collateral circulation through anastomotic channels over a 
period of time. A regular and well-planned exercise programme is likely to 
encourage good collateral circulation. 
Incidence. In industrialised countries, MI accounts for 10-25% of all 
deaths. Due to the dominant etiologic role of coronary atherosclerosis in MI, 
the incidence of MI correlates well with the incidence of atherosclerosis in a 
geographic area. 
Age. MI may virtually occur at all ages, though the incidence is higher 




of 40 years, particularly in those with major risk factors to develop athero- 
sclerosis like hypertension, diabetes mellitus, cigarette smoking, familial hy- 
percholesterolaemia etc. 
Sex. Males throughout their life are at a significantly higher risk of de- 
veloping MI as compared to females. Women during reproductive period 
have remarkably low incidence of MI, probably due to the protective influ- 
ence of oestrogen. The use of oral contraceptives is associated with high risk 
of developing MI. After menopause, this sex difference gradually declines 
but the incidence of disease among women never reaches that among men of 
the same age. 
Etiopathogenesis. The etiologic role of severe coronary atherosclero- 
sis (more than 75% compromise of lumen) of one or more of the three major 
coronary arterial trunks in the pathogenesis of about 90% cases of acute MI is 
well documented by autopsy studies as well as by coronary angiographic 
studies. A few notable features in the etiology and pathogenesis of acute MI 
are considered below: 
1. Mechanism of myocardial ischaemia. Myocardial ischaemia is 
brought about by one or more of the following mechanisms: 
i) Diminised coronary blood flow e.g. in coronary artery disease, 
shock. 
ii) Increased myocardial demand e.g. in exercise, emotions. 
iii) Hypertrophy of the heart without simultaneous increase of coronary 
blood flow e.g. in hypertension, valvular heart disease. 
2. Role of platelets. Rupture of an atherosclerotic plaque exposes the 
subendothelial collagen to platelets which undergo aggregation, activation 
and release reaction. These events contribute to the build-up of the platelet 
mass that may give rise to emboli or initiate thrombosis. 
3. Complicated plaques. Two important complications in coronary 
atherosclerotic plaques which are frequently encountered are coronary 
thrombosis and haemorrhage: 
i) Superimposed coronary thrombosis is seen in about half the cases of 
acute MI. Infusion of intracoronary fibrinolysins in the first few hours of de- 
velopment of acute MI in such cases restores blood flow in the blocked ves- 
sel in majority of cases. 
ii) Intramural haemorrhage is found in about one-third cases of acute 
MI. Haemorrhage and thrombosis may occur together in some cases. 
4. Non-atherosclerotic causes. About 10% cases of acute MI are 
caused by non-atherosclerotic factors such as coronary vasospasm, arteritis, 
coronary ostial stenosis, embolism, thrombotic diseases, trauma and outside 




5. Transmural versus subendocardial infarcts. There are some dif- 
ferences in the pathogenesis of the transmural infarcts involving the full 
thickness of ventricular wall and the subendocardial (laminar) infarcts affect- 
ing the inner subendocardial one-third to half. These are as under: 
i) Transmural (full thickness) infarcts are the most common type seen in 
95% cases. Critical coronary narrowing (more than 75% compromised lumen) is 
of great significance in the causation of such infarcts. Atherosclerotic plaques 
with superimposed thrombosis and intramural haemorrhage are significant in 
about 90% cases, and non-atherosclerotic causes in the remaining 10% cases. 
ii) Subendocardial (laminar) infarcts have their genesis in reduced cor- 
onary perfusion due to coronary atherosclerosis but without critical stenosis 
(not necessarily 75% compromised lumen), aortic stenosis or haemorrhagic 
shock. This is because subendocardial myocardium is normally least well 
perfused by coronaries and thus is more vulnerable to any reduction in the 
coronary flow. Superimposed coronary thrombosis is frequently encountered 
in these cases too, and hence the beneficial role of fibrinolytic treatment in 
such patients. 
Types of infarcts. Infarcts have been classified in a number of ways 
by the physicians and the pathologists: 
1.  According to the time of appearance: 
i) Primary MI continues 8 weeks from the onset of myocardium is- 
chemia. 
ii) Secondary MI develops in 4 weeks after primary one. 
iii) Recurrent MI arises during 4 weeks after appearance of primary one. 
2. According to tha anatomic region of the left ventricle involved, they 
are called anterior, posterior (inferior), lateral, septal and circumferential, and 
their combinations like anterolateral, posterolateral (or inferolateral) and an- 
teroseptal. 
3. According to the degree of thickness of the ventricular wall in- 
volved, infarcts are of four types: 
i) full-thickness or transmural, when necrosis involves the entire 
thickness of the ventricular wall, 
ii) subendocardial or laminar, when necrosis occupies the innner sub- 
endocardial half of the myocardium, 
iii) subepicardial, when necrosis occupies the outer subepicardial half 
of the myocardium; 
iv) Intramural, when they occupy the middle part of myocardium. 
4. According to the age of infarcts, they are of two types: 
i) Newly-formed infarcts are called acute, recent or fresh. 
ii) Advanced infarcts are called old, healed or organized. 




i) small focal, 
ii) large focal, 
iii) ) transmural. 
Location of infarcts. Infarcts are most frequently located in the left 
ventricle. Right ventricle is less susceptible to infarction due to its thin wall, 
having less metabolic requirements and is thus adequately nourished by the 
thebesian vessels. Atrial infarcts, whenever present, are more often in the 
right atrium, usually accompanying the infarct of the left ventricle. Left atri- 
um is relatively protected from infarction because it is supplied by the oxy- 
genated blood in the left atrial chamber. 
TABLE 2. Contrasting Features of Subendocardial and Transmural In- 
farcts   
















Most frequent (95%) 
Specific area of coronary supply 




Inner third to half, patchy 
Less frequent 
Circumferential 





The region of infarction depends upon the area of obstructed blood 
supply by one or more of the three coronary arterial trunks. Accordingly, 
there are three regions of myocardial infarction: 
1. Stenosis of the left anterior descending coronary artery is the most 
common (40-50%). The region of infarction is the anterior part of the left 
ventricle including the apex and the anterior two-thirds of the interventricular 
septum. 
2. Stenosis of the right coronary artery is the next most frequent (30- 
40%). It involves the posterior part of the left ventricle and the posterior one- 
third of the interventricular septum. 
3. Stenosis of the left circumflex coronary artery is seen least frequently 
(15-20%). Its area of involvement is the lateral wall of the left ventricle. 
Pathologic changes. The gross and microscopic changes in the myo- 
cardial infarction vary according to the age of the infarct. 
Grossly, most infarcts occur singly and vary in size from 4 to 10 cm. 
As explained above, they are found most often in the left ventricle. Less of- 
ten, there are multifocal lesions. The transmural infarcts, which by definition 




preserved subendocardiai myocardium which is perfused directly by  the 
blood in the ventricular chamber. The subendocardial infarcts which affect 
the inner subendocardial half of the myocardium produce less well-defined 
gross changes than the transmural infarcts. The sequence of macroscopic 
changes in all myocardial infarcts is as under: 
1. In 6 to 12-hour old infarcts, no striking gross changes are discernible 
except that the affected myocardium is slightly paler and drier than normal. 
However, the early infarcts (3 to 6 hours old) can be detected by histochemi- 
cal staining for dehydrogenases on unfixed slice of the heart. This consists of 
immersing a slice of unfixed heart in the solution of triphenyl tetrazolium chlo- 
ride (TTC) which imparts red brown colour to the normal heart muscle, while 
the area of infarcted muscle fails to stain due to lack of dehydrogenases. 
2. By about 24 hours, the infarct develops cyanotic, red-purple, blotchy 
areas of haemorrhage due to stagnation of blood. 
3. During the next 48 to 72 hours, these changes become progressively 
more distinct. 
4. By 4th day, the infarct develops a yellow border due to neutrophilic 
infiltration and thus becomes more well defined 
5. By the end of first week, the entire infarct is bright yellow or yel- 
low-green, soft and has thin hyperaemic border. 
6. By 10 days, the periphery of the infarct appears reddish-purple due 
to growth of granulation tissue. With the passage of time, further healing 
takes place; the necrotic muscle is resorbed and the infarct shrinks and be- 
comes pale grey. 
7. By the end of 6 weeks, the infarcted area is replaced by a thin, grey- 
white, hard, shrunken fibrous scar which is well developed in about 2 to 3 
months. However, the time taken by an infarct to heal by fibrous scar may vary 
depending upon the size of the infarct and adequacy of collateral circulation. 
Microscopically, the changes are similar in both transmural and suben- 
docardial infarcts. As elsewhere in the body, myocardial ischaemia induces 
ischaemic coagulative necrosis of the myocardium which eventually heals by 
fibrosis. 
I. First week: The progression of changes takes place in the following 
way:  
i) In the first 6 hours after infarction, usually no detectable histologic 
change is observed in routine light microscopy. However, some investigators 
have described stretching and waviness of the myocardial fibres within one 
hour of the onset of ischaemia. 
ii) After 6 hours, there is appearance of some oedema fluid between 
the myocardial fibres. The muscle fibres at the margin of the infarct show 




iii) By 12 hours, coagulative necrosis of the myocardial fibres sets in 
and neutrophils begin to appear at the margin of the infarct. Coagulative ne- 
crosis of fibres is characterised by loss of striations and intense eosinophilic, 
hyaline appearance and may show nuclear changes like karyolysis, pyknosis 
and karyorrhexis. Haemorrhages and oedema are present in the interstitium. 
iv) During the first 24 hours, coagulative necrosis progresses further as 
evidenced by shrunken eosinophilic cytoplasm and pyknosis of the nuclei. 
The neutrophilic infiltrate at the margins of the infarct is slight. 
v) During the first 48 to 72 hours, coagulative necrosis is complete 
with loss of nuclei. The neutrophilic infiltrate is well developed and extends 
centrally into the interstitium. 
vi) By 4th day, neutrophilic infiltrate is further pronounced with some 
of them undergoing degenerative changes. 
vii) By the end of first week, the process of resorption of necrosed 
muscle fibres by macrophages begins. Simultaneously, there is onset of pro- 
liferation of capillaries and fibroblasts from the margins of the infarct. 
 
TABLE 3. Sequential Pathologic Changes in Myocardial Infarction 
Time Gross changes Light microscopy 
First week   
0-6 hours No change or pale; 
TTC test negative in 
infarcted area 
No change; stretching and waviness 
of fibres 
6-12 hours -do- Coagulative necrosis begins; neutro- 
philic infiltration begins; oedema and 
haemorrhages present 
24 hours Cyanotic red-purple 
area of haemorrhage 
Coagulative necrosis progresses; 
marginal neutrophilic infiltrate 
48-72 hours Pale, hyperaemic Coagulative necrosis complete, neu- 
trophilic infiltrate well developed 
4th day Well-defined yellow 
border 
Prominent neutrophilic infiltrate 
some undergoing degeneration 
7th day Bright yellow to yel- 
low-green, soft 
Beginning of resorption of necrosed 
fibres by macrophages, onset of fi- 










  small infarct removed; fibrovascular 
reaction more prominent; pigmented 
macrophages, eosinophils, lympho- 
cytes, plasma cells present 
14th day ------- Necrosed muscle mostly removed; 
neutrophils disappear; fibrocollagen- 
ic tissue at the periphery 
Third 
week 
------- Necrosed muscle fibres from larger 




Thin,  grey-white, 
hard, shrunken fi- 
brous scar 
Increased fibrocollagenic tissue, de- 
creased vascularity; fewer pigmented 
macrophages, lymphocytes and 
plasma cells 
Many of the neutrophils are necrosed and gradually disappear. 
2. Second week: The changes are as under: 
i) By 10th day, most of the necrosed muscle at the periphery of infarct 
is removed. The fibrovascular reaction at the margin of infarct is more promi- 
nent. Many pigmented macrophages containing yellow-brown lipofuscin (derived 
from breakdown of myocardial cells) and golden brown haemosiderin (derived 
from lysed erythrocytes in haemorrhagic areas) are seen. Also present are a few 
other inflammatory cells like eosinophils, lymphocytes and plasma cells. 
ii) By the end of the 2nd week, most of the necrosed muscle in small 
infarcts is removed, neutrophils have almost disappeared, and newly laid col- 
lagen fibres replace the periphery of the infarct. 
3. Third week: Necrosed muscle fibres from larger infarcts continue 
to be removed and replaced by ingrowth of newly formed collagen fibres. 
Pigmented macrophages as well as lymphocytes and plasma cells are promi- 
nent while eosinophils gradually disappear. 
4. Fourth to sixth week: With further removal of necrotic tissue, there 
is increase in collagenous connective tissue, decreased vascularity and fewer 
pigmented macrophages, lymphocytes and plasma cells. Thus, at the end of 6 
weeks, a contracted fibrocollagenic scar with diminished vascularity is 
formed. The pigmented macrophages may persist for a long duration in the 
scar, sometimes for years. 
Changes in early infarcts. By special techniques like electron micros- 
copy, chemical and histochemical studies, changes can be demonstrated in 
early infarcts before detectable light microscopic alterations appear. It has 
been shown by experimental studies on early infarcts that recovery is possi- 
ble if blood flow is restored within 20 to 30 minutes of infarction after which 




1. Electron microscopic changes. Changes by EM examination are 
evident in less than half an hour on onset of infarction. These changes are: 
i) Disappearance of perinuclear glycogen granules within 5 minutes of 
ischaemia. 
ii) Swelling of mitochondria in 20 to 30 minutes. 
iii) Disruption of sarcolemma. 
iv) Nuclear alterations like peripheral clumping of nuclear chromatin. 
2. Chemical and histochemical changes. Analysis of tissues from 
early infarcts by chemical and histochemical techniques has shown a number 
of findings. These are: 
i) Glycogen depletion in myocardial fibres within 30 to 60 minutes of 
infarction. 
ii) Increase in lactic acid in the myocardial fibres. 
iii) Loss of K+ from the ischaemic fibres. 
iv) Increase of Na+ in the ischaemic cells. 
v) Influx of Ca++ into the cells causing irreversible cell injury. 
Based on the above observations and on leakage of enzymes from the 
ischaemic myocardium, alterations in the concentrations of various enzymes 
are detected in the blood of these patients. 
COMPLICATIONS. Following an attack of acute MI, only 10-20% cases 
do not develop major complications and recover. The remainder 80-90% cas- 
es develop one or more major complications, some of which are fatal. The 
immediate mortality from acute MI (sudden cardiac death) is about 25%. The im- 
portant complications which may develop following acute MI are as follows: 
1. Arrhythmias. Arrhythmias are the most common form of complica- 
tions in acute MI. These occur due to ischaemic injury or irritation to the 
conduction system, resulting in abnormal rhythm. Other causes of arrhythmi- 
as include leakage of K+ from ischaemic muscle cells and increased concen- 
tration of lactate and free fatty acids in the tissue fluid. Arrhythmias may be 
in the form of sinus tachycardia or sinus bradycardia, atrial fibrillation, prem- 
ature systoles, and the most serious ventricular fibrillation responsible for 
many sudden cardiac deaths. 
2. Congestive heart failure. About half the patients with MI develop 
CHF which may be in the form of right ventricular failure, left ventricular 
failure or both. CHF is responsible for about 40% of deaths from acute MI. If 
the patient survives, healing may restore normal cardiac function but in some 
CHF may persist and require regular treatment later. 
3. Cardiogenic shock. About 10% of patients with acute MI develop 
cardiogenic shock characterised by hypotension with systolic blood pressure 
of 80 mmHg or less for many days. Shock may be accompanied by peripheral 




4. Mural thrombosis and thromboembolism. The incidence of 
thromboembolism from intracardiac thrombi and from thrombosis in the leg 
veins is 15-45% in cases of acute MI and is the major cause of death in 12% 
cases. Mural thrombosis in the heart develops due to involvement of the en- 
docardium and subendocardium in the infarct and due to slowing of the heart 
rate. Mural thrombi often form thromboemboli. Another source of thrombo- 
emboli is the venous thrombosis in the leg veins due to prolonged bed rest. 
Thromboemboli from either source may cause occlusion of the pulmonary, 
renal, mesenteric, splenic, pancreatic or cerebral arteries and cause infarcts in 
these organs. 
5. Rupture. Rupture of heart occurs in upto 5% cases of acute MI 
causing death. Rupture occurs most often from the infarcted ventricular wall 
into the pericardial cavity causing haemopericardium and tamponade. Other 
sites of rupture are through interventricular septum and rupture of a papillary 
muscle in infarct of the left ventricle. Rupture at any of these sites occurs 
usually in the first week and is often fatal. 
6. Cardiac aneurysm. Another 5% of patients of MI develop aneu- 
rysm, often of the left ventricle. It occurs in healed infarcts through thin, fi- 
brous, non-elastic scar tissue. Cardiac aneurysms impair the function of the 
heart and are the common sites for mural thrombi. Rarely, calcification of the 
wall of aneurysm may occur. 
7. Pericarditis. Sterile pericarditis appearing on about the second day 
is common over transmural infarcts. It is characterised by fibrinous pericardi- 
tis and may be associated with pericardial effusion. Often, it is of no func- 
tional significance and resolves spontaneously. 
8. Post-myocardial infarction syndrome. About 3 to 4% of patients 
who suffered from acute MI develop post-myocardial infarction syndrome or 
Dressler's syndrome subsequently. It usually occurs 1 to 6 weeks after the at- 
tack of MI. It is characterised by pneumonitis. The symptoms are usually 
mild and disappear in a few weeks. The exact pathogenesis of this syndrome 
is not known. It may be due to autoimmune reaction as evidenced by circulat- 
ing anti-heart antibodies in the serum of these patients. But these antibodies 
are also present in patients with MI who do not develop this syndrome. 
 
B. NON-INFARCT EFFECTS OF MYOCARDIAL ISCHAEMIA 
Myocardial ischaemia may produce effects other than infarction. These 
are: angina pectoris, chronic ischaemic heart disease, and sudden cardiac 
(coronary) death. 
ANGINA PECTORIS is a clinical syndrome of IHD resulting from transi- 
ent myocardial ischaemia. It is characterised by paroxysmal pain in the sub- 




the demand of the heart and relieved by a decrease in the work of the heart. 
Often, the pain radiates to the left arm, neck, jaw or right arm. 
There are 3 overlapping clinical patterns of angina pectoris with some 
differences in their pathogenesis: 
i) Stable or typical angina, 
ii) Prinzmetal's variant angina, 
iii) Unstable or crescendo angina. 
CHRONIC ISCHAEMIC HEART DISEASE, or Ischaemic Cardiomyopa- 
thy, or Myocardial sclerosis are the terms used for focal or diffuse fibrosis 
in the myocardium characteristically found in elderly patients of progressive 
IHD. Such small areas of fibrous scarring are commonly found in the heart of 
patients who have history of episodes of angina and attacks of MI some years 
back. The patients generally have gradually developing CHF due to decom- 
pensation over a period of years. Occasionally, serious cardiac arrhythmias or 
infarction may supervene and cause death. 
Etiopathogenesis. In majority of cases, coronary atherosclerosis caus- 
es progressive ischaemic myocardial damage and replacement by myocardial 
sclerosis. A small percentage of cases may result from other causes such as 
emboli, coronary arteritis and myocarditis. 
The mechanism of development of myocardial sclerosis can be ex- 
plained by one of the following concepts: 
i) Myocardial fibrosis represents healing of minute infarcts involving 
small scattered groups of myocardial fibres. 
ii) An alternate concept of development of myocardial sclerosis is heal- 
ing of minute areas of focal myocytolysis – the myocardial fibres in a small area 
undergo slow degeneration due to myocardial ischaemia. These fibres lose their 
myofibrils but nuclei remain intact. These foci are infiltrated by macrophages and 
eventually are replaced by proliferating fibroblasts and collagen. 
Pathologic changes. Grossly, the heart may be normal in size or hyper- 
trophied. The left ventricular wall generally shows foci of grey-white fibrosis in 
brown myocardium. Healed scars of previous MI may be present. Valves of the 
left heart may be distorted, thickened and show calcification. Coronary arteries 
invariably show moderate to severe atherosclerosis. 
Microscopically, the characteristic features are as follows: 
i) There are scattered areas of diffuse myocardial fibrosis, especially 
around the small blood vessels in the interstitial tissue of the myocardium, 
ii) Intervening single fibres and groups of myocardial fibres show vari- 
ation in fibre size and foci of myocytolysis. 




iv) Coronary arteries show atherosclerotic plaques and may have com- 
plicated lesions in the form of superimposed thrombosis. 
Sudden Cardiac (Coronary) Death is defined as sudden natural death 
from cardiac causes within 1 hour of the onset of acute cardiac symptoms. 
The most important cause is IHD; other less common causes are: coronary 
vasospasm, calcific aortic stenosis, myocarditis of various types, hyper- 
trophic cardiomyopathy, mitral valve prolapse, endocarditis, and hereditary 
and acquired defects of the conduction system. The mechanism of sudden 
death by myocardial ischaemia is almost always by fatal arrhythmias, chiefly 
ventricular asystole or fibrillation. 
Pathologic changes. At autopsy, such cases reveal most commonly 
critical atherosclerotic coronary narrowing (more than 75% compromised 
lumen) in one or more of the three major coronary arterial trunks with super- 
imposed thrombosis or plaque-haemorrhage. Healed and new myocardial in- 
farcts are found in many cases. 
TABLE 4. Lesions in Coronary Artery in Various Forms of IHD 
Types of IHD Coronary lesion 
1. Myocardial infarction Plaque haemorrhage 
Fissuring and ulceration 
Complete mural thrombosis 
2. Stable angina Critical coronary narrowing (3/4th) 
3. Unstable (pre-infarction) an- 
gina 
Plaque rupture, haemorrhage ulceration, 
Mural thrombosis with thromboembolism 
4. Chronic IHD Chronic progressive coronary atheroscle- 
rosis 
5. Sudden ischaemic death Severe multivessel disease 
Acute changes in plaque 






RHEUMATIC (OR COLLAGEN-VASCULAR) DISEASES 
A number of collagen diseases may result in chronic interstitial fibro- 
sis and destruction of blood vessels. All rheumatic diseases are characterized 
by common features: 
 systemic disorganization of connective tissue; 
 impairment of microcirculatory bed vessels: 
 impairment of immune homeostasis: 
 chronic progressive wavy course of pathologic process: 
 positive effect of corticosteroid therapy. 
This group of diseases includes: 
1. Rheumatism (Rheumatic fever). This infection-allergic disease 
damages mainly the heart and vessels. It may have different form and dura- 
tion. Clinicomorhologic forms of rheumatism are polyarthritic, cardio- 
vascular, cerebral, nodular. 
2. Scleroderma (progressive systemic sclerosis). 
3. Rheumatoid arthritis. 
4. Systemic lupus erythematosus. 
5. Dermatomyositis and polymyositis. 
6. Sjogren's syndrome. Patients with Sjogren's syndrome often have 
rheumatoid arthritis and associated pulmonary changes. Involvement of the 
bronchial mucous gland by a process similar to that in the salivary glands can 
lead to inadequate bronchial clearance and repeated infections. 
7. Wegener's granulomatosis. 
All rheumatic diseases have common features: 
systemic disorganization of connective tissue, 
damage of microcirculatory bed vessels, 
impairment of immune homeostasis, 
progressive course of pathologic process, 
positive effect of corticosteroid therapy. 
Microscopically, these granulomas have foci of fibrinoid necrosis and 
intense exudate of lymphocytes, plasma cells and macrophages with scattered 
multinucleate giant cells. Besides necrotising granulomas, there is associated 
vasculitis. 
RHEUMATIC FEVER (RHEUMATISM) 
 
Rheumatic fever (RF) is a systemic, post-streptococcal, non- 
suppurative inflammatory disease, principally affecting the heart, joints, cen- 
tral nervous system, skin and subcutaneous tissues. The chronic stage of RF 
involves all the layers of the heart (pancarditis) causing major cardiac seque- 
lae referred to as rheumatic heart disease (RHD). In spite of its name suggest- 




is the heart rather than the joints which is first affected. William Boyd years 
ago gave the dictum 'rheumatism licks the joint, but bites the whole heart'. 
Incidence. The disease appears most commonly in children between 
the age of 5 to 15 years when the streptococcal infection is most frequent and 
intense. Both the sexes are affected equally, though some investigators have 
noted a slight female preponderance. 
The geographic distribution, incidence and severity of RF and RHD 
are generally related to the frequency and severity of streptococcal pharynge- 
al infection. The disease is seen more commonly in poor socioeconomic stra- 
ta of the society living in damp and overcrowded places which promote in- 
terpersonal spread of the streptococcal infection. Its incidence has declined in 
the developed countries as a result of improved living conditions and use of 
antibiotics in streptococcal infection. But it is still common in the developing 
countries of the world like in India, Pakistan, some Arab countries, parts of 
Africa and South America. 
Etiopathogenesis. After a long controversy, the etiologic role of preced- 
ing throat infection with β-haemolytic streptococci of group A in RF is now 
generally accepted. However, the mechanism of lesions in the heart, joints and 
other tissues is not by direct infection but by induction of hypersensitivity or au- 
toimmunity. Thus, there are 2 components in the etiology and pathogenesis of 
RF and RHD: the infective component and the autoimmune component. 
A. The infective component. There is a body of clinical and epidemi- 
ological evidence to support the concept that RF occurs following infection 
of the throat and upper respiratory tract with β-haemolytic streptococci of 
Lancefield group A. These evidences are as under: 
1. There is often a history of infection of the pharynx and upper respiratory 
tract with this microorganism about 2 to 3 weeks prior to the attack of RF. This 
period is usually the latent period required for sensitisation to the bacteria. 
2. Subsequent attacks of streptococcal infection are generally associat- 
ed with exacerbations of RF. 
3. A higher incidence of RF has been observed after outbreaks and ep- 
idemics of streptococcal infection of throat in children from schools or in 
youngmen from training camps. 
4. Administration of antibiotics leads to lowering of the incidence as 
well as severity of RF and its recurrences. 
5. Cardiac lesions similar to those seen in RHD have been produced in 
experimental animals by induction of repeated infection with P-haemolytic 
streptococci of group A. 
6. Patients with RF have elevated titres of antibodies to the antigens of 
β-haemolytic streptococci of group A such as anti-streptolysin O (ASO), anti- 




7. Socioeconomic factors like poverty, poor nutrition, density of popu- 
lation, overcrowding in quarters for sleeping etc are associated with spread of 
infection, lack of proper medical attention and hence higher incidence of RF. 
8. The geographic distribution of the disease, as already pointed out, 
shows higher frequency and severity of the disease in the developing coun- 
tries of the world where the living conditions are substandard and medical fa- 
cilities are insufficient. Populations in these regions develop recurrent throat 
infections which remain untreated and have higher incidence of RF. 
9. The role of climate in the development of RF has been reported by 
some workers. The incidence of the disease is higher in subtropical and tropi- 
cal regions with cold, damp climate near the rivers and waterways which fa- 
vour the spread of infection. 
10. The individual susceptibility to RF and familial incidence have 
been reported. The factors contributing to proneness to develop RF include 
adverse social conditions, presence of streptococcal carrier at home and, as 
yet unclear role of hereditary defect. 
Despite all these evidences, only a small proportion of patients with 
streptococcal pharyngeal infection develop RF – the attack rate is less than 
3%. There is a suggestion that a concomitant virus enhances the effect of 
streptococci in individuals who develop RF. The microorganisms are not cul- 
tured from the lesions in the heart, joints and other tissues at the time RF ap- 
pears 2 to 3 weeks after acute streptococcal infection. 
B. The autoimmune component. Failure to grow microorganism 
from the active rheumatic lesions in different tissues has led to the concept 
that some antigenic products of streptococci in throat are absorbed through 
the blood vessels and lymphatics and are then distributed to different tissues. 
These streptococcal antigens incite autogenous tissues to form autoantibodies 
which react with specific tissue components to produce the lesions in RF. 
The following evidences are cited in support of the autoimmune concept: 
1. Anti-heart antibodies formed as a result of autoimmune reaction to heart 
tissues have been demonstrated in patients of RF who develop cardiac lesions. 
2. Experimental induction of rheumatic condition in rats by injecting 
mixture of killed streptococci and emulsions of target tissue (e.g. heart or 
connective tissue) has been possible. Autoantibodies against its own respec- 
tive tissues are demonstrated in blood. 
However, it has not been possible to characterise the specific strepto- 
coccal products nor is it clear which individual will develop RF and RHD 
following streptococcal pharyngeal infection. 
Pathologic changes. RF is generally regarded as an autoimmune focal 




cardiac lesions of RF in the form of pancarditis, particularly the valvular le- 
sions, are its major manifestations. However, supportive connective tissues at 
other sites like the synovial membrane, periarticular tissue, skin and subcuta- 
neous tissue, arterial wall, lungs, pleura and the CNS are all affected (extra- 
cardiac lesions). 
A. CARDIAC LESIONS 
The cardiac manifestations of RF are in the form of focal inflammatory 
involvement of the interstitial tissue of all the three layers of the heart, the so- 
called pancarditis. The pathognomonic feature of pancarditis in RF is the 
presence of distinctive Aschoff nodules or Aschoff bodies. 
TABLE 5. Classification of Cardiovascular form of Rheumatic Fever 
 




Vasculitis Nodular productive 
(granulomatous) 
Serous 
Acute warty endo- 
carditis 
Diffusive exudative Serous-fibrinous 
Fibroplastic Spotted interstitial 
myocarditis 
Fibrinous 
Reverse warty   
The Aschoff nodules or bodies. The Aschoff nodules or the Aschoff 
bodies are spheroidal or fusiform distinct microscopic structures occurring in 
the interstitium of the heart in RF. They are especially found in the vicinity of 
small blood vessels in the myocardium and endocardium and occasionally in 
the pericardium and the adventitia of the proximal part of the aorta. Lesions 
similar to the Aschoff nodules may be found in the extra-cardiac tissues. 
Evolution of fully-developed Aschoff bodies involves 3 stages all of 
which may be found in the same heart at different stages of development. 
These are as follows: 
1. Early (exudative or degenerative) stage. The earliest sign of injury 
in the heart in RF is apparent by about 4th week of illness. Initially, there is 
oedema of the connective tissue and increase in acid mucopolysaccharide in 
the ground substance. This results in separation of the collagen fibres by ac- 
cumulating ground substance. Eventually, the collagen fibres are fragmented 
and disintegrated and the affected focus takes the appearance and staining 
characteristics of fibrin. This change is referred to as fibrinoid degeneration. 
2. Intermediate (proliferative or granulomatous) stage. It is this 
stage of the Aschoff body which is pathognomonic of rheumatic conditions. 




change is followed by proliferation of cells resulting in formation of lympho- 
cytes, plasma cells, a few neutrophils and the characteristic cardiac histiocytes 
(Anitschkow  cells)  at  the  margin  of  the  lesion.  Cardiac  histiocytes  or 
Anitschkow cells are present in small numbers in normal heart but their number 
is increased in the Aschoff bodies. These are large mononuclear cells having 
central round nuclei and contain moderate amount of amphophilic cytoplasm. 
The nuclei are vesicular and contain prominent central chromatin mass which in 
longitudinal section appears serrated or caterpillar-like, while in cross-section 
the chromatin mass appears as a small rounded body in the centre of the vesicu- 
lar nucleus, just like an owl's eye. Some of these modified cardiac histiocytes 
become multinucleate cells containing 1 to 4 nuclei and are called Aschoff cells. 
The origin and nature of the Anitschkow cells have long been debated. 
They are considered by most workers as modified cardiac histiocytes. How- 
ever, others consider Anitschkow cells as derivatives of striated heart muscle 
cells or of non-striated smooth muscle cells present in the endocardium. Still 
others have suggested the genesis of these cells from proliferation of diseased 
lymphatic vessels in RF. 
3. Late (healing or fibrous) stage. The stage of healing by fibrosis of 
the Aschoff nodule occurs in about 12 to 16 weeks after the illness. The nod- 
ule becomes oval or fusiform in shape, about 200 μm wide and 600 μm long. 
The Anitschkow cells in the nodule become spindle-shaped with diminished 
cytoplasm and the nuclei stain solidly rather than showing vesicular charac- 
ter. These cells tend to be arranged in a palisaded manner. With passage of 
months and years, the Aschoff body becomes less cellular and the collagen- 
ous tissue is increased. Eventually, it is replaced by a small fibrocollagenous 
scar with little cellularity, frequently located perivascularly. 
RHEUMATIC PANCARDITIS. Although all the three layers of the heart 
are affected in RF, the intensity of their involvement is variable. 
RHEUMATIC ENDOCARDITIS. Endocardial lesions of RF may involve 
the valvular and mural endocardium, causing rheumatic valvulitis and mural 
endocarditis, respectively. Rheumatic valvulitis is chiefly responsible for the 
major cardiac manifestations in chronic RHD. 
RHEUMATIC VALVULITIS. Grossly, the valves in acute RF show thick- 
ening and loss of translucency of the valve leaflets or cusps. This is followed 
by the formation of characteristic, small (1 to 3 mm in diameter), rnulitple, 
warty vegetations or verrucae, chiefly along the line of closure of the leaflets 
and cusps. These tiny vegetations are almost continuous so that the free mar- 
gin of the cusps or leaflets appears as a rough and irregular ridge. The vegeta- 




they are not likely to get detached to form emboli, unlike the friable vegeta- 
tions of infective endocarditis. 
Though all the four heart valves are affected, their frequency and se- 
verity of involvement varies: mitral valve alone being the most common site, 
followed in decreasing order of frequency, by combined mitral and aortic 
valve. The tricuspid and pulmonary valves usually show infrequent and slight 
involvement. The higher incidence of vegetations on left side of the heart is 
possibly because of the greater mechanical stresses on the valves of the left 
heart, especially along the line of closure of the valve cusps. The occurrence 
of vegetations on the atrial surfaces of the atrioventricular valves (mitral and 
tricuspid) and on the ventricular surface of the semilunar valves (aortic and 
pulmonary) further lends support to the role of mechanical pressure on the 
valves in the pathogenesis of vegetations. 
The chronic stage of RHD is characterised by permanent deformity of 
one or more valves, especially the mitral and aortic. The frequency of de- 
formity of various valves is as under: mitral alone in 65-70% of cases, mitral 
and aortic combined in about 25% cases, and rarely tricuspid and pulmonary 
valves are involved. The macroscopic appearance of chronic healed valves in 
RHD is the most characteristic 'fish mouth' or 'button hole' stenosis of the mi- 
tral valve. Mitral stenosis and insufficiency are commonly combined in 
chronic RHD; calcific aortic stenosis may also be found. These healed chron- 
ic valvular lesions in RHD occur due to diffuse fibrocollagenous thickening 
and calcification of the valve cusps or leaflets which cause adhesions be- 
tween the lateral portions, especially in the region of the commissures. 
Thickening, shortening and fusion of the chordae tendineae further contribute 
to the chronic valvular lesions. Microscopically, the inflammatory changes 
begin in the region of the valve rings (where the leaflets are attached to the 
fibrous annulus) and then extend throughout the entire leaflet, whereas vege- 
tations are usually located on the free margin of the leaflets and cusps. 
i) In the early (acute) stage, the histological changes are oedema of 
the valve leaflet, presence of increased number of capillaries and infiltration 
with lymphocytes, plasma cells, histiocytes with many Anitschkow cells and a 
few polymorphs. Occasionally, Aschoff bodies with central foci of fibrinoid ne- 
crosis and surrounded by palisade of cardiac histiocytes are seen, but more often 
the cellular infiltration is diffuse in acute stage of RF. Vegetations present at the 
free margins of cusps appear as eosinophilic, tiny structures mainly consisting of 
fibrin with superimposed platelet-thrombi and do not contain bacteria. 
ii) In the healed (chronic) stage, the vegetations have undergone or- 
ganisation. The valves show diffuse thickening as a result of fibrous tissue 




may still be evident in the form of thick-walled blood vessels with narrowed 
lumina. Typical Aschoff bodies are rarely seen in the valves at this stage. 
Rheumatic mural endocarditis. Mural endocardium may also show 
features of rheumatic carditis though the changes are less conspicuous as 
compared to valvular changes. 
Grossly, the lesions are seen most commonly as MacCallum's patch 
which is the region of endocardial surface in the posterior wall of the left 
atrium just above the posterior leaflet of the mitral valve. MacCallum's patch 
appears as a map-like area of thickened, roughened and wrinkled part of the 
endocardium. 
Microscopically, the appearance of MacCallum's patch is similar to 
that seen in rheumatic valvulitis. The affected area shows oedema, fibrinoid 
change in the collagen, and cellular infiltrate of lymphocytes, plasma cells 
and macrophages with many Anitschkow cells. Typical Aschoff bodies may 
sometimes be found. 
RHEUMATIC MYOCARDITIS. Grossly, in the early (acute) stage, the 
myocardium, especially of the left ventricle, is soft and flabby. In the inter- 
mediate stage, the interstitial tissue of the myocardium shows small foci of 
necrosis. Later, tiny pale foci of the Aschoff bodies may be visible through- 
out the myocardium. 
Microscopically, the most characteristic feature of rheumatic myocar- 
ditis is the presence of distinctive Aschoff bodies. These diagnostic nodules 
are scattered throughout the interstitial tissue of the myocardium and are 
most frequent in the interventricular septum, left ventricle and left atrium. 
Derangements of the conduction system may, thus, be present. The Aschoff 
bodies are best identified in the intermediate stage when they appear as granu- 
lomas with central fibrinoid necrosis and are surrounded by palisade of 
Anitschkow cells and multinucleate Aschoff cells. There is infiltration by lym- 
phocytes, plasma cells and some neutrophils. In the late stage, the Aschoff bod- 
ies are gradually replaced by small fibrous scars in the vicinity of blood vessels 
and the inflammatory infiltrate subsides. Presence of active Aschoff bodies 
along with old healed lesions is indicative of rheumatic activity. 
RHEUMATIC PERICARDITIS. Inflammatory involvement of the pericar- 
dium commonly accompanies RHD. 
Grossly, the usual finding is fibrinous pericarditis in which there is 
loss of normal shiny pericardial surface due to deposition of fibrin on its sur- 
face and accumulation of slight amount of fibrinous exudate in the pericardial 
sac. If the parietal pericardium is pulled off from the visceral pericardium, the 
two separated surfaces are shaggy due to thick fibrin covering them. This ap- 




buttered surfaces of two slices in a sandwich when they are gently pulled 
apart. If fibrinous pericarditis fails to resolve and, instead, undergoes organi- 
sation, the two layers of the pericardium form fibrous adhesions resulting in 
chronic adhesive pericarditis. Microscopically, fibrin is identified on the sur- 
faces. The subserosal connective tissue is infiltrated by lymphocytes, plasma 
cells, histiocytes and a few neutrophils. Characteristic Aschoff bodies may be 
seen which later undergo organisation and fibrosis. Organisation of the exu- 
date causes fibrous adhesions between the visceral and parietal surfaces of 
the pericardial sac and obliterates the pericardial cavity. 
B. EXTRA-CARDIAC LESIONS 
Patients of the syndrome of acute rheumatism develop lesions in con- 
nective tissue elsewhere in the body, chiefly the joints, subcutaneous tissue, 
arteries, brain and lungs. 
POLYARTHRITIS. Acute and painful inflammation of the synovial mem- 
branes of some of the joints, especially the larger joints of the limbs, is seen in 
about 90% cases of RF in adults and less often in children. As pain and swelling 
subside in one joint, others tend to get involved, producing the characteristic 
'migratory polyarthritis' involving two or more joints at a time. 
Histologically, the changes are transitory. The synovial membrane and 
the periarticular connective tissue show hyperaemia, oedema, fibrinoid change 
and neutrophilic infiltration. Sometimes, focal lesions resembling Aschoff bod- 
ies are observed. A serous effusion into the joint cavity is commonly present. 
SUBCUTANEOUS NODULES. The subcutaneous nodules of RF occur 
more often in children than in adult. These nodules are small (0.5 to 2 cm in 
diameter), spherical or ovoid and painless. They are attached to deeper struc- 
tures like tendons, ligaments, fascia or periosteum and therefore often remain 
unnoticed by the patient. Characteristic locations are extensor surfaces of the 
wrists, elbows, ankles and knees. 
Histologically, the subcutaneous nodules of RF are representative of giant 
Aschoff bodies of the heart. They consist of 3 distinct zones: a central area with 
fibrinoid changes, surrounded by a zone of histiocytes and fibroblasts forming a 
palisade arrangement, and the outermost zone of connective tissue which is infil- 
trated by nonspecific chronic inflammatory cells and proliferating blood vessels. 
It may be mentioned here that histologically similar but clinically dif- 
ferent subcutaneous lesions appear in rheumatoid arthritis; they are larger, 
painful and tender and persist for months to years. 
ERYTHEMA MARGINATUM. This nonpruritic erythematous rash is char- 
acteristic of RF. The lesions occur mainly on the trunk and proximal parts of the 
extremities. The erythematous area develops central clearing and has slightly 




RHEUMATIC ARTERITIS. Arteritis in RF involves not only the coronary 
arteries and aorta but also occurs in arteries of various other organs such as 
renal, mesenteric and cerebral arteries. The lesions in the coronaries are seen 
mainly in the small intramyocardial branches. 
Histologically, the lesions may be like those of hypersensitivity angiitis, 
or sometimes may resemble polyarteritis nodosa. Occasionally, foci of fibrinoid 
necrosis or ill-formed Aschoff bodies may be present close to the vessel wall. 
CHOREA MINOR. Chorea minor or Sydenham's chorea or Saint Virus' 
dance is a delayed manifestation of RF as a result of involvement of the cen- 
tral nervous system. The condition is characterised by disordered and invol- 
untary jerky movements of the trunk and the extremities accompanied by 
some degree of emotional instability. The condition occurs more often in 
younger age, particularly in girls. 
Histologically, the lesions are located in the cerebral hemispheres, 
brainstem and the basal ganglia. They consist of small haemorrhages, oedema 
and perivascular infiltration of lymphocytes. There may be endarteritis oblit- 
erans and thrombosis of cortical and meningeal vessels. 
RHEUMATIC PNEUMONITIS AND PLEURITIS. Involvement of the lungs 
and pleura occurs rarely in RF. Pleuritis is often accompanied with serofi- 
brinous pleural effusion but definite Aschoff bodies are not present. In rheu- 
matic pneumonitis, the lungs are large, firm and rubbery. 
Histologically, the changes are oedema, capillary haemorrhages and 
focal areas of fibrinous exudate in the alveoli. Aschoff bodies are generally 
not found. 
The major causes of death in RHD are cardiac failure, bacterial en- 
docarditis and embolism: 
1. Cardiac failure is the most common cause of from RHD. In young 
patients, cardiac failure occurs due to the chronic valvular deformities, while 
in patients coronary artery disease may be superim on old RHD. 
2. Bacterial endocarditis of both acute and subacul may supervene due 
to inadequate use of antibiotics. 
3. Embolism in RHD originates most commonly mural thrombi in the 
left atrium and its appendages, in association with mitral stenosis. The organs 
most frequently affected are the brain, kidneys, spleen and lungs. 
4. Sudden death may occur in RHD as a result of ball thrombus in the left 
atrium or due to acute coronary insufficiency in association with aortic stenosis. 
RHEUMATOID ARTHRITIS 
Rheumatoid arthritis (RA) is a chronic multisystem disease of un- 
known cause. Though the most prominent manifestation of RA is inflamma- 




its systemic manifestations include haematologic, pulmonary, neurological 
and cardiovascular abnormalities. 
RA is a common disease having peak incidence in 3rd to 4th decades of 
life, with 3-5 times higher preponderance in females. The condition has high as- 
sociation with FILA-DR4 and HLA-DR1 and familial aggregation. The onset of 
disease is insidious, beginning with prodrome of fatigue, weakness, joint stiff- 
ness, vague arthralgias and myalgias. This is followed by pain and swelling of 
joints usually in symmetrical fashion, especially involving joints of hands, 
wrists and feet. Unlike migratory polyarthritis of rheumatic fever, RA usually 
persists in the involved joint. Approximately 20% of patients develop rheuma- 
toid nodules located over the extensor surfaces of the elbows and fingers. 
About 80% of cases are seropositive for rheumatoid factor (RF). Howev- 
er, RF titres are elevated in certain unrelated diseases too such as in: viral hepati- 
tis, cirrhosis, sarcoidosis and leprosy. Advanced cases show characteristic radio- 
logic abnormalities such as narrowing of joint space and ulnar deviation of the 
fingers and radial deviation of the wrist. Other laboratory findings include mild 
normocytic and normochromic anaemia, elevated ESR, mild leucocytosis and 
hypergammaglobulinaemia. Extra-articular manifestations infrequently produce 
symptoms, but when present complicate the diagnosis. 
Etiopathogenesis. The exact etiology and pathogenesis of RA are not 
known. At different times, various factors have been implicated which include: 
endocrine imbalance, climate, hypersensitivity reactions, infections, postinfec- 
tious immunologic reactions, autoimmunity, heredity and psychophysiologic 
disorders. However, present concept on etiology and pathogenesis proposes that 
RA occurs in an immunogenetically predisposed individual to the effect of mi- 
crobial agents acting as trigger antigen. More recently, the role of superan- 
tigens which are produced by several microorganisms with capacity to bind 
to HLA-DR molecules has been proposed. 
I. Immunologic derangements. A number of observations in patients 
and experimental animals indicate the role of immune processes, particularly au- 
toimmune phenomenon, in the development of RA. These include the following: 
1. Detection of circulating autoantibody called rheumatoid factor (RF) 
against Fc portion of autologous IgG in about 80% cases of RA. RF antibod- 
ies are heterogeneous and consist of IgM, IgG and IgA. 
2. The presence of antigen-antibody complexes (IgG-RF complexes) in 
the circulation as well as in the synovial fluid. 
3. The presence of other autoantibodies such as antinuclear factor 
(ANF), antibodies to collagen type II, and antibodies to cytoskeleton. 
4. Antigenicity of proteoglycans of human articular cartilage. 





6. Association of RA with amyloidosis. 
7. Activation of cell-mediated immunity as evidenced by presence of 
numerous inflammatory cells in the synovium, chiefly CD4+ T lymphocytes 
and some macrophages. 
II. Trigger events. Though the above hypothesis of a possible role of 
autoimmunity in the etiology and pathogenesis of RA is generally widely ac- 
cepted, controversy continues as regards the trigger events which initiate the 
destruction of articular cartilage. Various possibilities which have been sug- 
gested are as follows: 
1. The existence of an infectious agent such as mycoplasma, Epstein- 
Barr virus (EBV), cytomegalovirus (CMV) or rubella virus, either locally in 
the synovial fluid or systemic infection some time prior to the attack of RA. 
2. The possible role of HLA-DR4 and HLA-DR1 in initiation of im- 
munologic damage. 
The various mediators which are potentially damaging to the cartilage 
and subjacent bone are elaborated by neutrophils (e.g. reactive free radicals, 
proteases, PGE2 and leukotrienes); synoviocytes (e.g. colla-genase, PGE2 
and IL-1), lymphocytes (e.g. lymphokines such as IL-2, γ-interferon, macro- 
phage inhibitory and activating factors) and macrophages (e.g. monokines 
such as interleukin-1 and tumour necrosis factor). 
Pathologic Changes. The predominant pathologic lesions are found in 
the joints and tendons, and less often, extra-articular lesions are encountered. 
Articular Lesions. RA involves first the small joints of hands and feet 
and then symmetrically affects the joints of wrists, elbows, ankles and knees. 
The proximal interphalangeal and metacarpo-phalangeal joints are affected most 
severely. Frequently cervical spine is involved but lumbar spine is spared. 
Histologically, the characteristic feature is diffuse proliferative synovi- 
tis with formation of pannus. The microscopic changes are as under: 
1. Numerous folds of large villi of synovium. 
2. Marked thickening of the synovial membrane due to oedema, con- 
gestion and multilayering of synoviocytes. 
3. Intense inflammatory cell infiltrate in the synovial membrane with 
predominence of lymphocytes, plasma cells and some macrophages, at places 
forming lymphoid follicles. 
4. Foci of fibrinoid necrosis and fibrin deposition. 
The pannus progressively destroys the underlying cartilage and sub- 
chondral bone. This invasion of pannus results in demineralisation and cystic 
resorption of underlying bone. Later, fibrous adhesions or even bony ankylo- 
sis may unite the two opposing joint surfaces. In addition, persistent inflam- 




Extra-Articular Lesions. Nonspecific inflammatory changes are seen 
in the blood vessels (acute vasculitis), lungs, pleura, pericardium, myocardium, 
lymph nodes, peripheral nerves and eyes. But one of the characteristic extra- 
articular manifestation of RA is occurrence of rheumatoid nodules in the skin. 
Rheumatoid nodules are particularly found in the subcutaneous tissue 
over pressure points such as the elbows, occiput and sacrum. The center of 
these nodules consists of an area of fibrinoid necrosis and cellular debris, sur- 
rounded by several layers of palisading large epithelioid cells, and peripheral- 
ly there are numerous lymphocytes, plasma cells and macrophages. Similar 
nodules may be found in the lung parenchyma, pleura, heart valves, myocar- 
dium and other internal organs. 
There are some variants of RA: 
1. Juvenile RA found in adolescent patients under 16 years of age is 
characterised by acute onset of fever and predominant involvement of knees 
and ankles. Pathologic changes are similar but RF is rarely present. 
2. Felty's syndrome consists of polyarticular RA associated with sple- 
nomegaly and hypersplenism and consequent haematologic derangements. 
3. Ankylosing spondylitis or rheumatoid spondylitis is rheumatoid 
involvement of the spine, particularly sacro-iliac joints, in young male pa- 
tients. The condition has a strong HLA-B27 association and may have asso- 
ciated inflammatory diseases such as inflammatory bowel disease, anterior 
uveitis and Reiter's syndrome. 
Pulmonary involvement in rheumatoid arthritis may result in pleural 
effusion, interstitial pneumonitis, necrobiotic nodules and rheumatoid pneumo- 
coniosis (Caplan's syndrome). The parenchymatous lesions in rheumatoid arthritis 
are most commonly seen in the lower lobe. Necrobiotic nodules are the most spe- 
cific manifestations of rheumatoid disease and closely resemble the subcutaneous 
nodules commonly found in rheumatoid arthritis. 
SYSTEMIC LUPUS ERYTHEMATOSUS 
Systemic lupus erythematosus (SLE), or Libman – Sak`s disease, is a 
chronic disease of connective tissue with expressive autoimmunization and 
predominant damage of skin, vessels and kidney. Mostly young women suf- 
fer (90%) from SLE. 
SLE is the classical example of systemic autoimmune or collagen diseases. 
The disease derives its name “lupus” from the Latin word meaning “wolf” since 
initially this disease was believed to affect skin only and eat away skin like a 
wolf. However, now 2 forms of lupus erythematosus are described: 
1. Systemic or disseminated form is characterised by acute and 
chronic inflammatory lesions widely scattered in the body and there is pres- 




2. Discoid form is characterised by chronic and localised skin lesions 
involving the bridge of nose and adjacent cheeks without any systemic manifes- 
tations. Rarely, discoid form may develop into disseminated form. 
Etiology. The exact etiology of SLE is not known. However, autoanti- 
bodies against nuclear and cytoplasmic components of the cells are demon- 
strable in plasma by immunofluorescence tests in almost all cases of SLE. 
There is impairment in regulation of both humoral and cell-mediated im- 
munity. Humoral reaction develops due to appearance of autoantibodies to 
different nuclear and cytoplasm components (to DNA, RNA, nucleoproteins, 
erythrocytes, lymphocytes and thrombocytes) and formation of large amount 
of immune complexes. It leads to fibrinoid necrosis resulting from delayed 
hypersensitivity reaction. 
Some of the important antinuclear antibodies (ANAs) against different 
nuclear antigens are: 
i) antibodies to double-stranded or single-stranded DNA; 
ii) antibodies to histones; 
iii) antibodies to non-histone proteins bound to RNA; and 
iv) antibodies to nucleolar antigens. 
Out of these ANAs, antibodies to double-stranded DNA are pathog- 
nomonic of SLE. 
The source of these autoantibodies as well as hypergammaglobulinae- 
mia in SLE is the polyclonal activation of B cells brought about by following 
derangements: 
1. Immunologic factors. These include: 
i) an inherited defect in B cells; 
ii) stimulation of B cells by microorganisms; 
iii) ) T helper cell hyperactivity; and 
iv) T suppressor cell defect. 
2. Genetic factors. Genetic predisposition to develop autoantibodies to 
nuclear and cytoplasmic antigens in SLE is due to the immunoregulatory 
function of class II HLA genes implicated in the pathogenesis of SLE. 
3. Other factors. Various other factors express the genetic susceptibil- 
ity of an individual to develop clinical disease. These factors are: 
i) certain drugs e.g. penicillamine D; 
ii) certain viral infections e.g. EBV infection; and 
iii) ) certain hormones e.g. oestrogen. 
Pathogenesis. The autoantibodies formed by any of the mechanisms 
explained above are the mediators of tissue injury in SLE. Two types of im- 
munologic tissue injury can occur in SLE: 
1. Type III hypersensitivity is characterised by antigen-antibody com- 




complex) which is deposited at sites such as renal glomeruli, walls of small 
blood vessels etc. 
2. Type II hypersensitivity is characterised by formation of autoanti- 
bodies against blood cells (red blood cells, platelets, leucocytes) and results 
in haematologic derangement in SLE. 
LE cell phenomenon. This was the first diagnostic laboratory test de- 
scribed for SLE. The test is based on the principle that ANAs cannot pene- 
trate the intact cells and thus cell nuclei should be exposed to bind them with 
the ANAs. The binding of exposed nucleus with ANAs results in homogene- 
ous mass of nuclear chromatin material which is called LE body or haema- 
toxylin body. 
LE cell is a phagocytic leucocyte, commonly polymorphonuclear neu- 
trophil, and sometimes a monocyte, which engulfs the homogeneous nuclear 
material of the injured cell. For demonstration of LE cell phenomenon in vitro, 
the blood sample is traumatized to expose the nuclei of blood leucocytes to AN- 
As. This results in binding of denatured and damaged nucleus with ANAs. The 
ANA-coated denatured nucleus is chemotactic for phagocytic cells. 
• If this mass is engulfed by a neutrophil, displacing the nucleus of 
neutrophil to the rim of the cell, it is called LE cell. 
• If the mass, more often an intact lymphocyte, is phagocytosed by a 
monocyte, it is called Tart cell. 
LE cell test is positive in 70% cases of SLE while newer and more sen- 
sitive immunofluorescence tests for autoantibodies are positive in almost 
100% cases of SLE. A few other conditions may also show positive LE test 
e.g., rheumatoid arthritis, lupoid hepatitis, penicillin sensitivity etc. 
Pathologic changes. The manifestations of SLE are widespread in dif- 
ferent visceral organs as well as show erythematous cutaneous eruptions. The 
principal lesions are renal, vascular, cutaneous and cardiac; other organs and 
tissues involved are serosal linings (pleuritis, pericarditis); joints (synovitis); 
spleen (vasculitis); liver (portal triaditis); lungs (interstitial pneumonitis, fi- 
brosing alveolitis) and CNS (vasculitis). 
Histologically, the characteristic lesion in SLE is fibrinoid necrosis 
which may be seen in the connective tissue, beneath the endothelium in small 
blood vessels, under the mesothelial lining of pleura and pericardium, under the 
endothelium in endocardium, or under the synovial lining cells of joints. 
Visceral manifestations of SLE are different. In 25% of cases heart 
damage is described with lesion of all there layers. In some patients abacteri- 
al endocarditis develops. There are butterfly rashes on the skin of face, glo- 
merulonephritis with proteinuria and hematuria. 
Renal manifestations of systemic lupus erythematosus (SLE) are 




from 40 to 75%. The two cardinal clinical manifestations of lupus nephritis 
are proteinuria and haematuria. In addition, hypertension and casts of differ- 
ent types such as red cell casts, fatty casts and leucocyte casts in the urinary 
sediment are found. 
Pathologic Changes, According to the WHO, six patterns of mutually- 
merging renal lesions are seen in lupus nephritis: 
Class I: Minimal lesions. On light microscopy, these cases do not 
show any abnormality. But examination by electron microscopy and immu- 
nofluorescence microscopy shows deposits within the mesangium which con- 
sist of IgG and C3. 
Class II: Mesangial lupus nephritis. These cases have mild clinical 
manifestations. By light micros copy, there is increase in the number of 
mesangial cells and of mesangial matrix. Ultrastructural and immunofluores- 
cence studies reveal granular mesangial deposits of IgG and C3; sometimes 
IgA and IgM are also present in the deposits. 
Class III: Focal segmental lupus nephritis. This is characterised by 
focal and segmental proliferation of endothelial and mesangial cells, together 
with infiltrarion by macrophages and sometimes neutrophils. 
Haematoxylin bodies of Gross may be present. Subendothelial and 
subepithelial deposits of IgG, often with IgM or IgA and C3, are seen. 
Class IV: Diffuse proliferative lupus nephritis. In this type, all the 
morphologic manifestations of lupus are present in most advanced form. This is 
the most severe and the most common form of lupus nephritis. There is diffuse 
proliferation of endothelial, mesangial, and sometimes epithelial cells, involving 
most or all glomeruli. Electron microscopy shows large electron-dense deposits in 
the mesangium and in the subendothelial region which on immuno-fluorescence 
are positive for IgG; sometimes also for IgA or IgM, and C3. 
Class V: Membranous lupus nephritis. These lesions resemble those of 
idiopathic membranous GN. These consist of diffuse thickening of glomeru- 
lar capillary wall on light microscopy and show subendothelial deposits of 
immune complexes containing IgG, IgM and C3 on ultrastructural studies. 
Class VI: Sclerosing lupus nephritis. This is end-stage kidney of SLE, 
akin to chronic GN. Most glomeruli are sclerosed and hyalinised and there 
may be remnants of preceding lesions. 
SLE, like most other autoimmune diseases, is more common in women 
in their 2nd to 3rd decades of life. SLE is a multisystem disease and thus a 
wide variety of clinical features may be present. A typical full-fledged case 
of SLE has the following characteristics: 
• butterfly-like erythematous rash on skin of face; 
• fever; 
• painful joints; 




• renal involvement (proteinuria, haematuria, casts); 
• haematologic derangements (haemolytic anaemia, thrombocytopenia, 
leucopenia); and 
• neurologic disorders (seizures, psychosis). 
The disease usually runs a long course of flare-ups and remissions; re- 
nal failure is the most frequent cause of death. 
Patients with systemic lupus erythematosus (SLE) commonly develop 
some form of lung disease during the course. The most common manifesta- 
tion of SLE is pleurisy with small amount of pleural effusion that may con- 
tain LE cells. Other pulmonary lesions in SLE are interstitial pneumonitis, 
pulmonary haemorrhage and vasculitis. 
SCLERODERMA (PROGRESSIVE SYSTEMIC SCLEROSIS) 
Just like SLE, scleroderma was initially described as a skin disease charac- 
terised by progressive fibrosis. But now, 2 main types are recognised: 
1. Diffuse scleroderma in which the skin shows widespread involve- 
ment and may progress to involve visceral structures. 
2. CREST syndrome of progressive systemic sclerosis characterised by 
Calcinosis (C), Raynaud's phenomenon (R), Esophageal hypomotility (E) 
Sclerodactyly (S) and Telangiectasia (T). 
Etiopathogenesis. The etiology of this disease is not known. However, 
antinuclear antibodies are detected in majority of cases of systemic sclerosis. 
Immunologic mechanisms have been implicated in the pathogenesis of lesions 
in systemic sclerosis which finally cause activation of fibroblasts. The immune 
mechanisms leading to stimulation of fibroblasts may act in the following ways: 
1. Elaboration of cytokines such as by fibroblast growth factor and 
chemotactic factors by activated T cells and macrophages. 
2. Endothelial cell injury due to cytotoxic damage to endothelium from 
autoantibodies or antigen-antibody complexes. This results in aggregation 
and activation of platelets which increases vascular permeability and stimu- 
lates fibroblastic proliferation. 
Pathological changes. Disseminated visceral involvement as well as 
cutaneous lesions are seen in systemic sclerosis. 
1. Skin changes. Skin is involved diffusely, beginning distally from 
fingers and extending proximally to arms, shoulders, neck and face. In ad- 
vanced stage, the fingers become claw-like and face mask-like. 
Microscopically, changes are progressive from early to late stage. 
• Early stage shows oedema and degeneration of collagen. The small- 
sized blood vessels are occluded and there is perivascular infiltrate of mono- 
nuclear cells. 
• Late stage reveals thin and flat epidermis. Dermis is largely replaced by 
compact collagen and there is hyaline thickening of walls of dermal blood ves- 




2. Kidney changes. Involvement of kidneys is seen in majority of cases 
of systemic sclerosis. The lesions are prominent in the walls of interlobular 
arteries which develop changes resembling malignant hypertension. There is 
thickening of tunica intima due to concentric proliferation of intimal cells and 
fibrinoid necrosis of vessel wall. 
3. Smooth muscle of GIT. Muscularis of the alimentary tract, particularly 
oesophagus, is progressively atrophied and replaced by fibrous tissue. 
4. Skeletal muscle. The interstitium of skeletal muscle shows progressive 
fibrosis and degeneration of muscle fibres with associated inflammatory changes. 
5. Cardiac muscle. Involvement of interstitium of the heart may result 
in heart failure. 
6. Lungs. Diffuse fibrosis may lead to contraction of the lung sub- 
stance. There may be epithelium-lined honeycombed cysts of bronchioles. 
The lungs are involved in 80% cases of scleroderma. Interstitial pulmonary 
fibrosis is the most common form of pulmonary involvement. The disease 
usually involves the lower lobes and subpleural regions of the lungs and may 
lead to honeycombing of the lung. There is increased risk of development of 
cancer of the lung in pulmonary fibrosis in scleroderma. 
7. Small arteries. The lesions in small arteries show endarteritis due to 
intimal proliferation and may be the cause for Raynaud's phenomenon. 
Systemic sclerosis is more common in middle-aged women. The clini- 
cal manifestations include claw-like flexion deformity of hands; Raynaud's 
phenomenon; oesophageal fibrosis causing dysphagia and hypomotility; mal- 
absorption syndrome; respiratory distress; malignant hypertension; pulmo- 
nary hypertension; and biliary cirrhosis. 
POLYMYOSITIS-DERMATOMYOSITIS 
As the name suggests, this disease is a combination of symmetric mus- 
cle weakness and skin rash. 
Etiopathogenesis. The exact cause of the disease is unknown. Howev- 
er, antinuclear antibodies are detected in 25% of cases. Thus, an immunolog- 
ic hypothesis has been proposed. The affected muscles are infiltrated by sen- 
sitised T lymphocytes of both T helper and T suppressor type which are con- 
sidered to bring about inflammatory destruction of muscle. Viral etiology due 
to infection with coxsackie B virus has also been suggested. 
Pathologic changes. The skeletal muscles usually affected are of pelvis, 
shoulders, neck, chest and diaphragm. Interstitial pneumonitis and interstitial 
fibrosis commonly accompany dermatomyositis and polymyositis. 
Histologically, vacuolisation and fragmentation of muscle fibres and 
numerous inflammatory cells are present. In late stage, muscle fibres are re- 




It is a multisystem disease characterised by muscle weakness, mainly 
proximal; skin rash, typically with heliotropic erythema and periorbital oe- 
dema; dysphagia due to involvement of pharyngeal muscles; respiratory dys- 
function; and association with deep-seated malignancies. 
SJOGREN'S SYNDROME 
Sjogren's syndrome is characterised by the triad of dry eyes (kerato- 
conjunctivitis sicca), dry mouth (xerostomia), and rheumatoid arthritis. The 
combination of the former two symptoms is called sicca syndrome. 
Etiopathogenesis. Immune mechanisms have been implicated in the 
etiopathogenesis of lesions in Sjogren's syndrome. Antinuclear antibodies are 
found in about 90% of cases; test for rheumatoid factor is positive in 25% of 
cases. The lesions in lacrimal and salivary glands are mediated by T lympho- 
cytes, B cells and plasma cells. 
Pathologic changes. In early stage, the lacrimal and salivary glands 
show periductal infiltration by lymphocytes and plasma cells, which at times 
may form lymphoid follicles (pseudolymphoma). In late stage, glandular pa- 
renchyma is replaced by fat and fibrous tissue. The ducts are also fibrosed 
and hyalinised. 
The disease is common in women in 4th to 6th decades of life. 
REITER'S SYNDROME 
This syndrome is characterised by triad of arthritis, conjunctivitis and 
urethritis. There may be mucocutaneous lesions on palms, soles, oral mucosa 
and genitalia. Antinuclear antibodies and RA factor are usually negative. 
MIXED CONNECTIVE TISSUE DISEASE 
This designation is applied to a syndrome having features of 3 collagen 
diseases – SLE, progressive systemic sclerosis, and dermatomyositis. High 
titers of antinuclear antibodies are detected. The clinical features are varied 
and consist of manifestations of diseases included. However, renal involve- 
ment is generally not seen and prognosis is good due to response to cortico- 
steroid therapy. 
WEGENER'S GRANULOMATOSIS 
Wegener's granulomatosis is an inflammatory lesion having 4 compo- 
nents –– granulomas of the upper respiratory tract, granulomas of the lungs, 
systemic vasculitis and focal necrotising glomerulonephritis. Localised or lim- 
ited form of the disease occurs in the lungs without involvement of other or- 
gans. Pulmonary involvement is in the form of single or multiple granulomas. 
Microscopically, these granulomas have foci of fibrinoid necrosis 
and intense exudate of lymphocytes, plasma cells and macrophages with scat- 





PATHOLOGY OF THE RESPIRATORY SYSTEM 
 
LUNGS 
Anatomy. The normal adult right lung weighs 375 to 550 gm (average 450 gm) 
and is divided by two fissures into three lobes - the upper, middle and lower lobes. The 
weight of the normal adult left lung is 325 to 450 gm (average 400 gm) and has one fis- 
sure dividing it into two lobes - the upper and lower lobes, while the middle lobe is repre- 
sented by the lingula. The airways of the lungs arise from the trachea by its division into 
right and left main bronchi which continue to divide and subdivide further so as to termi- 
nate into the alveolar sacs. The right main bronchus is more vertical so that aspirated for- 
eign material tends to pass down to the right lung rather than to the left. The trachea, ma- 
jor bronchi and their branchings possess cartilage, smooth muscle and mucous glands in 
their walls, while the bronchioles have smooth muscle but lack cartilage as well as the 
mucous glands. Between the tracheal bifurcation and the smallest bronchi, about 8 divi- 
sions take place. The bronchioles so formed further undergo 3 to 4 divisions leading to the 
terminal bronchioles which are less than 2 mm in diameter. The part of the lung tissue dis- 
tal to a terminal bronchiole is called an acinus. A cluster of about 5 acini supplied by ter- 
minal bronchioles and enclosed by visible fibrous septa is termed as the pulmonary lobule. 
An acinus consists of 3 parts: 
1. Several (usually 3 to 5 generations) respiratory bronchioles originate from a 
terminal bronchiole. 
2. Each respiratory bronchiole divides into several alveolar ducts. 
3. Each alveolar duct opens into many alveolar sacs (alveoli) which are blind ends 
of the respiratory passages. 
The lungs have double blood supply -oxygenated blood from the bronchial arteries 
and venous blood from the pulmonary arteries, and there is mixing of the blood to some 
extent. In case of blockage of one side of circulation, the supply from the other can main- 
tain the vitality of pulmonary parenchyma. The bronchial veins drain the blood supplied 
by the bronchial arteries. The lungs have abundant intercommunicating lymphatics on the 
surface which drain into the subpleural plexus. Hilar and tracheobronchial lymph nodes 
receive the lymph and drain into the thoracic duct. 
Histology. The bronchi and their subdivisions up to bronchioles are lined by pseu- 
dostratified columnar ciliated epithelial cells, also called respiratory epithelium. These 
cells are admixed with mucus-secreting goblet cells which decrease in number as the 
bronchioles are approached. The mucosa of bronchi but not of the bronchioles contains 
numerous submucosal mucous glands and neuro-endocrine cells which are bronchial 
counterparts of the argentaffin cells of the alimentary tract. The structure of bronchioles 
differs from that of bronchi and its subdivisions as well as from alveoli. They are lined by 
a single layer of pseudostratified columnar ciliated epithelium but no mucous cells and 
hence, unlike the bronchi, contain no mucus secretion on the surface. They contain some 
nonciliated Clara cells which secrete protein rich in lysozyme and immunoglobulins but 
unlike the alveoli contain no surfactant. 
The alveolar walls or alveolar septa are the sites of exchange between the blood 
and air and have the following microscopic features: 
1. The capillary endothelium lines the anastomotic capillaries in the alveolar walls. 
2. The capillary endothelium and the alveolar lining epithelial cells are separated 
by the capillary basement membrane and some interstitial tissue. The interstitial tissue 
consists of scanty amount of collagen, fibroblasts, fine elastic fibres, smooth muscle cells, 
a few mast cells and mononuclear cells. 
3. The alveolar epithelium consists of 2 types of cells: type I or membranous 




granular pneumocytes project into the alveoli and are covered by microvilli. Type II 
pneumocytes are essentially reserve cells which undergo hyperplasia when type I pneu- 
mocytes are injured and are the source of pulmonary surfactant rich in lecithin. The main 
functions of coating of surfactant are to lower the surface tension of the alveolar lining 
cells and in maintaining the stability of the alveoli. 
4. The alveolar macrophages belonging to mononuclear-phagocyte system are pre- 
sent either free in the alveolar spaces or are attached to the alveolar cells. 
5. The pores of Kohn are the sites of alveolar connections between the adjacent al- 
veoli and allow the passage of bacteria and exudate. 
 
The three important groups of diseases of the respiratory tract are: in- 




Acute and chronic pulmonary infections are common at all ages and 
are a frequent cause of death. They are generally caused by a wide variety of 
microorganisms such as bacteria, viruses, fungi and mycoplasma. 
 
PNEUMONIAS 
Pneumonia is defined as acute inflammation of the lung parenchyma 
distal to the terminal bronchioles which consist of the respiratory bronchiole, 
alveolar ducts, alveolar sacs and alveoli. The terms 'pneumonia' and 'pneu- 
monitis' are often used synonymously for inflammation of the lungs, while 
'consolidation' (meaning solidification) is the term used for macroscopic and 
radiologic appearance of the lungs in pneumonia. 
Pathogenesis. The microorganisms gain entry into the lungs by one of 
the following four routes: 
1. Inhalation of the microbes present in the air. 
2. Aspiration of organisms from the nasopharynx or oropharynx. 
3. Haematogenous spread from a distant focus of infection. 
4. Direct spread from an adjoining site of infection. The normal lung is 
free of bacteria because of the presence of a number of lung defense mecha- 
nisms at different levels such as nasopharyngeal filtering action, mucociliary 
action of the lower respiratory airways, the presence of phagocytosing alveo- 
lar macrophages and immunoglobulins. Failure of these defense mechanisms 
and presence of certain predisposing factors result in pneumonias. These 
conditions are as under: 
1. Altered consciousness. The oropharyngeal contents may be aspirat- 
ed in states causing unconsciousness e.g. in coma, cranial trauma, seizures, 
cerebrovascular accidents, drug overdose, alcoholism etc. 
2. Depressed cough and glottic reflexes. Depression of effective 
cough may allow aspiration of gastric contents e.g. in old age, pain from 




to malnutrition, kyphoscoliosis, severe obstructive pulmonary diseases, endo- 
tracheal intubation and tracheostomy. 
3. Impaired mucociliary transport. The normal protection offered by 
mucus-covered ciliated epithelium in the airways from the larynx to the ter- 
minal bronchioles is impaired or destroyed in many conditions favouring pas- 
sage of bacteria into the lung parenchyma. These conditions are cigarette 
smoking, viral respiratory infections, immotile cilia syndrome, inhalation of 
hot or corrosive gases and old age. 
4. Impaired alveolar macrophage function. Pneumonias may occur 
when alveolar macrophage function is impaired e.g. by cigarette smoke, hypox- 
ia, starvation, anaemia, pulmonary oedema and viral respiratory infections. 
5. Endobronchial obstruction. The effective clearance mechanism is 
interfered with in endobronchial obstruction from tumour, foreign body, cyst- 
ic fibrosis and chronic bronchitis. 
6. Leucocyte dysfunctions. Disorders of lymphocytes including con- 
genital and acquired immunodeficiencies (eg. AIDS, immunosuppressive 
therapy) and granulocyte abnormalities may predispose to pneumonia. 
Classification. On the basis of the anatomic part of the lung paren- 
chyma involved, pneumonias are traditionally classified into 3 main types: 
1. Lobar pneumonia, 
2. Bronchopneumonia (or Lobular pneumonia), 
3. Interstitial pneumonia. 
 
BACTERIAL PNEUMONIA 
Bacterial infection of the lung parenchyma is the most common cause of 
pneumonia or consolidation of one or both the lungs. Two kinds of acute bacte- 
rial pneumonias are distinguished – lobar pneumonia and broncho-(lobular-) 
pneumonia, each with distinct etiologic agent and morphologic changes. 
LOBAR PNEUMONIA 
Lobar pneumonia is an acute bacterial infection of a part of a lobe, the 
entire lobe, or even two lobes of one or both the lungs. 
Etiology. Based on the etiologic microbial agent causing lobar pneu- 
monia, the following types are described: 
1. Pneumococcal pneumonia: More than 90% of all lobar pneumoni- 
as are caused by Streptococcus pneumoniae, a lancet-shaped diplococcus. 
Out of various types, type 3 S. pneumoniae causes particularly virulent form 
of lobar pneumonia. Pneumococcal pneumonia in majority of cases is com- 
munity-acquired infection. 
2. Staphylococcal pneumonia: Staphylococcus aureus causes pneu- 





3. Streptococcal pneumonia: β-haemolytic streptococci may rarely 
cause pneumonia such as in children after measles or influenza, in severely 
debilitated elderly patients and in diabetics. 
4. Pneumonia by gram-negative aerobic bacteria: Less common 
causes of lobar pneumonia are gram-negative bacteria like Haemophilus in- 
fluenzae, Klebsiella pneumoniae (Friedlander's bacillus), Pseudomonas, 
Proteus and Escherichia coli, H. influenzae commonly causes pneumonia in 
children below 3 years of age after a preceding viral infection. 
Pathologic changes. Laennec's original description divides lobar 
pneumonia into 4 sequential pathologic phases: 
– stage of congestion (initial phase), 
– red hepatisation (early consolidation), 
– grey hepatisation (late consolidation) and 
– resolution. 
However, these classic stages seen in untreated cases are found much less 
often nowadays due to administration of antibiotics and improved medical care. 
In lobar pneumonia, as the name suggests, part of a lobe, a whole lobe, 
or two lobes are involved, sometimes bilaterally. The lower lobes are affected 
most commonly. The sequence of pathologic changes described below repre- 
sents the inflammatory response of lungs in bacterial infection. 
1. Stage of congestion: initial phase. The initial phase represents the early 
acute inflammatory response to bacterial infection and lasts for 1 to 2 days. 
Grossly, the affected lobe is enlarged, heavy, dark red and congested. 
Cut surface exudes blood-stained frothy fluid. 
Histologically, typical features of acute inflammatory response to the 
organisms are seen. These are: 
i) Dilatation and congestion of the capillaries in the alveolar walls. 
ii) Pale eosinophilic oedema fluid in the air spaces. 
iii) ) A few red cells and neutrophils in the intra-alveolar fluid. 
iv) Numerous bacteria demonstrated in the alveolar fluid by Gram's 
staining. 
2. Red hepatisation: early consolidation. This phase lasts for 2 to 4 
days. The term hepatisation in pneumonia refers to liver-like consistency of 
the affected lobe on cut section. 
Grossly, the affected lobe is red, firm and consolidated. The cut surface 
of the involved lobe is airless, red-pink, dry, granular and has liver-like con- 
sistency. The stage of red hepatisation is accompanied by serofibrinous pleurisy. 
Histologically, the following features are observed: 
i) The oedema fluid of the preceding stage is replaced by strands of fibrin. 





iii) ) Many neutrophils show ingested bacteria. 
iv) The alveolar septa are less prominent than in the first stage due to 
cellular exudation. 
3. Grey hepatisation: late consolidation. This phase lasts for 4 to 8 days. 
Grossly, the affected lobe is firm and heavy. The cut surface is dry, 
granular and grey in appearance with liver-like consistency. The change in 
colour from red to grey begins at the hilum and spreads towards the periph- 
ery. Fibrinous pleurisy is prominent. Histologically, the following changes 
are present: 
i) The fibrin strands are dense and more numerous, 
ii) The cellular exudate of neutrophils is reduced due to disintegration 
of many inflammatory cells as evidenced by their pyknotic nuclei. The red 
cells are also fewer. The macrophages begin to appear in the exudate. 
iii) The cellular exudate is often separated from the septal walls by a 
thin clear space, 
iv) The organisms are less numerous and appear as degenerated forms. 
4. Resolution: This stage begins by 8th to 9th day if no chemotherapy is 
administered and is completed in 1 to 3 weeks. However, antibiotic therapy in- 
duces resolution on about 3rd day. Resolution proceeds in a progressive manner. 
Grossly, the previously solid fibrinous constituent is liquefied by en- 
zymatic action, eventually restoring the normal aeration in the affected lobe. 
The process of softening begins centrally and spreads to the periphery. The 
cut surface is grey-red or dirty brown and frothy, yellow, creamy fluid can be 
expressed on pressing. The pleural reaction may also show resolution but 
may undergo organisation leading to fibrous obliteration of pleural cavity. 
Histologically, the following features are noted: 
i) Macrophages are the predominant cells in the alveolar spaces, while 
neutrophils diminish in number. Many of the macrophages contain engulfed 
neutrophils and debris. 
ii) Granular and fragmented strands of fibrin in the alveolar spaces are 
seen due to progressive enzymatic digestion. 
iii) Alveolar capillaries are engorged, 
iv) There is progressive removal of fluid content as well as cellular ex- 
udate from the air spaces, partly by expectoration but mainly by lymphatics, 
resulting in restoration of normal lung parenchyma with areation. 
Complications. Since the advent of antibiotics, serious complications of 
lobar pneumonia are uncommon. However, they may develop in neglected cases 
and in patients with impaired immunologic defenses. These are as under: 
1. Organisation. In about 3% of cases, resolution of the exudate does 




alveolar septa resulting in fibrosed, tough, airless leathery lung tissue. This 
type of post-pneumonic fibrosis is called carnification. 
2. Pleural effusion. About 5% of treated cases of lobar pneumonia de- 
velop inflammation of the pleura with effusion. The pleural effusion usually 
resolves but sometimes may undergo organisation with fibrous adhesions be- 
tween visceral and parietal pleura. 
3. Empyema. Less than 1% of treated cases of lobar pneumonia devel- 
op encysted pus in the pleural cavity termed empyema. 
4. Lung abscess. A rare complication of lobar pneumonia is formation of 
lung abscess, especially when there is secondary infection by other organisms. 
5. Metastatic infection. Occasionally, infection in the lungs and pleu- 
ral cavity in lobar pneumonia may extend into the pericardium and the heart 
causing purulent pericarditis, bacterial endocarditis and myocarditis. Other forms 
of metastatic infection encountered rarely in lobar pneumonias are otitis media, 
mastoiditis, meningitis, brain abscess and purulent arthritis. 
 
BRONCHOPNEUMONIA (LOBULAR PNEUMONIA) 
Bronchopneumonia or lobular pneumonia is infection of the terminal 
bronchioles that extends into the surrounding alveoli resulting in patchy con- 
solidation of the lung. The condition is particularly frequent at extremes of 
life (i.e. in infancy and old age), as a terminal event in chronic debilitating 
diseases and as a secondary infection following viral respiratory infections 
such as influenza, measles etc. 
Etiology. The common organisms responsible for bronchopneumonia 
are staphylococci, streptococci, pneumococci, Klebsiella pneumoniae, Hae- 
mophilus influenzae, and gram-negative bacilli like Pseudomonas and coli- 
form bacteria. 
Pathologic changes. Grossly, bronct monia is identified by patchy are- 
as of red or grey consolidation affecting one or more lobes, frequently found 
bilaterally and more often involving the lower zones of the lungs due to grav- 
itation of the secretions. On cut surface, these patchy consolidated lesions are 
dry, granular, firm, red or grey in colour, 3 to 4 cm in diameter, slightly ele- 
vated over the surface and are often centred around a bronchiole. These 
patchy areas are best picked up by passing the fingertips on the cut surface. 
Histologically, the following features are observed: 
i) Acute bronchiolitis. 
ii) Suppufative exudate, consisting chiefly of neutrophils, in the 
peribronchiolar alveoli, 
iii) Thickening of the alveolar septa by congested capillaries and leu- 
cocytic infiltration, 




Complications. The complications of lobar pneumonia may occur in 
bronchopneumonia as well. However, complete resolution of bronchopneu- 
monia is uncommon. There is generally some degree of destruction of the 
bronchioles resulting in foci of bronchiolar fibrosis that may eventually cause 
bronchiectasis. 
 
VIRAL AND MYCOPLASMAL PNEUMONIA (PRIMARY ATYPICAL PNEUMONIA) 
Viral and mycoplasmal pneumonia is characterised by patchy inflam- 
matory changes, largely confined to interstitial tissue of the lungs, without 
any alveolar exudate. Other terms used for these respiratory tract infections 
are interstitial pneumonitis, reflecting the interstitial location of the inflam- 
mation, and 'primary atypical pneumonia', atypicality being the absence of 
alveolar exudate commonly present in other pneumonias. Interstitial pneu- 
monitis may occur in all ages. Most of the cases are mild and transient; ex- 
ceptionally it may be severe and fulminant. 
Etiology. Interstitial pneumonitis is caused by a wide variety of agents, 
the most common being respiratory syncytial virus (RSV). Others are Myco- 
plasma pneumoniae and many viruses such as influenza and parainfluenza 
viruses, adenoviruses, rhinoviruses, coxsackieviruses and cytomegaloviruses 
(CMV). Occasionally, psittacosis (Chlamydia) and Q fever (Coxiella) are as- 
sociated with interstitial pneumonitis. Infections of the respiratory tract with 
these organisms are quite common. In most cases, the infection remains con- 
fined to the upper respiratory tract presenting as common cold. Occasionally, 
it may extend lower down to involve the interstitium of the lungs. The cir- 
cumstances favouring such extension of infection are malnutrition, chronic 
debilitating diseases and alcoholism. 
Pathologic changes. Irrespective of the etiologic agent, the pathologic 
changes are similar in all cases. 
Grossly, depending upon the severity of infection, the involvement 
may be patchy to massive and widespread consolidation of one or both the 
lungs. The lungs are heavy, congested and subcrepitant. Sectioned surface of 
the lung exudes small amount of frothy or bloody fluid. The pleural reaction 
is usually infrequent and mild. 
Histologically, hallmark of viral pneumonias is the interstitial nature of 
the inflammatory reaction. The microscopic features are as under: 
i) Interstitial inflammation: There is thickening of alveolar walls due 
to congestion, oedema and mononuclear inflammatory infiltrate comprised 
by lymphocytes, macrophages and some plasma cells. 
ii) Necrotising bronchiolitis: This is characterised by foci of necrosis 
of the bronchiolar epithelium, inspissated secretions in the lumina and mono- 




iii) Reactive changes: The lining epithelial cells of the bronchioles and 
alveoli proliferate in the presence of virus and may form multinucleate giant 
cells and syncytia in the bronchiolar and alveolar walls. Occasionally, viral 
inclusions (intranuclear and/or intracytoplasmic) are found, especially in 
pneumonitis caused by CMY. 
iv) Alveolar changes: In severe cases, the alveolar lumina may contain 
oedema fluid, fibrin, scanty inflammatory exudate and coating of alveolar walls 
by pink, hyaline membrane similar to the one seen in respiratory distress syn- 
drome. Alveolar changes are prominent if bacterial infection supervenes. 
Complications. The major complication of interstitial pneumonitis is 
superimposed bacterial infection and its complications. Most cases of intersti- 
tial pneumonitis recover completely. In more severe cases, there may be in- 
terstitial fibrosis and permanent damage. 
Clinical features. Majority of cases of interstitial pneumonitis initially have upper 
respiratory symptoms with fever, headache and muscle aches. A few days later appears 
dry, hacking, non-productive cough with retrosternal burning due to tracheitis and bron- 
chitis. Chest radiograph may show patchy or diffuse consolidation. Cold agglutinin titres 
in the serum are elevated in almost half the cases of mycoplasmal pneumonia, 20% cases 
of adenovirus infection but absent in other forms of viral pneumonia. Isolation of the etio- 
logic agent, otherwise, is difficult. 
 
OTHER TYPES OF PNEUMONIAS 
Some other types of pneumonias caused by infective agents (such as 
Pneumocystis carinii pneumonia and Legionella pneumonia) and certain non- 
infective varieties (e.g. aspiration pneumonia, hypostatic pneumonia and lipid 
pneumonia) are described here. 
I. PNEUMOCYSTIS CARINII PNEUMONIA 
Pneumocystis carinii, a protozoon widespread in the environment, 
causes pneumonia by inhalation of the organisms as an opportunistic infec- 
tion in neonates and immunosuppressed people. Almost 100% cases of AIDS 
develop opportunistic infection, most commonly Pneumocystis carinii pneu- 
monia. Other immunosuppressed groups are patients on chemotherapy for 
organ transplant and tumours, malnutrition, agamma-globulinaemia etc. 
Pathologic changes. Grossly, the affected parts of lung are consolidat- 
ed, dry and grey. 
Microscopicallyt the features are as under: 
i) Interstitial pneumonitis with thickening and mononuclear infiltration 
of the alveolar walls. 
ii) Alveolar lumina contain pink frothy fluid. 
iii) By Gomori's methenamine-silver (GMS) stain, the characteristic oval 
or crescentic cysts, about 5 μm in diameter and surrounded by numerous tiny 




iv) No significant inflammatory exudate is seen in the air spaces. 
Clinical features. There is rapid onset of dyspnoea, tachycardia, cyanosis and non- 
productive cough. If untreated, it causes death in one or two weeks. Chest radiograph 
shows diffuse alveolar and interstitial infiltrate. 
II. LEGIONELLA PNEUMONIA 
Legionella pneumonia or legionnaire's disease is an epidemic illness 
caused by gram-negative bacilli, Legionella pneumophila that thrives in 
aquatic environment. It was first recognised following investigation into high 
mortality among those attending American Legion Convention in Philadelph- 
ia in July 1976. The epidemic occurs in summer months by spread of organ- 
isms through contaminated drinking water or in air-conditioning cooling 
towers. Impaired host defenses in the form of immunodeficiency, corticoster- 
oid therapy, old age and cigarette smoking play important roles. 
Pathologic changes. Grossly, there are changes of widespread bron- 
chopneumonia involving many lobes and there may be consolidation of the 
entire lung. Pleural effusion is frequently present. 
Histologically, the changes are not distinctive. The features commonly 
seen are: 
i) Intra-alveolar exudate, initially of neutrophils but later composed 
mainly of macrophages. 
ii) Alveolar septa show foci of hyperplasia of the lining epithelium and 
thrombosis of vessels in the septa. 
iii) The organisms may be demonstrated in the macrophages by special 
stains or by immunofluorescent techniques. 
Clinical features. The disease begins with malaise, headache and muscle aches 
followed by high fever, chills, cough and tachypnoea. Systemic manifestations unrelated 
to pathologic changes in the lungs are seen due to bacteraemia and include abdominal 
pain, watery diarrhoea, proteinuria and mild hepatic dysfunction. 
III. ASPIRATION (INHALATION) PNEUMONIA 
Aspiration or inhalation pneumonia results from inhaling different 
agents into the lungs. These substances include food, gastric contents, foreign 
body and infected material from oral cavity. A number of factors predispose 
to inhalation pneumonia which include: unconsciousness, drunkenness, neu- 
rological disorders affecting swallowing, drowning, necrotic oropharyngeal 
tumours, in premature infants and congenital tracheo-oesophageal fistula. 
Some patients die immediately from asphyxiation or laryngospasm without 
developing pneumonia. 
Pathologic changes. Pathologic changes vary depending upon the par- 
ticulate matter aspirated but in general right lung is affected more often due 




1. Aspiration of small amount of sterile foreign matter such as acidic 
gastric contents produce chemical pneumonitis. It is characterised by haemor- 
rhagic pulmonary oedema with presence of particles in the bronchioles. Pa- 
tients rapidly develop cyanosis, dyspnoea, shock and bloody sputum and are 
often likely to die of cardiac failure. If the patient survives the acute episode, 
secondary bacterial infection is likely to occur. 
2. Non-sterile aspirate causes widespread bronchopneumonia with 
multiple areas of necrosis and suppuration. A granulomatous reaction with 
foreign body giant cells may surround the aspirated vegetable matter. 
IV. HYPOSTATIC PNEUMONIA 
Hypostatic pneumonia is the term used for the collection of oedema 
fluid and secretions in the dependent parts of the lungs in severely debilitat- 
ed, bed-ridden patients. The accumulated fluid in the basal zone and posterior 
part of lungs gets infected by bacteria from the upper respiratory tract and 
sets in bacterial pneumonia. Hypostatic pneumonia is a common terminal 
event in the old, feeble, comatose patients. 
V. LIPID PNEUMONIA 
Another variety of noninfective pneumonia is lipid pneumonia. It is of 
2 types: exogenous and endogenous. 
1. Exogenous lipid pneumonia. This is caused by aspiration of a vari- 
ety of oily materials. These are: inhalation of oily nasal drops, regurgitation 
of oily medicines from stomach (e.g. liquid paraffin), administration of oily 
vitamin preparation to reluctant children or to debilitated old patients. 
2. Endogenous lipid pneumonia. Endogenous origin of lipids causing 
pneumonic consolidation is more common. The sources of origin are tissue 
breakdown following obstruction to airways e.g. obstruction by bronchogenic 
cancer, tuberculosis and bronchiectasis. 
Pathologic changes. Grossly, the exogenous type affects the right lung 
more frequently due to direct path from the main bronchus. Quite often, the 
lesions are bilateral. The affected part of the lungs is consolidated. Cut sur- 
face is characteristically 'golden yellow'. 
Microscopically, the features are as under: 
i) The lipid is finely dispersed in the cytoplasm of macrophages form- 
ing foamy macrophages within the alveolar spaces. 
ii) There may be formation of cholesterol clefts due to liberation of 
cholesterol and other lipids. 
iii) Formation of granulomas with foreign body giant cells may be seen 





Lung abscess is a localised area of necrosis of lung tissue with suppu- 
ration. It is of 2 types: 
• Primary lung abscess that develops in an otherwise normal lung. The 
commonest cause is aspiration of infected material. 
• Secondary lung abscess that develops as a complication of some oth- 
er disease of the lung or from another site. 
Etiopathogenesis. The microorganisms commonly isolated from the 
lungs in lung abscess are streptococci, staphylococci and various gram- 
negative organisms. These are introduced into the lungs from one of the fol- 
lowing mechanisms: 
1. Aspiration of infected foreign material. A number of foreign ma- 
terials such as food, decaying teeth, gastric contents, severely infected gingi- 
vae and teeth, and necrotic tissue from lesions in the mouth, upper respiratory 
tract or nasopharynx may be aspirated. This occurs particularly in favourable 
circumstances such as during sleep, unconsciousness, anaesthesia, general 
debility and acute alcoholism. 
2. Preceding bacterial infection. Preceding bronchopneumonia in a 
debilitated patient may develop into lung abscess. Other infective conditions 
like tuberculosis, bronchiectasis and mycotic infections may occasionally re- 
sult in formation of lung abscess. 
3. Bronchial obstruction. An abscess may form distal to an obstructed 
bronchus such as from bronchial tumour or from impacted foreign body. 
4. Septic embolism. Infected emboli originating from pyaemia, throm- 
bophlebitis or from vegetative bacterial endocarditis may be disseminated in 
the venous circulation and reach the right side of the heart from where they 
are lodged in the lung and result in multiple abscesses. 
5. Miscellaneous. Rare causes of lung abscesses include: 
i) Infection in pulmonary infarcts. 
ii) Amoebic abscesses due to infection with Entamoeba histolytica. 
iii) Trauma to the lungs. 
iv) Direct extension from a suppurative focus in the mediastinum, oe- 
sophagus, subphrenic area or spine. 
Pathologic changes. Abscesses due to aspiration are more likely to be in 
right lung due to more vertical main bronchus and are frequently single. They are 
commonly located in the lower part of the right upper lobe or apex of right lower 
lobe. Abscesses developing from preceding pneumonia and septic or pyaemic ab- 
scesses are often multiple and scattered throughout the lung. 
Grossly, abscesses may be of variable size from a few millimeters to 
large cavities, 5 to 6 cm in diameter. The cavity often contains exudate. An 




ly-defined ragged wall. With passage of time, the abscess becomes chronic 
and develops fibrous wall. 
Histologically, the characteristic feature is the destruction of lung paren- 
chyma with suppurative exudate in the lung cavity. The cavity is initially sur- 
rounded by acute inflammation in the wall but later there is replacement by exu- 
date of lymphocytes, plasma cells and macrophages. In more chronic cases, 
there is considerable fibroblastic proliferation forming a fibrocollagenic wall. 
Clinical features. The clinical manifestations are fever, malaise, loss 
of weight, cough, purulent expectoration and haemoptysis in half the cases. 
Clubbing of the fingers and toes appears in about 20% of patients. Secondary 
amyloidosis may occur in chronic longstanding cases. 
 
FUNGAL INFECTIONS OF LUNG 
Fungal infections of the lung are more common than tuberculosis in the 
United States of America. These infections in healthy individuals are rarely 
serious but in immunosuppressed individuals may prove fatal. Some of the 
common examples of fungal infections of the lung are briefly outlined below: 
1. Histoplasmosis. It is caused by oval organism, Histoplasma capsu- 
latum, by inhalation of infected dust or bird droppings. The condition may 
remain asymptomatic or may produce lesions similar to the Ghon's complex. 
2. Coccidiodomycosis. Coccidiodomycosis is caused by Coccidioides 
immitis which are spherical spores. The infection in human beings is acquired 
by close contact with infected dogs. The lesions consist of peripheral paren- 
chymal granuloma in the lung. 
3. Cryptococcosis. It is caused by Cryptococcus neoformans which is 
round yeast having a halo around it due to shrinkage in tissue sections. The 
infection occurs from infection by inhalation of pigeon droppings. The le- 
sions in the body may range from a small parenchymal granuloma in the lung 
to cryptococcal meningitis. 
4. Blastomycosis. It is an uncommon condition caused by Blastomyces 
dermatitidis. The lesions result from inhalation of spores in the ground. 
Pathological features may present as Ghon's complex-like lesion, as a pneu- 
monic consolidation, and as multiple skin nodules. 
5. Aspergillosis. Aspergillosis is the most common fungal infection of 
the lung caused by Aspergillus fumigatus. The fungus exists as thin septate 
hyphae with dichotomous branching and grows best in cool, wet climate. The 
infection may result in allergic bronchopulmonary aspergillosis, aspergillo- 
ma and necrotising bronchitis. Immunocompromised persons develop more 
serious manifestations of aspergillus infection, especially in leukaemic pa- 




gillus infection may result in widespread changes in lung tissue due to arterial 
occlusion, thrombosis and infarction. 
6. Mucormycosis. Mucormycosis or phycomycosis is caused by Mu- 
cor and Rhizopus. The infection in the lung occurs in a similar way as in as- 
pergillosis.The pulmonary lesions are especially common in patients of dia- 
betic ketoacidosis. 
7. Candidiasis. Candidiasis or moniliasis caused by Candida albicans 
is a normal commensal in oral cavity, gut and vagina but attains pathologic 
form in immunocompromised host. Angio-invasive growth of the organism 
may occur in the airways. 
 
PULMONARY TUBERCULOSIS 
The classical and most common example of chronic infection of the 
lungs is pulmonary tuberculosis. Pulmonary lesions caused by Mycobacte- 
rium tuberculosis and other mycobacteria will be discussed later. 
 
CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
 
Chronic obstructive pulmonary disease (COPD) or chronic obstructive 
airways disease (COAD) are commonly-used clinical terms for a group of 
pathological conditions in which there is chronic, partial or complete, ob- 
struction to the airflow at any level from trachea to the smallest airways re- 
sulting in functional disability of the lungs. The obstructive pulmonary dis- 
ease must be distinguished from restrictive pulmonary disease. The following 
4 entities are included in COPD: 
I. Chronic bronchitis 
II. Emphysema 
III. Bronchial asthma 
IV. Bronchiectasis 
Chronic bronchitis and emphysema are quite common and often occur 
together. More recently, small airways disease involving inflammation of small 
bronchi and bronchioles (bronchiolitis) has been added to the group of COPD. 
 
CHRONIC BRONCHITIS 
Chronic bronchitis is a common condition defined clinically as persis- 
tent cough with expectoration on most days for at least three months of the 
year for two or more consecutive years. The cough is caused by over- 
secretion of mucus. In spite of its name, chronic inflammation of the bronchi 
is not a prominent feature. The condition is more common in middle-aged 
males than females; approximately 20% of adult men and 5% of adult women 




bling COPD or cor pulmonale. Quite frequently, chronic bronchitis is associ- 
ated with emphysema. 
Etiopathogenesis. The two most important etiologic factors responsi- 
ble for majority of cases of chronic bronchitis are: cigarette smoking and at- 
mospheric pollution. Other contributory factors are occupation, infection, 
familial and genetic factors. 
1. Smoking. The most commonly identified factor implicated in causation 
of chronic bronchitis and in emphysema is heavy smoking. Heavy cigarette 
smokers have 4 to 10 times higher proneness to develop chronic bronchitis. Pro- 
longed cigarette smoking appears to act on the lungs in a number of ways: 
i) It impairs ciliary movement, 
ii) It inhibits the function of alveolar macrophages. 
iii) ) It leads to hypertrophy and hyperplasia of mucus-secreting glands. 
iv) It causes considerable obstruction of small airways, 
v) It stimulates the vagus and causes broncho-constriction. 
2. Atmospheric pollution. The incidence of chronic bronchitis is higher 
in industrialised urban areas where air is polluted. Some of the atmospheric 
pollutants which increase the risk of developing chronic bronchitis are sulfur 
dioxide, nitrogen dioxide, particulate dust and toxic fumes. 
3. Occupation. Workers engaged in certain occupations such as in cotton 
mills (byssinosis), plastic factories etc are exposed to various organic or inor- 
ganic dusts which contribute to disabling chronic bronchitis in such individuals. 
4. Infection. Bacterial, viral and mycoplasmal infections do not initiate 
chronic bronchitis but usually occur secondary to bronchitis. Cigarette 
smoke, however, predisposes to infection responsible for acute exacerbation 
in chronic bronchitis. 
5. Familial and genetic factors. There appears to be a poorly-defined 
familial tendency and genetic predisposition to develop disabling chronic bron- 
chitis. However, it is more likely that nonsmoker family members who remain 
in the air-pollution of home are significantly exposed to smoke (passive smok- 
ing) and hence have increased blood levels of carbon monoxide. 
Pathologic changes. Grossly, the bronchial wall is thickened, hyper- 
aemic and oedematous. Lumina of the bronchi and bronchioles may contain 
mucus plugs and purulent exudate. Microscopically, the characteristic fea- 
tures are as follows: 
1. The cartilage-containing large airways have hypertrophy and hyper- 
plasia of submucosal mucous glands. The increase in thickness can be quanti- 
tatively assessed by Reid index which is the ratio between thickness of the 
submucosal glands to that of the bronchial wall. The bronchial epithelium 




2. The non-cartilage containing small airways show goblet cell hyper- 
plasia and intraluminal and peribronchial fibrosis. 
Clinical features. There is considerable overlap of clinical features of chronic 
bronchitis and pulmonary emphysema as quite often the two coexist. Some important fea- 
tures of 'predominant bronchitis' are: 
1. Persistent cough with copious expectoration of long duration; initially beginning in 
a heavy smoker with 'morning catarrh' or 'throat clearing' which worsens in winter. 
2. Recurrent respiratory infections are common. 
3. Dyspnoea is generally not prominent at rest but is more on exertion. 
4. Patients are called 'blue bloaters' due to cyanosis and oedema. 
5. Features of right heart failure (cor pulmonale) are common. 
6. Chest X-ray shows enlarged heart with prominent vessels. 
 
EMPHYSEMA 
The WHO has defined pulmonary emphysema as combination of per- 
manent dilatation of air spaces distal to the terminal bronchioles and the de- 
struction of the walls of dilated air spaces. Thus, emphysema is defined mor- 
phologically, while chronic bronchitis is defined clinically. Since the two 
conditions coexist frequently and show considerable overlap in their clinical 
features, it is usual to label patients as 'predominant emphysema' and 'pre- 
dominant bronchitis'. 
Classification. As mentioned in the beginning of this chapter, a lobule 
is composed of about 5 acini distal to a terminal bronchiole and that an acinus 
consists of 3 to 5 generations of respiratory bronchioles and a variable num- 
ber of alveolar ducts and alveolar sacs. By strictly adhering to the WHO defi- 
nition of pulmonary emphysema, it is classified, according to the portion of 
the acinus involved, into 5 types: 
- centri-acinar, 
- panacinar (panlobular), 
- para-septal (distal acinar), 
- irregular (para-cicatricial), 
- and mixed (unclassified) emphysema. 
A number of other conditions to which the term 'emphysema' is losely 
applied are, in fact, examples of 'over inflation. 
Etiopathogenesis. The commonest form of COPD is the combination of 
chronic bronchitis and pulmonary emphysema. Chronic bronchitis, however, 
does not always lead to emphysema nor all cases of emphysema have changes 
of chronic bronchitis. The association of the two conditions is principally linked 
to the common etiologic factors; most importantly, tobacco smoke and air pollu- 
tants. Other less significant contributory factors are occupational exposure, in- 
fection and somewhat poorly-understood familial and genetic influences. All 




However, the pathogenesis of the most significant event in emphyse- 
ma, the destruction of the alveolar walls, is not linked to bronchial changes 
but is closely related to deficiency of serum alpha-1-antitrypsin (al-protease 
inhibitor) commonly termed protease-antiprotease hypothesis detailed be- 
low. 
Protease-antiprotease hypothesis. Alpha-1-antitrypsin, also called 
α1-protease inhibitor, is a glycoprotein that forms the normal constituent of 
the α1-globulin fraction of the plasma proteins on serum electrophoresis. The 
single gene locus that codes for α-1-antitrypsin is located on the long arm of 
chromosome 14 that codes for immunoglobulin light chains as well. It is 
normally synthesised in the liver and is distributed in the circulating blood, 
tissue fluids and macrophages. The normal function of α1-antitrypsin is to 
inhibit proteases and hence its name α1-protease inhibitor. The proteases 
(mainly elastases) are derived from neutrophils. 
Neutrophil elastase has the capability of digesting lung parenchyma but 
is inhibited from doing so by anti-elastase (i.e. by α1-antitrypsin). 
Deficiency of the enzyme α1-antitrypsin develops in homozygous state 
due to genetically abnormal locus for protease inhibitor (Pi). The normal 
phenotype of individuals in homozygote is called PiMM, while the most 
common abnormal phenotype in classic al-antitrypsin deficiency in homozy- 
gous state is PiZZ. The heterozygote pattern of PiMZ is not sufficient to pro- 
duce clinical deficiency, but heterozygote individuals who smoke heavily 
have higher risk of developing emphysema. 
The α1-antitrypsin deficiency develops in adults and causes pulmonary 
emphysema in smokers as well as in non-smokers, though the smokers be- 
come symptomatic about 15 years earlier than non-smokers. The other organ 
showing effects of α1-antitrypsin deficiency is liver which may develop ob- 
structive jaundice early in infancy, and cirrhosis and hepatoma late in adult- 
hood. 
The mechanism of alveolar wall destruction in emphysema by elasto- 
lytic action is based on the imbalance between proteases (chiefly elastase) 
and anti-proteases (chiefly anti-elastase): 
• By decreased anti-elastase activity i.e. deficiency of α-1 antitrypsin. 
• By increased activity of elastase i.e. increased neutrophilic infiltration 
in the lungs causing excessive elaboration of neutrophil elastase. 
There are enough evidences to suggest that smoking promotes emphy- 
sema by both decreasing the amount of anti-elastase as well as by increasing 
the elastolytic protease in the lungs. These are as under: 
1. Oxidant in cigarette smoke has inhibitory influence on α1- 




2. Smokers have up to ten times more phagocytes and neutrophils in 
their lungs than nonsmokers. Thus they have very high elastase activity. 
Pathologic changes. Emphysema can be diagnosed with certainty only 
by gross and histologic examination of sections of whole lung. The lungs 
should be perfused with formalin under pressure in inflated state to grade the 
severity of emphysema with naked eye. 
Grossly, the lungs are voluminous, pale with little blood. The edges of 
the lungs are rounded. Mild cases show dilatation of air spaces visible with 
hand lens. Advanced cases show subpleural bullae and blebs bulging out- 
wards from the surface of the lungs with rib markings between them. The 
bullae are air-filled cyst-like or bubble-like structures, larger than 1 cm in di- 
ameter. They are formed by the rupture of adjacent air spaces while blebs are 
the result of rupture of alveoli directly into the subpleural interstitial tissue 
and are the common cause of spontaneous pneumothorax. 
Microscopically, depending upon the type of emphysema, there is dila- 
tation of air spaces and destruction of septal walls of part of acinus involved 
i.e. respiratory bronchioles, alveolar ducts and alveolar sacs. Changes of 
bronchitis may be present. Bullae and blebs when present show fibrosis and 
chronic inflammation of the walls. 
MORPHOLOGY OF INDIVIDUAL TYPES OF EMPHYSEMA 
1. CENTRIACINAR  (CENTRILOBULAR)  EMPHYSEMA.  Centriacinar  or 
centrilobular emphysema is one of the common types. It is characterised by ini- 
tial involvement of respiratory bronchioles i.e. the central or proximal part of the 
acinus. This is the type of emphysema that usually coexists with chronic bron- 
chitis and occurs predominantly in smokers and in coal miners' pneumoconiosis. 
Grossly, the lesions are more common and more severe in the upper 
lobes of the lungs. The characteristic appearance is obvious in cut surface of 
the lung. It shows distended air spaces in the centre of the lobules surrounded 
by a rim of normal lung parenchyma in the same lobule. The lobules are sep- 
arated from each other by fine fibrous tissue septa. Large amount of black 
pigment is often present in the walls of emphysematous spaces. In more se- 
vere cases, distal parts of acini are also involved and the appearance may 
closely resemble panacinar emphysema. 
Microscoptcally, there is distension and destruction of the respiratory 
bronchiole in the centre of lobules, surrounded peripherally by normal unin- 
volved alveoli. The terminal bronchioles supplying the acini show chronic 
inflammation and are narrowed. 
2. PANACINAR (PANLOBULAR) EMPHYSEMA. Panacinar or panlobular 
emphysema is the other common type. In this type, all portions of the acinus are 




ed with α1-antitrypsin deficiency in middle-aged smokers and is the one that 
produces the most characteristic anatomical changes in the lung in emphysema. 
Grossly, in contrast to centriacinar emphysema, the panacinar emphy- 
sema involves lower zone of lungs more frequently and more severely than 
the upper zone. The involvement may be confined to a few lobules, or may 
be more widespread affecting a lobe or part of a lobe of the lung. The lungs 
are enlarged and over inflated. 
Microscopically, usually all the alveoli within a lobule are affected to 
the same degree. All portions of acini are distended – respiratory bronchioles, 
alveolar ducts and alveoli, are all dilated and their walls stretched and thin. 
Ruptured alveolar walls and spurs of broken septa are seen between the adja- 
cent alveoli. The capillaries are stretched and thinned. Special stains show 
loss of elastic tissue. Inflammatory changes are usually absent. 
3. PARASEPTAL (DISTAL ACINAR) EMPHYSEMA. This type of emphy- 
sema involves distal part of acinus while the proximal part is normal. Para- 
septal or distal acinar emphysema is localised along the pleura and along the 
perilobular septa. The involvement is seen adjacent to the areas of fibrosis and 
atelectasis and involves upper part of lungs more severely than the lower. This 
form of emphysema is seldom associated with COPD but is the common cause 
of spontaneous pneumothorax in young adults. Grossly, the subpleural portion 
of the lung shows air-filled cysts, 0.5 to 2 cm in diameter. 
4. IRREGULAR (PARA-CICATRICIAL) emphysema. This is the most 
common form of emphysema, seen surrounding scars from any cause. The 
involvement is irregular as regards the portion of acinus involved as well as 
within the lung as a whole. During life, irregular emphysema is often asymp- 
tomatic and may be only an incidental autopsy finding. 
5. MIXED (UNCLASSIFIED) EMPHYSEMA. Quite often, the same lung may 
show more than one type of emphysema. It is usually due to more severe in- 
volvement resulting in loss of clearcut distinction between one type of emphy- 
sema and the other. Thus, the lungs of an elderly smoker at autopsy may show 
continuation of centriacinar emphysema in the upper lobes, pana-cinar in the 
lower lobes, and paraseptal emphysema in the subpleural region. 
 
MORPHOLOGY OF TYPES OF OVERINFLATION 
Under this heading are covered a group of lung conditions of heterogene- 
ous etiology characterised by overinflation of the parts of acini but without sig- 
nificant destruction of the walls and are sometimes loosely termed emphysema. 
1. Compensatory overinflation (compensatory emphysema). When 
part of a lung or a lobe of lung is surgically removed, the residual lung paren- 
chyma undergoes compensatory hyperinflation so as to fill the pleural cavity. 




tal walls and hence the term compensatory overinflation is preferable over 
'compensatory emphysema'. 
2. Senile hyperinflation (aging lung, senile emphysema). In old peo- 
ple, the lungs become voluminous due to loss of elastic tissue, thinning and 
atrophy of the alveolar ducts and alveoli. The alveoli are thin-walled and dis- 
tended throughout the lungs but there is no significant destruction of the sep- 
tal walls and, therefore, preferable designation is 'senile hyperinflation' over 
'senile emphysema.' 
3. Obstructive overinflation (infantile lobar emphysema). Partial 
obstruction to the bronchial tree such as by a tumour or a foreign body causes 
over inflation of the region supplied by obstructed bronchus. Infantile lobar 
emphysema is a variant of obstructive over inflation occurring in infants in the 
first few days of life who develop respiratory distress or who have congenital 
hypoplasia of bronchial cartilage. In all such cases, air enters the lungs during 
inspiration but cannot leave on expiration resulting in ballooning up of the af- 
fected part of the lung. 
4. Unilateral translucent lung (unilateral emphysema). This is a 
form of overinflation in which one lung or one of its lobes or segments of a 
lobe are radiolucent. The condition occurs in adults and there is generally a 
history of serious pulmonary infection in childhood, probably bronchiolitis 
obliterans. The affected lung is grossly overinflated. Microscopy shows over- 
inflated alveoli and there is histologic evidence of preceding widespread 
bronchiolitis obliterans. 
5. Interstitial emphysema (surgical emphysema). The entry of air in- 
to the connective tissue framework of the lung is called interstitial or surgical 
emphysema. The usual sources of entry of air into stroma of the lung are rup- 
ture of alveoli or of larger airways. The causes are as under: 
i) Violent coughing with bronchiolar obstruction e.g. in children with 
whooping cough, bronchitis, in patients with obstruction to the airways by 
foreign bodies, blood clots and exposure to irritant gases. 
ii) Rupture of the oesophagus, trauma to the lung, or major bronchus 
and trachea. 
iii) Entry of air through surgical incision. 
iv) Fractured rib puncturing the lung parenchyma. 
v) Sudden change in atmospheric pressure e.g. in decompression sick- 
ness.  
The condition may affect patients of all ages. On rupture of alveoli, the 
leaked air enters the fibrous connective tissue of the alveolar walls from where it 
extends into the fibrous septa of the lung, into the mediastinum, the pleura, and 
even the subcutaneous tissues. Escape of air into the pleural cavity may cause 




resorbed. However, extensive accumulation of air in surgical emphysema may 
produce impaired blood flow in the lungs. Pneumo-mediastinum may produce 
symptoms resembling myocardial infarction. 
Histologically, the alveoli are distended but septal walls are not dam- 
aged; therefore it is not true emphysema. There are clear spaces of leaked out 
air in connective tissue septa. 
 
BRONCHIAL ASTHMA 
Asthma is a disease of airways that is characterised by increased re- 
sponsiveness of the tracheobronchial tree to a variety of stimuli resulting in 
widespread spasmodic narrowing of the air passages which may be relieved 
spontaneously or by therapy. Asthma is an episodic disease manifested clinical- 
ly by paroxysms of dyspnoea, cough and wheezing. However, a severe and un- 
remitting form of the disease termed status asthmaticus may prove fatal. 
Bronchial asthma is common and prevalent worldwide; in the United 
States about 4% of population is reported to suffer from this disease. It occurs 
at all ages but nearly 50% of cases develop it before the age of 10 years. In 
adults, both sexes are affected equally but in children there is 2 : 1 male- 
female ratio. 
Etiopathogenesis and types. Based on the stimuli initiating bronchial 
asthma, two broad etiologic types are traditionally described: extrinsic (allergic, 
atopic) and intrinsic (idiosyncratic, non-atopic) asthma. A third type is a mixed 
pattern in which the features do not fit clearly into either of the two main types. 
1. Extrinsic (atopic, allergic) asthma. This is the most common type 
of asthma. It usually begins in childhood or in early adult life. Most patients 
of this type of asthma have personal and/or family history of preceding aller- 
gic diseases such as rhinitis, urticaria or infantile eczema. Hypersensitivity to 
various extrinsic antigenic substances or 'allergens' is usually present in these 
cases. Most of these allergens cause ill-effects by inhalation e.g. house dust, 
pollens, animal danders, moulds etc. Occupational asthma stimulated by 
fumes, gases and organic and chemical dusts is a variant of extrinsic asthma. 
There are increased levels of IgE in the serum and positive skin test with the 
specific offending inhaled antigen representing an IgE-mediated type I hy- 
persensitivity reaction which includes an 'acute immediate response' and a 
late phase reaction': 
• The acute immediate response is initiated by IgE-sensitised mast cells 
(tissue counterparts of circulating basophils) on the mucosal surface. Mast cells 
on degranulation release mediators like histamine, leukotrienes, prostaglandins, 
platelet activating factor and chemotactic factors for eosinophils and neutro- 
phils. The net effects of these mediators are broncho-constriction, oedema, mu- 




• The late phase reaction follows the acute immediate response and is 
responsible for the prolonged manifestations of asthma. It is caused by excessive 
mobilisation of blood leucocytes that include basophils besides eosinophils and 
neutrophils. These result in further release of mediators which accentuate the 
above-mentioned effects. In addition, inflammatory injury is caused by neutro- 
phils and by major basic protein (MBP) of eosinophils. 
2. Intrinsic (idiosyncratic, non atopic) asthma. This type of asthma 
develops later in adult life with negative personal or family history of allergy, 
negative skin test and normal serum levels of IgE. Most of these patients de- 
velop typical symptom-complex after an upper respiratory tract infection by 
viruses. Associated nasal polypi and chronic bronchitis are commonly pre- 
sent. There are no recognisable allergens but about 10% of patients become 
hypersensitive to drugs, most notably to small doses of aspirin (aspirin- 
sensitive asthma). 
3. Mixed type. Many patients do not clearly fit into either of the above 
two categories and have mixed features of both. Those patients who develop 
asthma in early life have strong allergic component, while those who develop 
the disease late tend to be non-allergic. Either type of asthma can be precipi- 
tated by cold, exercise and emotional stress. 
Pathologic changes. The pathologic changes are similar in both major 
types of asthma. The pathologic material examined is generally autopsy of 
lungs in patients dying of status asthmaticus but the changes are expected to 
be similar in non-fatal cases. 
Grossly, the lungs are overdistended due to over-inflation. The cut sur- 
face shows characteristic occlusion of the bronchi and bronchioles by viscid 
mucus plugs. 
Microscopically, the following changes are observed: 
1. The mucus plugs contain normal or degenerated respiratory epitheli- 
um forming twisted strips called Curschmann's spirals. 
2. The sputum usually contains numerous eosinophils and diamond- 
shaped crystals derived from eosinophils called Charcot-Leyden crystals. 
3. The bronchial wall shows thickened basement membrane of the bron- 
chial epithelium, submucosal oedema and inflammatory exudate consisting of 
lymphocytes and plasma cells with prominence of eosinophils. There is hyper- 
trophy of submucosal glands as well as of the bronchial smooth muscle. 
4. Changes of bronchitis and emphysema may supervene, especially in 
intrinsic asthma. 
Clinical features. Asthmatic patients suffer from episodes of acute ex- 
acerbations interspersed with symptom-free periods. Characteristic clinical 
features are paroxysms of dyspnoea, cough and wheezing. Most attacks typi- 




result in more serious condition called status asthmaticus. The clinical diag- 
nosis is supported by demonstration of circulation eosinophilia and sputum 
demonstration of Curschmann's spirals and Charcot-Leyden crystals. More 
chronic cases may develop cor pulmonale. 
 
BRONCHIECTASIS 
Bronchiectasis is defined as abnormal and irreversible dilatation of the 
bronchi and bronchioles (greater than 2 mm in diameter) developing secondary 
to inflammatory weakening of the bronchial walls. The most characteristic 
clinical manifestation of bronchiectasis is persistent cough with expectoration 
of copious amounts of foul-smelling, purulent sputum. Post-infectious cases 
commonly develop in childhood and in early adult life. 
Etiopathogenesis. The origin of inflammatory destructive process of 
bronchial walls is nearly always a result of two basic mechanisms: obstruc- 
tion and infection. 
• Endobronchial obstruction by foreign body, neoplastic growth or en- 
larged lymph nodes causes resorption of air distal to the obstruction with 
consequent atelectasis and retention of secretions. 
• Infection may be secondary to local obstruction and impaired systemic 
defense mechanism promoting bacterial growth, or infection may be a primary 
event i.e. bronchiectasis developing in suppurative necrotising pneumonia. 
These 2 mechanisms - endobronchial obstruction and infection, are 
seen in a number of clinical settings. These are as under: 
1. Hereditary and congenital factors. Several hereditary and congenital 
factors may result secondarily in diffuse bronchiectasis. These include: 
i) Congenital bronchiectasis caused by developmental defect of the 
bronchial system. 
ii) Cystic fibrosis, a generalised defect of exocrine gland secretions, re- 
sults in obstruction, infection and bronchiectasis. 
iii) Hereditary immune deficiency diseases are often associated with 
high incidence of bronchiectasis. 
iv) Immotile cilia syndrome that includes Kartagener's syndrome (bron- 
chiectasis, situs inversus and sinusitis) is characterised by ultrastructural changes 
in the microtubules causing immotility of cilia of the respiratory tract epitheli- 
um, sperms and other cells. Males in this syndrome are often infertile. 
v) Atopic bronchial asthma patients have often positive family history 
of allergic diseases and may rarely develop diffuse bronchiectasis. 
2. Obstruction. Post-obstructive bronchiectasis, unlike the congenital- 
hereditary forms, is of the localised variety, usually confined to one part of 
the bronchial system. The causes of endobronchial obstruction include for- 




nodes  and  post-inflammatory scarring  (e.g.  in healed tuberculosis)  all  of 
which favour the development of post-obstructive bronchiectasis. 
3. Secondary complication. Necrotising pneumonias such as in staphy- 
lococcal suppurative pneumonia and tuberculosis may develop bronchiectasis 
as a complication. 
Pathologic changes. The disease characteristically affects distal bron- 
chi and bronchioles beyond the segrnental bronchi. 
Macroscapicaly the lungs may be involved diffusely or segmentally. 
Bilateral involvement of lower lobes occurs most frequently. More vertical 
air passages of left lower lobe are more often involved than the right. The 
pleura is usually fibrotic and thickened with adhesions to the chest wall. Cut 
surface of the affected lobes, generally the lower zones, shows characteristic 
honeycombed appearance. The bronchi are extensively dilated nearly to the 
pleura, their walls are thickened and the lumina are filled with mucus or mu- 
copus. The intervening lung parenchyma is reduced and fibrotic. The dilated 
airways, depending upon their gross or bronchographic appearance, have 
been subclassified into the following different types: 
i) Cylindrical: the most common type characterised by tube-like bron- 
chial dilatation. 
ii) Fusiform: having spindle-shaped bronchial dilatation. 
iii) Saccular: having rounded sac-like bronchial distension, 
iv) Varicose: having irregular bronchial enlargements. 
Microscopically, fully-developed cases show the following histologic 
features. 
i) The bronchial epithelium may be normal, ulcerated or may show 
squamous metaplasia. 
ii) The bronchial wall shows infiltration by acute and chronic inflam- 
matory cells and destruction of normal muscle and elastic tissue with re- 
placement by fibrosis. 
iii) The intervening lung parenchyma shows fibrosis, while the sur- 
rounding lung tissue shows changes of interstitial pneumonia. 
iv) The pleura in the affected area is adherent and shows bands of fi- 
brous tissue between the bronchus and the pleura. 
 
CHRONIC RESTRICTIVE PULMONARY DISEASE 
 
The second large group of diffuse lung disease is 'chronic restrictive 
pulmonary disease' characterised by reduced expansion of lung parenchyma 
with decreased total lung capacity. This group of diseases must be distin- 





A. Restriction due to chest wall disorder. These causes are: 
1. Kyphoscoliosis 
2. Poliomyelitis 
3. Severe obesity 
4. Pleural diseases. 
B. Restriction due to interstitial and infiltrative diseases. These are 
diseases characterised by non-infectious involvement of the interstitial con- 
nective tissue of lung parenchyma. The term 'infiltrative' is used here to de- 
note the radiologic appearance of lungs in chest radiographs which show 
ground-glass shadows due to diffuse infiltration by small nodules or irregular 
lines. The conditions included in this group are as under: 
I. Pneumoconiosis, 
II. Immunologic lung diseases, 
III. Collagen-vascular diseases, 
IV. Idiopathic pulmonary fibrosis, 
V. Sarcoidosis. 
The pathogenesis of the interstitial lung disease is explained by in- 
flammatory reaction causing initial alveolitis in response to various stimuli. 
In alveolitis, there is accumulation of lymphocytes, macrophages, neutrophils 
and eosinophils, all of which result in inflammatory destruction of the pul- 
monary parenchyma followed by fibrosis. Eventually, there is widespread de- 
struction of alveolar capillary walls resulting in end-stage lung or 'honey- 
comb lung'. 
The major clinical manifestations of restrictive lung diseases are dyspnoea, 
tachypnoea and cyanosis, but no wheezing so characteristic of COPD. 
I. PNEUMOCONIOSES 
Pneumoconiosis is the term used for lung diseases caused by inhalation 
of dust, mostly at work. These diseases are, therefore, also called 'dust dis- 
eases' or 'occupational lung diseases'. 
The type of lung disease varies according to the nature of inhaled dust. 
Some dusts are inert and cause no reaction and no damage at all, while others 
cause immunologic damage and predispose to tuberculosis or to neoplasia. The 
factors which determine the extent of damage caused by inhaled dusts are: 
1) size and shape of the particles; 
2) their solubility and physic-chemical composition; 
3) the amount of dust retained in the lungs; 
4) the additional effect of other irritants such as tobacco smoke; and 
5) host factors such as efficiency of clearance mechanism and immune 




In general, most of the inhaled dust particles larger than 5 μm reach the 
terminal airways where they are ingested by alveolar macrophages. Most of 
these too are eliminated by expectoration but the remaining accumulate in al- 
veolar tissue. Of particular interest are the particles smaller than 1μm which 
are deposited in the alveoli most efficiently. Most of the dust-laden macro- 
phages accumulated in the alveoli die leaving the dust, around which fibrous 
tissue is formed. Some macrophages enter the lymphatics and reach regional 
lymph nodes. The tissue response to inhaled dust may be one of the following 
three types: 
• Fibrous nodules e.g. in coal-workers' pneumoconiosis and silicosis. 
• Interstitial fibrosis e.g. in asbestosis. 
• Hypersensitivity reaction e.g. in berylliosis. 
 
COAL-WORKERS' PNEUMOCONIOSIS 
This is the commonest form of pneumoconiosis and is defined as the 
lung disease resulting from inhalation of coal dust particles, especially in coal 
miners engaged in handling soft bituminous coal for a number of years, often 
20 to 30 years. It exists in 2 forms – a milder form of the disease called sim- 
ple coal workers' pneumoconiosis and an advanced form termed progressive 
massive fibrosis (complicated coal-miners pneumoconiosis). Anthracosis, on 
the other hand, is not a lung disease in true sense but is the common, benign 
and asymptomatic accumulation of carbon dust in the lungs of most urban 
dwellers due to atmospheric pollution and cigarette smoke. Anthracotic pig- 
ment is deposited in the macrophages in the alveoli and around the respirato- 
ry bronchioles and into the draining lymph nodes but does not produce any 
respiratory difficulty or radiologic changes. 
Pathogenesis. Pathogenetically, it appears that anthracosis, simple 
coal-workers pneumoconiosis and progressive massive fibrosis are different 
stages in the evolution of fully-developed coal-workers' pneumoconiosis. 
However, progressive massive fibrosis develops in a small proportion of cas- 
es (2-8%) of simple coal-workers pneumoconiosis. A number of predisposing 
factors have been implicated in this transformation. These are: 
1. Older age of the miners. 
2. Severity of coal dust burden engulfed by macrophages. 
3. Prolonged exposure (20 to 30 years) to coal dust. 
4. Concomitant tuberculosis. 
5. Additional role of silica dust. 
6. Immunological factors. 
The last named i.e. immunological mechanisms, are currently widely 




by humoral mechanism as evidenced by elevated levels of anti-nuclear anti- 
bodies and rheumatoid factor. Alternatively, these may act via cell-mediated 
mechanisms by elaboration of macrophage-derived fibroblast growth factor, 
or the fibrosis may be reparative response to tissue injury caused by lysoso- 
mal enzymes and toxic free-radicals. 
Pathologic changes. In life, the pathologic changes in lung in coal- 
workers' pneumoconiosis are graded by radiologic appearance according to 
the size and extent of opacities. The pathologic findings at autopsy of lungs 
in the major forms of coal workers' pneumoconiosis are considered below 
under 3 headings: simple coal-workers' pneumoconiosis, progressive massive 
fibrosis and rheumatoid pneumoconiosis (Caplan's syndrome). 
Simple ”coal-workers” pneumoconiosis. Grossly, the lung paren- 
chyma shows small, black focal lesions, measuring less than 5 mm in diame- 
ter and evenly distributed throughout the lung but have a tendency to be more 
numerous in the upper lobes. These are termed coal macules, and if palpable 
are called nodules. The air spaces around coal macules are dilated with little 
destruction of alveolar walls. Though some workers have called it centri lob- 
ular emphysema of coalminers, others prefer not to consider it emphysema 
because there is no significant destruction of alveolar walls. Similar blackish 
pigmentations are found on the pleural surface and in the regional lymph 
nodes. 
Histologically, the following features are seen: 
1. Coal macules are composed of aggregates of dust-laden macrophages. 
These are present in the alveoli and in the bronchiolar and alveolar walls. 
2. There is some increase in the network of reticulin and collagen in 
the coal macules. 
3. Respiratory bronchioles and alveoli surrounding the macules are dis- 
tended without significant destruction of the alveolar walls. 
PROGRESSIVE MASSIVE FIBROSIS 
Grossly, besides the coal macules and nodules of simple pneumoconio- 
sis, there are larger, hard, black scattered areas measuring more than 2 cm in 
diameter and sometimes massive. They are usually bilateral and located more 
often in the upper parts of the lungs posteriorly. Sometimes, these masses break 
down centrally due to ischaemic necrosis or due to tuberculosis forming cavities 
filled with black semifluid resembling India ink. The pleura and the regional 
lymph nodes are also blackened and fibrotic. 
Histologically, the following features are present: 
1. The fibrous lesions are composed almost entirely of dense collagen 




2. The wall of respiratory bronchioles and pulmonary vessels included 
in the massive scars are thickened and their lumina obliterated. 
3. There is scanty inflammatory infiltrate of lymphocytes and plasma 
cells around the areas of massive scars. 
4. The alveoli surrounding the scars are markedly dilated. 
Progressive massive fibrosis probably has immunological pathogenetic 
basis as described above. 
RHEUMATOID PNEUMOCONIOSIS (CAPLAN'S SYNDROME) 
The development or rheumatoid arthritis in a few cases of coal- 
workers' pneumoconiosis, silicosis or absestosis is termed rheumatoid pneu- 
moconiosis or Caplan's syndrome. 
Grossly, the lungs have rounded, firm nodules with central necrosis, 
cavitation or calcification. 
Histologically, the lung lesions are modified rheumatoid nodules with 
central zone of dust-laden fibrinoid necrosis enclosed by palisading fibro- 
blasts and mononuclear cells. 
The lung lesions in Caplan's syndrome have immunological basis for 
their origin as evidenced by detection of rheumatoid factor and antinuclear 
antibodies. 
SILICOSIS 
Historically, silicosis used to be called 'knife grinders' lung. Silicosis is 
caused by prolonged inhalation of silicon dioxide, commonly called silica. 
Silica constitutes about one-fourth of earth's crust. Therefore, a number of 
occupations engaged in silceous rocks or sand and products manufactured 
from them are at increased risk. 
These include miners (e.g. of granite, sandstone, slate, coal, gold, tin 
and copper), quarry workers, tunnellers, sandblasters, grinders, ceramic 
workers, foundry workers and those involved in the manufacture of abrasives 
containing silica. Peculiar to India are the occupational exposure to pencil, 
slate and agate grinding industry carrying high risk of silicosis (agate = sort 
of very hard stone containing silica). According to a recent ICMR report, it is 
estimated that about 3 million workers in India are at high potential risk of 
silica exposure employed in a variety of occupations including construction 
workers. An infrequent acute form of silicosis called accelerated silicosis pro- 
duces irregular fibrosis adjoining the alveoli which is filled with lipoproteina- 
ceous exudate and resembles alveolar proteinosis. However, if not specified, 
silicosis refers to the common chronic form of the disease characterised by 
formation of small collagenous silicotic nodules. 
Pathogenesis. Silicosis appears after prolonged exposure to silica dust, 




as total dose, duration of exposure, the type of silica inhaled and individual 
host factors. The mechanisms involved in the formation of silicotic nodules 
are not clearly understood. The following sequence of events has been pro- 
posed and schematically: 
1. Silica particles between 0.5 to 5 (im size on reaching the alveoli are 
taken by the macrophages which undergo necrosis. New macrophages engulf 
the debris and thus a repetitive cycle of phagocytosis and necrosis is set up. 
2. Some silica-laden macrophages are carried to the respiratory bron- 
chioles, alveoli and in the interstitial tissue. Some of the silica dust is trans- 
ported to the subpleural and interlobar lymphatics and into  the  regional 
lymph nodes. The cellular aggregates containing silica become associated 
with lymphocytes, plasma cells, mast cells and fibroblasts. 
3. Silica dust isfibrogenic. Crystalline form, particularly quartz, is more 
fibrogenic than non-crystalline form of silica. 
4. As noted above, silica is cytotoxic and kills the macrophages which 
engulf it. The released silica dust activates viable macrophages leading to se- 
cretion of macrophage-derived growth factors such as interleukin-1 that fa- 
vour fibroblast proliferation and collagen synthesis. 
5. Simultaneously, there is activation of T and B lymphocytes. This re- 
sults in increased serum levels of immunoglobulins (IgG and IgM), antinu- 
clear antibodies, rheumatoid factor and circulating immune complexes as 
well as proliferation of T cells. 
Pathologic changes. Grossly, the chronic silicotic lung is studded with 
well-circumscribed, hard, fibrotic nodules, 1 to 5 mm in diameters. They are 
scattered throughout the lung parenchyma but are initially more often located 
in the upper zones of the lungs. These nodular lesions frequently have simulta- 
neous deposition of coal-dust and may develop calcification. The pleura is 
grossly thickened and adherent to the chest wall. There may be similar fibrotic 
nodules on the pleura and within the regional lymph nodes. The nodular le- 
sions are detectable as egg-shell shadows in chest X-rays. The lesions may un- 
dergo ischaemic necrosis and develop cavitation, or be complicated by tuber- 
culosis and rheumatoid pneumoconiosis. 
Histologicaly, the following features are observed: 
1. The silicotic nodules are located in the region of respiratory bron- 
chioles, adjacent alveoli, pulmonary arteries, in the pleura and the regional 
lymph nodes. 
2. The silicotic nodules consist of central hyalinised material with scanty 
cellularity and some amount of dust. The hyalinised centre is surrounded by 
concentric laminations of collagen which is further enclosed by more cellular 
connective tissue, dust-filled macrophages and a few lymphocytes and plasma 




3. The collagenous nodules have cleft-like spaces between the lamellae 
of collagen which when examined polariscopically may demonstrate numer- 
ous birefringent particles of silica. 
4. The severe and progressive form of the disease may result in coales- 
cence of adjacent nodules and cause complicated silicosis similar to progres- 
sive massive fibrosis of coal-workers' pneumoconiosis. 
5. The intervening lung parenchyma may show hyperinflation or em- 
physema. 
6. Cavitation when present may be due to ischaemic necrosis in the 
nodules, or may reveal changes of tuberculosis or rheumatoid pneumoconio- 
sis (Caplan's syndrome), discussed already. 
ASBESTOS DISEASE 
Asbestos as a mineral is known to mankind for more than 4000 years 
but its harmful effects have come to light during the last few decades. Asbes- 
tos is a Greek word meaning 'unquenchable'. In general, if coal is lot of dust 
and little fibrosis, asbestos is little dust and lot of fibrosis. Prolonged expo- 
sure for a number of years to asbestos dust produces three types of severe 
diseases: asbestosis of lungs, pleural disease and tumours. In nature, asbestos 
exists as long thin fibrils which are fire-resistant and can be spun into yarns 
and fabrics suitable for thermal and electrical insulation and has many appli- 
cations in industries. Particularly at risk are workers engaged in mining, fab- 
rication and manufacture of a number of products from asbestos such as as- 
bestos pipes, tiles, roofs, textiles, insulating boards, sewer and water con- 
duits, brake lining, clutch castings etc. There are two major geometric forms 
of asbestos: 
• Serpentine consisting of curly and flexible fibres. It includes the most 
common chemical form chrysotile (white asbestos) comprising more than 
90% of commercially used asbestos. 
• Amphibole consists of straight, stiff and rigid fibres. It includes the 
less common chemical forms crocidolite (blue asbestos), amosite (brown as- 
bestos), tremolite, anthophyllite and actinolyte. However, the group of am- 
phibole, though less common, is more important since it is associated with 
induction of malignant pleural tumours, particularly in association with cro- 
cidolite. 
Pathogenesis. Overexposure to asbestos for more than a decade may 
produce asbestosis of the lung, pleural lesions and certain tumours. How as- 
bestos causes all these lesions is not clearly understood but the following 




1. The inhaled asbestos fibres are phagocytosed by alveolar macro- 
phages from where they reach the interstitium. Some of the engulfed dust is 
transported via lymphatics to the pleura and regional lymph nodes. 
2. The asbestos-laden macrophages release chemo-attractants for neu- 
trophils and for more macrophages, thus inciting cellular reaction around 
them. 
3. Asbestos fibres are coated with glycoprotein and endogenous hae- 
mosiderin to produce characteristic beaded or dumbbell-shaped asbestos bod- 
ies. 
4. All types of asbestos are fibrogenic and result in interstitial fibrosis. 
Fibroblastic proliferation may occur via macrophage-derived growth factor 
such as interleukin-1. Alternatively, fibrosis may occur as a reparative re- 
sponse to tissue injury by lysosomal enzymes released from macrophages and 
neutrophils or by toxic free radicals. 
5. A few immunological abnormalities such as antinuclear antibodies 
and rheumatoid factor have been found in cases of asbestosis but their role in 
the genesis of disease is not clear. 
6. Asbestos fibres are carcinogenic, the most carcinogenic being cro- 
cidolite. There is high incidence of bronchogenic carcinoma in asbestosis 
which is explained on the basis of the role of asbestos fibres as tumour pro- 
moters or by causing cell death of the airways so that it is exposed to the car- 
cinogenic effect of cigarette smoke. The development of pleural mesothelio- 
ma in these cases is probably by carrying of asbestos fibres via lymphatics to 
the pleura. 
Pathologic changes. As stated already, over-exposure to asbestos is 
associated with 3 types of lesions: asbestosis, pleural disease and certain tu- 
mours. 
ASBESTOSIS. The gross pulmonary fibrosis caused by asbestos expo- 
sure and histologic demonstration of asbestos bodies on asbestos fibres is 
termed asbestosis. 
Grossly, the affected lungs are small and firm with cartilage-like thick- 
ening of the pleura. The sectioned surface shows variable degree of pulmo- 
nary fibrosis, especially in the subpleural areas and in the bases of lungs. The 
advanced cases may show cystic changes. 
Histologically, the following changes are observed: 
1. There is non-specific interstitial fibrosis. 
2. There is presence of characteristic asbestos bodies in the involved 
areas. These are asbestos fibres coated with glycoprotein and haemosiderin 
and appear beaded or dumbbell-shaped. The coating stains positively for 




3. There may be changes of emphysema in the pulmonary parenchyma 
between the areas of interstitial fibrosis. 
4. The involvement of hilar lymph nodes in asbestosis is not as signifi- 
cant as in silicosis. 
 
PLEURAL DISEASE in asbestos exposure may produce one of the fol- 
lowing 3 types of lesions: 
1. Pleural Effusion. It develops in about 5% of asbestos workers and 
is usually serious type. Pleural effusion is generally accompanied by sub 
pleural asbestosis. 
2. Visceral pleural fibrosis. Quite often, asbestosis is associated with 
dense fibrous thickening of the visceral pleura encasing the lung. 
3. Pleural plaques, Fibrocalcific pleural plaques are the most common 
lesions associated with asbestos exposure. 
Grossly, the lesions appear as circumscribed, flat, small (upto 1 cm in 
diameter), firm or hard, bilateral nodules. They are seen more often on the 
postero-lateral part of parietal pleura and on the pleural surface of the dia- 
phragm. 
Microscopically, they consist of hyalinised collagenous tissue which 
may be calcified so that they are visible on chest X-ray. Asbestos bodies are 
generally not found within the plaques. 
 
TUMOURS. Asbestos exposure predisposes to a number of cancers, 
most importantly bronchogenic carcinoma and malignant mesothelioma. A 
few others are: carcinomas of oesophagus, stomach, colon, kidneys and lar- 
ynx and various lymphoid malignancies. 
1. Bronchogenic carcinoma is the most common malignancy in as- 
bestos workers. Its incidence is 5 times higher in non-smoker asbestos work- 
ers than the non-smoker general population and 10 times higher in smoker 
asbestos workers than the other smokers. 
2. Malignant mesothelioma is an uncommon tumour but association 
with asbestos exposure is present in 30 to 80% of cases with mesothelioma. 
The exposure need not be heavy because mesothelioma is known to develop 
in people living near asbestos plants or in wives of asbestos workers. 
BERYLLIOSIS 
Berylliosis is caused by heavy exposure to dust or fumes of metallic 
beryllium or its salts. Beryllium was used in the past in fluorescent tubes and 
light bulbs but currently it is principally used in nuclear and aerospace indus- 
tries and in the manufacture of electrical and electronic equipments. Two 




ACUTE BERYLLIOSIS. Acute berylliosis occurs in individuals who are 
unusually sensitive to it and are heavily exposed to it for 2 to 4 weeks. The 
pulmonary reaction is in the form of an exudative chemical pneumonitis in 
which the alveoli are filled with protein-rich fluid with formation of hyaline 
membrane. The patient develops sudden dyspnoea, hyperapnoea and subster- 
nal pain. Most patients recover completely. 
CHRONIC BERYLLIOSIS. Chronic berylliosis develops in individuals 
who are sensitised to it for a number of years, often after a delay of 20 or more 
years. The disease is a cell-mediated hypersensitivity reaction in which the met- 
al beryllium acts as a hapten. The condition is characterised by development of 
non-caseating epithelioid granulomas like those of sarcoidosis. These granulo- 
mas are diffusely scattered throughout the lung parenchyma. The granulomas 
have giant cells which frequently contain 3 types of inclusions: 
1. Birefringent crystals. 
2. Concentrically-laminated haematoxyphilic Schaumann or conchoid 
bodies. 
3. Acidophilic stellate-shaped asteroid bodies. These inclusions are de- 
scribed in giant cells of granulomas in sarcoidosis too. Similar sarcoid-like 
granulomas can occur in other organs such as in the liver, kidneys, spleen or 
lymph nodes in chronic berylliosis. 
 
PAEDIATRIC LUNG DISEASE 
 
A number of congenital anomalies (e.g. agenesis, hypoplasia, hetero- 
topic tissue, vascular anomalies, tracheal and bronchial anomalies, congenital 
pulmonary over-inflation or lobar emphysema, congenital cysts and bron- 
chopulmonary sequestration) and certain neonatal acquired lung diseases, 
(broncho-pulmonary dysplasia, meconium aspiration syndrome, persistent 
foetal circulation, atelactasis, collapse and bronchiolitis) have been described. 
A few important conditions will be discussed here. 
 
Congenital Cysts 
Developmental defects involving deficiency of bronchial or bronchio- 
lar cartilage, elastic tissue and muscle result in congenital cystic disease of 
lungs. A single large cyst of this type occupying almost a lobe is called 
pneumatocele. Multiple small cysts are more common and give sponge-like 
appearance to the lung. The cysts are thin-walled and dilated and generally 
lined by flattened ciliated epithelium overlying a thin layer of supportive 
connective tissue. These cysts may contain air or may get infected and be- 
come abscesses. Cysts may rupture into bronchi producing haemoptysis, or 





Sequestration is the presence of lobes or segments of lung tissue which 
are not connected to the airway system. The blood supply of the sequestered 
area is not from the pulmonary arteries but from the aorta or its branches. Se- 
questration may be intralobar or extra-lobar. 
• Intralobar sequestration is the sequestered bronchopulmonary mass 
within the pleural covering of the affected lung. 
• Extralobar sequestration is the sequestered mass of lung tissue ly- 
ing outside the pleural investing layer such as in the base of left lung or be- 
low the diaphragm. The extralobar sequestration is predominantly seen in in- 
fants and children and is often associated with other congenital malfor- 
mations. 
 
Neonatal Respiratory Distress Syndrome (Hyaline Membrane Disease) 
Neonatal respiratory distress syndrome (RDS) or hyaline membrane 
disease characterised by formation of pulmonary hyaline membrane is the 
most common and serious form of disease of the newborn infants. The condi- 
tion begins with dyspnoea a few hours after birth with tachypnoea, hypoxia 
and cyanosis and in severe cases death occurs in a few hours. The milder cas- 
es, however, recover with adequate oxygen therapy by ventilator-assist meth- 
ods in a few days. The mortality rate is high (20 to 30%) and is still higher in 
babies under 1 kg of body weight. Some who recover develop bronchopul- 
monary dysplasia later on. 
Etiology. The neonatal RDS is primarily initiated by hypoxia, either 
shortly before birth or immediately afterward. The following clinical settings 
are commonly associated with neonatal RDS: 
1. Preterm infants. 
2. Infants born to diabetic mothers. 
3. Delivery by caesarean section. 
4. Infants born to mothers with previous premature infants. 
5. Excessive sedation of the mother causing depression in respiration 
of the infant. 
6. Birth asphyxia from various causes such as coils of umbilical cord 
around the neck. 
7. Male preponderance (1.5 to 2 times) over female babies due to early 
maturation of female lungs. 
Besides all these factors causing respiratory distress, a number of cases 
of neonatal RDS remain idiopathic. 
Pathogenesis. The basic defect in neonatal RDS is a deficiency of 
pulmonary surfactant, normally synthesised by type II alveolar cells. The 




prematurity and in neonatal hypoxia from any of the foregoing causes, its 
synthesis is decreased. The main function of alveolar surfactant being lower- 
ing of alveolar surface tension, its deficiency leads to increased alveolar sur- 
face tension which in turn causes atelectasis. Atelectasis of the lungs results 
in hypoventilation, pulmonary hypoperfusion, ischaemic damage to capillary 
endothelium and necrosis of the alveolar cells, exudation of plasma proteins 
including fibrinogen into the alveoli and eventually formation of hyaline 
membrane containing largely fibrin. 
Pathologic changes. The pathologic changes of hyaline membrane 
disease are seldom seen in stillbirths or in those who die soon after birth. 
Grossly, the lungs are normal in size and reddish purple in colour. 
They are solid and airless so that they sink in water. 
1. The presence of collapsed alveoli (atelectasis) alternating with dilat- 
ed alveoli. 
2. Formation of characteristic eosinophilic hyaline membranes lining 
the respiratory bronchioles, alveolar ducts and the proximal alveoli. The 
membrane is largely composed of fibrin admixed with cell debris derived 
from necrotic alveolar cells. 
3. Vascular congestion, focal haemorrhages and dilatation of septal 
lymphatics. 
4. Absence of inflammatory reaction. 
 
Bronchopulmonary Dysplasia 
Bronchopulmonary dysplasia occurs as a complication in infants treat- 
ed for neonatal RDS with oxygen and assisted ventilation. The toxicity of 
oxygen and barotrauma from high pressure of oxygen give rise to subacute or 
chronic fibrosing condition of the lungs termed bronchopulmonary dysplasia. 
The condition is clinically characterised by persistence of respiratory distress 
for up to 3 to 6 months. 
Pathologically, there is organisation of hyaline membranes resulting in 
fibrous thickening of the alveolar walls, bronchiolitis, peribronchial fibrosis, 
and development of emphysema due to alveolar dilatation. Many bronchioles 
show squamous metaplasia. 
 
ATELECTASIS AND COLLAPSE 
Atelectasis in the newborn or primary atelectasis is defined as incom- 
plete expansion of a lung or part of a lung, while pulmonary collapse or sec- 
ondary atelectasis is the term used for reduction in lung size of a previously 
expanded and well-aerated lung. Obviously, the former occurs in newborn 




ATELECTASIS. Stillborn infants have total atelectasis, while the new- 
born infants with weak respiratory action develop incomplete expansion of 
the lungs and clinical atelectasis. The common causes are prematurity, cere- 
bral birth injury, CNS malformations and intrauterine hypoxia. 
Grossly, the lungs are small, dark blue, fleshy and non-crepitant 
Microscopically, the alveolar spaces in the affected area are small with 
thick interalveolar septa. The alveolar spaces contain proteinaceous fluid with 
a few epithelial squames and meconium. Scattered aerated areas of the lung 
are hyperinflated causing interstitial emphysema and pneumothorax. 
COLLAPSE. Pulmonary collapse or secondary atelectasis in children 
and adults may occur from various causes such as compression, obstruction, 
contraction and lack of pulmonary surfactant. Accordingly, collapse may be 
of the following types: 
1. Compressive collapse. Pressure from outside causes compressive 
collapse e.g. by massive pleural effusion, haemothorax, pneumothorax, in- 
trathoracic tumour, high diaphragm and spinal deformities. Compressive col- 
lapse involves subpleural regions and affects lower lobes more than the cen- 
tral areas. 
2. Obstructive/absorptive collapse. Obstruction of a bronchus or 
many bronchioles causes absorption of oxygen in the affected alveoli fol- 
lowed by collapse e.g. by viscid mucus secretions in bronchial asthma, chron- 
ic bronchitis, bronchiectasis, bronchial tumours and aspiration of foreign 
bodies. Obstructive collapse is generally less severe than the compressive 
collapse and is patchy. 
3. Contraction collapse. This type occurs due to localised fibrosis in 
lung causing contraction followed by collapse. 
 
BRONCHIOLITIS AND BRONCHIOLITIS OBLITERANS 
Bronchiolitis and bronchiolitis obliterans are the inflammatory condi- 
tions affecting the small airways occurring predominantly in older paediatric 
age group and in quite elderly persons. A number of etiologic factors have 
been stated to cause this condition. These include viral infection (frequently 
adenovirus and respiratory syncytial virus), bacterial infection, fungal infec- 
tion, inhalation of toxic gases (e.g. in silo-fillers' disease) and aspiration of 
gastric contents. 
Microscopically, the lumina of affected bronchioles are narrow and oc- 
cluded by fibrous plugs. The bronchiolar walls are inflamed and are infiltrat- 
ed by lymphocytes and plasma cells. There are changes of interstitial pneu- 




PULMONARY VASCULAR DISEASE 
 
As stated before, diseases of the heart affect the lungs and diseases of 
the lungs affect the heart. This is because of the peculiar characteristics of 
pulmonary vasculature. The pressure in the pulmonary arteries is much lower 
than in the systemic arteries. The pulmonary arterial system is thinner than 
the systemic arterial system. They are thin elastic vessels which can be easily 
distinguished from thick-walled bronchial arteries supplying the large air- 
ways and the pleura. 
General diseases of vascular origin occurring in the lungs such as pul- 
monary oedema, pulmonary congestion, pulmonary embolism and pulmonary 
infarction have all been already described in the section of General Pathology. 
Here, two specific forms of pulmonary vascular diseases – adult respiratory dis- 
tress syndrome and pulmonary hypertension, will be discussed. 
 
ADULT RESPIRATORY DISTRESS SYNDROME (ARDS) 
Adult respiratory distress syndrome (ARDS) is known by various syn- 
onyms such as shock-lung syndrome, diffuse alveolar damage (DAD), acute 
alveolar injury, traumatic wet lungs and post-traumatic respiratory insuffi- 
ciency. ARDS is a syndrome caused by diffuse alveolar capillary damage and 
clinically characterised by sudden and severe respiratory distress, tachypnoea, 
tachycardia, cyanosis and severe hypoxaemia that fails to respond to oxygen 
therapy and assisted ventilation unlike neonatal RDS described above. The con- 
dition was first recognised during World War II in survivors of non-thoracic in- 
juries with shock. The chest radiographs of these patients show diffuse bilateral 
alveolar infiltrates which may progress. 
Etiology. Diffuse alveolar damage in ARDS may occur from a number 
of causes. These are: 
1. Shock due to sepsis, trauma, burns, 
2. Diffuse pulmonary infections, chiefly viral pneumonia, 
3. Pancreatitis, 
4. Oxygen toxicity, 
5. Inhalation of toxins and irritants e.g. smoke, war gases, nitrogen di- 
oxide, metal fumes etc. 
6. Narcotic overdose, 
7. Drugs e.g. salicylates, colchicines, 
8. Aspiration pneumonia's, 
9. Fat embolism, 
10. Radiation. 
Pathogenesis. The basic initiating event in the pathogenesis of ARDS 
is diffuse damage to the alveolocapillary wall by one of the injurious factors 




may be by oxygen-derived free radicals, by intravascular aggregation of neu- 
trophils, or by liberation of mediators of inflammation. Injury to the capillary 
endothelium leads to increased vascular permeability. Injury to epithelial 
cells, especially to type 1 alveolar cells, causes necrosis of these cells. The 
net effect of injury to both capillary endothelium and alveolar epithelium is 
interstitial and intra-alveolar oedema, congestion, fibrin deposition and for- 
mation of hyaline membranes as seen in neonatal RDS. As a result of lining 
of the alveoli with hyaline membranes, there is loss of surfactant causing col- 
lapse with pulmonary oedema called 'stiff lung'. There is an attempt at regen- 
eration of alveolar cells by proliferation of type II alveolar cells. A stiff lung 
of ARDS may undergo complete recovery or may undergo organisation re- 
sulting in proliferation of interstitial cells leading to interstitial fibrosis or 
even death. 
Pathologic changes. Grossly, the lungs are characteristically stiff, 
congested and heavy. 
Microscopically, the following features are evident: 
1. Interstitial and intra-alveolar oedema. 
2. Necrosis of alveolar epithelial cells with formation of hyaline mem- 
branes. The hyaline membranes are structurally similar to those of neonatal 
RDS i.e. they are chiefly composed of fibrin admixed with necrotic epithelial 
cells. 
3. Congestion and intra-alveolar haemorrhages. 
4. Changes of bronchopneumonia. 
5. In organising stage, there may be interstitial fibrosis and regenerat- 
ing flat alveolar epithelial cells lining the denuded alveoli. 
 
PULMONARY HYPERTENSION 
Normally, the blood pressure in the pulmonary arterial circulation is 
much lower than the systemic blood pressure; it does not  exceed  30/15 
mmHg even during exercise (normally, blood pressure in the pulmonary 
veins is between 3 and 8 mmHg). Pulmonary hypertension is defined as a 
systolic blood pressure in the pulmonary arterial circulation above 30 mmHg. 
Pulmonary hypertension is broadly classified into 2 groups: primary (idio- 
pathic) and secondary; the latter being more common. 
PRIMARY (IDIOPATHIC) PULMONARY HYPERTENSION 
Primary or idiopathic pulmonary hypertension is an uncommon condi- 
tion of unknown cause. The diagnosis can be established only after a thor- 
ough search for the usual causes of secondary pulmonary hypertension (dis- 
cussed below). The patients are usually young females between the age of 20 




Etiopathogenesis. Though the etiology of primary pulmonary hyper- 
tension is unknown, a number of etiologic factors have been suggested to ex- 
plain its pathogenesis: 
1. A neurohumoral vasoconstrictor mechanism may be involved lead- 
ing to chronic vasoconstriction that induces pulmonary hypertension. 
2. The occurrence of disease in young females has prompted a sugges- 
tion that unrecognised thromboemboli or amniotic fluid emboli during preg- 
nancy may play a role. 
3. There is a suggestion that primary pulmonary hypertension may be a 
form of collagen vascular disease. This is supported by occurrence of Ray- 
naud's phenomenon preceding the onset of this disease by a number of years 
in many patients, and association of the disease with SLE, scleroderma and 
rheumatoid arthritis. 
4. Pulmonary veno-occlusive disease characterised by fibrous oblitera- 
tion of small pulmonary veins is believed to be responsible for some cases of 
primary pulmonary hypertension, especially in children. Generally, this is 
considered to be a consequence of thrombosis or vasculitis. 
5. Ingestion of substances like 'bush tea', oral contraceptives and appe- 
tite depressant agents like aminorex are believed to be related to primary 
pulmonary hypertension. 
6. Familial occurrence has been reported in a number of cases. 
 
SECONDARY PULMONARY HYPERTENSION 
When pulmonary hypertension occurs secondary to a recognised lesion 
in the heart or lungs, it is termed as secondary pulmonary hypertension. It is 
the more common type and may be encountered at any age, but more fre- 
quently over the age of 50 years. 
Etiopathogenesis. Based on the underlying mechanism, causes of sec- 
ondary pulmonary hypertension are divided into the following 3 groups: 
A. Passive pulmonary hypertension. This is the commonest and is 
produced by diseases raising pressure in the pulmonary veins. These diseases 
are: 
1. Mitral stenosis. 
2. Chronic left ventricular failure (e.g. in severe systemic hypertension, 
aortic stenosis, myocardial fibrosis). 
B. Hyperkinetic (Reactive) pulmonary hypertension. 
In this group are included causes in which the blood enters the pulmo- 
nary arteries in greater volume or at a higher pressure. These causes are: 
1. Patent ductus arteriosus. 




C. Vaso-occlusive pulmonary hypertension. All such conditions 
which produce progressive diminution of the vascular bed in the lungs are includ- 
ed in this group. Vaso-occlusive causes may be further subdivided into 3 types: 
1. Obstructive type, in which there is block in the pulmonary circula- 
tion e.g. 
i) Multiple emboli or thrombi 
ii) Sickle cell disease 
iii) ) Schistosomiasis 
2. Obliterative type, in which there is reduction of pulmonary vascular 
bed by chronic parenchymal lung diseases e.g. 
i) Chronic emphysema 
ii) Chronic bronchitis 
iii) ) Bronchiectasis 
iv) Pulmonary tuberculosis 
v) Pneumoconiosis 
3. Vasoconstrictive type, in which there is widespread and sustained 
hypoxic vasoconstriction and alveolar hyperventilation leading to pulmonary 
hypertension e.g. 
i) In residents at high altitude 
ii) Pathologic obesity (Pickwickian disease) 
iii) Upper airway disease such as tonsillar hypertrophy 
iv) Neuromuscular diseases such as poliomyelitis 
v) Severe kyphoscoliosis. 
Pathologic changes. Irrespective of the type of pulmonary hyperten- 
sion (primary or secondary), chronic cases invariably lead to cor pulmonale. 
The pathologic changes are confined to the right side of the heart and pulmonary 
arterial tree in the lungs. There is hypertrophy of the right ventricle and dilata- 
tion of the right atriurn. The vascular changes are similar in primary and sec- 
ondary types and involve the entire arterial tree from the main pulmonary arter- 
ies down to the arterioles. These changes are as under: 
1. Arterioles and small pulmonary arteries: These branches show most 
conspicuous changes. These are: 
i) Medial hypertrophy. 
ii) Thickening and reduplication of elastic laminae, 
iii) Plexiform pulmonary arteriopathy in which there is intraluminal 
tuft of capillary formation in dilated thin-walled arterial branches. These le- 
sions are not so marked in secondary pulmonary hypertension. 
2. Medium-sized pulmonary arteries: 
i) Medial hypertrophy, which is not so marked in secondary pulmonary 
hypertension. 




iii) Adventitial fibrosis. 
iv) Thickening and reduplication of elastic laminae. 
3. Large pulmonary arteries: 
i) Atheromatous deposits. 
 
IMMUNOLOGIC LUNG DISEASE 
 
Immunologic mechanisms play an important role in a number of lung 
diseases. These include the following important examples: 
1. Bronchial asthma 
2. Hypersensitivity (allergic) pneumonitis 
3. Pulmonary eosinophilia 
4. Goodpasture's syndrome 
5. Pulmonary alveolar proteinosis 
BRONCHIAL ASTHMA 
Though bronchial asthma is included in immunologic lung diseases, im- 
munologic reactions are one of the mechanisms involved in its pathogenesis. 
HYPERSENSITIVITY (ALLERGIC) PNEUMONITIS 
Hypersensitivity pneumonitis are a group of immunologically- 
mediated interstitial lung diseases occurring in workers inhaling a variety of 
organic (biologic) antigenic materials. The condition may have an acute on- 
set due to isolated exposure or may be chronic due to repeated low-dose ex- 
posure. 
Etiopathogenesis. The immunologic mechanisms underlying hyper- 
sensitivity pneumonitis from any of these causes appear to be either type III 
immune-complex disease or type IV delayed-hypersensitivity reaction. 
1. Farmers' lung is the classic example resulting from exposure to 
thermophilic actinomycetes generated by humid and warm mouldy hay. 
2. Bagassosis occurs in individuals engaged in manufacture of paper 
and cardboard from sugarcane bagasse. Spores of thermophilic actinomycetes 
grow rapidly in mouldy sugarcane bagasse which are inhaled. 
3. Byssinosis is an occupational lung disease occurring in workers ex- 
posed to fibres of cotton, flex and hemp for a number of years. The role of 
immunologic mechanisms in byssinosis is not as clear as in exposure to other 
organic dusts. 
4. Bird-breeders (Bird-fanciers) lung occurs in pigeon breeders, parrot 
breeders, chicken farmers and bird-fanciers who are exposed to bird- 
droppings and danders from their feathers. 
5. Mushroom-workers lung is found in mushroom cultivators exposed 




6. Malt-workers lung is seen in distillery and brewery workers who are 
exposed to mouldy barley and malt dust. 
7. Maple-bark disease occurs in those involved in stripping of maple 
bark and inhale mouldy maple bark (maple tree is grown in northern hemi- 
sphere for timber and its leaf is the emblem of Canada). 
8. Silo-fillers' disease occurs in individuals who enter the silo (silo is 
an airtight store-house of fodder for farm animals) in which toxic fumes of 
nitric oxide and nitrogen dioxide are formed due to fermentation of silage. 
The condition is generally rapidly fatal; less often it may lead to interstitial 
lung disease. 
Pathologic changes. The pathologic changes primarily involve the alve- 
oli in contrast to bronchiolar involvement in asthma. The changes vary depend- 
ing upon whether the biopsy is examined in early stage or in late stage. 
• In early stage, the alveolar walls are diffusely infiltrated with lym- 
phocytes, plasma cells and macrophages. A proportion of cases show granu- 
lomas consisting of histiocytes and giant cells of foreign body or Langhans 
type. 
• In chronic cases, the lungs show interstitial fibrosis with some in- 
flammatory infiltrate. Honey-combing of the lung may be present. 
PULMONARY EOSINOPHILIA 
Pulmonary eosinophilia, eosinophilic pneumonias or pulmonary infil- 
tration with eosinophilia (PIE) syndrome are a group of immunologically- 
mediated lung diseases characterised by combination of 2 features: 
1. Infiltration of the lungs in chest radiographs; and 
2. Elevated eosinophil count in the peripheral blood. 
Etiopathogenesis. PIE syndrome has a number of diverse causes and 
pathogenesis. These are as under: 
1. Loeffler's syndrome is characterised by eosinophilia in the blood and 
typical wandering radiologic shadows, appearing in some part of the lung for 
a few days and then disappearing so as to appear somewhere else in the lung. 
The condition is generally self-limiting and mild, associated with slight fever 
and a few respiratory symptoms. The etiology is unknown. 
2. Tropical pulmonary eosinophilia is caused by the passage of larvae 
of worms through the lungs e.g. in filariasis, ascariasis, strongyloidosis, toxo- 
cariasis and ancylostomiasis. 
3. Secondary chronic pulmonary eosinophilia occurs secondary to ad- 
verse drug reactions; infection with fungi, bacteria, and helminths; allergic 




4. Idiopathic chronic eosinophilic pneumonia is characterised by prom- 
inent focal areas of consolidation of the lung. The condition is clinically diag- 
nosed by excluding other known causes of pulmonary eosinophilia. 
5. Hypereosinophilic syndrome is occurrence of eosinophilia of over 
1500/μl for more than 6 months without any identifiable cause and without 
eosinophilic infiltrates in the lungs and other organs. 
Pathologic changes. The lesions in the lungs are similar in all cases. 
Grossly, the lungs usually show patchy consolidation. 
Microscopically, there is thickening of the alveolar walls by oedema 
and exudate, chiefly of eosinophils, and some lymphocytes and plasma cells. 
The alveolar lumina also contain eosinophils. Occasionally, small granu- 
lornas may be present. 
GOODPASTURE'S SYNDROME 
Goodpasture's syndrome is combination of necrotising haemorrhagic 
interstitial pneumonitis and rapidly progressive glomerulonephritis. 
Etiopathogenesis. The condition results from immunologic damage 
produced by anti-basement membrane antibodies formed against antigens 
common to the glomerular and pulmonary basement membranes. The trigger 
for initiation of this autoimmune response is not clear; it could be virus infec- 
tion, exposure to hydrocarbons and smoking. 
Pathologic changes. Grossly, the lungs are heavy with red-brown are- 
as of consolidation. 
Microscopically, the features vary according to the stage of the disease: 
• In acute stage, there are focal areas of haemorrhages in the alveoli 
and focal necrosis in the alveolar walls. 
• In more chronic cases, there is organisation of the haemorrhage lead- 
ing to interstitial fibrosis and filling of alveoli with haemosiderin-laden mac- 
rophages. 
PULMONARY ALVEOLAR PROTEINOSIS 
Pulmonary alveolar proteinosis is a rare chronic disease in which the 
distal airspaces of the lungs are filled with granular, PAS-positive, eosino- 
philic material with abundant lipid in it. The condition can occur at any age 
from infancy to old age. 
Etiopathogenesis. The etiology and pathogenesis of alveolar proteino- 
sis are unknown. A number of possibilities have been suggested: 
• Since the alveolar material is combination of lipid and protein, it is 
not simply an overproduction of surfactant. 
• Alveolar proteinosis may have an occupational etiology as seen in pa- 
tients heavily exposed to silica. 




• There may be defective alveolar clearance of debris. 
Pathologic changes. Grossly, usually both lungs are involved, particu- 
larly the lower lobes. The lungs are heavier with areas of consolidation. Sec- 
tioned surface exudes abundant turbid fluid. 
Histologically, the hallmark of the condition is presence of homogene- 
ous, granular, eosinophilic material which stains brightly with PAS. Often, 
the material contains cholesterol clefts. There is no significant inflammatory 
infiltrate in the affected alveoli. Biochemically, the material consists of serum 
proteins of low molecular weight, cholesterol and phospholipids similar to 
surfactant. Electron microscopy reveals that the material consists of necrotic 
alveolar macrophages and desquamated alveolar epithelial cells. 
 
COLLAGEN-VASCULAR DISEASE (SEE ABOVE) 
Microscopically, these granulomas have foci of fibrinoid necrosis and 
intense exudate of lymphocytes, plasma cells and macrophages with scattered 
multinucleate giant cells. Besides necrotising granulomas, there is associated 
vasculitis. 
 
IDIOPATHIC PULMONARY FIBROSIS 
Diffuse interstitial fibrosis can occur as a result of a number of patho- 
logic entities such as pneumoconiosis, hypersensitivity pneumonitis and col- 
lagen-vascular disease. However, in half the cases of diffuse interstitial fibro- 
sis, no apparent cause or underlying disease is identifiable. Such cases are in- 
cluded under the entity 'idiopathic pulmonary fibrosis' in the United States 
and 'cryptogenicfibrosing alveolitis' in Britain. Some authors have termed the 
fully-developed condition as 'chronic interstitial pneumonitis' or 'usual inter- 
stitial pneumonitis' and distinguished it from the early stage of the disease 
called 'desquamative interstitial pneumonitis'. 
Pathogenesis. The pathogenesis of idiopathic pulmonary fibrosis is 
unknown and the condition is diagnosed by excluding all known causes of 
interstitial fibrosis. However, a few evidences point toward immunologic 
mechanism. These are: 
1. High levels of autoantibodies such as rheumatoid factor and antinu- 
clear antibodies. 
2. Elevated titres of circulating immune complexes. 
3. Immunofluorescent demonstration of the deposits of immuno- 
globulins and complement on the alveolar walls in biopsy specimens. 
Pathologic changes. The lung involvement in idiopathic pulmonary 




Grossly, the lungs are firm, heavier with reduced volume. Honey- 
combing (i.e. enlarged, thick-walled air spaces) develops in parts of lung, 
particularly in the subpleural region. 
Histologically, the changes vary according to the stage of the disease. 
• In early stage, there is widening of the alveolar septa by oedema and 
cellular infiltrate by mononuclear inflammatory cells. The alveolar lining 
cells may show hyperplasia at places and are flattened at other places. There 
is often formation of hyaline membranes. The alveolar spaces contain exu- 
date consisting of macrophages, lymphocytes and neutrophils. Many of the 
macrophages contain lamellar bodies derived from surfactant of the necrotic 
alveolar lining epithelial cells. Based on the observation of desquamative 
component in the cellular exudate, some authors label the early stage of idio- 
pathic pulmonary fibrosis as 'desquamative interstitial pneumonitis'. 
• In advanced stage, there is organisation of the alveolar exudate and 
replacement fibrosis in the alveoli as well as in the interstitial septal wall with 
variable amount of inflammation. Eventually, there are small cystic areas 
(honeycomb lung) with alternating areas of fibrosis containing thick-walled 
and narrowed vessels. This stage is often referred to as 'chronic interstitial 
pneumonitis' or 'usual interstitial pneumonitis'. 
 
TUMOURS OF LUNGS 
 
A number of benign and malignant tumours occur in the lungs but the 
primary lung cancer, commonly termed bronchogenic carcinoma, is the most 
common (95% of all primary lung tumours). The lung is also the commonest 
site for metastasis from carcinomas and sarcomas. 
 
BRONCHOGENIC CARCINOMA 
Though the term bronchogenic carcinoma is commonly used for cancer of 
the lungs, it includes carcinomas having bronchial as well as bronchiolar origin. 
Incidence. Bronchogenic carcinoma is the most common primary ma- 
lignant tumour in men in industrialised nations and accounts for nearly one- 
third of all cancer deaths in both sexes. Currently, the incidence in females in 
the United States has already exceeded breast cancer as a cause of death in 
women. Cancer of the lung is a disease of middle and late life with peak inci- 
dence in 5th to 7th decades, after which there is gradual fall in its incidence. 
Etiopathogenesis. The high incidence of lung cancer is associated with a 
number of etiologic factors, most important of which is cigarette smoking. 
1. Smoking. The most important factor for rise in the incidence of 
bronchogenic carcinoma is tobacco smoking. About 80% of lung cancer oc- 
curs in active smokers. A number of evidences support the positive relation- 




i) Total dose: There is a direct statistical correlation between death rate 
from lung cancer and the total amount of cigarettes smoked e.g. 
• An average regular smoker has 10 times greater risk of developing 
lung cancer than a non-smoker. 
• The risk of smokers of more than 2 packs (40 cigarettes) per day for 
20 years is 20 times greater. 
• Cessation of smoking by a regular smoker results in gradual decline 
in the chances of developing lung cancer. After 10 years of abstinence from 
smoking, the risk is not greater than in a non-smoker. 
• Pipe and cigar smokers, though have higher risk than non-smokers 
but are at lesser risk than cigarette smokers. 
ii) Histologic alterations: The association of tobacco smoking is 
strongest for squamous cell carcinoma and small cell carcinoma of the lung. 
More than 90% of smokers have epithelial changes in the respiratory tract in 
the form of squamous metaplasia, dysplasia or carcinoma in situ. 
iii) Mechanism: How tobacco smoking causes lung cancer is not quite 
clear.  
• Analysis of the tar from cigarette smoke has revealed a number of 
known  carcinogens  (e.g.  polycyclic  aromatic  hydrocarbons, nitrosamines) 
and tumour promoters (e.g. phenol derivatives). 
• In experimental animal studies, it has been possible to induce cancer 
by skin painting experiments with smoke-tar. However, it has not been possi- 
ble to reproduce pattern of human respiratory tract cancer, probably because 
of the difficulty in reproducing human smoking methods in animals. 
2. Atmospheric pollution. There is increased risk of developing bron- 
chogenic carcinoma in nonsmokers living in industrialised and smoky cities 
than in the less polluted rural areas. It is possible that specific industrial pol- 
lutants may be at fault as evidenced by high rates for lung cancer in people 
living in the neigh bour hood of petrochemical industries. 
3. Occupational causes. There are number of well-established occupa- 
tional causes of lung cancer. These include workers exposed to asbestos, ra- 
diation of all types, bisethers, nickel, beryllium, arsenic, metallic iron and 
iron-oxide. Some industrial carcinogens and cigarette smoking have cocar- 
cinogenic effect, particularly in uranium mines and asbestos workers. 
4. Dietary factors. Susceptibility to respiratory cancers is increased in 
vitamin A deficiency. Smokers with low vitamin A intake have a greater risk of 
lung cancer than those with vitamin A-rich diet. The incidence of lung cancer is 
inversely related to socioeconomic level reflecting their dietary pattern. 
5. Genetic factors. The risk of developing lung cancer in the relatives 
of lung cancer patients is two and half times greater than that in the general 




genic polycyclic aromatic hydrocarbons is under genetic control but the exact 
nature of genetic and familial influence is uncertain. 
6. Chronic scarring. Peripheral adenocarcinomas occur more frequent- 
ly in areas of chronic scarring caused by chronic inflammatory changes, old 
tuberculosis, asbestosis, chronic interstitial fibrosis, old infarcts and in scle- 
roderma. 
Pathologic changes. Bronchogenic carcinoma can occur anywhere in 
the lung but the most common location is hilar, followed in descending fre- 
quency by peripheral type. 
Grossly, these 2 main types show variation in appearance: 
1. Hilar type: Most commonly, the lung cancer arises in the main 
bronchus or one of its segmental branches in the hilar parts of the lung, more 
often on the right side. The tumour begins as a small roughened area on the 
bronchial mucosa at the bifurcation. As the tumour enlarges, it thickens the 
bronchial mucosa producing nodular or ulcerated surface. As the nodules co- 
alesce, the carcinoma grows into a friable spherical mass, 1 to 5 cm in diame- 
ter, narrowing and occluding the lumen. The cut surface of the tumour is yel- 
lowish-white with foci of necrosis and haemorrhages which may produce 
cavitary lesions. It is common to find secondary changes in bronchogenic 
carcinoma of lung such as bronchopneumonia, abscess formation and bron- 
chiectasis as a result of obstruction and intercurrent infections. The tumour 
soon spreads within the lungs by direct extension or by lymphatics, and to 
distant sites by lymphatic or haematogenous routes, as described later. 
2. Peripheral type: A small proportion of lung cancers, chiefly adeno- 
carcinomas including bronchioloalveolar carcinomas, originate from a small 
peripheral bronchiole but the exact site of origin may not be discernible. The 
tumour may be a single nodule or multiple nodules in the periphery of the 
lung producing pneumonia-like consolidation of a large part of the lung. The 
cut surface of the tumour is greyish and mucoid. 
Histologically, as per the World Health Organisation recommenda- 
tions, bronchogenic carcinoma is divided into 5 main histologic types: squa- 
mous cell or epidermoid carcinoma (35-50%), small cell carcinoma (20- 
25%), adenocarcinoma (15-35%), large cell carcinoma (10-15%), and com- 
bined squamous cell carcinoma and adenocarcinoma (adenosquamous carci- 
noma, 1-3%). For therapeutic purposes, bronchogenic carcinoma can be clas- 
sified into 3 groups: 
1. Small cell carcinoma (20-25%) 
2. Non-small cell carcinomas (70-75%) (includes squamous cell carci- 
noma, adenocarcinoma, and large cell carcinoma) 




By light microscopy, precise histologic classification of bronchogenic 
carcinoma is possible which is important because of prognostic and therapeu- 
tic considerations. 
1. Squamous cell (epidermoid) carcinoma: This is the most common 
type of bronchogenic carcinoma found more commonly in men, particularly 
with history of tobacco smoking. These tumours usually arise in a large bron- 
chus and are prone to massive necrosis and cavitation. The tumour is diag- 
nosed microscopically by identification of either intercellular bridges or ke- 
ratinisation. The tumour may show varying histologic grades of differentia- 
tion such as well-differentiated, moderately-differentiated and poorly- 
differentiated. Occasionally, a variant of squamous cell carcinoma, spindle 
cell carcinoma, having biphasic pattern of growth due to the presence of a 
component of squamous cell carcinoma and the other sarcoma-like spindle 
cell component, is found. Usually the spread of squamous cell carcinoma is 
more rapid than the other histologic types. Frequently, the edge of the growth 
and the adjoining uninvolved bronchi show squamous metaplasia, epithelial 
dysplasia and carcinoma in situ. 
2. Small cell carcinoma: Small cell carcinomas are frequently hilar or 
central in location, have strong relationship to cigarette smoking and are 
highly malignant tumours. They are most often associated with ectopic hor- 
mone production because of the presence of neurosecretory granules in ma- 
jority of tumour cells which are similar to those found in argentaffin or 
Kulchitsky cells normally found in bronchial epithelium. Small cell carcino- 
mas have 3 subtypes: 
i) Oat cell carcinoma is composed of uniform, small cells, larger than 
lymphocytes with dense, round or oval nuclei having diffuse chromatin, in- 
conspicuous nucleoli and very sparse cytoplasm (oat = a form of grain). 
These cells are organised into cords, aggregates and ribbons or around small 
blood vessels forming pseudorosettes. 
ii) Small cell carcinoma, intermediate cell type is composed of cells 
slightly larger than those of oat cell carcinoma and have similar nuclear char- 
acteristics but have more abundant cytoplasm. These cells are organised into 
lobules, 
iii) Combined oat cell carcinoma is a tumour in which there is a definite 
component of oat cell carcinoma with squamous cell and/or adenocarcinoma. 
3. Adenocarcinoma: Adenocarcinoma, also called peripheral carci- 
noma due to its location and scar carcinoma due to its association with areas of 
chronic scarring, is the most common bronchogenic carcinoma in women and is 
slow-growing. Adenocarcinoma is further subclassified into 4 types: 
i) Acinar adenocarcinoma which has predominance of glandular struc- 




ii) Papillary adenocarcinoma which has a pronounced papillary con- 
figuration and is frequently peripherally located in the lungs and is found in 
relation to pulmonary, scars (scar carcinoma), 
iii) Bronchiolo-alveolar carcinoma is characterised by cuboidal to tall 
columnar and mucus-secreting epithelial cells growing along the existing al- 
veoli and forming numerous papillary structures. Ultrastructurally, these tu- 
mour cells resemble Clara cells or less often type II pneumocytes. 
iv) Solid carcinoma is a poorly-differentiated adenocarcinoma lacking 
acini, tubules or papillae but having mucus-containing vacuoles in many tu- 
mour cells. 
4. Large cell carcinoma: These are undifferentiated carcinomas which 
lack the specific features by which they could be assigned into squamous cell 
carcinoma or adenocarcinoma. Large cell carcinomas are more common in 
men, have strong association with cigarette smoking and are highly malig- 
nant tumours. The tumour cells have large nuclei, prominent nucleoli, abun- 
dant cytoplasm and well-defined cell borders. Variants of large cell undiffer- 
entiated carcinomas include giant cell carcinoma with prominence of highly 
pleomorphic multinucleate cells and clear cell carcinoma composed of cells 
with clear or foamy cytoplasm without mucin. 
5. Adenosquamous carcinoma: These are a small proportion of pe- 
ripheral scar carcinomas having clear evidence of both keratinisation and 
glandular differentiation. 
Spread. Bronchogenic carcinoma can invade the adjoining structures 
directly, or may spread by lymphatic and haematogenous routes. 
1. Direct spread. The tumour extends directly by invading through the 
wall of the bronchus and destroys and replaces the peribronchial lung tissue. 
As it grows further, it spreads to the opposite bronchus and lung, into the 
pleural cavity, the pericardium and the myocardium and along the great ves- 
sels of the heart causing their constriction. Extension of the cancer located at 
the apex of the lung into the thoracic cage may involve brachial plexus and 
the sympathetic chain causing pain and sensory disturbances, so called Pan- 
coast's syndrome. 
2. Lymphatic spread. Initially, hilar lymph nodes are affected. Later, 
lymphatic metastases occur to the other groups leading to spread to mediasti- 
nal, cervical, supraclavicular and paraaortic lymph nodes. Invasion of the 
thoracic duct may produce chylous ascites. 
3. Haematogenous spread. Distant metastases via blood stream are wide- 
spread and early. The sites affected, in descending order of involvement, are: the 
liver, adrenals, bones, pancreas, brain, opposite lung, kidneys and thyroid. 
Staging and prognosis. The widely accepted clinical staging of lung 




Tumours, Nodal involvement and distant Metastases. TNM staging divides 
all lung cancers into the following 4 stages: 
Occult: Malignant cells in the broncho-pulmonary secretions but no 
evidence of primary tumour or metastasis. 
Stage I: Tumour less than 3 cm, with or without ipsilateral nodal in- 
volvement, no distant metastasis. 
Stage II: Tumour larger than 3 cm, with ipsilateral hilar lymph node 
involvement, no distant metastasis. 
Stage III: Tumour of any size, involving adjacent structures, involving 
contralateral lymph nodes or distant metastasis. 
In general, tumour size larger than 5 cm has worse prognosis. Sympto- 
matic patients, particularly with systemic symptoms, fare far badly than the non- 
symptomatic patients. The overall prognosis of bronchogenie carcinoma is dis- 
mal; 5-year survival rate with surgery combined with radiotherapy or chemo- 
therapy is about 9%. Adenocarcinoma and squamous cell carcinoma which are 
localised, are resectable and have a slightly better prognosis. Small cell carci- 
noma has the worst prognosis since surgical treatment is ineffective though the 
rumour is sensitive to radiotherapy and chemotherapy. 
 
BRONCHIAL CARCINOID 
Bronchial carcinoids are tumours of low grade malignancy arising from 
neuroendocrine (Kulchitsky) cells of bronchial mucosa in common with cell of 
origin for small cell carcinomas described above. Formerly, they used to be 
classified as 'bronchial adenomas' but now it is known that these tumours are lo- 
cally invasive and have the capacity to metastasise. Bronchial carcinoids tend to 
occur at a younger age than broncho-genie carcinoma, often appearing below 
the age of 40 years, and are not related to cigarette smoking. 
Pathologic changes. Grossly, bronchial carcinoids most commonly 
arise from a major bronchus and project into the bronchial lumen as a spheri- 
cal polypoid mass, 3-4 cm in diameter. Less commonly, the tumour may 
grow into the bronchial wall and produce collar-button like lesion. The over- 
lying bronchial mucosa is usually intact. Cut surface of the tumour is yellow- 
tan in colour. 
Histiologically, the tumour is composed of uniform cubodial cells 
forming aggregates, trabeculae or ribbons separated by fine fibrous septa. 
The tumour cells have abundant, finely granular cytoplasm and oval central 
nuclei with clumped nuclear chromatin. Mitoses are rare and necrosis is un- 
common. The secretory granules of bronchial carcinoids resemble those of 
other foregut carcinoids and stain positively with argyrophilic stains in which 





Hamartoma is a tumour-like lesion composed of an abnormal admix- 
ture of pulmonary tissue components and is discovered incidentally as a coin- 
lesion in the chest-X-ray. Pulmonary hamartomas are of 2 types: chondroma- 
tous and leiomyomatous. 
• Chondromatous hamartoma is more common and usually asymp- 
tomatic. It forms a solitary, spherical mass, 2-5 cm in diameter, usually at the 
periphery of the lung. Typically, it shows nodules of cartilage associated with 
fibrous and adipose tissue admixed with bronchial epithelium. 
• Leiomyomatous hamartoma has a prominent smooth muscle com- 
ponent and bronchiolar structures. They are frequently multiple, 1-2 mm in 
diameter and are more commonly located near the pleura. 
 
METASTATIC LUNG TUMOURS 
Secondary tumours of the lungs are more common than the primary 
pulmonary tumours. Metastases from carcinomas as well as sarcomas arising 
from anywhere in the body may spread to the lung by haematogenous or 
lymphatic routes, or by direct extension. Blood-borne metastases are the most 
common since emboli of tumour cells from any malignant tumour entering 
the systemic venous circulation are likely to be lodged in the lungs. Metasta- 
ses are most common in the peripheral part of the lung forming single or mul- 
tiple, discrete nodular lesions which appear radiologically as 'cannon-ball 
secondaries'. Less frequently, the metastatic growth is confined to peribron- 
chiolar and perivascular locations which is due to spread via lymphatics. 
Most common sources of metastases in the lungs are: carcinomas of 
the bowel, breast, thyroid, kidney, pancreas, lung (ipsilateral or contralateral) 
and liver. Other tumours which frequently metastasise to the lungs are osteo- 








Normal structure. Visceral pleura covers the lungs and extends into the fissures 
while the parietal pleura limits the mediastinum and covers the dome of the diaphragm 
and inner aspect of the chest wall. The two layers between them enclose pleural cavity 
which contains less than 15 ml of clear serous fluid. 
Microscopically, both the pleural layers are lined by a single layer of flattened 
mesothelial cells facing each other. Underneath the lining cells is a thin layer of connec- 
tive tissue. 
Diseases affecting the pleura are nearly always secondary to some oth- 
er underlying disease. Broadly, they fall into inflammations, non- 
inflammatory pleural effusions, pneumothorax, and tumours. 
INFLAMMATIONS 
Inflammatory involvement of the pleura is commonly termed pleuritis 
or pleurisy. Depending upon the character of resultant exudate, it can be di- 
vided into serous, fibrinous and serofibrinous, suppurative or empyema, and 
haemorrhagic pleuritis. 
1. Serous, fibrinous and serofibrinous pleuritis. Acute inflammation 
of the pleural sac (acute pleuritis) can result in serous, serofibrinous and fi- 
brinous exudate. Most of the causes of such pleuritis are infective in origin, par- 
ticularly within the lungs, such as tuberculosis, pneumonias, pulmonary infarcts, 
lung abscess and bronchiectasis. Other causes include a few collagen diseases 
(e.g. rheumatoid arthritis and disseminated lupus erythematosus), uraemia, meta- 
static involvement of the pleura, irradiation of lung tumours and diffuse systemic 
infections (e.g. typhoid fever, tularaemia, blastomycosis and coccidiodomycosis). 
Pleurisy causes pain in the chest on breathing and a friction rub is audible 
on auscultation. In most patients, the exudate is minimal and is resorbed result- 
ing in resolution. Repeated attacks of pleurisy may result in organisation leading 
to fibrous adhesions and obliteration of the pleural cavity. 
2. Suppurative pleuritis (empyema thoracis). Bacterial or mycotic 
infection of the pleural cavity that converts a serofibrinous effusion into pu- 
rulent exudate is termed suppurative pleuritis or empyema thoracis. The most 
common cause is direct spread of pyogenic infection from the lung. Other caus- 
es are direct extension from subdiaphragmatic abscess or liver abscess and pene- 
trating injuries to the chest wall. Occasionally, the spread may occur by haema- 
togenous or lymphatic routes. 
In empyema, the exudate is yellow-green, creamy pus that accumulates in 
large volumes. Empyema is eventually replaced by granulation tissue and fibrous 
tissue. In time, tough fibrocollagenic adhesions develop which obliterate the cavi- 
ty, and with passage of years, calcification may occur. The effect of these is seri- 




3. Haemorrhagic pleuritis. Haemorrhagic pleuritis differs from 
haemothorax in having inflammatory cells or exfoliated tumour cells in the 
exudate. The causes of haemorrhagic pleuritis are metastatic involvement of 
the pleura, bleeding disorders and rickettsial diseases. 
NON-INFLAMMATORY PLEURAL EFFUSIONS 
These include fluid collections in the pleural cavity such as hydrotho- 
rax, haemothorax and chylothorax. 
1. HYDROTHORAX. Hydrothorax is non-inflammatory accumulation of 
serous fluid within the pleural cavities. Hydrothorax may be unilateral or bi- 
lateral depending upon the underlying cause. Occasionally, an effusion is 
limited to part of a pleural cavity by preexisting pleural adhesions. 
The most common cause of hydrothorax, often bilateral, is congestive 
heart failure. Other causes are renal failure, cirrhosis of liver. Meig's syndrome, 
pulmonary oedema and primary and secondary tumours of the lungs. 
The non-inflammatory serous effusion in hydro-thorax is clear and straw- 
coloured and has the characteristics of transudate with a specific gravity of un- 
der 1.012, protein content below 1 gm/dl and little cellular content. 
If the fluid collection in pleural cavity is less than 300 ml (normal is less 
than 15 ml), no signs or symptoms are produced and may be apparent in chest X- 
ray in standing posture as obliterated costodiaphragmatic angle. If the pleural cav- 
ity contains abundant fluid, it imparts a characteristic opaque radiographic ap- 
pearance to the affected side with deviation of trachea to the opposite side. In 
such cases, symptoms such as respiratory embarrassment and dyspnoea are pro- 
duced which are promptly relieved on withdrawal of fluid. 
2. HAEMOTHORAX. Accumulation of pure blood in the pleural cavity is 
termed as haemothorax. The most common causes of haemothorax are trau- 
ma to the chest wall or to the thoracic viscera and rupture of aortic aneurysm. 
It is important to remove the blood from the pleural cavity as early as possi- 
ble. Otherwise the blood will clot and organise, resulting in fibrous adhesions 
and obliteration of the pleural cavity. 
3. CHYLOTHORAX. Chylothorax is an uncommon condition in which 
there is accumulation of milky fluid of lymphatic origin into the pleural cavity. 
Chylothorax results most commonly from rupture of the thoracic duct by trauma 
or obstruction of the thoracic duct such as by malignant tumours, most often ma- 
lignant lymphomas. Chylothorax is more often confined to the left side. Chylous 
effusion is milky due to high content of finely emulsified fats in the chyle. 
PNEUMOTHORAX 
An accumulation of air in the pleural cavity is called pneumothorax. It 





i) Spontaneous pneumothorax occurs due to spontaneous rupture of 
alveoli in any form of pulmonary disease. Most commonly, spontaneous 
pneumothorax occurs in association with emphysema, asthma and tuberculo- 
sis. Other causes include chronic bronchitis in an old patient, bronchiectasis, 
pulmonary infarction and bronchial cancer. In young patients, recurrent spon- 
taneous rupture of peripheral subpleural blebs may occur without any cause 
resulting in disabling condition termed spontaneous idiopathic pneumothorax. 
ii) Traumatic pneumothorax is caused by trauma to the chest wall or 
lungs, ruptured oesophagus or stomach, and surgical operations of the thorax. 
iii) Therapeutic (artificial) pneumothorax used to be employed for- 
merly in the treatment of chronic pulmonary tuberculosis in which air was 
introduced into the pleural sac so as to collapse the lung and limit its respira- 
tory movements. 
The effects of pneumothorax due to any cause depend upon the amount of 
air collected in the pleural cavity. If the quantity of air in the pleura is small, it is 
resorbed. Larger volume of air collection in the pleural cavity causes dyspnoea 
and pain in the chest. Pneumothorax causes lung collapse and pulls the mediasti- 
num to the unaffected side. Occasionally, the defect in the lungs is such that it acts 
as flap-valve and allows entry of air during inspiration but does not permit its es- 
cape during expiration, creating tension pneumothorax which requires urgent re- 
lief of pressure so as to relieve severe dyspnoea and circulatory failure. 
 
TUMOURS OF PLEURA 
Pleural tumours may be primary or secondary. In line with pulmonary 
tumours, the secondary tumours in the pleura are more common. The only 
important primary tumour of pleura is mesothelioma. 
MESOTHELIOMA 
Mesothelioma is an uncommon tumour arising from mesothelial lining of 
serous cavities, most often in pleural cavity, and rarely in peritoneal cavity and 
pericardial sac. Mesotheliomas are of 2 types – benign (solitary) and malignant 
(diffuse). The biologic behaviour of pleural mesotheliomas is usually predicted 
by their gross appearance – those forming solitary, discrete masses are generally 
benign, whereas those which grow diffusely are usually malignant. 
Benign (Solitary) Mesothelioma 
Benign or solitary mesothelioma is also called as pleural fibroma. As- 
bestos exposure plays no role in etiology of benign mesothelioma. 
Grossly, it consists of a solitary, circumscribed, small, firm mass, generally 
less than 3 cm in diameter. Cut surface shows whorls of dense fibrous tissue. 
Microscopically, the tumour is predominantly composed of whorls of 
collagen fibres and reticulin with interspersed fibroblasts. Rarely, mesotheli- 




Benign mesothelioma causes no symptoms and is detected as an inci- 
dental radiologic finding. Sometimes the tumour is associated with systemic 
syndrome of osteoarthropathy or hypoglycaemia. Removal of the tumour is 
generally curative. 
Malignant (Diffuse) Mesothelioma 
Malignant or diffuse mesothelioma is rare. It is a highly malignant tu- 
mour associated with high mortality. The tumour is significant in view of its 
recognised association with occupational exposure to asbsestos (particularly 
crocidolite) for a number of years, usually 20 to 40 years. About 90% of ma- 
lignant mesotheliomas are asbestos-related. However, prolonged asbestos- 
exposure is considered more significant rather than heavy exposure as docu- 
mented by occurrence of malignant mesothelioma in the family members of as- 
bestos workers. There is no extra increased risk of developing mesothelioma in 
asbestos workers who smoke, while asbestos-related bronchogenic carcinoma 
has a much higher risk in smoker asbestos workers. 
Grossly, the tumour is characteristically diffuse, forming a thick, white, 
fleshy coating over the parietal and visceral surfaces. Microscopically, ma- 
lignant mesothelioma may have epithelial, sarcomatoid or biphasic patterns. 
i) Epithelial pattern resembles an adenocarcinoma, consisting of 
tubular and tubulo-papillary formations. The tumour cells are usually well- 
differentiated, cuboidal, flattened or columnar cells. 
ii) Sarcomatoid pattern consists of spindle cell sarcoma resembling 
fibrosarcoma. The tumour cells are arranged in a storiform pattern with 
abundant collagen between them. 
iii) Biphasic pattern shows mixed growth having epithelial as well as 
sarcomatoid pattern. Usually, there are slit-like or gland-like spaces lined by neo- 
plastic mesothelial cells separated by proliferating spindle-shaped tumour cells. 
Asbestos bodies are found in the lungs of most patients with malignant 
mesothelioma of any histologic type. 
Clinical manifestations include chest pain, dyspnoea, pleural effusion 
and infections. The tumour spreads rapidly by direct invasion into lung and 
by lymphatic spread into hilar lymph nodes and pericardium. Sometimes dis- 
tant metastases, particularly to the liver, occur. The prognosis is poor; 50% of 
patients die within one year of diagnosis. 
 
SECONDARY PLEURAL TUMORS 
Metastatic malignancies in the pleura are more common than the pri- 
mary tumours and appear as small nodules scattered over the lung surface. 
The most frequent primary malignant tumours metastasizing to the pleura are 









The oral cavity is the point of entry for digestive and respiratory tracts. The mucous 
membrane of the mouth consists of squamous epithelium covering vascularised connective 
tissue. The epithelium is keratinised over the hard palate, lips and gingiva, while elsewhere it 
is non-keratinised. Mucous glands (minor salivary glands) are scattered throughout the oral 
mucosa. Sebaceous glands are present in the region of the lips and the buccal mucosa only. 
Lymphoid tissue is present in the form of tonsils and adenoids. 
The oral cavity is the site of numerous congenital and acquired diseases. Besides, 
many systemic diseases have oral manifestations. Some of the commonly occurring condi- 
tions are discussed here. 
 
DEVELOPMENTAL ANOMALIES 
1. Facial clefts. Cleft upper lip (harelip) and cleft palate, alone or in 
combination, are the commonest developmental anomalies of the face. These 
occur from the failure of fusion of facial processes. 
2. Fordyce's granules. Fordyce's granules are symmetric, small, light 
yellow macular spots on the lips and buccal mucosa and represent collections 
of sebaceous glands. They remain undeveloped until puberty but occur quite 
commonly in adults. 
3. Leukoedema. This is an asymptomatic condition occurring in chil- 
dren and is characterised by symmetric, gray white areas on the buccal muco- 
sa. Histologically, there is pronounced intracellular oedema. There is no in- 
creased malignant potential compared to leukoplakia discussed below. 
4. Developmental defects of the tongue. 
These are as under: 
i) Macroglossia is the enlargement of the tongue, usually due to lym- 
phangioma or haemangioma, and sometimes due to amyloid tumour. 
ii) Microglossia and aglossia are rare congenital anomalies represent- 
ing small-sized and absence of tongue respectively. 
iii) Fissured tongue (scrotal, furrowed or grooved tongue) is a genetical- 
ly-determined condition characterised by numerous small furrows or grooves on 
the dorsum of the tongue. It is often associated with mild glossitis. 
iv) Bifid tongue is a rare condition occurring due to failure of the two 
lateral halves of the tongue to fuse in the midline. 
v) Tongue tie occurs when the lingual fraenum is quite short, or when 
the fraenum is attached near the tongue tip. 
vi) Hairy tongue is not a true developmental defect, but is mentioned 
here along with other similar conditions. The fili form papillae are hypertro- 
phied and elongated. These 'hairs' are stained black, brown or yellowish- 





Lesions of the oral mucosa occur in many diseases of the skin. Some of 
these are as under: 
1. Lichen planus. Characteristically, oral lichen planus appears as inter- 
lacing network of whitening or keratosis on the buccal mucosa. 
2. Vesicular lesions. A number of vesicular or bullous diseases of the 
skin have oral lesions. 
i) Pemphigus vulgaris. Vesicular oral lesions appear invariably in all 
cases at some time in the course of pemphigus vulgaris. In about half the cas- 
es oral lesions are the initial manifestations. 
ii) Pemphigoid. Vesicles or bullae appear on oral mucosa as well as on 
conjunctiva in pemphigoid and are seen more often in older women. 
iii) Erythema multiforme. Subepithelial vesicles may occur on the skin 
as well as mucosae. 
iv) Stevens-Johnson syndrome is a rather fatal and severe form of ery- 
thema multiforme involving oral and other mucous membranes occurring fol- 
lowing ingestion of sulfa drugs. 
v) Epidermolysis bullosa is a hereditary condition having subepidermal 
bullae on the skin as well as has oral lesions. 
 
INFLAMMATORY DISEASES 
1. Stomatitis. Inflammation of the mucous membrane of the mouth is 
called stomatitis. It can occur in the course of many different diseases. 
i) Aphthous ulcers (Canker sores) is the commonest form of oral ulcer- 
ation. The etiology is unknown but may be precipitated by emotional factors, 
stress, allergy, hormonal imbalance, nutritional deficiencies, gastrointestinal 
disturbances, trauma etc. The condition is characterised by painful oral ul- 
cers, 1 cm or more in size. Recurrent aphthae may form a part of Behcet's 
syndrome and inflammatory bowel disease. 
ii) Herpetic stomatitis is an acute disease occurring in infants and 
young children. It is the most common manifestation of primary infection 
with herpes simplex virus. The lesions are in the form of vesicles around the 
lips. Similar lesions may appear on the genital skin. Recurrent attacks occur 
due to stress, emotional upsets and upper respiratory infections. 
iii) Necrotising stomatitis (Noma or Cancrum oris) occurs more com- 
monly in poorly-nourished children like in kwashiorkor; infectious diseases 
such as measles; immunodeficiencies and emotional stress. The lesions are 
characterised by necrosis of the marginal gingiva and may extend on to oral 
mucosa, causing cellulitis of the tissue of the cheek. The condition may pro- 




iv) Mycotic infections commonly involving the oral mucosa are acti- 
nomycosis and candidiasis. 
• Cervicofacial actinomycosis is the commonest form of the disease 
developing at the angle of the mandible. 
• Candidiasis (moniliasis or thrush) is caused by Candida albicans 
which is a commensal in the mouth. It appears as an opportunistic infection 
in immunocompromised host. There are erythematous lesions on the palate 
and angular cheilitis. 
2. Glossitis. Acute glossitis characterised by swollen papillae occurs in 
eruptions of measles and scarlet fever. In chronic glossitis, the tongue is raw 
and red without swollen papillae and is seen in malnutrition such as in pella- 
gra, ariboflavinosis and niacin deficiency. In iron deficiency anaemia, perni- 
cious anaemia and sprue, there is chronic atrophic glossitis characterised by 
atrophied papillae and smooth raw tongue. 
3. Syphilitic lesions. Oral lesions may occur in primary, secondary, ter- 
tiary and congenital syphilis. 
i) Extragenital chancre of primary syphilis occurs most commonly on 
the lips. 
ii) Secondary syphilis shows maculopapular eruptions and mucous 
patches in the mouth. 
iii) In the tertiary syphilis, gumrnas or diffuse fibrosis may be seen on 
the hard palate and tongue. 
iv) Oral lesions of the congenital syphilis are fissures at the angles of 
mouth and characteristic peg-shaped notched Hutchinson's incisors. 
4. Tuberculous lesions. Involvement of the mouth in tuberculosis is ra- 
re. The lesions are in the form of ulcers or elevated nodules. 
5. HIV infection. HIV infection of low grade as well as full-blown ac- 
quired immunodeficiency syndrome (AIDS) are associated with oral manifes- 
tations such as opportunistic infections, malignancy, hairy leukoplakia and 
others. About half the cases of Kaposi's sarcoma have intraoral lesions as part 
of systemic involvement. 
PIGMENTARY LESIONS 
Oral and labial melanotic pigmentation may be observed in certain sys- 
temic and metabolic disorders such as Addison's disease, Albright syndrome, 
Peutz-Jeghers syndrome and haemochromatosis. All types of pigmented naevi 
as well as malignant melanoma can occur in oral cavity. Exogenous pigmenta- 
tion such as due to deposition of lead sulfide can also occur. 
TUMOURS AND TUMOUR-LIKE LESIONS 
Benign and malignant tumours of various types and also a number of 





A. TUMOUR-LIKE LESIONS 
A number of proliferative lesions arising from the oral tissues are tu- 
mour-like masses which clinically may resemble neoplasms. Some of these 
are as under: 
1. Fibrous growths. Fibrous growths of the oral soft tissues are very 
common. These are not true tumours (unlike intraoral fibroma and papillo- 
ma), but are instead inflammatory or irritative in origin. A few common vari- 
eties are as under: 
i) Fibroepithelial polyps occur due to irritation or chronic trauma. 
These are composed of reparative fibrous tissue, covered by a thin layer of 
stratified squamous epithelium. 
ii) Fibrous epulis is a lesion occurring on the gingiva and is localised hy- 
perplasia of the connective tissue following trauma or inflammation in the area. 
iii) Denture hyperplasia occurs in edentulous or partly edentulous pa- 
tients. The lesion is an inflammatory hyperplasia in response to local irrita- 
tion by ill-fitting denture or an elongated tooth. 
2. Pyogenic granuloma. This is an elevated, bright red swelling of var- 
iable size occurring on the lips, tongue, buccal mucosa and gingiva. It is a 
vasoproliferative inflammatory lesion. Pregnancy tumour is a variant of pyo- 
genic granuloma. 
3. Mucocele. Also called mucous cyst, it is a cystic dilatation of the 
mucous glands of the oral mucosa. The cyst often ruptures on distension and 
incites inflammatory reaction. 
4. Ranula. It is a large mucocele located on the floor of the mouth. The 
cyst is lined by true epithelial lining. 
5. Dermoid cyst. This tumour-like mass in the floor of the mouth repre- 
sents a developmental malformation. The cyst is lined by stratified squamous 
epithelium. The cyst wall contains sebaceous glands, sweat glands, hair folli- 
cles and other mature tissues. 
B.BENIGN TUMOURS 
Different parts of the mouth have a variety of mesodermal tissues and ke- 
ratinising and non-keratinising epithelium. Therefore, the majority of neoplasms 
arising from the oral tissues are just like their counterparts in other parts of the 
body. Some of the common benign tumours of the mouth are as under: 
1. Squamous papilloma. Papilloma can occur anywhere in the mouth 
and has the usual papillary or finger-like projections. 
Microscopically, each papilla is composed of valarised connective tis- 




2. Haemangioma. Haemangioma can occur anywhere in the mouth; 
when it occurs on tongue it may cause macroglossia. It is most commonly 
capillary type, although cavernous and mixed types may also occur. 
3. Lymphangioma. Lymphangioma may develop most commonly on 
the tongue producing macroglossia; on the lips producing macrocheilia, and 
on the cheek. Cystic hygroma is a special variety of lymphangioma occurring 
in children on the lateral side of neck. 
Microscopically, lymphangioma is characterised by large lymphatic 
spaces lined by endothelium and containing lymph. 
4. Fibroma. The true fibroma of mouth is relatively uncommon benign 
tumour and is more often a tumour-like lesion (discussed above). 
Microscopically, fibroma is composed of collagenic fibrous connective 
tissue covered by stratified squamous epithelium. 
5. Fibromatosis gingivae. This is a fibrous overgrowth of unknown 
etiology involving the entire gingiva. Sometimes the fibrous overgrowth is so 
much that the teeth are covered by fibrous tissue. 
6. Tumours of minor salivary glands. 
Minor salivary glands present in the oral cavity may sometimes be the 
site of origin of salivary tumours similar to those seen in the major salivary 
glands. Pleomorphic adenoma is a common example. 
7. Granular cell myoblastoma. This is an unusual oral benign tumour, 
seen more often in the tongue. 
Microscopically, the tumour is composed of large polyhedral cells with 
granular, acidophilic cytoplasm. The covering epithelium usually shows pro- 
nouncec pseudoepitheliomatous hyperplasia. 
8. Other rare benign tumours. Some other rare benign tumours which 
can occur in the oral soft tissues are: neurilemmoma, neurofibroma, lipoma, 
giant cell granuloma, rhabdomyoma, leiomyoma, solitary plasmacytoma, os- 
teoma, chondroma, naevi and vascular oral lesions seen in hereditary haemor- 
rhagic telangiectasia (Osler-Rendu-Weber syndrome) and encephalofacial 
angiomatosis (Sturge-Weber syndrome). 
C. PREMALIGNANT LESIONS 
LEUKOPLAKIA (WHITE LESIONS) 
Leukoplakia (white plaque) may be clinically defined as a white patch 
or plaque on the oral mucosa, exceeding 5 mm in diameter, which cannot be 
rubbed off nor can be classified into any other diagnosable disease. A number 
of other lesions are characterised by the formation of white patches. Howev- 
er, from the pathologist's point of view, the term 'leukoplakia' is reserved for 
epithelial thickening which may range from completely benign to atypical 




Incidence. It occurs more frequently in males than females. The lesions 
may be of variable size and appearance. The sites of predilection, in descending 
order of frequency, are: cheek mucosa, angles of mouth, alveolar mucosa, 
tongue, lip, hard and soft palate, and floor of the mouth. In about 4-6% cases of 
leukoplakia, carcinomatous change is reported. However, it is difficult to decide 
which white lesions may undergo malignant transformation, but speckled or 
nodular form is more likely to progress to malignancy. Therefore, it is desirable 
that all oral white patches be biopsied to exclude malignancy. 
Etiology. The etiological factors are similar to those suggested for car- 
cinoma of the oral mucosa. It is most severe in heavy smokers, especially in 
pipe and cigar smokers, and improves when smoking is discontinued. The 
condition is also known by other names such as smokers keratosis and stoma- 
titis nicotina. Other etiological factors implicated are chronic friction such as 
with ill-fitting dentures or jagged 'teeth, and local irritants like excessive con- 
sumption of alcohol and very hot and spicy foods and beverages. A special 
variety of leukoplakia called 'hairy leukoplakia' has been described in pa- 
tients of AIDS and has hairy or corrugated surface but is not related to devel- 
opment of oral cancer. 
Pathologic changes. Grossly, the lesions of leukoplakia may appear 
white, whitish-yellow, or red-velvety of more than 5 mm diameter and varia- 
ble in appearance. They are usually circumscribed, slightly elevated, smooth 
or wrinkled, speckled or nodular. 
Histologicalty, leukoplakia is of 2 types: 
1. Hyperkeratotic type. This is characterised by an orderly and regular 
hyperplasia of squamous epithelium with hyperkeratosis on the surface. 
2. Dysplastic type. When the changes such as irregular stratification of 
the epithelium, focal areas of increased and abnormal mitotic figures, hyper- 
chromatism, pleomorphism, loss of polarity and individual cell keratinisation 
are present, the lesion is considered as epithelial dysplasia. The subepithelial 
tissues usually show an inflammatory infiltrate composed of lymphocytes 
and plasma cells. The extent and degree of the epithelial changes indicate the 
degree of severity of the epithelial dysplasia. Usually, mild dysplasia may re- 
vert back to normal if the offending etiologic factor is removed, whereas se- 
vere dysplasia indicates that the case may progress to carcinoma. Erithro- 
plasm is a form of dysplastic leukoplakia in which the epithelial atypia is 
more marked and thus has higher risk of developing malignancy. If the epi- 
thelial dysplasia is extensive so as to involve the entire thickness of the epi- 






SQUAMOUS CELL (EPIDERMOID) CARCINOMA 
Oral cancer is a disease with very poor prognosis because it is not rec- 
ognised and treated when small and early. 
Incidence. Squamous cell (epidermoid) carcinoma comprises 90% of 
all oral malignant tumours and 5% of all human malignancies. The peak inci- 
dence in the UK and the USA is from 55 to 75 years of age, whereas in India 
it is from 40 to 45 years of age. Oral cancer is a very frequent malignancy in 
India, Sri Lanka and some Eastern countries, probably related to habits of be- 
tel-nut chewing and reversed smoking. There is a definite male preponder- 
ance. It can occur anywhere in the mouth but certain sites are more common- 
ly involved. These sites, in descending order of frequency, are: the lips (more 
commonly lower), tongue, anterior floor of mouth, buccal mucosa in the re- 
gion of alveolar lingual sulcus, and palate. 
Etiology. As with other forms of cancer, the etiology of squamous cell 
carcinoma is unknown. But a number of etiological factors have been impli- 
cated. These are: 
i) Tobacco smoking and tobacco chewing, most important factor. 
ii) Chronic alcohol consumption. 
iii) Chronic irritation from ill-fitting denture or jagged teeth. 
iv) Submucosal fibrosis as seen in Indians consuming excess of chillies. 
v) Poor orodental hygiene. 
vi) Nutritional deficiencies. 
vii) Human papilloma virus infection, particularly HPV16, 18 and 11 
types.  
viii) Exposure to sunlight (in relation to lip cancer). 
ix) Exposure to radiation. 
x) Plummer-Vinson syndrome, characterised by atrophy of the upper 
alimentary tract. 
Pathologic changes. Grossly, squamous cell carcinoma of oral cavity 
may have the following types: 
i) Ulcerative type – is the most frequent type and is characterized by 
indurated ulcer and firm everted or rolled edges. 
ii) Papillary or verrucous type is soft and wartlike growth. 
iii) Nodular type appears as a firm, slow growing submucosal nodule. 
iv) Seirrhous type is characterised by infiltration into deeper structures. 
All these types may appear on a background of leukoplakia or erythropla- 
sia of the oral mucosa. Enlarged cervical lymph nodes may sometimes be present. 
Histologicalty squamous cell carcinoma ranges from well- 
differentiated  keratinising  carcinoma  to  highly-undifferentiated  neoplasm. 




the lesion. Carcinoma of the lip and intraoral squamous carcinoma are usual- 
ly always well-differentiated. 
Carcinoma of the lip has a more favourable prognosis due to visible and 
easily accessible location and less frequent metastasis to the regional lymph 
nodes. However, intraoral squamous carcinomas have poor prognosis because 
they are detected late and metastasis to regional lymph nodes occur early, espe- 
cially in the case of carcinoma of tongue and soft palate. Verrucous carcinoma, 
on the other hand, is composed of very well-differentiated squamous epithelium 
with minimal atypia and hence has very good prognosis. 
OTHER MALIGNANT TUMOURS 
Other less common malignant neoplasms which may be encountered in 
the oral cavity are: malignant melanoma, lymphoepithelial carcinoma, malig- 
nant lymphoma, malignant tumours of minor salivary glands, and various 
sarcomas like rhabdomyosarcoma, liposarcoma, alveolar soft part sarcoma, 
Kaposi's sarcoma and fibrosarcoma. Metastatic tumours can also occur in the 
soft tissues of the mouth. 
 
TEETH AND PERIODONTAL TISSUES 
 
Although care of the teeth belongs to the field of dental profession, the 
fully educated doctor should be familiar with certain principal diseases of 
teeth and periodontal tissues, especially about dental caries, periapical ab- 
scess and periodontitis, and common cysts and odontogenic tumours of the 
jaw. But first, a brief account of normal structure of these tissues. 
NORMAL STRUCTURE 
The teeth are normally composed of 3 calcified tissues, namely: enamel, dentine 
and cementum; and the pulp composed of connective tissue. The teeth are surrounded by 
the portion of oral mucosa called the gingiva or gum. 
Enamel in the outer covering of teeth composed almost entirely of inorganic mate- 
rial (as in bone) which can be demonstrated in ground sections only as it is lost in decalci- 
fied section. 
Dentine lies under the enamel and comprises most of the tooth substance. It is 
composed of organic material in the form of collagen fibrils as well as inorganic material 
in the form of calcium phosphates as in bone. Dentine is composed of odontoblasts or den- 
tine cells which are counterparts of osteocytes in bone but differ from the latter in having 
odontoblast processes. 
Cementum is the portion of tooth which covers the dentine at the root of tooth and 
is the site where periodontal ligament is attached. Cementum is similar to bone in mor- 
phology and composition. 
Dental pulp is inner to dentine and occupies the pulp cavity and root canal. It con- 
sists of connective tissue, blood vessels and nerves. 
 
DENTAL CARIES 
Dental caries is the most common disease of dental tissues, causing de- 




Etiopathogenesis. Dental caries is essentially a disease of modern so- 
ciety, associated with diet containing high proportion of refined carbohy- 
drates. It has been known for almost 100 years that mixture of sugar or bread 
with saliva in the presence of acidogenic bacteria of the mouth, especially 
streptococci, produces organic acids which can decalcify enamel and dentine. 
Enamel is largely composed of inorganic material which virtually disinte- 
grates. Dentine contains organic material also which is left after decalcifica- 
tion. Bacteria present in the oral cavity cause proteolysis of the remaining or- 
ganic material of dentine so that the process of destruction is complete. Diets 
rich in carbohydrates do not require much chewing and thus the soft and 
sticky food gets clung to the teeth rather than being cleared away, particularly 
in the areas of occlusal pits and fissures. 'Bacterial plaques' are formed in 
such stagnation areas. If these plaques are not removed by brushing or by 
vigorous chewing of fibrous foods, the process of tooth decay begins. There 
is evidence that consumption of water containing one part per million (ppm) 
fluoride is sufficient to reduce the rate of tooth decay in children. 
Pathologic changes. Caries occurs chiefly in the areas of pits and fis- 
sures, mainly of the molars and premolars, where food retention occurs, and 
in the cervical part of the tooth. 
Microscopically ,the earliest change is the appearance of a small, 
chalky-white spot on the enamel which subsequently enlarges and often be- 
comes yellow or brown and breaks down to form carious cavity. Eventually/ 
the cavity becomes larger due to fractures of enamel. Once the lesion reaches 
enamel-dentine junction, destruction of dentine also begins. 
Microscopically, inflammation (pulpitis) and necrosis of pulp take 
place. There is evidence of reaction of the tooth to the carious process in the 
formof secondary dentine, which is a layer of odontoblasts laid down under 
the original dentine. 
Sequelae of caries. Carious destruction of dental hard tissues frequent- 
ly produces pulpitis and other inflammatory lesions like apical granuloma 
and apical abscess. Other less common causes of these lesions are fracture of 
tooth and accidental exposure of pulp by the dentist. 
1. Pulpitis. Pulpitis may be acute or chronic. 
• Acute pulpitis is accompanied by severe pain which may be continu- 
ous, throbbing or dull, and is accentuated by heat or cold. It is often accom- 
panied by mild fever and leucocytosis. 
• Chronic pulpitis occurs when pulp is exposed widely. It is often not 
associated with pain. Chronically inflamed pulp tissue may protrude through 





2. Apical granuloma. Pulpitis may lead to spread of infection through 
the apical foramen into the tissues surrounding the root of the tooth. 
Histologically, there is chrome inflammatory reaction with formation 
of granulation tissue and inclusion of nests or strands of squamous epithelium 
derived from remnants of odontogenic epithelium normally present in the 
periodontal membrane. An apical granuloma may develop into a dental 
(radicular) cyst as discussed below. 
3. Apical abscess. An apical granuloma or acute pulpitis may develop in- 
to apical abscess. Acute abscess is very painful, while pus in chronic abscess may 
escape through root canal and cause further complications like osteomyelitis, cel- 
lulitis, cerebral abscess, meningitis and cavernous sinus thrombosis. 
 
PERIODONTAL DISEASE 
Chronic inflammation and degeneration of the supporting tissues of teeth 
resulting in teeth loss is a common condition. Besides inflammation, two other 
diseases – leukaemia and scurvy, are associated with gingival swelling. 
The inflammatory periodontal disease affects adults more commonly. 
Pregnancy, puberty and use of drugs like dilantin are also associated with perio- 
dontal disease more often. The disease begins as chronic marginal gingivitis, 
secondary to bacterial plaques around the teeth such as due to calculus (tartar) 
on the tooth surface, impacted food, uncontrolled diabetes, tooth-decay and ill- 
fitting dental appliances. The gingival sulcus acts as convenient site for lodge- 
ment of food debris and bacterial plaque leading to formation of periodontal 
pocket from which purulent discharge can be expressed by digital pressure. 
Pathologically, chronic marginal gingivitis is characterised by heavy 
chronic inflammatory cell infiltrate, destruction of collagen, and epithelial 
hyperplasia so as to line the pocket. Untreated chronic marginal gingivitis 
slowly progresses to chronic periodontitis or pyorrhea in which there is in- 
flammatory destruction of deeper tissues. At this stage, progressive resorp- 
tion of alveolar bone occurs and the tooth ultimately gets detached. 
 
EPITHELIAL CYSTS OF JAW 
The epithelium-lined cysts of dental tissue can have inflammatory or 
developmental origin. 
A. INFLAMMATORY CYSTS 
Radicular Cyst 
Radicular cyst, also called as apical, periodontal or simply dental cyst, 
is the most common cyst originating from the dental tissues. It arises conse- 
quent to inflammation following destruction of dental pulp such as in dental 
caries, pulpitis, and apical granuloma. The epithelial cells of Mallasez, which 




under the influence of inflammation, leading to the formation of an epitheli- 
um-lined cystic cavity. Most often, radicular cyst is observed at the apex of 
an erupted tooth and sometimes contains thick pultaceous material. 
Hisiologically, the radicular cyst is lined by nonkeratinised squamous epi- 
thelium. Epithelial rete may penetrate the underlying connective ues. Radicular 
cyst of maxilla may be lined by respiratory epithelium. The cyst wall is fibrous 
and contains chronic inflammatory cells (lymphocytes, plasma cells with Russell 
bodies and macrophages) hyaline bodies and deposits of cholesterol crystals 
which may be associated with foreign body giant cells. 
B. DEVELOPMENTAL CYSTS 
1. Odontogenic Cysts 
I) Dentigerous (Follicular) Cyst. Dentigerous cyst arises from enamel 
of an unerupted tooth. The mandibular third molars and the maxillary canines 
are most often involved. Dentigerous cysts are less common than radicular 
cysts and occur more commonly in children and young individuals. These 
cysts are more significant because of reported occurrence of ameloblastoma 
and carcinoma in them. 
Histologically, dentigerous cyst is composed of a thin fibrous tissue 
wall lined by stratified squamous epithelium. Thus, the cyst may resemble 
radicular cyst, except that chronic inflammatory changes so characteristic of 
radicular cyst, are usually absent in dentigerous cyst. 
II) Eruption Cyst. This is a cyst lying over the crown of an unerupted 
tooth and is lined by stratified squamous epithelium. It is thus a form of den- 
tigerous cyst. 
III) Gingival Cyst. It arises from the epithelial rests in the gingiva and 
is lined by keratinising squamous epithelium. 
IV) Primordial Cyst (Odontogenic Kera-Tocyst). Primordial cyst, like 
dentigerous cyst, also arises from tooth-forming epithelium. The common lo- 
cation is mandibular third molar. 
Histologically, the cyst wall is thin and is lined by regular layer of kerat- 
inising stratified squamous epithelium. Inflammatory changes are normally ab- 
sent. Primordial cysts have a marked tendency to recur (50%). Multiple primor- 
dial cysts occur in association with naevoid basal cell carcinoma syndrome. 
2. Non-Odontogenic and Fissural Cysts 
I) Nasopalatine Duct (Incisive Canal, Median, Anterior Maxillary) 
Cyst. This is the most common non-odontogenic (fissural) cyst and arises 
from the epithelial remnants of the nasopalatine duct. 
Histologically, the cyst is lined by stratified squamous epithelium, res- 




II) Nasolabial (Nasoalveolar) Cyst. This cyst is situated in the soft tis- 
sues at the junction of median nasal, lateral nasal and maxillary processes, at 
the ala of the nose, and sometimes extending into the nostril. 
Histologically, the cyst is lined by squamous or respiratory epithelium, 
or both. 
III) Globulomaxillary Cyst. This is an intraosseous cyst and is rare. 
IV) Dermoid Cyst. The dermoid cyst is common in the region of head 
or neck, especially in the floor of the mouth. The cyst arises from remains in 
the midline during closure of mandibular and branchial arches. 
 
ODONTOGENIC TUMOURS 
Odontogenic tumours are a group of uncommon lesions of jaw derived 
from the odontogenic apparatus. These tumours are usually benign but some 
have malignant counterparts. 
A. BENIGN ODONTOGENIC TUMOURS 
Ameloblastoma 
Ameloblastoma is the most common benign but locally invasive epi- 
thelial odontogenic tumour. It is commonest in the 3rd to 5th decades of life. 
Preferential sites are the mandible in the molar-ramus area and the maxilla. The 
tumour originates from dental epithelium of the enamel itself or its epithelial resi- 
dues. Sometimes, the tumour may arise from the epithelial lining of a dentigerous 
cyst or from basal layer of oral mucosa. Radiologically, typical picture is of a 
multilocular destruction of bone. Rare instances of an extraosseous example, 
presence of an embedded tooth, or unilocular ameloblastoma can occur. Tumour 
with histologic resemblance to ameloblastoma can occur occasionally in the long 
bone, like adamantinoma of the tibia. 
Grossly, the tumour is greyish-white, usually solid, sometimes cystic, 
replacing and expanding the affected bone. 
Histologicalty, ameloblastoma can show different patterns: 
i) Follicular pattern is the most common. The tumour consists of folli- 
cles of variable size and shape and separated from each other by fibrous tis- 
sue. The structure of follicles is similar to that of enamel organ consisting of 
central area of stellate cells resembling stellate reticulum, and peripheral lay- 
er of cuboidal or columnar cells resembling epithelium. The central stellate 
areas may show cystic changes. 
ii) Plexiform pattern is the next common pattern after foiiicular pattern. 
The tumour epithelium is seen to form irregular plexiform masses or network 
of strands. The stroma is usually scanty. Microcyst formation can occur in the 
stroma. 
iii) Acanthomatous pattern is squamous metaplasia within the islands 




iv) Basal cell pattern of ameloblastoma is similar to basal cell carci- 
noma of the skin. 
v) Granular cell pattern is characterised by appearance of acidophilic 
granularity in the cytoplasm of rumour cells. 
Odontogenic Adenomatoid Tumour (Adeno-ameloblastoma) 
This is a benign tumour seen more frequently in females in their 2nd dec- 
ade of life. The tumour is commonly associated with an unerupted tooth and thus 
closely resembles dentigerous cyst radiologically. Unlike ameloblastoma, adeno- 
matoid odontogenic tumour is not invasive nor does it recur after enucleation. 
Histologically, the lesion has extensive cyst formations. The wall of 
cyst contains scanty fibrous connective tissue in which are present character- 
istic tubule-like structures composed of epithelial cells and hence the name 
'adenomatoid' (gland-like). 
Calcifying Epithelial Odontogenic Tumour 
This is a rare lesion which is locally invasive and recurrent like amelo- 
blastoma. It is seen commonly in 4th and 5th decades and occurs more com- 
monly in the region of mandible. 
Histologically, the tumour consists of closely packed polyhedral epi- 
thelial cells having features of nuclear pleomorphism, giant nuclei and rare 
mitotic figures. The stroma is often scanty and appears homogeneous and hy- 
alinised in which small calcified deposits are seen which are a striking feature 
of this tumour. 
Odontogenic Myxoma (Myxofibroma) 
Odontogenic myxoma is a locally invasive and recurring rumour. 
Microscopically, it is characterised by abundant mucoid stroma and 
loose stellate cells in which are seen a few strands of odontogenic epithelium. 
Ameloblastic Fibroma 
This is a benign tumour consisting of epithelial and connective tissues 
derived from odontogenic apparatus. It resembles ameloblastoma but can be dis- 
tinguished from it because ameloblastic fibroma occurs in younger age group 
(below 20 years) and the clinical behaviour is always benign. 
Histologically, it consists of epithelial follicles similar to those of ame- 
loblastoma, set in a very cellular connective tissue stromc 
Odontomas 
Odontomas are hamartomas that contain both epithelial and mesoder- 
mal dental tissue components. There are 3 subtypes: 
i) Complex odontoma is always benign and consists of enamel, dentine 
and cementum which are not differentiated, so that the structure of actual 
tooth is not identifiable. 
ii) Compound odontoma is also benign and is comprised of differentiated 




iii) Ameloblastic fibro-odontoma is a lesion that resembles amelo- 
blastic fibroma with odontoma formation. 
Cementomas 
Cementomas are a variety of benign lesions which are characterised by 
the presence of cementum or cementum-like tissue. Five types of cemento- 
mas are described: 
i) Benign cementoblastoma (true cementoma) is a solitary lesion of 
jaw, characterised by features comparable to those of osteoid osteoma and 
osteoblastoma. 
ii) Cementifying fibroma consists of cellular fibrous tissue containing 
calcified masses of cementum-like tissue. 
iii) Periapical cemental dysplasia (Periapical fibrous dysplasia) is most 
common and resembles cementifying fibroma except that it contains more 
fibrous tissue as well as cementum-like tissue. 
iv) Multiple apical cementomas are found on the apical region of teeth 
and detected incidentally in post-menopausal women. 
v) Gigantiform cementoma is a large lobulated mass of cementum-like 
tissue. Sometimes, there are multiple such masses in the jaw. 
B. MALIGNANT ODONTOGENIC TUMOURS 
Malignant odontogenic tumours are rare. 
Odontogenic Carcinoma 
i) Malignant ameloblastoma is the term used for the uncommon metas- 
tasising ameloblastoma. 
ii) Ameloblastic carcinoma is the term employed for the ameloblastic 
tumour having cytologic features of malignancy in the primary tumour. 
iii) Primary intraosseous carcinoma may develop within the jaw from 
the rests of odontogenic epithelium. 
iv) Rarely, carcinomas may arise from the odontogenic epithelium lin- 
ing the odontogenic cysts. 
Odontogenic Sarcomas 
The only example of odontogenic sarcoma is a rare ameloblastic fibro- 
sarcoma. This tumour resembles ameloblastic fibroma but in this the meso- 
dermal component is malignant (sarcomatous) whereas the ameloblastic epi- 
thelium remains differentiated and benign. 
 
PATHOLOGY OF SALIVARY GLANDS 
 
There are two main groups of salivary glands – major and minor. The major sali- 
vary glands are the three paired glands: parotid, submandibular and sublingual. The minor 
salivary glands are numerous and widely distributed in the mucosa of oral cavity. The 
main duct of the parotid gland drains into the oral cavity opposite the second maxillary 




mouth. At times, heterotopic salivary gland tissue may be present in lymph nodes near or 
within the parotid gland. 
Histologically, the salivary glands are tubuloalveolar glands and may contain mu- 
cous cells, serous cells, or both. The parotid gland is purely serous. The submandibular 
gland is mixed type but is predominantly serous, whereas the sublingual gland though also 
a mixed gland is predominantly mucous. Similarly, minor salivary glands may also be se- 
rous, mucous or mixed type. 
The secretory acini of the major salivary glands are drained by ducts lined by: low 
cuboidal epithelium in the intercalated portion, by tall columnar epithelium in the intra- 
lobular ducts, and by simpler epithelium in the secretory ducts. 
The product of major salivary glands is saliva which performs various functions 
such as lubrication for swallowing and speech, and has enzyme amylase and antibacterial 
properties too. 
 
SALIVARY FLOW DISTURBANCES 
Sialorrhoea (Ptyalism). Increased flow of saliva is termed sialorrhoea 
or ptyalism. It occurs commonly due to: stomatitis, teething, mentally retarded 
state, schizophrenia, neurological disturbances, increased gastric secretion and 
sialosis (i.e. uniform, symmetric, painless hypertrophy of salivary glands). 
Xerostomia. Decreased salivary flow is termed xerostomia. It is asso- 
ciated with the following conditions: Sjogren's syndrome, sarcoidosis, 
mumps parotitis, Mikulicz's syndrome, megaloblastic anaemia, dehydration, 
drug intake (e.g. antihistamines, antihypertensives, antidepressants). 
 
SIALADENITIS 
Inflammation of salivary glands, sialadenitis, may be acute or chronic, 
the latter being more common. 
Etiology. Sialadenitis can occur due to the following causes: 
1. Viral infections. The most common inflammatory lesion of the sali- 
vary glands particularly of the parotid glands, is mumps occurring in children 
of school-age. It is characterised by triad of pathological involvement – epi- 
demic parotitis (mumps), orchitis-oophoritis, and pancreatitis. Involvement 
of testis and pancreas may lead to their atrophy. Less commonly, cytomegal- 
ovirus infection may occur in parotid glands of infants and young children. 
2. Bacterial and mycotic infections. Bacterial infections may cause 
acute sialadenitis more often. Sometimes there are recurrent attacks of acute 
parotitis when parotitis becomes chronic. 
i) Acute sialadenitis. The causes are: 
a) Acute infectious fevers, 
b) Acute postoperative parotitis (ascent of microorganisms up the pa- 
rotid duct from the mouth), 
c) General debility, 





ii) Chronic sialadenitis. This may result from the following causes: 
a) Recurrent obstructive type. Recurrent obstruction due to calculi (si- 
alolithiasis), stricture, surgery, injury etc may cause repeated attacks of acute 
sialadenitis by ascending infection and then chronicity. 
b) Recurrent non-obstructive type. Recurrent mild ascending infection 
of the parotid gland may occur due to non-obstructive causes which reduce 
salivary secretion like due to intake of drugs causing hyposalivation (e.g. an- 
tihistamines, antihypertensives, antidepressants), effect of irradiation and 
congenital malformations of the duct system. 
c) Chronic inflammatory diseases. Tuberculosis, actinomycosis and 
other mycoses may rarely occur in the salivary glands. 
3. Autoimmune disease. Inflammatory changes are seen in salivary 
glands in 2 autoimmune diseases: 
i) Sjogren's syndrome characterised by triad of dry eyes (keratocon- 
junctivitis sicca), dry mouth (xerostomia) and rheumatoid arthritis. 
ii) Mikulicz's syndrome is the combination of inflammatory enlarge- 
ment of salivary and lacrimal glands with xerostomia. 
Pathologic changes. Irrespective of the underlying etiology of sialade- 
nitis, there is swelling of the affected salivary gland, usually restricted by the 
fibrous capsule. Acute stage is generally associated with local redness, pain 
and tenderness with purulent ductal discharge. Late chronic cases may be re- 
placed by firm fibrous swelling. 
Microscopically, acute viral sialadenitis in mumps shows swelling and 
cytoplasmic vacuolation of the acinar epithelial cells and degenerative 
changes in the ductal epithelium. There is interstitial oedema, fibrinoid de- 
generation of the collagen and dense infiltration by mononuclear cells (lym- 
phocytes, plasma cells and macrophages). Chronic and recurrent sialadenitis 
is characterised by increased lymphoid tissue in the interstitium, progressive 
loss of secretory tissue and replacement by fibrosis. 
 
TUMOURS OF SALIVARY GLANDS 
The major as well as minor salivary glands can give rise to a variety of 
benign and malignant tumours. The major glands, particularly the parotid 
glands (85%), are the most common sites. Majority of the parotid gland tu- 
mour (65-85%) are benign, while in the other major and minor salivary 
glands 35-50% of the tumours are malignant. Most of the salivary gland tu- 
mours originate from the ductal lining epithelium and the underlying myoepi- 
thelial cells; a few arise from acini. Recurrent tumours of the parotid glands, 
due to their location, are often associated with facial palsy and obvious scar- 




A. BENIGN SALIVARY GLAND TUMOURS 
ADENOMAS 
The adenomas of the salivary glands are benign epithelial tumours. 
They are broadly classified into 2 major groups – pleomorphic and mono- 
morphic adenomas. 
Pleomorphic Adenoma (Mixed Salivary Tumour) 
This is the most common tumour of major (60-75%) and minor (50%) 
salivary glands. Pleomorphic adenoma is the commonest tumour in the parot- 
id gland and occurs less often in other major and minor salivary glands. The 
tumour is commoner in women and is seen more frequently in 3rd to 5th dec- 
ades of life. The tumour is solitary, smooth-surfaced but sometimes nodular, 
painless and slow-growing. It is often located below and in front of the ear. 
Pathologic changes. Grossly, pleomorphic adenoma is a circum- 
scribed, pseudoencapsulated, rounded, at times multilobulated, firm mass, 2- 
5 cm in diameter, with bosselated surface. The cut surface is grey-white and 
bluish, variegated, semitranslucent, usually solid but occasionally may show 
small cystic spaces. The consistency is soft and mucoid. 
Microscopically, the pleomorphic adenoma is characterised by pleo- 
morphic or 'mixed' appearance in which there are epithelial elements present 
in a martix of mucoid, myxoid and chondroid tissue: 
 The epithelial component may form various patterns like ducts, acini, 
tubules, sheets and strands of cells of ductal or myoepithelial origin. The ductal 
cells are cuboidal or columnar, and the underlying myoepithelial cells may be po- 
lygonal or spindle-shaped resembling smooth muscle cells. The material found in 
the lumina of duct-like structures is PAS-positive epithelial mucin. Focal areas of 
squamous metaplasia and keratinisation may be present. Immunohistochemically, 
the tumour cells are immunoreactive for epithelial (cytokeratin, EMA, CEA) as 
well as myoepithelial (actin, vimentin) antibodies. 
 The mesencnymal elements are present as loose connective tissue and as 
myxoid, mucoid and chondroid matrix, which simulates cartilage (pseudocarti- 
lage) but is actually connective tissue mucin. More recently, the matrix of the tu- 
mour has been characterised as a product of myoepithelial cells. However, true 
cartilage and even bone is observed in a small proportion of these tumours. 
The epithelial and mesenchymal elements are intermixed and either of 
the two components may be dominant in any tumour. 
Prognosis. Pleomorphic adenoma is notorious for recurrences, sometimes 
after many years. The main factors responsible for the tendency to recur are in- 
complete surgical removal due to proximity to the facial nerve, multiple foci of 
tumour, pseudoencapsulation, and implantation in the surgical field. Although 




nary pleomorphic adenoma may metastasise to distant sites which too will have 
benign appearance as the original tumour. However, actual malignant transfor- 
mation can also occur in a pleomorphic adenoma (vide infra). 
Monomorphic Adenomas 
These are benign epithelial tumours of salivary glands without any ev- 
idence of mesenchyme-like tissues. Their various forms are as under: 
a) Warthin's Tumour (Papillary Cysta-Denoma Lymphomatosum, 
Adenolym-Phoma). It is a benign tumour of the parotid gland comprising 
about 8% of all parotid neoplasms, seen more commonly in men from 4th to 7th 
decades of life. Rarely, it may arise in the submandibular gland or in minor sali- 
vary glands. Histogenesis of the tumour has been much debated. Most accepted 
theory is that the tumour develops from parotid ductal epithelium present in 
lymph nodes adjacent to or within parotid gland. 
Pathologic changes. Grossly, the tumour is encapsulated, round or 
oval with smooth surface. The cut surface shows characteristic slit-like or 
cystic spaces, containing milky fluid and having papillary projections. 
Microscopically, the tumour shows 2 components: epithelial paren- 
chyma and lymphoid stroma. 
 The epithelial parenchyma is composed of glandular and cystic 
structures having papillary arrangement and lined by characteristic eosino- 
philic epithelium. Variants of epithelial patterns include presence of mucous 
goblet cells and sebaceous differentiation. 
 The lymphoid stroma is present under the epithelium in the form of 
prominent lymphoid tissue, often with germinal centres. 
b) Oxyphil Adenoma (Oncocytoma). It is a benign slow-growing tu- 
mour of the major salivary glands. The tumour consists of parallel sheets, ac- 
ini or tubules of large cells with glandular eosinophilic cytoplasm (oncocytes) 
and hence the name. 
c) Other Types Of Monomorphic Adenomas. There are some un- 
common forms of monomorphic adenomas: 
i) Myoepittielioma is an adenoma composed exclusively of myoepitheli- 
al cells which may be arranged in tubular, alveolar or trabecular pattern. 
ii) Basal cell adenoma is characterised by the type and arrangement of 
cells resembling basal cell carcinoma of the skin. 
iii) Clear cell adenoma has spindle-shaped or polyhedral cells with 
clear cytoplasm. 
Miscellaneous Benign Tumours 
A number of mesenchymal tumours can rarely occur in salivary glands. 
These include: fibroma, lipoma, neurilemmomas, neurofibroma, haemangio- 









B. MALIGNANT SALIVARY GLAND TUMOURS 
Mucoepidermoid Carcinoma. It`s status as an intermediate grade tu- 
mour in the previous classification has undergone upgradation to full-fledged mu- 
coepidermoid carcinoma now having the following peculiar features: 
• It is the most common malignant salivary gland tumour (both in the 
major and minor glands). 
• The parotid gland amongst the major salivary glands and the minor 
salivary glands in the palate are the most common sites. 
• The common age group affected is 30-60 years but it is also the most 
common malignant salivary gland tumour affecting children and adolescents. 
• It is the most common example of radiation-induced malignant ru- 
mour, especially therapeutic radiation. 
Pathologic changes. Grossly, the tumour is usually circumscribed but 
not encapsulated. It varies in size from 1 to 4 cm. 
Microscopically, the tumour is classified into low, intermediate and 
high grade depending upon the degree of differentiation and tumour inva- 
siveness. The tumour is composed of combination of epidermoid cells and 
mucus-secreting cells (as the name implies) as also cells with intermediate 
differentiation between these two cell types and clear cells. 
 
Malignant Mixed Tumour comprises three distinct clinicopathologic 
entities: 
Carcinoma arising in benign mixed salivary gland tumour (carci- 
noma ex pleomorphic adenoma); 
Carcinosarcoma; and 
Metastasising mixed salivary tumour. 
Carcinoma ex pleomorphic adenoma is more common while the other 
two are rare tumours. Approximately 2 to 5% of pleomorphic adenomas re- 
veal areas of frank malignancy. The slow-growing adenoma may have been 
present for a number of years when suddenly it undergoes rapid increase in 
its size, becomes painful and the individual may develop facial palsy. Malig- 
nant transformation occurs in later age (6th decade) than the usual age for 
pleomorphic adenoma (4th to 6th decades). It may occur in primary tumour 
but more often occurs in its recurrences. 
Pathologic changes. Grossly, the tumour is poorly-circumscribed with 
irregular infiltrating margin. Cut section may show haemorrhages, necrosis 
and cystic degeneration. 
Microscopically, besides the typical appearance of pleomorphic ade- 
noma, malignant areas show cytologic features of carcinoma such as anapla- 





Adenoid Cystic Carcinoma (Cylindroma) is a highly malignant tu- 
mour due to its typical infiltrative nature, especially along the nerve sheaths. 
Adenoid cystic carcinoma is histologically characterised by cribriform appear- 
ance i.e. the epithelial tumour cells of duct-lining and myoepithelial cells are ar- 
ranged in duct-like structures or masses of cells, having typical fenestrations or 
cyst-like spaces and hence the name 'adenoid cystic'. 
Acinic Cell Carcinoma is a rare tumour composed of acinic cells re- 
sembling serous cells of normal salivary gland. These cells are arranged in 
sheets or acini and have characteristic basophilic granular cytoplasm. The 
degree of arypia may vary from a benign cytologic appearance to cellular fea- 
tures of malignancy. 
Adenocarcinoma of the salivary gland does not differ from adenocar- 
cinoma elsewhere in the body. It may have some variants such as mucoid ad- 
enocarcinoma, clear-cell adenocarcinoma and papillary cystadenocarcinoma. 
Epidermoid Carcinoma is rare tumour, has features of squamous cell 
carcinoma with keratin formation and has intercellular bridges. The tumour 
commonly infiltrates the skin and involves the facial nerve early. 
Undifferentiated Carcinoma is highly malignant tumour, consists of 
anaplastic epithelial cells which are too poorly differentiated to be placed in any 
other known category. 
Miscellaneous Malignant Tumours 
Some rare malignant tumour of epithelial and mesenchymal origin are 
melanoma, sebaceous carcinoma, undifferentiated carcinoma, lymphoma, fi- 
brosarcoma and leiomyosarcoma and are similar in morphology to such tu- 
mours elsewhere in the body. Besides, metastatic involvement of major sali- 
vary glands or the adjacent lymph nodes is common, especially from epider- 
moid carcinoma and malignant melanoma. 
 
DISEASES OF ISTHMUS AND PHARYNX 
 
TONSILLITIS 
It is the more frequent infectious disease of tonsils. It may be acute and 
chronic. 
Etiology. Tonsillitis develops due to action of pathogens on organism (e.g. 
streptococci, staphylococci and viruses). It can occur due to trauma and cold. 
Forms of Acute tonsillitis: 
1. Catarrhal – there is congestion and edema of tonsillary mucous 
membrane. 
2. Lacunar – there is accumulation of exudates in depth of tonsillary 
lacunas, then exudate appears on tonsillary surface as yellow spots. Tonsils 




3. Follicular – is charavterized by the damage of lymphoid follicles. 
Tonsils are enlarged and follicles contain purulent infiltrate and pus degradation. 
4. Fibrinous – is charavterized by formation of fibrinous layers on 
tonsillar surface. This process is known as diphtheritic tonsillitis. Fibrinous 
exudate is tightly attached with tonsillar mucous membrane. Ulcer formation 
takes place if this fibrinous exudate is removed. 
5. Purulent – is charavterized by formation of abscesses. 
6. Necrotic – there is necrosis of tonsillary mucous membrane. It is 
usually secondary (in leucosis, scarlet fever). 
In chronic tonsillitis there is sclerosis of tonsils, extension of lacunas 
and sometimes enlargement of tonsils. 
 
DISEASES OF ESOPHAGUS 
 
The oesophagus is a muscular tube extending from the pharynx to the stomach. In 
an adult, this distance measures 25 cm. However, from the clinical point of view, the dis- 
tance from the incisor teeth to the gastro-oesophageal junction is about 40 cm. The region 
of proximal oesophagus at the level of cricopharyngeus muscle is called the upper oe- 
sophageal sphincter, while the portion adjacent to the anatomic gastro-oesophageal junc- 
tion is referred to as lower oesophageal sphincter. 
Histologically, the wall of the oesophagus consists of mucosa, submucosa, muscu- 
laris propria and adventitia/serosa. 
The mucosa is composed of non-keratinising stratified squamous epithelium over- 
lying lamina propria. The basal layer of the epithelium may contain some melanocytes, 
argyrophil cells and Langerhans' cells. At the lower end of the oesophagus, there is sudden 
change from stratified squamous epithelium to mucin-secreting columnar epithelium for a 
distance of 0.5 to 1.5 cm; this is called the junctional mucosa. 
The submucosa consists of loose connective tissue with sprinkling of lympho- 
cytes, plasma cells, and occasional eosinophil and mast cell. Mucus-producing glands are 
scattered throughout the submucosa. 
The muscularis propria is composed of 2 layers of smooth muscle – an inner cir- 
cular coat and an outer longitudinal coat. The proximal portion of oesophagus contains 
skeletal muscle fibres from cricopharyngeus muscle. The parasympathetic nerve supply by 
the vagus nerve is in the form of extrinsic and intrinsic plexuses. 
The adventitia/serosa is the outer covering of oesophagus. Serosa is present in in- 
tra-abdominal part of oesophagus only, while elsewhere the perioesophageal adventitia 
covers it. 
The major functions of oesophagus are swallowing by peristaltic activity and to 
prevent the reflux of gastric contents into the oesophagus. 
 
CONGENITAL ANOMALIES 
Congenital anomalies of the oesophagus are uncommon and are detect- 
ed soon after birth. Some of these are as under: 
Oesophageal atresia and tracheo- oesophageal fistula. In about 85% 
of cases, congenital atresia of the oesophagus is associated with tracheo- 
oesophageal fistula, usually at the level of tracheal bifurcation. For survival, the 
condition must be recognised and corrected surgically within 48 hours of birth 




every feed, hypersalivation, attacks of cough and cyanosis. Death usually results 
from asphyxia, aspiration pneumonia and fluid-electrolyte imbalance. Morpho- 
logically, the condition is recognised by cord-like non-canalised segment of oe- 
sophagus having blind pouch at both ends. 
Certain uncommon congenital anomalies of oesophagus are as follows: 
• Agenesis. Congenital absence of oesophagus is quite rare and is in- 
compatible with life. 
• Duplication of oesophagus. This is another rare congenital abnor- 
mality in which there is double oesophagus. 
• Stenosis. Oesophageal stenosis may occur as developmental anomaly 
or may follow oesophagitis. There is fibrous thickening of the oesophageal 
wall and atrophy of the mucularis propria. 
 
MUSCULAR DYSFUNCTIONS 
These are disorders in which there is motor dysfunction of the oesoph- 
agus, manifested clinically by dysphagia. 
These include achalasia, hiatus hernia, oesophageal diverticula, and 
webs and rings. 
Achalasia (Cardiospasm) 
Achalasia of the oesophagus is a neuromuscular dysfunction due to 
which the cardiac sphincter fails to relax during swallowing and results in 
progressive dysphagia and dilatation of the oesophagus (mega-oesophagus). 
Etiology. The exact etiology is not known. It may be congenital. Emo- 
tional stress has been believed to contribute to the onset of the disease. Some 
investigators have demonstrated total absence of nerve fibres and ganglia of Au- 
erbach's plexus in the terminal few centimetres of the oesophagus in achalasia. 
Chagas' disease, an epidemic parasitosis with Trypansoma cruzi has also been 
found to be associated with alterations of Auerbach's plexus. 
Pathologic changes. There is dilatation above the short contracted 
terminal segment of the oesophagus. Muscularis propria of the wall may be 
of normal thickness, hypertrophied as a result of obstruction, or thinned out 
due to dilatation. Secondary oesophagitis may supervene and cause oesopha- 
geal ulceration and haematemesis. 
Hiatus Hernia 
Hiatus hernia is the herniation or protrusion of the stomach through the 
oesophageal hiatus of the diaphragm. Oesophageal hiatal hernia is the cause 
of diaphragmatic hernia in 98% of cases. The condition is diagnosed radio- 
logically in about 5% of apparently normal asymptomatic individuals. In 
symptomatic cases, especially the elderly women, the clinical features are 




into  the  mouth,  both  of  which  are  worsened  due  to  heavy  work,  lifting 
weights and excessive bending. 
Etiology. The basic defect is the failure of the muscle fibres of the dia- 
phragm that form the margin of the oesophageal hiatus. This occurs due to 
shortening of the oesophagus which may be congenital or acquired, 
i) Congenitally short oesophagus may be the cause of hiatus hernia in 
a small proportion of cases, 
ii) More commonly, it is acquired due to secondary factors which 
cause fibrous scarring of the oesophagus. 
These factors are: 
a) Degeneration of muscle due to aging. 
b) Increased intra-abdominal pressure such as in pregnancy, abdominal 
tumours etc. 
c) Recurrent oesophageal regurgitation and spasm causing inflamma- 
tion and fibrosis. 
d) Increase in fatty tissue in obese people causing decreased muscular 
elasticity of diaphragm. 
Pathologic changes. There are 3 patterns in hiatus hernia: 
i) Sliding or oesophago-gastric hernia is the most common, occur- 
ring in 85% of cases. The herniated part of the stomach appears as supradi- 
aphragmatic bell due to sliding up on both sides of the oesophagus. 
ii) Rolling or para-oesophageal hernia is seen in 10% of cases. This 
is a true hernia in which cardiac end of the stomach rolls up para- 
oesophageally, producing an intrathoracic sac. 
iii) Mixed or transitional hernia constitutes the remaining 5% cases 
in which there is combination of sliding and rolling hiatus hernia. 
Oesophageal Diverticula 
Diverticula are the outpouchings of oesophageal wall at the point of 
weakness. They may be congenital or acquired. 
Congenital diverticula occur either at the upper end of the oesopha- 
gus or at the bifurcation of trachea. 
Acquired diverticula may be of 2 types: 
a) Pulsion (Zenker's) type– is seen in the region of hypopharynx and 
occurs due to oesophageal obstruction such as due to chronic oesophagitis, 
carcinoma etc. The mucosa and submucosa herniate through the weakened 
area or through defect in the muscularis propria. 
b) Traction type – occurs in the lower third of oesophagus from con- 
traction of fibrous tissue such as from pleural adhesions, scar tissue of healed 
tuberculous lesions in the hilum, silicosis etc. 
Complications of diverticula include obstruction, infection, perforation, 




Oesophageal Webs and Rings 
Radiological shadows in the oesophagus resembling 'webs' and 'rings' 
are observed in some patients complaining of dysphagia. 
Webs. Those located in the upper oesophagus, seen more commonly in 
adult women, and associated with dysphagia, iron deficiency anaemia and 
chronic atrophic glossitis (Plummer-Vinson syndrome) are called 'webs'. 
Rings. Those located in the lower oesophagus, not associated with 
iron-deficiency anaemia, nor occurring in women alone, are referred to as 
'Schatzki's rings'. 
Pathologic changes. The rings and webs are transverse folds of muco- 
sa and submucosa encircling the entire circumference, or are localised annu- 
lar thickenings of the muscle. These give characteristic radiological shadows. 
 
HAEMATEMESIS OF OESOPHAGEAL ORIGIN 
Massive haematemesis (vomiting of blood) may occur due to vascular 
lesions in the oesophagus. These lesions are as under: 
1. Oesophageal Varices. Oesophageal varices are tortuous, dilated and 
engorged oesophageal veins, seen along the longitudinal axis of oesophagus. 
They occur as a result of elevated pressure in the portal venous system, most 
commonly in cirrhosis of the liver. Less common causes are: portal vein throm- 
bosis, hepatic vein thrombosis (Budd-Chiari syndrome) and pylephlebitis. The 
lesions occur as a result of bypassing of portal venous blood from the liver to the 
oesophageal venous plexus. The increased venous pressure in the superficial 
veins of the oesophagus may result in ulceration and massive bleeding. 
2. Mallory-Weiss Syndrome. In this condition, oesophageal lacera- 
tions and bleeding may occur following minor trauma such as reflex relaxa- 
tion of the muscularis resulting in overstretching and subsequent tearing at 
the oesophago-gastric junction. The condition is common in chronic alcohol- 
ics who develop vomitings and haematemesis. 
3. Upture of the Oesophagus. Rupture of the oesophagus may occur 
following trauma, during oesophagoscopy, indirect injury (e.g. due to sudden 
acceleration and deceleration of the body) and spontaneous rupture (e.g. after 
overeating, extensive aerophagy etc). 
4. Other Causes. Oesophageal haematemesis may also occur in the 
following conditions: 
i) Bursting of aortic aneurysm into the lumen of oesophagus, 
ii) Vascular erosion by malignant growth in the vicinity, 
iii) Hiatus hernia, 







Inflammation of the oesophagus, oesophagitis, occurs most commonly 
from reflux, although a number of other clinical conditions and infections 
may also cause oesophagitis as under: 
REFLUX (PEPTIC) OESOPHAGITIS 
Reflux of the gastric juice is the commonest cause of oesophagitis. 
Pathogenesis. Gastro-oesophageal reflux, to an extent, may occur in 
normal healthy individuals after meals and in early pregnancy. However, in 
some clinical conditions, the gastro-oesophageal reflux is excessive, resulting 
in inflammation of the lower oesophagus. These conditions are: 
i) Sliding hiatus hernia, 
ii) Chronic gastric and duodenal ulcers, 
iii) Nasogastric intubation, 
iv) Persistent vomiting, 
v) Surgical vagotomy, 
vi) Neuropathy in alcoholics, diabetics, 
vii) Oesophago-gastrostomy. 
Pathologic changes. Endoscopically, the demarcation between normal 
squamous and columnar epithelium at the junctional mucosa is lost. The af- 
fected distal oesophageal mucosa is red, erythematous, friable and bleeds on 
touch. In advanced cases, there are features of chronic disease such as nodu- 
larity, strictures, ulcerations and erosions. Microscopically, the reflux chang- 
es in the distal oesophagus include basal cell hyperplasia and deep elongation 
of the papillae touching close to the surface epithelium. Inflammatory chang- 
es vary according to the stage of the disease. In early stage, mucosa and 
submucosa are infiltrated by some polymorphs and eosinophils; in chronic 
stage, there is lymphocytic infiltration and fibrosis of all the layers of the oe- 
sophageal wall. 
BARRETT'S OESOPHAGUS 
This is a condition in which, following reflux oesophagitis, the strati- 
fied squamous epithelium of the lower oesophagus is replaced by columnar 
epithelium. The condition is seen more commonly in later age and is caused 
by factors producing gastro-oesophageal reflux disease. Barrett's oesophagus 
is a premalignant condition in which changes of dysplasia and carcinoma 
have been reported. 
Pathologic changes. Endoscopically, the affected area is red and vel- 
vety. Hiatus hernia and peptic ulcer at squamo-columnar junction (Barrett's 
ulcer) are frequently associated. Microscopically, the most common finding 
is the replacement of squamous epithelium by metaplastic columnar cells. 




• Intestinal epithelium; 
• Fundic gastric glands; 
• Cardiac mucous glands. 
Other cells present in the glands may be Paneth cells, goblet cells, 
chief cells, parietal cells, mucus-secreting cells and endocrine cells. 
Inflammatory changes, acute or chronic, are commonly accompanied. 
Dysplastic changes of the columnar epithelium or glands may be present. 
Longstanding cases of Barrett's oesophagus have 5-8% risk of developing ad- 
enocarcinoma of the oesophagus. 
INFECTIVE OESOPHAGITIS 
A number of opportunistic infections in immuno- suppressed individu- 
als can cause oesophagitis. Some of these agents are: 
i) Candida (Monilial) oesophagitis, 
ii) Herpes simplex (Herpetic oesophagitis), 
iii) ) Cytomegalovirus, 
iv) Tuberculosis. 
Other Causes of Oesophagitis 
i) Intake of certain drugs (anticholinergic drugs, doxycycline, tetracycline), 
ii) Ingestion of hot, irritating fluids, 
iii) ) Radiation, 
iv) Crohn's disease, 
v) Various vesiculobullous skin diseases. 
 
TUMOURS OF OESOPHAGUS 
BENIGN TUMOURS 
Benign tumours of the oesophagus are uncommon and small in size 
(less than 3 cms). The epithelial benign tumours project as intraluminal 
masses arising from squamous epithelium (squamous cell papilloma), or from 
columnar epithelium (adenoma). The stromal or mesenchymal benign tu- 
mours are intramural masses such as leiomyoma and others like lipoma, fi- 
broma, neurofibroma, rhabdomyoma, lymphangioma and haemangioma. 
MALIGNANTTUMOURS 
For all practical purposes, malignant tumours of the oesophagus are 
carcinomas because sarcomas such as leiomyo sarcoma and fibro sarcoma 
occur with extreme rarity. 
Carcinoma of Oesophagus 
Carcinoma of the oesophagus is diagnosed late, after symptomatic oe- 




gressed the anatomical limits of the organ. The tumour occurs more common- 
ly in men over 50 years of age. Prognosis is dismal: with standard methods of 
therapy (surgical resection and/or irradiation), 70% of the patients die within 
one year of diagnosis. Five-year survival rate is 5-10%. 
Etiology. Although exact etiology of carcinoma of the oesophagus is not 
known, a number of conditions and factors have been implicated as under: 
1. Diet and personal habits: 
i) Heavy smoking, 
ii) Alcohol consumption, 
iii) Intake of foods contaminated with fungus, 
iv) Nutritional deficiency of vitamins and trace elements. 
2. Oesophageal disorders: 
i) Oesophagitis (especially Barrett's oesophagus in adenocarcinoma), 
ii) Achalasia, 
iii) Hiatus hernia, 
iv) Diverticula, 
v) Plummer-Vinson syndrome. 
3. Other factors: 
i) Race – more common in the Chinese and Japanese than in West- 
ern races; more frequent in blacks than whites. 
ii) Family history – association with tylosis (keratosis palmaris et 
plantaris). 
iii) Genetic factors – predisposition with coeliac disease, epidermol- 
ysis bullosa, tylosis. 
Pathologic changes. Carcinoma of the oesophagus is mainly of 2 types 
– squamous cell (epider-moid) and adenocarcinoma. The sites of predilection 
for each of these 2 forms. 
Squamous Cell (Epidermoid) Carcinoma. Squamous cell or epider- 
moid carcinoma comprises 90% of primary oesophageal cancers. It is ex- 
ceeded in incidence by carcinoma colon, rectum and stomach amongst all the 
gastrointestinal cancers. The disease occurs in 6th to 7th decades of life and is 
more common in men than women. The sites of predilection are the three areas 
of oesophageal constrictions. Half of the squamous cell carcinomas of oesopha- 
gus occur in the middle third, followed by lower third, and the upper third of oe- 
sophagus in that order of frequency. Macroscopically, 3 types are recognised: 
i) Polypoid fungating type – is the most common form. It appears as a 
cauliflower-like friable mass protruding into the lumen. 
ii) Ulcerating type – is the next common form. It looks grossly like a 




iii) Diffuse infiltrating type – appears as an annular, stenosing narrow- 
ing of the lumen due to infiltration into the wall of oesophagus. 
Microscopically, majority of the squamous cell carcinomas of the oe- 
sophagus are well-differentiated or moderately-differentiated. Prickle cells, 
keratin formation and epithelial pearls are commonly seen. However, non- 
keratinising and anaplastic growth patterns can also occur. An exophytic, 
slow-growing, extremely well-differentiated variant, verrucous  squamous 
cell carcinoma, has also been reported in the oesophagus. 
Adenocarcinoma. Adenocarcinoma of the oesophagus constitutes less 
than 10% of primary oesophageal cancer. It occurs predominantly in men in 
their 4th to 5th decades. The common locations are lower and middle third of 
the oesophagus. These tumours have a strong and definite association with 
Barrett's oesophagus in which there are foci of gastric or intestinal type of ep- 
ithelium. Macroscopically, oesophageal adenocarcinoma appears as nodular, 
elevated mass in the lower oesophagus. 
Microscopically, adenocarcinoma of the oesophagus can have 3 patterns: 
i) Intestinal type – is the adenocarcinoma with a pattern similar to that 
seen in adenocarcinoma of intestine or stomach. 
ii) Adenosquamous type – is the pattern in which there is an irregular 
admixture of adenocarcinoma and squamous cell carcinoma. 
iii) Adenoid cystic type – is an uncommon variety and is akin to similar 
growth in salivary gland i.e. a cribriform appearance in an epithelial tumour. 
The adenocarcinoma of the oesophagus must be distinguished from the ad- 
enocarcinoma of the gastric cardia. This is done by identifying normal oesopha- 
geal mucosa on distal as well as proximal margin of the tumour. 
Other Carcinomas. Besides the two main histological types of oe- 
sophageal cancer, a few other varieties are occasionally encountered. These 
are as follow: 
i) Mucoepidermoid carcinoma is a tumour having characteristics of 
squamous cell as well as mucus-secreting carcinomas. 
ii) Malignant melanoma is derived from melanoblasts in the epithelium 
of the oesophagus, 
iii) Oat cell carcinoma arises from argyrophil cells in the basal layer of 
the epithelium, 
iv) Undifferentiated carcinoma is an anaplastic carcinoma which can- 
not be classified into any recognisable type of carcinoma. 
v) Carcinosarcoma consists of malignant epithelial as well as sarcoma- 
tous components, 
vi) Secondary tumours rarely occur in the oesophagus from carcinomas 
of the breast, kidney and adrenals. 




i) Local spread. This is the most important mode of spread and is of 
great importance for surgical treatment. The local spread may occur in the 
transverse as well as longitudinal direction. The tumour may invade below 
into the stomach, above into the hypopharynx, into the trachea resulting in 
tracheo-oesophageal fistula, and may involve larynx causing hoarseness. The 
humour may invade the muscular wall of the oesophagus and involve the 
mediastinum, lungs, bronchi, pleura and aorta. 
ii) Lymphatic spread. Submucosal lymphatic permeation may lead to 
multiple satellite nodules away from the main tumour. Besides, the lymphatic 
spread may result in metastases to the cervical, paraoesophageal, tracheo- 
bronchial and subdiaphragmatic lymph nodes. 
iii) Haematogenous spread. Blood-borne metastases from the oesopha- 
geal cancer are rare, probably because the death occurs early due to invasion of 
important structures by other modes of spread. However, metastatic deposits by 
haematogenous route can occur in the lungs, liver and adrenals. 
 
 
PATHOLOGY OF STOMACH 
 
The stomach is 'gland with cavity', extending from its junction with lower end of 
the oesophagus (cardia) to its junction with the duodenum (pylorus). The lesser curvature 
is inner concavity on the right, while the greater curvature is the outer convexity on the 
left side of the stomach. 
The stomach has 5 anatomical regions: 
1. Cardia is the oesophago-gastric junction and lacks the sphincter. 
2. Fundus is the portion above the horizontal line drawn across the oesophago- 
gastric junction. 
3. Body is the middle portion of the stomach between the fundus and the pyloric 
antrum. 
4. Pyloric antrum is the distal third of the stomach. 
5. Pylorus is the junction of distal end of the stomach with the duodenum. It has 
powerful sphincter muscle. 
The mucosal folds in the region of the body and the fundus are loose (rugae), while 
the antral mucosa is somewhat flattened. Gastric canal is the relatively fixed portion of 
the pyloric antrum and the adjoining lesser curvature; it is the site for numerous pathologi- 
cal changes such as gastritis, peptic ulcer and gastric carcinoma. 
The stomach receives its blood supply from the left gastric artery and the branches 
of the hepatic and splenic arteries with widespread anastomoses. Numerous gastric lym- 
phatics which communicate freely with each other are also present. The innervation of the 
stomach is by the vagi and branches of the sympathetic which are connected with ganglia 
in the muscular and submucous layers. 
Histologically, the wall of the stomach consists of 4 layers – serosa, muscularis, 
submucosa and mucosa. 
1. Serosa is derived from the peritoneum which is deficient in the region of lesser 
and greater curvatures. 
2. Muscularis consists of 3 layers of smooth muscle fibres – the outer longitudinal, 




between the longitudinal and circular layers of muscle. The pyloric sphincter is the thick- 
ened circular muscle layer at the gastroduodenal junction. 
3. Submucosa is a layer of loose fibroconnective tissue binding the mucosa to the 
muscularis loosely and contains branches of blood vessels, lymphatics and nerve plexuses 
and ganglion cells. 
4. Mucosa consists of 2 layers – superficial and deep. Between the two layers is 
the lamina propria composed of network of fibrocollagenic tissue with a few lymphocytes, 
plasma cells, macrophages and eosinophils. The mucosa is externally bounded by muscu- 
laris mucosae. 
i) THE SUPERFICIAL LAYER consists of a single layer of surface epithelium 
composed of regular, mucin-secreting, tall columnar cells with basal nuclei. There is a 
very rapid turnover of these cells. These dip down at places to form crypts (or pits or fo- 
veolae). 
• Cardiac mucosa is the transition zone between the oesophageal squamous muco- 
sa and the oxyntic mucosa of the fundus and body with which it gradually merges. 
• Oxyntic mucosa lines both gastric fundus and body. 
• Antral mucosa lines the pyloric antrum. 
ii) THE DEEP LAYER consists of glands that open into the bottom of the crypts. 
Depending upon the structure, these glands are of 3 types: 
a) Glands of the cardia are simple tubular or compound tubulo-racemose, lined by 
mucin secreting cells. A few endocrine cells and occasional parietal and chief cells are al- 
so present. 
b) Glands of the body-fundus are long, tubular and tightly packed which may be 
coiled or dilated. There are 4 types of cells present in the glands of body-fundic mucosa: 
   Parietal (Oxyntic) cells – are the most numerous and line the superficial (up- 
per) part of the glands. Parietal cells are triangular in shape, have dark-staining nuclei and 
epsinophilic cytoplasm. These cells are responsible for production of hydrochloric acid of 
the gastric juice and the blood group substances. 
   Chief (Peptic) cells – are the dominant cells in the deeper (lower) parts of the 
glands. Their basal nuclei are large with prominent nucleoli and the cytoplasm is coarsely 
granular and basophilic. These cells secrete pepsin of the gastric juice. 
   Mucin-secreting neck cells – are small and fewer. These cells are present in the 
region of the narrow neck of the gastric glands i.e. at the junction of the glands with the pits. 
   Endocrine (Kulchitsky or Enterochromaffin) cells – are widely distributed in 
the mucosa of all parts of the alimentary tract and are described later. 
c) Glands of the pylorus are much longer than the body- fundic glands. These are 
simple tubular glands which are often coiled. They are lined mainly by small, granular, 
mucin-secreting cells resembling neck cells and.occasional parietal cells but no chief cells. 
Gastrin- producing G-cells are present predominantly in the region of antropyloric muco- 
sa, with a small number of these cells in the crypts and Brunner's glands of the proximal 
duodenum. 
The secretory products of the gastric mucosa are the gastric juice and the intrinsic 
factor, required for absorption of vitamin B12. Gastric juice consists of hydrochloric acid, 
pepsin, mucin and electrolytes like Na+, K+, HCO'3 and Cl-. Hydrochloric acid is produced 
by the parietal (oxyntic) cells by the interaction of Q' ions of the arterial blood with water 
and carbon dioxide in the presence of the enzyme, carbonic anhydrase. The degree of gas- 
tric activity is correlated with the 'total parietal cell mass'. Injection of histamine can stim- 
ulate the production of acid component of the gastric juice, while the pepsin-secreting 
chief cells do not respond to histamine. Physiologically, the gastric secretions are stimu- 






Hypertrophy and narrowing of the pyloric lumen occurs predominantly in 
male children as a congenital defect (infantile pyloric stenosis). The adult form 
is rarely seen, either as a result of late manifestation of mild congenital anomaly 
or may be acquired type due to inflammatory fibrosis or invasion by tumours. 
Etiology. The exact cause of congenital (infantile) pyloric stenosis is not 
known but it appears to have familial clustering and recessive genetic origin. 
The acquired (adult) pyloric stenosis is related to antral gastritis, and tumours in 
the region (gastric carcinoma, lymphoma, pancreatic carcinoma). 
Pathologic changes. Grossly and microscopically, there is hypertrophy 
as well as hyperplasia of the circular layer of muscularis in the pyloric 
sphincter accompanied by mild degree of fibrosis. 
Clinical features. The patient, usually a first born male infant 3 to 6 
weeks old, presents with the following clinical features: 
1. Vomiting, which may be projectile and occasionally contains bile or 
blood. 
2. Visible peristalsis, usually noticed from left to right side of the upper 
abdomen. 
3. Palpable lump, better felt after an episode of vomiting. 
4. Constipation. 
5. Loss of weight. 
Other Congenital Anomalies 
Some other rare congenital anomalies of the stomach are: 
• Congenital diverticula 
• Juxta-gastric cysts 
• Misplacement of the stomach 
• Heterotopic tissue. 
 
MISCELLANEOUS ACQUIRED CONDITIONS 
Bezoars. Bezoars are foreign bodies in the stomach, usually in pa- 
tients with mental illness who chew these substances. Some of the common 
bezoars are: 
• Trichobezoars composed of a ball of hair. 
• Phytobezoars composed of vegetable fibres, seeds or fruit skin. 
• Trichophytobezoars combining both hair and vegetable matter. 
Acute Dilatation. Sudden and enormous dilatation of the stomach by 
gas or fluids due to paralysis of the gastric musculature may occur after ab- 




Gastric Rupture. The stomach may rupture rarely and prove fatal e.g. 
due to blunt trauma, external cardiac massage, ingestion of heavy meal or 
large quantity of liquid intake like beer. 
 
INFLAMMATORY CONDITIONS 
The two important inflammatory conditions of the stomach are gastri- 
tis and peptic ulcer. Rarely, stomach may be involved in tuberculosis, sar- 
coidosis and Crohn's disease. 
GASTRITIS 
The term 'gastritis' is commonly employed for any clinical condition 
with upper abdominal discomfort like indigestion or dyspepsia in which the 
specific clinical signs and radiological abnormalities are absent. The condi- 
tion is of great importance due to its relationship with peptic ulcer and gastric 
cancer. Broadly speaking, gastritis may be of 2 types – acute and chronic. 
The chronic gastritis can further be of various types. 
Acute Gastritis 
Acute gastritis is a transient acute inflammatory involvement of the 
stomach, mainly mucosa. 
Etiopathogenesis. A variety of etiologic agents have been implicated 
in the causation of acute gastritis. These are as follows: 
1. Diet and personal habits: 
• Highly spiced food 
• Excessive alcohol consumption 
• Malnutrition 
• Heavy smoking 
2. Infections: 
• Bacterial infections e.g. Helicobacter pylori, diphtheria, salmonello- 
sis, pneumonia, staphylococcal food poisoning. 
• Viral infections e.g. viral hepatitis, influenza, infectious mononucleosis. 
3. Drugs: 
• Intake of drugs like aspirin, cortisone, phenylbuta-zone, indometha- 
cin, preparations of iron, chemo-therapeutic agents. 
4. Chemical and physical agents: 
• Intake of corrosive chemicals such as caustic soda, phenol, lysol 
• Gastric irradiation 
• Freezing 
5. Severe stress: 
• Emotional factors like shock, anger, resentment etc. 






The mucosal injury and subsequent acute inflammation in acute gastri- 
tis occurs by one of the following mechanisms: 
1. Reduced blood flow, resulting in mucosal hypoperfusion due to is- 
chaemia. 
2. Increased acid secretion and its accumulation due to H. pylori infec- 
tion resulting in damage to epithelial barrier. 
3. Decreased production of bicarbonate buffer. 
Pathologic changes. Grossly, the gastric mucosa is oedematous with 
abundant mucus and haemorrhagic spots. Microscopically, depending upon 
the stage (form), there is variable amount of oedema and infiltration by neu- 
trophils in the lamina propria. 
There are some forms of acute gastritis: 
1. Catarrhal (edema and hyperemia of gastric mucosa, formation of 
mucous exudate, small hemorrhages and erosions (defect up to lamina pro- 
pria of mucous membrane); 
2. Fibrous (on the gastric mucous membrane grey color fibrous layers 
are formed, superficial and deep necrosis develops at different depth of gas- 
tric mucosa,); 
3. Purulent (whole gastric wall is infiltrated by neutrophilic granulo- 
cytes, and it can lead to peritonitis as complication). 
4. Necrotic gastritis (superficial or deep damage of gastric mucosa de- 
velops after use of chemical substances (acids, bases). It leads to formation of 
erosions and ulcers. 
In acute haemorrhagic and erosive gastritis, the mucosa is sloughed off 
and there are haemorrhages on the surface. 
Chronic Gastritis 
Chronic gastritis is the commonest histological change observed in bi- 
opsies from the stomach. The microscopic change is usually poorly correlat- 
ed to the symptomatology, as the change is observed in about 35% of endo- 
scopically normal mucosal biopsies. The condition occurs more frequently with 
advancing age; average age for symptomatic chronic gastritis being 45 years 
which corresponds well with the age incidence of gastric ulcer. 
Etiopathogenesis. In the absence of clear etiology of chronic gastritis, 
a number of etiologic factors have been implicated. All the causative factors 
of acute gastritis described above may result in chronic gastritis too. Recur- 
rent attacks of acute gastritis may result in chronic gastritis. Some other caus- 
es are as under: 
1. Reflux of duodenal contents into the stomach, especially in cases 




2. Associated disease of stomach and duodenum, such as gastric or du- 
odenal ulcer, gastric carcinoma. 
3. Chronic hypochromic anaemia, especially associated with atrophic 
gastritis. 
4. Immunological factors such as autoantibodies to gastric parietal cells 
in atrophic gastritis and autoantibodies against intrinsic factor. 
The mechanism of chronic gastric injury by any of the etiologic agents 
is by cytotoxic effect of the injurious agent on the gastric mucosal epitheli- 
um, thus breaking the barrier and then inciting the inflammatory response. 
Classification. Based on the type of mucosa affected (i.e. cardiac, 
body, pyloric, antral or transitional), a clinicopathologic classification has 
been proposed. 
1. Type A Gastritis (Autoimmune gastritis). Type A gastritis in- 
volves mainly the body-fundic mucosa. It is also called autoimmune gastritis 
due to the presence of circulating antibodies and is sometimes associated 
with other autoimmune diseases such as Hashimoto's thyroiditis and Addi- 
son's disease. As a result of the antibodies against parietal cells and intrinsic 
factor, there is depletion of parietal cells and impaired secretion of intrinsic 
factor. These changes may lead to significant gastric atrophy where intestinal 
metaplasia may occur, and a small proportion of these patients may develop 
pernicious anaemia. Due to depletion of gastric acid-producing mucosal area, 
there is hypo- or achlorhydria, and hyperplasia of gastrin-producing G cells 
in the antrum resulting in hypergastrinaemia. 
2. Type B Gastritis (H. pylori-related). Type B gastritis mainly in- 
volves the region of antral mucosa and is more common. It is also called hy- 
persecretory gastritis due to excessive secretion of acid, commonly due to in- 
fection with H. pylori. These patients may have associated duodenal or gas- 
tric ulcer. Unlike type A gastritis, this form of gastritis has no autoimmune 
basis nor has association with other autoimmune diseases. 
3. Type AB Gastritis (Environmental gastritis, Chronic atrophic 
gastritis). Type AB gastritis affects the mucosal region of A as well as B 
types (body-fundic and antral mucosa). This is the most common type of gas- 
tritis in all age groups. It is also called environmental gastritis because a 
number of as yet unidentified environmental factors have been implicated in 
its etiopathogenesis. Chronic atrophic gastritis is also used synonymously 
with type AB gastritis because in advanced stage, there is progression from 
chronic superficial gastritis to chronic atrophic gastritis, characterised by mu- 
cosal atrophy and metaplasia of intestinal or pseudopyloric type. 
Pathologic changes. Macroscopically, the features of all forms of gas- 
tritis are inconclusive. The gastric mucosa may be normal, atrophied, or oe- 







Histologically, based on: 
i) the extent of inflammatory changes in the mucosa (i.e. superficial or 
 
ii) the activity of inflammation (i.e. quiscent or active; acute or chronic), 
iii) the presence of and type of metaplasia (i.e. intestinal or pseudo- 
pyloric), the following simple classification has emerged: 
1. Chronic superficial gastritis, 
2. Chronic atrophic gastritis, 
3. Gastric atrophy, 
4. Chronic hypertrophic gastritis (Menetrier's disease), 
5. Uncommon forms of chronic gastritis. 
 
1. Chronic Superficial Gastritis. As the name suggests there is in- 
flammatory infiltrate consisting of plasma cells and lymphocytes in the superfi- 
cial layer of the gastric mucosa, but there are no histological changes in the 
deep layer of mucosa containing gastric glands. Chronic superficial gastritis 
may resolve completely or may progress to chronic atrophic gastritis. 
H. pylori, a spiral-shaped bacteria, is found in almost all active cases of 
chronic superficial gastritis and about 65% of quiscent cases. The organism is 
identified on the epithelial layer on the luminal surface and does not invade 
the mucosa. It is not seen on areas with intestinal metaplasia. H. Pylori is eas- 
ily identified with Giemsa, Steiner silver or Warthin-Starry stain. Chronic su- 
perficial gastritis due to H. pylori may lead to chronic atrophic gastritis, gas- 
tric atrophy, peptic ulcer and malignant transformation. 
2. Chronic Atrophic Gastritis. In this stage, there is inflammatory 
cell infiltrate in the deeper layer of the mucosa and atrophy of the epithelial 
elements including destruction of the glands. Two types of metaplasia are 
commonly associated with atrophic gastritis: 
i) Intestinal metaplasia. Intestinal metaplasia is more common and in- 
volves antral mucosa more frequently. Characteristic histologic feature is the 
presence of intestinal type mucus-goblet cells; Paneth cells and endocrine cells 
may also be present. Parietal cells are very few or absent. Intestinal metaplasia, 
focal or extensive, in atrophic gastritis is significant because its incidence is high 
in populations having high prevalence rate of gastric cancer like in Japan. 
ii) Pseudopyloric metaplasia. It involves the body glands which are re- 
placed by proliferated mucous neck cells, conforming in appearance to nor- 
mal pyloric glands. Its significance is not known. 
3. Gastric Atrophy. In this, there is thinning of the gastric mucosa 





4. Chronic Hypertrophic Gastritis (Menetrier's Disease). This is an 
uncommon condition characterised pathologically by enormous thickening of 
gastric rugal folds resembling cerebral convolutions, affecting mainly the region 
of fundic-body mucosa and characteristically sparing antral mucosa. The patients 
present with dyspepsia, haematemesis, melaena or protein-losing enteropathy. 
Histologically, the gastric pits are elongated and are tortuous. The mucosa 
is markedly thickened and parts of muscularis mucosae may extend into the 
thickened folds. Epithelium-lined cysts are commonly seen in the glandular layer. 
Inflammatory infiltrate is usually mild but lymphoid follicles may be present. The 
condition is considered significant in view of the risk of developing cancer. 
5. Uncommon Forms Of Chronic Gastritis. A few other types of 
gastritis which do not fit into the description of the types of gastritis de- 
scribed above are listed below: 
i) Gastric candidiasis. Infection with Candida albicans may occur as 
an opportunistic infection in immunosuppressed and debilitated individuals. 
ii) Eosinophilic gastritis. This condition is characterised by diffuse 
thickening of the pyloric antrum due to oedema and extensive infiltration by 
eosinophils in all the layers of the wall of antrum. Eosinophilic gastritis prob- 
ably has an allergic basis. 
iii) Chronic follicular gastritis. This is a variant of chronic atrophic 
gastritis in which numerous lymphoid follicles are present in the mucosa and 
submucosa of the stomach. 
iv) Haemorrhagic (Erosive) gastritis. In this condition, there are su- 
perficial erosions and mucosal haemorrhages, usually following severe hae- 
matemesis. The causes for such erosions and haemorrhages are duodenal- 
gastric reflux, administration of non-steroidal antiinflammatory drugs 
(NSAIDs), portal hypertension. 
v) Granulomatous gastritis. Rarely, granulomas may be present in the 
gastric mucosa such as in tuberculosis, sarcoidosis, Crohn's disease, syphilis, 
various mycoses, and as a reaction to endogenous substance or foreign material. 
 
PEPTIC ULCERS 
Peptic ulcers are the areas of degeneration and necrosis of gastrointes- 
tinal mucosa exposed to acid-peptic secretions. Though they can occur at any 
level of the alimentary tract that is exposed to hydrochloric acid and pepsin, 
they occur most commonly (98-99%) in either the duodenum or the stomach 
in the ratio of 4:1. Each of the two main types may be acute or chronic. In the 
discussion below, a brief account of acute peptic ulcers (stress ulcers) is fol- 




Acute Peptic (Stress) Ulcers 
Acute peptic ulcers or stress ulcers are multiple, small mucosal ero- 
sions, seen most commonly in the stomach but occasionally involving the 
duodenum. 
Etiology. These ulcers occur following severe stress. The causes are: 
i) Psychological stress 
ii) Physiological stress as in: 
• Shock 
• Severe trauma 
• Septicaemia 
• Extensive burns (Curling's ulcers in the posterior aspect of the first 
part of the duodenum). 
• Intracranial lesions (Cushing's ulcers developing from hyperacidity 
following excessive vagal stimulation). 
• Drug intake (e.g. aspirin, steroids, butazolidine, indomethacin). 
• Local irritants (e.g. alcohol, smoking, coffee etc). 
Pathogenesis. It is not clear how the mucosal erosions occur in stress 
ulcers because actual hypersecretion of gastric acid is demonstrable in only 
Cushing's ulcers occurring from intracranial conditions such as due to brain 
trauma, intracranial surgery and brain tumours. In all other etiologic factors, 
gastric acid secretion is normal or below normal. In these conditions, the pos- 
sible hypotheses for genesis of stress ulcers are: 
1. Ischaemic hypoxic injury to the mucosal cells. 
2. Depletion of the gastric mucus 'barrier' rendering the mucosa sus- 
ceptible to attack by acid-peptic secretions. 
Pathologic changes. Grossly, acute stress ulcers are multiple (more 
than three ulcers in 75% of cases). They are more common anywhere in the 
stomach, followed in decreasing frequency by occurrence in the first part of 
duodenum. They may be oval or circular in shape, usually less than 1 cm in 
diameter. 
Microscopically, the stress ulcers are shallow and do not invade the 
muscular layer. The margins and base may show some inflammatory reaction 
depending upon the duration of the ulcers. These ulcers commonly heal by 
complete re-epithelialisation without leaving any scars. Complications such 
as haemorrhage and perforation may occur. 
Chronic Peptic Ulcers (Gastric and Duodenal Ulcers) 
If not specified, chronic peptic ulcers would mean gastric and duodenal 
ulcers, the two major forms of 'peptic ulcer disease' of the upper GI tract in 




ulcers are common in the present-day life of the industrialised and civilised 
world. 
Gastric and duodenal ulcers represent two distinct diseases as far as 
their etiology, pathogenesis and clinical features are concerned. However, 
pathological findings in both are similar and quite diagnostic. The contrasting 
features of both these conditions are described together below. 
Incidence. Peptic ulcers are more frequent in middle-aged adults. The 
peak incidence for duodenal ulcer is 5th decade, while for gastric ulcer it is a 
decade later (6th decade). Duodenal as well as gastric ulcers are more com- 
mon in males than in females. Duodenal ulcer is almost four times more 
common than gastric ulcer; the overall incidence of gastroduodenal ulcers be- 
ing approximately 10% of the male population. 
Etiology. The immediate cause of peptic ulcer disease is disturbance in 
normal protective mucosal 'barrier' by acid-pepsin, resulting in digestion of 
the mucosa. However, in contrast to duodenal ulcers, the patients of gastric 
ulcer have low-to-normal gastric acid secretions, though true achlorhydria in 
response to stimulants never occurs in benign gastric ulcer. Besides, 10-20% 
patients of gastric ulcer may have coexistent duodenal ulcer as well. Thus, the 
etiology of peptic ulcers possibly may not be explained on the basis of a single 
factor but is multifactorial. These factors are as under: 
1. Psychological factors. Psychological stress, anxiety, fatigue and ulcer- 
type personality may exacerbate as well as predispose to peptic ulcer disease. 
2. Acid-pepsin secretions. There is conclusive evidence that some 
level of acid-pepsin secretion is essential for the development of duodenal as 
well as gastric ulcer. Peptic ulcers never occur in association with pernicious 
anaemia in which there are no acid and pepsin-secreting parietal and chief 
cells respectively. 
3. Mucus secretion. Any condition that decreases the quantity or qual- 
ity of normal protective mucus 'barrier' predisposes to the development of 
peptic ulcer. 
4. Gastritis. Some degree of gastritis is always present in the region of 
gastric ulcer, though it is not clear whether it is the cause or the effect of ul- 
cer. Besides, the population distribution pattern of gastric ulcer is similar to 
that of chronic gastritis. 
5. Local irritants. Pyloric antrum and lesser curvature of the stomach 
are the sites most exposed for longer periods to local irritants and thus are the 
common sites for occurrence of gastric ulcers. Some of the local irritating 
substances implicated in the etiology of peptic ulcers are heavily spiced 
foods, alcohol, cigarette smoking, unbuffered aspirin, non-steroidal anti- 




6. Dietary factors. Nutritional deficiencies have been regarded as etio- 
logic factors in peptic ulcers e.g. occurrence of gastric ulcer in poor socioec- 
onomic strata, higher incidence of duodenal ulcer in parts of South India. 
However, malnutrition does not appear to have any causative role in peptic 
ulceration in European countries and the U.S. 
7. Helicobacter pylori gastritis. About 15-20% cases infected with H. 
pylori develop duodenal ulcer in their life time while gastric colonisation by 
H. pylori never develops ulceration and remain asymptomatic.  However, 
there is evidence to suggest that increased density of H. pylori in the antrum 
is associated with greater likelihood of development of duodenal ulcer. H. py- 
lori can be identified in mucosal samples by histologic examination, culture, 
increased activity, and serology (IgG and IgA antibodies to H. pylori). 
8. Genetic factors. People with blood group O appear to be more prone 
to develop peptic ulcers than those with other blood groups. Genetic influences 
appear to have greater role in duodenal ulcers as evidenced by their occurrence 
in families, monozygotic twins and association with HLA-B5 antigen. 
9. Hormonal factors. Secretion of certain hormones by tumours is as- 
sociated with peptic ulceration e.g. elaboration of gastrin by islet cell tumour 
in Zollinger-Ellison syndrome, endocrine secretions in hyperplasia and ade- 
nomas of parathyroid glands, adrenal cortex and anterior pituitary. 
10. Miscellaneous. Duodenal ulcers have been observed to occur in 
association with various other conditions such as alcoholic cirrhosis, chronic 
renal failure, hyperparathyroidism, chronic obstructive pulmonary disease, 
and chronic pancreatitis. 
Pathogenesis. Although the role of various etiologic factors just de- 
scribed is well known in ulcerogenesis, two most important factors in peptic 
ulcer are: 
• Exposure of mucosa to gastric acid and pepsin secretion; and 
• Strong etiologic association with H. pylori infection. There are dis- 
tinct differences in the pathogenetic 
Mechanisms involved in duodenal and gastric ulcers as under: 
Duodenal ulcer. There is conclusive evidence to support the role of high 
acid-pepsin secretions in the causation of duodenal ulcers. Besides this, a few 
other noteworthy features in the pathogenesis of duodenal ulcers are as follows: 
1. There is generally hypersecretion of gastric acid into the fasting 
stomach at night which takes place under the influence of vagal stimulation. 
There is high basal as well as maximal acid output (BAO and MAO) in re- 
sponse to various stimuli. 
2. Patients of duodenal ulcer have rapid emptying of the stomach so 




down into the small intestine, leaving the duodenal mucosa exposed to the 
aggressive action of gastric acid. 
3. Helicobacter gastritis caused by H. pylori is seen in 95-100% cases 
of duodenal ulcers. The mucosal areas colonised by this organism are deplet- 
ed of the protective mucus 'barrier', thus exposing the underlying epithelial 
cells to the injurious effects of acid-pepsin secretions. 
Gastric ulcer. The pathogenesis of gastric ulcer is mainly explained on 
the basis of impaired gastric mucosal defenses against acid-pepsin secretions. 
Some other features in the pathogenesis of gastric ulcer are as follows: 
1. Hyperacidity may occur in gastric ulcer due to increased serum gas- 
trin levels in response to ingested food in an atonic stomach. 
2 However, many a patients of gastric ulcer have low-to-normal gastric 
acid levels. Ulcerogenesis in such patients is explained on the basis of damaging 
influence of other factors such as gastritis, bile reflux, cigarette smoke etc. 
3. The normally protective gastric mucus 'barrier' against acid-pepsin 
is deranged in gastric ulcer. There is depletion in the quantity as well as qual- 
ity of gastric mucus. One of the mechanisms for its depletion is colonisation 
of the gastric mucosa by H. pylori seen in 75-80% patients of gastric ulcer. 
Pathologic changes. Gross and microscopic changes in gastric and 
duodenal ulcers are similar and quite characteristic. Gastric ulcers are found 
predominantly along the lesser curvature in the region of pyloric antrum, 
more commonly on the posterior than the anterior wall. Most duodenal ulcers 
are found in the first part of the duodenum, usually immediate post-pyloric, 
more commonly on the anterior than the posterior wall. Uncommon locations 
include ulcer in the cardia, marginal ulcer and in the Meckel's diverticulum. 
Grossly, typical peptic ulcers are commonly solitary (80%), small (1-2.5 cm 
in diameter), round to oval and characteristically 'punched out'. Benign ulcers 
usually have flat margins in level with the surrounding mucosa. 'The mucosal 
folds converge towards the ulcer. The ulcers may vary in depth from being 
superficial (confined to mucosa) to deep ulcers (penetrating into the muscular 
layer). In about 10-20% of cases, gastric and duodenal ulcers are coexistent. 
Vast majority of the peptic ulcers are benign. Chronic duodenal ulcer never 
turns malignant, while chronic gastric ulcer may develop carcinoma in less 
than 1% of cases. Malignant gastric ulcers are larger, bowl-shaped with ele- 
vated and indurated mucosa at the margin. 
Microscopically, chronic peptic ulcers have 4 histological zones. From 
within outside, these are as under; 
1. Necrotic zone – lies in the floor of the ulcer and is composed of fi- 




2. Superficial exudative zone – lies underneath the necrotic zone. The 
tissue elements here show coagulative necrosis giving eosinophilic, smudgy 
appearance with nuclear debris. 
3. Granulation tissue zone – is seen merging into the necrotic zone. It is 
composed of nonspecific inflammatory infiltrate and proliferating capillaries. 
4. Zone of cicatrisation – is seen merging into thick layer of granula- 
tion tissue. It is composed of dense fibrocollagenic scar tissue over which 
granulation tissue rests. Thrombosed or sclerotic arteries may cross the ulcer 
which on erosion haemorrhage. 
Complications. Acute and subacute peptic ulcers usually heal without 
leaving any visible scar. However, healing of chronic, larger and deeper ul- 
cers may result in complications. These are as follows: 
1. Ulcerative- destructive: 
Haemorrhage. Minor bleeding by erosion of small blood vessels in 
the base of an ulcer occurs in all the ulcers and can be detected by testing the 
stool for occult blood. Chronic blood loss may result in iron deficiency 
anaemia. Severe bleeding may cause 'coffee ground' vomitus or melaena. A 
penetrating chronic ulcer may erode a major artery (e.g. left gastric, gastro- 
duodenal or splenic artery) and cause a massive and severe hematemesis and 
sometimes death. 
Perforation. A perforated peptic ulcer is an acute abdominal emergen- 
cy. Perforation occurs more commonly in chronic duodenal ulcers than 
chronic gastric ulcers. Following sequelae may result: 
i) On perforation the contents escape into the lesser sac or into the peri- 
toneal cavity, causing acute peritonitis. 
ii) Air escapes from the stomach and lies between the liver and the dia- 
phragm giving the characteristic radiological appearance of air under the di- 
aphragm. 
iii) Subphrenic abscess between the liver and the diaphragm may de- 
velop due to infection. 
iv) Perforation may extend to involve the adjacent organs e.g. the liver 
and pancreas. 
2. Ulcerative- obstructive. Development of fibrous scar at or near the 
pylorus results in pyloric stenosis. In the case of healed duodenal ulcer, it 
causes duodenal stenosis. Healed ulcers along the lesser curvatures may pro- 
duce 'hour glass' deformity due to fibrosis and contraction. 
3. Ulcerative-inflammatory (gastritis, perigastritis, duodenitis, peri- 
duodenitis) 
4. Malignant transformation. The dictum 'cancers ulcerate but ulcers 




never turns malignant, while less than 1% of chronic gastric ulcers may trans- 
form into carcinoma. 
5. Combined. 
 
HAEMATEMESIS AND MELAENA OF GASTRIC ORIGIN 
In continuity with the discussion on peptic ulcers which are the com- 
monest cause of haematemesis and melaena, it is worthwhile listing the vari- 
ous causes of haematemesis. 
These are: 
i) Chronic peptic ulcers (gastric as well as duodenal) 
ii) Acute peptic ulcers (stress ulcers) 
iii) Multiple gastric and duodenal erosions 
iv) Carcinoma of the stomach 
v) Peptic ulcer in Meckel's diverticulum 





TUMOURS AND TUMOUR-LIKE LESIONS 
A. TUMOUR-LIKE LESIONS (POLYPS) 
Tumour-like lesions are the polyps of the stomach which are of the fol- 
lowing types: 
Hyperplastic (Inflammatory) or inflammatory polyps are the regen- 
erative, non-neoplastic lesions which are the most common type (90%). They 
may be single or multiple and are more often located in the pyloric antrum. 
Grossly, the lesions may be sessile or pedunculated, 1 cm or larger in 
size, smooth and soft. The surface may be ulcerated or haemorrhagic. Micro- 
scopically, they are composed of irregular hyperplastic glands, which may 
show cystic change. The lining epithelium is mostly superficial gastric type 
but antral glands, chief cells and parietal cells may be present. These lesions 
do not have cellular atypia and do not have malignant potential. 
Hamartomatous Polyps are not true neoplasms but are malformations. 
They are of various types such as gastric polyps of the Peutz-Jeghers syndrome, 
juvenile polyp, pancreatic heterotopia, heterotopia of Brunner's glands and in- 
flammatory fibroid polyps (eosinophilic granulomatous polyps). 
B.BENIGNTUMOURS 
Benign tumours of the stomach are uncommon and usually incidental 
findings. 




Adenomas, also, referred to as adenomatous or neoplastic polyps, are true 
benign epithelial neoplasms and are much rarer in the stomach than in the large 
intestine. They are also found more often in the region of pyloric antrum. They 
are commonly associated with atrophic gastritis and pernicious anaemia. 
Spindle Cell (Stromal) Tumours 
These are a group of rare benign tumours of the stomach having spin- 
dle cell or stromal cell appearance. They are usually firm, circumscribed 
nodules, less than 4 cm in size and appear as submucosal nodules. The more 
common example is leiomyoma; others are neurofibromas, schwannomas etc. 
They resemble in gross and microscopic appearance with their counterparts 
in other parts of the body. 
C. MALIGNANTTUMOURS 
GASTRIC CARCINOMA 
Incidence. Carcinoma of the stomach comprises more than 90% of all 
gastric malignancies and is the leading cause of cancer-related deaths in 
countries where its incidence is high. The highest incidence is between 4th to 
6th decades of life and is twice more common in men than in women. 
Etiology. A number of etiologic factors have been implicated in causa- 
tion of gastric cancer. These are as under: 
1. H. pylori infection. H. pylori infection of the stomach is an im- 
portant risk factor for the development of gastric cancer. Epidemiologic stud- 
ies throughout world have shown that a seropositivity with H. pylori is asso- 
ciated with 3 to 6 times higher risk of development of gastric cancer. It may 
be mentioned here that similar association of H. pylori infection exists with 
gastric lymphomas as well. 
2. Dietary factors. Epidemiological studies suggest that dietary factors 
are most significant in the etiology of gastric cancer. The evidences in sup- 
port of this are multifold: 
i) Occurrence of gastric cancer in the region of gastric canal (i.e. along 
the lesser curvature and the pyloric antrum) where irritating foods exert their 
maximum effect. 
ii) Populations consuming certain food stuffs have high risk of devel- 
oping gastric cancer e.g. ingestion of smoked foods, high intake of salt, pick- 
led raw vegetables, high intake of carcinogens as nitrates in foods and drink- 
ing water, nitrites as preservatives for certain meats etc. However, intake of 
green leafy vegetables, citrus fruits and animal fats has been reported to have 
protective role in gastric cancer. 
iii) Tobacco smoke, tobacco juice and consumption of alcohol have all 




3. Geographical factors. There are geographic variations in the inci- 
dence of gastric cancer. Japan, Chile, Finland and Iceland have highest record- 
ed death rate from gastric cancer, while the incidence is considerably low in the 
US, UK and Canada. The higher incidence in certain geographic locales is likely 
to be the result of environmental influences as observed from the finding of in- 
cidence of gastric cancer in the next generation of Japanese immigrants to the 
US which is comparable to that of native Americans. 
4. Racial factors. Within the country, different ethnic groups may 
have variations in incidence of gastric cancer e.g. incidence is higher in 
Blacks, American Indians, Chinese in Indonesia, North Wales than other 
parts of Wales. 
5. Genetic factors. Generic influences have some role in the etiology 
of gastric cancer. Not more than 4% of patients of gastric cancer have a fami- 
ly history of this disease. Individuals with blood group A have higher tenden- 
cy to develop gastric cancer (Recall that the peptic ulcer is more common in 
individuals with blood group O). 
6. Pre-malignant changes in the gastric mucosa. There are some pre- 
cancerous conditions of gastric mucosa implicated in the etiology of gastric 
cancer. These are: 
i) Hypo- or achlorhydria in atrophic gastritis of gastric mucosa. 
ii) Adenomatous (neoplastic) polyps of the stomach. 
iii) Chronic gastric ulcer (ulcer-cancer), and its association with 
achlorhydria. 
iv) Stump carcinoma in patients who have undergone partial gastrec- 
tomy.  
Pathologic changes. Gastric carcinoma is most commonly located in the 
region of gastric canal (prepyloric region) formed by lesser curvature, pylorus and 
antrum. Other less common locations are the body, cardia and fundus. 
Before turning to classification of carcinoma of the stomach, it must be 
stated here that current studies indicate a pathogenetic evolution for all gas- 
tric carcinomas from an initial stage of in situ carcinoma confined to mucosal 
layers called early gastric carcinoma (EGC). EGC eventually penetrates the 
muscularis or beyond, resulting in advanced gastric carcinoma. 
Based on this pathogenetic sequence, gastric carcinomas are broadly 
classified into 2 main groups: 
I. Early gastric carcinoma (EGC). 
II. Advanced gastric carcinoma, which has 5 further major gross sub- 
types:  
i) ulcerative carcinoma, 
ii) fungating (polypoid) carcinoma, 




iv) colloid (mucoid) carcinoma, 
v) ulcer-cancer. 
In addition to the above classification, gastric carcinomas have been 
classified, on the basis of extent of invasion, into 2 groups: 
I. Expanding (formerly intestinal type) carcinomas that grow laterally 
by an invasive margin. The tumour cells are in the form of cohesive clusters. 
II. Infiltrating (formerly diffuse type) carcinomas have poorly-defined 
invasive border. The tumour cells are loose and invade singly or in small group. 
I. Early Gastric Carcinoma (EGC). EGC is the term used to describe 
cancerlimited to the mucosa and submucosa. The diagnosis of this condition has 
been made possible by extensive work on histogenesis of gastric cancer by Japa- 
nese pathologists by the use of fibreoptic endoscope and gastrocarnera. In Japan, 
EGC comprises 35% of newly-diagnosed cases of gastric cancer. 
Grossly, the lesion of EGC may have 3 patterns – polypoid (protrud- 
ed), superficial and ulcerated: 
Type I Polypoid type 
Type ILa Superficial elevated 
Type IIb Superficial flat 
Type IIc Superficial depressed 
Type III Ulcerated type 
Histologically, EGC is a typical glandular adenocarcinoma, usually 
well-differentiated type. 
Prognosis of EGC after surgical resection is quite good; 5-year survival 
rate being 93-99%. 
Early gastric carcinoma must be distinguished from certain related 
terms as under. 
  Epithelial dysplasia is cellular atypia seen in intestinal metaplasia 
such as in atrophic gastritis and pernicious anaemia. 
   Carcinoma in situ in the stomach is a state of severe cellular atypia or 
dysplasia, without invasion across the basement membrane of the glands. 
II. Advanced Gastric Carcinoma. When the carcinoma crosses the 
basement membrane into the muscularis propria or beyond, it is referred to as ad- 
vanced gastric carcinoma. Advanced gastric carcinoma has further 5 patterns: 
i) Ulcerative carcinoma. This is the most common pattern. The tu- 
mour appears as a flat, infiltrating and ulcerative growth with irregular ne- 
crotic base and raised margin. It is seen more commonly in the region of gas- 
tric canal. Histologically, ulcerative carcinomas are poorly- differentiated ad- 
enocartinomas, which invade deeply into the stomach wall. Tubular and aci- 
nar patterns are seen more commonly. 
ii) Fungating (polypoid) carcinoma. The second common pattern is a 




seen in the large intestine. It is seen more often in the fundus. The tumour 
undergoes necrosis and infection commonly. 
Histologically, fungating or polypoid carcinomas are well- 
differentiated adenocarcinomas, commonly papillary type. 
iii) Scirrhous carcinoma (Linitis plastica). In this pattern, the stom- 
ach wall is thickened due to extensive desmoplasia giving the appearance as 
'leather-bottle stomach' or 'linitis plastica'. The involvement may be localised 
to pyloric antrum, or diffuse affecting whole of the stomach from the cardia 
to pylorus. The lumen of the stomach is reduced. There are no ulcers but ru- 
gae are prominent. 
Histologically, it may be an adenocarcinoma or signet-ring cell carci- 
noma, extensively infiltrating the stomach wall, but due to marked 
desmoplasia cancer cells may be difficult to find. 
iv) Colloid (Mucoid) carcinoma- This pattern is usually seen in the 
fundus. The tumour grows like masses having gelatinous appearance due to 
secretion of large quantities of mucus. Histologically, mucoid carcinoma con- 
tains abundant pools of mucin in which are seen a small number of tumour 
cells, sometimes having signet-ring appearance. 
v) Ulcer-cancer. Development of cancer in chronic gastric ulcer is a 
rare occurrence(less than 1%). Majority of ulcer-cancers are malignant le- 
sions from the beginning. For confirmation of cancer in a pre-existing gastric 
ulcer, the characteristic microscopic appearance of peptic ulcer should be 
demonstrable with one portion of the base or the margin of the ulcer showing 
carcinomatous changes. Histologically, ulcer-cancers are adenocarcinomas 
without any specific features. 
Spread. Carcinoma of the stomach may spread by the following 
routes: 
1. Direct spread. Direct spread by local extension is the most common 
feature of gastric carcinoma. The spread occurs mainly from the loose sub- 
mucosal layer but eventually muscularis and serosa are also invaded. After 
the peritoneal covering of the stomach is involved, transcoelomic dissemina- 
tion may occur in any other part of the peritoneal cavity but ovarian masses 
(one side or both-sided) occur more commonly, referred to as Krukenberg 
tumours. Submucosal spread occurs more often upwards into the oesophagus 
due to continuity of the layers of stomach with those of oesophagus, while 
the spread downwards into the duodenum occurs less often due to the pres- 
ence of pyloric sphincter and submucosal Brunner's glands. The tumour may 
directly involve other neighbouring structures and organs like lesser and 





2. Lymphatic spread. Metastases to regional lymph nodes occur early, 
especially in the scirrhous carcinoma. The groups of lymph nodes involved 
are along the lesser and greater curvature around the cardia and suprapancre- 
atic lymph nodes. Involvement of left supraclavicular lymph node, Virchow 
or Troisier's sign, is sometimes the presenting feature of gastric carcinoma. 
3. Haematogenous spread. Blood spread of gastric carcinoma may 
occur to the liver, lungs, brain, bones, kidneys and adrenals. It occurs more 
commonly with the poorly-differentiated carcinoma. 
The American joint Committee on Cancer has developed TNM staging 
system for gastric carcinoma based on tumour invasion (T)/ lymph node in- 
volvement (N) and distant metastasis (M) into earliest stage Tis NQ MQ (in- 
traepithelial tumour) to most advanced stage TanyNanyM1. 
 
Other Carcinomas 
Besides the various morphologic patterns of adeno-carcinoma just de- 
scribed, other carcinomas that occur rarely in the stomach are: adenosquamous 
carcinoma, squamous cell carcinoma and undifferentiated carcinoma, all of 
which are morphologically similar to such tumours elsewhere. 
Leiomyosarcoma, though rare, is the commonest soft tissue sarcoma, 
the stomach being the more common site in the gastrointestinal tract. 
Grossly, the tumour may be of variable size but is usually quite large, 
pedunculated and lobulated mass into the lumen. 
Microscopically, leiomyosarcoma is characterised by high cellularity 
and presence of mitotic figures. Tumour is usually well-differentiated. 
Leiomyoblastoma (Epithelioid Leiomyoma) is a rare tumour, the be- 
haviour of which is intermediate between clearly benign and malignant tumour. 
Grossly, the tumour is large, circumscribed and projects into the lumen. 
Microscopically, it is characterised by round to polygonal cells with 
clear perinuclear halos. The number of mitoses determines the biological be- 
haviour of the tumour. 
Carcinoid Tumours are rare in the stomach and are usually non- 
argentaffin type but argentaffinomas also occur. Their behaviour is usually 
malignant. 
Lymphomas of Gut 
Primary gastrointestinal lymphomas are defined as lymphomas arising 
in the gut without any evidence of systemic involvement at the time of 
presentation. 
Secondary gastrointestinal lymphomas, on the other hand, appear in the 
gut after dissemination from other primary site. Gastric lymphomas constitute 
over 50% of all bowel lymphomas; other sites being small and large bowel in 




than for intestinal lymphomas. Primary lymphoma of stomach is the most com- 
mon malignant gastric tumour (4%) next to carcinoma. 
Clinical manifestations of gastric lymphomas may be similar to gastric 
carcinoma. Age incidence for lymphomas of the gastrointestinal tract is usu- 
ally lower than that for carcinoma (30-40 years as compared to 40-60 years in 
gastric carcinoma) and may occur even in childhood. Relationship with long- 
standing chronic H. pylori gastritis with lymphoid hyperplasia has been 
strongly suggested. 
Grossly, gastric lymphomas have 2 types of appearances: 
1. Diffusely infiltrating type, producing thickening of the affected gut 
wall, obliteration of mucosal folds and ulcerations. Cut section shows lesions 
in the mucosa and submucosa but in late stage whole thickness of the gut 
wall may be affected. 
2. Polypoid type, which produces large protruding mass into the lumen 
with ulcerated surface. 
Lymph node involvement may occur in either of the two patterns. 
Microscopically gastric lymphomas are most often non-Hodgkin's 
lymphomas of the following types: 
• High-grade large cell immunoblastic lymphoma being the most 
common. 
• Low-grade small lymphocytic well-differentiated B-cell lymphoma 
referred to as MALToma is the next in frequency (arising from Mucosa Asso- 
ciated Lymphoid Tissue). The term pseudolymphoma is sometimes used for 
non-invasive stage of MALToma. 
 
 
PATHOLOGY OF SMALL INTESTINE 
 
Anatomically, the small bowel includes the duodenum, jejunum and ileum and 
tends to become narrower throughout its course. 
Histologically, the small bowel is identified by recognition of villi. The wall of the 
small intestine consists of 4 layers: 
1. The serosa is the outer covering of the small bowel which is complete except 
over a part of the duodenum. 
2. The muscularis propria is composed of 2 layers of smooth muscle tissue – outer 
thinner longitudinal and inner thicker circular layer. These muscles are functionally im- 
portant for peristalsis. Between the two layers of muscle lie ganglionated plexus, myenter- 
ic plexus of Auerbach. 
3. The submucosa is composed of loose fibrous tissue with blood vessels and lac- 
teals in it. It contains a gangliated plexus, Meissner's plexus, having fewer and smaller 
cells than the Auerbach's plexus. 
4. The mucosa consists of glandular epithelium overlying the lamina propria com- 
posed of loose connective tissue and contains phagocytic cells and abundance of lymphoid 




er of smooth muscle fibres, muscularis mucosae. The mucous membrane is thrown into 
folds or plicae which are more in the jejunum and less in the ileum, thus increasing the 
absorptive surface enormously. The absorptive surface is further increased by the intesti- 
nal villi. Villi are finger-like or leaf-like projections which contain 3 types of cells: 
i) simple columnar cells which perform absorptive function due to the presence of 
brush border consisting of large number of microvilli. 
ii) goblet cells which are mucus-secreting cells and are interspersed between the 
columnar cells. 
iii) endocrine cells. These are scattered in the villi as well as are widely distributed 
throughout the gastrointestinal tract. These cells have various synonyms as under: 
• Kulchitsky cells, after the name of its discoverer; 
• Enterochromaffin cells, due to their resemblance to chromaffin cells of the adren- 
al medulla; 
• Argentaffin cells, as the intracytoplasmic granules stain positively with silver 
salts by reduction reaction (argyrophil cells, on the other hand, require the addition of ex- 
ogenous reducing substance for staining); and 
• Endocrine cells, as these specialised cells are considered to be part of APUD cell 
system (having common properties as Amine content, amine Precursor Uptake and Decarbox- 
ylation). APUD cells are considered to be of endodermal origin, while previously they were 
thought to be neural crest derivative. Other endocrine cells belonging to the APUD cell system 
are C-cells of the thyroid, chromaffin cells of the adrenal medulla, certain cells of the carotid 
body, bronchi, hypothalamus, pituitary and sympathetic ganglia. 
Endocrine cells are heavily populated in the proximal small bowel as this is the 
most active site for absorption and secretory activities. They are sparse in the colon which 
is less active site for such functions. 
The duodenum contains distinctively branched Brunner's glands present in the 
submucosa and going up to muscularis mucosae. The deeper layer of the mucosa of the 
small intestine elsewhere contains intestinal glands or crypts of Lieberkuhn. They are lined 
by columnar cells, goblet cells, endocrine cells and Paneth cells. Paneth cells are normally 
exclusively found in the small intestine and occasionally in the caecum. These cells are 
characterised by the presence of supranuclear granules rich in lysozyme. 
The blood supply of the whole of small intestine, except the first part of the duode- 
num, is by the superior mesenteric artery which supplies blood by mesenteric arterial ar- 
cades and the straight arteries. 
The main function of the small intestine is digestion and absorption so that ulti- 
mately nutrients passing into the blood stream are utilised by the cells in metabolism. The 
mucosal layer of the small intestine has remarkable capacity for regeneration and new lin- 
ing is laid every 3-4 days. 
CONGENITAL ANOMALIES 
INTESTINAL ATRESIA AND STENOSIS 
• Intestinal atresia is congenital absence of lumen, most commonly af- 
fecting the ileum or duodenum. The proximal segment has a blind end which 
is separated from distal segment freely, or the two segments are joined by a 
fibrous cord. The condition must be recognised early and treated surgically, 




• Intestinal stenosis is congenital narrowing of the lumen affecting a 
segment of the small intestine. Intestinal segment above the level of obstruc- 
tion is dilated and that below it is collapsed. 
MECKEL'S DIVERTICULUM 
Meckel's diverticulum is the most common congenital anomaly of the gas- 
trointestinal tract, occurring in 2% of population. It is more common in males. 
The anomaly is commonly situated on the antimesenteric border of the ileum, 
about 1 meter above the ileocaecal valve. Like other true diverticula, Meckel's di- 
verticulum is an outpouching containing all the layers of the intestinal wall in 
their normal orientation. It is almost always lined by small intestinal type of epi- 
thelium, though at times it may contain islands of gastric mucosa and ectopic 
pancreatic tissue. Embryologic origin of Meckel's diverticulum is from incom- 
plete obliteration of vitellointestinal duct. (Other anomalies resulting from the 
remnants of vitellointestinal duct are vitelline sinus and vitelline cyst). 
The common complications of Meckel's diverticulum are perforation, 
haemorrhage and diverticulitis. 
In addition to congenital Meckel's diverticulum, acquired diverticula 
also occur in the small intestine. 
These are commonly multiple (diverticulosis), frequently located on 
the mesenteric border, and are sometimes associated with malabsorption. 
 
INTESTINAL MALROTATION 
Malrotation is a developmental abnormality of the midgut (i.e. the por- 
tion of intestine between the duodeno-jejunal flexure and the middle of trans- 
verse colon). Due to failure of normal rotation of midgut, the following con- 
sequences can occur: 
i) Exomphalos i.e. intestinal eventration at the umbilicus. 
ii) Misplacement of the caecum, appendix and ascending colon, 
iii) Mobile caecum. 
 
COELIAC SPRUE (NON-TROPICAL SPRUE, GLUTEN-SENSITIVE EN- 
TEROPATHY, IDIOPATHIC STEATORRHOEA) 
This is the most important cause of primary malabsorption occurring in 
temperate climates. The condition is characterised by significant loss of villi 
in the small intestine and thence diminished absorptive surface area. The 
condition occurs in 2 forms: 
Childhood form, seen in infants and children and is commonly referred 
to as coeliac disease. 
Adult form, seen in adolescents and early adult life and used to be 




In either case, there is genetic abnormality resulting in sensitivity to 
gluten (a protein) and its derivative, gliadin, present in diets such as grains of 
wheat, barley and rye. The symptoms are usually relieved on elimination of 
gluten from the diet. The role of heredity is further supported by the observa- 
tion of familial incidence and HLA association of the disease. Exact patho- 
genesis of the condition is not clear. However, following hypotheses are sig- 
nificant in causing mucosal cell damage: 
1. Hypersensitivity reaction as evidenced by gluten-stimulated antibodies. 
2. Toxic effect of gluten due to inherited enzyme deficiency in the mu- 
cosal cells. 
Pathologic changes. There are no differences in the pathological find- 
ings in children and adults. Histologically, there is variable degree of flatten- 
ing of the mucosa, particularly of the upper jejunum, and to some extent of 
the duodenum and ileum. The surface epithelial cells are cuboidal or low co- 
lumnar type. There may be partial villous atrophy which is replacement of 
normal villous pattern by convolutions, or subtotal villous atrophy character- 
ised by flat mucosal surface. Lamina propria shows increased number of 
plasma cells and lymphocytes. 
The major sequela of long-term coeliac sprue is increased incidence of 
intestinal carcinoma in these cases. 
COLLAGENOUS SPRUE 
This entity is regarded as the end-result of coeliac sprue in which the 
villi are totally absent (total villous atrophy) and there are unique and diag- 
nostic broad bands of collagen under the basal lamina of surface epithelium. 
The condition is refractory to any treatment and the course is generally fatal. 
Some workers consider collagenous sprue as a variant of coeliac sprue with- 
out classifying it separately. 
TROPICAL SPRUE 
This disease, as the name suggests, occurs in individuals living in or 
visiting tropical areas such as Caribbean countries, South India, Sri Lanka 
and Hong Kong. Pathogenesis of the condition is not clear but there is evi- 
dence to support enterotoxin production by some strains of E. coli which 
causes the intestinal injury. Severe cases are characterised by additional fea- 
tures such as macrocytic anaemia, glossitis and emaciation due to intestinal 
malabsorption of vitamin B12 and folate. 
WHIPPLE'S DISEASE (INTESTINAL LIPODYSTROPHY) 
This is an uncommon bacterial disease involving not only the intestines 
but also various other systems such as central nervous system, heart, blood 




common in males in 4th to 5th decades of life. Patients may present with fea- 
tures of malabsorption or may have atypical presentation in the form of mi- 
gratory polyarthritis, neurological disturbances and focal hyperpigmentation 
of the skin. 
Pathologic changes. Histologically, the affected tissues show presence 
of characteristic macrophages containing PAS-positive granules and rod- 
shaped microorganisms (Whipple's bacilli). These macrophages are predomi- 
nantly present in the lamina propria of the small intestine and mesenteric 
lymph nodes. 
Patients respond very well to oral antibiotic therapy. 
PROTEIN-LOSING ENTEROPATHIES 
A number of disorders of the gastrointestinal tract are accompanied by 
excessive protein loss without concomitant increase in protein synthesis, thus 
resulting in hypoproteinaemia. These diseases are listed below: i) Whipple's 
disease ii) Crohn's disease iii) Ulcerative colitis iv) Sprue v) Intestinal lym- 
phangiectasia vi) Menetrier's disease (Hypertrophic gastritis). 
 
SMALL INTESTINAL TUMOURS 
For obscure reasons, benign as well as malignant tumours of the small 
bowel are surprisingly rare. Most common benign tumours, in descending or- 
der of frequency, are: leiomyomas, adenomas and vascular rumours (hae- 
mangioma, lymphangioma). Amongst the malignant tumours, the most fre- 
quently encountered, in descending frequency, are: carcinoid tumours, lym- 
pho-mas and adenocarcinoma. All these tumours are identical in morphology to 
those seen elsewhere in the alimentary tract. Carcinoid rumour, a peculiar neo- 
plasm most common in the midgut, is described below. 
CARCINOID TUMOUR (ARGENTAFFINOMA) 
Carcinoid tumour or argentaffinoma is a generic term applied to tu- 
mours originating from endocrine cells (synonyms: argentaffin cells, Kulchitsky 
cells, enterochromaffin cells) belonging to APUD cell system and are therefore 
also called as apudomas. The endocrine cells are distributed throughout the mu- 
cosa of GI tract. These cells have secretory granules which stain positively with 
silver salts (argentaffin granules) or many stain after addition of exogenous reduc- 
ing agent (non-argentaffin or argyrophil granules). Accordingly, carcinoid tumour 
may be argentaffin or argyrophil type. Depending upon the embryologic deriva- 
tion of the tissues where the tumour is located, these are classified as foregut, 
midgut, and hindgut carcinoids. 
• Midgut carcinoids, seen in terminal ileum and appendix are the most 




• Hindgut carcinoids, occurring in rectum and colon are more com- 
monly argyrophil type, and comprise about 10-20% of carcinoids. 
• Foregut carcinoids, located in the stomach, duodenum and oesopha- 
gus are also argyrophil type and are encountered as frequently as in the hind- 
gut (10-20%). 
Other uncommon locations are bronchus, trachea, gallbladder, and 
Meckel's diverticulum. 
Appendix and terminal ileum, the two most common sites for carcinoids, 
depict variation in their age and sex incidence and biologic behaviour: 
• Appendiceal carcinoids, occur more frequently in 3rd and 4th decades 
of life without any sex predilection, are often solitary and behave as locally 
malignant tumours. 
• Ileal carcinoids, on the other hand, are seen more often in later age 
(7th decade) with female preponderance, are more commonly multiple and 
behave like metastasising carcinomas. 
Pathologic changes. Macroscopically, all carcinoids are small, button- 
like submucosal elevations with intact or ulcerated overlying mucosa. They 
are usually small; those larger than 2 cm are more often metastasising. Ileal 
and gastric carcinoids are commonly multiple, whereas appendiceal car- 
cinoids commonly involve the tip of the organ and are solitary. Cut section of 
all the carcinoids is bright yellow. 
Histologically, the tumour cells may be arranged in a variety of pat- 
terns — solid nests, sheets, cords, trabeculae and clusters, all of which show 
characteristic palisading of the peripheral cells. Aeirtar arrangement and ro- 
settes are rarely seen. The rumour cells are classically small, monotonous, 
having uniform nuclei and poorly-defined cell boundaries. The argentaffin 
carcinoids show eosinophilic granules in the cytoplasm which stain positively 
by the argentaffin reaction. Mitotic figures are rare. However, the cytologic 
features are a poor guide for distinguishing clinically benign from malignant 
behaviour of the tumour, but all carcinoids infiltrate the bowel wall. 
CARCINOID SYNDROME 
Carcinoid tumours that metastasise, especially to the liver, are some- 
times associated with the carcinoid syndrome. The syndrome consists of the 
following features: 
1. Intermittent attacks of flushing of the skin of face 
2. Episodes of watery diarrhoea 
3. Abdominal pain 
4. Attacks of dyspnoea due to bronchospasm 
5. Right-sided heart failure due to involvement of tricuspid and pulmo- 




A number of secretory products in a functioning carcinoid tumour have 
been demonstrated. These are: 
i) 5-Hydroxytryptamine (5-HT, serotonin) 
ii) 5-Hydroxytryptophan 




However, 5-HT and its degradation product, 5-HIAA, are particularly 
significant in the production of carcinoid syndrome. 5-HT, a potent vasodila- 
tor and smooth muscle stimulant, is normally synthesised in the endocrine 
cells of the gut from dietary tryptophan. Tryptophan is first hydroxylated to 
5-hydroxytryptophan, then decarboxylated to 5-HT and further oxidised to 5- 
HLAA by the monoamine oxidase in the liver cells. It is then excreted in the 
urine. This capacity to synthesise 5-HT and 5-HIAA is markedly elevated in 
primary and hepatic metastatic carcinoids. Midgut carcinoids have rich decar- 
boxylating enzymes and are thus able to produce large quantities of 5-HT and 
5-HIAA, accounting for high frequency of carcinoid syndrome in them. Fore- 
gut and hindgut carcinoids, on the other hand, lack decarboxylating enzymes 
and, therefore, are less often associated with carcinoid syndrome. 
 
INFLAMMATORY BOWEL DISEASE 
The term 'inflammatory bowel disease (IBD)' is commonly used to in- 
clude 2 idiopathic bowel diseases having many similarities but the conditions 
usually have distinctive morphological appearance. These 2 conditions are 
Crohn's disease (regional enteritis) and ulcerative colitis: 
1. CROHN'S DISEASE OR REGIONAL ENTERITIS is an idiopathic chronic 
ulcerative IBD, characterised by transmural, non-caseating granulomatous in- 
flammation, affecting most commonly the segment of terminal ileum and/or co- 
lon, though any part of the gastrointestinal tract may be involved. 
2. ULCERATIVE COLITIS is an idiopathic form of acute and chronic ul- 
cero-inflammatory colitis affecting chiefly the mucosa and submucosa of the 
rectum and descending colon, though sometimes it may involve the entire 
length of large bowel. 
Both these disorders primarily affect the bowel but may have systemic in- 
volvement in the form of polyarthritis, uveitis, ankylosing spondyliris, skin le- 
sions and hepatic involvement. Both diseases can occur at any age but are more 
common in 2nd and 3rd decades of life. Females are affected slightly more often. 
Etiopathogenesis. The exact etiology of IBD remains unknown. A few 




1. Infectious mechanism. Many microorganisms have been implicated 
as causative for IBD but none has been conclusively proved. These include: 
bacteria (e.g. mycobacteria, dysentery bacilli, chlamydia), viruses (e.g. rota- 
viruses, EB virus, intestinal cytopathic viruses), protozoa and fungi. There is, 
however, indirect evidence in support of their role in the etiology of IBD like 
production of pathologic changes in the bowel of experimental animals by in- 
jecting tissue homogenates of Crohn's disease or of ulcerative colitis. 
2. Immunologic mechanisms. Immunologic factors, both humoral and 
cellular, as well as immunodeficiency, have been recently shown to play sig- 
nificant, but as yet unproven role, in the pathogenesis of IBD. 
i) Humoral factors implicated in the pathogenesis of IBD are as under: 
a) Demonstration of specific anti-colon antibodies to bacterial antigen 
such as Escherichia coli which may cause the lesions but there is no correla- 
tion between the levels of these antibodies and activity of the IBD. 
b) Increased synthesis of IgG by the lymphoid cells of the diseased 
bowel may produce antibody-mediated damage but IBD has been observed to 
occur in patients with agammaglobulinaemia as well. 
c) Circulating immune complexes may produce extra-intestinal lesions of 
IBD but their role in the intestinal lesions of IBD is not established. 
d) IgE-mediated hypersensitivity reaction leading to excessive hista- 
mine release by mast cells in the bowel wall may cause oedema of the bowel 
wall in IBD but the evidence is not conclusive as administration of antihis- 
taminics does not alter the course of the disease, 
ii) Cell-mediated immunologic factors have attracted more attention. 
The evidences in support are: 
a) Decreased number of peripheral T cells and cutaneous anergy. 
b) Presence of T cells sensitised to various bowel antigens may be cy- 
totoxic to mucosa. 
c) Antibody-dependent cellular cytotoxicity (ADCC) may occur by in- 
teraction of K cells with humoral antibodies. 
iii) Immunodeficiency of IgA in Crohn's disease has been suggested 
more recently as possible immune mechanism for the lesions. 
3. Other mechanisms. Many other etiologic factors have been implicat- 
ed in the etiopathogenesis of IBD, all without definite proof of their involve- 
ment. These are as under: 
i) Psychological factors such as individuals who are unduly sensitive, de- 
pendent on others and unable to express themselves suffer from irritable colon. 
ii) Genetic factors have been implicated due to familial incidence of 





iii) Racial factors have been reported such as observation of high inci- 
dence of IBD in Jews and in Whites. 
iv) Food allergies, particularly to milk, have been shown to provoke at- 
tacks of IBD. 
v) Trauma has been thought to activate clinically latent disease. 
CROHN'S DISEASE 
Crohn's disease may involve any portion of the gastrointestinal tract but af- 
fects most commonly 15-25 cms of the terminal ileum which may extend into the 
caecum and sometimes into the ascending colon: 
Grossly, characteristic feature is the multiple, well-demarcated seg- 
mental bowel involvement with intervening uninvolved 'skip areas'. The wall 
of the affected bowel segment is thick and hard, resembling a 'hose pipe'. Se- 
rosa may be studded with minute granulomas. The lumen of the affected 
segment is markedly narrowed. The mucosa shows 'serpiginous ulcers', while 
intervening surviving mucosa is swollen giving 'cobblestone appearance'. 
There may be deep fissuring into the bowel wall. Histologically, the charac- 
teristic features are as follows: 
1. Transmural inflamatory cell infiltrate consisting of chronic inflam- 
matory cells (lymphocytes, plasma cells and macrophages) is the classical 
microscopic feature. 
2. Non-caseating, sarcoid-like granulomas are present in all the layers 
of the affected bowel wall in 60% of cases and may even be seen in the re- 
gional lymph nodes. 
3. There is patchy ulceration of the mucosa which may take the form of 
deep fissures, accompanied by inflammatory infiltrate of lymphocytes and 
plasma cells. 
4. There is widening of the submucosa due to oedema and foci of lym- 
phoid aggregates. 
5. In more chronic cases, fibrosis becomes increasingly prominent in 
all the layers disrupting muscular layer. 
Complications of Crohn's disease are: 
1. Malabsorption due to impaired absorption of fat, vitamin B12, pro- 
teins and electrolytes from the diseased small bowel. 
2. Fistula formation may occur in long-standing cases. These may be 
internal fistulae between the loops of the intestine, or external fistulae such as 
enterocutaneous, rectal and anal fistulae. 
3. Stricture formation may occur in chronic cases due to extensive fi- 




4. Carcinoma may develop very rarely in the small intestine as a late 
complication of Crohn's disease. 
ULCERATIVE COLITIS 
Classically, ulcerative colitis begins in the rectum, and in continuity 
extends upwards into the sigmoid colon, descending colon, transverse colon, 
and sometimes may involve the entire colon. The colonic contents may rarely 
backflow into the terminal ileum in continuity, causing 'back-wash ileitis' in 
about 10% of cases. 
Grossly, the characteristic feature is the continuous involvement of rec- 
tum and colon without any uninvolved skip areas as seen in Crohn's disease. 
The appearance of colon may vary depending upon the stage and intensity of 
the disease because of remissions and exacerbations. Mucosa shows linear 
and superficial ulcers, usually not penetrating the muscular layer. The inter- 
vening intact mucosa may form inflammatory 'pseudopolyps.' The muscle 
layer is thickened due to contraction, producing shortening and narrowing of 
the affected colon with loss of normal haustral folds giving 'garden-hose ap- 
pearance'. 
Histologicalty, ulcerative colitis because of remission and exacerba- 
tions, is characterised by alternating 'active disease process' and 'resolving co- 
litis.' The changes in the 'active disease process' are as under: 
1. Crypt distortion, cryptitis and focal accumulations of neutrophils 
forming crypt abscesses. 
2. Marked congestion, dilatation and haemorrhages from mucosal ca- 
pillaries. 
3. Superficial mucosal ulcerations, usually not penetrating into the 
muscle coat, except in severe cases, and is accompanied by nonspecific in- 
flammatory cell infiltrate of lymphocytes, plasma cells, neutrophils, some eo- 
sinophils and mast cells in the lamina propria. 
4. Goblet cells are markedly diminished in cases of active disease. 
5. Areas of mucosal regeneration and mucodepletion of lining cells. 
6. In long-standing cases, epithelial cytologic atypia ranging from mild 
to marked dysplasia and sometimes developing into carcinoma-in-situ and 
frank carcinoma. 
Complications of ulcerative colitis are as follows: 
1. Toxic megacolon (Fulminant colitis) is the acute fulminating colitis 
in which the affected colon is thin-walled and dilated and is prone to perfora- 
tion and faecal peritonitis. There is deep penetration of the inflammatory cell 
infiltrate into muscle layer which is disrupted. 




3. Carcinoma may develop in long-standing cases of ulcerative colitis 
of more than 10 years duration. 
4. Stricture formation almost never occurs in ulcerative colitis. 
OTHER INFLAMMATORY LESIONS OF THE BOWEL 
Besides the IBD, a variety of other acute and chronic inflammatory 
conditions affect small bowel (enteritis), large bowel (colitis), or both (enter- 
ocolitis); the last named being more common. Hence, all these conditions in- 
volving small bowel and/or large bowel are described together here for better 
correlation of features. 
The various other forms of inflammations of the bowel (besides IBD) 
can be categorised broadly into 'infective enterocolitis' and 'pseudomembra- 
nous enterocolitis.' 
INFECTIVE ENTEROCOLITIS 
These are a group of acute and chronic inflammatory lesions of small 
intestine and/or colon caused by microorganisms (bacteria, viruses, fungi, 
protozoa and helminths). All these are characterised by diarrhoeal syn- 
dromes. Pathogenetically speaking, these microorganisms can cause entero- 
colitis by 2 mechanisms— by enteroinvasive bacteria producing ulcerative 
lesions, and by enterotoxin-producing bacteria resulting in non-ulcerative le- 
sions. 
Some of the important forms are described below: 
INTESTINAL TUBERCULOSIS 
Intestinal tuberculosis can occur in 3 forms: primary, secondary and 
hyperplastic caecal tuberculosis. 
1. Primary intestinal tuberculosis. 
Though an uncommon disease in the Western world, primary tubercu- 
losis of the ileocaecal region is quite common in India. It used to occur by in- 
gestion of unpas-teurised cow's milk infected with Mycobacterium bovis. But 
nowadays due to control of tuberculosis in cattle and pasteurisation of milk, 
virtually all cases of intestinal tuberculosis are caused by M, tuberculosis. 
The predominant changes are in the mesenteric lymph nodes without any 
significant intestinal lesion. 
Grossly, the affected lymph nodes are enlarged, matted and caseous (ta- 
bes mesenterica). Eventually, there is healing by fibrosis and calcification. 
Microscopically,  in  the  initial  stage,  there  is  primary  complex  or 
Ghon's focus in the intestinal mucosa. Subsequently, the mesenteric lymph 
nodes are affected which show typical tuberculous granulomatous inflammatory 
reaction with caseation necrosis. Tuberculous peritonitis may occur due to 




2. Secondary intestinal tuberculosis. 
Swallowing of sputum in patients with active pulmonary tuberculosis 
may cause secondary intestinal tuberculosis, most commonly in the terminal 
ileum and rarely in the colon. 
Grossly, the intestinal lesions are prominent than the lesions in regional 
lymph nodes as in secondary pulmonary tuberculosis. The lesions begin in the 
Peyer's patches or the lymphoid follicles with formation of small ulcers that 
spread through the lymphatics to form large ulcers which are transverse to the 
long axis of the bowel. These ulcers may be coated with caseous material. Sero- 
sa may be studded with visible tubercles. In advanced cases, transverse fibrous 
strictures and intestinal obstruction are seen. 
Histologically, the tuberculous lesions in the intestine are similar to 
those observed elsewhere i.e. presence of tubercles. Mucosa and submucosa 
show ulceration and the muscularis may be replaced by variable degree of fi- 
brosis. Tuberculous peritonitis may be observed. 
3. Hyperplastic caecal tuberculosis. This is a variant of secondary tu- 
berculosis secondary to pulmonary tuberculosis. 
Grossly, the caecum and/or ascending colon are thick-walled with mu- 
cosal ulceration. Clinically, the lesion is palpable and may be mistaken for 
carcinoma. 
Microscopically, the presence of caseating tubercles distinguishes the 
condition from Crohn's disease in which granulomas are non-caseating. Be- 
sides, bacteriological evidence by culture or animal inoculation and Mantoux 
test are helpful in differential diagnosis of the two conditions. 
ENTERIC FEVER 
The term enteric fever is used to describe acute infection caused by 
Salmonella typhi (typhoid fever) or Salmonella paratyphi (paratyphoid fe- 
ver). Besides these 2 salmonellae, Salmonella typhimurium causes food poi- 
soning. 
Pathogenesis. The typhoid bacilli are ingested through contaminated 
food or water. During the initial asymptomatic incubation period of about 2 
weeks, the bacilli invade the lymphoid follicles and Peyer's patches of the 
small intestine and proliferate. Following this, the bacilli invade the blood 
stream causing bacteraemia, and the characteristic clinical features of the dis- 
ease like continuous rise in temperature and 'rose spots' on the skin are ob- 
served. Immunological reactions (Widal's test) begin after about 10 days and 
peak titres are seen by the end of the third week. Eventually, the bacilli are 
localised in the intestinal lymphoid tissue (producing typhoid intestinal le- 
sions), in the mesenteric lymph nodes (leading to haemorrhagic lymphadeni- 




(producing typhoid cholecystitis), and in the spleen (resulting in splenic reac- 
tive hyperplasia). 
Pathologic changes. The lesions are observed in the intestines as well 
as in other organs. 
1. Intestinal lesions. Macroscopically, terminal ileum is affected most of- 
ten, but lesions may be seen in the jejunum and colon. The Peyer's patches show 
oval typhoid ulcers with their long axis along the length of the bowel. The base of 
the ulcers is black due to sloughed mucosa. The margins of the ulcers are slightly 
raised due to inflammatory oedema and cellular proliferation. There is never sig- 
nificant fibrosis and hence fibrous stenosis seldom occurs in healed typhoid le- 
sions. The regional lymph nodes are invariably enlarged. 
Microscopically, there is hyperaemia, oedema and cellular proliferation 
consisting of phagocytic histiocytes (showing characteristic erythrophagocy- 
tosis), lymphocytes and plasma cells. Though enteric fever is an example of 
acute inflammation, neutrophils are invariably absent from the cellular infil- 
trate and this is reflected in the leucopenia with neutropenia and relative lym- 
phocytosis in the peripheral blood. 
The main complications of the intestinal lesions of typhoid are perfora- 
tion of the ulcers and haemorrhage. 
2. Other lesions. Besides the intestinal involvement, various other or- 
gans and tissues showing pathological changes in enteric fever are: 
i) Mesenteric lymph nodes—haemorrhagic lymphadenitis. 
ii) Liver—foci of parenchymal necrosis, 
iii) Gallbladder—typhoid cholecystitis, 
iv) Spleen—splenomegaly with reactive hyperplasia. 
v) Kidneys—nephritis. 





Persistence of organism in the gallbladder or urinary tract may result in 
passage of organisms in the faeces or urine creating a 'carrier state' which is a 
source of infection to others. 
BACTERIAL FOOD POISONING 
This is a form of acute bacterial illness that occurs following ingestion 
of food or water contaminated with bacteria other than those that cause spe- 
cific acute intestinal infections like typhoid, paratyphoid, cholera or dysen- 




genic effect on the bowel. The commonest causes of bacterial food poisoning 
resulting in enteritis or enterocolitis are as under: 
1. Staphylococcal food poisoning. Staphylococcus aureus infection ac- 
quired from contaminated food produces either mild food poisoning by en- 
terotoxins, or may cause more severe form of the illness called pseudo- 
membranous enterocolitis described below. Staphylococcal food poisoning 
occurs due to liberation of enterotoxins by the bacteria. 
2. Clostridial food poisoning. Infection with anaerobic organisms Clos- 
tridium welchii, following consumption of contaminated meat results in acute 
food poisoning. The illness occurs both by bacterial invasion as well as by toxins. 
3. Botulism. This is a severe form of paralysing illness caused by in- 
gestion of organism, Clostridium botulinum, which produces neurotoxin. 
4. Salmonella food poisoning (Salmonellosis). This is an infection (and 
not caused by toxins) occurring due to food contaminated by S. typhimurium or 
S. enteritidis. The condition manifests with fever, vomiting, and diarrhoea. 
Death may result from depletion of water and electrolytes. 
DYSENTERIES 
The term 'dysentery' is used to mean diarrhoea with abdominal cramps, 
tenesmus and passage of mucus in the stools, from any cause. There are 2 
main forms of dysenteries — bacillary and amoebic. 
1. Bacillary dysentery. Bacillary dysentery is the term used for infec- 
tion by shigella species: S. dysenteriae, S. flexneri, S. boydii and S. sonnei. 
Infection occurs by foecooral route and is seen with poor personal hygiene, in 
densely populated areas, and with contaminated food and water. The com- 
mon housefly plays a role in spread of infection. 
Microscopically, the lesions are mainly found in the colon and occa- 
sionally in the ileum. Superficial trans-weise tikerations of mucosa of the 
bowel wall occur in the region of lymphoid follicles but perforation is seldom 
seen. The intervening intact mucosa is hyperaemic and oedematous. Follow- 
ing recovery from the acute attack, complete healing usually takes place. Mi- 
croscopically, the mucosa overlying the lymphoid follicles is necrosed. The 
surrounding mucosa shows congestion, oedema and infiltration by neutro- 
phils and lymphocytes. The mucosa may be covered by greyish-yellow 
'pseudomembrane' composed of fibrino-suppurative exudate. 
The complications of bacillary dysentery are haemorrhage, perforation, 
stenosis, polyarthritis and iridocyclitis. 
2. Amoebic dysentery. This is due to infection by Entamoeba histolyt- 
ica. It is more prevalent in the tropical countries and primarily affects the 
large intestine. Infection occurs from ingestion of cyst form of the parasite. 




amoebae pass into the large intestine. Here, they invade the epithelium of the mu- 
cosa, reach the submucosa and produce the characteristic flask-shaped ulcers. 
Macroscopically, early intestinal lesions appear as small areas of eleva- 
tion on the mucosal surface. In advanced cases, typical flask-shaped ulcers 
having narrow neck and broad base are seen. They are more conspicuous in 
the caecum, rectum and in the flexures. 
Microscopically, the ulcerated area shows chronic inflammatory reac- 
tion consisting of lymphocytes, plasma cells, macrophages and eosinophils. 
The trophozoites of Entamoeba are seen in the inflammatory exudate and are 
concentrated at the advancing margin of the lesion. Intestinal amoebae char- 
acteristically have ingested red cells in their cytoplasm. Oedema and vascular 
congestion are present in the area surrounding the ulcers. 
Complications of intestinal amoebic ulcers are: amoebic liver abscess 
or amoebic hepatitis, perforation, haemorrhage and formation of amoeboma 
which is a tumour-like mass. 
PSEUDOMEMBRANOUS ENTEROCOLITIS (ANTIBIOTIC-ASSOCIATED DI- 
ARRHOEA) 
Pseudomembranous enterocolitis is a form of acute inflammation of 
colon and/or small intestine characterised by formation of 'pseudomembrane' 
over the site of mucosal injury. 
Etiology. Numerous studies have established the overgrowth of Clos- 
tridium difficile with production of its toxin in the etiology of antibiotic- 
associated diarrhoea culminating in pseudomembranous colitis. Oral antibiot- 
ics such as clindamycin, ampicillin and the cephalosporins are more often 
(20%) associated with antibiotic-associated diarrhoea, while development of 
pseudomembranous colitis may occur in 1-10% cases. Pseudomembrane 
formation may also occur in various other conditions such as in: 
• Staphylococcal enterocolitis 
• Bacillary (Shigella) dysentery 
• Candida enterocolitis 
Pathologic changes. Macroscopically, the lesions may be confined, to 
the large intestine or small intestine, or both may be involved. The mucosa of 
the bowel is covered by patchy, raised yellow-white plaques. Elsewhere, the 
mucosa is congested and may show small mucosal ulcerations. Microscopi- 
cally, the 'pseudomembrane' is composed of network of fibrin and mucus, in 
which are entangled inflammatory cells and mucosal epithelial cells. There is 
focal necrosis of surface epithelial cells. The lamina propria contains in- 
flammatory cell infiltrate, mainly neutrophils. The submucosa has congested 
capillaries and may show micrpthrombi. The inflammation spreads laterally 





Conditions which interfere with the propulsion of contents in the intes- 
tine are considered under the heading of intestinal obstruction. The causes of 
intestinal obstruction can be classified under the following 3 broad groups: 
1. Mechanical obstruction. It can occur as a result of the following causes: 
i) Internal obstruction (in the wall or the lumen) such as due to: 
• inflammatory strictures (e.g. crohn's disease), 
• congenital stenosis, atresia, imperforate anus, 
• tumours, 
• meconium in mucoviscidosis, 
• roundworms, 
• gallstones, faecoliths, foreign bodies, 
• ulceration induced by potassium chloride tablets prescribed to coun- 
ter hypokalaemia. 
ii) External compression such as from: 
• peritoneal adhesions and bands, 
• strangulated hernias, 
• intussusception, 
• volvulus, 
• intra-abdominal tumour. 
2. Neurogenic obstruction. It occurs due to paralytic ileus i.e. paraly- 
sis of muscularis of the intestine as a result of shock after abdominal opera- 
tion or by acute peritonitis. 
3. Vascular obstruction. Obstruction of the superior mesenteric artery 
or its branches may result in infarction causing paralysis. The causes are throm- 
bosis, embolism, accidental ligation. 
Out of the various causes listed above, conditions producing external 
compression on the bowel wall are the most common cause of intestinal ob- 
struction (80%). Some of these are described below. 
Peritoneal Adhesions and Bands 
Adhesions and bands in the peritoneum composed of fibrous tissue result 
following healing in peritonitis. Rarely, such fibrous adhesions and bands may 
be without any preceding peritoneal inflammation and are of congenital origin. 
In either case, peritoneal bands and adhesions result in partial or complete intes- 
tinal obstruction by outside pressure on the bowel wall. 
Hernias 
Hernia is protrusion of portion of a viscus through an abnormal open- 
ing in the wall of its natural cavity. 
• External hernia is the protrusion of the bowel through a defect or 




• Internal hernia is the term applied for herniation that does not pre- 
sent on the external surface. 
Two major factors involved in the formation of a hernia are: 
i) Local weakness which may be congenital e.g. at the umbilicus, in- 
guinal and femoral canals, and in surgical scars called 'incisional hernia'. 
ii) Increased intra-abdominal pressure that is produced by coughing, 
straining and exertion. 
Inguinal hernias are more common, followed in decreasing frequency, 
by femoral and umbilical hernias. Inguinal hernias may be: 
• Direct when hernia passes medial to the inferior epigastric artery and 
it appears through the external abdominal ring; and 
• Indirect when it follows the inguinal canal lateral to the inferior epi- 
gastric artery. 
When the contents of hernia such as loop of intestine can be returned to 
the abdominal cavity, it is called reducible. When it is not possible to reduce 
hernia due to large contents or due to adhesions in the hernial sac, it is re- 
ferred to as irreducible. 
When the blood flow in the hernial sac is obstructed, it results in stran- 
gulated hernia. Obstruction to the venous drainage and arterial supply may 
result in infarction or gangrene of the affected loop of intestine. The gross 
and microscopic appearance of strangulated intestine is the same as that of 
infarction of intestine. 
Intussusception 
Intussusception is the telescoping of a segment of intestine into the 
segment below due to peristalsis. The telescoped segment is called the intus- 
susceptum and lower receiving segment is called the intussuscipiens. The 
condition occurs more commonly in infants and young children, more often 
in the ileocaecal region when the portion of ileum invaginates into the as- 
cending colon without affecting the position of the ileocaecal valve. Less 
common forms are ileo-ileal and colo-colic intussusception. 
In children, the cause is usually not known though enlargement of the 
lymphoid tissue in the terminal ileum has been suggested by some. In the 
case of adults, the usual causes are foreign bodies and tumours. 
The main complications of intussusception are intestinal obstruction, 
infarction, gangrene, perforation and peritonitis. 
Volvulus 
Volvulus is the twisting of loop of intestine upon itself through 180° or 
more. This leads to obstruction of the intestine as well as cutting off of the 
blood supply to the affected loop. The usual causes are bands and adhesions 
(congenital or acquired) and long mesenteric attachment. The condition is 






The liver is the largest organ in the body weighing 1400-1600 gm in the males and 
1200-1400 gm in the females. There are 2 main anatomical lobes – right and left, the right 
being about six times the size of the left lobe. The right lobe has quadrate lobe on its infe- 
rior surface and a caudate lobe on the posterior surface. The right and left lobes are sepa- 
rated anteriorly by a fold of peritoneum called the falciform ligament, inferiorly by the fis- 
sure for the ligamentum teres, and posteriorly by the fissure for the ligamentum venosum. 
The port a hepatis is the region on the inferior surface of the right lobe where 
blood vessels, lymphatics and common hepatic duct form the hilum of the liver. A firm 
smooth layer of connective tissue called Glisson's capsule encloses the liver and is contin- 
uous with the connective tissue of the porta hepatis forming a sheath around the structures 
in the porta hepatis. The liver has a double blood supply – the portal vein brings the ve- 
nous blood from the intestines and spleen, and the hepatic artery coming from the coeliac 
axis supplies arterial blood to the liver. This dual blood supply provides sufficient protec- 
tion against infarction in the liver. 
The portal vein and hepatic artery divide into branches to the right and left lobes in 
the porta. The right and left hepatic ducts also join in the porta to form the common hepat- 
ic duct. The venous drainage from the liver is into the right and left hepatic veins which 
enter the inferior vena cava. Lymphatics and the nerve fibres accompany the hepatic artery 
into their branchings and terminate around the porta hepatis. 
The hepatic parenchyma is composed of numerous hexagonal or pyramidal classi- 
cal lobules; each with a diameter of 0.5 to 2 mm. Each classical lobule has a central tribu- 
tary from the hepatic vein and at the periphery are 4 to 5 portal tracts or triads containing 
branches of bile duct, portal vein and hepatic artery. Cords of hepatocytes and blood- 
containing sinusoids radiate from the central vein to the peripheral portal triads. The func- 
tioning lobule or liver acinus as described by Rappaport has a portal triad in the centre and 
is surrounded at the periphery by portions of several classical lobules. However, in most 
descriptions on pathology of the liver, the term lobule is used in its classical form. 
The blood supply to the liver parenchyma flows from the portal triads to the cen- 
tral veins. Accordingly, the hepatic parenchyma of liver lobule is divided into 3 zones: 
   Zone 1 or the periportal (peripheral) area is closest to the arterial and portal 
blood supply and hence bears the brunt of all forms of toxic injury. 
   Zone 3 or the centrilobular area surrounds the central vein and is most remote 
from the blood supply and thus suffers from the effects of hypoxic injury. 
   Zone 2 is the intermediate midzonal area. 
The hepatocytes are polygonal cells with a round single nucleus and a prominent nu- 
cleolus. The liver cells have a remarkable capability to undergo mitosis and regeneration. Thus it 
is not uncommon to find liver cells containing more than one nuclei and having polyploidy up to 
octoploidy. A hepatocyte has 3 surfaces: one facing the sinusoid and space of Disse, the second 
facing the canaliculus, and the third facing neighbouring hepatocytes. 
The blood-containing sinusoids between cords of hepatocytes are lined by discontinuous 
endothelial cells and scattered flat Kupffer cells belonging to the reticuloendothelial system. 
The space of Disse is the space between hepatocytes and sinusoidal lining endothe- 
lial cells. A few scattered fat storing Ito cells lie within the space of Disse. 
The portal triad or tract besides containing portal vein radicle, the hepatic arteriole and 
bile duct, has a few mononuclear cells and a little connective tissue considered to be extension of 
Glisson's capsule. The portal triads are surrounded by a limiting plate of hepatocytes. 
The intrahepatic biliary system begins with the bile canaliculi interposed between 




The bile canaliculi are simply grooves between the contact surfaces of the liver 
cells and are covered by microvilli. These canaliculi join at the periphery of the lobule to 




Jaundice or icterus refers to the yellow pigmentation of the skin or 
sclerae by bilirubin. Bilirubin pigment has high affinity for elastic tissue and 
hence jaundice is particularly noticeable in tissues rich in elastin content. 
Jaundice is the result of elevated levels of bilirubin in the blood termed hy- 
perbilirubinaemia. Normal serum bilirubin concentration ranges from 0.2-0.8 
mg/ dl, about 80% of which is unconjugated. Jaundice becomes clinically ev- 
ident when the total serum bilirubin exceeds 2 mg/dl. A rise of serum biliru- 
bin between the normal and 2 mg/dl is generally not accompanied by visible 
jaundice and is called latent jaundice. 
Before considering the features and types of jaundice, it is essential to 
review the normal bilirubin metabolism. 
Classification and features of jaundice 
Based on pathophysiology, jaundice may result from one or more of 
the following mechanisms: 
1. Increased bilirubin production, 
2. Decreased hepatic uptake, 
3. Decreased hepatic conjugation, 
4. Decreased excretion of bilirubin into bile Accordingly, a simple 
classification of jaundice is into 3 predominant types: pre-hepatic (haemolyt- 
ic), hepatic, and post-hepatic cholestatic. Hyperbilirubinaemia due to first 
three mechanisms is mainly unconjugated while the last variety yields mainly 
conjugated hyperbilirubinaemia. A simple test to determine whether hyper- 
bilirubinaemia is of unconjugated or conjugated variety is to determine whether 
bilirubin is present in urine or not; its absence in urine suggests unconjugated 
hyperbilirubinaemia since unconjugated bilirubin is not filtered by the glomeru- 
lus. The presence of bilirubin in the urine is evidence of conjugated hyperbiliru- 
binaemia. Based on these mechanisms, the pathogenesis and main features of 
the two predominant forms of hyperbilirubinaemia are discussed below. 
Predominantly Unconjugated Hyperbilirubinaemia 
This form of jaundice can result from the following three sets of condi- 
tions:  
1. Increased Bilirubin Production (Haemolytic, Acholuric Or Pre- 
hepatic Jaundice). This results from excessive red cell destruction as occurs 
in intra- and extravascular haemolysis or due to ineffective erythropoiesis. 




cells that leads to overproduction of bilirubin. Hyperbilirubinaemia develops 
when the capacity of the liver to conjugate large amount of bilirubin is ex- 
ceeded. In premature infants, the liver is deficient in enzyme necessary for 
conjugation while the rate of red cell destruction is high. This results in icter- 
us neonatorum which is particularly severe in haemolytic disease of the new- 
born due to maternal isoantibodies. Since there is predominantly unconjugat- 
ed hyperbilirubinaemia in such cases, there is danger of permanent brain 
damage in these infants when the serum level of unconjugated bilirubin ex- 
ceeds 15 mg/dl. 
Laboratory data in haemolytic jaundice, in addition to predominant un- 
conjugated hyperbilirubinaemia, reveal normal serum levels of transaminas- 
es, alkaline phosphatase and proteins. Bile pigment being unconjugated type 
is absent from urine (acholuric jaundice). However, there is dark brown col- 
our of stools due to excessive faecal excretion of bile pigment and increased 
urinary excretion of urobilinogen. 
2. Decreased Hepatic Uptake. The uptake of bilirubin by the hepato- 
cyte that involves dissociation of the pigment from albumin and its binding to 
cytoplasmic protein, ligandin, may be deranged in certain conditions e.g. due 
to drugs, prolonged starvation and sepsis. 
3. Decreased Bilirubin Conjugation. This mechanism involves de- 
ranged hepatic conjugation due to defect or deficiency of the enzyme, glucu- 
ronosyl transferase. This can occur in certain inherited disorders of the en- 
zyme (e.g. Gilbert's syndrome and Crigler-Najjar syndrome), or acquired de- 
fects in its activity (e.g. due to drugs, hepatitis, cirrhosis). However, hepato- 
cellular damage causes deranged excretory capacity of the liver more than its 
conjugating capacity (see below). The physiologic neonatal jaundice is also 
partly due to relative deficiency of UDP-glucuronosyl transferase in the neonatal 
liver and is partly as a result of increased rate of red cell destruction in neonates. 
II. Predominantly Conjugated Hyperbilirubinaemia (Cholestasis) 
This form of hyperbilirubinaemia is defined as failure of normal 
amounts of bile to reach the duodenum. Morphologically, cholestasis means 
accumulation of bile in liver cells and biliary passages. The defect in excre- 
tion may be within the biliary canaliculi of the hepatocyte and in the micro- 
scopic bile ducts (intrahepatic cholestasis or medical jaundice), or there may 
be mechanical obstruction to the extrahepatic biliary excretory apparatus (ex- 
trahepatic cholestasis or obstructive jaundice). It is important to distinguish 
these two forms of cholestasis since extrahepatic cholestasis or obstructive 
jaundice is often treatable with surgery, whereas the intrahepatic cholestasis 
or medical jaundice cannot be benefitted by surgery but may in fact worsen 
by the operation. Prolonged cholestasis of either of the two types may pro- 




1. Intrahepatic Cholestasis. Intrahepatic cholestasis is due to im- 
paired hepatic excretion of bile and may occur from hereditary or acquired 
disorders. 
i) Hereditary disorders producing intrahepatic obstruction to biliary ex- 
cretion are characterised by 'pure cholestasis' e.g. in Dubin-Johnson syn- 
drome, Rotor syndrome, fibrocystic disease of pancreas, benign familial re- 
current cholestasis, intrahepatic atresia and cholestatic jaundice of pregnancy. 
ii) Acquired disorders with intrahepatic excretory defect of bilirubin 
are largely due to hepatocellular diseases and hence are termed 'hepatocellu- 
lar cholestasis' e.g. in viral hepatitis, alcoholic hepatitis, and drug-induced cho- 
lestasis such as from administration of chlorpromazine and oral contraceptives. 
The features of intrahepatic cholestasis include: predominant conjugated 
hyperbilirubinaemia due to regurgitation of conjugated bilirubin into blood, bili- 
rubinuria, elevated levels of serum bile acids and consequent pruritus, elevated 
serum alkaline phosphatase, hyperlipidaemia and hypoprothrombinaemia. 'Pure 
cholestasis' can be distinguished from 'hepatocellular cholestasis' by elevated 
serum levels of transaminases in the latter due to liver cell injury. 
Liver biopsy in cases with intrahepatic cholestasis reveals milder degree of 
cholestasis than the extra-hepatic disorders. The biliary canaliculi of the hepato- 
cytes are dilated and contain characteristic elongated green-brown bile plugs. The 
cytoplasm of the affected hepatocytes shows feathery degeneration. Canalicular 
bile stasis eventually causes proliferation of intralobular ductules followed by 
periportal fibrosis and produces a picture resembling biliary cirrhosis. 
2. Extrahepatic Cholestasis. Extrahepatic cholestasis results from 
mechanical obstruction to large bile ducts outside the liver or within the porta 
hepatis. The common causes are gallstones, inflammatory strictures, carci- 
noma head of pancreas, tumours of bile duct, sclerosing cholangitis and con- 
genital atresia of extrahepatic ducts. The obstruction may be complete and 
sudden with eventual progressive obstructive jaundice, or the obstruction 
may be partial and incomplete resulting in intermittent jaundice. 
The features of extrahepatic cholestasis (obstructive jaundice), like in 
intrahepatic cholestasis, are predominant conjugated hyperbilirubinaemia, bili- 
rubinuria, elevated serum bile acids causing intense pruritus, high serum alka- 
line phosphatase and hyperlipidaemia. However, there are certain features which 
help to distinguish extrahepatic from intrahepatic cholestasis. In obstructive 
jaundice, there is malabsorption of fat-soluble vitamins (A, D, E and K) and ste- 
atorrhoea resulting in vitamin K deficiency. Prolonged prothrombin time in such 
cases shows improvement following parenteral administration of vitamin K, 
whereas hypo-prothrombinemia due to hepatocellular disease shows no such 
improvement in prothrombin time with vitamin K administration. The stools of 




in, in faeces and there is virtual disappearance of urobilinogen from the urine. 
These patients may have fever due to high incidence of ascending bacterial in- 
fections (ascending cholangitis). 
Liver biopsy in cases with extrahepatic cholestasis shows more 
marked changes of cholestasis. Since the obstruction is in the extrahepatic 
bile ducts, there is progressive retrograde extension of bile stasis into intrahe- 
patic duct system. This results in dilatation of bile ducts and rupture of cana- 
liculi with extravasation of bile producing bile lakes. Since bile is toxic, the 
regions of bile lakes are surrounded by focal necrosis of hepatocytes. Stasis of 
bile predisposes to ascending bacterial infections with accumulation of poly- 
morphs around the dilated ducts (ascending cholangitis). Eventually, there is 
proliferation of bile ducts and the appearance may mimic biliary cirrhosis. 
NEONATAL JAUNDICE 
Jaundice appears in neonates when the total serum bilirubin is more 
than 3 mg/dl. It may be the result of unconjugated or conjugated hyperbiliru- 
binaemia; the former being more common. Important causes of neonatal 
jaundice. Some of these conditions are considered below, while others are 
discussed elsewhere in the relevant sections. 
HEREDITARY NON-HAEMOLYTIC HYPERBILIRUBINAEMIAS 
Hereditary non-haemolytic hyperbilirubinaemias are a small group of 
uncommon familial disorders of bilirubin metabolism when haemolytic caus- 
es have been excluded. The commonest is Gilbert's syndrome; others are 
Crigler-Najjar syndrome, Dubin-Johnson syndrome, Rotor's syndrome and 
benign familial recurrent cholestasis. The features common to all these condi- 
tions are presence of icterus but almost normal liver function tests and no 
well-defined morphologic changes except in Dubin-Johnson syndrome. Gil- 
bert's syndrome and Crigler-Najjar syndrome are examples of liereditary 
non-haemolytic unconjugated hyperbilirubinaemia, whereas Dubin-Johnson 
syndrome, Rotor's syndrome and benign familial recurrent cholestasis are 
conditions with hereditary conjugated hyperbilirubinaemia. 
Gilbert's Syndrome 
This is the commonest of the familial, genetically-determined diseases 
of the liver affecting 2-5% of the population. Gilbert's syndrome is character- 
ised by mild, benign, unconjugated hyperbilirubinaemia (serum bilirubin 1-5 
mg/dl) which is not due to haemolysis. The condition is inherited as an auto- 
somal dominant character. The defect in bilirubin metabolism is complex and 
appears to be reduced activity of UDP-glucuronosyl transferase with de- 
creased conjugation, or an impaired hepatic uptake of bilirubin. The jaundice 
is usually mild and intermittent. There are no morphologic abnormalities in 




cytes. The prognosis of patients with Gilbert's syndrome is excellent, though 
chronic jaundice persists throughout life. 
Crigler-Najjar Syndrome 
Crigler-Najjar syndrome is a rare form of familial non-haemolytic 
jaundice with very high unconjugated hyperbilirubinaemia. There are  2 
forms of this condition: type I and type II. 
Type I Crigler-Najjar syndrome. This is inherited as an autosomal re- 
cessive disorder. There is complete absence of conjugating enzyme UDP- 
glucuronosyl transferase in the hepatocytes and hence no conjugated bilirubin 
is formed. There is extreme elevation of unconjugated bilirubin (usually more 
than 20 mg/dl) with high risk of developing permanent CNS damage from 
kernicterus. The prognosis is generally fatal, with death coming from kernic- 
terus usually in the first year of life. There are no significant morphologic 
changes except some canalicular stasis. 
Type II Crigler-Najjar syndrome. This is inherited as an autosomal 
dominant disease. There is deficiency of enzyme UDP-glucuronosyl transfer- 
ase but not complete absence. Thus, unconjugated hyperbilirubinaemia is 
generally mild to moderate (usually less than 20 mg/dl). Occurrence of ker- 
nicterus is exceptional and patients respond well to phenobarbital therapy. 
There are no morphologic changes in the liver. 
Dubin-Johnson Syndrome 
Dubin-Johnson syndrome is autosomal recessive disorder characterised 
by predominant conjugated hyperbilirubinaemia (usually less than 5 mg/dl) 
with genetic defect in canalicular excretion of conjugated bilirubin. The condi- 
tion differs from other forms of hereditary hyperbilirubinaemias in producing 
grossly greenish-black pigmented liver. The hepatocytes show dark-brown, 
melanin-like pigment in the cytoplasm, the exact nature of which is obscure but 
it is neither iron nor bile. Unrelated viral hepatitis mobilises the hepatic pigment 
of Dubin-Johnson syndrome leading to its excretion in urine but the pigment re- 
appears after recovery from viral hepatitis. A prolonged BSP dye excretion test 
is diagnostic of Dubin-Johnson syndrome. The disease runs a benign course and 
does not interfere with life. 
Rotor's Syndrome 
This is another form of familial conjugated hyperbilirubinaemia with 
mild chronic jaundice but differs from Dubin-Johnson syndrome in having no 
brown pigment in the liver cells. The disease is inherited as an autosomal re- 
cessive character. Rotor's syndrome has an excellent prognosis. 
 
NEONATAL HEPATITIS 
Neonatal hepatitis, also termed giant cell hepatitis or neonatal hepato- 




change seen in conjugated hyperbilirubinaemia as a result of known infec- 
tious and metabolic causes may have an idiopathic etiology. The 'idiopathic' 
neonatal hepatitis is more common and accounts for 75% of cases. Though 
all the cases with either known etiologies or idiopathic type are grouped to- 
gether under neonatal hepatitis, all of them are not necessarily inflammatory 
conditions, thus belying their nomenclature as 'hepatitis'. The condition usu- 
ally presents in the first week of birth with jaundice, bilirubinuria, pale stools 
and high serum alkaline phosphatase. 
Pathologic changes. Irrespective of the etiology, there is morphologic 
similarity in all these cases. The histologic features are: 
1. Loss of normal lobular architecture of the liver. 
2. Presence of prominent multinucleate giant cells derived from 
hepatocytes. 
3. Mononuclear inflammatory cell infiltrate in the portal tracts with 
some periportal fibrosis. 
4. Haemosiderosis. 
5. Cholestasis in small proliferated ductules in the portal tract and be- 
tween necrotic liver cells. 
 
BILIARY ATRESIAS 
Biliary atresias, also called as infantile cholangiopathies, are a group 
of intrauterine developmental abnormalities of the biliary system. Though 
they are often classified as congenital, the abnormality of development in 
most instances is extraneous infection during the intrauterine development or 
shortly after birth that brings about inflammatory destruction of the bile 
ducts. The condition may, therefore, have various grades of destruction rang- 
ing from complete absence of bile ducts termed atresia, to reduction in their 
number called paucity of bile ducts. 
Depending upon the portion of biliary system involved, biliary atresias 
may be extrahepatic or intrahepatic. 
Extrahepatic Biliary Atresia 
The extrahepatic bile ducts fail to develop normally so that in some 
cases the bile ducts are absent at birth, while in others the ducts may have 
been formed but start undergoing sclerosis in the perinatal period. It is com- 
mon to have multiple defects and other congenital lesions. Extrahepatic bili- 
ary atresia is found in 1 per 10,000 livebirths. Cholestatic jaundice appears by 
the first week after birth. The baby has severe pruritus, pale stools, dark urine 
and elevated serum transa-minases. In some cases, the condition is correctable 
by surgery, while in vast majority the atresia is not correctable and in such cases 
hepatic portoenterostomy (Kasai procedure) or hepatic transplantation must be 




bleeding due to vitamin K deficiency or oesophageal varices. Cirrhosis and asci- 
tes are late complications appearing within 2 years of age. 
Pathologic changes. Grossly, the liver is enlarged and dark green. The 
atretic segments of biliary system are reduced to cord-like structures. Histo- 
logically, the condition must be distinguished from idiopathic neonatal hepa- 
titis as surgical treatment is possible in extrahepatic biliary atresia but not in 
the latter. Besides, the α-l antitrypsin deficiency also produces similar ap- 
pearance in liver biopsy. The main histologic features are: 
1. Inflammation and fibrous obliteration of the extrahepatic ducts with 
absence of bile in them. 
2. Ductular proliferation and periductular inflammation. 
3. Cholestasis and bile thrombi in the portal area. 
4. Periportal fibrosis and later secondary biliary cirrhosis (page 606). 
5. Transformation of hepatic parenchyma to neonatal (giant cell) hepa- 
titis in 15% of cases. 
Intrahepatic Biliary Atresia 
Intrahepatic biliary atresia is characterised by biliary hypoplasia so that 
there is paucity of bile ducts rather than their complete absence. The condi- 
tion probably has its origin in viral infection acquired during intra-uterine pe- 
riod or in the neonatal period. Cholestatic jaundice usually appears within the 
first few days of birth and is characterised by high serum bile acids with as- 
sociated pruritus, and hypercholesterolaemia with appearance of xanthomas 
by first year of life. Hepatic as well as urinary copper concentrations are ele- 
vated. In some cases, intrahepatic biliary atresia is related to α-1-antitrypsin 
deficiency. 
Pathologic changes. The microscopic features are: 
1. Paucity of intrahepatic bile ducts. 
2. Cholestasis. 
3. Increased hepatic copper. 




Reye's syndrome is defined as an acute postviral syndrome of encepha- 
lopathy and fatty change in the viscera. The syndrome may follow almost any 
known viral disease but is most common after influenza A or B and varicella. 
Viral infection may act singly, or more often its effect is modified by certain 
exogenous factors such as by administration of salicylates, aflatoxins and in- 
secticides. These effects cause mitochondrial injury and decreased activity of 
mitochondrial enzymes in the liver. This eventually leads to rise in blood 




are generally children between 6 months and 15 years of age. Within a week 
after a viral illness, the child develops intractable vomiting and progressive 
neurological deterioration due to encephalopathy, eventually leading to stu- 
por, coma and death. Characteristic laboratory findings are elevated blood 
ammonia, serum transaminases, bilirubin and prolonged prothrombin time. 
Pathologic changes. Grossly, the liver is enlarged and yellowish- 
orange. Microscopically, the hepatocytes show small droplets of neutral fat in 
their cytoplasm (microvesicular fat). Similar fatty change is seen in the renal 
tubular epithelium and in the cells of skeletal muscles and heart. The brain 
shows oedema and sometimes focal necrosis of neurons. 
HEPATIC FAILURE 
Though the liver has a marked regenerative capacity and a large func- 
tional reserve, hepatic failure may develop from severe acute and fulminant 
liver injury with massive necrosis of liver cells (acute hepatic failure), or 
from advanced chronic liver disease (chronic hepatic failure). Acute hepatic 
failure develops suddenly with severe impairment of liver functions whereas 
chronic liver failure comes insidiously. The prognosis is much worse in acute 
hepatic failure than that in chronic liver failure. 
Etiology. The two types of hepatic failure result from different causes: 
• Acute (fulminant) hepatic failure occurs most frequently in severe 
viral hepatitis. Other causes are hepatotoxic drug reactions (e.g. anaesthetic 
agents, nonsteroidal anti-inflammatory drugs, antidepressants), carbon tetra- 
chloride poisoning, acute alcoholic hepatitis, mushroom poisoning and preg- 
nancy complicated with eclampsia. 
• Chronic hepatic failure is most often due to cirrhosis. Other causes 
include chronic active hepatitis, chronic cholestasis (cholestatic jaundice) and 
Wilson's disease. 
Manifestations. In view of the diverse functions performed by the liver, 
the syndrome of acute or chronic hepatic failure produces complex manifes- 
tations. The major manifestations are briefly discussed below. 
1. Jaundice. Jaundice usually reflects the severity of liver cell damage 
since it occurs due to failure of liver cells to metabolise bilirubin. In acute 
failure such as in viral hepatitis, jaundice nearly parallels the extent of liver 
cell damage, while in chronic failure such as in cirrhosis jaundice appears 
late and is usually of mild degree. 
2. Hepatic encephalopathy (Hepatic coma). Neuro-psychiatric syn- 
drome may complicate liver disease of both acute and chronic types. The fea- 
tures include disturbed consciousness, personality changes, intellectual dete- 
rioration, low slurred speech, flapping tremors, and finally, coma and death. 




toxic products not metabolised by diseased liver. The toxic products may be 
ammonia and other nitrogenous substances from intestinal bacteria which 
reach the systemic circulation without detoxification in the damaged liver and 
thus damage the brain. Advanced cases of hepatic coma have poor prognosis 
but may respond favourably to hepatic transplantation. 
3. Hyperkinetic circulation. All forms of hepatic failure are associat- 
ed with a hyperkinetic circulation characterised by peripheral vasodilatation, 
increased splanchnic blood flow and increased cardiac output. There is in- 
creased splenic flow but reduced renal blood flow resulting in impaired renal 
cortical perfusion. These changes result in tachycardia, low blood pressure 
and reduced renal function. 
4. Hepatorenal syndrome. The hepatorenal syndrome is a complication 
of both acute and chronic hepatic failure in which acute renal failure occurs 
in the absence of clinical, laboratory or morphologic evidence of other causes 
of renal dysfunction. The acute renal failure is usually associated with oligu- 
ria and uraemia but with good tubular function. The histology of kidney is 
virtually normal, suggesting functional defect for the renal failure. The path- 
ogenesis of the syndrome is unclear but appears to be initiated by effective 
reduction of the renal blood flow (effective hypovolaemia) as a consequence 
of systemic vasodilatation and pooling of blood in portal circulation. The re- 
nal failure in the hepatorenal syndrome is reversible with improvement in he- 
patic function. 
Diagnosis of hepatorenal syndrome should be made only after exclud- 
ing other causes producing concomitant damage to both the organs, circulato- 
ry failure leading to acute tubular necrosis and other forms of reversible tubu- 
lar damage. 
5. Hepatopulmonary syndrome. The pulmonary changes in chronic he- 
patic failure such as in cirrhosis consist of pulmonary vasodilatation with in- 
trapulmonary arteriovenous shunting. This results in ventilation-perfusion in- 
equality that may lead to impaired pulmonary function, clubbing of fingers 
and sometimes cyanosis. 
6. Coagulation defects. Impaired synthesis of a number of coagulation 
factors by the diseased liver may result in coagulation disorders. These include 
disseminated intravascular coagulation (consumption coagulopathy), thrombo- 
cytopenia and presence of fibrin degradation products in the blood. 
7. Ascites and oedema. Chronic liver failure due to cirrhosis may result 
in portal hypertension and ascites. Decreased synthesis of albumin by the liv- 
er resulting in hypoproteinemia and consequent fall in plasma oncotic pres- 
sure, increased hydrostatic pressure due to portal hypertension and secondary 





8. Endocrine changes. Endocrine changes may be found in association 
with chronic hepatic failure. The changes are more common in alcoholic cir- 
rhosis in active reproductive life. In the male, the changes are towards femi- 
nisation such as gynaecomastia and hypogonadism. In the female, the chang- 
es are less towards masculinisation but atrophy of gonads and breasts occurs. 
The underlying mechanism appears to be changed end-organ sensitiveness to 
sex hormones in cirrhosis. 
9. Skin changes. In alcoholic cirrhosis 'arterial spiders' having radiat- 
ing small vessels from a central arteriole are frequent in the vascular region 
drained by superior vena cava such as in the neck, face, forearms and dorsum of 
hands. Less frequently, palmar erythema, especially in the hypothenar and thenar 
eminences and on the pulps of the fingers, is observed in chronic liver disease. 
10. Foetor hepaticus. A sweetish pungent smell of the breath is found 
in severe cases of acute and chronic hepatocellular diseases. It appears to be 
of intestinal origin, possibly due to failure of the liver to detoxify sulfur- 
containing substances absorbed from the gut. 
 
CIRCULATORY DISTURBANCES 
Vascular disorders of general nature involving the liver such as chronic 
passive congestion and infarction have already been discussed elsewhere. 
Hepatic and portal venous obstruction and hepatic arterial obstruction are 
considered here. 
1. Hepatic Venous Obstruction 
The central veins of lobules of the liver are tributaries of the hepatic 
veins. In the normal liver, there are no anastomoses between hepatic vein and 
portal vein but in cirrhotic liver there are such anastomoses. Normal pressure 
in the free hepatic vein is about 6 mmHg. 
Two uncommon diseases produced by obstruction of the hepatic veins 
are Budd-Chiari syndrome (hepatic vein thrombosis) and hepatic veno- 
occlusive disease. 
Budd-Chiari Syndrome (Hepatic Vein Thrombosis) 
Budd-Chiari syndrome in its pure form consists of slowly developing 
thrombosis of the hepatic veins and the adjacent inferior vena cava, while 
some workers include hepatic veno-occlusive disease in this syndrome. 
Etiology. The etiology of hepatic venous thrombosis in about a third of 
cases is unknown (idiopathic), while in the remaining cases various causes 
associated with increased thrombotic tendencies are attributed such as due to 
polycythaemia vera, paroxysmal nocturnal haemoglobinuria, oral contracep- 
tives, pregnancy, post-partum state, intra-abdominal cancers (e.g. hepato- 
cellular carcinoma), chemotherapy, radiation and myeloproliferative diseases. 




organised thrombosis, in the suprahepatic portion of inferior vena cava is an- 
other important cause. 
Pathologic changes. Grossly, the liver is enlarged, swollen, red-purple 
and has a tense capsule. 
Histologicallly, the changes in sudden hepatic vein occlusion are those 
of centrilobular congestion, necrosis and rupture of sinusoids into the space 
of Disse. In slowly developing thrombosis, the changes are more chronic and 
include fibrosing reaction in the centrilobular zone that may progress to car- 
diac cirrhosis. 
Clinical features. Budd-Chiari syndrome is clinically characterised by ei- 
ther an acute form or chronic form depending upon the speed of occlusion. 
• In the acute form, the features are abdominal pain, vomiting, enlarged 
liver, ascites and mild icterus. 
• In the more usual chronic form, the patients present with pain over 
enlarged tender liver, ascites and other features of portal hypertension. The 
acute form of illness leads to acute hepatic failure and death, whereas in 
chronic form the patient may live for months to a few years. 
Hepatic Veno-Occlusive Disease 
Hepatic veno-occlusive disease consists of intimal thickening, stenosis 
and obliteration of the terminal central veins and medium-sized hepatic veins. 
The venous occlusion results in pathologic changes similar to those of Budd- 
Chiari syndrome and can be distinguished from the latter by demonstration of 
absence of thrombosis in the major hepatic veins. 
The cause and stimulus for hepatic veno-occlusive disease are obscure. 
The condition is more widespread in countries such as Africa, India and cer- 
tain other tropical countries where 'bush tea' (medicinal tea) is consumed that 
contains hepatotoxic alkaloids. More recently, the disease has been found in 
association with administration of antineoplastic drugs and immuno- 
suppressive therapy. 
II. Portal Venous Obstruction 
Obstruction of the poral vein may occur within the intrahepatic course 
or in extrahepatic site. 
• Intrahepatic cause of portal venous occlusion is hepatic cirrhosis as 
the commonest and most important, followed in decreasing frequency by tu- 
mour invasion, congenital hepatic fibrosis and schistosomiasis. 
• Extrahepatic causes of portal vein obstruction are intra-abdominal 
cancers, intra-abdominal sepsis, direct invasion by tumour, myeloproliferative 
disorders and upper abdominal surgical procedure followed by thrombosis. 
The effects of portal venous obstruction depend upon the site of ob- 
struction. The most important effect, irrespective of the site of occlusion or 




extrahepatic portal vein along with extension of occlusion into splenic vein, it 
may result in venous infarction of the bowel. Pylephlebitis may be followed 
by multiple pyaemic liver abscesses. 
III. Hepatic Arterial Obstruction 
Diseases from obstruction of the hepatic artery are uncommon. Rarely, 
accidental ligation of the main hepatic artery or its branch to right lobe may 
be followed by fatal infarction. Obstruction of the small intrahepatic arterial 
banches usually does not produce any effects because of good collateral cir- 
culation. 
 
LIVER CELL NECROSIS 
All forms of injury to the liver such as microbiologic, toxic, circulatory 
or traumatic, result in necrosis of liver cells. The extent of involvement of 
hepatic lobule in necrosis varies. Accordingly, liver cell necrosis is divided 
into 3 types: diffuse (submassive to massive), zonal and focal 
1. Diffuse (Submassive To Massive) Necrosis. When there is exten- 
sive and diffuse necrosis of the liver involving all the cells in groups of lob- 
ules, it is termed diffuse, or submassive to massive necrosis. It is most com- 
monly caused by viral hepatitis or drug toxicity. 
2. Zonal Necrosis. Zonal necrosis is necrosis of hepatocytes in 3 dif- 
ferent zones of the hepatic lobule. Accordingly, it is of 3 types; each type af- 
fecting respective zone is caused by different etiologic factors: 
i) Centrilobular necrosis is the commonest type involving hepato- 
cytes in zone 3 (i.e. located around the central vein). Centrilobular necrosis is 
characteristic feature of ischaemic injury such as in shock and CHF since 
zone 3 is farthest from the blood supply. Besides, it also occurs in poisoning 
with chloroform, carbon tetra-chloride and certain drugs. 
ii) Midzonal necrosis is uncommon and involves zone 2 of the he- 
patic lobule. This pattern of necrosis is seen in yellow fever and viral hepati- 
tis. In viral hepatitis, some of the necrosed hepatocytes of the mid-zone are 
transformed into acidophilic, rounded Councilman bodies. 
iii) Periportal (peripheral) necrosis is seen in zone 1 involving 
the parenchyma closest to the arterial and portal blood supply. Since zone 1 is 
most well perfused, it is most vulnerable to the effects of circulating hepato- 
toxins e.g. in phosphorus poisoning and eclampsia. 
3. Focal necrosis. This form of necrosis involves small groups of 
hepatocytes irregularly distributed in the hepatic lobule. Focal necrosis is most 
often caused by microbiologic infections. These include viral hepatitis, miliary 
tuberculosis, typhoid fever and various other forms of bacterial, viral and fungal 




A group of liver diseases with dystrophy and necrosis of hepatocytes is 
termed hepatosis. It may be congenital and acquired (acute and chronic). 
Acute hepatosis, or toxic dystrophy of liver is characterized by pro- 
gressing massive liver necrosis and development of liver insufficiency. 
Etiology: 
1. Poisoning with food products (e.g. mushroom poisoning), 
2. Poisons (e.g phosphor), 
3. Auto intoxication (e.g. thyreotoxicosis), 
4. Severe forms of viral hepatitis. 
At 1st week in hepatocytes fat dystrophy develops. Then it leads to ne- 
crosis and autolysis of hepatocytes). Necrosis continues up to 2nd week of 
disease and effects all lobules of liver (stage of yellow dystrophy). In this 
stage fat – protein droplets are formed at the place of dead liver cells. On 3rd 
week the sizes of liver are more decreased and liver becomes red in color be- 
cause the necrotic debris formed after death of hepatocytes are resolved and 
inflammatory reaction with hyperrhemia of blood vessels develops in the 
stroma (stage of red dystrophy). 
These patients have: 
a) Jaundice due to increased level of bilirubin in the blood. 
b) Hemorrhagic syndrome due to deficiency of coagulation factors. 
c) Acute renal deficiency due to necrosis of tubular epithelium. 
d) Dystrophic changes in internal organs due to intoxication. 
The death occurs due to liver insufficiency. If patient remain alive then 
post necrotic liver cirrhosis develops. 
FAT HEPATOSIS, OR STEATOSIS, also called fatty change, is a chronic 
disease describing the abnormal retention of lipids within a hepatocytes or 
organ. When not further specified (such as cardiac steatosis), it is defined as 
affecting the liver. It reflects an impairment of the normal processes of syn- 
thesis and elimination of triglyceride fat. 
Etiology. 
1. Intoxication (alcohol, medicines). 
2. Impairment of metabolism (Diabetes mellitus, Cushing`s desease, 
hypothyreosis and other). 
3. Impaired diet (food contеinning more fats and carbohydrates). 
4. Hypoxia (anemias, circulatory disordes). 
Excess lipid accumulates in vesicles that displace the cytoplasm. Liver is 
increased in size with smooth surface and yellow or brown-red in color. Fat in- 
clusions are determined in hepatocytes. These inclusions may be present in sep- 
arate hepatocytes (disseminated obesity) or in group of hepatocytes (zonal obe- 




When the vesicles are large enough to distort the nucleus, the condition 
is known as macrovesicular steatosis; otherwise, the condition is known as 
microvesicular steatosis. While not particularly detrimental to the cell in mild 
cases, large accumulations can disrupt cell constituents, and in severe cases 
the cell may even burst. 
Stages of fat hepatosis: 
1. Simple obesity – there is accumulation of fat inclusions inside 
cells, but witout necrotic changes. 
2. Obesity with necrobiosis of hepatocytes and inflammatory reaction. 
3. Obesity with beginning of lobular structure damage. 
Lipid inclusions may lead to death of hepatocytes and formation of fat 
droplets located outside the cells with inflammatory reaction surrounding them. 
 
VIRAL HEPATITIS 
The term viral hepatitis is used to describe infection of the liver caused by 
hepatotropic viruses. Currently there are 5 main varieties of these viruses and a 
sixth poorly-characterised virus, causing distinct types of viral hepatitis: 
• Hepatitis A virus (HAV), causing a faecally-spread self-limiting disease; 
• Hepatitis B virus (HBV), causing a parenterally transmitted disease 
that may become chronic; 
• Hepatitis C virus (HCV), previously termed non-A, non-B (NANB) 
hepatitis virus involved chiefly in transfusion-related hepatitis; 
• Hepatitis delta virus (HDV) which is sometimes associated as super- 
infection with hepatitis B infection; 
• Hepatitis E virus (HEV), causing water-borne infection; and 
• Hepatitis G virus (HGV), has recently been discovered. 
All these human hepatitis viruses are RNA viruses except HBV which 
is a DNA virus. 
Though a number of other viral diseases such as infection with Ep- 
stein-Barr virus (in infectious mononucleosis), arbovirus (in yellow fever), 
cytomegalovirus, herpes simplex and several others affect the liver but the 
changes produced by them are nonspecific and the term Viral hepatitis' is 
strictly applied to infection of the liver by the hepatitis viruses. 
Etiologic classification. Based on the etiologic agent, viral hepatitis is 
currently classified into 6 etiologic types -hepatitis A, hepatitis B, hepatitis C, 
hepatitis D, hepatitis E and hepatitis G. 
HEPATITIS A 
Infection with HAV causes hepatitis A (infectious hepatitis). Hepatitis A 
is responsible for 20-25% of clinical hepatitis in the developing countries of the 
world but the incidence is much lower in the developed countries. Hepatitis A is 




days. The disease occurs in epidemic form as well as sporadically. It is usually 
spread by faeco-oral route. Parenteral transmission is extremely rare. The spread 
is related to close personal contact such as in overcrowding, poor hygiene and 
poor sanitation. Most frequently affected age is 5-14 years; adults are often in- 
fected by spread from children. 
HEPATITIS A VIRUS (HAV). The etiologic agent for hepatitis A, HAV, is 
a small, 27 nm diameter, icosahedral non-enveloped, single-stranded RNA 
virus. Viral genome has been characterised but only a single serotype has 
been identified. HAV infection can be transmitted to primates and the virus 
can be cultivated in vitro. Inactivation of viral activity can be achieved by 
boiling for 1 minute, by ultraviolet radiation on by contact with formaldehyde 
and chlorine. The virus is present in the liver cells, bile, stool and blood dur- 
ing the incubation period and in pre-icteric phase but viral shedding dimin- 
ishes after the onset of jaundice. Chronic carriers have not been identified for 
HAV infection. 
Pathogenesis. The mechanism by which HAV infection causes hepati- 
tis A is poorly understood. An immunologic basis is suspected but the evi- 
dence in support is indirect in the form of immunologic markers but not di- 
rect demonstration of the etiologic agent in the affected hepatocytes. These 
markers are: 
1. IgM anti-HAV antibody appears in the serum at the onset of symp- 
toms of acute hepatitis A. 
2. IgG anti-HAV antibody is detected in the serum after IgM antibody 
and gives life-long protective immunity against reinfection with HAV. 
HEPATITIS B 
Hepatitis B (serum hepatitis) caused by HBV infection has a longer in- 
cubation period (30-180 days) and is transmitted parenterally such as in re- 
cipients of blood and blood products, intravenous drug addicts, patients treat- 
ed by renal dialysis and hospital workers exposed to blood, and by intimate 
physical contact such as from mother to child and sexually. The disease may 
occur at any age. HBV infection causes more severe form of illness that in- 
cludes: acute hepatitis B, chronic hepatitis, progression to cirrhosis, fulminant 
hepatitis and an asymptomatic carrier stage. HBV plays some role in the de- 
velopment of hepatocellular carcinoma. 
HEPATITIS B VIRUS (HBV). The etiologic agent for hepatitis B, HBV, is 
a DNA virus which has been extensively studied. Electron microscopic stud- 
ies on serum of patients infected with HBV show 3 types of viral particles: 
small 20 nm spheres, tubules 20 nm in diameter and 100 nm long, and large 




and represent excess of viral surface coat protein (HBsAg), while Dane parti- 
cle is believed to represent the intact HBV. 
Dane particle is spherical with a diameter of 42 nm, partially single- 
stranded and partially double-stranded. It has an outer surface envelope of 
protein, carbohydrate and lipid and an inner hexagonal core measuring 27 nm 
in diameter and containing double-stranded DNA which is associated with 
DNA polymerase. The surface envelope of Dane particle (as also the small 
spheres and tubules present in the serum of HBV-infected individual) con- 
tains hepatitis B surface antigen (HBsAg) and its subtypes, whereas the inner 
core has hepatitis core antigen (HBcAg), and another antigen subunit of the 
core protein called 'e' (HBeAg). 
Pathogenesis. The evidence linking immunopathogenetic mechanism 
with hepatocellular damage is much stronger in HBV infection than with 
HAV infection. In support of immune pathogenesis are several immunologi- 
cal markers, cellular immunity (delayed hypersensitivity) and immune- 
complex mediated tissue injury, discussed below. 
I. Immunological markers. Various immunological markers indicative 
of presence of HBV infection can be demonstrated in the sera as well as in 
the hepatocytes of infected individuals. These are as under: 
1. HBsAg. In 1965, Blumberg and colleagues in Philadelphia found a 
lipoprotein complex in the serum of a multiple-transfused haemophiliac of 
Australian aborigine which was subsequently shown by them to be associated 
with serum hepatitis. This antigen was termed Australia antigen by them (in 
1977, Blumberg was awarded the Nobel prize for this discovery). Australia 
antigen is now used synonymous with hepatitis B surface antigen (HBsAg). 
HBsAg appears early in the blood after about 6 weeks of infection and its de- 
tection is an indicator of active HBV infection. It usually disappears in 3-6 
months. Its persistence for more than 6 months implies a carrier state. HBsAg 
may also be demonstrated in the cell membrane of hepatocytes of carriers and 
chronic hepatitis patients by Orcein staining (orange positivity) but not in the 
hepatocytes during acute stage of illness. 
2. Anti-HBs. Specific antibody to HBsAg in serum called anti-HBs 
appears late, about 3 months after the onset. Anti-HBs response may be both 
IgM and IgG type. The prevalence rate of anti-HBs ranges from 10-15%. In 
these individuals it persists for life providing protection against reinfection 
with HBV. 
3. HBeAg. HBeAg derived from core protein is present transiently (3-6 
weeks) during an acute attack. Its persistence beyond 10 weeks is indicative 




4. Anti-HBe. Antibody to HBeAg called anti-HBe appears after disap- 
pearance of HBeAg. Seroconversion from HBeAg to anti-HBe during acute 
stage of illness is a prognostic sign for resolution of infection. 
5. HBeAg. HBeAg derived from core protein cannot be detected in the 
blood. But HBeAg can be demonstrated in the nuclei of hepatocytes in carrier 
state and in chronic hepatitis patients by Orcein staining but not in the liver 
cells during acute stage. 
6. Anti-HBe. Antibody to HBeAg called anti-HBe can, however, be 
detected in the serum of acute hepatitis B patients during pre-icteric stage. 
Anti-HBe may be IgM or IgG class antibody. IgM anti-HBe persists for 4-6 
months and is followed later by IgG anti-HBe. Thus detection of high titre of 
IgM anti-HBe is indicative of recent acute HBV infection, while elevated 
level of IgG anti-HBe suggests HBV infection in the remote past. 
7. HBV-DNA. Detection of HBV-DNA by molecular hybridisation us- 
ing the Southern blot technique is the most sensitive index of hepatitis B in- 
fection. It is present in pre-symptomatic phase and transiently during early 
acute stage. 
II. Cellular Immunity (delayed hypersensitivity). There is increasing 
evidence to suggest that hepatocellular damage results from cell-mediated 
immune mechanism rather than direct cytopathic effect by the virus. These 
evidences are: 
1. Absence of hepatocellular damage in HBV-infected carrier state. 
2. Demonstration, of specifically-sensitised cytotoxic T-lymphocytes at 
the sites of hepatocellular injury. 
3. Patients with depressed cell-mediated immunity have high frequen- 
cy of progression from acute to chronic hepatitis. 
However, certain lacunae exist in the cell-mediated immune damage in 
HBV infection. These are explained by additional support from other influ- 
ences such as genetic factors, increased T cell activity by antibody-dependent 
cellular cytotoxicity (ADCC), and possibly concomitant infection with an- 
other hepatotropic virus i.e. delta virus. 
III. Immune-complex mediated mechanism. The formation of circu- 
lating immune complexes by combination of antigen (HBsAg) with antibody 
(anti-HBs) leads to activation of the complement system. This results in tis- 
sue damage which is the major pathogenetic mechanism for extrahepatic 
manifestations of HBV infection such as serum sickness-like syndrome, glo- 
merulonephritis and polyarteritis nodosa. 
HEPATITIS D 
Infection with delta virus (HDV) in the hepatocyte nuclei of HBsAg- 




HBV is the helper. Thus, hepatitis D develops when there is concomitant hepa- 
titis B infection. HDV infection and hepatitis B may be simultaneous (co- 
infection), or HDV may infect a chronic HBsAg carrier (superinfection). 
• With co-infection, acute hepatitis D may range from mild to fulmi- 
nant hepatitis but fulminant hepatitis is more likely in such simultaneous del- 
ta infection. Chronicity rarely develops in co-infection. 
• With super-infection, (incubation period 30-35 days), chronic HBV 
infection gets worsened indicated by appearance of severe and fulminant 
acute attacks, progression of carrier stage to chronic delta hepatitis or accel- 
eration towards cirrhosis. Hepatocellular carcinoma is, however, less com- 
mon in HBsAg carriers with HDV infection. 
HDV infection is worldwide in distribution though the incidence may 
vary in different countries. Endemic regions are Southern Europe, Middle- 
East, South India and parts of Africa. The high risk individuals for HDV in- 
fection are the same as for HBV infection i.e. intravenous drug abusers, ho- 
mosexuals, transfusion recipients, and health care workers. 
HEPATITIS DELTA VIRUS (HDV). The etiologic agent, HDV, is a small 
single-stranded RNA particle with a diameter of 36 nm. It is double-shelled – 
the outer shell consists of HBsAg and the inner shell consists of delta antigen 
provided by a circular RNA strand. It is highly infectious and can induce 
hepatitis in any HBsAg-positive host. HDV replication  and  proliferation 
takes place within the nuclei of liver cells. Markers for HDV infection in- 
clude the following: 
1. HDV identification in the blood and in the liver cell nuclei. 
2. HDAg detectable in the blood and on fixed liver tissue specimens. 
3. Anti-HD antibody in acute hepatitis which is initially IgM type and 
later replaced by IgG type anti-HD antibody which persists for life to confer 
immunity against reinfection. 
Pathogenesis. HDV, unlike HBV, is thought to cause direct cytopathic 
effect on hepatocytes. However, there are examples of transmission of HDV 
infection from individuals who themselves have not suffered from any attack 
of hepatitis, suggesting that it may not be always cytopathic. Thus, the exact 
mechanism remains unresolved. 
HEPATITIS C 
The diagnosis of a third major category of hepatitis was earlier made 
after exclusion of infection with other known hepatitis viruses and was des- 
ignated non-A, non-B (NANB) hepatitis. However, now this third type has 
been characterised and is called hepatitis C. 
Hepatitis C infection is acquired by blood transfusions, blood products, 




health workers. About 90% of post-transfusion hepatitis is of hepatitis C 
type. About 1-2% of volunteer blood donors and up to 5% of professional 
blood donors are carriers of HCV. Hepatitis C has an incubation period of 20- 
90 days (mean 50 days). Clinically, acute HCV hepatitis is milder than HBV 
hepatitis but HCV has a higher rate of progression to chronic hepatitis than 
HBV. Persistence of infection and chronic hepatitis are the key features of 
HCV. Occurrence of cirrhosis after 5 to 10 years and progression to hepatocellu- 
lar carcinoma are other consequences of HCV infection. Currently, HCV is con- 
sidered more important cause of chronic liver disease worldwide than HBV. 
HEPATITIS C VIRUS (HCV). HCV is a single-stranded, enveloped 
RNA virus, having a diameter of 30-60 nm. The serologic and virologic 
markers for HCV infection are as under: 
1. Anti-HCV antibodies. Three generations of anti-HCV IgG assays are 
available: 
i) Antibodies to C 100-3 region appear 1 to 3 months after infection, ii) 
Antibodies to C 33c region appear about one month earlier than the first gen- 
eration, iii) Antibodies to NS-5 region are detected even earlier. 
2. HCV-RNA. HCV infection is, however, confirmed by HCV-RNA 
employing PCR technique which can be detected within a few days after ex- 
posure to HCV infection, much before appearance of anti-HCV and persists 
for the duration of HCV infection. 
Pathogenesis. How HCV causes liver cell injury is not yet clearly es- 
tablished. HCV virions have not been identified in hepatocytes. Possibly, 
immunologic mechanism and cell destructive replication are both involved. 
In patients with chronic hepatitis C, HCV-specific CD4 + T cells and HLA- 
restricted CDS + T cells have been identified. 
HEPATITIS E 
Hepatitis E is an enterically-transmitted virus, previously labelled as 
epidemic or enterically transmitted type of non-A non-B hepatitis. The infec- 
tion occurs in young or middle-aged individuals, primarily in India, other 
Asian countries, Africa and central America. 
The infection is generally acquired by contamination of water supplies 
such as after monsoon flooding. However, compared with HAV, secondary 
person-to-person infection does not occur with HEV. Thus HEV has some 
common epidemiologic features with HAV. HEV infection has a particularly 
high mortality in pregnant women but is otherwise a self-limited disease and 
has not been associated with chronic liver disease. 
HEPATITIS E VIRUS (HEV). HEV is a single stranded 32-34 nm, icosa- 
hedral non-enveloped virus. The virus has been isolated from stools, bile and 




1. Anti-HEV antibodies of both IgM and IgG class. 
2. HEV-RNA. 
However, testing for these markers for HEV is currently not available. 
HEPATITIS G 
A virus distinct from the foregoing hepatitis viruses has been designat- 
ed separately by two groups of workers as hepatitis G (HGV) and hepatitis F 
(HFV) virus. Like HCV, HGV is a blood-borne infection and may cause 
acute and chronic viral hepatitis. 
HEPATITIS G VIRUS (HGV). HGV is a single-stranded RNA virus. At 
present HGV infection has been found in blood donors and is transmitted by 
blood transfusion. The virus has been identified by PCR amplification tech- 
nique but is yet to be fully characterised. 
CLINICOPATHOLOGIC SPECTRUM 
Of the various etiologic types of hepatitis, evidence linking HBV and 
HCV infection with the spectrum of clinicopathologic changes is stronger 
than with other hepatotropic viruses. The typical pathologic changes of hepa- 
titis by all hepatotropic viruses are virtually similar. HAV and HEV, howev- 
er, do not have a carrier stage or cause chronic hepatitis. The various clinical 
patterns and pathologic consequences of different hepatotropic viruses can be 
considered under the following headings: 
i) Carrier state, 
ii) Asymptomatic infection, 
iii) Acute hepatitis, 
iv) Chronic hepatitis, 
v) Fulminant hepatitis (Submassive to massive necrosis). 
In addition, progression to cirrhosis and association with hepatocellular 
carcinoma are known to occur in certain types of hepatitis which are dis- 
cussed separately later. 
1. Carrier State 
An asymptomatic individual without manifest disease, harbouring in- 
fection with hepatotropic virus and capable of transmitting it is called carrier 
state. There can be 2 types of carriers: 
1. An 'asymptomatic healthy carrier' who does not suffer from ill- 
effects of the virus infection. 
2. An 'asymptomatic carrier with chronic disease' capable of transmit- 
ting the organisms. 
As stated before, hepatitis A and E do not produce the carrier state. 
Hepatitis B is responsible for the largest number of carriers in the world, 
while concomitant infection with HDV more often causes progressive disease 




population are asymptomatic carriers of HCV. Data on HBV carrier state re- 
veal role of 2 important factors rendering the individual more vulnerable to 
harbour the organisms—early age at infection and impaired immunity. 
Whereas approximately 10% of adults contracting hepatitis B infection de- 
velop carrier state, 90% of infected neonates fail to clear HBsAg from the se- 
rum within 6 months and become HBV carriers. 
Clinical recognition of carrier state of HBV is more frequently done by 
detection of HBsAg in the serum and less often by other markers such as 
HBeAg, HBcAg and antibodies. Concomitant infection of HDV with HBV 
depends upon the demonstration of anti-HD. 
Pathologic changes. Carriers of HBV may or may not show changes 
on liver biopsy. 
• Healthy HBV carriers may show no changes or minor hepatic change 
such as presence of finely granular, ground-glass, eosinophilic cytoplasm as 
evidence of HBsAg. 
• Asymptomatic carriers with chronic disease may show changes of 
chronic hepatitis and even cirrhosis. 
II. Asymptomatic Infection 
These are cases which are detected incidentally to have infection with 
one of the hepatitis viruses as revealed by their raised serum transaminases or by 
detection of the presence of antibodies but are otherwise asymptomatic. 
III. Acute Hepatitis 
The most common consequence of all hepatotropic viruses is acute in- 
flammatory involvement of the entire liver. In general, type A, B, C, D and E 
run similar clinical course and show identical pathologic findings. Clinically, 
acute hepatitis is categorised into 4 phases: incubation period, pre-icteric 
phase, icteric phase and post-icteric phase. 
1. Incubation period: It varies among different hepatotropic viruses: 
for hepatitis A it is about 4 weeks (15-45 days); for hepatitis B the average is 
10 weeks (30-180 days); for hepatitis D about 6 weeks (30-50 days); for hep- 
atitis C the mean incubation period is about 7 weeks (42-56 days), and for 
hepatitis E it is 2-8 weeks (15-60 days). The patient remains asymptomatic 
during incubation period but the infectivity is highest during the last days of 
incubation period. 
2. Pre-icteric phase: This phase is marked by prodromal constitutional 
symptoms that include anorexia, nausea, vomiting, fatigue, malaise, distaste for 
smoking, arthralgia and headache. There may be low-grade fever preceding the 
onset of jaundice, especially in hepatitis A. The earliest laboratory evidence of 
hepatocellular injury in pre-icteric phase is the elevation of transaminases. 
3. Icteric phase: The prodromal period is heralded by the onset of clinical 




coloured urine due to bilirubinuria, clay-coloured stools due to cholestasis, pruri- 
tus as a result of elevated serum bile acids, loss of weight and abdominal discom- 
fort due to enlarged, tender liver. The diagnosis is based on deranged liver func- 
tion tests (e.g. elevated levels of serum bilirubin, transaminases and alkaline phos- 
phatase; prolonged prothrombin time and hyperglobulinaemia) and serologic de- 
tection of hepatitis antigens and antibodies. 
4. Post-icteric phase: The icteric phase lasting for about 1 to 4 weeks 
is usually followed by clinical and biochemical recovery in 2 to 12 weeks. 
The recovery phase is more prolonged in hepatitis B and hepatitis C. Up to 
1% cases of acute hepatitis may develop severe form of the disease (fulmi- 
nant hepatitis); and 5-10% of cases progress on to chronic hepatitis. Evolu- 
tion into the carrier state (except in HAV and HEV infection) has already 
been described above. 
Pathologic changes. Grossly, the liver is slightly enlarged, soft and 
greenish. Histologically, the changes are as follows: 
1. Hepatocellular injury: There may be variation in the degree of liv- 
er cell injury but it is most marked in zone 3 (centrilobular zone): 
i) Mildly injured hepatocytes appear swollen with granular cytoplasm 
which tends to condense around the nucleus (ballooning degeneration). 
ii) Others show acidophilic degeneration in which the cytoplasm be- 
comes intensely eosinophilic, the nucleus becomes small and pyknotic and is 
eventually extruded from the cell, leaving behind necrotic, acidophilic mass 
called Councilman body or acidophil body by the process known as apoptosis. 
iii) Another type of hepatocellular necrosis is dropout necrosis in 
which isolated or small clusters of hepatocytes undergo lysis. 
iv) Bridging necrosis is a more severe form of hepatocellular injury in 
acute viral hepatitis and may progress to fulminant hepatitis or chronic hepa- 
titis. Bridging necrosis is characterised by bands of necrosis linking portal 
tracts to central hepatic veins, one central hepatic vein to another, or a portal 
tract to another tract. 
2. Inflammatory infiltrate: There is infiltration by mononuclear in- 
flammatory cells, usually in the portal tracts, but may permeate into the lobules. 
3. Kupffer cell hyperplasia: There is reactive hyperplasia of Kupffer 
cells many of which contain phagocytosed cellular debris, bile pigment and 
lipofuscip. granules. 
4. Cholestasis: Biliary stasis is usually not severe in viral hepatitis and 
may be present as intracytoplasmic bile pigment granules. 
5. Regeneration: As a result of necrosis of hepatocytes, there is lobu- 
lar disarray. Surviving adjacent hepatocytes undergo regeneration and hyper- 
plasia. If the necrosis causes collapse of reticulin framework of the lobule, 




IV. Chronic Hepatitis 
Chronic hepatitis is defined as continuing or relapsing hepatic disease 
for more than 6 months with symptoms alongwith biochemical, serologic and 
histopathologic evidence of inflammation and necrosis. Majority of cases of 
chronic hepatitis are the result of infection with hepatotropic viruses – hepati- 
tis B, hepatitis C and combined hepatitis B and hepatitis D infection. Howev- 
er, some non-viral causes of chronic hepatitis include: Wilson's disease, α-1 
antitrypsin deficiency, chronic alcoholism, drug-induced injury and autoim- 
mune diseases. The last named gives rise to autoimmune or lupoid hepatitis 
which is characterised by positive serum autoantibodies (e.g. antinuclear, anti- 
smooth muscle and anti-mitochondrial) and a positive LE cell test but negative 
for serologic markers of viral hepatitis. 
Until recent years, prediction of prognosis of chronic hepatitis used to be 
made on the basis of morphology which divided it into 2 types – chronic persis- 
tent and chronic active (aggressive) hepatitis. However, subsequent studies have 
revealed that morphologic subtypes do not necessarily correlate with the prog- 
nosis since the disease is not essentially static but may vary from mild form to 
severe and vice versa. Besides, two other factors which determine the vulnera- 
bility of a patient of viral hepatitis to develop chronic hepatitis are: impaired 
immunity and extremes of age at which the infection is first contracted. 
Currently, chronic hepatitis is classified on the basis of etiology. The 
frequency and severity with which hepatotropic viruses cause chronic hepati- 
tis varies with the organisms as under: 
• HCV infection accounts for 40-60% cases of chronicity in adults. 
HCV infection is particularly associated with progressive form of chronic 
hepatitis that may evolve into cirrhosis. 
• HBV causes chronic hepatitis in 90% of infected infants and in about 
5% adult cases of hepatitis B. 
• HDV superinfection on HBV carrier state may be responsible for 
chronic hepatitis in 10-40% cases. 
• HAV and HEV do not produce chronic hepatitis. 
Pathologic changes. The pathologic features are common to  both 
HBV and HCV infection and include the following lesions. 
1. Piecemeal necrosis. Piecemeal necrosis is defined as periportal de- 
struction of hepatocytes at the limiting plate (piecemeal = piece by piece). Its 
features in chronic hepatitis are: 
i) Necrosed hepatocytes at the limiting plate in periportal zone. 
ii) Interface hepatitis due to expanded portal tract by infiltration of 
lymphocytes, plasma cells and macrophages. 
iii) Expanded portal tracts are often associated with proliferating bile 




2. Portal tract lesions. All forms of chronic hepatitis are characterised 
by variable degree of changes in the portal tract. 
i) Inflammatory cell infiltration by lymphocytes, plasma cells and mac- 
rophages (triaditis). 
ii) Proliferated bile ductules in the expanded portal tracts. 
iii) Additionally, chronic hepatitis C may show lymphoid aggregates or 
follicles with reactive germinal centre and infiltration of inflammatory cells 
in the damaged bile duct epithelial cells. 
3. Intralobular lesions. Generally, the architecture of lobule is re- 
tained in mild to moderate chronic hepatitis. 
i) There are focal areas of necrosis and inflammation within the hepatic 
parenchyma. 
ii) Scattered acidophilic bodies in the lobule. 
iii) Kupffer cell hyperplasia. 
iv) More severe form of injury shows bridging necrosis (i.e. bands of 
necrosed hepatocytes that may bridge portal tract-to-central vein, central 
vein-to-central vein, and portal tract-to-portal tract), 
v) Regenerative changes in hepatocytes in cases of persistent hepato- 
cellular necrosis, 
vi) Cases of chronic hepatitis C show moderate fatty change. 
vii) Cases of chronic hepatitis B show scattered ground-glass hepato- 
cytes indicative of abundance of HBsAg in the cytoplasm. 
4. Bridging fibrosis. The onset of fibrosis in chronic hepatitis from the 
area of interface hepatitis and bridging necrosis is a feature of irreversible 
damage, 
i) At first, there is periportal fibrosis at the sites of interface hepatitis 
giving the portal tract stellate-shaped appearance. 
ii) Progressive cases show bridging fibrosis connecting portal tract-to- 
portal tract or portal tract-to-central vein traversing the lobule, 
iii) End stage of chronic hepatitis is characterised by dense collagenous 
septa destroying lobular architecture and forming nodules resulting in post- 
necrotic cirrhosis. 
V. Fulminant Hepatitis (Submassive to Massive Necrosis) 
Fulminant hepatitis is the most severe form of acute hepatitis in which 
there is rapidly progressive hepatocellular failure. Two patterns are recog- 
nized – submassive necrosis having a less rapid course extending up to 3 
months; and massive necrosis in which the liver failure is rapid and fulminant 
occurring in 2-3 weeks. 
Fulminant hepatitis of either of the two varieties can occur from viral 




• Acute viral hepatitis accounts for about half the cases, most often 
from HBV and HCV; less frequently from combined HBV-HDV and rarely 
from HAV. However, HEV infection is a serious complication in pregnant 
women. In addition, herpesvirus can also cause serious viral hepatitis. 
• Non-viral causes include acute hepatitis due to drug toxicity (e.g. ac- 
etaminophen, non-steroidal anti-inflammatory drugs, isoniazid, halothane and 
anti-depressants), poisonings, hypoxic injury and massive infiltration of ma- 
lignant tumours into the liver. 
The patients present with features of hepatic failure with hepatic encepha- 
lopathy. The mortality rate is high if hepatic transplantation is not undertaken. 
Pathologic changes. Grossly, the liver is small and shrunken, often 
weighing 500-700 gm. The capsule is loose and wrinkled. The sectioned sur- 
face shows diffuse or random involvement of hepatic lobes. There are exten- 
sive areas of muddy-red and yellow necrosis (previously called acute yellow 
atrophy) and patches of green bile staining. Histologically, two forms of ful- 
minant necrosis are distinguished submassive and massive necrosis, 
i) In submassive necrosis, large groups of hepatocytes in zone 3 (cen- 
trilobular area) and zone 2 (mid zone) are wiped out leading to a collapsed 
reticulin framework. Regeneration in submassive necrosis is more orderly 
and may result in restoration of normal architecture. 
ii) In massive necrosis, the entire liver lobules are necrotic. As a result 
of loss of hepatic parenchyma, all that is left is the collapsed and condensed 
reticulin framework and portal tracts with proliferated bile ductules plugged 
with bile. Inflammatory infiltrate is scanty. Regeneration, if it takes place, is 
disorderly forming irregular masses of hepatocytes. Fibrosis is generally not 
a feature of fulminant hepatitis. 
OTHER INFECTIONS AND INFESTATIONS 
Apart from viral hepatitis, the liver is affected by infections with bacte- 
ria, spirochaetes and fungi and is involved in some parasitic infestations. 
Some common examples of such conditions are described below. 
 
CHOLANGITIS 
Cholangitis is the term used to describe inflammation of the extrahepatic 
or intrahepatic bile ducts, or both. There are two main types of cholangitis – py- 
ogenic and primary sclerosing. While primary sclerosing cholangitis is dis- 
cussed later with biliary cirrhosis, pyogenic cholangitis is described below. 
PYOGENIC CHOLANGITIS 
Cholangitis occurring secondary to obstruction of a major extrahepatic 
duct causes pyogenic cholangitis. Most commonly, the obstruction is from im- 




carcinoma head of pancreas, acute pancreatitis and inflammatory strictures in 
the bile duct. Bacteria gain entry to the obstructed duct and proliferate in the 
bile. Infection spreads along the branches of obstructed duct and reaches the liv- 
er, termed ascending cholangitis. The common infecting bacteria are enteric 
organisms such as E.coli, Klebsiella and Enterobacter. 
Pathologic changes. The affected ducts show serial beaded abscesses 
accompanied by bile stasis along their course and larger abscesses within the 
liver. The abscesses are composed of acute inflammatory cells which in time are 
replaced by chronic inflammatory cells and enclosed by fibrous capsule. 
 
PYOGENIC LIVER ABSCESS 
Most liver abscesses are of bacterial (pyogenic) origin; less often they are 
amoebic, hydatid and rarely actinomycotic. Pyogenic liver abscesses are becom- 
ing uncommon due to improved diagnostic facilities and the early use of antibiot- 
ics. However, their incidence is higher in old age and in immunosuppressed pa- 
tients such as in AIDS, transplant recipients and those on intensive chemotherapy. 
Pyogenic liver abscesses are classified on the basis of the mode of en- 
try. These are: 
1. Ascending cholangitis through ascending infection in the biliary 
tract due to obstruction e.g. gallstones, cancer, sclerosing cholangitis and bil- 
iary strictures. 
2. Portal pyaemia by means of spread of pelvic or gastrointestinal in- 
fection resulting in portal pylephlebitis or septic emboli e.g. from appendici- 
tis, empyema of gallbladder, diverticulitis, regional enteritis, pancreatitis, in- 
fected haemorrhoids and neonatal umbilical vein sepsis. 
3. Septicaemia through spread by hepatic artery. 
4. Direct infection resulting in solitary liver abscess e.g. from adjacent 
perinephric abscess, secondary infection in amoebic liver abscess, metastasis 
and formation of haematoma following trauma. 
5. Jatrogenic causes include liver biopsy, percutaneous biliary drain- 
age and accidental surgical trauma. 
6. Cryptogenic from unknown causes, especially in the elderly. 
The commonest infecting organisms are gram-negative bacteria chiefly 
E. coli; others are Pseudomonas, Klebsiella, Enterobacter and a number of 
anaerobic organisms, bacteroides and actinomyces. 
Liver abscesses are clinically characterised by pain in the right upper 
quadrant, fever, tender hepatomegaly and sometimes jaundice. Laboratory 
examination reveals leucocytosis, elevated serum alkaline phosphatase, hy- 
poalbuminaemia and a positive blood culture. 
Pathologic changes. Grossly depending upon the cause for pyogenic 




in diameter, in an enlarged liver. A single abscess generally has a thick fibrous 
capsule. The abscesses are particularly common in right lobe of the liver. 
Microscopically, typical features of abscess are seen. There are multi- 
ple small neutrophilic abscesses with areas of extensive necrosis of the af- 
fected liver parenchyma. The adjacent viable area shows pus and blood clots 
in the portal vein, inflammation, congestion and proliferating fibroblasts. Di- 
rect extension from the liver may lead to subphrenic or pleuropulmonary 
suppuration or peritonitis. There may be small pyaemic abscesses elsewhere 
such as in the lungs, kidneys, brain and spleen. 
 
AMOEBIC LIVER ABSCESS 
Amoebic liver abscesses are less common than pyogenic liver abscess- 
es and have many similar features. They are caused by the spread of Enta- 
moeba histolytica from intestinal lesions. The trophozoite form of amoebae 
in the colon invade the colonic mucosa forming flask-shaped ulcers from 
where they are carried to the liver in the portal venous system. Amoebae mul- 
tiply and block small intrahepatic portal radicles resulting in infarction necro- 
sis of the adjacent liver parenchyma. 
The patients, generally from tropical and subtropical countries, may 
give history of amoebic dysentery in the past. Cysts of E. histolytica in stools 
are present in only 15% of patients of hepatic amoebiasis. Intermittent low- 
grade fever, pain and tenderness in the liver area are common presenting fea- 
tures. A positive haemagglutination test is quite sensitive and useful for diag- 
nosis of amoebic liver abscess. 
Pathologic changes. Grossly, amoebic liver abscesses are usually soli- 
tary and more often located in the right lobe in the posterosuperior portion. 
Amoebic liver abscess may vary greatly in size but is generally of the size of 
an orange. The centre of the abscess contains large necrotic area having red- 
dish-brown, thick pus resembling anchovy or chocolate sauce. The abscess 
wall consists of irregular shreds of necrotic liver tissue. Histologically, the 
necrotic area consists of degenerated liver cells, leucocytes, red blood cells, 
strands of connective tissue and debris. Amoebae are most easily found in the 
liver tissue at the margin of abscess. PAS-staining is employed to confirm the 
trophozoites of E. histolytica. 
HEPATIC TUBERCULOSIS 
Tuberculosis of the liver occurs as a result of miliary dissemination 
from primary complex or from chronic adult pulmonary tuberculosis. The di- 
agnosis is possible by liver biopsy. The patients may have unexplained fever, 
jaundice, hepatomegaly or hepatosplenomegaly. There may be elevated se- 




Pathologic changes. The basic lesion is the epithelioid cell granuloma 
characterised by central caseation necrosis with destruction of the reticulin 
framework and peripheral cuff of lymphocytes. Ziehl-Neelsen staining for 
AFB or culture of the organism from the biopsy tissue is confirmatory. Rare 
lesions consist of tuberculous cholangitis and tuberculous pylephlebitis. 
HYDATID DISEASE (ECHINOCOCCOSIS) 
Hydatid disease occurs as a result of infection by the larval cyst stage 
of the tapeworm, Echinococcus granulosus. The dog is the common definite 
host, while man, sheep and cattle are the intermediate hosts. The dog is in- 
fected by eating the viscera of sheep containing hydatid cysts. The infected 
faeces of the dog contaminate grass and farmland from where the ova are in- 
gested by sheep, pigs and man. Thus, man can acquire infection by handling 
dogs as well as by eating contaminated vegetables. The ova ingested by man 
are liberated from the chitinous wall by gastric juice and pass through the in- 
testinal mucosa from where they are carried to the liver by portal venous sys- 
tem. These are trapped in the hepatic sinusoids where they eventually devel- 
op into hydatid cyst. About 70% of hydatid cysts develop in the liver which 
acts as the first filter for ova. However, ova which pass through the liver en- 
ter the right side of the heart and are caught in the pulmonary capillary bed 
and form pulmonary hydatid cysts. Some ova which enter the systemic circu- 
lation give rise to hydatid cysts in the brain, spleen, bone and muscles. 
The disease is common in sheep-raising countries such as Australia, 
New Zealand and South America. The uncomplicated hydatid cyst of the liv- 
er may be silent or may produce dull ache in the liver area and some ab- 
dominal distension. 
Complications of hydatid cyst include its rupture (e.g. into the perito- 
neal cavity, bile ducts and lungs), secondary infection and hydatid allergy 
due to sensitisation of the host with cyst fluid. The diagnosis is made by pe- 
ripheral blood eosinophilia, radiologic examination and serologic tests such 
as indirect haemagglutination test and Casoni skin test. 
Pathologic changes. Hydatid cyst grows slowly and may eventually 
attain a size over 10 cm in diameter in about 5 years. £. granulosus generally 
causes unilocular hydatid cyst while E. multilocularis results in multilocular 
or alveolar hydatid disease in the liver. 
The cyst wall is composed of 3 distinguishable zones outer pericyst, in- 
termediate characteristic ectocyst and inner endocyst: 
1. Pericyst is the outer host inflammatory reaction consisting of fibro- 
blastic proliferation, mononuclear cells, eosinophils and giant cells, eventual- 




2. Ectocyst is the intermediate layer composed of characteristic acellu- 
lar, chitinous, laminated hyaline material. 
3. Endocyst is the inner germinal layer bearing daughter cysts (brood- 
capsules) and scolices projecting into the lumen. 
Hydatid sand is the grain-like material composed of numerous scolices 
present in the hydatid fluid. Hydatid fluid, in addition, contains antigenic pro- 
teins so that its liberation into circulation gives rise to pronounced eosino- 
philia or may cause anaphylaxis. 
 
ALCOHOLIC HEPATITIS 
It is an acute or chronic liver disease caused by alcohol. Alcohol in 
large doses causes liver cell necrosis. It there is prolonged alcohol in take it 
may lead to chronic persistent hepatitis liver. In acute alcohol hepatitis liver 
becomes dense. Necrosis of hepatocytes is determined. There is leukocyte in- 
filtration and alcoholic hyaline appears (Mallory`s body). It alcohol in take is 
stopped in early stages there may be complete recovery. 
 
CIRRHOSIS 
Cirrhosis of the liver is a diffuse disease having the following 4 features: 
1. It involves the entire liver. 
2. The normal lobular architecture of hepatic parenchyma is disorganised. 
3. There is formation of nodules separated from one another by irregu- 
lar bands of fibrosis. 
4. It occurs following hepatocellular necrosis of varying etiology so 
that there are alternate areas of necrosis and regenerative nodules. 
However, regenerative nodules are not essential for diagnosis of cir- 
rhosis since biliary cirrhosis and haemochromatosis have little regeneration. 
The fibrosis once developed is irreversible. 
In the Western world, cirrhosis of the liver is one of the ten leading 
causes of death. 
Pathogenesis. Irrespective of the etiology, cirrhosis in general is initi- 
ated by hepatocellular necrosis. Continued destruction of hepatocytes causes 
collapse of normal lobular hepatic parenchyma followed by fibrosis around 
necrotic liver cells and proliferated ductules and there is formation of com- 
pensatory regenerative nodules. 
Fibrogenesis. The mechanism of fibrosis that may be portal-central, 
portal-portal, or both, is by increased synthesis of all types of collagen and 
increase in the number of collagen-producing cells. Development of fibrosis 
leads to proliferation of fat-storing Ito cells underlying the sinusoidal epithe- 
lium which become transformed into myofibroblasts and fibrocytes. Besides 




sive amounts in area of liver cell damage. The nature of factors acting as 
stimulants for fibrosis is not clearly known, but possible candidate mediators 
are lymphokines and monokines. 
Regenerative nodule. The cause of compensatory proliferation of 
hepatocytes to form regenerative nodules is obscure. Possibly, growth fac- 
tors, chalones and hormonal imbalance, play a role in regeneration. 
CLASSIFICATION. Cirrhosis can be classified on the basis of morpholo- 
gy and etiology. 
A. Morphologic Classification. There are 3 morphologic types of cir- 
rhosis – micronodular, macronodular and mixed. Each of these forms may 
have an active and inactive form. 
• An active form is characterised by continuing hepatocellular necrosis 
and inflammatory reaction, a process that closely resembles chronic hepatitis. 
• An inactive form, on the other hand, has no evidence of continuing 
hepatocellular necrosis and has sharply-defined nodules of surviving hepatic 
parenchyma without any significant inflammation. 
1. Micronodular cirrhosis. In micronodular cirrhosis, the nodules are 
usually regular and small, less than 3 mm in diameter. There is diffuse in- 
volvement of all the hepatic lobules forming nodules by thick fibrous septa 
which may be portal-portal, portal-central, or both. The micronodular cirrho- 
sis includes etiologic types of alcoholic cirrhosis, nutritional cirrhosis and 
Laennec's cirrhosis and represents impaired capacity for regrowth as seen in 
alcoholism, malnutrition, severe anaemia and old age. 
2. Macronodular cirrhosis. In this type, the nodules are of variable 
size and are generally larger than 3 mm in diameter. The pattern of involve- 
ment is more irregular than in micronodular cirrhosis, sparing some portal 
tracts and central veins, and more marked evidence of regeneration. Mac- 
ronodular cirrhosis corresponds to post-necrotic or post-hepatitic cirrhosis of 
the etiologic classification. 
3. Mixed cirrhosis. In mixed type, some parts of the liver show mi- 
cronodular appearance while other parts show macronodular pattern. All the 
portal tracts and central veins are not involved by fibrosis but instead some of 
them are spared. Mixed pattern is a kind of incomplete expression of mi- 
cronodular cirrhosis. 
B. Etiologic Classification. 
SPECIFIC TYPES OF CIRRHOSIS 
ALCOHOLIC LIVER DISEASE AND CIRRHOSIS 
Alcoholic liver disease is the term used to describe the spectrum of liv- 
er injury associated with acute and chronic alcoholism. There are three stages 
in alcoholic liver disease: alcoholic steatosis (fatty liver), alcoholic hepatitis 




er injury is controversial, available evidence suggests that an alcoholic who 
continues to drink, progresses from fatty liver to alcoholic hepatitis, and 
eventually to alcoholic cirrhosis in more than 10 years. On the other hand, 
there is experimental evidence that fatty change by itself does not lead to the 
development of cirrhosis, but alcoholic hepatitis in some cases appears to be 
the forerunner of alcoholic cirrhosis. 
Ethanol Metabolism. One gram of alcohol gives 7 calories. But alcohol cannot be 
stored and must undergo obligatory oxidation, chiefly in the liver. Thus, these empty calo- 
ries make no contribution to nutrition other than to give energy. 
Ethanol after ingestion and absorption from the small bowel circulates through the 
liver where about 90% of it is oxidised to acetate by a two-step enzymatic process involv- 
ing two enzymes: alcohol dehydrogenase (ADH) present in the cytosol, and acetaldehyde 
dehydrogenase (ALDH) in the mitochondria of hepatocytes. The remaining 10% of etha- 
nol is oxidised elsewhere in the body. 
First step: Ethanol is catabolised to acetaldehyde in the liver by the following 
three pathways, one major and two minor: 
i) In the cytosol, by the major rate-limiting pathway of alcohol dehydrogenase (ADH). 
ii) In the smooth endoplasmic reticulum, via microsomal P-450 oxidases (also called mi- 
crosomal ethanol oxidising system, MEOS), where only part of ethanol is metabolised. 
iii) In the peroxisomes, minor pathway via catalase such as H2O2. 
Acetaldehyde is toxic and may cause membrane damage and cell necrosis. Simul- 
taneously, the cofactor nicotinamide-adenine dinucleotide (NAD) which is a hydrogen ac- 
ceptor, is reduced to NADH. 
Second step: The second step occurs in the mitochondria where acetaldehyde is 
converted to acetate with ALDH acting as a co-enzyme. Most of the acetate on leaving the 
liver is finally oxidised to carbon dioxide and water, or converted by the citric acid cycle 
to other compounds including fatty acids. Simultaneously, the same cofactor, NAD, is re- 
duced to NADH resulting in increased NADH: NAD redox ratio which is the basic bio- 
chemical alteration occurring during ethanol metabolism. A close estimate of 
NADH:NAD ratio is measured by the ratio of its oxidised and reduced metabolites. 
 
Etiology. All those who indulge in alcohol abuse do not develop liver 
damage. The incidence of cirrhosis among alcoholics at autopsy is about 10- 
15%. Why some individuals are predisposed to alcoholic cirrhosis is not 
clearly known, but a few factors have been implicated. These are as under: 
1. Drinking patterns. Most epidemiologic studies have attributed al- 
coholic cirrhosis to chronic alcoholism. The quantity and duration of drinking 
necessary to cause cirrhosis is largely unknown but it is generally agreed that 
continued daily imbibing of more than 80 gm of any type of alcoholic bever- 
age for at least 10 years is likely to result in alcoholic cirrhosis. Liver injury 
is related to the alcoholic content only and not to the type of alcoholic bever- 
age consumed. Intermittent drinking for long duration is less harmful since 
the liver is given chance to recover. 
2. Malnutrition. Absolute or relative malnutrition of proteins and vit- 
amins is regarded as a contributory factor in the evolution of cirrhosis. The 




coholic liver disease and not malnutrition per se. It appears that calories de- 
rived from alcohol displace other nutrients leading to malnutrition and defi- 
ciency of vitamins in alcoholics. Additional factors contributing to malnutri- 
tion in alcoholics are chronic gastritis and pancreatitis. The evidence in fa- 
vour of synergistic effect of malnutrition in chronic alcoholism comes from 
clinical and morphologic improvement in cases of alcoholic cirrhosis on 
treatment with protein-rich diets. 
3. Infections. Intercurrent bacterial infections are common in cirrhotic 
patients and may accelerate the course of the disease. Lesions similar to alco- 
holic cirrhosis may develop in non-alcoholic patients who have had viral in- 
fections in the past. 
4. Genetic factors. The rate of ethanol metabolism is under genetic 
control. It is chiefly related to altered rates of elimination of ethanol due to 
genetic polymorphism for the two main enzyme systems, MEOS (microsomal 
P-450 oxidases) and alcohol dehydrogenase (ADH). Various HLA histocompat- 
ibility types have been associated with susceptibility of different populations to 
alcoholic liver damage but no single genotype has been identified yet. 
Pathogenesis. The liver injury due to alcohol consumption culminating 
in morphologic lesions of alcoholic steatosis (fatty liver), alcoholic hepatitis 
and alcoholic cirrhosis is explained on the basis of the following mecha- 
nisms: 
1. Hepatotoxicity by ethanol. There is some evidence to suggest that 
ethanol ingestion for a period of 8-10 days regularly may cause direct hepato- 
toxic effect on the liver and produce fatty change. Ethanol is directly toxic to 
microtubules, mitochondria and membrane of hepatocytes. 
2. Hepatotoxicity by ethanol metabolites. The major hepatotoxic ef- 
fects of ethanol are exerted by its metabolites, chiefly acetaldehyde. Acetal- 
dehyde levels in blood are elevated in chronic alcoholics. Acetaldehyde is ex- 
tremely toxic and can cause cytoskeletal and membrane damage and bring 
about hepatocellular necrosis. 
3. Free radicals. Oxidation of ethanol by the cytochrome-450 oxidases 
(MEOS) leads to generation of free radicals which attack the membrane and 
proteins. 
4. Increased redox ratio. Marked increase in the NADH:NAD redox 
ratio in the hepatocytes results in increased redox ratio of lactate-pyruvate, 
leading to lactic acidosis. This altered redox potential has been implicated in 
a number of metabolic consequences such as in fatty liver, collagen for- 
mation, occurrence of gout, impaired gluconeogenesis and altered steroid me- 
tabolism. 
5. Retention of liver cell water and proteins. Alcohol is inhibitory to 




in the hepatocytes. Water is simultaneously retained in the cell in proportion 
to the protein and results in swelling of hepatocytes resulting in hepatomeg- 
aly in alcoholics. 
6. Hypoxia. Chronic ingestion of alcohol results in increased oxygen 
demand by the liver resulting in a hypoxic state which causes hepatocellular 
necrosis in centrilobular zone (zone 3). Redox changes are also more marked 
in zone 3. 
7. Increased liver fat. In chronic alcoholism, there is rise in the amount 
of fat available to the liver which could be from exogenous (dietary) sources, 
excess mobilisation from adipose tissue or increased lipid synthesis by the liver 
itself. This may account for lipid accumulation in the hepatocytes. 
8. Immunological mechanism. Cell-mediated immunity is impaired in 
alcoholic liver disease. Ethanol causes direct immunologic attack on hepato- 
cytes. In a proportion of cases, alcohol-related liver cell injury continues un- 
abated despite cessation of alcohol consumption which is attributed to immu- 
nologic mechanisms. Immunological mechanism may also explain the gene- 
sis of Mallory's alcoholic hyalin though more favoured hypothesis for its 
origin is the aggregation of intermediate filaments of prekeratin type due to 
alcohol-induced disorganisation of cytoskeleton. 
9. Fibrogenesis and inflammation. The mechanisms of fibrosis and 
inflammatory response in alcoholic liver disease are uncertain but the possi- 
ble mediators are lymphokines and monokines. The major stimulus for fibro- 
genesis is cell necrosis. All forms of collagen are increased and there is in- 
creased transformation of fat-storing Ito cells into myofibroblasts and fibro- 
cytes. Leukotrienes which are important mediators of inflammation are pro- 
duced by alcohol-damaged hepatocytes resulting in inflammatory reaction in 
the affected areas. 
Pathologic changes. Three types of me logic lesions are described in 
alcoholic liver disease – alcoholic steatosis (fatty liver), alcoholic hepatitis 
and alcoholic cirrhosis. 
1. Alcoholic Steatosis (Fatty Liver). 
Grossly, the liver is enlarged, yellow, greasy and firm with a smooth 
and glistening capsule. Microscopically, the features consist of initial micro- 
vesicular droplets of fat in the hepatocyte cytoplasm followed by more com- 
mon and pronounced feature of macrovesicular large droplets of fat displac- 
ing the nucleus to the periphery. Fat cysts may develop due to coalescence 
and rupture of fat-containing hepatocytes. Less often, lipogranulomas con- 
sisting of collection of lymphocytes, macrophages and some multinucleate 




2. Alcoholic Hepatitis. Alcoholic hepatitis develops acutely, usually fol- 
lowing a bout of heavy drinking. Repeated episodes of alcoholic hepatitis super- 
imposed on pre-existing fatty liver are almost certainly a forerunner of alcoholic 
cirrhosis. Histologically, the features of alcoholic hepatitis are as follows. 
i) Hepatocellular necrosis: Single or small clusters of hepatocytes, es- 
pecially in the centrilobular area (zone 3), undergo ballooning degeneration 
and necrosis. 
ii) Mallory bodies or alcoholic hyalin: These are eosinophilic, intra- 
cytoplasmic inclusions seen in perinuclear location within swollen and bal- 
looned hepatocytes. They represent aggregates of cytoskeletal intermediate 
filaments (prekeratin). They can be best visualised with connective tissue 
stains like Masson's trichrome and chromophobe aniline blue, or by the use 
of immunoperoxidase methods. Mallory bodies are highly suggestive of, but 
not specific for, alcoholic hepatitis since Mallory bodies are also found in 
certain other conditions such as: primary biliary cirrhosis, Indian childhood 
cirrhosis, cholestatic syndromes, Wilson's disease, intestinal bypass surgery, 
focal nodular hyperplasia and hepatocellular carcinoma. 
iii) Inflammatory response: The areas of hepatocellular necrosis and 
regions of Mallory bodies are associated with an inflammatory infiltrate, 
chiefly consisting of polymorphs and some scattered rnononuclear cells. In 
more extensive necrosis, the inflammatory infiltrate is more widespread and 
may involve the entire lobule. 
iv) Fibrosis: Most cases of alcoholic hepatitis are accompanied by pe- 
ricellular and perivenular fibrosis, producing a web-like or chickenwire-like 
appearance. This is also termed as creeping collagenosis. 
3. Alcoholic Cirrhosis. Alcoholic cirrhosis is the most common form 
of lesion, constituting 60-70% of all cases of cirrhosis. A multitude of terms 
have been used for this type of cirrhosis such as Laennec's cirrhosis, portal 
cirrhosis, hobnail cirrhosis, nutritional cirrhosis, diffuse cirrhosis and mi- 
cronodular cirrhosis. Macroscopically, alcoholic cirrhosis classically begins 
as micronodular cirrhosis (nodules less than 3 mm diameter), the liver being 
large, fatty and weighing usually above 2 kg. Eventually over a span of years, 
the liver shrinks to less than 1 kg in weight, becomes nonfatty, having mac- 
ronodular cirrhosis (nodules larger than 3 mm in diameter), resembling post- 
necrotic cirrhosis. The nodules of the liver due to their fat content are tawny- 
yellow, on the basis of which Laennec in 1818 introduced the term cirrhosis 
first of all (from Greek kirrhos-tawny). The surface of liver in alcoholic cirrho- 
sis is studded with diffuse nodules which vary little in size, producing hobnail 
liver (because of the resemblance of the surface with the sole of an old- 
fashioned shoe having short nails with heavy heads). On cut section, spheroidal 




Microscopically, alcoholic cirrhosis is a progressive alcoholic liver 
disease. Its features include the following: 
i) Lobular architecture: No normal lobular architecture can be identi- 
fied and central veins are hard to find. 
ii) Fibrous septa: The fibrous septa that divide the hepatic parenchyma 
into nodules are initially delicate and extend from central vein to portal re- 
gions, or portal tract to portal tract, or both. As the fibrous scarring increases 
with time, the fibrous septa become jdense and more confluent. 
iii) Hepatic parenchyma: The hepatocytes in the islands of surviving 
parenchyma undergo slow proliferation forming regenerative nodules having 
disorganised masses of hepatocytes. The hepatic parenchyma within the nod- 
ules shows extensive fatty change early in the disease. But as the fibrous sep- 
ta become more thick, the amount of fat in hepatocytes is reduced. Thus, 
there is an inverse relationship between the amount of fat and the amount of 
fibrous scarring in the nodules. 
iv) Necrosis, inflammation and bile duct proliferation: The etiologic 
clue to diagnosis in the form of Mallory bodies is hard to find in a fully- 
developed alcoholic cirrhosis. The fibrous septa usually contain sparse infil- 
trate of mononuclear cells with some bile duct proliferation. Bile stasis and 
increased cytoplasmic haemosiderin deposits due to enhanced iron absorption 
in alcoholic cirrhosis are some other noticeable findings. 
Laboratory diagnosis. The laboratory findings in the course of alcoholic liver dis- 
ease may be quite variable and liver biopsy is necessary in doubtful cases. Progressive 
form of the disease, however, generally presents the following biochemical and haemato- 
logical alterations: 
1. Elevated transaminases: increase in SCOT (AST) is more than that of SGPT (ALT). 
2. Rise in serum γ-gluramyl transpeptidase (γ-GT). 
3. Marked elevation in serum alkaline phosphatase. 
4. Hyperbilirubinaemia. 
5. Hypoproteinaemia with reversal of albumin-globulin ratio. 
6. Prolonged prothrombin time and partial thromboplastin time. 
7. Anaemia. 
POST-NECROTIC CIRRHOSIS 
Post-necrotic cirrhosis, also termed post-hepatitic cirrhosis, mac- 
ronodular cirrhosis and coarsely nodular cirrhosis, is characterised by large 
and irregular nodules with broad bands of connective tissue and occurring 
most commonly after previous viral hepatitis. 
Etiology. Based on epidemiologic and serologic studies, the following 
factors have been implicated in the etiology of post-necrotic cirrhosis. 
1. Viral hepatitis. About 25% of patients give history of recent or re- 
mote attacks of acute viral hepatitis followed by chronic hepatitis. Most 
common association is with hepatitis C and B but hepatitis A is not known to 




2. Drugs and chemical hepatotoxins. A small percentage of cases may 
have origin from toxicity due to chemicals and drugs such as phosphorus, 
carbon tetrachloride, mushroom poisoning, acetaminophen and α-methyldopa. 
3. Others. Certain infections (e.g. brucellosis), parasitic infestations 
(e.g. clonorchiasis), metabolic diseases (e.g. Wilson's disease or 
hepatolenticular degeneration) and advanced alcoholic liver disease may pro- 
duce a picture of post-necrotic cirrhosis. 
4. Idiopathic. After all these causes have been excluded, a group of 
cases remain in which the etiology is unknown. 
Pathologic changes. Typically, post-necrotic cirrhosis is macronodular 
type. Grossly, the liver is usually small, weighing less than 1 kg, having distort- 
ed shape with irregular and coarse scars and nodules of varying size. Sectioned 
surface shows scars and nodules varying in diameter from 3 mm to a few centi- 
meters. Microscopically, the features are as follows: 
1. Lobular architecture: The normal lobular architecture of hepatic pa- 
renchyma is not completely lost. Instead, uninvolved portal tracts and central 
veins in the hepatic lobules can still be seen in some parts of surviving paren- 
chyma. 
2. Fibrous septa: The fibrous septa dividing the variable-sized nodules 
are generally thick. 
3. Necrosis, inflammation and bile duct proliferation: Active liver cell 
necrosis is usually inconspicuous. Fibrous septa contain prominent mono- 
nuclear inflammatory cell infiltrate which may even form follicles. Often 
there is extensive proliferation of bile ductules derived from collapsed liver 
lobules. 
4. Hepatic parenchyma: Liver cells vary considerably in size and mul- 
tiple large nuclei are common in regenerative nodules. Fatty change may or 
may not be present in the hepatocytes. 
BILIARY CIRRHOSIS 
Biliary cirrhosis is defined as a chronic disorder characterised by clinical, 
biochemical and morphological features of long-continued cholestasis of intra- 
hepatic or extrahepatic origin. Accordingly, biliary cirrhosis is of 2 main types: 
• Primary biliary cirrhosis in which the destructive process of un- 
known etiology affects intrahepatic bile ducts. 
• Secondary biliary cirrhosis resulting from prolonged mechanical ob- 
struction of the extrahepatic biliary passages. 
• In addition, a third cause for biliary cirrhosis is primary sclerosing 
cholangitis discussed at the end of this discussion. 




A. Primary biliary cirrhosis. The etiology of this type remains unknown. 
However, a few observations have been made to unfold its possible etiology: 
1. The condition is predominant in middle-aged women (male: female ratio 
= 1:9) and has led to the suggestion of a possible endocrine origin. 
2. Familial incidence has been observed suggesting the role of some 
genetic influence and certain HLA types. 
3. There is elevated cholesterol level with appearance of xanthoma and 
xanthelasma. Hepatomegaly and chronic liver disease are late features of the 
disease. 
4. However, presently the most widely accepted hypothesis is autoim- 
mune origin of the disease. In support are the following observations: 
• increased incidence of associated autoimmune diseases (e.g. scleroder- 
ma, Sjogren's syndrome, CREST syndrome, and autoimmune thyroiditis), 
• circulating anti-mitochondrial antibody; 
• elevated levels of immunoglobulins, particularly of IgM; 
• increased levels of circulating immune complexes; 
• decreased number of circulating T-cells; and 
• accumulation of T cells around bile ducts. 
B. Secondary biliary cirrhosis. Most cases of secondary biliary cirrho- 
sis result from prolonged obstruction of extrahepatic biliary passages. These 
causes include: 
1. Extrahepatic cholelithiasis, most common 
2. Biliary atresia 
3. Cancer of biliary tree and of head of pancreas 
4. Postoperative strictures with superimposed ascending cholangitis. 
Pathologic changes. Grossly, in both primary and secondary biliary 
cirrhosis, the liver is initially enlarged and greenish-yellow in appearance, but 
later becomes smaller, firmer and coarsely micronodular. 
The salient features of the two forms of biliary cirrhosis are as under: 
A. Primary biliary cirrhosis: The diagnostic histologic feature is a 
chronic, non-suppurative, destructive cholangitis involving intrahepatic bile 
ducts. The disease evolves through the following 4 histologic states: 
Stage I: There are florid bile duct lesions confined to portal tracts. The 
changes in the affected area consist of destruction of bile ducts, presence of 
bile plugs, infiltration with acute and chronic inflammatory cells and some- 
times formation of granulomas and lymphoid follicles. 
Stage II: There is ductular proliferation. The ductal involvement is 
quite widespread with very few normal bile ducts. The inflammatory infil- 
trate too extends beyond the portal tracts into surrounding hepatic parenchy- 




Stage III: This stage is characterised by fibrous scarring interconnect- 
ing the portal areas. There is diminished inflammatory infiltrate and reduced 
number of bile ducts. 
Stage IV: Well-formed micronodular pattern of cirrhosis develops in a 
period of a few years. 
B. Secondary biliary cirrhosis: Prolonged obstruction of extrahepatic 
bile ducts may produce the following histologic changes: 
1. Bile stasis, degeneration and focal areas of centrilobular necrosis of 
hepatocytes. 
2. Proliferation, dilatation and rupture of bile ductules in the portal area 
with formation of bile lakes. 
3. Cholangitis, sterile or pyogenic, with accumulation of polymorphs 
around the bile ducts. 
4. Progressive expansion of the portal tract by fibr and evolution into 
micronodular cirrhosis. 
PRIMARY SCLEROSING CHOLANGITIS. Primary or idiopathic sclerosing 
cholangitis is characterised by progressive, inflammatory, sclerosing and 
obliterative process affecting mainly extra-hepatic, and sometimes intrahepat- 
ic ducts as well. The disease occurs in 3rd to 5th decade of life with two fold 
preponderance in males. 
Etiology. Though idiopathic, the condition coexists with the following: 
1. Inflammatory bowel disease, particularly idiopathic. 
2. Multifocal fibrosclerosis syndromes 
3. AIDS. 
Pathologic changes. The liver shows varying grades of changes that 
include fatty change, acute and chronic active hepatitis, submassive liver ne- 
crosis and macronodular cirrhosis. Mallory bodies are present in some cases. 
Copper is usually deposited in the periportal hepatocytes in the form of red- 
dish granules in the cytoplasm or as reddish cytoplasmic coloration, stainable 
by rubeanic acid or rhodamine stains for copper. 
Involvement of basal ganglia in brain is in the form of toxic injury to 
neurons, in the cornea as greenish-brown deposits of copper in Descemet's 
membrane, and in the kidney as fatty and hydropic change. 
CIRRHOSIS IN A1-ANTITRYPSIN DEFICIENCY 
Alpha-1-antitrypsin deficiency is an autosomal codominant condition in 
which the homozygous state produces liver disease (cirrhosis), pulmonary dis- 
ease (emphysema), or both. α1-antitrypsin is a glycoprotein normally synthe- 
sised in the rough endoplasmic reticulum of the hepatocytes and is the most po- 




titrypsin is located on long arm of chromosome 14 that codes for immuno- 
globulin light chains too. Out of 24 different alleles labelled alphabetically, 
PiMM is the most common normal phenotype, while the most frequent abnor- 
mal phenotype in α1-antitrypsin deficiency leading to liver and/or lung disease 
is PiZZ in homozygote form. Other phenotypes in which liver disease occurs are 
PiSS and Pi-null in which serum α1-antitrypsin value is nearly totally deficient. 
Intermediate phenotypes, PiMZ and PiSZ persons are predisposed to develop 
hepatocellular carcinoma. 
The patients may present with respiratory disease due to the develop- 
ment of emphysema, or may develop liver dysfunction, or both. At birth or in 
neonates, the features of cholestatic jaundice of varying severity may appear. 
In adolescence, the condition may evolve into hepatitis or cirrhosis which is 
usually well compensated. 
Pathologic changes. Pulmonary changes in α1-antitrypsin deficiency in 
the form of emphysema. The hepatic changes vary according to the age at which 
the deficiency becomes apparent. At birth or in neonates, the histologic features 
consist of neonatal hepatitis that may be acute or 'pure cholestasis'. Micronodu- 
lar or macronodular cirrhosis may appear in childhood or in adolescence in 
which the diagnostic feature is the presence of intracellular, acidophilic, PAS- 
positive globules in the periportal hepatocytes. Ultrastructurally, these globules 
consist of dilated rough endoplasmic reticulum. 
CARDIAC CIRRHOSIS 
Cardiac cirrhosis is an uncommon complication of severe right-sided 
congestive heart failure of longstanding duration. The common causes culmi- 
nating in cardiac cirrhosis are cor pulmonale, tricuspid insufficiency or con- 
strictive pericarditis. The pressure in the right ventricle is elevated which is 
transmitted to the liver via the inferior vena cava and hepatic veins. The pa- 
tients generally have enlarged and tender liver with mild liver dysfunction. 
Splenomegaly occurs due to simple passive congestion. 
Pathologic changes. Grossly, the liver is enlarged and firm with 
stretched Glisson's capsule. Histologically, in acute stage, the hepatic sinus- 
oids are dilated and congested with haemorrhagic necrosis of centrilobular 
hepatocytes (central haemorrhagic necrosis). Severe and more prolonged 
heart failure results in delicate fibrous strands radiating from the central 
veins. These fibrous strands may form interconnections leading to cardiac 
cirrhosis and regenerative nodules. 
INDIAN CHILDHOOD CIRRHOSIS 
Indian childhood cirrhosis (ICC) is an unusual form of cirrhosis seen in 




dus in India and in parts of South-East Asia and the Middle-East. The disease 
has some familial incidence suggesting a possible genetic or common environ- 
mental origin. Death occurs due to hepatic failure within a year of diagnosis. 
Pathologic changes. Five histologic types ICC have been distin- 
guished of which type II is the most common. This form is characterised by 
ballooning degeneration of hepatocytes, with some liver cells showing Mallo- 
ry bodies and surrounded by neutrophilic exudate. Eventually, a fine mi- 
cronodular cirrhosis results. Thus, the picture resembles acute alcoholic hepa- 
titis but without the fatty change and with greatly impaired regeneration. 
There is marked increase in hepatic copper since the milk consumed by such 
infants is often boiled and stored in copper vessels in India. The condition 
should, therefore, be distinguished from Wilson's disease. 
MISCELLANEOUS FORMS OF CIRRHOSIS 
In addition to the various types of cirrhosis just described, a few other un- 
common types are sometimes distinguished. These include the following: 
1. Metabolic disorders e.g. in galactosaemia, hereditary fructose intol- 
erance, glycogen storage diseases. 
2. Infectious diseases e.g. in brucellosis, schistosomiasis, syphilis (hep- 
ar lobatum) and toxoplasma infection. 
3. Gastrointestinal disorders e.g. in inflammatory bowel disease, cystic 
fibrosis of the pancreas and intestinal bypass surgery for obesity. 
4. Infiltrative diseases e.g. in sarcoidosis. 
CRYPTOGENIC CIRRHOSIS 
Finally, when all the known etiologic types of cirrhosis have been ex- 
cluded, there remain patients with cirrhosis in whom the cause is unknown. 
These cases are grouped under a waste-basket diagnosis of cryptogenic cir- 
rhosis (crypto = concealed). 
NON-CIRRHOTIC PORTAL FIBROSIS 
Non-cirrhotic portal fibrosis (NCPF) is a group of congenital and ac- 
quired diseases in which there is localised or generalized hepatic fibrosis 
without nodular regenerative activity and there is absence of clinical and 
functional evidence of cirrhosis. One of the types associated with increased 
portal fibrosis without definite cirrhosis is seen in idiopathic portal hyperten- 
sion with splenomegaly, reported from India and Japan. Another variant is 
congenital hepatic fibrosis seen in polycystic disease of the liver. The type 
common in India, particularly in young males, is related to chronic arsenic 
ingestion in drinking water and intake of orthodox medicines. NCPF is notable 




CLINICAL MANIFESTATIONS AND COMPLICATIONS OF CIRRHOSIS 
The range of clinical features in cirrhosis varies widely, from an 
asymptomatic state to progressive liver failure and death. The onset of dis- 
ease is insidious. In general, the features of cirrhosis are more marked in the 
alcoholic form than in other varieties. These include weakness, fatiguability, 
weight loss, anorexia, muscle wasting, and low grade fever due to hepatocel- 
lular necrosis or some latent infection. Advanced cases develop a number of 
complications which are as follows: 
1. Portal hypertension and its major effects such as ascites, spleno- 
megaly and development of collaterals (e.g. oesophageal varices, spider naevi 
etc) as discussed below. 
2. Progressive hepatic failure and its manifestations as described already. 
3. Development of hepatocellular carcinoma, more often in postnecrot- 
ic cirrhosis (HBV and HCV more often) than following alcoholic cirrhosis. 
4. Chronic relapsing pancreatitis, especially in alcoholic liver disease. 
5. Steatorrhoea due to reduced hepatic bile secretion. 
6. Gallstones usually of pigment type, are seen twice more frequently 
in patients with cirrhosis than in general population. 
7. Infections are more frequent in patients with cirrhosis due to im- 
paired phagocytic activity of reticuloendothelial system. 
8. Haematologic derangements such as bleeding disorders and anaemia 
due to impaired hepatic synthesis of coagulation factors and hypoalbumi- 
naemia are present. 
9. Cardiovascular complications such as atherosclerosis of coronaries 
and aorta and myocardial infarction are more frequent in cirrhotic patients. 
10. Musculoskeletal abnormalities like digital clubbing, hypertrophic 
osteoarthropathy and Dupuytren's contracture are more common in cirrhotic 
patients. 
11. Endocrine disorders. In males these consist of feminisation such as 
gynaecomastia, changes in pubic hair pattern, testicular atrophy and impotence, 
whereas in cirrhotic women amenorrhoea is a frequent abnormality. 
12. Hepatorenal syndrome leading to renal failure may occur in late 
stages of cirrhosis. 
The ultimate causes of death are hepatic coma, massive gastrointestinal 
haemorrhage from oesophageal varices (complication of portal hypertension), 




Increase in pressure in the portal system usually follows obstruction to 




and thus obstruction anywhere in the portal system raises pressure in all the 
veins proximal to the obstruction. However, unless proved otherwise, portal 
hypertension means obstruction to the portal blood flow by cirrhosis of the 
liver. The normal portal venous pressure is quite low (10-15 mm saline). Por- 
tal hypertension occurs when the portal pressure is above 30 mm saline. 
Measurement of intra-splenic pressure reflects pressure in the splenic vein; 
the percutaneous trans-hepatic pressure provides a measure of pressure in 
the main portal vein; and wedged hepatic venous pressure represents sinusoi- 
dal pressure. Measurement of these pressures helps in localising the site of 
obstruction and classifying the portal hypertension. 
Classification. Based on the site of obstruction to portal venous blood 
flow, portal hypertension is categorised into 3 main types – intrahepatic, 
posthepatic and prehepatic. Rare cases of idiopathic portal hypertension show- 
ing non-cirrhotic portal fibrosis are encountered as discussed above. 
1. Intrahepatic portal hypertension. Cirrhosis is by far the commonest 
cause of portal hypertension. Other less frequent intrahepatic causes are met- 
astatic tumours, non-cirrhotic nodular regenerative conditions, hepatic ve- 
nous obstruction (Budd-Chiari syndrome), veno-occlusive disease, schisto- 
somiasis, diffuse granulomatous diseases and extensive fatty change. In cir- 
rhosis and other conditions, there is obstruction to the portal venous flow by 
fibrosis, thrombosis and pressure by regenerative nodules. About 30-60% pa- 
tients of cirrhosis develop significant portal hypertension. 
2. Posthepatic portal hypertension. This is uncommon and results from 
obstruction to the blood flow through hepatic vein into inferior vena cava. 
The causes are neoplastic occlusion and thrombosis of the hepatic vein or of 
the inferior vena cava (including Budd-Chiari syndrome). Prolonged conges- 
tive heart failure and constrictive pericarditis may also cause portal hyperten- 
sion by transmitting the elevated pressure through the hepatic vessels into the 
portal vein. 
3. Prehepatic portal hypertension. Blockage of portal flow before por- 
tal blood reaches the hepatic sinusoids results in prehepatic portal hypertension. 
Such conditions are thrombosis and neoplastic obstruction of the portal vein be- 
fore it ramifies in the liver, myelofibrosis, and congenital absence of portal vein. 
Major sequelae of portal hypertension. 
Irrespective of the mechanisms involved in the pathogenesis of portal 
hypertension, there are 4 major clinical consequences – ascites, varices (col- 
lateral channels or portosystemic shunts), splenomegaly and hepatic encepha- 
lopathy. 
1. ASCITES. Ascites is the accumulation of excessive volume of fluid 
within the peritoneal cavity. It frequently accompanies cirrhosis and other 




modilution, oedema and decreased urinary output. Ascitic fluid is generally 
transudate with specific gravity of 1.010, protein content below 3 gm/dl and 
electrolyte concentrations like those of other extracellular fluids. It may con- 
tain a few mesothelial cells and mononuclear cells. But presence of neutro- 
phils is suggestive of secondary infection and red blood cells in ascitic fluid 
points to disseminated intra-abdominal cancer. 
Pathogenesis. The ascites becomes clinically detectable when more 
than 500 ml of fluid has accumulated in the peritoneal cavity. Briefly, the 
systemic and local factors favouring ascites formation are as under: 
A. Systemic factors: 
i) Decreased plasma colloid oncotic pressure. There is hypoalbumi- 
naemia from impaired hepatic synthesis of plasma proteins including albu- 
min, as well as from loss of albumin from the blood plasma into the peritone- 
al cavity. Hypoalbuminaemia, in turn, causes reduced plasma oncotic pres- 
sure and leads to loss of water into extravascular space. 
ii) Hyperaldosteronism. In cirrhosis, there is increased aldosterone se- 
cretion by the adrenal gland, probably due to reduced renal blood flow, and 
impaired hepatic metabolism and excretion of aldosterone. 
iii) Impaired renal excretion. Reduced renal blood flow and excessive 
release of antidiuretic hormone results in renal retention of sodium and water 
and impaired renal excretion. 
B. Local factors: 
i) Portal hypertension. Portal venous pressure is not directly related to 
ascites formation but portal hypertension in combination with other factors 
contributes to the formation and localisation of the fluid retention in the peri- 
toneal cavity. 
ii) Increased hepatic lymph formation. Obstruction of hepatic  vein 
such as in Budd-Chiari syndrome and increased intrasinusoidal pressure 
found in cirrhotic patients stimulates hepatic lymph formation that oozes 
through the surface of the liver. 
2. VARICES (Collateral channels or Porto-systemic shunts). As a re- 
sult of rise in portal venous pressure and obstruction in the portal Circulation 
within or outside the liver, the blood tends to bypass the liver and return to the 
heart by development of porto-systemic collateral channels (or shunts or vari- 
ces). These varices develop at sites where the systemic and portal circulations 
have common capillary beds. The principal sites are as under: 
i) Oesophageal varices: The development of oesophago-gastric varices 
which is frequently manifested by massive haematemesis is the most im- 
portant consequence of portal hypertension. 
ii) Haemorrhoids: Development of collaterals between the superior, 




common accompaniment. Bleeding from haemorrhoids is usually not as seri- 
ous a complication as haematemesis from oesophageal varices. 
iii) Caput medusae: Anastomoses between the portal and systemic 
veins may develop between the hilum of the liver and the umbilicus along the 
paraumbilical plexus of veins resulting in abdominal wall collaterals. These 
appear as dilated subcutaneous veins radiating from the umbilicus and are 
termed caput medusae (named after the snake-haired Medusa). 
iv) Retroperitoneal anastomoses: In the retroperitoneum, portocaval 
anastomoses may be established through the veins of Retzius and the veins of 
Sappey. 
3. SPLENOMEGALY. The enlargement of the spleen in prolonged portal 
hypertension is called congestive splenomegaly. The spleen may weigh 500- 
1000 gm and is easily palpable. The spleen is larger in young people and in 
macronodular cirrhosis than in micronodular cirrhosis. 
4. HEPATIC ENCEPHALOPATHY. Porto-systemic venous shunting may 
result in a complex metabolic and organic syndrome of the brain character- 
ised by disturbed consciousness, neurologic signs and flapping tremors. He- 
patic encephalopathy is particularly associated with advanced hepatocellular 
disease such as cirrhosis. 
 
HEPATIC TUMOURS AND TUMOUR-LIKE LESIONS 
The liver is the site for benign tumours, tumour-like lesions, and both 
primary and metastatic malignant tumours. However, metastatic tumours are 
much more common than primary tumours and tumour-like lesions. Primary 
hepatic tumours may arise from hepatic cells, bile duct epithelium, or meso- 
dermal structures. But first, brief comments on tumour-like lesions occurring 
in the liver are given below. 
TUMOUR-LIKE LESIONS 
These include cysts in the liver and focal nodular hyperplasia. 
HEPATIC CYSTS 
Cysts in the liver may be single or multiple. They are mainly of 3 types 
– congenital, simple (nonparasitic) and hydatid (Echinococcus) cysts. 
1. Congenital cysts. These are uncommon. They are usually small (less 
than 1 cm in diameter) and are lined by biliary epithelium. They may be single, 
or occur as polycystic liver disease, often associated with polycystic kidney. 
On occasions, these cysts have abundant connective tissue and  numerous 
ducts, warranting the designation of congenital hepatic fibrosis. 
2. Simple (non-parasitic) cysts. Simple cysts are solitary non-parasitic 
cysts seen more frequently in middle-aged women. The cyst is usually large 




with serous fluid. The cyst produces a palpable mass and may be associated 
with jaundice. 
Histologically, the cyst wall is composed of compact fibrous tissue and is 
lined by low columnar to cuboid epithelium and occasionally by squamous lining. 
3. Hydatid (echinococcus) cysts. 
FOCAL NODULAR HYPERPLASIA 
Focal nodular hyperplasia is a well-demarcated tumour-like nodule oc- 
curring underneath the Glisson's capsule. The nodules may be single or mul- 
tiple, measuring about 5 cm in diameter. It may be tan-yellow or bile-stained. 
The sectioned surface shows a central fibrous scar. 
Histologically, it is composed of collagenous septa radiating from the 
central fibrous scar which separate nodules of normal hepatocytes without 
portal triads or central hepatic veins. The fibrous septa contain prominent 
lymphocytic infiltrate. 
The etiology of focal nodular hyperplasia is not known but these le- 
sions are more common in women taking oral contraceptives. 
BENIGN HEPATIC TUMOURS 
These are uncommon and some of them are incidental autopsy find- 
ings. These include hepatocellular (liver cell) adenoma, bile duct adenoma 
(cholangioma) and haemangioma. 
HEPATOCELLULAR (LIVER CELL) ADENOMA 
Adenomas arising from hepatocytes are rare and are reported in wom- 
en in reproductive age group in association with use of oral contraceptives, 
sex hormone therapy and with pregnancy. The tumour presents as intrahepat- 
ic mass that may be mistaken for hepatocellular carcinoma and may rupture 
causing severe intraperitoneal haemorrhage. 
Pathologic changes. Grossly, the tumour usually occurs singly but 
about 10% are multiple. It is partly or completely encapsulated and slightly 
lighter in colour than adjacent liver or may be bile-stained. The tumours vary 
from a few centimeters up to 30 cm in diameter. On cut section, many of the 
tumours have varying degree of infarction and haemorrhage. 
Histologically, liver cell adenomas are composed of sheets and cords 
of hepatocytes which may be normal-looking or may show slight variation in 
size and shape but no mitoses. The hepatocytes in adenomas contain greater 
amount of glycogen than the surrounding liver cells and may sometimes show 
fatty change. Hepatocellular adenomas lack portal tracts and bile ducts but bile 
canalculi containing bile-plugs may be present. Numerous blood vessels are 
generally present in the rumour which may be thrombosed. Thrombosis leads to 




BILE DUCT ADENOMA (CHOLANGIOMA) 
Intra-hepatic or extrahepatic bile duct adenoma is a rare benign tu- 
mour. The tumour may be small, composed of acini lined by biliary epitheli- 
um and separated by variable amount of connective tissue, or are larger 
cystadenomas having loculi lined by biliary epithelium. 
HAEMANGIOMA 
Haemangioma is the commonest benign tumour of the liver. Majority 
of them are asymptomatic and discovered incidentally. Rarely, a haemangi- 
oma may rupture into the peritoneal cavity. 
Pathologic changes. Grossly, haemangiomas appear as solitary or 
multiple, circumscribed, red-purple lesions, commonly subcapsular and vary- 
ing from a few millimetres to a few centimetres in diameter. They are com- 
monly cavernous type giving the sectioned surface a spongy appearance. His- 
tologically, haemangioma of the liver shows characteristic large, cavernous, 
blood-filled spaces, lined by a single layer of endothelium and separated by 
connective tissue. Some haemangiomas may undergo progressive fibrosis 
and may later get calcified. 
PRIMARY MALIGNANT HEPATIC TUMOURS 
Among the primary malignant tumours of the liver, hepatocellular (liv- 
er cell) carcinoma accounts for approximately 85% of all primary malignant 
tumours, cholangiocarcinoma for about 5-10%, and infrequently mixed pat- 
tern is seen. The remainder are rare tumours that include hepatoblastoma, 
haemangiosarcoma (angiosarcoma) and embryonal sarcoma. Hepatic hae- 
mangiosarcoma and embryonal sarcoma resemble in morphology with their 
counterparts elsewhere in the body. 
HEPATOCELLULAR CARCINOMA 
Hepatocellular or liver cell carcinoma (HCC), sometimes termed hepa- 
toma, is the most common primary malignant tumour of the liver. The tu- 
mour shows marked geographic variations in incidence which is closely re- 
lated to hepatitis B virus infection in the region. Whearas the prevalence of 
HCC is less than 1% of all autopsies in the United States and Europe, the in- 
cidence in Africa and South-East Asia is 2-8%. HCC is the leading malignant 
tumour in South-East Asia. Liver cell cancer is 4-6 times more common in 
males than in females. The peak incidence occurs in 5th to 6th decades of life 
but in high incidence areas where HBV infection is prevalent, it occurs a dec- 
ade or two earlier. The tumour supervenes on cirrhosis, usually post-necrotic 
macronodular type, in 70-80% of cases. 
Etiology. A number of etiologic factors are implicated in the etiology 
of HCC, most important being HBV infection (and now HCV infection also) 




1. Relation to HBV infection. Genesis of HCC is linked to prolonged in- 
fection with HBV. The evidence in support is both epidemiologic and direct. 
i) The incidence of HBsAg positivity is higher in HCC patients. For 
example, in Taiwan, HBsAg-positive carriers have more than 200 times 
greater risk of developing HCC than HBsAg-negative patients, particularly 
when the infection is acquired in early life, 
ii) In African and Asian patients, 95% cases of HCC have anti-HBc. 
iii) There is more direct evidence of integration of HBV-DNA genome 
in the genome of tumour cells of HCC. 
2. Relation to HCV infection. More recent evidence points to long- 
standing HCV infection as a major factor in the etiology of HCC. The evi- 
dences in support are as under: 
i) In developed countries where higher incidence of HCC was earlier 
attributed to endemic infection (e.g. in Japan) has shown a remarkable shift to 
HCV infection. However, in less developed countries HBV is still the pre- 
dominant etiologic factor in the pathogenesis of HCC. 
ii) The patients having anti-HCV and anti-HBc antibodies together 
have three times higher risk of developing HCC than in those with either an- 
tibody alone. 
iii) It is also possible that HBV and HCV infection act synergistically 
to predispose to HCC. 
3. Relation to cirrhosis. Cirrhosis of all etiologic types is more com- 
monly associated with HCC but the most frequent association is with mac- 
ronodular post-necrotic cirrhosis. The mechanism of progression to HCC ap- 
pears to be chronic regenerative activity in cirrhosis, or that the damaged liv- 
er in cirrhosis is rendered vulnerable to carcinogenic influences. Liver cell 
dysplasia identified by cellular enlargement, nuclear hyper-chromatism and 
multinucleate cells, is found in 60% of cirrhotic livers with HCC and in only 
10% of non-cirrhotic livers. 
4. Relation to alcohol. It has been observed that alcoholics have about 
four-fold increased risk of developing HCC. It is possible that alcohol may 
act as co-carcinogen with HBV infection, but alcohol does not appear to be a 
hepatic carcinogen perse. 
5. Mycotoxins. An important mycotoxin, aflatoxin Bl, produced by a 
mould Aspergillusflavus, can contaminate stored grains or groundnuts, especial- 
ly in less developed countries. Aflatoxin Bl is carcinogenic; it may act as a co- 
carcinogen with hepatitis B or may suppress the cellular immune response. 
6. Chemical carcinogens. A number of chemical carcinogens can in- 
duce liver cancer in experimental animals. These include butter-yellow and 




7. Miscellaneous factors. Limited role of various other factors in HCC 
has been observed. These include: 
i) haemochromatosis; 
ii) CXL-antitrypsin deficiency; 
iii) prolonged immunosuppressive therapy in renal transplant patients; 
iv) other types of viral hepatitis; 
v) tobacco smoking; and 
vi) parasitic infestations such as clonorchiasis and schistosomiasis. 
Pathologic changes. Macroscopically, the HCC may form one of the 
following 3 patterns of growth, in decreasing order of frequency: i) Expand- 
ing type: Most frequently, it forms a single, yellow-brown, large mass, most 
often in the right lobe of the liver with central necrosis, haemorrhage and oc- 
casional bile-staining. It may be deceptively encapsulated. 
ii) Multifocal type: Less often, multifocal, multiple masses, 3-5 cm in 
diameter, scattered throughout the liver are seen. 
iii) Infiltrating (Spreading) type: Rarely, the HCC forms diffusely in- 
filtrating tumour mass. Microscopically, the tumour cells in the typical HCC 
resemble hepatocytes but vary with the degree of differentiation, ranging 
from well-differentiated to highly anaplastic lesions. Most of the HCC have 
trabecular growth pattern. The tumour cells have a tendency to invade and 
grow along blood vessels. Thus important diagnostic features are the patterns 
of tumour cells and their cytologic features: 
1. Histologic patterns: These include the following: 
i) Trabecular or sinusoidal pattern is the most common. The trabecu- 
lae are made up of 2-8 cell wide layers of tumour cells separated by vascular 
spaces or sinusoids which are endothelrum-lined. 
ii) Pseudoglandular or acinar pattern is seen sometimes. The tumour 
cells are disposed around central cystic space formed by degeneration and 
breakdown in solid trabeculae. 
iii) Compact pattern resembles trabecular pattern but the tumour cells 
form large solid masses with inconspicuous sinusoids. 
iv) Scirrhous pattern is characterised by more abundant fibrous stroma. 
2 Cytologic features: The typical cytologic features in the HCC consist 
of cells resembling hepatocytes having vesicular nuclei with prominent nu- 
cleoli. The cytoplasm is granular and eosinophilic but becomes increasingly 
basophilic with increasing malignancy. Aside from these features, a few other 
cytologic variants are: pleomorphism, bizarre giant cell formation, spindle- 
shaped cells, tumour cells with clear cytoplasm, presence of bile within dilat- 





A clinicopathologic variant of the HCC is fibrolamellar carcinoma of the 
liver found in young people of both sexes. The tumour forms a single large mass 
which may be encapsulated and occurs in the absence of cirrhosis. 
Histologically, the tumour is composed of eosinophilic polygonal cells (on- 
cocytes) forming cords and nests which are separated by bands of fibrous stroma. 
The prognosis of fibrolamellar carcinoma is better than other forms of 
HCC.  
Spread. The HCC can have both intrahepatic and extrahepatic spread 
which faithfully reproduces the structure of the primary tumour. 
• Intrahepatic spread occurs by haematogenous route and forms multi- 
ple metastases in the liver. 
• Extrahepatic spread occurs via hepatic or portal veins to different 
sites, chiefly to lungs and bones, and by lymphatic route to regional lymph 
nodes at the porta hepatis and to mediastinal and cervical lymph nodes. 
The causes of death from the HCC are cachexia, massive bleeding 
from oesophageal varices, and liver failure with hepatic coma. 
CHOLANGIOCARCINOMA 
Cholangiocarcinoma is the designation used for carcinoma  arising 
from bile duct epithelium within the liver (peripheral Cholangiocarcinoma). 
Carcinomas arising from the large hilar ducts (hilar Cholangiocarcinoma) 
and from extrahepatic ducts are termed bile duct carcinomas. None of the 
etiologic factors related to HCC have any role in the genesis of Cholangio- 
carcinoma. However, the etiological factors involved in it are exposure to ra- 
dio-opaque dye thorotrast, anabolic steroids, clonorchiasis and fibrocystic 
disease. The tumour affects older people and the clinical features are those of 
HCC but with prominence of jaundice. 
Pathologic changes. Grossly, the tumour i firm to hard and whitish. 
Microscopically, the tumourhas glandular structure. The tumour cells resem- 
ble biliary epithelium but without bile secretion. They form various patterns 
such as tubular, ductular or papillary. The stroma consists of fibrous tissue 
with little or no capillary formation. Occasionally, mucinous, signet-ring and 
adenosquamous type of patterns are found. An uncommon variant is com- 
bined hepatocellular-cholangiocarcinoma. 
HEPATOBLASTOMA 
Hepatoblastoma is a rare malignant tumour arising from primitive he- 
patic parenchymal cells. It presents before the age of 2 years as progressive 
abdominal distension with anorexia, failure to thrive, fever and jaundice. It is 




grows rapidly and causes death by haemorrhage, hepatic failure or wide- 
spread metastases. 
Pathologic changes, Grossly, the tumour is circumscribed and tabulat- 
ed mass measuring 5-25 cm in size, having areas of cystic degeneration, 
haemorrhage and necrosis. 
Microscopically, hepatoblastoma consists of 2 components: 
i) Epithelial component contains 2 types of cells – 'embryonal' 
hepatocytes are small with dark-staining, hyperchromatic nuclei and scanty 
cytoplasm, and 'foetal' hepatocytes are larger with more cytoplasm that may 
be granular or clear. The epithelial cells are organised in trabeculae, ribbons 
or rosettes, 
ii) Mesenchymal component includes fibrous connective tissue, car- 
tilage and osteoid of variable degree of maturation. Extramedullary haemato- 
poiesis is a frequent accompaniment. 
SECONDARY HEPATIC TUMOURS 
Metastatic tumours in the liver are more common than the primary he- 
patic tumours. Most frequently, they are blood-borne metastases, irrespective 
of whether the primary tumour is drained by portal vein or systemic veins. 
Most frequent primary rumours metastasising to the liver, in descending or- 
der of frequency, are those of stomach, breast, lungs, colon, oesophagus, 
pancreas, malignant melanoma and haematopoietic malignancies. Sarcomas 
rarely metastasise to the liver. Occasionally, metastatic involvement may be 
present in the absence of obvious evidence of primary tumour. Aside from 
general features of disseminated malignancy such as anorexia, cachexia and 
anaemia, the patients have hepatomegaly with nodular free margin. There is 
little hepatic dysfunction until late in the course of hepatic metastatic disease. 
Pathologic changes. Grossly, most metastatic carcinomas form multi- 
ple, spherical, nodular masses which are of variable size. Liver is enlarged 
and heavy, weighing 5 kg or more. The tumour deposits are white, well- 
demarcated, soft or haemorrhagic. The surface of the liver shows characteris- 
tic umbilication due to central necrosis of nodular masses. 
Histologically, the metastatic tumours generally reproduce the struc- 




PATHOLOGY OF BILIARY SYSTEM 
The gallbladder is a pear-shaped organ, 9 cm in length and has a capacity of ap- 
proximately 50 ml. It consists of the fundus, body and neck that tapers into the cystic duct. 
The two hepatic ducts from right and left lobes of the liver unite at the porta hepatis to 
form the common hepatic duct which is joined by the cystic duct from the gallbladder to 
form the common bile duct. The common bile duct enters the second part of the duode- 
num posteriorly. In about 70% of cases, it is joined by the main pancreatic duct to form 
the combined opening in the duodenum (ampulla of Vater). In 30% cases, the common 
bile duct and the pancreatic duct open separately into the duodenum. The common bile 
duct in its duodenal portion is surrounded by longitudinal and circular muscles derived 
from the duodenum forming sphincter of Oddi. 
Histologically, the gallbladder, unlike the rest of gastrointestinal tract, lacks the 
muscularis mucosae and submucosa. The wall of the gallbladder is composed of the fol- 
lowing 4 layers: 
1. Mucosal layer: It has a single layer of tall columnar epithelium which is thrown 
into permanent folds that are larger and more numerous in the neck of the gallbladder. Be- 
neath the epithelium is delicate lamina propria that contains capillaries, and in the region 
of the neck, a few acinar glands are present. 
2. Smooth muscle layer: External to the lamina propria are smooth muscle bundles 
in layers –inner longitudinal, middle oblique, and outer circular. 
3. Perimuscular layer: Outer to the muscle layer is a zone of fibrous connective tis- 
sue with some interspersed 
4. Serosal layer: The perimuscular layer is covered by serosa on the peritoneal sur- 
face of the gallbladder. The peritoneum covers the gallbladder except in the region of 
gallbladder fossa where it is embedded in the liver. The extrahepatic bile ducts are also 
lined by tall columnar epithelium that overlies the lamina propria. It is surrounded by 
dense layer of fibromuscular tissue. The ducts which lie between the lobules of the liver 
and receive bile from the canaliculi are lined by cuboidal or flattened cells. 
The main function of the gallbladder is to store and concentrate the bile secreted by 
the liver and then deliver it into the intestine for digestion and absorption of fat. The con- 
centrating ability of the gallbladder is due to its absorptive mucosal surface that has nu- 
merous folds. Normally, the liver secretes approximately 500 ml of bile per day and the 
gallbladder concentrates it 5-10 times. The motility, concentration and relaxation of the 
gallbladder are under the influence of a peptide hormone, cholecystokinin, released from 
neuro-endocrine cells of the duodenum and jejunum. 
CONGENITAL ANOMALIES 
Several uncommon congenital anomalies of the biliary system have been 
described. These include: agenesis, duplication and heterotopic tissue. However, 
congenital cystic lesions of the bile ducts (as also of the liver) are more frequent- 
ly being diagnosed. These conditions include: congenital intrahepatic biliary di- 
latation (Caroli's disease), choledochal cysts, polycystic liver disease and con- 
genital hepatic fibrosis. They are found in various combinations and are usually 
inherited. All of them may be complicated by malignant change. 
CHOLELITHIASIS (GALLSTONES) 
Gallstones are formed from constituents of the bile (viz. cholesterol, 




cordingly, the gallstones commonly contain cholesterol, bile pigment and 
calcium salts in varying proportions. They are usually formed in the gallblad- 
der, but sometimes may develop within extrahepatic biliary passages, and 
rarely in the larger intrahepatic bile duct. 
Risk factors. The incidence of gallstones varies markedly indifferent 
geographic areas, age, sex, diet and various other risk factors. These factors 
which largely pertain to cholesterol stones can be summed up in the old say- 
ing that gallstones are common in 4F's – 'fat, female, fertile (multipara) and 
forty'. Some of the risk factors in lithogenesis are explained below: 
1. Geography. Gallstones are quite prevalent in almost the entire Western 
world. American Indians have the highest known prevalence. Black Africans 
and populations in the Eastern world are relatively free of cholelithiasis. 
2. Genetic factors. There is increased frequency of gallstones in family 
members of patients with cholelithiasis. 
3. Age. There is steady increase in the prevalence of gallstones with 
advancing age which may be related to increased cholesterol content in the 
bile. The incidence increases above the age of 40 and presentation is usually 
in the 50s and 60s. 
4. Sex. Gallstones are twice more frequent in women than in men. In 
the United States, autopsy series have shown gallstones in about 20% of 
women and 8% of men above the age of 40. The incidence is higher in mul- 
tiparous women than in nulliparous women. 
5. Drugs. Women on oestrogen therapy or on birth control pills have 
higher incidence of gallstones. This is considered to be due to production of 
more lithogenic bile as a result of cholestatic effect of oestrogen. Similar is 
the influence of clofibrate used for lowering blood cholesterol. 
6. Obesity. Obesity is associated with increased cholesterol synthesis 
and excretion resulting in higher incidence of gallstones in obese patients. 
7. Diet. Deficiency of dietary fibre content in Western countries is 
linked to higher prevalence of gallstones. A moderate consumption of alco- 
hol, however, seems to protect against gallstones. 
8. Gastrointestinal diseases. Certain gastrointestinal disorders such as 
Crohn's disease, ileal resection, ileal bypass surgery etc are associated with in- 
terruption in enterohepatic circulation followed by gallstone formation. 
9. Factors in pigment gallstones. All the above factors apply largely to 
cholesterol stones. Pigment stones, whether pure or mixed type, are more fre- 
quently associated with haemolytic anaemias which lead to increased content 
of unconjugated bilirubin in the bile. Pigment stones are also more frequent 
in cirrhosis and hepatocellular disease. 
Pathogenesis. The mechanism of cholesterol gallstone formation or litho- 




ol, cholesterol nucleation, and the hyperfunction of gallbladder. However, the 
mechanism of pigment stones is less clear and discussed separately. 
1. Supersaturation of bile. Gallstone formation is related to supersatu- 
ration of bile with cholesterol due to increased proportion of cholesterol with 
a decreased proportion of bile acids in it. Normally, water is the major con- 
stituent (85-95%) of the bile, while cholesterol present in bile is insoluble in 
water. It is kept in solution by formation of micelles that have a hydrophilic 
external surface and a hydrophobic internal surface. Cholesterol is incorpo- 
rated into the wall of the micelles, thus producing a bile that is supersaturated 
with cholesterol, termed lithogenic bile. 
2. Cholesterol nucleation. Initiation of cholesterol stones occurs by nu- 
cleation of cholesterol monohydrate crystals. Bile from patients of gallstones con- 
tains a potent nucleating factor and the gallbladder mucin secreted by epithelial 
cells, both of which play a role in cholesterol nucleation. A deficiency of anti- 
nucleating factors has also been suggested to play role in nucleation. 
3. Gallbladder hyperfunction. Normally, the gallbladder is capable of 
emptying and clearing any sludge or debris which might initiate stone for- 
mation. This takes place under the influence of cholecystokinin secreted from 
small intestine. However, the motility of gallbladder may be impaired due to 
decrease in cholecystokinin receptors in the gallbladder resulting in stasis of 
biliary sludge and lithogenesis. 
Pathogenesis of pigment gallstones. The mechanism of pigment stone 
formation is mainly explained on the basis of increased level of unconjugated 
bilirubin in the bile as a result of excessive haemolysis of red blood cells. In 
Oriental countries, pigment stones are associated with parasitic infestations of 
the biliary tract such as Clonorchis sinensis and Ascaris lumbricoides. 
TYPES OF GALLSTONES. As stated before, gallstones contain cholesterol, 
bile pigment and calcium carbonate, either in pure form or in various combina- 
tions. Accordingly, gallstones are of 3 major types — pure gallstones, mixed gall- 
stones and combined gallstones. Mixed gallstones are the most common (80%) 
while pure and combined gallstones comprise 10% each. In general, gallstones 
are formed most frequently in the gallbladder but may xicur in extrahepatic as 
well as intrahepatic biliary massages. Gallbladders containing pure stones show 
no significant inflammatory reaction, whereas chronic rholecystitis is invariably 
present in gallbladders with nixed and combined gallstones. Presence of calcium 
salts renders gallstones radio-opaque, while cholesterol stones appear as radiolu- 
cent filling defects in the gallbladder. 
The salient features of various types of gallstones: 
1. Pure gallstones. They constitute about 10% of all gallstones. They 
are further divided into 3 types according to the component of bile forming 




i) Pure cholesterol gallstones: They are usually solitary, oval and fairly 
large (3 cm or more) filling the gallbladder. Their surface is hard, smooth, 
whitish-yellow and glistening. On cut section, the pure cholesterol stone 
shows radiating glistening crystals. It may result in deposition of cholesterol 
within the mucosal macrophages of the gallbladder producing cholesterolosis 
which is an asymptomatic condition. Pure cholesterol stones are radiolucent but 
10-20% of them have calcium carbonate in them which renders them opaque. 
ii) Pure pigment gallstones: These stones composed of bile pigment 
(calcium bilirubinate) are generally multiple, jet-black and small (less than 1 
cm in diameter). They have mulberry like external surface. They are soft and 
can be easily crushed. The gallbladder usually appears uninvolved. 
iii) Pure calcium carbonate gallstones: They are rare. Calcium car- 
bonate gallstones are usually multiple, grey-white, small (less than 1 cm in 
diameter), faceted and fairly hard due to calcium content. They, too, do not 
produce any change in the gallbladder wall. 
2. Mixed gallstones. Mixed gallstones are the most common (80%). 
They are always multiple, multifaceted so that they fit together and vary in 
size from as tiny as sand-grain to 1 cm or more in diameter. On section, they 
have distinct laminated structure with alternating dark pigment layer and 
pale-white layer revealing different combinations of cholesterol, bilirubin 
pigment and calcium carbonate, laid down in layers at different times. Mixed 
gallstones are invariably accompanied by chronic cholecystitis. 
3. Combined gallstones. They comprise about 10% of all gallstones. 
Combined gallstones are usually solitary, large and smooth-surfaced. It has a pure 
gallstone nucleus (cholesterol, bile pigment or calcium carbonate) and outer shell 
of mixed gallstone; or a mixed gallstone nucleus with pure gallstone shell. Com- 
bined gallstones, too, are associated with chronic cholecystitis. 
Clinical manifestations and complications. In about 50% cases, gall- 
stones cause no symptoms and may be diagnosed by chance during investiga- 
tions for some other condition (silent gallstones). The future course in such 
asymptomatic silent cases is controversial, most surgeons advocating cholecys- 
tectomy while physicians advising watchful waiting. Follow-up studies, howev- 
er, show that only about 10% of such cases develop symptoms. Symptomatic 
gallstone disease appears only when complications develop. These are as under: 
1. Cholecystitis. The relationship between cholelithiasis and cholecysti- 
tis is well known but it is not certain which of the two comes first. The pa- 
tients with gallstones develop symptoms due to cholecystitis which include 
typical biliary colic precipitated by fatty meal, nausea, vomiting, fever 
alongwith leucocytosis and high serum bilirubin. 
2. Choledocholithiasis. Gallstones may pass down into the extrahepatic 




biliary tree. Patients with gallstone in the common bile duct frequently devel- 
op pain and obstructive jaundice. Fever may develop due to bacterial ascend- 
ing cholangitis. 
3. Mucocele. Mucocele or hydrops of the gallbladder is distension of 
the gallbladder by clear, watery mucinous secretion resulting from impacted 
stones in the neck of the gallbladder. 
4. Biliary fistula. An uncommon complication of cholelithiasis is for- 
mation of fistulae between one part of the biliary system and the bowel, and 
rarely between the gallbladder and the skin. 
5. Gallstone ileus. A gallstone in the intestine may be passed in the 
faeces without causing symptoms. 
Occasionally, however, gallstones in the intestine may cause intestinal 
obstruction called gallstone ileus. 
6. Gallbladder cancer. There is a small and doubtful risk of develop- 
ment of cancer of the gallbladder in cases with cholelithiasis. 
 
CHOLECYSTITIS 
Cholecystitis or inflammation of the gallbladder may be acute, chronic, 
or acute superimposed on chronic. Though chronic cholecystitis is more 
common, acute cholecystitis is a surgical emergency. 
ACUTE CHOLECYSTITIS 
In many ways, acute cholecystitis is similar to acute appendicitis. The 
condition usually begins with obstruction, followed by infection later. 
Etiopathogenesis. Based on the initiating mechanisms, acute cholecys- 
titis occurs in two types of situations – acute calculous and acute acalculous 
cholecystitis. 
• Acute calculous cholecystitis. In 90% of cases, acute cholecystitis is 
caused by obstruction in the neck of the gallbladder or in the cystic duct by a 
gallstone. The commonest location of impaction of a gallstone is in Hart- 
mann's pouch. Obstruction results in distension of the gallbladder followed 
by acute inflammation which is initially due to chemical irritation. Later, 
however, secondary bacterial infection, chiefly by E. coli and Streptococcus 
faecalis, supervenes. 
• Acute acalculous cholecystitis. The remaining 10% cases of acute 
cholecystitis do not contain gallstones. In such cases, a variety of causes have 
been assigned such as previous nonbiliary surgery, multiple injuries, burns, 
recent childbirth, severe sepsis, dehydration, torsion of the gallbladder and 
diabetes mellitus. Rare causes include primary bacterial infection like salmo- 
nellosis and cholera and parasitic infestations. 
Pathologic changes. Except for the presence or absence of calculi, the 




gallbladder is distended and tense. The serosal surface is coated with fibrin- 
ous exudate with congestion and haemorrhages. The mucosa is bright red. 
The lumen is filled with pus mixed with green bile. In cakulous cholecystitis, 
a stone is generally impacted in the neck or in the cystic duct. When obstruc- 
tion of the cystic duct is complete, the lumen is filled with purulent exudate 
and the condition is known as empyema of the gallbladder. Microscopically, 
wall of the gallbladder shows marked inflammatory oedema, congestion and 
neutrophilic exudate. There may be frank abscesses in the wall and gangrenous 
necrosis with rupture into the peritoneal cavity (gangrenous cholecystitis). 
CHRONIC CHOLECYSTITIS 
Chronic cholecystitis is the commonest type of clinical gallbladder disease. 
There is almost constant association of chronic cholecystitis with cholelithiasis. 
Etiopathogenesis. The association of chronic cholecystitis with mixed 
and combined gallstones is virtually always present. However, it is  not 
known what initiates the inflammatory response in the gallbladder wall. Pos- 
sibly, supersaturation of the bile with cholesterol predisposes to both gall- 
stone formation and inflammation. In some patients, repeated attacks of mild 
acute cholecystitis result in chronic cholecystitis. 
Pathologic changes. Grossly, the gallbladder is generally contracted 
but may be normal or enlarged. The wall of the gallbladder is thickened 
which on cut section is grey-white due to dense fibrosis or may be even calci- 
fied. The mucosal folds may be intact, thickened, or flattened and atrophied. 
The lumen commonly contains multiple mixed stones or a combined stone. 
Histologically, the features are as under: 
1. Thickened and congested mucosa but occasionally mucosa may be 
totally destroyed. 
2. Penetration of the mucosa deep into the wall of the gallbladder up to 
muscularis layer to form Rokitansky-Aschoffsm uses. 
3. Variable degree of chronic inflammatory reaction, consisting of 
lymphocytes, plasma cells and macrophages, present in the lamina propria 
and subserosal layer. 
4. Variable degree of fibrosis in the subserosal and subepithelial layers. 
A few morphologic variants of chronic cholecystitis are considered below: 
• Cholecystitis glandularis, when the mucosal folds fuse together due 
to inflammation and result in formation of crypts of epithelium buried in the 
gallbladder wall. 
• Porcelain gallbladder is the pattern when the gallbladder wall is calci- 
fied and cracks like an eggshell. 
• Acute on chronic cholecystitis is the term used for the morphologic 




TUMOURS OF BILIARY SYSTEM 
Tumours of the biliary tract include benign and malignant tumours and 
carcinoid of the biliary tract. 
BENIGN TUMOURS 
Benign tumours such as papilloma, adenoma, adenomyoma, fibroma, 
lipoma, myxoma, and haemangioma have been described in the biliary tract 
but all of them are exceedingly rare. Adenomyoma is more common benign 
tumour than the rest. All these tumours resemble their counterparts in mor- 
phology elsewhere in the body. 
MALIGNANTTUMOURS 
Carcinoma of the gallbladder and carcinoma of the bile ducts and ampulla 
of Vater are among the more frequent malignant tumours of the biliary tract. 
CARCINOMA OF THE GALLBLADDER 
Primary carcinoma of the gallbladder is more prevalent than other can- 
cers of the extrahepatic biliary tract. Like cholelithiasis and cholecystitis, it is 
more frequent in women than in men with a peak incidence in 7th decade of 
life. It is usually slow-growing and may remain undetected until the time it is 
widely spread and rendered inoperable. 
Etiology. A number of etiologic factors have been implicated. 
1. Cholelithiasis and cholecystitis. The most signin cant association of 
cancer of the gallbladder is with cholelithiasis and cholecystitis, though there 
is no definite evidence of causal relationship. Cholelithiasir and cholecystitis 
are present in about 75% cases of gallbladder cancer. But, on the other hand, 
the incidence of documented gallbladder cancer in the presence of cholelithi- 
asis and cholecystitis is about 0.5% only. Porcelain gall bladdder is particu- 
larly likely to become cancerous. 
2. Chemical carcinogens. A number of chemical carcinogens structur- 
ally similar to naturally-occurring bile acids have been considered to induce 
gallbladder cancer. These include methyl cholanthrene, various nitrosamines 
and pesticides. Workers engaged in rubber industry have higher incidence of 
gallbladder cancer. 
3. Genetic factors. There is higher incidence of cancer of the gallblad- 
der in certain populations living in the same geographic region suggesting a 
strong genetic component in the disease. Japanese immigrants and Native 
Americans of the South-Western America have increased frequency while 
American Indians and Mexicans have lower incidence. 
4. Miscellaneous. Patients who have undergone previous surgery on 
the biliary tract have higher incidence of subsequent gallbladder cancer. Pa- 
tients with inflammatory bowel disease (ulcerative colitis and Crohn's dis- 




Pathologic changes. The commonest site is the fundus, followed next 
in frequency by the neck of the gallbladder. 
Grossly, cancer of the gallbladder is of 2 types – infiltrating and fun- 
gating type. 
1. Infiltrating type appears as an irregular area of diffuse thickening 
and induration of the gallbladder wall. It may have deep ulceration causing 
direct invasion of the gallbladder wall and liver bed. On section, the gallblad- 
der wall is firm due to scirrhous growth. 
2. Fungating type grows like an irregular, friable, papillary or cauli- 
flower-like growth into the lumen as well as into the wall of the gallbladder 
and beyond. 
Histologicaltyf the following patterns are observed: 
1. Most gallbladder cancers are adenocarcinomas (90%). They may be 
papillary or infiltrative, well-differentiated or poorly-differentiated. Most are 
non-mucin secreting but some are colloid carcinomas forming mucus pools: 
2. About 5% of gallbladder cancers are squamous cell carcinomas aris- 
ing from squamous metaplastic epithelium. 
3. A few cases show both squamous and adenocarcinoma pattern of 
growth called adenosquamous carcinoma. 
CARCINOMA OF EXTRAHEPATIC BILE DUCTS AND AMPULLA OF VATER 
This is an infrequent neoplasm but is more common than the rare benign 
tumours of the biliary tract. Unlike other diseases of the biliary passages, it is 
more common in males with peak incidence in 6th decade of life. 
Etiology. There is no association between bile duct carcinoma and 
gallstones. Bile duct cancers are associated with a number of other conditions 
such as ulcerative colitis, sclerosing cholangitis, parasitic infestations of the 
bile ducts with Fasciola hepatica (liver fluke), Ascaris lumbricoides and 
Clonorchis sinensis. 
Pathologic changes. Extrahepatic bile duct carcinoma may arise any- 
where in the biliary tree but the most frequent sites, in descending order of 
frequency, are: the ampulla of Vater, lower end of common bile duct, hepatic 
ducts, and the junction of hepatic ducts to form common bile duct. 
Grossly, bile duct carcinoma is usually small, extending for 1-2 cm 
along the duct, producing thickening of the affected duct. 
Histologically, the tumour is usually well-differentiated adenocarcino- 





PATHOLOGY OF PANCREAS 
 
The human pancreas, though anatomically a single organ, histologically and physi- 
ologically has 2 distinct parts – the exocrine and endocrine parts. The endocrine part of 
the gland is dealt with in Chapter 24 while the exocrine gland is considered here. The 
whole of pancreas, exocrine and endocrine, is embryologically derived from the foregut 
endoderm. 
The pancreas lies obliquely in the concavity of the duodenum as an elongated structure 
about 15 cm in length and 100 gm in weight. It is subdivided into 3 topographic zones: 
1. The head lying in the concavity of the duodenum and the uncinate process pro- 
jecting from the head. 
2. The body comprises the main part of the gland. 
3. The tail is the thin, tapering part of the gland towards the hilum of the spleen. 
The exocrine pancreas constitutes 80 to 85% of the total gland, while the endocrine 
pancreas comprises the remaining part. 
The exocrine part is divided into rhomboid lobules separated by thin fibrous tissue 
septa containing blood vessels, lymphatics, nerves and ducts. Each lobule is composed of 
numerous acini. The acini are lined by pyramid-shaped columnar epithelial cells. These 
secretory epithelial cells have microvilli projecting into the lumen from their surface. The 
apical portions of these cells contain zymogen granules in their cytoplasm, while the basal 
region is deeply basophilic and free of zymogen granules. The zymogen granules are 
membrane-bound sacs which fuse with the plasma membrane and are then released into 
the lumina of the acini. The secretions are carried from the acini by fine ductal branches 
into the small ducts in the lobules and eventually into the main pancreatic duct. The main 
pancreatic duct is formed by fusion of the ventral duct with the dorsal duct; the latter also 
called the duct of Wirsung, provides the main drainage for pancreatic secretions into the 
duodenum. The pancreatic secretions are delivered into the second part of the duodenum 
either by a combined opening of the pancreatic and bile ducts in the ampulla of Vater, or 
less often both open separately into the duodenum. Occasionally, the proximal part of the 
dorsal duct persists as the duct of Santorini. 
The main functions of the exocrine pancreas is the alkaline secretion of digestive 




The significant developmental anomalies of the pancreas are ectopic or 
aberrant pancreatic tissue in Meckel's diverticulum, anomalies of the ducts, 
and cystic fibrosis. Only the last named requires elaboration here. 
Cystic Fibrosis 
Cystic fibrosis of the pancreas or fibrocystic disease is a hereditary 
disorder characterised by viscid mucous secretions in all the exocrine glands 
of the body (mucoviscidosis) and associated with increased concentrations of 
electrolytes in the eccrine glands. The terms 'cystic fibrosis' and 'fibrocystic 
disease' are preferable over 'mucoviscidosis' in view of the main pathologic 
change of fibrosis produced as a result of obstruction of the passages by vis- 




trait with apparent clinical features in homozygotes only. The genetic defect 
appears to lie in chromosome 7. It is quite common in the whites (1 per 2000 
livebirths). The clinical manifestations may appear at birth or later in adoles- 
cence and pertain to multiple organs and systems such as pancreatic insuffi- 
ciency, intestinal obstruction, steatorrhoea, malnutrition, hepatic cirrhosis and 
respiratory complications. 
Pathologic changes. Depending upon the severity of involvement and 
the organs affected, the pathologic changes are variable. Most of the changes 
are produced as a result of obstruction by viscid mucous. 
1. Pancreas. The pancreas is almost invariably involved in cystic fibrosis. 
Grossly, pancreatic lobules are ovoid rather than rhomboid. Fatty re- 
placement of the pancreas and grossly visible cysts may be seen. 
Microscopically the lobular architecture of pancreatic parenchyma is 
maintained. There is increased interlobular fibrosis. The acini are atrophic 
and many of the acinar ducts contain laminated, eosinophilic concretions. 
Rarely, inflammation, fat necrosis and cyst formation may be seen. The islet 
tissue (endocrine pancreas) generally remains intact. Atrophy of the exocrine 
pancreas may cause impaired fat absorption, steatorrhoea, intestinal obstruc- 
tion and avitaminosis A. 
2. Liver. The bile canaliculi are plugged by viscid mucous which may 
cause diffuse fatty change, portal fibrosis and ductular proliferation. More 
severe involvement may cause biliary cirrhosis. 
3. Respiratory tract. Changes in the respiratory passages are seen in 
almost all typical cases of cystic fibrosis. The viscid mucous secretions of the 
submucosal glands of the respiratory tract cause obstruction, dilatation and 
infection of the airways. The changes include chronic bronchitis, bronchiec- 
tasis, bronchiolitis, bronchiolectasis, peribronchiolar pneumonia and inflam- 
matory nasal polyps. 
4. Salivary glands. Pathologic changes in the salivary glands are simi- 
lar to those in pancreas and include obstruction of the ducts, dilatation, fibro- 
sis and glandular atrophy. 
5. Sweat glands. Hypersecretion of sodium and chloride in the sweat 
observed in these patients may be reflected pathologically by diminished 
vacuolation of the cells of eccrine glands. 
 
PANCREATITIS 
Pancreatitis is inflammation of the pancreas with acinic cell injury. It is 
classified into acute and chronic forms both of which are two distinct entities. 
ACUTE PANCREATITIS 
Acute pancreatitis is an acute inflammation of the pancreas presenting 




with macroscopic haemorrhages and fat necrosis in and around the pancreas 
is termed acute haemorrhagic pancreatitis or acute pancreatic necrosis. The 
condition occurs in adults between the age of 40 and 70 years and is com- 
moner in females than in males. 
The onset of acute pancreatitis is sudden, occurring after a bout of al- 
cohol or a heavy meal. The patient presents with abdominal pain, vomiting 
and collapse and the condition must be differentiated from other diseases 
producing acute abdomen such as acute appendicitis, perforated peptic ulcer, 
acute cholecystitis, and infarction of the intestine following sudden occlusion 
of the mesenteric vessels. Characteristically, there is elevation of serum am- 
ylase level within the first 24 hours and of serum lipase level after 3 to 4 
days; the latter being more specific for pancreatic disease. Glucosuria occurs 
in 10% of cases. 
Etiology. The two leading causes associated with acute pancreatitis are 
alcoholism and cholelithiasis, both of which are implicated in more than 80% 
of cases. Less common causes of acute pancreatitis include trauma, ischae- 
mia, shock, extension of inflammation from the adjacent tissues, blood-borne 
bacterial infection, viral infections, certain drugs (e.g. thiazides, sulfona- 
mides, oral contraceptives), hypothermia, hyperlipoproteinaemia and hyper- 
calcaemia from hyperparathyroidism. Rarely, familial pancreatitis is encoun- 
tered. In a proportion of cases of acute pancreatitis, the etiology remains un- 
known (idiopathic pancreatitis). 
Pathogenesis. The destructive changes in the pancreas are attributed to 
the liberation and activation of pancreatic enzymes. Though more than 20 en- 
zymes are secreted by exocrine pancreas, 3 main groups of enzymes which 
bring about destructive effects on the pancreas are as under: 
1. Proteases such as trypsin and chymotrypsin play the most important 
role in causing proteolysis. Trypsin also activates the kinin system by con- 
verting prekallikrein to kallikrein, and thereby the clotting and complement 
systems are activated. This results in inflammation, thrombosis, tissue dam- 
age and haemorrhages found in acute haemorrhagic pancreatitis. 
2. Lipases and phospholipases degrade lipids and membrane phospho- 
lipids.  
3. Elastases cause destruction of the elastic tissue of the blood vessels. 
The activation and release of these enzymes is brought about by one of 
the following mechanisms: 
1. Acinic cell damage caused by the etiologic factors such as alcohol, vi- 
ruses, drugs, ischaemia and trauma result in release of the intracellular enzymes. 
2. Duct obstruction caused by cholelithiasis, chronic alcoholism and 
other obstructing lesions is followed by leakage of pancreatic enzymes from 




3. Block in exocytosis of pancreatic enzymes occurring from nutritional 
causes results in activation of these intracellular enzymes by pancreatic lyso- 
somal hydrolases. 
Pathologic changes. Macroscopically, in the early stage, the pancreas 
is swollen and oedematous. Subsequently, in a day or two, the characteristic 
variegated appearance of grey-white pancreatic necrosis, chalky-white fat ne- 
crosis and blue-black haemorrhages are seen. In typical case, the peritoneal 
cavity contains blood-stained ascitic fluid and white flecks of fat necrosis in 
the omentum, mesentry and peripancreatic tissue. The resolved lesions show 
areas of fibrosis, calcification and ductal dilatation. Microscopically, the fol- 
lowing features in varying grades are noticeable: 
1. Necrosis of pancreatic lobules and ducts. 
2. Necrosis of the arteries and arterioles with areas of haemorrhages. 
3. Fat necrosis. 
4. Inflammatory reaction, chiefly by polymorphs, around the areas of 
necrosis and haemorrhages. 
Complications. A patient of acute pancreatitis who survives may de- 
velop a variety of systemic and local complications. 
Systemic complications. These are: 
1. Chemical and bacterial peritonitis. 
2. Endotoxic shock. 
3. Acute renal failure. 
Local sequelae. These result after widespread involvement of the pan- 
creas. These are: 
1. Pancreatic abscess. 
2. Pancreatic pseudocyst. 
3. Duodenal obstruction. 
Mortality in acute pancreatitis is high (20-30%). Patients succumb to 
hypotensive shock, infection, acute renal failure, and DIC. 
CHRONIC PANCREATITIS 
Chronic pancreatitis or chronic relapsing pancreatitis is the progres- 
sive destruction of the pancreas due to repeated mild and subclinical attacks 
of acute pancreatitis. Most patients present with recurrent attacks of severe 
abdominal pain at intervals of months to years. Weight loss and jaundice are 
often associated. Later manifestations include associated diabetes mellitus 
and steatorrhoea. Abdominal radiographs show calcification in the region of 
pancreas and presence of pancreatic calculi in the ducts. 
Etiology. Most cases of chronic pancreatitis are caused by the same 
factors as for acute pancreatitis. Thus, most commonly, chronic pancreatitis 




ary tract disease. Familial hereditary pancreatitis, though uncommon, is 
more frequently chronic than the acute form. Other rare causes of chronic 
pancreatitis are hypercalcaemia, hyperlipidaemia and developmental failure 
of fusion of dorsal and ventral pancreatic ducts. 
Pathogenesis. Acute haemorrhagic pancreatitis seldom develops into 
chronic pancreatitis, but instead develops pancreatic pseudocysts following 
recovery. Pathogenesis of alcoholic and non-alcoholic chronic pancreatitis is 
explained by different mechanisms: 
1. Chronic pancreatitis due to chronic alcoholism accompanied by a 
high-protein diet results in increase in protein concentration in the pancreatic 
juice which obstructs the ducts and causes damage. 
2. Non-alcoholic cases of chronic pancreatitis seen in tropical countries 
(tropical chronic pancreatitis) result from protein-calorie malnutrition. Genet- 
ic factors play a role in some cases of chronic pancreatitis. 
Pathologic changes. Macroscopically, the pancreas is enlarged, firm 
and nodular. The cut surface shows a smooth grey appearance with loss of 
normal lobulation. Foci of calcification and tiny pancreatic concretions to 
larger visible stones are frequently found. Pseudocysts may be present. Mi- 
croscopically, depending upon the stage of development, the following 
changes are seen: 
1. Obstruction of the ducts by fibrosis in the wall and protein plugs or 
stones in the lumina. 
2. Squamous metaplasia and dilatation of some inter- and intralobular 
ducts.  
3. Chronic inflammatory infiltrate around the lobules as well as the ducts. 
4. Atrophy of the acinar tissue with marked increase in interlobular fi- 
brous tissue. 
5. Islet tissue is involved in late stage only. 
Complications. Late stage of chronic pancreatitis may be complicated 
by diabetes mellitus, pancreatic insufficiency with steatorrhoea and malab- 
sorption and formation of pancreatic pseudocysts. 
 
 
TUMOURS AND TUMOUR-LIKE LESIONS 
Tumour-like masses of the exocrine pancreas include congenital cystic 
disease (involving the pancreas, liver and kidney) and pancreatic pseudo- 
cysts. True pancreatic tumours are classified into benign (e.g. serous cysta- 
denoma, fibroma, lipoma and adenoma) and malignant (i.e. carcinoma of the 
pancreas). Out of all these, only two pancreatic lesions—pseudocyst and carci- 





Pancreatic pseudocyst is a localised collection of pancreatic juice, ne- 
crotic debris and haemorrhages. It develops following either acute pancreati- 
tis or trauma. The patients generally present with abdominal mass producing 
pain, intraperitoneal haemorrhage and generalised peritonitis. 
Pathologic changes. Grossly, the pseudocyst may be present within or 
adjacent to the pancreas. Usually it is solitary, unilocular, measuring up to 10 
cm in diameter with thin or thick wall. Microscopically, the cyst wall is com- 
posed of dense fibrous tissue with marked inflammatory reaction. There is evi- 
dence of preceding haemorrhage and necrosis in the form of deposits of hae- 
mosiderin pigment, calcium and cholesterol crystals. The lumen of the cyst 
contains serous or turbid fluid. The cyst does not show any epithelial lining. 
 
CARCINOMA OF PANCREAS 
Pancreatic cancer is the term used for cancer of the exocrine pancreas. 
It is one of the common cancers, particularly in the Western countries and Ja- 
pan. In the United States, cancer of the pancreas is the second most common 
cancer of the alimentary tract after colorectal cancer, and accounts for 5% of 
all cancer deaths in that country. It is commoner in males than in females and 
the incidence increases progressively after the age of 50 years. 
Etiology. A significant increase in the incidence of pancreatic cancer 
has been observed in the UK and US during the last 50 years. A number of 
etiologic factors have been implicated. These include the following: 
1. Smoking: heavy cigarette smokers have higher incidence than the 
non-smokers. 
2. Diet: Diet with high total caloric value and high consumption of an- 
imal proteins and fats is related to higher incidence of pancreatic cancer. 
3. Chemical carcinogens: Individuals exposed to (3 naphthylamine, ben- 
zidine and nitrosamines have higher incidence of cancer of the panceras. 
4. Diabetes mellirus. 
5. Hereditary chronic pancreatitis. 
6. Disease of the gallbladder. 
Pathologic changes. The most common location of pancreatic cancer 
is the head of pancreas (70%), followed in decreasing frequency, by the body 
and the tail of pancreas. 
Grossly, carcinoma of the head of pancreas is generally small, homo- 
geneous, poorly-defined, grey-white mass without any sharp demarcation be- 
tween the tumour and the surrounding pancreatic parenchyma. The tumour of 
the head extends into the ampulla of Vater, common bile duct and duodenum, 
producing obstructive biliary symptoms and jaundice early in the course of 




are fairly large and irregular masses and frequently infiltrate the transverse 
colon, stomach, liver, spleen and regional lymph nodes. Microscopically, 
most pancreatic carcinomas arise from the ductal epithelium which normally 
comprises less than 4% of total pancreatic cells, whereas carcinoma of the 
acini constitutes less than 1% of pancreatic cancers. The following histologic 
patterns of pancreatic carcinoma are seen: 
1. Well-differentiated adenocarcinoma, both mucinous and non-mucin 
secreting type, is the most common pattern. Perineural invasion is commonly 
present and is diagnostic of malignancy. 
2. Adenoacanthoma consisting of glandular carcinoma and benign 
squamous elements is seen in a proportion of cases. 
3. Rarely, peculiar tumour giant cell formation is seen with marked an- 
aplasia, pleomorphism and numerous mitoses. 
4. Acinar cell carcinoma occurs rarely and reproduces the pattern of 
acini in normal pancreas. 
Generally, the following features are present: 
1. Obstructive jaundice, more often and early in the course of disease 
in cases with carcinoma head of the pancreas (80%), and less often in cancer 
of the body and tail of the pancreas. It is characterised by: dark urine, clay- 
like stools, pruritus, and very high serum alkaline phosphatase. 
2. Other features. These include: abdominal pain, anorexia, weight 
loss, cachexia, weakness and malaise, nausea and vomiting, and migratory 
thrombophlebitis (Trousseau's syndrome), GI bleeding and splenomegaly. 
The prognosis of pancreatic cancer is dismal: median survival is 6 
months from the time of diagnosis. Approximately 10% patients survive 1 




PATHOLOGY OF KIDNEY AND LOWER URINARY 
TRACT 
 
The kidneys are bean-shaped paired organs, each weighing about 150 gm in the 
adult male and about 135 gm in the adult female. The hilum of the kidney is situated at the 
midpoint on the medial aspect where the artery, vein, lymphatics and ureter are located. The 
kidney is surrounded by a thin fibrous capsule which is adherent at the hilum. 
Cut surface of the kidney is made up of well-demarcated peripheral cortex and in- 
ner medulla. The cortex is 1.2 to 1.5 cm in thickness and shows faint striations called me- 
dullary rays formed by the collecting tubules, ascending limbs and straight portions of the 
proximal convoluted tubules. The medulla is composed of several cone-shaped renal pyr- 
amids, the apex of each of which called the papilla is related to a calyx. Cortical tissue 
that extends into the space between adjacent pyramids is called the renal column (septa) of 
Berlin. The pelvis is the funnel-shaped, dilated proximal part of the ureter formed by the 
union of 2 to 3 major calyces, each of which is further subdivided into 3 to 4 minor caly- 
ces into which the papillae project. 
The parenchyma of each kidney is composed of approximately one million micro- 
structures called nephrons. A nephron, in turn, consists of 5 major parts, each having a 
functional role in the formation of urine: the glomerular capsule (glomerulus and Bow- 
man's capsule), the proximal convoluted tubule (PCT), the loop of Henle, the distal convo- 
luted tubule (DCT), and the collecting ducts. From point of view of diseases of the kid- 
neys, 4 components of renal parenchyma require further elaboration: renal vasculature, 
glomeruli, tubules and interstitium. 
1. Renal vasculature. Each kidney is supplied with blood by a main renal artery 
which arises from the aorta at the level of the 2nd lumbar vertebra. It usually divides into 
anterior and posterior divisions at the hilum although occasionally these divisions may 
even arise directly from the aorta. The anterior and posterior divisions divide into segmen- 
tal branches from which interlobar arteries arise. Along their course, they give off the ar- 
cuate arteries which arch between the cortex and medulla. The arcuate arteries, in turn, 
give off interlobular arteries which lie in the cortex perpendicular to the capsular surface 
in the part overlying the pyramids and, therefore, are also called straight arteries. It is 
from the interlobular arteries that the afferent arterioles take their origin, each one supply- 
ing a single glomerulus. From the glomerulus emerge the efferent arterioles. Up to this 
stage, the arteries and arterioles are end-vessels. The efferent arterioles leaving the 
glomerulus supply peritubular capillary plexus which anastomoses with the capillary 
plexus of another nephron. 
The juxtamedullary glomeruli, however, give off a series of parallel vessels called 
vasa recta which descend to the inner medulla supplying the loop of Henle and collecting 
ducts and anastomose at all levels throughout the medulla with the ascending vasa recta. 
These drain into arcuate veins and then into the veins that accompany the corresponding 
arteries and finally through a single renal vein into the inferior vena cava. Lymphatic 
drainage likewise occurs through lymphatics associated with the intrarenal vasculature 
leaving the kidney at the hilum and draining to lateral aortic lymph nodes. 
The following important derivations can be made from the peculiarities of the re- 
nal vasculature: 
i) The renal cortex receives about 90% of the total renal blood supply and that the 
pressure in the glomerular capillaries is high. Therefore, renal cortex is more prone to the 




ii) The renal medulla, on the other hand, is poorly perfused and any interference in 
blood supply to it results in medullary necrosis. 
iii) The divisions and subdivisions of the renal artery up to arterioles are end- 
arteries and have no anastomoses. Thus, occlusion of any of the branches results in infarc- 
tion of the renal parenchyma supplied by it. 
iv) Since the tubular capillary beds are derived from the efferent arterioles leaving 
the glomeruli, diseases affecting the blood flow through glomerular tuft have significant 
effects on the tubules as well. 
2. Glomerulus. The glomerulus consists of invagination of the blind end of the 
proximal tubule and contains a capillary tuft fed by the afferent arteriole and drained by 
efferent arteriole. The capillary tuft is covered by visceral epithelial cells (podocytes) 
which are continuous with those of the parietal epithelium at the vascular pole. The transi- 
tion to proximal tubular cells occurs at the urinary pole of the glomerulus. The visceral 
and parietal epithelial cells are separated by the urinary space or Bowman's space, into 
which glomerular filtrate passes. 
Subdivisions of capillaries derived from the afferent arterioles result in the for- 
mation of lobules of which there are not more than eight within a glomerulus. Each lobule 
of a glomerular tuft consists of a centrilobular supporting stalk composed of mesangium 
containing mesangial cells and mesangial matrix. The mesangium is continuous at the hilum 
with the lads cells of the Juxtaglomerular apparatus. Besides their role as supportive cells, 
mesangial cells are involved in the production of mesangial matrix and glomerular basement 
membrane; they function in endocytosis of leaked macromolecules and also possibly in the 
control of glomerular blood flow through contractile elements present in these cells. The ma- 
jor function of glomerulus is complex filtration from the capillaries to the urinary space. The 
barrier to glomerular filtration consists of the following 3 components: 
i) Fenestrated endothelial cells lining the capillary loops. 
ii) Glomerular basement membrane (GBM) on which the endothelial cells rest and 
consists of 3 layers – the central lamina densa, bounded by lamina rara interna and lamina 
rara externa. 
iii) Filtration slit pores between the foot processes of the visceral epithelial cells 
(podocytes) external to GBM. 
The barrier to filtration of macromolecules of the size and molecular weight of al- 
bumin and larger depends upon the following: 
• A normal lamina densa. 
• Maintenance of negative charge on both lamina rarae. 
• A healthy covering of glomerular epithelial cells. 
Juxtaglomerular apparatus. The Juxtaglomerular apparatus QGA) is situated at 
the vascular pole of the glomerulus and is made up of 3 parts: 
i) The Juxtaglomerular cells are modified granular smooth muscle cells in the me- 
dia of the afferent arteriole and contain the hormone, renin. 
ii) The macula densa is comprised by specialised region of the distal tubule when 
it returns to the vascular pole of its parent glomerulus. The tubular cells here are taller and 
narrower than elsewhere with the nuclei lying close together. 
iii) The lads cells or non-granular cells occupy the space between the macula den- 
sa and the arterioles and merge with the glomerular mesangium. 
The JGA is intimately concerned with sodium metabolism and is the principal 




3. Tubules. The tubules of the kidney account for the greatest amount of the renal 
parenchyma. The structure of renal tubular epithelium varies in different parts of the neph- 
ron and is correlated with the functional capacity of that part of the tubule. 
i) Proximal convoluted tubule (PCT). This is the first part arising from the glomer- 
ulus and is highly specialised part functionally. It is lined by cuboidal cells with a brush 
border composed of microvilli and contains numerous mitochondria, Golgi apparatus and 
endoplasmic reticulum. The major functions of PCT are: active reabsorption of filtered 
sodium, potassium, glucose, amino acids, proteins, phosphate, calcium and uric acid, and 
passive reabsorption of 80% of filtered water. 
ii) Loop of Henle. The PCT drains into the straight part of loop of Henle that con- 
sists of thin, descending and ascending limbs and the actual loop, all of which are found in 
the medulla. They are lined by a flattened type of epithelium. The thin ascending limb 
continues as thick ascending limb in the medullary rays. In cross section, the thick ascend- 
ing limb is nearly of the same size as that of PCT and the lining cells are columnar. The 
major function of loop of Henle is active reabsorption of sodium and chloride, and passive 
diffusion of water resulting in urinary concentration. 
iii) Distal convoluted tubule (DCT). The DCT represents a transition from thick 
ascending limb from the point where the ascending limb meets the vascular pole of the 
glomerulus of its origin, to the early collecting ducts. The lining cells are cuboidal which 
are lower than those of PCT. The epithelial cells at the point of beginning of DCT are tall- 
er, narrower and more closely packed to form the macula densa of JGA as already de- 
scribed. The DCT further contributes to urinary concentration and acidification, while the 
macula densa of JGA is the source of renin and has a role in sodium metabolism. 
iv) Collecting ducts. The system of collecting ducts is the final pathway by which 
urine reaches the tip of renal papilla. The cells lining the collecting ducts are cuboidal but 
lack the brush border. 
4. Interstitium. In health, the renal cortical interstitium is scanty and consists of a 
small number of fibroblast-like cells. But the medullary interstitium is more plentiful and 
contains stellate interstitial cells which are considered to produce an antihypertensive 
agent and are involved in the metabolism of prostaglandins. 
In general, the kidney performs the following vital functions in the body: 
1. Excretion of waste products resulting from protein metabolism. 
2. Regulation of acid-base balance by excretion of H+ ions (acidification) and bi- 
carbonate ions. 
3. Regulation of salt-water balance by hormones secreted both intra- and extra- 
renally. 
4. Formation of renin and erythropoietin and thereby playing a role in the regula- 
tion of blood pressure and erythropoiesis respectively. 
To confirm the diagnosis of renal disease renal biopsy is performed. Renal biopsy 
is ideally fixed in alcoholic Bouin's solution and examined morphologically supported by 
special stains and further studies as under: 
1. Periodic acid-Schiff stain for highlighting glomerular basement membrane. 
2. Silver impregnation to outline the glomerular and tubular basement membrane. 
3. Immunofluorescence to localise the antigens, complements and immunoglobulins. 
4. Electron microscopy to see the ultrastructure of glomerular changes. 
Traditionally, diseases of the kidneys are divided into 8 major groups 





1. Glomerular diseases (Glomerulopathies): These are most often im- 
munologically-mediated and may be acute or chronic, acquired and congeni- 
tal, inflammatory and noninflammatory; 
2. Tubular diseases (Tubulopathies): These are acquired and congenital, 
necrotized and obstructive and more likely to be caused by toxic or infectious 
agents and may be acute or chronic; 
3. Interstitial diseases: These are likewise commonly due to toxic or 
infectious agents and quite often involve interstitium as well as tubules (tubu- 
lo-interstitial diseases); 
4. Vascular diseases: These include changes in the nephron as a con- 
sequence of increased intra-glomerular pressure such as in hypertension or 
impaired blood flow; 
5. Obstructive uropathy (including urolithiasis); 
6. Tumours; 
7. Congenital malformations (anomalies); 
8. Nephrosclerosis (kidney shrinkage). It is classified into primary and 
secondary. 
The major morphologic involvements of the kidneys in the initial stage 
is confined to one component (glomeruli, tubules, interstitium or blood ves- 
sels), but eventually all components are affected leading to end-stage kidneys. 
Regardless of cause, renal disease usually results in the evolution of one 
of the two major pathological syndromes: acute renal failure and chronic renal 
failure. The term 'azotaemia' is used for biochemical abnormality characterised 
by elevation of the blood urea nitrogen (BUN) and creatinine levels, while 
'uraemia' is defined as association of these biochemical abnormalities with clin- 
ical signs and symptoms. The pathophysiological aspects of acute and chronic 
renal failure are briefly discussed below. 
 
PATHOPHYSIOLOGY OF RENAL DISEASE (RENAL FAILURE) 
 
ACUTE RENAL FAILURE (ARF) 
Acute renal failure (ARF) is a syndrome characterised by rapid onset 
of renal dysfunction, chiefly oliguria or anuria, and sudden increase in meta- 
bolic waste-products (urea and creatinine) in the blood with consequent de- 
velopment of uraemia. 
Etiopathogenesis. The causes of ARF may be classified as pre-renal, 
intra-renal and post-renal i nature. 
1. Pre-renal causes. Pre-renal diseases are those which cause sudden 
decrease in blood flow to the nephron. Renal ischaemia ultimately results in 
functional disorders or depression of GFR, or both. These causes include in- 
adequate cardiac output and hypovolaemia or vascular disease causing re- 




2. Intra-renal causes. Intra-renal disease is characterised by disease of 
renal tissue itself. These include vascular disease of the arteries and arterioles 
within the kidney, diseases of glomeruli, acute tubular necrosis due to is- 
chaemia, or the effect of a nephrotoxin, acute tubulointerstitial nephritis and 
pyelonephritis. 
3. Post-renal causes. Post-renal disease is characteristically caused by 
obstruction to the flow of urine anywhere along the renal tract distal to the 
opening of the collecting ducts. This may be caused by a mass within the lu- 
men or from wall of the tract, or from external compression anywhere along 
the tract – ureter, bladder neck or urethra. 
It is important to note that ARF originating in pre-and post-renal disease, 
such as by renal ischaemia or renal infection eventually leads to intra-renal dis- 
ease. Thus, full-blown ARF reflects some degree of nephron damage. 
Clinical features. The clinical features will depend to a large extent on the under- 
lying cause of ARF and on the stage of the disease at which the patient presents. However, 
one of the following three major patterns usually emerge: 
1. Syndrome of acute nephritis. This is most frequently associated with acute 
post-streptococcal glomerulonephritis and rapidly progressive glomerulonephritis. Renal 
dysfunction results from extensive proliferation of epithelial cells in the glomeruli with 
consequent mild increase in glomerular permeability and decrease in GFR. The character- 
istic features are: mild proteinuria, haematuria, oedema and mild hypertension. Fluid re- 
tention in acute nephritis syndrome appears to be due to both diminished GFR and in- 
creased salt and water reabsorption in distal nephron. 
2. Syndrome accompanying tubular pathology. When the ARF is caused by de- 
struction of the tubular cells of the nephron as occurs in acute tubular necrosis, the disease 
typically progresses through 3 characteristic stages from oliguria to diuresis to recovery. 
i) Oliguric phase: The initial oliguric phase lasting on an average from 7 to 10 
days is characterised by urinary output of less than 400 ml per day. The decline in for- 
mation of the urine leads to accumulation of waste products of protein metabolism in the 
blood and resultant azotaemia, metabolic acidosis, hyperkalaemia, hypernatraemia and 
hypervolaemia due to secondary effects of circulatory overload and pulmonary oedema. 
The specific gravity of the urine is low but the concentration of sodium in urine tends to 
be elevated. 
ii) Diuretic phase: With the onset of healing of tubules, there is improvement in 
urinary output. This is believed to occur due to drawing of water and sodium by preceding 
high levels of creatinine and urea as they move through the nephron so as to be excreted. 
Since tubular cells have not regained normal functional capacity, the urine is of low or 
fixed specific gravity. 
iii) Phase of recovery: Full recovery with healing of tubular epithelial cells occurs 
in about half the cases, while others terminate in death. The process of healing may take 
up to one year with restoration of normal tubular function. 
3. Pre-renal syndrome. The ARF occurring secondary to disorders in which nei- 
ther the glomerulus nor the tubules are damaged, results in pre-renal syndrome. Most typi- 
cally, this pattern is seen in marginal ischaemia caused by renal arterial obstruction, 
hypovolaemia, hypotension or cardiac insufficiency. Due to depressed renal blood flow, 




and possible fluid retention and oedema. Since the tubular cells are functioning normally, 
the nephron retains its ability to concentrate the glomerular filtrate according to the adap- 
tive needs. 
 
CHRONIC RENAL FAILURE (CRF) 
Chronic renal failure is a syndrome characterised by progressive and 
irreversible deterioration of renal function due to slow destruction of renal 
parenchyma, eventually terminating in death when sufficient number of 
nephrons have been damaged. Acidosis is the major problem in CRF with 
development of biochemical azotaemia and clinical uraemia syndrome. 
Etiopathogenesis. All chronic nephropathies can lead to CRF. The 
diseases leading to CRF can generally be classified into two major groups: 
those causing glomerular pathology, and those causing tubulointerstitial pa- 
thology. Though this classification is useful to facilitate study, the disease 
rarely remains confined to either glomeruli or tubulointerstitial tissue alone. 
In the final stage of CRF, all parts of the nephron are involved. 
1. Diseases causing glomerular pathology. A number of glomerular 
diseases associated with CRF have their pathogenesis in immune mechanisms. 
Glomerular destruction results in changes in filtration process and leads to de- 
velopment of the nephrotic syndrome characterised by proteinuria, hypoalbumi- 
naemia and oedema. The important examples of chronic glomerular diseases 
causing CRF are covered under two headings: primary and systemic. 
i) Primary glomerular pathology: The major cause of CRF is chronic 
glomerulonephritis, usually initiated by various types of glomerulonephritis 
such as membranous glomerulonephritis, membranoproliferative glomerulo- 
nephritis, lipoid nephrosis (minimal change disease) and anti-glomerular 
basement membrane nephritis. 
ii) Systemic glomerular pathology: Certain conditions originate outside 
the renal system but induce changes in the nephrons secondarily. Major ex- 
amples of this type are systemic lupus erythematosus, serum sickness nephri- 
tis and diabetic nephropathy. 
2. Diseases causing tubulointerstitial pathology. 
Damage to tubulointerstitial tissues results in alterations in reabsorp- 
tion and secretion of important constituents leading to excretion of large vol- 
umes of dilute urine. Tubulointerstitial diseases can be categorised according 
to initiating etiology into 4 groups: vascular, infectious, toxic and obstructive. 
i) Vascular causes: Long-standing primary or essential hypertension 
produces characteristic changes in renal arteries and arterioles referred to as 
nephrosclerosis. Nephrosclerosis causes progressive renal vascular occlusion 




ii) Infectious causes: A good example of chronic renal infection caus- 
ing CRF is chronic pyelonephritis. The chronicity of process results in pro- 
gressive damage to increasing number of nephrons leading to CRF. 
iii) Toxic causes: Some toxic substances induce slow tubular injury, 
eventually culminating in CRF. The most common example is intake of high 
doses of analgesics such as phenacetin, aspirin and acetaminophen (chronic 
analgesic nephritis). Other substances that can cause CRF after prolonged 
exposure are lead, cadmium and uranium. 
iv) Obstructive causes: Chronic obstruction in the urinary tract leads to 
progressive damage to the nephron due to fluid back-pressure. The examples 
of this type of chronic injury are stones, blood clots, rumours, strictures and 
enlarged prostate. 
Clinical features. Regardless of the initiating cause, CRF evolves progressively 
through 4 stages: 
1. Decreased renal reserve. At this stage, damage to renal parenchyma is marginal 
and the kidneys remain functional. The GFR is about 50% of normal, BUN and creatinine 
values are normal and the patients are usually asymptomatic except at times of stress. 
2. Renal insufficiency. At this stage, about 75% of functional renal parenchyma 
has been destroyed. The GFR is about 25% of normal accompanied by elevation in BUN 
and serum creatinine. Polyuria and nocturia occur due to tubulointerstitial damage. Sudden 
stress may precipitate uraemic syndrome. 
3. Renal failure. At this stage, about 90% of functional renal tissue has been de- 
stroyed. The GFR is approximately 10% of normal. Tubular cells are essentially nonfunc- 
tional. As a result, the regulation of sodium and water is lost resulting in oedema, metabol- 
ic acidosis, hypocalcaemia, and signs and symptoms of uraemia. 
4. End-stage kidney. The GFR at this stage is less than 5% of normal and results in 
complex clinical picture of uraemic syndrome with progressive primary (renal) and sec- 
ondary systemic (extra-renal) symptoms. 
Clinical manifestations of full-blown CRF culminating in uraemic syndrome are 
thus described under 2 main headings: primary (renal) uraemic manifestations and sec- 
ondary (systemic or extra-renal) uraemic manifestations. 
A. Primary uraemic (renal) manifestations. Primary symptoms of uraemia develop 
when there is slow and progressive deterioration of renal function. The resulting imbal- 
ances cause the following manifestations: 
1. Metabolic acidosis. As a result of renal dysfunction, acid-base balance is pro- 
gressively lost. Excess of hydrogen ions occurs, while bicarbonate level declines in the 
blood, resulting in metabolic acidosis. The clinical symptoms of metabolic acidosis in- 
clude: compensatory Kussmaul breathing, hyperkalaemia and hypercalcaemia. 
2. Hyperkalaemia. A decreased GFR results in excessive accumulation of potassi- 
um in the blood since potassium is normally excreted mainly in the urine. Hyperkalaemia 
is further worsened by metabolic acidosis. The clinical features of hyperkalaemia are: car- 
diac arrhythmias, weakness, nausea, intestinal colic, diarrhoea, muscular irritability and 
flaccid paralysis. 
3. Sodium and water imbalance. As GFR declines, sodium and water cannot pass 
sufficiently into Bowman's capsule leading to their retention. Release of renin from jux- 




toms referable to sodium and water retention are: hypervolaemia and circulatory overload 
with congestive heart failure. 
4. Hvperuricaemia. Decreased GFR results in excessive accumulation of uric acid 
in the blood. 
Uric acid crystals may be deposited in joints and soft tissues resulting in gout. 
5. Azotaemia. The waste-products of protein metabolism fail to be excreted result- 
ing in elevation in the blood levels of urea, creatinine, phenols and guanidines causing bi- 
ochemical abnormality, azotaemia. The secondary manifestations of uraemia are related to 
toxic effects of these metabolic waste-products. 
B. Secondary uraemic (extra-renal) manifestations. A number of extra-renal sys- 
temic manifestations develop secondarily following fluid-electrolyte and acid-base imbal- 
ances. These include the following: 
1. Anaemia. Decreased production of erythropoietin by diseased kidney results in 
decline in erythropoiesis and anaemia. Besides, gastrointestinal bleeding may further ag- 
gravate anaemia. 
2. Integumentary system. Deposit of urinary pigment such as urochrome in the 
skin causes sallow-yellow colour. The urea content in the sweat as well as in the plasma 
rises. On evaporation of the perspiration, urea remains on the facial skin as powdery 
'uraemic frost'. 
3. Cardiovascular system. Fluid retention secondarily causes cardiovascular symp- 
toms such as increased workload on the heart due to the hypervolaemia and eventually 
congestive heart failure. 
4. Respiratory system. Hypervolaemia and heart failure cause pulmonary conges- 
tion and pulmonary oedema due to back pressure. Radiologically, uraemic pneumonitis 
shows characteristic central, butterfly-pattern of oedema and congestion in the chest radi- 
ograph. 
5. Digestive system. Azotaemia directly induces mucosal ulcerations in the lining 
of the stomach and intestines. Subsequent bleeding can aggravate the existing anaemia. 
Gastrointestinal irritation may cause nausea, vomiting and diarrhoea. 
6. Skeletal system. The skeletal manifestations of renal failure are referred to as 
renal osteodystrophy. Two major types of skeletal disorders may occur: 
i) Osteomalacia occurs from deficiency of a form of vitamin D which is normally 
activated by the kidney. Since vitamin D is essential for absorption of calcium, its defi- 
ciency results in inadequate deposits of calcium in bone tissue. 
ii) Osteitis fibrosa occurs due to elevated levels of parathormone. How parathormone 
excess develops in CRF is complex. As the GFR is decreased, increasing levels of phosphates 
accumulate in the extracellular fluid which, in turn, cause decline in calcium levels. Decreased 
calcium level triggers the secretion of parathormone which mobilises calcium from bone and 
increases renal lubular reabsorption of calcium thereby conserving it. However, if the process 
of resorption of calcium phosphate from bone continues for sufficient time, hypercalcaemia 
may be induced with deposits of excess calcium salts in joints and soft tissues and weakening 
of bones (renal osteodystrophy). 
 
CONGENITAL MALFORMATIONS 
Approximately 10% of all persons are born with potentially significant 
malformations of the urinary system. These range in severity from minor 




which are incompatible with extrauterine life. About half of all patients with 
malformations of the kidneys have coexistent anomalies either elsewhere in 
the urinary tract or in other organs. 
Malformations of the kidneys are classified into 3 broad groups: 
I. Abnormalities in amount of renal tissue. These include: anomalies with 
deficient renal parenchyma (e.g. unilateral or bilateral renal hypoplasia) or with 
excess renal tissue (e.g. renomegaly, supernumerary kidneys). 
II. Anomalies of position, form and orientation. These are: renal ectopia 
(pelvic kidney), renal fusion (horseshoe kidney) and persistent foetal lobation. 
III. Anomalies of differentiation. This group consists of the more im- 
portant and common morphologic forms covered under the heading of 'cystic 
diseases of the kidney' described in detail below. 
CYSTIC DISEASES OF KIDNEY 
Cystic lesions of the kidney may be congenital or acquired, non- 
neoplastic or neoplastic. Majority of these lesions are congenital non- 
neoplastic. Cystic lesions in the kidney may occur at any age, extending from 
foetal (detected on ultrasonography) to old age. Their clinical presentation 
may include: abdominal mass, infection, respiratory distress (due to accom- 
panied pulmonary hypoplasia), haemorrhage, and neoplastic transformation. 
Potter divided developmental renal cystic lesions into three types – I, II 
and III. 
I. RENAL CYSTIC DYSPLASIA 
The term 'renal cystic dysplasia' or Potter type II is used for defective 
renal differentiation with persistence of structures in the kidney not repre- 
sented in normal nephrogenesis such as presence of undifferentiated mesen- 
chyme containing smooth muscle or cartilage and immature collecting ducts. 
Renal dysplasia is thus diagnosed on the basis of histologic features. The 
condition is fairly common in the newborn and infants. The pathogenesis of 
renal dysplasia is unknown. Since renal dysplasia is commonly associated 
with obstructive abnormalities of the ureter and lower urinary tract, it is hy- 
pothesised that the condition results from intrauterine obstruction and disor- 
ganised metanephrogenic differentiation. 
Pathologic changes. Unilateral renal dysplasia is frequently discov- 
ered in newborn or infants as a flank mass. Often, renal dysplasia is associat- 
ed with other congenital malformations and syndromes such as ventricular 
septal defect, tracheo-esophageal fistula, lumbosacral meningomyelocele and 
Down's syndrome. The prognosis of unilateral renal dysplasia following re- 
moval of the abnormal kidney is excellent while bilateral renal dysplasia re- 




Renal dysplasia may be unilateral or bilateral. The dysplastic process 
may involve the entire renal mass or a part of it. Grossly, the dysplastic kid- 
ney is almost always cystic. The kidney is replaced by disorderly mass of 
multiple cysts that is not reniform but resembles a bunch of grapes. No nor- 
mal renal parenchyma is recognisable, and calyces and pelvis are not present. 
The ureter is invariably abnormal, being either absent or atretic. Histological- 
ly, the characteristic feature is the presence of undifferentiated mesenchyme 
that contains smooth muscle or cartilage. The cysts are dilated tubules lined 
by flattened epithelium surrounded by concentric layers of connective tissue. 
Glomeruli are scanty or absent. 
II. POLYCYSTIC KIDNEY DISEASE 
Polycystic disease of the kidney (PKD) is a disorder in which major 
portion of the renal parenchyma is converted into cysts of varying size. The 
disease occurs in two forms: 
A. An adult type inherited as an autosomal dominant disease; and 
B. An infantile type inherited as an autosomal recessive disorder. 
A. Adult Polycystic Kidney Disease 
Adult (autosomal dominant) polycystic kidney disease (ADPKD) is 
relatively common and is the cause of end-stage renal failure in approximate- 
ly 10% of haemodialysis patients. The pattern of inheritance is autosomal 
dominant having high penetrance with variable expressivity. Family history 
of renal disease may be present. The condition occurs due to mutation in 
chromosome 16. The true adult polycystic renal disease is always bilateral 
and diffuse. Though the kidneys are abnormal at birth, renal function is re- 
tained, and symptoms appear in adult life, mostly between the age of 30 and 
50 years. 
Pathologic changes. Grossly, kidneys in ADPKD are always bilateral- 
ly enlarged, usually symmetrically, heavy (weighing up to 4 kg) and cystic. 
The cut surface shows cysts throughout the renal parenchyma varying in size 
from tiny cysts to 4-5 cm in diameter. The contents of the cysts vary from 
clear straw-yellow fluid to reddish-brown material. The renal pelvis and cal- 
yces are present but are greatly distorted by the cysts. The cysts, however, do 
not communicate with the pelvis of the kidney – a feature that helps to distin- 
guish polycystic kidney from hydronephrotic kidney on sectioned surface. 
Histologically, the cysts arise from all parts of nephron. It is possible to 
find some cysts containing recognisable glomerular tufts reflecting their 
origin from Bowman's capsule, while others have epithelial lining like that of 
distal or proximal tubules or collecting ducts. The intervening tissue between 




the patient, acquired lesions such as pyelonephritis, nephrosclerosis, fibrosis 
and chronic inflammation are increasingly seen. 
The condition may become clinically apparent at any age but most 
commonly manifests in 3rd to 5th decades of life. The most frequent and ear- 
liest presenting feature is a dullache in the lumbar regions. In others, the pre- 
senting complaints are haematuria or passage of blood clots in urine, renal 
colic, hypertension, urinary tract infections and progressive CRF with polyu- 
ria and proteinuria. 
About a third of patients with adult polycystic kidney disease have cysts 
of the liver. Other associated congenital anomalies seen less frequently are cysts 
in the pancreas, spleen, lungs and other organs. Approximately 15% of patients 
have one or more intracranial berry aneurysms of the circle of Willis. Any ac- 
quired renal disease is more prone to occur in polycystic kidneys. 
B. Infantile Polycystic Kidney Disease 
The infantile (autosomal recessive) form of polycystic kidney disease 
(ARPKD) is distinct from the adult form. Infantile polycystic kidney disease 
is rare. It is transmitted as an autosomal recessive trait and the family history of 
similar disease is usually not present. The condition occurs due to a mutation in 
chromosome 6. It is invariably bilateral. The age at presentation may be perina- 
tal, neonatal, infantile or juvenile, but frequently serious manifestations are pre- 
sent at birth and result in death from renal failure in early childhood. 
Pathologic changes. Grossly, the kidneys are bilaterally enlarged with 
smooth external surface and retained normal shape. Cut surface reveals small, 
fusiform or cylindrical cysts formed from dilatation of collecting tubules 
which extend radially to the outer cortex. This gives the sectioned surface of 
the kidney sponge-like appearance. No normal renal parenchyma is grossly 
recognised. Pelvis, calyces and ureters are normal. 
Histologically, the total number of nephrons is normal but all the collecting 
tubules show cylindrical or saccular dilatations and are lined by cuboidal to low 
columnar epithelium. Many of the glomeruli are also cystically dilated. 
Almost all the cases of infantile polycystic kidney disease have associ- 
ated multiple epithelium-lined cysts in the liver or proliferation of portal bile 
ductules. In older children, these associated hepatic changes develop into 
what is termed congenital hepatic fibrosis which may lead to portal hyperten- 
sion and splenomegaly. 
III. GLOMERULOCYSTIC KIDNEY DISEASE 
Many cystic diseases of kidney may have both glomerular as well as tubu- 
lar cysts e.g. in renal cystic dysplasia, ADPKD. In glomerulocystic kidney dis- 




Pathologic changes. Grossly, there is marked bilateral enlargement of 
kidneys. Cut surface shows tiny cysts, 2-3 mm in size. 
Microscopically, glomerular cysts are lined by flattened to cuboidal ep- 
ithelium and have compressed glomerular tuft. 
IV. MEDULLARY CYSTIC DISEASE 
Cystic disease of the renal medulla has two main types: 
A. Medullary sponge kidney, a relatively common and innocuous con- 
dition; and 
B. Nephronophthiasis-medullary cystic disease complex, a common 
cause of chronic renal failure in juvenile age group. 
A. Medullary Sponge Kidney 
Medullary sponge kidney consists of multiple cystic dilatations of the 
papillary ducts in the medulla. The condition occurs in adults and may be 
recognised as an incidental radiographic finding in asymptomatic cases, or 
the patients may complain of colicky flank pain, dysuria, haematuria and pas- 
sage of sandy material in the urine. Renal function remains largely normal or 
may be mildly impaired in long-standing disease with secondary complica- 
tions of infection and calculus formation. 
Pathologic changes. Grossly, the kidneys may be enlarged, normal or 
shrunken in size depending upon the extent of secondary pyelonephritis. On 
cut surface, the characteristic feature is the presence of several, small (less 
than 0.5 cm diameter), cystically dilated papillary ducts, which may contain 
spherical calculi. 
Microscopically, the cysts are lined by tall columnar, cuboidal, transi- 
tional or squamous epithelium. Renal cortex may show secondary pyelonephri- 
tis but cortical cysts are never a component of medullary sponge kidney. 
B. Nephronophthiasis-Medullary Cystic Disease Complex 
This form of medullary cystic disease, also called juvenile nephronophthi- 
asis or uraemic sponge kidney, is a progressive renal disease that makes its ap- 
pearance in childhood. Familial occurrence is common and both patterns of inher- 
itance occur, recessive transmission being more common than dominant trans- 
mission. The clinical manifestations are due to impaired urinary concentration 
consequent upon the medullary lesions and consist of polyuria, polydipsia and 
enuresis. Other features include renal osteodystrophy, growth retardation, anae- 
mia and progressive renal failure leading to uraemia. 
Pathologic changes. Grossly, the kidneys are moderately reduced in 
size and granular and have narrow cortices. Cut surface reveals minute cysts, 
majority of which are present at the cortico-medullary junction. 
Microscopically, the cysts are lined by flattened or cuboidal epithelium. 




fibrosis. Many glomeruli are hyalinised but tubular atrophy is more pronounced 
due to marked thickening of tubular basement membrane. 
V. SIMPLE RENAL CYSTS 
Simple renal cysts are a very common postmortem finding. They are 
seen in about half of all persons above the age of 50 years. Since these cysts are 
rare in infants and children, they appear to be acquired rather than congenital 
lesions. Simple cysts of the kidneys are rarely responsible for symptoms. How- 
ever, symptoms may result from rupture, haemorrhage or infection. The associa- 
tion between simple cysts and hypertension is common. 
Pathologic changes. Grossly, simple renal cysts are usually solitary 
but may be multiple. They are commonly located in the cortex. Their size 
varies from a few millimeters to 10 cm in diameter. The wall of cyst is char- 
acteristically yellowish-white and translucent. The cyst usually contains clear 
straw-coloured fluid which may become rust-coloured due to haemorrhage. 
Microscopically, the lining of the cyst is by flattened epithelium. The 
cyst wall contains variable amount of collagenised fibrous tissue which may 
occasionally have deposits of haemosiderin or calcium salts. 
VI. ACQUIRED RENAL CYSTS 
A number of acquired conditions give rise to renal cysts. These include 
the following: 
1. Patients with end-stage renal disease on prolonged dialysis (dialysis- 
associated cystic disease). 
2. Hydatid (echinococcal) cyst. 
3. Tuberculosis of the kidney. 
4. Cystic degeneration in carcinoma of kidney. 
5. Traumatic intrarenal haematoma. 
6. Drug-induced cystic disease in experimental animals. 
VII. PARARENAL CYSTS 
Cysts occurring adjacent to a kidney are termed pararenal cysts. These 
include the following: 
1. Pyelocalyceal cysts 
2. Hilar lymphangiectatic cysts 
3. Retroperitoneal cysts 
4. Perinephric pseudocysts from trauma. 
 
GLOMERULAR DISEASES 
Glomerular diseases encompass a large and clinically significant group 
of renal diseases. Glomerulonephritis (GN) or Bright's disease is the term 
used for diseases that primarily involve the renal glomeruli. It is convenient 




I. Primary glomerulonephritis in which the glomeruli are the predomi- 
nant site of involvement. 
II. Secondary glomerular diseases include certain systemic and heredi- 
tary diseases which secondarily affect the glomeruli. 
Though this division is widely followed, it is somewhat arbitrary since 
many primary forms of glomerulonephritis have systemic effects, and many 
systemic diseases may initially present with glomerular involvement. 
Clinical manifestations 
The clinical presentation of glomerular disease is quite variable but in general four 
features – proteinuria, haematuria, hypertension and disturbed excretory function, are pre- 
sent in varying combinations depending upon the underlying condition. A firm diagnosis, 
however, can be established by examination of renal biopsy under light, electron and im- 
munofluorescence microscopy. 
A number of clinical syndromes are recognised in glomerular diseases. The following 
are six major glomerular syndromes commonly found in different glomerular diseases: 
• nephritic and nephrotic syndromes; 
• acute and chronic renal failure; 
• asymptomatic proteinuria and haematuria. 
These are briefly described below. 
I. ACUTE NEPHRITIC SYNDROME. This is the acute onset of haematuria, 
proteinuria, hypertension, oedema and oliguria following an infective illness about 10 to 
20 days earlier. 
1. The haematuria is generally slight giving the urine smoky appearance and eryth- 
rocytes are detectable by microscopy or by chemical testing for haemoglobin. Appearance 
of red cell casts is another classical feature of acute nephritic syndrome. 
2. The proteinuria is mild (less than 3 gm per 24 hrs) and is usually non-selective 
(nephritic range proteinuria). 
3. Hypertension is variable depending upon the severity of the glomerular disease 
but is generally mild. 
4. Oedema in nephritic syndrome is usually mild and results from sodium and wa- 
ter retention. 
5. Oliguria is variable and reflects the severity of glomerular involvement. 
The underlying causes of acute nephritic syndrome may be primary glomerulone- 
phritic diseases (classically acute glomerulonephritis and rapidly progressive glomerulo- 
nephritis) or certain systemic diseases. 
II. NEPHROTIC SYNDROME Nephrotic syndrome is a group of diseases having 
different pathogenesis and characterised by clinical findings of massive proteinuria, hypoal- 
buminaemia, oedema, hyperlipidaemia, lipiduria, and hypercoagulability. 
1. Heavy proteinuria (protein loss of more than 3 gm per 24 hrs) is the chief charac- 
teristic of nephrotic syndrome (nephrotic range proteinuria). In children, protein loss is corre- 
spondingly less. A small amount of protein (20 to 150 mg/day) normally passes through the 
glomerular filtration barrier and is reasorbed by the tubules. But in case of increased glomeru- 
lar permeability to plasma proteins, excess of protein is filtered out exceeding the capacity of 
tubules for reabsorption and, therefore, appears in the urine. Another feature of protein loss is 
its 'selectivity'. A highly-selective proteinuria consists mostly of loss of low molecular weight 




urine. In nephrotic syndrome, proteinuria mostly consists of loss of albumin (molecular weight 
66,000) in the urine. 
2. Hypoalbuminaemia is produced primarily consequent to urinary loss of albumin, 
and partly due to increased renal catabolism and inadequate hepatic synthesis of albumin. Often, 
the plasma albumin level is 1 to 3 gm/dl (normal 3.5 to 5.5 gm/dl) and there is reversed albumin- 
globulin ratio. The concentration of other proteins in the plasma such as immunoglobulins, clot- 
ting factors and antithrombin may fall rendering these patients more vulnerable to infections and 
thrombotic and thromboembolic complications. 
3. Oedema in nephrotic syndrome appears due to fall in colloid osmotic pressure 
consequent upon hypoalbuminaemia. Sodium and water retention further contribute to oe- 
dema. Nephrotic oedema is usually peripheral but in children facial oedema may be more 
prominent. 
4. Hyperlipidaemia is a frequent accompaniment of nephrotic syndrome. The ex- 
act mechanism of its genesis is not clear. It is hypothesised that the liver faced with the 
stress of massive protein synthesis in response to heavy urinary protein loss, also causes 
increased synthesis of lipoproteins. There are increased blood levels of total lipids, choles- 
terol, triglycerides, VLDL and LDL but decrease in HDL. Low blood level of HDL is 
partly due to its loss in the urine. 
5. Lipiduria occurs following hyperlipidaemia due to excessive leakiness of glo- 
merular filtration barrier. 
6. Hypercoaguability. Patients with nephrotic syndrome may develop spontane- 
ous arterial or venous thrombosis, renal vein thrombosis and pulmonary embolism as a 
result of various factors. These include: increased urinary loss of antithrombin III, hyper- 
fibrinogenaemia due to increased synthesis in the liver, decreased fibrinolysis, increased 
platelet aggregation and altered levels of protein C and S. 
The morphology of individual types is described later. But it must be mentioned 
here that: 
• In children, primary glomerulonephritis is the cause in majority of cases of the 
nephrotic syndrome, most frequently lipoid nephrosis (65%). 
• In adults, on the other hand, systemic diseases (diabetes, amyloidosis and SLE) 
are more frequent causes of nephrotic syndrome. The most common primary glomerular 
disease in adults is membranous glomerulonephritis (40%). 
III. ACUTE RENAL FAILURE. 
IV. CHRONIC RENAL FAILURE. These cases have advanced renal impair- 
ment progressing over years and is detected by significant proteinuria, haematuria, hyper- 
tension and azotaemia. Such patients generally have small contracted kidneys as a result 
of chronic glomerulonephritis. 
V. ASYMPTOMATIC PROTEINURIA. Presence of proteinuria unexpectedly in 
a patient may be unrelated to renal disease (e.g. exercise-induced, extreme lordosis and orthos- 
tatic proteinuria), or may indicate an underlying mild glomerulonephritis. Association of 
asymptomatic haematuria, hypertension or impaired renal function with asymptomatic pro- 
teinuria should raise strong suspicion of underlying glomerulonephritis. 
VI. ASYMPTOMATIC HAEMATURIA. Asymptomatic microscopic haematu- 
ria is common in children and young adolescents and has many diverse causes such as dis- 
eases of the glomerulus, renal intersritium, calyceal system, ureter, bladder, prostate, ure- 
thra, and underlying bleeding disorder, congenital abnormalities of the kidneys or neo- 
plasia. Glomerular haematuria is indicated by the presence of red blood cells, red cell casts 





Pathogenesis of glomerular injury 
It is widely believed that most forms of primary GN and many of the 
secondary glomerular diseases in human beings have immunopathogenetic 
mechanisms. This view is largely based on immunofluorescence studies of 
GN in humans which have revealed glomerular deposits of immunoglobulins 
and complement in patterns that closely resemble those of experimental mod- 
els. Non-immunologic mechanisms, however, play some role in certain forms 
of glomerular damage as discussed later. 
The consequences of injury at different sites within the glomerulus can 
be assessed when compared with the normal physiologic role of the main 
cells involved i.e. endothelial, mesangial, visceral epithelial, and parietal ep- 
ithelial cells as well as of the GBM. 
Immunologic mechanisms underlying glomerular injury are primarily an- 
tibody-mediated (immune-complex disease). However, more recently there has 
been evidence to suggest that cell-mediated immune reactions in the form of de- 
layed type hypersensitivity can cause glomerular injury. In addition, a few sec- 
ondary mechanisms are involved in the pathogenesis of GN in human beings. 
I. Immunologic mechanisms 
Experimental studies and observations in man have revealed that im- 
munologic mechanisms, most importantly antigen-antibody complexes, un- 
derlie most forms of glomerular injury. The general principles of these mech- 
anisms in different forms of glomerular diseases are discussed below, while 
more specific features are described under the specific types of GN. 
A. Antibody-Mediated Glomerular Injury 
1. Immune complex disease. Majority of cases of glomerular disease 
result from deposits of immune complexes (antigen-antibody complexes). 
The immune complexes are represented by irregular or granular glomerular 
deposits of immunoglobulins (IgG, IgM and IgA) and complement (mainly 
C3). Based on the experimental models and studies in human beings, the fol- 
lowing 3 patterns of glomerular deposits of immune complexes in various 
glomerular diseases have been observed: 
i) Exclusive mesangial deposits are characterised by very mild form of 
glomerular disease. 
ii) Extensive subendothelial deposits along the GBM are accompanied 
by severe hypercellular sclerosing glomerular lesions. 
iii) Subepithelial deposits are seen between the outer surface of the 
GBM and the podocytes. 
Deposits may be located at one or more of the above sites in any case 
of glomerular. injury. It was widely believed earlier that glomerular deposits 
result from circulating immune complexes. Now, it has been shown that glo- 




i) Local immune complex deposits. Formation of glomerular deposits 
of immune complex in situ occurs as a result of combination of antibodies 
with autologous non-basement membrane antigens or nonglomerular antigens 
planted on glomeruli. Currently, this mechanism is considered responsible for 
most cases of immune complex GN. Classic experimental model of in situ 
immune complex GN is Hermann nephritis (autologous immune complex 
nephritis) induced in rats by immunising animals with homologous prepara- 
tions of proximal tubular brush border. The rats develop antibodies to brush 
border antigens and thereby membranous GN that closely resembles human 
membranous GN. The examples of planted nonglomerular antigens are cati- 
onic proteins, lectins, DNA, bacterial products (e.g. a protein of group A 
streptococci), viral and parasitic products and drugs. 
ii) Circulating immune complex deposits. This mechanism used to be 
considered very important for glomerular injury but now it is believed that 
circulating immune complexes cause glomerular damage under certain cir- 
cumstances only. These situations are: their presence in high concentrations for 
prolonged periods, or when they possess special properties that cause their bind- 
ing to glomeruli, or when host mechanisms are defective and fail to eliminate 
immune complexes. The antigens evoking antibody response may be endoge- 
nous (e.g. in SLE) or may be exogenous (e.g. Hepatitis B virus, Treponema pal- 
lidum, Plasmodium falciparum and various tumour antigens). The antigen- 
antibody complexes are formed in the circulation and then trapped in the glo- 
meruli where they produce glomerular injury after combining with complement. 
Immune complex GN is observed in the following human diseases: 
i) Primary GN e.g. acute diffuse proliferative GN, membranous GN, 
membranoproliferative GN, IgA nephropathy and some cases of rapidly pro- 
gressive GN and focal GN. 
ii) Systemic diseases e.g. glomerular disease in SLE, malaria, syphilis, 
hepatitis, Henoch-Schonlein purpura and idiopathic mixed cryoglobulinaemia. 
2. Anti-GBM disease. Less than 5% cases of human GN are associated 
with anti-GBM antibodies. The constituent of GBM acting as antigen appears 
to be a component of collagen IV of the basement membrane. The experi- 
mental model of anti-GBM disease is Masugi nephritis (nephrotoxic serum 
nephritis) produced in rats by injection of heterologous antibodies against 
GBM prepared in rabbits by immunisation with rat kidney tissue. 
Anti-GBM disease is classically characterised by interrupted linear de- 
posits of anti-GBM antibodies (mostly IgG; rarely IgA and IgM) and comple- 
ment (mainly C3) along the glomerular basement membrane. These deposits are 




Anti-GBM disease is characteristically exemplified by glomerular inju- 
ry in Goodpasture's syndrome in some cases of rapidly progressive GN. 
About half to two-third of the patients with renal lesions in Goodpasture's 
syndrome have pulmonary haemorrhage mediated by cross-reacting autoanti- 
bodies against alveolar basement membrane. 
3. Alternate pathway disease. As apparent from the above mechanisms, 
the complement system, in particular C3, contributes to glomerular injury in 
most forms of GN. Deposits of C3 are associated with the early components 
Cl, C2 and C4 which are evidence of classic pathway activation of comple- 
ment. But in alternate pathway activation, there is decreased serum C3 level, 
decreased serum levels of factor B and properdin, normal serum levels of Cl, 
C2 and C4 but C3 and properdin are found deposited in the glomeruli without 
immunoglobulin deposits, reflecting activation of alternate pathway of com- 
plement. Such patients have circulating anti-complementary nephritic factor 
called C3NeF which is an IgG antibody and acts as an auto-antibody to the 
alternate C3 convertase and enhances alternate pathway activity. 
The deposits in alternate pathway disease are characteristically elec- 
tron-dense under electron microscopy, glomerular lesions in such cases are 
referred to as dense-deposit disease. 
Alternate pathway disease occurs in most cases of type II membranop- 
roliferative GN, some patients of rapidly progressive GN, acute diffuse pro- 
liferative GN, IgA nephropathy and in SLE. 
4. Other mechanisms of antibody-mediated injury. A few autoantibod- 
ies have been implicated in some patients of glomerulonephritis. These in- 
clude the following: 
i) Anti-neutrophil cytoplasmic antibodies (ANCA). 
About 40% cases of rapidly progressive GN are deficient in immuno- 
globulins in glomeruli and are positive for ANCA against neutrophil cyto- 
plasmic antigens in their circulation. ANCA causes endothelial injury by 
generation of reactive oxygen radicals. 
ii) Anti-endothelial cell antibodies (AECA). Auto-antibodies against 
endothelial antigens have been detected in circulation is several inflammatory 
vasculitis and glomerulonephritis. These antibodies increase the adhesiveness 
of leucocytes to endothelial cells. 
B. Cell-mediated Glomerular Injury (Delayed-type Hypersensitivity) 
Recent evidence suggests that cell-mediated immune reactions may be 
involved in causing glomerular injury, particularly in cases with deficient 
immunoglobulins (pauci-immune glomerulonephritis). Cytokines and other 
mediators released by activated T cells stimulate cytotoxicity, recruitment of 




rophages while CDS + cytotoxic T lymphocytes and natural killer cells cause 
further glomerular cell injury. However, cell-mediated injury, is yet less clear 
than antibody-mediated glomerular injury. 
C. Secondary Pathogenetic Machanisms (Mediators of Immuno- 
logic Injury) 
Secondary pathogenetic mechanisms are a number of mediators of 
immunologic glomerular injury operating in man and in experimental mod- 
els. These include the following: 
1. Neutrophils. Neutrophils are conspicuous in certain forms of glo- 
merular disease such as in acute diffuse proliferative GN, and may also be 
present in membranoproliferative GN and lupus nephritis. Neutrophils can 
mediate glomerular injury by activation of complement as well as by release 
of proteases, arachidonic acid metabolites and oxygen-derived free radicals. 
These agents cause degradation of GBM and cell injury. 
2. Mononuclear phagocytes. Many forms of human and experimental 
proliferative GN are associated with glomerular infiltration by monocytes 
and macrophages. Accumulation of mononuclear phagocytes is considered an 
important constituent of hypercellularity in these forms of GN aside from prolif- 
eration of rnesangial and endothelial cells. Activated macrophages release a va- 
riety of biologically active substances which take part in glomerular injury. 
3. Complement system. The pathogenetic role of classical and alternate 
pathway of activation of complement has already been highlighted above. 
Besides the components of complement which mediate glomerular injury via 
neutrophils already mentioned, C5b9 is capable of inducing damage to GBM 
directly. 
4. Platelets. Platelet aggregation and release of mediators play a role in 
the evolution of some forms of GN. Increased intrarenal platelet consumption 
has been found to occur in some forms of glomerular disease. 
5. Mesangial cells. There is evidence to suggest that rnesangial cells 
present in the glomeruli may be stimulated to produce mediators of inflam- 
mation and take part in glomerular injury. 
6. Coagulation system. The presence of fibrin in early crescents in cer- 
tain forms of human and experimental GN suggests the role of coagulation 
system in glomerular damage. Fibrinogen may leak into Bowman's space and 
act as stimulus for cell proliferation. Crescents usually transform into scar tis- 
sue under the influence of fibronectin which is regularly present in crescents 
in human glomerular disease. 
II. Non-immunologic mechanisms 
Though most forms of GN are mediated by immunologic mechanisms, 
a few examples of glomerular injury by non-immunologic mechanisms are 




1. Metabolic glomerular injury e.g. diabetic nephropathy, Fabry's disease. 
2. Haemodynamic glomerular injury e.g. systemic hypertension. 
3. Deposition diseases e.g. cryoglobulinaemia, amyloidosis. 
4. Infectious diseases e.g. HBV, HCV, HIV, E. coil-derived nephrotoxin. 
5. Inherited glomerular diseases e.g. Alport's syndrome, nail-patella 
syndrome. 
The evolution of end-stage renal failure is explained on the basis of 
adaptive glomerular hypertrophy of unaffected glomeruli that results in in- 
creased glomerular blood flow and increased glomerular capillary pressure 
inducing intraglomerular hypertension. These events lead to increased depo- 
sition of mesangial matrix and proliferation of mesangial cells, endothelial 
and epithelial cell injury, and eventually to progressive glomerulosclerosis 
and end-stage renal failure. 
So, GLOMERULONEPHRITIS can be classifide according to: 
I. Primary and secondary 
II. Etiology: 
1. Of determined etiology, 
2. Of undetermined etiology 
III. Pathogenesis: 
1. With immune mechanisms of development (antibodies and im- 
mune complexes), 
2. Without immune changes. 




V. Morphological criteria: 
- topography of process: 
1) intracapillary, 2) extracapillary, 
- character of inflammation: 
1) exudative, 2) proliferative, 3) mixed, 
- spreading of process: 
1) diffuse, 2) focal. 
 
PRIMARY GLOMERULONEPHRITIS 
ACUTE  GLOMERULONEPHRITIS(SYNONYMS:  ACUTE  DIFFUSE  PRO- 
LIFERATIVE GN, DIFFUSE ENDOCAPILLARY GN) 
Acute GN is known to follow acute infection and characteristically 
presents as acute nephritic syndrome. Based on etiologic agent, acute GN is 
subdivided into 2 main groups: acute post-streptococcal GN and acute non- 




ACUTE POST-STREPTOCOCCAL GN 
Acute post-streptococcal GN is fairly common form of GN, seen most 
commonly in children 6 to 16 years of age but adolescents and adults may also 
be affected. The onset of disease is generally sudden after 1-2 weeks of strepto- 
coccal infection, most frequently of the throat and sometimes of the skin. 
Etiopathogenesis. The relationship between strep tococcal infection 
and this form of GN is now well established. Particularly nephritogenic are 
types 12,4,1 and Red Lake of group A β-haemolytic streptococci. The glo- 
merular lesions appear to result from deposition of immune complexes in the 
glomeruli. The evidences cited in support are as under: 
i) There is epidemiological evidence of preceding streptococcal sore 
throat or skin infection about 1-2 weeks prior to the attack. 
ii) The latent period between streptococcal infection and onset of clini- 
cal manifestations of the disease is compatible with the period required for 
building up of antibodies. 
iii) Streptococcal infection may be identified by culture or may be in- 
ferred from elevated titres of antibodies against streptococcal antigens. These 
include: 
• anti-streptolysin O (ASO); 
• anti-deoxyribonuclease B (anti-DNAse B); 
• anti-streptokinase (ASKase); 
• anti-nicotinyl adenine dinucleoridase (anti-NADase); and 
• anti-hyaluronidase (AHase). 
iv) There is usually hypocomplementaemia indicating involvement of 
complement in the glomerular deposits, 
v) More recently, it has been possible to identify antigeniс component 
of streptococci which is cytoplasmic antigen, endostreptosin. 
Pathologic changes. Grossly, the kidneys are symmetrically enlarged, 
weighing one and a half to twice the normal weight. The cortical as well as 
sectioned surface show petechial haemorrhages giving the characteristic ap- 
pearance of flea-bitten kidney. 
i) Glomeruli – The glomeruli are affected diffusely. They are enlarged 
and hypercellular. The diffuse hypercellulariry of the tuft is due to prolifera- 
tion of mesangial, endothelial and occasionally epithelial cells (acute prolif- 
erative lesions) as well as by infiltration of leucocytes, chiefly polymorphs 
and sometimes monocytes. There may be small deposits of fibrin within the 
capillary lumina and in the mesangium. 
ii) Tubules – Tubular changes are not very striking. There may be 
swelling and hyaline droplets in tubular cells, and tubular lumina may contain 




iii) Interstitium – There may be sorm degree of interstitial oedema 
and leucocytic infiltration. 
iv) Vessels – Changes in arteries and arterioles are seldom present in 
acute GN. 
Electron microscopic findings, aside from confirming the light microscopic 
findings, are the characteristic electron-dense irregular deposits Chumps' on the 
epithelial side of the GBM. These deposits represent the immune complexes. Im- 
munofluorescence microscopy reveals that the irregular deposits along the GBM 
consist principally of IgG and complement C3. 
Prognosis varies with the age of the patient. Children almost always 
(95%) recover completely with reversal of proliferative glomerular changes. 
Complications arise moie often in adults and occasionally in children. These 
include development of rapidly progressive GN, chronic GN, uraemia and 
chronic renal failure. 
ACUTE NON-STREPTOCOCCAL GN 
About one-third cases of acute GN are caused by organisms other than 
haemolytic streptococci. These include other bacteria (e.g. staphylococci, pneu- 
mococci, meningococci, Salmonella and Pseudomonas), viruses (e.g. hepatitis B 
virus, mumps, infectious mononucleosis and varicella), parasitic infections (e.g. 
malaria, toxoplasmosis and schistosomiasis) and syphilis. The appearance of renal 
biopsy by light microscopy, EM and immunofluorescence microscopy is similar 
to that seen in acute post-streptococcal GN. The prognosis of non-streptococcal 
GN is not as good as that of streptococcal GN. 
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS (SYNONYMS; RPGN, 
CRESCENTIC GN, EXTRACAPILLARY GN) 
RPGN presents with an acute reduction in renal function resulting in 
acute renal failure in a few weeks or months. 
It is characterised by formation of 'crescents' (crescentic GN) outside 
the glomerular capillaries (extracapillary GN). 'Crescents' are formed from 
the proliferation of parietal epithelial cells lining Bowman's capsule with con- 
tribution from visceral epithelial cells and the invading mononuclear cells. 
The stimulus for crescent formation appears to be the presence of fibrin in the 
capsular space. RPGN occurs most frequently in adults, with a slight male 
preponderance. Prognosis of RPGN in general is dismal. 
Etiopathogenesis. A number of primary glomerular and systemic dis- 
eases are characterised by formation of crescents. Based on the etiologic 
agents and pathogenetic mechanism, patients with RPGN are divided into 3 
groups: 
• RPGN in systemic diseases (anti-GBM type); 




• pauci-immune RPGN. 
There are three main serologic markers in RPGN: 
i) serum C3 level, 
ii) anti-GBM antibody; and 
iii) anti-neutrophil cytoplasmic antibody (ANCA). 
Type I RPGN: Anti-GBM disease. A number of systemic diseases 
such as Goodpasture's syndrome, SLE, vasculitis, Wegener's granulomatosis, 
Henoch-Schonlein purpura and idiopathic mixed cryoglobulinaemia are asso- 
ciated with crescentic GN. 
Goodpasture's syndrome. Goodpasture's syndrome is characterised 
by acute renal failure due to RPGN and pulmonary haemorrhages. The condi- 
tion is more common in males in 3rd decade of life. The disease results from 
damage to the glomeruli by anti-GBM antibodies which cross-react with al- 
veolar basement membrane and hence, produce renal as well as pulmonary 
lesions. The evidences in support are the characteristic linear deposits of anti- 
GBM antibodies consisting of IgG and complement along the GBM, detection 
of circulating anti-GBM antibodies and induction of glomerular lesions with in- 
jection of anti-GBM antibodies experimentally in monkeys. Pulmonary lesions 
can be experimentally induced if the lungs are previously injured by viral or 
bacterial infection or exposed to hydrocarbons. The Goodpasture's antigen ap- 
pears to be a component of collagen type IV. 
Type II RPGN: Immune complex disease. A small proportion of 
cases of post-streptococcal GN, particularly in adults and sometimes of non- 
streptococcal origin, develop RPGN. The evidences in support of post- 
infectious RPGN having immune complex pathogenesis are granular deposits 
of immune complexes of IgG and C3 along the glomerular capillary walls, 
lowering of blood complement levels and demonstration of circulating com- 
plexes. 
Type III RPGN: Pauci-immune type. These include cases of Wegen- 
er's granulomatosis and polyarteritis. The pathogenesis of pauci-immune GN 
is yet not fully defined. However, majority of these patients are ANCA- 
positive, implying a defect in humoral immunity. Serum complement levels 
are normal and anti-GBM antibody is negative. There is little or no glomeru- 
lar immune deposit (i.e. pauci-immune). 
Pathologic changes. Grossly, the kidneys are usually enlarged and 
pale with smooth outer surface (large white kidney). Cut surface shows pale 
cortex and congested medulla. 
Light Microscopic findings vary according to the cause but in general 
following features are present: 
i) Glomeruli. Irrespective of the underlying etiology, all forms of 




These are collections of pale-staining polygonal cells which commonly tend to 
be elongated. Eventually, crescents obliterate the Bowman's space and compress 
the glomerular tuft. Fibrin deposition is invariably present alongside crescents. 
Besides the crescents, glomerular tufts may show increased cellularity as a result 
of proliferation of endothelial and rnesangial cells and leucocytic infiltration. 
Fibrin thrombi are frequently present in the glomerular tufts. 
ii) Tubules. Tubular epithelial cells may show hyaline droplets. Tubu- 
lar lumina may contain casts, red blood cells and fibrin. 
iii) Interstitium. The interstitium is oedematous and may show early fi- 
brosis. Inflammatory cells, usually lymphocytes and plasma cells, are com- 
monly distributed in the interstitial tissue. 
iv) Vessels. Arteries and arterioles may show no change, but cases as- 
sociated with hypertension usually show severe vascular changes. 
Electron microscopic findings vary according to the type of RPGN. 
Post-infectious RPGN cases show electron-dense subepithelial granular de- 
posits similar to those seen in acute GN, while cases of RPGN in Goodpas- 
ture's syndrome show characteristic linear deposits along the GBM. 
Immunofluorescence microscopy shows: 
• linear pattern of RPGN in Goodpasture's syndrome (type I RPGN), 
containing IgG accompanied by C3 along the capillaries 
• granular pattern of post-infectious RPGN (type II RPGN) consisting 
of IgG and C3 along the capillary wall; and 
• scanty or no deposits of immunoglobulin and C3 in pauci-immune 
GN (type III RPGN). 
Prognosis of all forms of RPGN is poor. However, post-infectious cas- 
es have somewhat better outcome and may show recovery. 
MEMBRANOUS GLOMERULONEPHRITIS (SYNONYM: EPIMEMBRANOUS 
NEPHROPATHY) 
Membranous GN is characterised by wide-spread thickening of the 
glomerular capillary wall and is the most common cause of nephrotic syn- 
drome in adults. In about 15% of cases, membranous GN is secondary to an 
underlying condition (e.g. SLE, malignancies, infections such as chronic 
hepatitis B and C, syphilis, malaria and drugs), while in the majority of cases 
(85%) it is truly idiopathic. 
Etiopathogenesis. Idiopathic membranous GN is an immune complex 
disease. The deposits of immune complex are formed locally because circu- 
lating immune complexes are detected in less than a quarter of cases. Since 
leucocytic infiltration is not a feature of membranous GN, damage to the 
GBM is mediated directly by complement. While nephritogenic antigen 




known yet, the antigen in cases of secondary membranous GN is either an 
endogenous (e.g. DNA in SLE) or exogenous one (e.g. hepatitis B virus, tu- 
mour antigen, treponema antigen etc). 
Pathologic changes. Grossly, the kidneys are enlarged, pale and 
smooth. 
Light microscopy shows the following findings: 
i) Glomeruli. The characteristic finding is diffuse thickening of the 
glomerular capillary walls with all the glomeruli being affected more or less 
uniformly. As the disease progresses, the deposits are incorporated into 
enormously thickened basement membrane, producing 'duplication' of GBM 
which is actually formation of a new basement membrane. These basement 
membrane changes are best appreciated by silver impregnation stains (black 
colour) or by periodic acid-Schiff stain (pink colour). 
There is no cellular proliferation in the glomerular tufts. 
ii) Tubules. The renal tubules remain normal except in the early stage 
when lipid vacuolation of the proximal convoluted tubules may be seen. 
iii) Interstitium. The interstitium may show fine fibrosis and scanty 
chronic inflammatory cells. 
iv) Vessels. In the early stage, vascular changes are not prominent, 
while later hypertensive changes of arterioles may occur. 
Electron microscopy shows electron-dense deposits situated in the epi- 
thelial side of the GBM. The basement membrane material protrudes between 
deposits as 'spikes'. Immunofluorescence microscopy reveals granular depos- 
its of immune complexes consisting of IgG associated with complement C3. 
In secondary cases of membranous GN the relevant antigen such as hepatitis 
B or tumour antigen may be seen. 
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (SYNONYMS: 
MPGN, MESANGIOCAPILLARY GN) 
Membranoproliferative GN is another important cause of nephrotic 
syndrome in children and young adults. As the name implies, it is character- 
ised by two histologic features increase in cellularity of the mesangium asso- 
ciated with increased lobulation of the tuft, and irregular thickening of the 
capillary wall. 
Etiopathogenesis. Etiology of MPGN is unknown though in some 
cases there is evidence of preceding streptococcal infection. Based on ultra- 
structural, immunofluorescence and pathogenetic mechanisms, three types of 
MPGN are recognised: 
• Type I or classic form is an example of immune complex disease and 





• Type II or dense deposit disease is the example of alternate pathway 
disease and constitutes about 30% cases. The capillary wall thickening is due 
to the deposition of electron-dense material in the lamina densa of the GBM. 
• Type III is rare and shows features of type I MPGN and membranous 
nephropathy in association with systemic diseases or drugs. 
Pathologic changes. Grossly and by light microscopy, all the three 
types of MPGN are similar. 
Grossly, the kidneys are usually pale in appearance and firm in con- 
sistency. 
By light microscopy, the features are as under: 
i) Glomeruli. Glomeruli show highly characteristic changes. They are en- 
larged with accentuated lobular pattern. The enlargement is due to variable de- 
gree of mesangial cellular proliferation and increase in mesangial matrix. The 
GBM is considerably thickened, which with silver stains shows two basement 
membranes with a clear zone between them. This is commonly referred to as 
'double contour', splitting, or 'tram track' appearance. 
ii) Tubules. Tubular cells may show vacuolation and hyaline droplets. 
iii) Interstitium. There may be scattered chronic inflammatory cells and 
some finely granular foam cells in the interstitium. 
iv) Vessels. Vascular changes are prominent in cases in which hyper- 
tension develops. 
By electron microscopy and immunofluorescence microscopy, the 
changes are different in the three types of MPGN: 
Type I: It shows electron-dense deposits in subendothelial location 
conforming to immune-complex character of the disease. These deposits re- 
veal positive fluorescence for C3 and slightly fainter staining for IgG. 
Type II: The hallmark of type II MPGN is the presence of dense amor- 
phous deposits within the lamina densa of the GBM and in the mesangium. Im- 
munofluorescence studies reveal the universal presence of C3 and properdin in 
the deposits but the immunoglobulins are usually absent. 
Type III: This rare form has electron-dense deposits within the GBM 
as well as in subendothelial and subepithelial regions of the GBM. Immuno- 
fluorescence studies show the presence of C3, IgG and IgM. 
FOCAL GLOMERULONEPHRITIS (SYNONYMS: FOCAL SEGMENTAL 
GN, FOCAL PROLIFERATIVE GN) 
Focal GN is characterised by pathologic changes in certain number of 
glomeruli (focal), and often confined to one or two lobules of the affected 
glomeruli (segmental), while other glomeruli are normal. Focal GN is, thus, a 
pathologic diagnosis. It may occur as a primary glomerular disease or may be 




pura, subacute bacterial endocarditis, Wegener's granulomatosis, vasculitis, 
Goodpasture's syndrome and IgA nephropathy. 
Etiopathogenesis. The diverse settings under which focal GN is en- 
countered make it unlikely that there are common etiologic agents or patho- 
genetic mechanisms. However, the observation of mesangial deposits of im- 
munoglobulins and complement suggest immune complex disease and partic- 
ipation of the mesangium. 
Pathologic changes. By light microscopy, the single most important 
feature in focal GN is the abnormality seen in certain number of glomeruli 
and generally confined to one or two lobules of the affected glomeruli i.e. fo- 
cal and segmental glomerular involvement. The pathologic change most fre- 
quently consists of focal and segmental cellular proliferation but sometimes 
necrotising changes can be seen. The condition must be distinguished from 
focal and segmental glomerulosclerosis (discussed below). 
By immunofluorescence microscopy, widespread mesangial deposits of 
immunoglobulins (mainly IgA with or without IgG), complement (C3) and 
fibrin are demonstrated in most cases of focal GN. 
 
MINIMAL CHANGE DISEASE (SYNONYMS: LIPOID NEPHROSIS, FOOT PRO- 
CESS DISEASE, NIL DEPOSIT DISEASE) 
Minimal change disease is a condition in which the nephrotic syn- 
drome is accompanied by no apparent change in glomeruli by light micros- 
copy. Its other synonyms, lipoid nephrosis and foot process disease, are de- 
scriptive terms for fatty changes in the tubules and electron microscopic ap- 
pearance of flattened podocytes respectively. Minimal change disease ac- 
counts for 80% cases of nephrotic syndrome in children under 16 years of 
age with preponderance in boys (ratio of boys to girls 2:1). 
Etiopathogenesis. The etiology and pathogenesis of minimal change 
disease remain elusive, and majority of cases are idiopathic but the following 
features point to possible immunologic mechanisms: 
i) Absence of deposits by electron microscopy. 
ii) Normal circulating levels of complement but presence of circulating 
immune complexes in many cases. 
iii) Clinical association, relapses and immunisation of the disease with 
respiratory infections. 
iv) Universal satisfactory response to steroid therapy. 
v) HLA association of the disease as with other forms of GN. 
vi) Increased suppressor T cell activity as evidenced by association of 




The proteinuria of nephrotic syndrome in minimal change disease in 
children is characteristically selective (albuminuria). The basis for selective 
proteinuria appears to be: 
i) reduction of normal negative charge on GBM due to loss of heparan 
sulfate proteoglycan from the GBM; and 
ii) change in the shape of epithelial cells producing foot process flat- 
tening due to reduction of sialoglycoprotein cell coat. 
Adults having MCD, however, have non-selective proteinuria, suggest- 
ing more extensive membrane permeability defect. 
Pathologic  changes.  Grossly,  the  kidneys  are  of  normal  size  and 
shape.  
By light microscopy, the findings are as under: 
i) Glomeruli. The most characteristic feature is no apparent abnormali- 
ty in the glomeruli except for slight increase in the mesangial matrix at the 
most. 
ii) Tubules. There is presence of fine lipid vacuolation and hyaline 
droplets in the cells of proximal convoluted tubules and, hence, the older 
name of the condition as 'lipoid nephrosis'. 
iii) Interstitium. There may be oedema of the interstitium. 
iv) Vessels. Blood vessels do not show any significant change (mini- 
mal change). 
By electron microscopy, the most characteristic feature of the disease is 
identified which is diffuse flattening of foot processes of the visceral epithe- 
lial cells (podocytes) and, hence, the name foot process disease. Unlike other 
forms of GN, no deposits are seen and the GBM is normal. By immunofluo- 
rescence microscopy, no deposits of complement or immunoglobulins are 
recognised (nil deposit disease). 
 
FOCAL SEGMENTAL GLOMERULOSCLEROSIS (SYNONYMS: FOCAL SCLERO- 
SIS, FOCAL HYALINOSIS) 
Focal segmental glomerulosclerosis is a condition in which there is 
sclerosis and hyalinosis of some glomeruli and portions of their tuft, while 
the other glomeruli are normal by light microscopy i.e. involvement is focal 
and segmental. 
Etiopathogenesis. Focal segmental glomerulosclerosis was previously 
believed to be a variant of minimal change disease with accentuation of epi- 
thelial damage in the form of hyalinosis and sclerosis. Currently, the condi- 
tion is divided into 3 groups: 
i) Idiopathic type. It is found in children and young adults with presen- 
tation of nephrotic syndrome. It differs from minimal change disease in hav- 




chronic renal failure. Immunofluorescence microscopy reveals deposits of 
IgM and C3 in the sclerotic segment. 
ii) With superimposed primary glomerular disease. There may be cases 
of focal segmental glomerulosclerosis with superimposed minimal change 
disease or IgA nephropathy. Those associated with minimal change disease 
show good response to steroid therapy and progression to chronic renal fail- 
ure may occur after a long time. 
iii) Secondary type. This group consists of focal segmental sclerotic le- 
sions as a secondary manifestation of certain diseases such as AIDS, reflux 
nephropathy and analgesic nephropathy. Infection with HIV, particularly in 
blacks, has been found associated with a variant of focal segmental glomeru- 
losclerosis which is characterised by collapsing sclerosis. 
Pathologic changes. By light microscopy, depending upon the severity 
of the disease, variable number of glomeruli are affected focally and segmen- 
tally, while others are normal. The affected glomeruli show solidification or 
sclerosis of one or more lobules of the tuft. Hyalinosis refers to collection of 
eosinophilic, homogeneous, PAS-positive, hyaline material present on the in- 
ner aspect of a sclerotic peripheral capillary loop. Mesangial hypercellularity 
is present in appreciable number of cases. 
HTV-associated nephropathy is characterised by focal sclerosis that may 
be segmental or global, having collapsed capillaries in the tuft. Besides glo- 
merular changes, there is interstitial fibrosis and infiltration by mononuclear 
leucocytes, and tubular epithelial cell atrophy and degeneration. 
By electron microscopy, diffuse loss of foot processes as seen in minimal 
change disease is evident but, in addition, there are electron-dense deposits in the 
region of hyalinosis and sclerosis which are believed to be immune complexes. 
By Immunofluorescence microscopy, the deposits in the lesions are 
shown to contain IgM and C3. 
 
IGA NEPHROPATHY (SYNONYMS: BERGER'S DISEASE, IGA GN) 
IgA nephropathy is characterised by aggregates of IgA, deposited prin- 
cipally in the mesangium. The condition was first described by Berger, a 
French physician in 1968. 
Etiopathogenesis. The etiology and pathogenetic mechanism are not 
quite clear. A number of theories have been proposed: 
i) In view of exclusive mesangial deposits of IgA and elevated serum 
levels of IgA and IgA-immune complexes, IgA nephropathy has been con- 
sidered to arise from entrapment of these complexes in the mesangium. 
ii) There is absence of early components of the complement but pres- 
ence of C3 and properdin in the mesangial deposits, which point towards ac- 




iii) Since there is close association between mucosal infections (e.g. of 
the respiratory, gastrointestinal or urinary tract), it is suggested that IgA de- 
posited in the mesangium could be of mucosal origin. 
iv) Another possibility is genetically-determined abnormality of the 
immune system producing an increase in circulating IgA. 
Pathologic changes. By light microscopy, the pattern of involvement 
varies. These include: focal proliferative GN, focal segmental glomeruloscle- 
rosis, membranoproliferative GN, and rarely RPGN. By electron microscopy, 
finely granular electron-dense deposits are seen in the mesangium. By immu- 
nofluorescence microscopy, the diagnosis is firmly established by demonstra- 
tion of mesangial deposits of IgA, with or without IgG, and usually with C3 
and properdin. 
 
CHRONIC GLOMERULONEPHRITIS (SYNONYM: END-STAGE KIDNEY) 
Chronic GN is the final stage of a variety of glomerular diseases which 
result in irreversible impairment of renal function. The conditions which may 
progress to chronic GN, in descending order of frequency, are as under: 
i) Rapidly progressive GN (90%) 
ii) Membranous GN (50%) 
iii) ) Membranoproliferative GN (50%) 
iv) Focal segmental glomerulosclerosis (50%) 
v) IgA nephropathy (40%) 
vi) Acute post-streptococcal GN (1%) 
However, about 20% cases of chronic GN are idiopathic without evi- 
dence of preceding GN of any type. 
Pathologic changes. Grossly, the kidneys are usually small and con- 
tracted weighing as low as 50 gm each. The capsule is adherent to the cortex. 
The cortical surface is generally diffusely granular. On cut section, the cortex 
is narrow and atrophic, while the medulla is unremarkable. 
Microscopically, the changes vary greatly depending upon the underly- 
ing glomerular disease. In general, the following changes are seen: 
i) Glomeruli. Glomeruli are reduced in number and most of those pre- 
sent show completely hyalinised tufts, giving the appearance of acellular, eo- 
sinophilic masses which are PAS-positive. Evidence of underlying glomeru- 
lar disease may be present, 
ii) Tubules. Many tubules completely disappear and there may be atro- 
phy of tubules close to scarred glomeruli. Tubular cells show hyaline- 
droplets, degeneration and tubular lumina frequently contain eosinophilic, 
homogeneous casts. 
iii) Interstitium. There is fine and delicate fibrosis of the interstitial tis- 




iv) Vessels. Advanced cases which are frequently associated with hy- 
pertension show conspicuous arterial and arteriolar sclerosis. 
Patients of end-stage kidney disease on dialysis show a variety of dial- 
ysis associated changes that include acquired cystic disease, occurrence of 
adenomas and adenocarcinomas of the kidney, calcification of tufts and dep- 
osition of calcium oxalate crystals in tubules. 
 
II. SECONDARY GLOMERULAR DISEASES 
 
Glomerular involvement may occur secondary to certain systemic dis- 
eases or a few hereditary diseases. In some of these, renal involvement may 
be the initial presentation, while in others clinical evidence of renal disease 
appears long after other manifestations have appeared. 
 
DIABETIC NEPHROPATHY 
Renal involvement is an important complication of diabetes mellitus. 
End-stage kidney with renal failure accounts for deaths in more than 10% of 
all diabetics. Renal complications are more severe and develop early in juve- 
nile-onset diabetes (insulin-dependent diabetes) than in maturity-onset diabe- 
tes (non-insulin dependent diabetes). A variety of clinical syndromes are as- 
sociated with diabetic nephropathy that includes asymptomatic proteinuria, 
nephrotic syndrome, progressive renal failure and hypertension. 
Pathologic changes. Diabetic nephropathy is the term that encom- 
passes 4 types of renal lesions in diabetes mellitus: diabetic glomerulosclero- 
sis, vascular lesions, diabetic pyelonephritis and tubular lesions (Armanni- 
Ebstein lesions). 
1. Diabetic glomerulosclerosis. Glomerular lesions in diabetes mellitus 
are particularly common and account for majority of abnormal findings refer- 
able to the kidney. These may take one of the 2 forms: diffuse or nodular le- 
sions: 
i) Diffuse glomerulosclerosis. Diffuse glomerular lesions are the most 
common. There is involvement of all parts of glomeruli. The pathologic changes 
consist of thickening of the GBM and diffuse increase in mesangial matrix with 
mild proliferation of mesangial cells. Various exudative lesions such as capsular 
hyaline drops and fibrin caps may also be present Capsular drop is an eosino- 
philic hyaline thickening of the parietal layer of Bowman's capsule and bulges 
into the glomerular space. Fibrin cap is homogeneous, brightly eosinophilic ma- 
terial appearing on the wall of a peripheral capillary of a lobule. 
ii) Nodular glomerulosclerosis. Nodular lesions of diabetic glomerulo- 
sclerosis are also called as Kinimelstiel-Wilson (KW) lesions or intercapillary 
glomerulosclerosis. These lesions are specific for juvenile-onset diabetes or 




one or more nodules in a few or many glomeruli. Nodule is an ovoid or spheri- 
cal, laminated, hyaline, acellular mass located within a lobule of the glomeru- 
lus. The nodules are surrounded peripherally by glomerular capillary loops 
which may have normal or thickened GBM. The nodules are PAS-positive and 
contain lipid and fibrin. As the nodular lesions enlarge, they compress the glo- 
merular capillaries and obliterate the glomerular tuft. As a result of glomerular 
and arteriolar involvement, renal ischaemia occurs leading to tubular atrophy 
and interstitial fibrosis and grossly small, contracted kidney. 
Pathogenesis. The pathogenesis of diffuse or nodular diabetic glomer- 
ulosclerosis is closely linked with the pathogenesis of diabetic microangiopa- 
thy. Available evidences support a role for metabolic defect in diabetes in the 
form of insulinopenia, hyperglycaemia and glycosuria, increased synthesis of 
collagen types IV, fibronectin, and haemodynamic changes, in causing dia- 
betic glomerulosclerosis. 
2. Vascular lesions. Atherosclerosis of renal arteries is very common 
and severe in diabetes mellitus. Hyaline arteriolosclerosis affecting the affer- 
ent and efferent arterioles of the glomeruli is also often severe in diabetes. 
These vasrular lesions are responsible for renal ischaemia that results in tubu- 
lar atrophy and interstitial fibrosis. 
3. Diabetic pyelonephritis. Poorly-controlled diabetics are particularly 
susceptible to bacterial infections. Papillary necrosis (necrotising papillitis is an 
important complication of diabetes that may result in acute pyelonephritis. Chron- 
ic pyelonephritis is 10 to 20 times more common in diabetics than in others. 
4. Tubular lesions (armanni-ebstein lesions). In untreated  diabetics 
who have extremely high blood sugar level, the epithelial cells of the proxi- 
mal convoluted tubules develop extensive glycogen deposits appearing as 
vacuoles. These are called Armanni-Ebstein lesions. The tubules return to 
normal on control of hyperglycaemic state. 
 
HEREDITARY NEPHRITIS 
A group of hereditary diseases principally involving the glomeruli are 
termed hereditary nephritis. These include the following: 
1. Alport's syndrome 
2. Fabry's disease 
3. Nail-patella syndrome 
1. Alport's syndrome. Out of various hereditary nephritis, Alport's syn- 
drome is relatively more common and has been extensively studied. This is an 
X-linked dominant disorder with variable penetrance and affects males more se- 
verely than females. The syndrome consists of sensorineural deafness and oph- 
thalmic complications (lens dislocation, posterior cataracts and corneal dystro- 




terminating in end-stage kidney in the 2nd to 3rd decades of life. The common 
presenting features are persistent or recurrent haematuria accompanied by eryth- 
rocyte casts, proteinuria and hypertension. 
By light microscopy, the glomeruli have predominant involvement and 
show segmental proliferation of mesangial cells with increased mesangial 
matrix and occasional segmental sclerosis. Another prominent feature is the 
presence of lipid-laden foam cells in the intersritium. As the disease pro- 
gresses, there is increasing sclerosis of glomeruli, tubular atrophy and inter- 
stitial fibrosis. 
Electron microscopy reveals characteristic basement membrane split- 
ting or lamination in the affected parts of glomeruli. 
Immunofluorescence studies fail to show deposits of immunoglobulins 
or complement components. 
2. Fabry's disease, another hereditary nephritis is characterised by ac- 
cumulation of neutral glycosphingolipids in lysosomes of glomerular, tubu- 
lar, vascular and interstitial cells. 
3. Nail-patella syndrome or osteonychodysplasia is a rare hereditary 
disease associated with multiple osseous defects of elbows, knees and nail 




Acute tubular necrosis is the pathologic entity that affects exclusively 
renal tubules. Many other diseases involve the tubules secondarily, or the 
tubular involvement is accompanied by interstitial involvement as well and 
are described later under the heading of 'tubulo-interstitial diseases.' 
 
ACUTE TUBULAR NECROSIS 
Acute tubular necrosis (ATN) is the term used for acute renal failure 
(ARF) resulting from destruction of tubular epithelial cells. ATN is the most 
common and most important cause of ARF characterised by sudden cessation 
of renal function. Here, the two distinct forms of ATN – ischaemic and tox- 
ic, are discussed. 
ISCHAEMIC ATN 
Ischaemic ATN, also called tubulorrhectic ATN, lower nephron ne- 
phrosis, or shock kidney, occurs due to hypoperfusion of the kidneys result- 
ing in focal damage to the tubules. 
Etiopathogenesis. Ischaemic ATN is more common than toxic ATN 
and accounts for more than 80% cases of tubular injury. Ischaemia may result 
from a variety of causes such as: 





2. Crush injuries. 
3. Non-traumatic rhabdomyolysis induced by alcohol, coma, muscle 
disease or extreme muscular exertion (myoglobinuric nephrosis). 
4. Mismatched blood transfusions, black-water fever (haemoglobinuric 
nephrosis). 
The pathogenetic mechanism of ischaemic ATN resulting in ARF is 
explained on the basis of the following 4 factors, which may be operating 
singly or in combination: 
• Arteriolar vasoconstriction induced by reninangiotensin system. 
• Tubular obstruction by casts in the lumina or by interstitial oedema. 
• Back-leak of tubular fluid into the interstitium. 
• Abnormal glomerular permeability. 
Pathologic changes. Grossly, the kidneys are enlarged and swollen. 
On cut section, the cortex is often widened and pale, while medulla is dark. 
Histologically, predominant changes are seen in the tubules, while glomeruli 
are normal. Interstitium shows oedema and mild chronic inflammatory cell 
infiltrate. Tubular changes are as follows: 
1. Dilatation of the proximal and distal convoluted tubules. 
2. Focal tubular necrosis at different points along the nephron. 
3. Flattened epithelium lining the tubules suggesting epithelial regen- 
eration. 
4. Eosinophilic hyaline casts or pigmented haemoglobin and myoglo- 
bin casts in the tubular lumina. 
5. Disruption of tubular basement membrane adjacent to the cast (tubu- 
lorrhexis). 
Prognosis of ischaemic ATN depends upon the underlying etiology. In 
general, cases that follow severe trauma, surgical procedures, extensive burns 
and sepsis have much worse outlook than the others. 
TOXIC ATN 
Toxic or nephrotoxic ATN occurs as a result of direct damage to tubular 
cells by ingestion, injection or inhalation of a number of toxic agents. 
Etiopathogenesis. The toxic agents causing toxic ATN are: 
1. General poisons such as mercuric chloride, carbon tetrachloride, 
ethylene glycol, mushrooms and insecticides. 
2. Heavy metals (mercury, lead, arsenic, phosphorus and gold). 
3. Drugs such as sulfonamides, certain antibiotics (gentamycin, cephalo- 
sporin), anaesthetic agents (methoxyflurane, halothane), barbiturates, salicylates. 
4. Radiographic contrast material. 
The pathogenetic mechanism producing ARF in toxic ATN is in prin- 




arteriolar vasoconstriction, tubular obstruction, back-leak of tubular fluid and 
abnormal glomerular permeability. 
Pathologic changes. Poisoning with mercuric chloride provides the 
best example that produces widespread and readily discernible tubular necro- 
sis (acute mercury nephropathy). 
Grossly, the kidneys are enlarged and swollen. On cut section, the cor- 
tex is pale and swollen, while the medulla is slightly darker than normal. His- 
tologically, the appearance varies according to the cause of toxic ATN but, in 
general, involves the segment of tubule diffusely (unlike ischaemic ATN 
where the involvement of nephron is focal). In mercuric chloride poisoning, 
the features are as follows: 
1. Epithelial cells of mainly proximal convoluted tubules are necrotic 
and desquamated into the tubular lumina. 
2. The desquamated cells may undergo dystrophic calcification. 
3. Tubular basement membrane is generally intact. 
4. The regenerating epithelium, which is flat and thin with few mitoses, 
may be seen lining the tubular basement membrane. 
Prognosis of toxic ATN is good if there is no serious damage to other 




The term tubulointerstitial nephritis is used for inflammatory process that 
predominantly involves the renal interstitial tissue and is usually accompanied 
by some degree of tubular damage. A number of primary glomerular, tubular, 
vascular and obstructive diseases are secondarily associated with interstitial re- 
action. However, the term interstitial nephritis is reserved for those cases where 
there is no primary involvement of glomeruli, tubules or blood vessels. The old- 
er nomenclature, interstitial nephritis, is currently used syronymously with tubu- 
lointerstitial nephritis or tubulr interstitial nephropathy. 
 
ACUTE PYELONEPHRITIS 
Acute pyelonephritis is an acute suppurativg inflammation of the kid- 
ney caused by pyogenic bacteria. 
Etiopathogenesis. Most cases of acute pyelonephritis follow infection of 
the lower urinary tract. The most common pathogenic organism in urinary tract 
infection (UTI) is Escherichia coli (in 90% of cases), followed in decreasing 
frequency, by Enterobacter, Klebsiella, Pseudomonas and Proteus. The bac- 
teria gain entry into the urinary tract, and thence into the kidney by one of the two 
routes: ascending infection and haematogenous infection: 
1. Ascending infection. This is the most common route of infection. 




cause faecal contamination of the urethral orifice, especially in females in re- 
productive age group. This has been variously attributed to shorter urethra in 
females liable to faecal contamination, hormonal influences facilitating bac- 
terial adherence to the mucosa, absence of prostatic secretions which have 
antibacterial properties, and urethral trauma during sexual intercourse. The 
last named produces what is appropriately labelled as 'honeymoon pyelitis'. 
Ascending infection may occur in a normal individual but the susceptibility is 
increased in patients with diabetes mellitus, pregnancy, urinary tract obstruc- 
tion or instrumentation. Bacteria multiply in the urinary bladder and produce 
asymptomatic bacteriuria found in many of these cases. After having caused 
urethritis and cystitis, the bacteria in a small proportion of cases ascend fur- 
ther up into the ureters against the flow of urine, extend into the renal pelvis 
and then the renal cortex. The role of vesico-ureteral reflux is primarily of 
importance in the pathogenesis of chronic pyelonephritis but not in acute 
pyelonephritis. 
2. Haematogenous infection. Less often, acute pyelonephritis may re- 
sult from blood-borne spread of infection. This occurs more often in patients 
with obstructive lesions in the urinary tract, and in debilitated or immunosup- 
pressed patients. 
Pathologic changes. Grossly, well-developed cases of acute pyelone- 
phritis show enlarged and swollen kidney mat bulges on section. The cut surface 
shows small, yellow-white abscesses with a haemorrhagic rim. These abscesses 
may be several millimetres across and are situated mainly in the cortex. 
Microscopically, acute pyelonephritis is characterised by extensive acute 
inflammation involving the interstitium and causing destruction of the tubules. 
Generally, the glomeruli and renal blood vessels show considerable resistance to 
infection and are spared. The acute inflammation may be in the form of large 
number of neutrophils in the interstitial tissue and bursting into tubules, or may 
form focal neutrophilic abscesses in the renal parenchyma. 
Complications. Complications of acute pyelonephritis are encountered 
more often in patients with diabetes mellitus or with urinary tract obstruction. 
There are 3 important complications of acute pyelonephritis. These are as under: 
1. Papillary necrosis. Papillary necrosis or necrotising papillitis devel- 
ops more commonly in analgesic abuse nephropathy and in sickle cell disease 
but may occur as a complication of acute pyelonephritis as well. It may affect 
one or both kidneys. 
Grossly, the necrotic papillae are yellow to grey-white, sharply-defined 
areas with congested border and resemble infarction. The pelvis may be di- 
lated. Microscopically, necrotic tissue is separated from the viable tissue by a 
dense zone of polymorphs. The necrotic area shows characteristic coagulative 




2. Pyonephrosis. Rarely, the abscesses in the kidney in acute pyelone- 
phritis are extensive, particularly in cases with obstruction. This results in in- 
ability of the abscesses to drain and this transforms the kidney into a multi- 
locular sac filled with pus called as pyonephrosis or renal carbuncle. 
3. Perinephric abscess. The abscesses in the kidney may extend 




Chronic pyelonephritis is a chronic tubulointerstitial disease resulting 
from repeated attacks of inflammation and scarring. 
Etiopathogenesis. Depending upon the etiology and pathogenesis, two 
types of chronic pyelonephritis are described—reflux nephropathy and ob- 
structive pyelonephritis. 
1. Reflux nephropathy. Reflux of urine from the bladder into one or 
both the ureters during micturition is the major cause of chronic pyelonephri- 
tis. Vesicoureteric reflux is particularly common in children, especially in 
girls, due to congenital absence or shortening of the intravesical portion of 
the ureter so that ureter is not compressed during the act of micturition. Re- 
flux results in increase in pressure in the renal pelvis so that the urine is 
forced into renal tubules which is eventually followed by damage to the kid- 
ney and scar formation. Vesicoureteric reflux is more common in patients 
with urinary tract infection, whether symptomatic or asymptomatic, but re- 
flux of sterile urine can also cause renal damage. 
2. Obstructive pyelonephritis. Obstruction to the outflow of urine at dif- 
ferent levels predisposes the kidney to infection. Recurrent episodes of such ob- 
struction and infection result in renal damage and scarring. Rarely, recurrent at- 
tacks of acute pyelonephritis may cause renal damage and scarring. 
Pathologic changes. Grossly, the kidneys show rather characteristic 
appearance. The kidneys are usually small and contracted (weighing less than 
100 gm) showing unequal reduction so as to distinguish it from other forms 
of contracted kidney. The surface of the kidney is irregularly scarred; the cap- 
sule can be stripped off with difficulty due to adherence to scars. These scars are 
of variable size and show characteristic U-shaped depressions on the cortical 
surface. There is generally dilatation of pelvis and blunted calyces. 
Microscopically, predominant changes are seen in interstitium and tubules: 
i) Interstitium. There is chronic interstitial inflammatory reaction, 
chiefly composed of lymphocytes, plasma cells and macrophages with pro- 
nounced interstitial fibrosis. Xanthogranulomatous pyelonephritis is an un- 
common variant characterised by collection of foamy macrophages admixed 




ii) Tubules. The tubules show varying degree of atrophy and dilatation. 
Dilated tubules may contain eosinophilic colloid casts producing thy- 
roidisarion of tubules. A few tubules may contain neutrophils. 
iii) Pelvicalyceal system. The renal pelvis and calyces are dilated. The 
walls of pelvis and calyces show marked chronic inflammation and fibrosis. 
Lymphoid follicles with germinal centres may be present in the pelvicalyceal 
walls. 
iv) Blood vessels. Blood vessels entrapped in the scarred areas show 
obliterative endarteritis. There may be changes of hypertensive hyaline arte- 
riolosclerosis. 
v) Glomeruli. Though glomerular tuft in the scarred area is usually in- 
tact, there is often periglomerular fibrosis. In advanced cases, there may be 
hyalinisation of glomeruli. 
 
TUBERCULOUS PYELONEPHRITIS 
Tuberculosis of the kidney occurs due to haematogenous spread of in- 
fection from another site, most often from the lungs. Less commonly, it may 
result from ascending infection from tuberculosis of the genitourinary system 
such as from epididymis or Fallopian tubes. The renal lesions in tuberculosis 
may be in the form of tuberculous pyelonephritis or appear as multiple mil- 
iary tubercles. 
Pathologic changes. Grossly, the lesions in tuberculous pyelonephritis 
are often bilateral, usually involving the medulla with replacement of the papil- 
lae by caseous tissue. Obstruction may result in tuberculous pyonephrosis in 
which thinned out renal parenchyma surrounds dilated pelvis and calyces filled 
with caseous material. Histologically, typical granulomatous reaction is seen. 
Acid-fast bacilli can often be demonstrated in the lesions. 
 
MYELOMA NEPHROPATHY 
Renal involvement in multiple myeloma is referred to as myeloma 
nephropathy or myeloma kidney. Functional renal impairment in multiple 
myeloma is a common manifestation, developing in about 50% of patients. 
The pathogenesis of myeloma kidney is related to excess filtration of Bence- 
Jones proteins through the glomerulus, usually kappa (K) light chains. These 
light chain proteins are precipitated in the distal convoluted tubules in com- 
bination with Tamm-Horsfall proteins, the urinary glycoproteins. The pre- 
cipitates form tubular casts which are eosinophilic and often laminated. The- 
se casts may induce peritubular interstitial inflammatory reaction. Not all 





Pathologic changes. Grossly, the kidneys may be normal or small and 
shrunken. Histologically, there are some areas of tubular atrophy while many 
other tubular lumina are dilated and contain characteristic bright pink lami- 
nated casts. These casts are surrounded by peritubular interstitial inflammato- 
ry reaction including the presence of nonspecific inflammatory cells and 
some multinucleate giant cells induced by tubular casts. 
 
NEPHROCALCINOSIS 
Nephrocalcinosis is a diffuse deposition of calcium salts in renal tissue 
in a number of renal diseases, in hypercalcaemia, hyperphosphataemia and 
renal tubular acidosis. Most commonly, it develops as a complication of se- 
vere hypercalcaemia such as due to hyperparathyroidism, hypervitaminosis 
D, excessive bone destruction in metastatic malignancy, hyperthyroidism, 
excessive calcium intake such as in milk-alkali syndrome and sarcoidosis. 
Clinically, patients of hypercalcaemia and nephrocalcinosis may have renal 
colic, band keratopathy due to calcium deposits in the cornea, visceral meta- 
static calcification, polyuria and renal failure. 
Pathologically, nephrocalcinosis due to hypercalcaemia characteristical- 
ly shows deposition of calcium in the tubular epithelial cells in the basement 
membrane, within the mitochondria and the cytoplasm. These concretions may 
produce secondary tubular atrophy, interstitial fibrosis and nonspecific chronic 
inflammation in the interstitium. As the calcification occurs intracellularly, radi- 
ological evidence is usually not present until fairly late in the disease. The calci- 
um deposits are first visible as small opacities in the renal papillae. 
 
RENAL VASCULAR DISEASES 
 
Renal blood vessels which enormously perfuse the kidney are affected 
secondarily in majority of renal diseases. Renal blood flow is controlled by 
systemic and local haemodynamic, hormonal and intrinsic intra-renal mecha- 
nisms. Diseases which disturb these controlling mechanisms give rise to pri- 
mary renal vascular lesions. These diseases are as under: 
I. Most importantly, hypertensive vascular disease and its consequent 
renal manifestations in the form of benign and malignant nephrosclerosis. 
II. Thrombotic microangiopathy. 
III. Renal cortical necrosis. 
IV. Renal infarcts. 
I. Hypertensive vascular disease (see above) 
II. Thrombotic microangiopathy 
Thrombotic renal disease encompasses a group of diseases having in com- 
mon the formation of thrombi composed by platelets and fibrin in arterioles 




The common clinical manifestations include micro-angiopathic haemo- 
lytic anaemia, thrombocytopenia, DIC, and eventually renal failure. 
Pathogenesis. In all such cases, endothelial injury appears to be the 
trigger for vascular changes. The injured endothelial surface causes the fol- 
lowing effects: 
• Passage of plasma constituents to the subendothelial zone of micro- 
vasculature. 
• Promotes thrombosis. 
Morphologically, the lesions closely resemble those of malignant 
nephrosclerosis. The features include: 
• Fibrinoid necrosis of arterioles. 
• Thrombi in renal microvasculature. 
• Oedema of intima of arterioles. 
• Consolidation, necrosis and congestion of glomeruli. 
If the renal lesions are massive, the prognosis is generally lethal. 
III. Renal cortical necrosis 
Renal cortical necrosis is infarction of renal cortex varying from micro- 
scopic foci to a situation where most of the renal cortex is destroyed. The me- 
dulla, the juxtamedullary cortex and a rim of cortex under the capsule are usual- 
ly spared. The condition develops most commonly as an obstetrical emergency 
(e.g. in eclampsia, preeclampsia, premature separation of the placenta). Other 
causes include septic shock, poisoning, severe trauma etc. 
The lesions may be present focally, patchily or diffusely. The gross 
and microscopic characteristics of infarcts of cortex are present. Patients pre- 
sent with sudden oliguria or anuria and haematuria. If the process has in- 
volved renal cortex extensively, acute renal failure and uraemia develop and 




Obstruction in the urinary tract is common and important because it in- 
creases the susceptibility to infection and stone formation. Obstruction can oc- 
cur at any age and in either sex. The cause of obstruction may lie at any level of 
the urinary tract – renal pelvis, ureters, urinary bladder and urethra. 
The obstruction may be unilateral or bilateral, partial or complete, sud- 
den or insidious. Complete bilateral obstruction may result in irreversible re- 
nal failure, whereas long-standing chronic partial obstruction may cause vari- 
ous functional abnormalities and anatomic changes. There are three important 
anatomic sequelae of obstruction, namely: hydronephrosis, hydroureter and 
hypertrophy of the bladder. But before describing these conditions, an ac- 
count of the most common and important cause of obstructive uropathy, uro- 





Urolithiasis or formation of urinary calculi at any level of the urinary 
tract is a common condition. Urinary calculi are worldwide in distribution but 
are particularly common in some geographic locales such as in parts of the 
United States, South Africa, India and South-East Asia. It is estimated that 
approximately 2% of the population experiences renal stone disease at some- 
time in their life with male-female ratio of 2:1. The peak incidence is ob- 
served in 2nd to 3rd decades of life. Renal calculi are characterised clinically 
by colicky pain (renal colic) as they pass down along the ureter and manifest 
by haematuria. 
Types of Urinary Calculi 
There are 4 main types of urinary calculi – calcium containing, mixed 
(struvite), uric acid and cystine stones, and a small number of rare types. 
1. CALCIUM STONES. Calcium stones are the most common comprising 
about 75% of all urinary calculi. They may be pure stones of calcium oxalate 
(50%) or calcium phosphate (5%), or mixture of calcium oxalate and calcium 
phosphate (45%). 
Etiology of calcium stones is variable. 
i) About 50% of patients with calcium stones have idiopathic hyper- 
calciuria without hypercalcaemia. 
ii) Approximately 10% cases are associated with hypercalcaemia and hy- 
percalciuria, most commonly due to hyperparathyroidism or a defect in the 
bowel (i.e. absorptive hypercalciuria) or in the kidney (i.e. renal hypercalciuria). 
iii) About 15% of patients with calcium stones have hyperuricosuria 
with a normal blood uric acid level and without any abnormality of calcium 
metabolism. 
iv) In about 25% of patients with calcium stones, the cause is unknown 
as there is no abnormality in urinary excretion of calcium, uric acid or oxalate 
and is referred to as 'idiopathic calcium stone disease'. 
Pathogenesis. The mechanism of calcium stone formation is explained 
on the basis of imbalance between the degree of super saturation of the ions 
forming the stone and the concentration of inhibitors in the urine. Most likely 
site where the crystals of calcium oxalate and/or calcium phosphate are pre- 
cipitated is the tubular lining or around some fragment of debris in the tubule 
acting as nidus of the stone. The stone grows, as more and more crystals are 
deposited around the nidus. A number of other predisposing factors contributing 
to formation of calcium stones are alkaline urinary pH, decreased urinary vol- 
ume and increased excretion of oxalate and uric acid. 
Morphology. Calcium stones are usually small (less than a centime- 




blood pigment deposited in them as a result of repeated trauma caused to the 
urinary tract by these sharp-edged stones. 
2. MIXED (STRUVITE) STONES. About 15% of urinary calculi are made 
of magnesium-ammonium-calcium phosphate, often called struvite. That is 
why mixed stones are also called as 'struvite stones' or 'triple phosphate 
stones'. 
Struvite stones are formed as a result of infection of the urinary tract 
with urea-splitting organisms that produce urease such as by species of Pro- 
teus, and occasionally Klebsiella, Pseudomonas and Enterobacter. These are, 
therefore, also known as infection-induced stones. However, E. coli does not 
form urease. 
Morphology. Struvite stones are yellow-white or grey. They tend to be 
soft and friable and irregular in shape. 'Staghorn stone' which is a large, soli- 
tary stone that takes the shape of the renal pelvis where it is often formed is 
an example of struvite stone. 
3. URIC ACID STONES. Approximately 6% of urinary calculi are made 
of uric acid. Uric acid calculi are radiolucent unlike radio-opaque calcium 
stones. 
Uric acid stones are frequently formed in cases with hyperuricaemia 
and hyperuricosuria such as due to primary gout or secondary gout due to 
myeloproliferative disorders (e.g. in leukaemias), especially those on chemo- 
therapy, and administration of uricosuric drugs (e.g. salicylates, probenacid). 
Pathogenesis. The solubility of uric acid at pH of 7 is 200 mg/dl while 
at pH of 5 is 15 mg/dl. Thus, as the urine becomes more acidic, the solubility 
of uric acid in urine decreases and precipitation of uric acid crystals increases 
favouring the formation of uric acid stones. Hyper uricosuria is the most im- 
portant factor in the production of uric acid stones, while hyper uricaemia is 
found in about half the cases. 
Morphology. Uric acid stones are smooth, yellowish-brown, hard and 
often multiple. On cut section, they show laminated structure. 
4. CYSTINE STONES. Cystine stones comprise less than 2% of urinary 
calculi. 
Cystine stones are associated with cystinuria due to a genetically- 
determined defect in the transport of cystine and other amino acids across the 
cell membrane of the renal tubules and the small intestinal mucosa. 
Pathogenesis. The resultant excessive excretion of cystine which is 
least soluble of the naturally-occurring amino acids leads to formation of 
crystals and eventually cystine calculi. 
Morphology. Cystine stones are small, rounded, smooth and often mul- 




5. OTHER CALCULI. Less than 2% of urinary calculi consist of other ra- 
re types such as due to inherited abnormality of xanthine metabolism result- 
ing in xanthinuria and consequently xanthine stones. 
 
HYDRONEPHROSIS 
Hydronephrosis is the term used for dilatation of renal pelvis and caly- 
ces due to partial or intermittent obstruction to the outflow of urine. Hydro- 
nephrosis develops if one or both the pelviureteric sphincters are incompe- 
tent, as otherwise there will be dilatation and hypertrophy of the urinary 
bladder but no hydronephrosis. Hydroureter nearly always accompanies hy- 
dronephrosis. Hydronephrosis may be unilateral or bilateral. 
Unilateral Hydronephrosis 
This occurs due to some form of ureteral obstruction at the level of 
pelviureteric junction (PUJ). The causes are: 
1. Intraluminal e.g. a calculus in the ureter or renal pelvis. 
2. Intramural e.g. congenital PUJ obstruction, atresia of ureter, in- 
flammatory stricture, trauma, neoplasm of ureter or bladder. 
3. Extramural e.g. obstruction of upper part of ureter by inferior renal 
artery or vein, pressure on ureter from outside such as carcinoma cervix, 
prostate, rectum, colon or caecum and retroperitoneal fibrosis. 
Bilateral Hydronephrosis 
This is generally the result of some form of urethral obstruction but can 
occur from the various causes listed above if the lesions involve both sides. 
The causes are: 
1. Congenital e.g. atresia of the urethral meatus, congenital posterior 
urethral valve. 
2. Acquired e.g. bladder tumour involving both ureteric orifices, pros- 
tatic enlargement, prostatic carcinoma and prostatitis, bladder neck stenosis, 
inflammatory or traumatic urethral stricture and phimosis. 
Pathologic changes. The pathologic changes vary depending upon 
whether the obstruction is sudden and complete, or incomplete and intermit- 
tent. The latter situation is more common. 
Grossly, the kidneys may have moderate to marked enlargement. Ini- 
tially, there is extrarenal hydronephrosis characterised by dilatation of renal 
pelvis medially in the form of a sac. As the obstruction persists, there is pro- 
gressive dilatation of pelvis and calyces and pressure atrophy of renal paren- 
chyma. Eventually, the dilated pelvi-calyceal system extends deep into the 
renal cortex so that a thin rim of renal cortex is stretched over the dilated cal- 
cyes and the external surface assumes lobulated appearance. This advanced 




between the sectioned surface of advanced hydronephrosis and polycystic 
kidney disease is the direct continuity of dilated cystic spaces (i.e. dilated 
calcyes) with the renal pelvis in the former. 
Microscopically, the wall of hydronephrotic sac is thickened due to fi- 
brous scarring and chronic inflammatory cell infiltrate. There is progressive 
atrophy of tubules and glomeruli alongwith interstitial fibrosis. Stasis of urine 
in hydronephrosis causes infection (pyelitis) resulting in filling of the sac 
with pus, a condition called pyonephrosis. 
 
TUMOURS OF KIDNEY 
 
Both benign and malignant tumours occur in the kidney, the latter be- 
ing more common. These may arise from renal tubules (adenoma, adenocar- 
cinoma), embryonic tissue (mesoblastic nephroma, Wilms' tumour), mesen- 
chymal tissue (angiomyolipoma, medullary interstitial tumour) and from the 
epithelium of the renal pelvis (urothelial carcinoma). Besides these tumours, 
the kidney may be the site of the secondary tumours. 
 
BENIGN TUMOURS 
Benign renal tumours are usually small and are often an incidental 
finding at autopsy or nephrectomy. 
CORTICAL ADENOMA 
Cortical tubular adenomas are more common than other benign renal 
neoplasms. They are frequently multiple and associated with chronic pyelo- 
nephritis or benign nephrosclerosis. 
Grossly, these tumours may form tiny nodules up to 3 cm in diameter. 
They are encapsulated and white or yellow. 
Microscopically, they are composed of tubular cords or papillary struc- 
tures projecting into cystic space. The cells of the adenoma are usually uni- 
form, cuboidal with no atypicality or mitosis. However, size of the tumour 
rather than histologic criteria is considered more significant parameter to pre- 
dict the behaviour of the tumour — those larger than 3 cm in diameter are po- 
tentially malignant and metastasising. 
ONCOCYTOMA 
Oncocytoma  is  a  benign  epithelial  tumour  arising  from  collecting 
ducts.  
Grossly, The tumour is encapsulated and has variable size. Cut section 
is homogeneous and has characteristic mahogany-brown or tan colour. 
Microscopically, the tumour cells are plump with abundant, finely 
granular, acidophilic cytoplasm and round nuclei. Electron microscopy 




OTHER BENIGN TUMOURS 
• Angiomyolipoma is a hamartoma of the kidney that contains differen- 
tiated tissue element derived from blood vessels, smooth muscle and fat. 
• Mesoblastic nephroma is a congenital benign tumour. 
Grossly, the tumour resembles a uterine leiomyoma in having whorled 
appearance. 
Microscopically, it shows cellular growth of spindle cells derived from 
secondary mesenchyme. 
• Multicystic nephroma is another uncommon tumour of early infancy. 
Grossly, it is a solitary, unilateral well demarcated tumour of varying 
size. Cut surface shows characteristic multilocular appearance. 
Microscopically, the cysts are lined by tubular epithelium while the 
stroma between the cysts contains mesenchymal tissue with some immature 
blastemal or abortive tubules. Some authors consider this entity as fully- 
differentiated variant of Wilms' tumour. However, clinically multicystic 
nephroma is always benign compared to Wilms' tumour. 
• Medullary interstitial cell tumour is a tiny nodule in the medulla 
composed of fibroblast-like cells in hyalinised stroma. These tumours used to 
be called renal fibromas but electron microscopy has revealed that the tu- 
mour cells are not fibrocytes but are medullary interstitial cells. 
• Juxtaglomerular tumour or reninoma is a rare rumour of renal cor- 
tex consisting of sheets of epithelioid cells with many small blood vessels. 
The tumour secretes excessive quantities of renin and, thus, the patients are 
likely to have hypertension. 
 
MALIGNANT TUMOURS 
The two most common primary malignant tumours of the kidney are 
adenocarcinoma and Wilms' tumour. A third less common tumour is urothe- 
lial carcinoma of renal pelvis which is described in the next section along- 
with similar tumours of the lower urinary tract. 
ADENOCARCINOMA OF KIDNEY (Synonyms: Renal cell carcinoma, 
Hypernephroma, Grawitz tumour) 
Hypernephroma is an old misnomer under the mistaken belief that the 
tumour arises from adrenal rests because of the resemblance of the tumour 
cells with clear cells of the adrenal cortex. It is now known that the renal cell 
carcinoma (RCC) is an adenocarcinoma arising from tubular epithelium. This 
cancer comprises 70 to 80% of all renal cancers and occurs most commonly 
in 50 to 70 years of age with male preponderance (2:1). 
Etiology and pathogenesis. Various etiologic factors implicated in the 




1. Tobacco. Tobacco is the major risk factor for RCC, whether chewed or 
smoked. Cigarette smokers have 2-times higher risk of developing RCC. 
2. Additional risk factors. These include: 
i) Exposure to asbestos, heavy metals and petrochemical products. 
ii) In women, obesity and oestrogen therapy. 
iii) Hereditary and acquired cystic diseases of the kidney. 
iv) Analgesic nephropathy. 
v) Hereditary and family history are associated with 4-5 times higher risk. 
vi) Hypertension. 
Majority of cases of RCC are sporadic but about 5% cases are inherited 
in which carcinogenesis has been studied in detail. Carcinongenesis in he- 
reditary RCC is explained on the basis of 3 distinct syndromes: 
1. Von Hippel-Lindau (VHL) disease: It is an autosomal dominant can- 
cer syndrome that includes: haemangioblastoma of the cerebellum, retinal 
angiomas, multiple RCC (clear cell type) and pheochromocytoma and cysts 
in different organs. 
2. Hereditary clear cell RCC: These are cases of RCC of clear cell 
type confined to the kidney without other manifestations of VHL but having 
autosomal dominant inheritance. 
3. Hereditary papillary RCC: This form of RCC is characterised by bi- 
lateral and multifocal cancer with papillary growth pattern. 
Classification. Based on cytogenetics of sporadic and familial ru- 
mours, RCC has been reclassified recently into clear cell, papillary, granular 
cell, chromophobe, sarcoma toid and collecting duct type. 
Pathologic changes. Grossly, the RCC commonly arises from  the 
poles of the kidney as a solitary and unilateral tumour, more often in the up- 
per pole. The tumour is generally large, golden yellow and circumscribed. 
Papillary tumours may be multifocal and bilateral, besides grossly visible pa- 
pillae. Cut section of the tumour commonly shows large areas of ischaemic 
necrosis, cystic change and foci of haemorrhages. Another significant charac- 
teristic is the frequent presence of tumour thrombus in the renal vein which 
may extend into the vena cava. 
Histologically, the features of various types of RCC are as under: 
1. Clear cell type RCC (70%): This is the most common pattern. The 
clear cytoplasm of tumour cells is due to removal of glycogen and lipid from 
the cytoplasm during processing of tissues. The tumour cells have a variety 
of patterns: solid, trabecular and tubular, separated by delicate vasculature. 
Majority of clear cell rumours are well differentiated. 
2. Papillary type RCC (15%): The tumour cells are arranged in papil- 
lary pattern over the fibrovascular stalks. The tumour cells are cuboidal with 




3. Granular cell type RCC (8%): The tumour cells have abundant aci- 
dophilic cystoplasm. These tumours have more marked nuclear pleo- 
morphism, hyperchromatism and cellular atypia. 
4. Chromophobe type RCC (5%): This type shows admixture of pale 
clear cells with perinuclear halo and acidophilic granular cells. The cyto- 
plasm of these tumour cells contains many vesicles. 
5. Sarcomatoid type RCC (1.5%): This is the most anaplastic and poor- 
ly differentiated form. The tumour is characterised by whorls of atypical 
spindle tumour cells. 
6. Collecting duct type RCC (0.5%): This is a rare type that occurs in 
the medulla. It is composed of a single layer of cuboidal tumour cells ar- 
ranged in tubular and papillary pattern. 
The prognosis in renal cell carcinoma depends upon the extent of tu- 
mour involvement at the time of diagnosis. The overall 5-year survival rate is 
about 45%. Presence of metastases lowers the survival rate. 
WILMS' TUMOUR (SYNONYM: NEPHROBLASTOMA) 
Nephroblastoma, or Wilms' tumour is an embryonic tumour derived 
from primitive renal epithelial and mesenchymal components. It is the most 
common abdominal malignant tumour of young children, seen most com- 
monly between 1 to 6 years of age with equal sex incidence. 
Pathologic changes. Grossly, the tumour is usually quite large, sphe- 
roidal, replacing most of the kidney. It is generally solitary and unilateral but 
5-10% cases may have bilateral rumour. On cut section, the tumour shows 
characteristic variegated appearance – soft, fishflesh-like grey-white to 
cream-yellow tumour with foci of necrosis and haemorrhages and grossly 
identifiable myxomatous or cartilaginous elements. Invasion into renal vein is 
grossly evident in half the cases. 
Microscopically, nephroblastoma shows mixture of primitive epithelial 
and mesenchymal elements. Most of the tumour consists of small, round to 
spindled, anaplastic, sarcomatoid tumour cells. In these areas are present 
abortive tubules and poorly-formed glomerular structures. Sometimes, mes- 
enchymal elements such as smooth and skeletal muscle, cartilage and bone, 
fat cells and fibrous tissue, may be seen. 
SECONDARY TUMOURS 
Leukaemic infiltration of the kidneys is a common finding, particularly 
in chronic myeloid leukaemia. Kidney is a common site for blood-borne me- 
tastases from different primary sites, chiefly from cancers of lungs, breast 
and stomach. 
 
LOWER URINARY TRACT 




Ureters are tubular structures, 30 cm in length and half a centimeter in diameter, 
and extend from the renal pelvis (pelvi-ureteric junction) to the urinary bladder (vesico- 
ureteric junction). Normally they enter obliquely into the bladder, so that ureter is com- 
pressed during micturition, thus preventing vesico-ureteric reflux. Ureters lie retroperito- 
neally throughout their course. 
Histologically, ureter has an outer fibrous investing layer which overlies a thick 
muscular layer and is lined internally by transitional epithelium or urothelium similar to 
the lining of the renal pelvis above and bladder below. 
Urinary bladder lies extraperitoneally and the peritoneum is reflected on its supe- 
rior surface. Normally, the capacity of bladder is about 400 to 500 ml without over- 
distension. Micturition is partly a reflex and partly a voluntary act under the control of 
sympathetic and parasympathetic innervation. 
Histologically, the greater part of the bladder wall is made up of muscular layer 
(detrusor muscle) having 3 coats – internal, middle and external. The trigone muscle is 
derived from the prolongation of the longitudinal muscle layer of each ureter. The inner 
layer of bladder consists of urothelium up to 6 layers in thickness. 
Urethra runs from the bladder up to the external meatus. The male urethra con- 
sists of 3 parts – prostatic, membranous and penile. It is lined in the prostatic part by 
urothelium but elsewhere by stratified columnar epithelium except near its orifice where 
the epithelium is stratified squamous. The urethral mucosa rests ont highly vascular sub- 
mucosa and outer layer of striated muscle. There are numerous small mucous glands in the 
urethral mucosa. The female urethra is shorter and runs from the bladder parallel with the 
anterior wall of the vagina. The mucous membrane in female urethra is lined throughout 
by columnar epithelium except near the bladder where the epithelium is transitional. The 
other layers and mucous glands are similar to those in male urethra. 
 
CONGENITAL ANOMALIES 
Double Ureter. This is a condition in which the entire ureter or only 
the upper part is duplicated. Double ureter is invariably associated with a 
double renal pelvis, one in the upper part and the other in the lower part of 
the kidney. If double ureter affects the entire length, then there are two sepa- 
rate openings into the bladder on one side but more commonly they are 
joined in the intravesical portion and open by a single ureteric orifice. 
Ureterocele. Ureterocele is cystic dilatation of the terminal part of the 
ureter which lies within the bladder wall. The cystic dilatation lies beneath 
the bladder mucosa and can be visualised by cystoscopy. 
Ectopia vesicae (exstrophy). This is a rare condition owing to congen- 
ital developmental deficiency of anterior wall of the bladder and is associated 
with splitting of the overlying anterior abdominal wall. This results in ex- 
posed interior of the bladder. There may be prolapse of the posterior wall of 
the bladder through the defect in the anterior bladder and abdominal wall. 




thra opens on the dorsal aspect of penis. If the defect is not properly repaired, the 
exposed bladder mucosa gets infected repeatedly and may undergo squamous 
metaplasia with increasing tendency to develop carcinoma of the bladder. 
Urachal abnormalities. Rarely, there may be persistence of urachus in 
which urine passes from the bladder to the umbilicus. More often, part of 
urachus remains patent which may be the umbilical end, bladder end, or cen- 
tral portion. Persistence of central portion gives rise to urachal cyst lined by 




Urinary tract infection (UTI) is common, especially in females and has 
been described already alongwith its morphologic consequences. Inflamma- 
tion of the tissues of urinary tract (ureteritis, cystitis and urethritis) are con- 
sidered here. 
URETERITIS 
Infection of the ureter is almost always secondary to pyelitis above, or 
cystitis below. Ureteritis is usually mild but repeated and longstanding infec- 
tion may give rise to chronic ureteritis. 
CYSTITIS 
Inflammation of the urinary bladder is called cystitis. Primary cystitis 
is rare since the normal bladder epithelium is quite resistant to infection. Cys- 
titis may occur by spread of infection from upper urinary tract as seen follow- 
ing renal tuberculosis, or may spread from the urethra such as in instrumenta- 
tion. Cystitis is caused by a variety of bacterial and fungal infections as dis- 
cussed in the etiology of pyelonephritis. The most common pathogenic or- 
ganism in urinary tract infection is E. coli, followed in decreasing frequency 
by Enterobacter, Klebsiella, Pseudomonas and Proteus. Infection with Can- 
dida albicans may occur in the bladder in immunosuppressed patients. Be- 
sides bacterial and fungal organisms, parasitic infestations such as with 
Schistosoma haematobium is common in the Middle-East countries, particu- 
larly in Egypt. Chlamydia and Mycoplasma may occasionally cause cystitis. 
In addition, radiation, direct exposure to chemical irritant, foreign bodies and 
local trauma may all initiate cystitis. 
Cystitis, like UTI, is more common in females than in males because 
of the shortness of urethra which is liable to faecal contamination and due to 
mechanical trauma during sexual intercourse. In males, prostatie obstruction 
is a frequent cause of cystitis. All forms of cystitis are clinically characterised 




burning micturition) and low abdominal pain. There may, however, be sys- 
temic manifestations of bacteraemia such as fever, chills and malaise. 
Pathologic changes. Cystitis may be acute or chronic. 
Acute cystitis. Grossly, the bladder mucosa is red, swollen and haem- 
orrhagic. There may be suppurative exudate or ulcers on the bladder mucosa. 
Microscopically, this form of cystitis is characterised by intense neutrophilic 
exudate admixed with lymphocytes and macrophages. There is oedema and 
congestion of mucosa. 
Chronic cystitis. Repeated attacks of acute cystitis lead to chronic cystitis. 
Grossly, the mucosal epithelium is thickened, red and granular with 
formation of polypoid masses. Long-standing cases result in thickened blad- 
der wall and shrunken cavity. 
Microscopically, there is patchy ulceration of the mucosa with for- 
mation of granulation tissue in the regions of polypoid masses. Submucosa 
and muscular coat show fibrosis and infiltration by chronic inflammatory 
cells. A form of chronic cystitis characterised by formation of lymphoid folli- 
cles in the bladder mucosa is termed cystitis follicularis. 
A few other special forms of cystitis having distinct clinical and mor- 
phological appearance are described below. 
Interstitial cystitis (Runner's ulcer). This variant of cystitis occurs in 
middle-aged women. The patients get repeated attacks of severe and excruciat- 
ing pain on distension of the bladder, frequency of micturition and great de- 
crease in bladder capacity. Cystoscopy often reveals a localised ulcer. The etiol- 
ogy of the condition is unknown but it is thought to be neurogenic in origin. 
Microscopically, the submucosa and muscle coat show increased fibro- 
sis and chronic inflammatory infiltrate, chiefly lymphocytes, plasma cells and 
eosinophils. 
Cystitis cystica. As a result of long-standing chronic inflammation, 
there occurs a downward projection of epithelial nests known as Brunn's 
nests from the deeper layer of bladder mucosa. These epithelial cells may ap- 
pear as small cystic inclusions in the bladder wall, or may actually develop 
columnar metaplasia with secretions in the lumen of cysts. 
Malakoplakia. This is a rare condition most frequently found in the 
urinary bladder but can occur in the ureters, kidney, testis and prostate, and 
occasionally in the gut. The etiology of the condition is unknown but proba- 
bly results from persistence of chronic inflammation with defective phago- 
cytic process by the macrophages. Malakoplakia occurs more frequently in 




Grossly, the lesions appear as soft, flat, yellowish, slightly raised plaques 
on the bladder mucosa. They may vary from 0.5 to 5 cm in diameter. 
Microscopically, the plaques are composed of massive accumulation of 
foamy macrophages with occasional multinucleate giant cells and some lym- 
phocytes. These macrophages have granular PAS-positive cytoplasm and 
some of them contain cytoplasmic laminated concretions of calcium phos- 
phate called Michaelis-Gutmann bodies. These bodies ultrastructurally repre- 
sent lysosomes filled with partly digested debris of bacteria phagocytosed by 
macrophages which have not been digested fully by them due to defective 
phagocytosis. 
Polypoid cystitis. Polypoid cystitis is characterised by papillary pro- 
jections on the bladder mucosa due to submucosal oedema and can be con- 
fused with transitional cell carcinoma. The condition occurs due to indwell- 
ing catheters and infection. 
URETHRITIS 
Urethritis may be gonococcal or non-gonococcal. 
• Gonococcal (gonorrhoeal) urethritis is an acute suppurative condition 
caused by gonococci (Neisseria gonorrhoeae). The mucosa and submucosa 
are eventually converted into granulation tissue which becomes fibrosed and 
scarred resulting in urethral stricture. 
• Non-gonococcal urethritis is more common and is most frequently 
caused by E. coli. The infection of urethra often accompanies cystitis in fe- 
males and prostatitis in males. Urethritis is one of the components in the triad 
of Reiter's syndrome which comprises arthritis, conjunctivitis and urethritis. 
The pathologic changes are similar to inflammation of the lower urinary tract 
elsewhere but strictures are less common than following gonococcal infection 
of the urethra. 
TUMOURS 
The urinary bladder and renal pelvis are more common sites for urinary 
tract tumours than the ureters and urethra. Majority of urinary tract tumours 
are epithelial. Both benign and malignant tumours occur; the latter being 
more common. 
 
EPITHELIAL (UROTHELIAL) BLADDER TUMOURS 
More than 90% of bladder tumours arise from transitional epithelial 
(urothelium) lining of the bladder in continuity with the epithelial lining of 
the renal pelvis, ureters, and the major part of the urethra. Though many 
workers consider all transitional cell tumours as transitional cell carcinoma, 





Bladder cancer comprises about 3% of all cancers. Most of the cases 
appear beyond 5th decade of life with preponderance in males. 
Etiopathogenesis. Urothelial tumours in the urinary tract are typically 
multifocal and the pattern of disease becomes apparent over a period of 
years. A number of environmental and host factors are associated with in- 
creased risk of bladder cancer. These are as under: 
1. Industrial occupations. Workers in industries that produce aniline 
dyes, rubber, plastic, textiles, and cable have high incidence of bladder can- 
cer. Bladder cancer may occur in workers in these factories after a prolonged 
exposure of about 20 years. The carcinogenic substances responsible for 
bladder cancer in these cases are the metabolites of J3-naphthylamine and 
benzene. 
2. Schistosomiasis. There is increased risk of bladder cancer, particu- 
larly squamous cell carcinoma, in patients having bilharzial infestation 
(Schistosoma haematobium) of the bladder. Schistosomiasis is common in 
Egypt and accounts for high incidence of bladder cancer in that country. It is 
thought to induce local irritant effect and initiate squamous metaplasia fol- 
lowed by squamous cell carcinoma. 
3. Dietary factors. Certain carcinogenic metabolites of tryptophan are 
excreted in urine of patients with bladder cancer. These metabolites have 
been shown to induce bladder cancer in experimental animals. The role of ar- 
tificial sweeteners like saccharin, coffee or caffeine and chronic alcoholism 
in the etiology of bladder cancer in man is controversial. 
4. Local lesions. A number of local lesions in the bladder predispose to 
the development of bladder cancer. These include ectopia vesicae (extrophied 
bladder), vesical diverticulum, leukoplakia of the bladder mucosa and urinary 
diversion in defunctionalised bladder. All these conditions are associated 
with squamous metaplasia and high incidence of bladder cancer. 
5. Smoking. Tobacco smoking is associated with 2 to3 fold increased 
risk of developing bladder cancer, probably due to increased urinary excre- 
tion of carcinogenic substances. 
6. Drugs. Immunosuppressive therapy with cyclophosphamide and pa- 
tients having analgesic-abuse (phenacetin) nephropathy have high risk of de- 
veloping bladder cancer. 
Pathologic changes. Grossly, urothelial tumours may be single or mul- 
tiple. About 90% of the rumours are papillary (non-invasive or invasive), 
whereas the remaining 10% are flat indurated (non-invasive or invasive). The 
papillary tumours have free floating fern-like arrangement with a broad or 
narrow pedicle. The non-papillary tumours are bulkier with ulcerated surface. 
More common locations for either of the two types are the trigone, the region 




Histologically, urothelial tumours are of 3 cell types – transitional cell, 
squamous cell, and glandular. 
A. Transitional Cell Tumours. Approximately 90% of all epithelial 
tumours of the bladder are transitional cell tumours. As stated before, transi- 
tional cell papilloma is distinguished by some workers from grade I transitional 
cell carcinoma (TCC), whereas others do not consider this as a distinct entity. 
Here, we follow the widely accepted classification of Mostofi (1960) adopted by 
the American Bladder Tumour Registry that divides TCC into 3 grades. 
1. Transitional cell papilloma. Papillomas may occur singly or may 
be multiple. They are generally small, less than 2 cm in diameter, papillary 
with branching pattern. Each papilla is composed of fibrovascular stromal 
core covered by normal-looking transitional cells having normal number of 
layers (not more than six) in thickness. The individual cells resemble the 
normal transitional cells and do not vary in size and shape. Mitoses are absent 
and basal polarity is retained. It must be emphasised that the designation 
transitional cell papilloma is purely a histological diagnosis but does not im- 
ply an innocent biologic behaviour. In fact, it may recur and behave in a ma- 
lignant manner. 
2. Transitional cell carcinoma. This is the commonest cancer of the 
bladder and is divided into 3 grades depending upon 2 features: the degree of 
anaplasia and the extent of invasion. 
• The criteria for anaplasia are: increased cellularity, nuclear crowd- 
ing, deranged cellular polarity, failure of normal orientation from base to the 
surface, variation in cell and shape, variation in nuclear chromatin pattern, 
mitotic figures and giant cells. 
• The criteria for invasion in papillary as well as non-papillary tumours 
are: penetration of the basement membrane of bladder mucosa. 
Based on these salient features, the characteristics of three grades of 
transitional cell carcinoma are as under: 
Grade I: The tumour cells are clearly transitional type but show in- 
creased number of layers of cells (c.f. transitional cell papilloma). The indi- 
vidual cells are generally regular but are slightly larger and show mild hyper- 
chromatism. 
Grade II: The tumour cells are still recognisable as of transitional cell 
origin and the number of layers of cells is increased. The individual tumour cells 
are less regular, larger in size, and show pronounced nuclear hyperchromatism, 
mitotic activity and loss of polarity. The tumour may or may not be invasive. 
Grade III: This is the anaplastic or undifferentiated grade of the tu- 
mour which is always invasive extending into the bladder wall to variable 
depth depending upon the clinical stage (described later). The tumour cells 




cells show pronounced features of anaplasia such as marked pleomorphism, 
hyperchromatism, total loss of polarity with loosened surface cells exfoliated 
in the bladder lumen. 
There may be foci of squamous or glandular metaplasia in any grade of 
the tumour. 
B. Carcinoma In Situ. Foci of epithelial hyperplasia, dysplasia and 
carcinoma in situ are seen in other parts of the bladder in non-invasive as 
well as in invasive carcinomas. Similar foci may be present in the ureters and 
renal pelvis. The malignant potential of epithelial hyperplasia and dysplasia 
is uncertain but carcinoma in situ is certainly precancerous and is currently 
included as grade 0 transitional cell carcinoma. Carcinoma in situ is charac- 
terised by highly anaplastic malignant cells confined to layers superficial to 
basement membrane of the bladder mucosa. These pathologic changes can be 
induced in experimental animals by chemical carcinogens. Therefore, it is rea- 
sonable to assume that these stages are precursors of invasive bladder cancer. 
C. Squamous Cell Carcinoma. Squamous cell carcinoma comprises 
about 5% of the bladder carcinomas. Unlike transitional cell carcinomas 
which are mostly papillary and non-ulcerating, most squamous carcinomas of 
the bladder are sessile, nodular, infiltrating and ulcerating. Association of 
squamous carcinoma and schistosomiasis has already been highlighted. The 
carcinoma may be well-differentiated with keratin pearl formation, or may be 
anaplastic. 
D. Adenocarcinoma. Adenocarcinoma of the bladder is rare. Adeno- 
carcinoma has association with exostrophy of the bladder with glandular 
metaplasia, or may arise from urachal rests, periurethral and periprostatic 
glands, or from cystitis cystica. The tumour is characterised by glandular and 
tubular pattern with or without mucus production. 
E. Mixed Carcinoma. About 50% of epithelial tumours of the bladder 
show mixed pattern, usually of transitional and squamous cell combination. 
Staging of bladder cancer. The clinical behaviour and prognosis of 
bladder cancer can be assessed by the following simple staging system: 
Stage O: Carcinoma confined to the mucosa. 
Stage A: Carcinoma invades the lamina propria but not the muscularis. 
Stage Bl: Carcinoma invades the superficial muscle layer. 
Stage B2: Carcinoma invades the deep muscle layer. 
Stage C: Carcinoma invades the perivesical tissues. 
Stage Dl: Carcinoma shows regional metastases. 
Stage D2: Carcinoma shows distant metastases. 
 
NON-EPITHELIAL BLADDER TUMOURS 




Benign. The most common benign mesenchymal tumour of the blad- 
der is leiomyoma. Other less common examples are neurofibroma, haeman- 
gioma and granular cell myoblastoma. 
Malignant. Rhabdomyosarcoma is the most frequent malignant mes- 
enchymal tumour. It exists in 2 forms: 
Adult form occurring in adults over 40 years of age and resembles the 
rhabdomyosarcoma of skeletal muscle. 
Childhood form occurring in infancy and childhood and appears as 
large polypoid, soft, fleshy, grapelike mass and is also called sarcoma botry- 
oides or embryonal rhabdomyosarcoma. It is morphologically characterised 
by masses of embryonic mesenchyme consisting of masses of highly pleo- 
morphic stellate cells in myxomatous background. Similar tumours occur in 
the female genital tract. 
 
TUMOURS OF RENAL PELVIS AND URETERS 
Almost all the tumours of the renal pelvis and ureters are of epithelial 
origin. They are of the same types as are seen in the urinary bladder. Howev- 
er, tumours in the ureters are quite rare. 
TUMOURS OF URETHRA 
Tumours of the urethra are rare except for the urethral caruncle which 
is a tumour-like lesion. 
Urethral caruncle. Urethral caruncle is not uncommon. It is an in- 
flammatory lesion present on external urethral meatus in elderly females. 
Grossly, the caruncle appears as a solitary, 1 to 2 cm in diameter, pink 
or red mass, protruding from urethral meatus. It is quite friable and ulcerated. 
Microscopically, the mass may be covered by squamous or transitional 
epithelium or there may be ulcerated surface. The underlying tissues show 
proliferating blood vessels, fibroblastic connective tissue and intense acute 
and chronic inflammatory infiltrate. Thus the histologic appearance closely 
resembles a pyogenic granuloma. 
Urethral carcinoma. Carcinoma of the urethra is uncommon. In most 
cases it occurs in the distal urethra near the external meatus and thus is com- 
monly squamous cell carcinoma. Less often, there may be transitional cell 






PATHOLOGY OF THE PITUITARY GLAND 
Acromegaly, gigantism, Itsenko-Cushing disease, hypophyseal nanism, 
cerebro-hypophyseal cachexia, diabetes insipidus, tumors are the most frequent. 
 
ACROMEGALY AND GIGANTISM usually develop in eosinophil- 
cell tumors, adenocarcinoma of pituitary anterior lobe. Excess of STH stimu- 
lates all mesenchymal derivatives (bones, cartilages, connective tissue). If the 
disease occurs at a young age, it is called gigantism; if at an older age, it is 
called acromegaly (the bones does not grow but ears, nose, lower jaw, feet 
and hands enlarge). 
The other glands are also involved by the process (goiter, atrophy of 
insulin apparatus of pancreas, thymus and epiphysis hyperplasia, adrenal cor- 
tex hyperplasia, sexual glands atrophy occur). 
ITSENKO-CUSHING DISEASE occurs in adenomas from baso- 
philic cells of anterior lobe of the pituitary or adenocarcinoma in rare cases. 
Increased ACTH production causes cortex hyperplasia as well as increased 
production of glucocorticoids. It results in obesity of face and body, elevation 
of arterial pressure, diabetes mellitus, sexual gland dysfunction. Osteoporo- 
sis, nephrolithiasis and chronic pyelonephritis may also develop. 
The disease should be differentiated from Itsenko-Cushing syndrome. 
Its clinical manifestations are the same as in the disease (obesity of the upper 
part of the body), but the other signs are not clearly marked. The causes of 
these states are different. The syndrome is characterized by adrenals damage 
(tumor of zona fasciculata) which causes increased production of glucocorti- 
coids. Cushingoid can be caused by administration of hormones (cortisole, 
prednisolone, hydrocortisone). 
Pituitary nanism develops in congenital hypoplasia of the pituitary 
body or its necrosis in children. General underdevelopment of the organism 
with preserved proportions is observed. 
SIMMONDS` DISEASE (CEREBRO-HYPOPHYSEAL CA- 
CHEXIA) is caused by necrosis of pituitary anterior lobe. It may occur after 
childbirth due to vascular embolism as well as due to syphilis, tuberculosis, 
tumor. It manifests by cachexia, inner organ atrophy, sexual dysfunction. 
DIABETES INSIPIDUS is caused by tumors, inflammation, sclero- 
sis, trauma of the posterior lobe of pituitary. It manifests by increased urine 




PATHOLOGY OF THE ADRENAL GLANDS 
 
Adrenal glands consist of cortex and medullar substance. There are 3 
zones in the cortex: glomerular zone which produces mineralocorticoids (e.g. 
aldosterone), zona fasciculata (produces glucocorticoids), reticular zone 
(produces sexual hormones). 
The adrenal medulla is derived embryologically from neural crest ec- 
toderm and is a part of the sympathetic nervous system. It synthesizes and se- 
cretes vasoactive amines, adrenaline and noradrenaline (epinephrine and 
norepinephrine). 
Excessive production of adrenal cortical hormones usually results from 
hyperplasia or tumour. Production of adrenal cortical hydrocortisone and sex 
steroids is controlled by ACTH secreted by the pituitary gland; aldosterone 
secretion is controlled by renin production by the juxtaglomerular apparatus 
in the kidney. 
Excessive ACTH production, for example by an ACTH-secreting ade- 
noma of the pituitary, stimulates an increase in the number, size and secretory 
activity of the adrenal cortical cells, leading to adrenal cortical hyperplasia. 
The uncontrolled excessive production of adrenal cortical hormones may 
produce Cushing's syndrome. Excessive production of adrenal cortical hor- 
mones usually results from hyperplasia or a tumour. When a tumor develops 
in a definite zone of the cortex the following conditions develop respectively: 
a) in glomerular zone — hyperaldosteronism syndrome; 
b) in zona fasciculata — Cushing's syndrome; 
c) in reticular zone — reduction in sexual function; 
d) in medullar substance — pheochromocytoma. 
ADRENAL CORTICAL ADENOMA is a well-circumscribed, yel- 
low tumour in the adrenal cortex, which is usually 2—5 cm in diameter. The 
colour of the tumour is yellow (as in the adrenal cortex) due to the stored lipid 
(mainly cholesterol), from which the cortical hormones are synthesized. These 
tumours are frequent incidental findings at postmortem examination without 
significant metabolic disorders; only a very small percentage produce Cushing's 
syndrome. Nevertheless, these apparently «non-functioning» adenomas are most 
often encountered in elderly obese people. There is some debate that they may 
really represent nodules in diffuse nodular cortical hyperpiasia. 
Very occasionally, a true adrenal cortical adenoma is associated with 
the clinical manifestations of Conn's syndrome, and can be shown to be ex- 
creting mineralocorticoids. 
ADRENAL CORTICAL CARCINOMA is rare and usually is asso- 
ciated with excessive production of hormones (usually glucocorticoids and 




drome mixed with androgenic effects, which are particularly noticeable in 
women. The tumours are usually large and yellowish- white. Llocal invasion 
and metastatic spread are common. 
ACUTE ADRENAL CORTICAL FAILURE is usually due hemor- 
rhagic Infarction, but may be iatrogenic. 
Bilateral hemorrhagic necrosis of the adrenal is usually associated with 
disseminated intravascular coagulation. It is a feature of sepsis (particularly 
meningococcal septicemia) and is known as the Waterhouse-Friderichsens` 
syndrome. It manifests by hypovolemic and hypotensive shock, hypoglyce- 
mia, and high risk of sudden death. 
Jatrogenic acute adrenal cortical failure may occur when prolonged 
high-dose therapeutic corticosten therapy is abraptly stopped. Prolonged cor- 
ticosteron therapy leads to suppression of normal endogenic steroid produc- 
tion by the adrenal cortex, which becomes markedly atrophied. 
Cessation of exogenic steroid therapy produces acute adrenal cortical 
failure (adrenal crisis), with hypovolemic and hypotensive shock, hypogly- 
cemia, and risk of sudden death. 
Tumours of the adrenal medulla may produse excess of adrena- 
line/noradrenaline or their breakdown products. 
The two principal types of tumour of the adrenal medulla are pheochro- 
mocytomas (occurring in adul and neuroblastomas (occurring in children). 
PHEOCHROMOCYTOMA is a tumour of the adrenaline and noradren- 
aline (epinephrine and norepinephrine) secreting cells of the adrenal medulla. 
It produces high levels of both hormones and their breakdown prod- 
ucts, Vanillylmandelic Acid (VMA) and Homovanillic Acid (HVA), both of 
which are excreted in the urine and can be estimated as a diagnostic test. 
Macroscopically, the tumour is usually spherical and less than 5 cm in 
diameter. It has a pale, creamy cut surface that changes to dark brown almost 
instantly when exposed to air, due to oxygenation of tumour pigments. De- 
spite the fact that the tumour is usually small and non-metastatic, it is a haz- 
ardous condition with high perioperative mortality. 
The excessive amine production produces hypertension that is often in- 
itially paroxysmal and associated with severe headaches, but the hypertension 
eventually becomes constant. There may be intractable, and often unex- 
plained, cardiac failure. Pheochromocytoma is one of the causes of surgically 
treatable systemic hypertension. 
ADDISON'S DISEASE was described in 1849 by Addison and is also 
called bronze disease. It develops in bilateral lesion of adrenal cortex with the 




The causes of Addison's disease are divided into two groups. One of them 
causes primary Addison's disease (genetic autoimmune disturbances). Second- 
ary Addison's disease is caused by metastases into the adrenal glands, amyloido- 
sis, hemorrhage, tuberculosis, necrosis due to vascular thrombosis, damage of 
the pituitary body (decreases ACTH or cortlcotro releasing factor). 
It manifests by: 1) hyperpigmenfation of skin and mucous membrane 
due to excessive production of melanin stimulating hormone, 2) myocardial 
atrophy, 3) changes of the lumen in the aorta and large vessels, 4) hyperplasia 
of the Lаngerhаns island cells in the pancreas (hypoglycemia), 5) gastric mu- 
cosa atrophy, 6) hyperplasia of thymus and lymphatic peripheral tissue. 
The cause of death: 1) acute adrenal failure, 2) cachexia (suprarenal 
cachexia), 3) cardiovascular insufficiency. 
PATHOLOGY OF THE THYROID GLAND 
GOITROUS HYPOTHYROIDISM 
There are a number of conditions in which thyroid enlargement 
(goiter) is associated with hypothyroidism. The causes are diverse, but in all 
cases goiter is a compensatory response to the lack of adequate secretion of 
thyroid hormone. The etiology of Goitrous hypothyroidism includes iodine 
deficiency, antithyroid agents (drugs or dietary goitrogens), chronic iodide 
intake, and a number of hereditary defects in the synthesis of thyroid hor- 
mone. The evolution of the pathologic changes in goitrous hypothyroidism is 
similar to that described earlier for nontoxic goiter. 
ENDEMIC GOITER 
Endemic goiter refers to the goitrous hypothyroidism of dietary iodine de- 
ficiency in locales with a high prevalence of the disease. In areas far from salt wa- 
ter and seafood, which are rich sources of iodides, goiters are (or were) common. 
The Great Lakes region of the United States, alpine Europe, central Africa, and 
the Himalayas are such places. Iodized salt is an effective preventive dietary 
measure, and its wide availability has essentially eliminated endemic goiter in 
many areas. Nevertheless, it has been estimated that more than 200 million per- 
sons worldwide are still afflicted with the disease. 
The pathologic evolution of endemic goiter is comparable to that of non- 
toxic goiter discussed earlier. However, in contrast to the latter, endemic goiter 
rarely eventuates in hyperthyroidism, presumably because iodine protects 
against this complication. Although the administration of iodine may reverse the 
early, diffuse stage of endemic goiter, such therapy has little effect on a fully 
developed multinodular goiter. Replacement therapy with thyroid hormone is 





Endemic cretinism refers to congenital hypothyroidism in areas of en- 
demic goiter. Both parents are usually goitrous. The disease encompasses 
two overlapping clinical presentations, a neurologic syndrome and a Pre- 
dominantly hypothyroid one. 
Neurologic cretinism features mental retardation, ataxia, spasticity, 
and deaf-mutism. In the pure form of neurologic cretinism, the children 
may be of normal stature and virtually euthyroid. Thus, it is postulated 
that iodine deficiency in the first trimester of pregnancy may damage the 
developing nervous system independently of its effect on thyroid hormone 
production. 
Hypothyroid cretinism is thought to arise from iodine deficiency in 
late fetal life and in the neonatal period. The clinical course in these children 
is similar to that of other forms of congenital hypothyroidism. 
 
GOITER INDUCED BY ANTITHYROID AGENTS 
There are a number of drugs and naturally occurring chemicals in foods 
that are goitrogenic, owing to their suppression of thyroid hormone synthesis. 
Such goiters may or may not be associated with hypothyroidism. The most 
commonly used goitrogenic drug is lithium, which is employed in the manage- 
ment of manic-depressive states. Women older than the age of 40 years are at 
particular risk for lithium-induced hypothyroidism, with as many as one third 
being affected. Other common goitrogenic drugs include phenylbutazone and ρ- 
aminosalicylic acid. Certain cruciferous vegetables (turnips, rutabaga, cassava) 
contain goitrogens, and their ingestion can potentiale an iodine-deficient diet to 
produce goitrous hypothyroidism. 
IODINE-INDUCED GOITER 
Goiter and hypothyroidism, or either alone, may occur in persons who 
consume large amounts of iodine, either as a medicinal component (potassium 
iodine-containing expectorans) or in foods particularly rich in this halide (e.g., 
seaweed in Japan). In most cases, iodine-induced goiter develops in the context 
of preexisting thyroid disease, such as thyroiditis. Women given large doses of 
iodine during pregnancy may be delivered if goitrous infants. 
 
HEREDITARY DEFECTS IN THYROID HORMONE SYNTHESIS 
Goitrous hypothyroidism secondary to inherited defects in the synthe- 
sis of thyroid hormone is rare. These abnormalities include (1) defective io- 
dide transport, (2) an inability of the thyroid to iodinate thyroglobulin, (3) 
impaired deiodination of iodotyrosines, and (4) abnormal secretion of iodo- 
proteins. In addition, there exist several syndromes in which peripheral tis- 





Hyperthyroidism refers to the clinical consequences of an excessive 
amount of circulating thyroid hormone. In general, the signs and symptoms 
of hyperthyroidism reflect a hypermetabolic state of the target tissues. Pro- 
longed hypersecretion of thyroid hormone can result from (1) an excess pro- 
duction of THS (rare), (2) the presence of an abnormal thyroid stimulator 
(Graves disease), and (3) intrinsic disease of the thyroid gland (toxic mul- 
tinodular goiter of functional adenoma). Rare instances of hyperthyroidism 
follow the release of preformed thyroid hormone during a bout of thyroiditis 
or the production of thyroid hormone by ectopic thyroid tissue. 
 
GRAVES DISEASE 
Graves disease, also known as Basedow disease in continental Europe, 
is an autoimmune disorder characterized by diffuse goiter, hyperthyroidism, 
and exophthalmos. In the US, Graves disease is the most frequent cause of 
hyperthyroidism in patients younger than age 40 years, affecting as many as 
0.4% of the population. Taken together, autoimmune disease of the thyroid 
(e.g., Graves disease, Hashimoto thyroiditis) are as common as diabetes 
mellitus. 
Pathogenesis: the etiology of Graves disease is not fully understood 
and seems to involve an interplay between immune mechanism, heredity, 
sex, and possibly emotional factors, in addition, it is clear that the mecha- 
nisms underlying Graves ophthalmopathy are distinct from those that mediate 
hyperthyroidism. 
Immune mechanisms: patients with graves disease are hyperthyroid 
owing to the presence of IgG antibodies directed against components of the 
plasma membrane of thyroid follicular epithelium, presumably the TSH re- 
ceptor. These antibodies function as agonists, that is, they stimulate the TSH 
receptor, thereby activating adenylyl cyclase and increasing thyroid hormone 
secretion. Under this continued stimulation, the thyroid becomes diffusely hy- 
perplastic and excessively vascular. The autoantibodies of Graves disease were 
originally termed long-acting thyroid stimulator (LATS), because the peak se- 
cretion of thyroid hormone occurs 16 hours after the exposure of thyroid tissue 
to antibody, compared with 2 hours for TSH. 
Graves autoantibodies are actually heterogeneous, and those that 
stimulate thyroid hormone secretion represent only one component. Other an- 
tibodies seem to be cytotoxic and may account for the thyroid failure that of- 
ten follows long-stanting Graves disease. There is also a suggestion that sen- 





The mechanism underlying the origin of the autoantibodies in Graves 
disease remains unclear, but there is evidence that sensitization to antigens of 
Yersinia enterocolitica plays a role. This gram-negative enteric pathogen dis- 
plays a TSH binding site that also binds Graves autoantibodies, suggesting 
that antibodies to Y.enterocolitica may cross-reach with thyroid tissue. There 
is reason to believe that an abnormality of T suppressor cell function permits 
the persistence of sensitized B cell clones. Another theory holds that an anti- 
body to anti-TSH antibody (anti-idiotypic antibody) mimics TSH and, there- 
by, stimulates the TSH receptor. 
Genetic factors: Graves disease exhibits a higher concordance rate in 
monozygotic twins than in dizygotic ones. Moreover, patients with Graves dis- 
ease and their relatives have a considerably higher incidence of other autoimmune 
diseases, including pernicious anemia and Hashimoto thyroiditis. Some asymp- 
tomatic, first-degree relatives of these patients also have an increased uptake of 
iodine-131. White patients with Graves disease display an increased frequency of 
HLA-B8 and HLA-DR3, whereas Chinese patients are more likely to manifest 
HLA-Bw46 and Japanese ones to exhibit HLA-Bw35. 
Sex: Like other autoimmune diseases, Graves disease is far more 
common (7 to 10 times) in women than in men. Interestingly, the disorder 
tends to arise during periods of hormonal imbalance, including puberty, 
pregnancy, and menopause. Men with Graves disease are usually older, and 
although the degree of thyroid hyperfunction is often greater than in wom- 
en, the symptoms tend to be less severe. 
Emotional influences: Quantitative data are lacking, but endocrinol- 
ogists have long observed that the onset of Graves disease often follows a 
period of emotional stress, such as separation anxiety, death of a loved one, 
or near injury in an accident. 
Ophthalmopathy: Although exophthalmos is a common complica- 
tion of Graves disease, its occurrence and severity correlate poorly with 
the levels of thyroid hormone. It seems likely that a combination of hu- 
moral and cell-mediated immune mechanisms are involved. T lympho- 
cytes that are sensitized to antigens shared by thyroid follicular cells and 
orbital fibroblasts accumulate around the eye, where they secrete cytokines 
that activate fibroblasts. There is also evidence for the systemic or local pro- 
duction of antibodies that stimulate orbital fibroblasts to proliferate and 
produce collagen and glycosaminoglycans. 
Pathology: The thyroid in Graves disease is symmetrically enlarged, 
usually weighing 35 to 40 g. The cut surface is firm and dark red. The tan 
translucence of the normal cut surface of the thyroid, attributable to stored col- 
loid, is notably absent. Microscopically, the thyroid is diffusely hyperplastic 




ranged as papillae that project into the lumen of the follicles. The colloid tends 
to be depleted and presents a scalloped or "moth-eaten" appearance where it 
abuts the epithelial cells. Scattered lymphocytes and plasma cells infiltrate the 
interstitial tissue and may even aggregate to form germinal follicles. 
Treatment of Graves disease with iodine, which is only rarely em- 
ployed today, causes involutional changes in the thyroid. The vascularity is 
diminished, and dilated, colloid-containing follicles appear. These effects are 
often not uniform, and some hyperplastic areas persist. Therapy with antithy- 
roid medication (e.g., methimazole or propylthiouracil) commonly results in 
increased thyroid hyperplasia and a complete absence of colloid. 
Exophthalmos is caused by enlargement of the extraocular muscles 
within the orbit. The muscles themselves are normal, but they are swol- 
len by mucinous edema, the accumulation of fibroblasts, and infiltration 
by lymphocytes. The increased orbital contents cause forward displace- 
ment of the eye (proptosis). 
Clinical features: patients with Graves disease note the gradual onset of nonspecific 
symptoms, such as nervousness, emotional lability, tremor, weakness, and weight loss. They 
are intolerant of heat, seek cooler environments, and tend to sweat profusely. Almost all pa- 
tients exhibit tachycardia, and many complain of palpitations. In patients with preexisting 
heart disease, congestive heart failure may ensue. Women develop oligomenorrhea, which 
may progress to amenorrhea. 
Physical examination reveals a symmetrically enlarged thyroid, often with an audible 
bruit and a palpable thrill. Protrusion of the eyeball and retraction of the eyelids expose the 
sclera above the superior margin of the limbus. The skin is warm and moist, and some patients 
exhibit Graves dermopathy, a peculiar pretibial edema caused by the accumulation of fluid 
and glycosaminoglycans. The diagnosis of Graves disease is documented by an increased up- 
take of radioactive iodine by the thyroid and elevated serum levels of T4 and T3. 
The course of Graves disease is characterized by exacerbations and remissions. 
In untreated cases hyperthyroidism may eventually be replaced by progressive thyroid 
failure and hypothyroidism, presumably as a result of chronic thyroiditis. Treatment of 
the disorder depends on many individual factors and includes the use of anti-thyroid 
medication, destruction of thyroid tissue with radioactive iodine, and adjunctive thera- 
py with corticosteroids and adrenergic antagonists. Surgical ablation is not commonly 
performed today. Unfortunately, despite successful relief of hyperthyroidism, exoph- 
thalmos often persists and may even worsen. 
 
TOXIC MULTINODULAR GOITER 
Many patients with nontoxic multinodular goiter, usually older than 
the age of 50 years, eventually develop functional autonomy of the nod- 
ules and a toxic form of the disease. Like its precursor disease, toxic goi- 
ter is ten times as frequent in women as in men. 
Pathogenesis and pathology: The precise mechanisms by which a 
nontoxic multinodular goiter assumes functional autonomy are not clear, 




In some patients, the uptake of iodine is diffuse and not affected by 
the administration of thyroid hormone. Microscopic examination of the 
thyroid shows groups of small hyperplastic follicles mixed with other nod- 
ules of varying size that appear to be inactive. 
The second pattern is characterized by focal accumulation of radio- 
labeled iodine in one or more nodules. Hyperfunction of these nodules 
suppresses the function of the remainder of the thyroid. As in the first type 
of toxic multinodular goiter, exogenous thyroid hormone produces no fur- 
ther suppression of iodine uptake, although the previously inactive areas 
will respond to TSH by sequestering iodine. On microscopic examination, 
the functional nodules are clearly demarcated from the inactive areas and 
consist of large hyperplastic follicles, thus resembling adenomas. Although 
there is little evidence to suggest that the functional nodules have neo- 
plastic characteristics, the clinical presentation is similar to that of a normal 
thyroid with a single hyperfunctioning adenoma. 
Clinical features: Patients with toxic multinodular goiter usually have less 
severe symptoms of hyperthyroidism than those with Graves disease and never devel- 
op exophthalmos. Since patients with a toxic goiter tend to be older, cardiac complica- 
tions, including atrial fibrillation and congestive heart failure, may dominate the clini- 
cal presentation. Serum T4 and T3 levels are frequently only minimally elevated, and the 
uptake of radiolabeled iodine may be within the normal range or only slightly in- 
creased. Radiolabeled iodine administration after a course of antithyroid therapy is the 
most common therapy for toxic multinodular goiter. 
 
TOXIC ADENOMA 
Toxic adenoma, defined as a solitary, hyperfunctioning, follicular 
neoplasm in an otherwise normal thyroid, is an infrequent cause of hyper- 
thyroidism. Such tumors display autonomous function, are not dependent 
on TSH, and are not suppressed by the administration of thyroid hormone. 
Hyperfunction of the toxic adenoma eventually suppresses the remainder of 
the thyroid, which then atrophies. Under these circumstances, a 131I scinti- 
scan shows a solitary focus of iodine uptake ("hot nodule") in a background 
of minimal uptake. 
Toxic adenoma of the thyroid is most common in the fourth and fifth 
decades of life. Most patients do not suffer symptoms of hyperthyroidism 
until the adenoma has grown to a diameter of about 3 cm. On occasion, 
spontaneous necrosis and hemorrhage within the adenoma relieves the hy- 
perthyroidism, after which the remainder of the gland resumes its normal 
function. In such cases, the adenoma appears as a "cold" nodule in a scin- 
tigram and may simulate thyroid cancer. 
Since the normal thyroid tissue is suppressed, toxic adenoma is ef- 




may be excised surgically, especially in young patients who are at risk for 
the development of thyroid cancer many years after radiolabeled iodine 
administration. 
 
HYPERSECRETION OF TSH 
Pituitary adenomas that secrete TSH are rare causes of hyperthy- 
roidism. Increased hypothalamic secretion of TSH has also been implicat- 
ed in some cases of hyperthyroidism. Resistance on the part of thyrotropes 
in the pituitary to suppression by thyroid hormone has been documented 
on rare occasions. A thyroid stimulator distinct from TSH may also be 
produced by trophoblastic tumors, and hyperthyroidism may actually be 
the first manifestation of a molar pregnancy. 
 
IODINE-INDICED HYPERTHYROIDISM 
In areas of endemic iodine deficiency, treatment of a goiter with io- 
dine infrequently leads to hypersecretion of thyroid hormone, a situation 
termed jobbasedow. It is now clear that jobbasedow occurs only in goiters 
that contain nodules capable of autonomous function independent of TSH 
stimulation. Even in areas in which iodine supplies are adequate, exces- 
sive iodine intake (e.g., iodine-containing expectorants in the treatment of 
pulmonary disease) may induce hyperthyroidism. 
 
THYROIDITIS 
Thyroiditis is a term that encompasses a heterogeneous group of inflam- 
matory disorders of the thyroid gland, including those that are caused by 
autoimmune mechanisms and infectious agents. 
 
HASHIMOTO THYROIDITIS 
Hashimoto thyroiditis, also termed lymphadenoid thyroiditis and 
lymphocytic thyroiditis, is an autoimmune disease characterized by the 
presence of circulating antibodies to thyroid antigens and features sugges- 
tive of cell-mediated immunity to thyroid tissue. The disease arises most 
commonly in the fourth and fifth decades and afflicts women more often 
than men. In regions where supplies of iodine are adequate, hashimoto 
thyroiditis is the most common cause of goitrous hypothyroiditis. 
Pathogenesis: Hashimoto thyroiditis is one of a triad of autoim- 
mune thyroid disorders, the other two being graves disease and primary 
hypothyroidism (primary thyroid atrophy). However, it is not clear how 
thyroid tissue is destroyed by immune mechanisms. Patients with Hash- 
imoto thyroiditis exhibit high titers of circulating antimicrosomal antibod- 




vitro. In addition, the intense infiltration of the thyroid parenchyma by 
lymphocytes and plasma cells suggests cell-mediated destruction of the 
gland. These mechanisms may operate in concert through antibody- 
dependent, cell-mediated cytotoxicity (ADCC). It is speculated that a de- 
fect in suppressor cell activity may allow the persistence of sensitized 
clones of antithyroid lymphocytes. 
Genetic influences also seem to play a role in the pathogenesis of Hash- 
imoto thyroiditis. A familial tendency for the disease has been documented, and 
both patients and their relatives have a higher incidence of other autoimmune dis- 
eases, including insulin-dependent diabetes mellitus, pernicious anemia, Addison 
disease, and myasthenia gravis. Hashimoto thyroiditis is associated with an in- 
creased frequency of the HLA-B8 haplotype. In addition, HLA-DR3 is more 
common in those who progress to thyroid atrophy and HLA-DR5 accompanies 
diffuse goiter. Interestingly, Hashimoto thyroiditis is particularly frequent 
in the context of Down syndrome. 
Pathology: on gross examination, the gland in cases of Hashimoto 
thyroiditis is diffusely enlarged, firm, and slightly lobular, weighing 60 to 
200 g. The cut surface is pale tan and fleshy and exhibits a vaguely nodu- 
lar pattern. The inflammatory infiltrates are focally arranged in lymphoid 
follicles, often with germinal centers. The Askanazy cells are filled with 
mitohondria and frequently display cytologic atypia, which may be mistaken 
for cancer. Interstitial fibrosis is present to a varying extent and in 10% of the 
cases is particularly conspicuous (fibrous variant). 
 
SUBACUTE THYROIDITIS (DEQUERVAIN, GRANULOMATOUS, OR GIANT CELL 
THYROIDITIS) 
Subacute thyroiditis is an infrequent, self-limited viral infection of the 
thyroid characterized by granulomatous inflammation. The disease typically 
occurs after upper respiratory tract infections, including those caused by influ- 
enza virus, adenovirus, echovirus, and coxsackievirus. Mumps virus has also 
been incriminated in some cases. DeQuervain thyroiditis principally affects 
women between the ages of 30 and 50 years. 
Pathology: The thyroid gland is enlarged to 40 to 60 g, and the cut sur- 
face is firm and pale. Initially, microscopic examination reveals an acute in- 
flammatory reaction, often with microabscesses. This is followed by the appear- 
ance of a patchy infiltrate of lymphocytes, plasma cells, and macrophages 
throughout the thyroid. Destruction of follicles allows the release of colloid, 
which elicits a conspicuous granulomatous reaction. Numerous multinucleated 




sis of the thyroid may follow resolution of the inflammatory reaction, but the 
normal thyroid architecture is usually restored. 
 
SILENT THYROIDITIS 
Silent thyroiditis, also termed painless subacute thyroiditis or lymphocytic 
thyroiditis, is a transient illness characterized by painless enlargement of the thy- 
roid, self-limited hyper thyroid ism, and, on biopsy, destruction of thyroid paren- 
chyma with a lymphocytic infiltrate. Thus, it clinically resembles subacute thy- 
roiditis but pathologically is more similar to Hashimoto thyroiditis. Importantly, 
silent thyroiditis is distinguished from the latter by the lack of antithyroid antibod- 
ies or other evidence of autoimmune thyroiditis. However, an association with 
HLA-DR3 has been reported. As in subacute thyroiditis, the hyperthyroid state is 
a reflection of the release of preformed thyroid hormone from the injured gland. 
Silent thyroiditis predominantly affects women, often in the postpartum period. 
Hyperthyroidism usually persists for 2 to 4 months. Treatment is symptomatic, 
and most patients become euthyroid. 
 
RIEDEL THYROIDITIS 
Reidel thyroiditis is a rare disease characterized by dense fibrosis of 
the thyroid. The term thyroiditis is something of a misnomer since the disease 
also involves extrathyroidal soft tissue of the neck and is often associated 
with progressive fibrosis in other locations, including the retroperitoneum, 
mediastinum, and orbit. Reidel thyroiditis is primarily a disease of middle 
age with a female-to-male ratio of 3:1. The etiology is unknown, but is does 
not appear to be related to other forms of thyroiditis. 
Pathology: on gross examination, part or all of the thyroid is stony hard 
and is described as ―woody‖. In most instances, the process is asymmetric and 
often affects only one lobe. Characteristically, fibrosis extends beyond the bor- 
ders of the gland, and the surgeon may have extreme difficulty in identifying a 
tissue plane. The follicles are normal in the unaffected portions of the glands. 
Fibrous tissue also surrounds and infiltrates other tissues, including skeletal 
muscle, nerves, fat, and blood vessels. In some cases, the parathyroids are also 
embedded in the fibrosis. 
TUMORS OF THE THYROID 
FOLLICULAR ADENOMA 
Thyroid adenomas are by definition benign neoplasms. they typically 
present as solitary ―cold‖ nodules, that is, tumors that do not take up radio- 
labeled iodine. Follicular adenoma is an encapsulated neoplasm in which 
the cells are either arranged in follicles resembling normal thyroid tissue or 








phasis that up to 90% of palpable, solitary follicular lesions are actually the 
dominant nodule in a multinodular goiter and that follicular adenomas are 
correspondingly infrequent. Follicular adenoma is most common in the 
fourth and fifth decades, with a female-to-male of 7:1. 
Pathology: on gross examination, follicular adenoma is a solitary, cir- 
cumscribed nodule, 1 to 3cm in diameter, which protrudes from the surface of the 
thyroid. The cut surface of the tumor is soft and paler than the surrounding paren- 
chyma. Hemorrhage, fibrosis, and cystic change are common. Histologically, a 
number of distinctive patterns are observed. 
  Embryonal adenoma is distinguished by a trabecular pattern in 
which poorly formed follicles contain little or no colloid. 
  Fetal adenoma features cells that are similar to those of embryonal 
adenoma but tend to be arranged in microfollicles containing little colloid. 
Simple adenoma exhibits mature follicles with a normal amount of 
colloid.  
Colloid adenoma is similar to simple adenoma except that the 
follicles are larger and contain more abundant colloid. 
  Hiirthle cell adenoma is a solid tumor characterized by oxyphil 
cells, small follicles, and scanty colloid. 
  Atypical adenoma is a follicular tumor that displays mitoses, exces- 
sive cellularity, nuclear atypism, or equivocal capsular invasion but in which a 
diagnosis of carcinoma cannot be established with certainty. 
THYROID CARCINOMA 
The topic of thyroid neoplasia has aroused the interest of clinicians and 
pathologists out of proportion to the incidence of thyroid cancer. This atten- 
tion can be attributed to the frequency of nontoxic thyroid nodules and the 
difficulty of distinguishing clinically between non-neoplastic lesions, benign 
tumors, and thyroid cancer. Whereas thyroid nodules are found in as many as 
1% to 10% of the population, malignant tumors of the thyroid account for 
about 1 % of all cancers and only 0.4% of cancer-related deaths. It is there- 
fore clear that only a very small proportion of clinically evident thyroid nod- 
ules are malignant. Nevertheless, thyroid cancer is the most common malig- 
nant endocrine tumor. 
The large majority of cases of carcinoma of the thyroid occur between 
the third and seventh decades. The prognosis is related to the morphologic fea- 
tures of the tumor, ranging from a virtually benign clinical course to a rapidly fa- 
tal disease. The latter outcome is fortunately uncommon. 
Before the advent of fine-needle aspiration, the definitive diagnosis of 
a thyroid nodule required open biopsy, often with the resection of a signifi- 




sy of thyroid nodules is a safe and rapid procedure that provides a diagnosis 
in the majority of cases. As a result, the incidence of cancer in resected thy- 
roid nodules has increased from 3% to over 70%. 
 
PAPILLARY CARCINOMA 
Papillary carcinoma is the most common thyroid cancer, comprising 
more than three fourths of all cases in the United States. The tumor is most 
frequent between the ages of 20 and 50 years, with a female-to-male ratio of 
3:1. However, papillary carcinoma may arise at any age, even in children. 
The reported incidence of this tumor has varied from 35% to 90% of all thyroid 
cancers because some pathologists consider the most mature variant to be a pa- 
pillary adenoma and others classify papillary tumors with follicular elements as 
follicular carcinoma. In this context we consider all neoplasms with papillary 
elements to be papillary cancers. Such a classification is of more than academic 
interest, since the biologic behavior of papillary cancers is different from that of 
other malignant tumors of the thyroid. 
Pathogenesis: Although the etiology of papillary carcinoma of the thy- 
roid remains to be established, a number of associations have been identified.  
  Iodine excess: Papillary thyroid cancer has been produced in ani- 
mals by administering excess iodine. In endemic goiter regions, the addition 
of iodine to the diet has increased the proportion of papillary carcinoma com- 
pared with follicular cancer. 
   Radiation: External radiation to the neck of children and adults in- 
creases the incidence of later papillary carcinoma of the thyroid. Survivors of 
the atomic bomb Explosions in Japan experienced more papillary cancers than 
would otherwise be expected. On the other hand, treatment with radiolabeled 
iodine has not been shown to increase the risk of this tumor. 
   Genetic factors: a concordance for papillary carcinoma of the thy- 
roid has been described in monozygotic twins, and an association between 
this tumor and HLA-DR7 has been reported. 
Pathology: Papillary carcinomas of the thyroid vary from microscopic 
lesions to tumors large than the normal gland. Serial sections of ostensibly 
normal thyroids obtained at autopsy have revealed a high proportion of papil- 
lary cancers that measure less than 1 mm across, but lymph node metastases 
in such cases are distinctly uncommon. On gross examination, most papillary 
carcinomas are pale and firm or hand and gritty lesions, with less than 10% 
being truly encapsulated. A few tumors display cystic changes.Microscopic 
examination reveals branching papillae that are composed of a central fibro- 
vascular core and a single or stratified lining of cuboidal to columnar cells. In 
most instances, irregularly shaped or tubular neoplastic follicles are present 




are highly variable. Nuclear atypism is an important diagnostic feature and 
includes clear (―ground-glass‖ or ―orphan Annie‖) nuclei, eosinophilic 
pseudoinclusions (which represent invaginations of the cytoplasm into the 
nucleus), and nuclear grooves. Many papillary cancers show dense fibro- 
sis,and calcospherites (psammoma bodies) are present in half the cases. The 
latter feature is virtually diagnostic of papillary carcinoma, being rare in other 
conditions. The stroma may be infiltrated by lymphocytes and Largenhans 
cells. In over three fourth of the cases of papillary cancer, careful sectioning 
of the resected thyroid reveals multiple microscopic foci of tumor, but it is 
not clear whether this represents a multifocal origin of the tumor or lymphatic 
spread from a solitary primary. Vascular invasion is distinctly uncommon. 
Papillary thyroid carcinoma typically invades lymphatics and spreads to the 
regional cervical lymph nodes. The lymph node metastases vary from micro- 
scopic foci in otherwise normal lymph nodes to large masses that dwarf the 
primary lesion. direct extension of papillary carcinoma into the soft tissues of 
the neck occurs in one fourth of the cases. Although hematogenous metasta- 
ses are less common than in other varieties of thyroid cancer, they occasion- 
ally occur, most commonly to the lungs. 
In general, the prognosis of papillary carcinoma is excellent, and life 
expectancy for these patients differs little from that of the general population. 
The prognosis in individual cases is influenced by age, sex, and the size and 
differentiation of the tumor. The prognosis is more serious in patients older 
than 50 years of age, whereas in children the outlook is good even when lung 
metastases are detected. Papillary cancer tends to be more aggressive in men 
than in women. As a rule, the larger the size of the primary tumor, the more 
aggressive it is, and direct extension into the adjacent soft tissues points to a 
poorer prognosis. The proportion of papillary and follicular elements contrib- 
utes little to the prognosis, but less-differentiated papillary carcinomas tend 
to be more aggressive. The presence of metastases to cervical nodes at the 
time or surgery does not change the prognosis, and less than 10% of these pa- 
tients succumb to the tumor. In fatal cases of papillary cancer, death is caused 




Follicular carcinoma of the thyroid is defined as a malignant neoplasm 
that is purely follicular and does not contain any papillary or other elements. 
This tumor represents about 15% of all thyroid cancers. Most patients are 
older than 40 years of age, and the female-to-male ratio is 3:1. The risk fac- 
tors for follicular carcinoma are not as clear as those for papillary cancer, be- 




The incidence of follicular carcinoma seems to be increased in endemic goi- 
ter areas among persons who do not receive iodine supplements. The effect 
of radiation with respect to this tumor is controversial. 
Pathology: Follicular carcinomas are subdivided into minimally inva- 
sive and widely invasive variants. 
Minimally invasive follicular carcinoma is seen grossly as a well- 
defined, encapsulated tumor, which on cut section is soft and pale tan to pink 
and bulges from the confines of its capsule. Microscopically, most lesions re- 
semble follicular adenoma, although they tend more to a microfollicular or 
trabecular pattern. Occasionally, hemorrhagic necrosis is present in the center 
of the tumor. Mitoses are commonly encountered, a feature that distinguishes 
follicular cancer from a benign adenoma. The principal distinction from ade- 
noma is in the interface of the capsule and the normal parenchyma. Carcinoma 
is diagnosed when the tumor extends into or through the capsule and invades 
small veins external to the capsule. Interestingly, intravascular masses of follicu- 
lar carcinoma are often covered by endothelium in a manner similar to that of an 
ordinary thrombus. 
Widely invasive follicular carcinoma presents few diagnostic diffi- 
culties, since it is not encapsulated, exhibits widespread infiltration of blood 
vessels, and often extends into the surrounding soft tissues. 
Follicular carcinoma differs from papillary cancer in being solitary and rarely 
occult. Metastases are blood borne rather than lymphatic and are directed 
principally to the bones of the shoulder and pelvic girdles, sternum, and skull. 
Whereas metastases in widely invasive follicular carcinoma are common, less 
than 5% of the minimally invasive variants metastasize. The metastases may 
be so well differentiated that they are hardly recognizable as neoplastic tissue 
and at one time were referred to as ―benign metastasizing struma‖. 
Minimally invasive follicular tumors have a 10-year survival rate of 
85%, compared with a rate of only 45% for the widely invasive form. 
 
MEDULLARY CARCINOMA 
Medullary carcinoma of the thyroid is a tumor derived from the para- 
follicular or C cells of the thyroid, ehich are distinguished by their secretion 
of the calcium-lowering hormone calcitonin. This tumor presents no more 
yhan 5% of all thyroid cancers, although the proportion in referral centers is 
higher. The disease occurs in sporadic and familial forms, the latter account- 
ing for 20% of the cases. Patients with the familial form of medullary carci- 
noma are often afflicted with multiple endocrine neoplasia (MEN) type 2, 
which includes pheochromocytoma of the adrenal medulla and parathyroid 
hyperplasia or adenoma. The mean age of patients with medullary carcinoma 




slight female predominance (1.5:1); in familial cases the inheritance is auto- 
somal dominant and the sex distribution is equal. 
Pathology: on gross examination, medullary carcinomas tend to arise 
in the superior portion of the thyroid, the regions that are richest in C cells. 
Although they are not encapsulated, they are usually circumscribed. The cut 
surface is firm and grayish white. The histologic appearance is highly varia- 
ble. Characteristically, the tumor is solid and composed of polygonal, granular 
cells, which are separated by a distinctly vascular stroma. A conspicuous feature 
is the presence of stromal amyloid, representing the deposition of procalcitonin. 
The nests of tumor cells are embedded in a hyalinized collagenous framework. 
Focal calcification is often present and may be sufficiently extensive to be detect- 
ed radiologically. The histologic variability of medullary carcinoma is evidenced 
by different architectural patterns, including trabecular, tubular, follicular, car- 
cinoid-like, or pseudopapillary arrangements. The neoplastic cells may exhibit 
peripheral nuclei (plasmacytoid pattern) or may be spindle shaped, anaplastic, or 
oxyphilic. In addition, the stroma may feature hemorrhage or bone formation and 
amyloid may be absent. By electron microscopy, the neoplastic C cells show 
dense-core secretory granules, which stain immunohistochemically for a variety 
of endocrine markers, including calcitonin, synaptophysin, chromogranin, and 
neuronspecific enolase. Almost all of these tumors are positive for carcinoembry- 
onic antigen (CEA). Many cases are also positive for ACTH, serotonin, substance 
P, glucagons, insulin, and human chorionic gonadotropin (hCG). Medullary car- 
cinoma extends by direct invasion into soft tissues and metastasizes to the region- 
al lymph nodes and to lung, liver, and bones. In some instances, metastatic dis- 
ease is responsible for the initial presentation. The metastatic deposits resemble 
the primary tumor and also tend to contain amyloid. The precursor lesion of the 
familial variety of medullary carcinoma is C cell hyperplasia. Thus, patients with 
MEN types 2A and 2B who are at risk for the development of medullary carci- 
noma of the thyroid are monitoredby periodic measurements of serum calcitonin, 
CEA, and sometimes chromogranin. When levels of these substances are elevat- 
ed, the patient is subjected to total thyroidectomy. 
 
ANAPLASTIC (UNDIFFERENTIATED) CARCINOMA 
Anaplastic carcinoma is a highly aggressive, undifferentiated thyroid can- 
cer, which is usually rapidly fatal. This type of thyroid cancer principally afflicts 
women (female:male ratio of 4:1) over the age of 60 years. The tumor comprises 
10% of thyroid cancer and is more common in endemic goiter areas. In fact, 
overall at least half of the patients have a history of long-standing goiter. In addi- 
tion, many cases of anaplastic carcinoma occur in patients with a history of a 
lower-grade thyroid cancer. Thus, it seems likely that anaplastic thyroid carcino- 




into a poorly differentiated and highly aggressive cancer. There is evidence that 
the risk of such an event is enhanced by external radiation. 
Pathology: Anaplastic carcinoma of the thyroid presents as large masses 
in the gland, which are poorly circumscribed and frequently extend into the soft 
tissues of the neck. The cut surface is hard and grayish white. The histologic ap- 
pearance is highly variable. The most common pattern is a sarcoma-like prolif- 
eration of bizarre spindle and giant cells, with polyploid nuclei, many mitoses, 
necrosis, and stromal fibrosis. Other specimens reveal distinct epithelial differ- 
entiation. The tumor tends to invade veins and arteries, often occluding the ves- 
sels and producing foci of infarction within the tumor. 
The prognosis is dismal and widespread metastases are frequent. Less 
than 10% of patients survive for 5 years. 
 
THYROID LYMPHOMA 
Lymphoma originating in the thyroid is distinctly uncommon, account- 
ing for 2% of all thyroid cancers. The large majority (95%) are B cell tumors. 
Most if not all cases arise in the setting of chronic thyroiditis, and in regions 
where this disorder is frequent, up to 10% of malignant tumors of the thyroid 
are lymphomas. Similar to chronic thyroiditis, thyroid lymphoma is more 
common in women than in men (4:1), but the mean age at presentation (sev- 
enth decade) is older. 
Thyroid lymphomas present as large, soft, tannish masses in the thyroid, 
usually extending beyond the confines of the gland. Microscopically, they pre- 
sent the spectrum of lymphomas seen at other sites, the most common subtype 
being the diffuse large cell pattern. A few tumors exhibit plasmacytoid differen- 
tiation, whereas others resemble immunoblastic lymphoma. 
The prognosis of thyroid lymphoma depends on the stage at the time of di- 
agnosis. If restricted to the thyroid gland, the prognosis is excellent, and three 
fourths of the patients now survive for 10 years. The outlook for patients with dis- 




The parathyroid glands are small endocrine glands which secrete the 
parathormone. There are usually four (sometimes up to eight) parathyroid 
glands, which are usually located close to the thyroid gland. 
Parathormone (PTH), the parathyroid hormone, is important in calcium 
balance, acting at two sites: 
1. The bone surface, where it stimulates the resorption of bone by 
osteoclasts and release of calcium. 
2. The renal tubules, where it stimulates the resorption of calcium 




Parathyroid adenoma is usually a solitary tumour that affects only one 
of the parathyroid gland; the other parathyroids often showing atrophy. The 
tumour is usually small and very rarely palpable in the neck. The main present- 
ing symptoms develop due to excessive secretion of parathyroid hormone 
(primary hyperparathyroidism) with the symptoms and signs of hypercalcemia. 
Malignant parathyroid tumours, with invasion and metastatic spread, 
are very rare, although some parathyroid adenoma may show considerable 
pleomorphism and nuclear and cytoplasmic atypia. 
Primary parathyroid adenoma is only one of the possible causes of hy- 
percaleemia. Rarely, primary hyperparathyroidism is the result of diffuse hy- 
perplasia of the parathyroids rather than a solitary tumour. 
Diffuse hyperplasia of all parathyroid glands is usually a compensatory 
response to persistently low serum calcium levels. The most common cause 
of compensatory parathyroid hyperplasia is in renal failure, in which exces- 
sive urinary loss of calcium leads to a persistent serum hypocalcemia. 
The parathyroid glands may be removed inadvertently or deliberately 
during surgery on the thyroid gland. If not surgically excised, they may be 
severely damaged by operative trauma or by interference with their blood 
supply. Much less commonly, the parathyroid glands may be affected by an 
autoimmune process (autoimmune parathyroid disease) associated with the 
presence of an autoantibody; this usually occurs in patients who have another 
autoimmune endocrine disease, e.g. Hashimoto's disease or Addison's dis- 
ease. Reduced PTH secretion leads to a reduction in the serum calcium, with 
a corresponding increase in serum phosphate levels. Hypoparathyroidism is 




DIABETES MELLITUS (DM) 
DIABETES MELLITUS, commonly referred to as diabetes, is a disease 
which results from absolute or relative insufficiency of insulin and is charac- 
terized by severe carbohydrate metabolism disturbances with hyperglycemia 
and glucosuria, and other metabolic disturbances too. 
Diabetes is due to either the pancreas not producing enough insulin or 
the cells of the body not responding properly to the insulin produced. 
Classification of diabetes mellitus and mixed categories of tol- 
lerance to glucose disturbances (WHО) 
А. Clinical class 
I. Diabetes mellitus. 
II. Disturbed tolerance to glucose : 




- in patient with obesity, 
- disturbed tolerance to glucose, resulting from other states 
and syndromes. 
III. Gestational diabetes. 
B. Classes of risk. 
Type 1 DM results from the pancreas's failure to produce enough insu- 
lin. This form was previously referred to as "insulin-dependent diabetes 
mellitus" (IDDM) or "juvenile diabetes". 
Type 2 DM begins with insulin resistance, a condition in which cells 
fail to respond to insulin properly. As the disease progresses a lack of insulin 
may also develop. This form was previously referred to as "non insulin- 
dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". 
Gestational diabetes (Diabetus mellitus of pregnant female) is the third 
main form, and occurs when pregnant women without a previous history of 
diabetes develop high blood sugar levels. 
Table 6. Carachteristics of Type 1 DM and Type 1 DM 
 
Risk factors Type 1 Type 2 
Age Until 30 After 40 
Virus infection High antibody titres to a 
number of viruses 
Antibodies to virus are absent 
Genetic factors Association with definite 
HLA-D antigens 
Association with histocompati- 
bility antigens is absent 
Autoimmunization Presence of antibodies to 
beta-cells 
None 
Obesity None Marked 
The classic symptoms of untreated diabetes are weight loss, polyuria 
(increased urination), polydipsia (increased thirst), and polyphagia (increased 
hunger). Symptoms may develop rapidly (weeks or months) in type 1 DM, 
while they usually develop much more slowly and may be subtle or absent in 
type 2 DM. 
Several other signs and symptoms can mark the onset of diabetes alt- 
hough they are not specific to the disease. In addition to the known ones 
above, they include blurry vision, headache, fatigue, slow healing of cuts, and 
itchy skin. Prolonged high blood glucose can cause glucose absorption in the 
lens of the eye, which leads to changes in its shape, resulting in vision chang- 
es. A number of skin rashes that can occur in diabetes are collectively known 




Pathology: The pancreas is diminished with lipomatosis and sclerosis 
(liposclerosis). Degeneration and hyalinosis are observed in the islets, some 
of them are hypertrophic. The liver is enlarged, glycogen is absent, fat de- 
generation is observed. 
Diabetic macro- and microanglopathy is seen in the vessels. Macro- 
angiopathy is represented by arterial atheroscierosis. Microangiopathy is 
characterized by plasmatic saturation, hyalinosis, sclerosis with lipohyalin 
appearance. There is marked proliferation of endothelium and perithelium 
accompanied by lymphohistiocyte infiltration. The signs of vasculitis can be 
seen. There is generalized microangiopathy in the kidneys, retina, skeletal 
muscles, digestive tract mucosa, pancreas, brain, nerves. 
In the kidneys, diabetic glomerulonephritis and glomerulosclerosis de- 
velop. Microscopically proliferation of mesangial cells in response to mesan- 
gium clogging with «ballast» metabolic products and immune complexes are 
observed. Mesangium hyalinosis and glomerulosclerosis develop. Diabetic 
glomerulosclerosis may be diffuse and nodular as well as mixed type. Its 
clinical manifestations are Kimmelstiel-Wilson syndrome (proteinuria, ede- 
ma, arterial hypertension). 
In the lungs, lipogranulomas consisting of macrophages and gigantic 
cell of foreign bodies are present in the walls of the arteries. 
In the spleen, liver, lymphatic glands: infiltration of histiomacrophagal 
system and skin with cell lipids (xantomatosis) develop. 
Complications: All forms of diabetes increase the risk of long-term 
complications. These typically develop after many years (10–20) but may be 
the first symptom in those who have otherwise not received a diagnosis be- 
fore that time. 
The major long-term complications relate to damage to blood vessels. 
Diabetes doubles the risk of cardiovascular disease and about 75% of deaths 
in diabetics are due to coronary artery disease. Other "macrovascular" diseas- 
es are stroke, and peripheral artery disease. 
The primary complications of diabetes due to damage in small blood 
vessels (microangiopathy) include damage to the eyes, kidneys, and nerves. 
Damage to the eyes, known as diabetic retinopathy, is caused by damage to 
the blood vessels in the retina of the eye, and can result in gradual vision loss 
and blindness. Diabetes also increases the risk of having glaucoma, cataracts, 
and other eye problems. Damage to the kidneys, known as diabetic nephropa- 
thy, can lead to tissue scarring, urine protein loss, and eventually chronic 
kidney disease, sometimes requiring dialysis or kidney transplantation. 
Damage to the nerves of the body, known as diabetic neuropathy, is the 
most common complication of diabetes. The symptoms can include numb- 




the skin. Diabetes-related foot problems (such as diabetic foot ulcers) may 
occur, and can be difficult to treat, occasionally requiring amputation. Addi- 
tionally, proximal diabetic neuropathy causes painful muscle atrophy and 
weakness. 
So, common complications of DM are: 
1) diabetic coma, 
2) those connected with angiopathy (gangrene of extremities, myo- 
cardial infarction, blindness), 
3) diabetic nephropathy (acute and chronic renal failure), 
4) infectious sepsis. 
Though gestational diabetes may be transient, untreated it can damage 
the health of the fetus or mother. Risks to the baby include macrosomia (high 
birth weight), congenital heart and central nervous system abnormalities, and 
skeletal muscle malformations. Increased levels of insulin in a fetus's blood 
may inhibit fetal surfactant production and cause respiratory distress syn- 
drome. A high blood bilirubin level may result from red blood cell destruc- 
tion. In severe cases, perinatal death may occur, most commonly as a result 
of poor placental perfusion due to vascular impairment. Labor induction may 
be indicated with decreased placental function. A Caesarean section may be 
performed if there is marked fetal distress or an increased risk of injury asso- 
ciated with macrosomia, such as shoulder dystocia. 
The death of patients with DM can be caused by coma, diabetic glo- 
merulopathy with uremia, gangrene, myocardium infarction, stroke, compli- 








MALE REPRODUCTIVE SYSTEM 
CONGENITAL ANOMALIES 
CRYPTORCHIDISM 
Cryptorchidism or undescended testis is a condition in which the testicle is 
arrested at some point in its descent. Its incidence is about 0.2% in adult male 
population. In 70% of cases, the undescended testis lies in the inguinal ring, in 
25% in the abdomen and, in the remaining 5%, it may be present at other sites 
along its descent from intra-abdominal location to the scrotal sac. 
Etiology. The exact etiology is not known in majority of cases. However, 
a few apparent causes associated with Cryptorchidism are as under: 
1. Mechanical factors e.g. short spermatic cord, narrow inguinal canal, 
adhesions to the peritoneum. 
2. Genetic factors e.g. trisomy 13, maldevelopment of scrotum or 
cremaster muscles. 
3. Hormonal factors e.g. deficient androgenic secretions. 
Pathologic changes. Cryptorchidism is unilateral in majority of cases 
but in 25% of patients, it is bilateral. 
Grossly, the cryptorchid testis is small in size, firm and fibrotic. 
Histologically, contrary to previous beliefs, the changes of atrophy begin 
to appear by about 2 years of age. These changes are as under: 1. Seminiferous 
tubules: There is progressive loss of germ cell elements so that the tubules may 
be lined by only spermatogonia and spermatids but foci of spermatogenesis are 
discernible in 10% of cases. The tubular basement membrane is thickened. Ad- 
vanced cases show hyalinised tubules with a few Sertoli cells only, surrounded 
by prominent basement membrane. 2. Interstitial stroma: There is usually in- 
crease in the interstitial fibrovascular stroma and conspicuous presence of 
Leydig cells, seen singly or in small clusters. 
As such, cryptorchidism is completely asymptomatic and is discovered 
only on physical examination. However, if surgical correction by orchiopexy 
is not undertaken by about 2 years of age, or certainly in the prepubertal peri- 
od, significant adverse clinical outcome may result as under: 
1. Sterility-infertility. Bilateral cryptorchidism is associated with ste- 
rility while unilateral disease may result in infertility. 
2. Inguinal hernia. A concomitant inguinal hernia is frequently present 
along with cryptorchidism. 
3. Malignancy. Cryptorchid testis is at 35-times increased risk of devel- 
oping testicular malignancy, most commonly seminoma and embryonal carci- 
noma, than a normally descended testis. The risk of malignancy is greater in in- 





The morphologic pattern of testicular atrophy described above for cryp- 
torchidism can result from various other causes of male infertility. These causes 
can be divided into 3 groups: pre-testicular, testicular and post-testicular. 
A. Pre-testicular causes: 
1. Hypopituitarism. Pre-pubertal or  post-pubertal  hypopituitarism 
such as from tumour, trauma, infarction, cyst and genetic deficiency of FSH 
and LH secretion. 
2. Oestrogen excess. Endogenous excess such as from hepatic cirrho- 
sis, adrenal tumour, Sertoli and Leydig cell tumour; or exogenous excess 
such as in the treatment of carcinoma of the prostate. 
3. Glucocorticoid excess. Endogenous excess may occur in Cushing's 
syndrome while exogenous excess may occur in the treatment of ulcerative 
colitis, bronchial asthma, rheumatoid arthritis etc. 
Other endocrine disorders. Hypothyroidism and diabetes mellitus are 
associated with hypospermatogenesis. 
B. Testicular causes: 
1. Agonadism i.e. total absence of the testes. 
2. Cryptorchidism or undescended testis described above. 
3. Maturation arrest i.e. failure of spermatogenesis beyond one of the 
immature stages. 
4. Hypospermatogenesis i.e. presence of all the maturation stages of 
spermatogenesis but in decreased number. 
5. Sertoli cell-only syndrome. Congenital or acquired absence of all 
germ cells so that the seminiferous tubules are lined by Sertoli cells only. 
6. Klinefelter's syndrome. An XXY intersexuality characterised by 
primary hypogonadism, azoospermia, gynaecomastia, eunuchoid built and 
subnormal intelligence. 
7. Mumps orchitis occurring as a complication of parotitis. 
8. Irradiation damage resulting in permanent germ cell destruction. 
C. Post-testicular causes: 
1. Congenital block e.g. absence or atresia of vas deferens. 
2. Acquired block e.g. due to gonorrhoea and surgical intervention. 
3. Impaired sperm motility in the presence of normal sperm counts 
e.g. immotile cilia syndrome. 
 
INFLAMMATIONS 
Inflammation of the testis is termed as orchitis and of epididymis as 
epididymitis; the latter being more common. A combination epididymo- 




NON-SPECIFIC EPIDIDYMITIS AND ORCHITIS 
Nonspecific epididymitis and orchitis, or their combination, may be 
acute or chronic. The common routes of spread of infection are via the vas 
deferens, or via lymphatic and haematogenous routes. Most frequently, the 
infection is caused by urethritis, cystitis, prostatitis and seminal vesiculitis. 
Other causes are mumps, smallpox, dengue fever, influenza, pneumonia and 
filariasis. The common infecting organisms in sexually-active men under 35 
years of age are Neisseria gonorrhoeae and Chlamydia trachomatis, whereas 
in older individuals the common organisms are urinary tract pathogens like 
Escherichia coli and Pseudomonas. 
Pathologic changes. Grossly, in acute stage the testicle is firm, tense, 
swollen and congested. There may be multiple abscesses, especially in gonor- 
rheal infection. In chronic cases, there is usually variable degree of atrophy 
and fibrosis. Histologically, acute orchitis and epididymitis are characterised 
by congestion, oedema and diffuse infiltration by neutrophils, lymphocytes, 
plasma cells and macrophages or formation of neutrophilic abscesses. Acute 
inflammation may resolve, or may progress to chronic form. In chronic epi- 
didymoorchitis, there is focal or diffuse chronic inflammation, disappearance 
of seminiferous tubules, fibrous scarring and destruction of interstitial Leydig 
cells. Such cases usually result in permanent sterility. 
 
GRANULOMATOUS (AUTOIMMUNE) ORCHITIS 
Non-tuberculous granulomatous orchitis is a peculiar type of unilateral, 
painless testicular enlargement in middle-aged men that may resemble a tes- 
ticular tumour clinically. The exact etiology and pathogenesis of the condi- 
tion are not known though an autoimmune basis is suspected. 
Pathologic changes. Grossly, the affected testis is enlarged with 
thickened tunica. Cut section of the testicle is greyish-white to tan-brown. 
Histologically, there are circumscribed non-caseating granulomas lying with- 
in the seminiferous tubules. These granulomas are composed of epithelioid 
cells, lymphocytes, plasma cells, some neutrophils and multinucleate giant 
cells. The origin of the epithelioid cells is from Sertoli cells lining the tu- 
bules. The tubules show peritubular fibrosis which merges into the interstitial 
tissue that is infiltrated by lymphocytes and plasma cells. 
 
TUBERCULOUS EPIDIDYMO-ORCHITIS 
Tuberculosis invariably begins in the epididymis and spreads to in- 
volve the testis. Tuberculous epididymo-orchitis is generally secondary tu- 
berculosis from elsewhere in the body. It may occur either by direct spread 
from genitourinary tuberculosis such as tuberculous seminal vesiculitis, pros- 




fection such as from tuberculosis of the lungs. Primary genital tuberculosis 
may occur rarely. 
Pathologic changes. Macroscopically, discrete, yellowish, caseous 
necrotic areas are seen. Microscopically, numerous tubercles which may coa- 
lesce to form large caseous mass are seen. Characteristics of typical tubercles 
such as epithelioid cells, peripheral mantle of lymphocytes, occasional multi- 
nucleate giant cells and central areas of caseation necrosis are seen. Numer- 
ous acid-fast bacilli can be demonstrated by Ziehl-Neelsen staining. The le- 
sions produce extensive destruction of the epididymis and may form chronic 
discharging sinuses on the scrotal skin. In late stage, the lesions heal by fi- 
brous scarring and may undergo calcification. 
 
SPERMATIC GRANULOMA 
Spermatic granuloma is the term used for development of inflammato- 
ry lesions due to invasion of spermatozoa into the stroma. Spermatic granu- 
loma may develop due to trauma, inflammation and loss of ligature following 
vasectomy. 
Pathologic changes. Grossly, the sperm granuloma is a small nodule, 
3 mm to 3 cm in diameter, firm, white to yellowish-brown. Histologically, it 
consists of a granuloma composed of histiocytes, epithelioid cells, lympho- 
cytes and some neutrophils. Characteristically, the centre of spermatic granu- 
loma contains spermatozoa and necrotic debris. The late lesions have fibro- 
blastic proliferation at the periphery and hyalinisation. 
 
ELEPHANTIASIS 
Elephantiasis is enormous thickening of the scrotal skin resembling the 
elephant's hide and results in enlargement of the scrotum. The condition re- 
sults from filariasis in which the adult worm lives in the lymphatics, while 
the larvae travel in the blood. The most important variety of filaria is Wu- 
chereria bancrofti. The condition is common in all tropical countries. The 
vector is generally the Culex mosquito. The patients may remain asympto- 
matic or may manifest with fever, local pain, swelling, rash, tender lymphad- 
enopathy and blood eosinophilia. An asthma-like respiratory complaint may 
develop in some cases. 
Pathologic changes. Grossly, the affected leg and scrotum are enor- 
mously thickened with enlargement of regional lymph nodes. The affected 
area of skin may show dilated dermal lymphatics and varicosities. 
Histologically, the changes begin with lymphatic obstruction by the 
adult worms. The worm in alive, dead or calcified form may be found in the 
dilated lymphatics or in the lymph nodes. Dead or calcified worm in lym- 




ophils. Sometimes, granulomatous reaction may be evident. In advanced cas- 
es, chronic lymphoedema with tough subcutaneous fibrosis and epidermal 




TORSION OF TESTIS 
Torsion of the testicle may occur either in a fully-descended testis or in 
an undescended testis. The latter is more common and more severe. It results 
from sudden cessation of venous drainage and arterial supply to the testis, 
usually following sudden muscular effort or physical trauma. Torsion is 
common in boys and young men. 
Pathologic changes. The pathologic changes vary depending upon the 
duration and severity of vascular occlusion. There may be coagulative necro- 
sis of the testis and epididymis, or there may be haemorrhagic infarction. The 
inflammatory reaction is generally not so pronounced. 
 
VARICOCELE 
Varicocele is the dilatation, elongation and tortuosity of the veins of 
the pampiniform plexus in the spermatic cord. It is of 2 types: primary (idio- 
pathic) and secondary. 
• Primary or idiopathic form is more frequent and is common in 
young unmarried men. It is nearly always on the left side as the loaded rec- 
tum presses the left vein. Besides, the left spermatic vein enters the renal vein 
at right angles while the right spermatic vein enters the vena cava obliquely. 
• Secondary form occurs due to pressure on the spermatic vein by en- 
larged liver, spleen or kidney. It is commoner in middle-aged people. 
 
HYDROCELE 
A hydrocele is abnormal collection of serous fluid in the tunica 
vaginalis. It may be acute or chronic, congenital or acquired. The usual caus- 
es are trauma, systemic oedema such as in cardiac failure and renal disease, 
and as a complication of gonorrhoea, syphilis and tuberculosis. 
The hydrocele fluid is generally clear and straw-coloured but may be 
slightly turbid or haemorrhagic. The hydrocele sac may have single loculus 
or may have multiple loculi. The wall of the hydrocele sac is composed of 
fibrous tissue infiltrated with lymphocytes and plasma cells. 
 
HAEMATOCELE 
Haematocele is haemorrhage into the sac of the tunica vaginalis. It may 
result from direct trauma, from injury to a vein by the needle, or from haem- 




coated with ragged deposits of fibrin. In longstanding cases, the tunica 





Testicular tumours are the cause of about 1% of all cancer deaths. 
They are more frequent in white male population but are less common in Af- 
ricans and Asians. They have trimodal age distribution – a peak during infan- 
cy, another during late adolescence and early adulthood, and a third peak af- 
ter 60 years of age. 
Classification. The most widely accepted classification is the histoge- 
netic classification proposed by the World Health Organisation. Based on 
this, all testicular tumours are divided into: germ cell tumours, sex-cord 
stromal tumours and mixed forms. Vast majority of the testicular tumours 
(95%) arise from germ cells or their precursors in the seminiferous tubules, 
while less than 5% originate from sex cord-stromal components of the testis. 
Etiologic factors. The cause of testicular germ cell tumours is un- 
known, but a few factors have been implicated. These are as under: 
1. Cryptorchidism. The probability of a germ cell tumour developing 
in an undescended testis is 35 times greater than in a normally-descended tes- 
tis. About 10% of testicular germ cell tumours are associated with cryptor- 
chidism. The high incidence is attributed to higher temperature to which the 
undescended testis in the groin or abdomen is exposed. Intraabdominal testis 
is at greater risk than the inguinal testis. There is increased incidence of tu- 
mour in the contralateral normally-descended testis. There are no data to con- 
firm or deny whether surgical repositioning or orchiopexy of a cryptorchid 
testis alters the incidence of testicular tumour. However, surgical correction 
is still helpful since it is easier to detect the tumour in scrotal testis than in an 
abdominal or inguinal testis. 
2. Other developmental disorders. Dysgenetic gonads associated with 
endocrine abnormalities such as androgen insensitivity syndrome have higher 
incidence of development of germ cell tumours. 
3. Genetic factors. Genetic factors play a role in the development of 
germ cell tumours supported by the observation of high incidence in other 
family members, twins and in white male populations while blacks in Africa 
have a very low incidence. However, no definite pattern of inheritance has 
been recognised. 
4. Other factors. A few less common factors include the following: 
i) Orchitis. A history of mumps or other forms of orchitis may be given 




ii) Trauma. Many patients give a history of trauma prior to the devel- 
opment of the tumour but it is not certain how trauma initiates the neoplastic 
process. 
iii) Carcinogens. A number of carcinogens such as use of certain drugs 
(e.g. LSD, hormonal therapy for sterility, copper, zinc etc), exposure to radia- 
tion and endocrine abnormalities may play a role in the development of tes- 
ticular tumours. 
Histogenesis. Pathogenesis of testicular tumours remains controversial 
except that vast majority of these tumours originate from germ cells. Based 
on current concepts on histogenesis of testicular tumours, following agree- 
ments and disagreements have emerged: 
1. Developmental disorders: Disorders such as cryptorchidism, gonadal 
dysgenesis and androgen insensitivity syndrome are high risk factors for devel- 
opment of testicular germ cell tumours. These observations point to developmen- 
tal defect in gonadogenesis. In more than 90% of testicular germ cell tumours ir- 
respective of histologic type (as also ovarian germ cell tumours), anisochromo- 
some of short arm of chromosome 12, abbreviated as i (12p), is found suggesting 
a common molecular pathogenesis of all germ cell tumours. 
2. CIS: A preinvasive stage of carcinoma in situ (CIS) termed intra- 
tubular germ cell neoplasia generally precedes the development of most of 
the invasive testicular germ cell tumours in adults. CIS originates from sper- 
matogenic elements. Areas of CIS are found in seminiferous tubules adjacent 
to most seminomas, embryonal carcinomas and other mixed germ cell tu- 
mours. However, CIS is not found in seminiferous tubules adjoining yolksac 
carcinoma of childhood, benign teratoma in children and adolescents, and 
spermatocytic seminoma indicating different pathogenetic mechanisms. 
3. ―Three hit‖ process: Germ cells in seminiferous tubules undergo ac- 
tivation ('first hit') before undergoing malignant transformation confined to 
seminiferous tubules (CIS) ('second hit') and eventually into invasive stage 
by some epigenetic phenomena ('third hit'). Though this sequential tumor- 
igenesis explains the development of seminomatous tumours, it is yet not 
clear whether non-seminomatous germ cell tumours develop directly or 
through intermediate stage. 
Clinical features and diagnosis. The usual presenting clinical symptoms of tes- 
ticular tumours are gradual gonadal enlargement and a dragging sensation in the testis. 
Metastatic involvement may produce secondary symptoms such as pain, lymph- 
adenopathy, haemoptysis and urinary obstruction. 
Spread. Since testicular germ cell tumours originate from potipotent 
germ cells, it is not unusual to find metastases of histologic types different 
from the primary growth. Testicular tumours may spread by both lymphatic 




• Lymphatic spread occurs to retroperitoneal paraaortic lymph nodes, 
mediastinal lymph nodes and supraclavicular lymph nodes. 
• Haematogenous spread primarily occurs to the lungs, liver, brain 
and bones. 
Tumour markers. Germ cell tumours of the testis secrete polypeptide 
hormones and certain enzymes which can be detected in the blood. Two tu- 
mour markers widely used in the diagnosis, staging and monitoring the fol- 
low-up of patients with testicular tumours are: human chorionic gonadotropin 
(HCG) and alphafoetoprotein (AFP). In addition, carcinoembryonic antigen 
(CEA), human placental lactogen (HPL), placental alkaline phosphatase, tes- 
tosterone, oestrogen and luteinising hormone may also be elevated. 
• HCG is synthesised by placental syncytiotrophoblast such as in vari- 
ous non-seminomatous germ cell tumours of the testis (e.g. in choriocarcinoma, 
yolk sactumour and embryonal carcinoma). However, ectopic HCG production 
may occur in a variety of non-testicular non-germ cell tumours as well. 
• AFP is normally synthesised by the foetal liver cells, yolk sac and 
foetal gut. Its levels are elevated in testicular tumours associated with yolk 
sac components. However, elevated serum AFP levels are also found in liver 
cell carcinoma. 
Prognosis for selecting post-orchiectomy treatment (radiation, surgery, 
chemotherapy or all the three) and for monitoring prognosis, 3 clinical stages 
are defined: 
Stage I: tumour confined to the testis. 
Stage II: distant spread confined to retroperitoneal lymph nodes below 
the diaphragm. 
Stage III: distant metastases above the diaphragm. 
Seminomas tend to remain localised to the testis (stage I) while non- 
seminomatous germ cell tumours more often present with advanced clinical 
disease (stage II and III). Seminomas are extremely radiosensitive while non- 
seminomatous germ cell tumours are radio-resistant. In general, seminomas 
have a better prognosis with 90% cure rate while the non-seminomatous tu- 
mours behave in a more aggressive manner and have poor prognosis. 
GERMCELLTUMOURS 
Germ cell tumours comprise approximately 95% of all testicular tu- 
mours and are more frequent before the age of 45 years. Testicular germ cell 
tumours are almost always malignant. Nearly half of them contain more than 
one histologic type. Germ cell tumours are also found in the ovary, retroperi- 
toneum and mediastinum. 
INTRATUBULAR GERM CELL NEOPLASIA 
The term intratubular germ cell neoplasia (ITGCN) is used to describe 




and intratubular embryonal carcinoma. Others have used carcinoma in situ 
(CIS) stage of germ cell tumours as synonymous term. 
Histologically, the malignant atypical tumour cells are restricted to the 
seminiferous tubules without evident invasion into the interstitium. 
SEMINOMA 
Seminoma is the commonest malignant tumour of the testis and corre- 
sponds to dysgerminoma in the female. It constitutes about 45% of all germ cell 
tumours, and in another 15% comprises the major component of mixed germ cell 
tumour. The tumour has a peak incidence in the 4th decade of life and is rare be- 
fore puberty. Undescended testis harbours seminoma more frequently as com- 
pared to other germ cell tumours. Only about 10% pure seminomas are associated 
with elevated AFP or HCG levels in serum. 
Pathologic changes. Grossly, the involved testis is enlarged up to 10 
times its normal size but tends to maintain its normal contour since the tumour 
rarely invades the tunica. The larger tumour replaces the entire testis, whereas the 
smaller tumour appears as circumscribed mass in the testis. Cut section of the af- 
fected testis shows homogeneous, grey-white lobulated appearance. Necrosis and 
haemorrhage in the tumour are rare. Microscopically, the tumour has the follow- 
ing characteristics; 
1. Tumour cells. The seminoma cells generally lie in cords, sheets or col- 
umns forming lobules. Typically, in a classic seminoma, the tumour cells are fair- 
lyuniform in size with clear cytoplasm and well-defined cell borders. The cyto- 
plasm contains variable amount of glycogen that stains positively with PAS reac- 
tion. The nuclei are centrally located, large, hyperchromatic and usually contain 
1-2 prominent nucleoli. Tumour giant cells may be present. Mitotic figures are 
infrequent. However, about 10% of seminomas have increased mitotic activity 
and have aggressive behaviour and are referred to as anaplastic seminomas. 
2. Stroma. The stroma of seminoma is delicate fibrous tissue which divides 
the tumour into lobules. The stroma shows a characteristic lymphocytic infiltra- 
tion, indicative of immunologic response of the host to the tumour. About 20% of 
the tumours show granulomatous reaction in the stroma. 
The prognosis of seminoma is better than other germ cell tumours. The 
tumour is highly radiosensitive. 
SPERMATOCYTIC SEMINOMA 
Spermatocytic seminoma is both clinically and morphologically a distinc- 
tive tumour from classic seminoma and is, therefore, classified separately in the 
WHO classification. It is an uncommon tumour having an incidence of about 5% 
of all germ cell tumours. Spermatocytic seminoma usually occurs in older pa- 




Pathologic changes. Grossly, Spermatocytic seminoma is homogene- 
ous, larger, softer and more yellowish and gelatinous than the classic semi- 
noma. Histologically, the distinctive features are as under: 
1. Tumour cells. The tumour cells vary considerably in size from lym- 
phocyte-like to huge mononucleate or multinucleate giant cells. Majority of 
the tumour cells are, however, of intermediate size. The cells have eosino- 
philic cytoplasm devoid of glycogen. The nuclei of intermediate and large 
cells have filamentous or spireme pattern. Mitoses are often frequent. 
2. Stroma. The stroma lacks lymphocytic and granulomatous reaction 
seen in classic seminoma. 
The prognosis of spermatocytic seminoma is excellent since the tu- 
mour is slow-growing and rarely metastasises. The tumour is believed to be 
radiosensitive. 
EMBRYONAL CARCINOMA 
Pure embryonal carcinoma constitutes 30% of germ cell tumours but 
areas of embryonal carcinoma are present in 40% of germ cell tumours. The- 
se tumours are more common in 2nd to 3rd decades of life. About 90% cases 
are associated with elevation of AFP or HCG or both. They are more aggres- 
sive than the seminomas. 
Pathologic changes. Grossly, embryonal carcinoma is usually a small 
tumour in the testis. It distorts the contour of the testis as it frequently in- 
vades the tunica and the epididymis. The cut surface of the tumour is grey- 
white, soft with areas of haemorrhages and necrosis. Microscopically, the fol- 
lowing features are seen: 
1. The tumour cells are arranged in a variety of patterns – glandular, 
tubular, papillary and solid. 
2. The tumour cells are highly anaplastic carcinoma tous cells having 
large size, indistinct cell borders, amphophilic cytoplasm and prominent hy- 
perchromatic nuclei showing considerable variation in nuclear size. Mitotic 
figures and tumour giant cells are frequently present. Haemorrhage and ne- 
crosis are common. 
• 3. The stroma is not as distinct as in seminoma and may contain vari- 
able amount of primitive mesenchyme. 
Embryonal carcinoma is more aggressive and less radiosensitive than sem- 
inoma. Chemotherapy is considered more effective in treating this tumour. 
 
YOLK SAC TUMOUR 
(Synonyms: Endodermal Sinus Tumour, Orchioblastoma, Infantile 
Embryonal Carcinoma) is the most common testicular tumour of infants and 
young children up to the age of 4 years. In adults, however, yolk sac tumour in 
pure form is rare but may be present as the major component in 40% of germ 




Pathologic changes. Grossly, the tumour is generally soft, yellow- 
white, mucoid with areas of necrosis and haemorrhages. 
Microscopically, yolk sac rumour has the following features: 
1. The rumour cells form a variety of patterns - loose reticular net- 
work, papillary, tubular and solid arrangement. 
2. The tumour cells are flattened to cuboid epithelial cells with clear 
vacuolated cytoplasm. 
3. The rumour cells may form distinctive perivascular structures re- 
sembling the yolk sac or endodermal sinuses of the rat placenta called Schil- 
ler-Duval bodies. 
There may be presence of both intracellular and extracellular PAS- 
positive hyaline globules, many of which contain AFP. 
POLYEMBRYOMA 
Polyembryoma is defined as a tumour composed predominantly of 
embryoid bodies. Embryoid bodies are structures containing a disc and cavi- 
ties surrounded by loose mesenchyme simulating an embryo of  about  2 
weeks gestation. Polyembryoma is extremely rare but embryoid bodies may 
be present with embryonal carcinoma and teratoma. 
CHORIOCARCINOMA 
Pure choriocarcinoma is a highly malignant tumour composed of ele- 
ments consisting of syncytiotrophoblast and cytotrophoblast. 
However, pure form is extremely rare and occurs more often in combi- 
nation with other germ cell tumours. The patients are generally in their 2nd 
decade of life. The primary tumour is usually small and the patient may man- 
ifest initially with symptoms of metastasis. The serum and urinary levels of 
HCG are greatly elevated in 100% cases. 
Pathologic changes. Grossly, the tumour is usually small and may ap- 
pear as a soft, haemorrhagic and necrotic mass. 
Microscopically, the characteristic feature is the identification of inti- 
mately related syncytiotrophoblast and cytotrophoblast without formation of 
definite placental-type villi. 
• Syncytiotrophoblastic cells are large with many irregular and bizarre 
nuclei and abundant eosinophilic vacuolated cytoplasm which stains positive- 
ly for HCG. These cells often surround masses of cytotrophoblastic cells. 
• Cytotrophoblastic cells are polyhedral cells which are more regular 
and have clear or eosinophilic cytoplasm with hyperchromatic nuclei. 
TERATOMA 
Teratomas are complex tumours composed of tissues derived from 
more than one of the three germ cell layers – endoderm, mesoderm and ecto- 




constitute about 40% of testicular tumours in infants, whereas in adults they 
comprise 5% of all germ cell tumours. However, teratomas are found in 
combination with other germ cell tumours (most commonly with embryonal 
carcinoma) in about 45% of mixed germ cell tumours. About half the terato- 
mas have elevated HCG or AFP levels or both. 
Pathologic changes. Testicular teratomas are classified into 3 types: 
1. Mature (differentiated) teratoma 
2. Immature teratoma 
3. Teratoma with malignant transformation. Grossly, most teratomas 
are large, grey-white masses enlarging the involved testis. Cut surface shows 
characteristic variegated appearance – grey-whitesolid areas, cystic and hon- 
ey-combed areas, and foci of cartilage and bone. Dermoid tumours common- 
ly seen in the ovaries are rare in testicular teratomas. 
Microscopically, the three categories of teratomas show different ap- 
pearances: 
1. Mature (differentiated) teratoma. Mature teratoma is composed 
of disorderly mixture of a variety of well-differentiated structures such as carti- 
lage, smooth muscle, intestinal and respiratory epithelium, mucous glands, cysts 
lined by squamous and transitional epithelium, neural tissue, fat and bone. This 
type of mature or differentiated teratoma is the most common, seen more fre- 
quently in infants and children and has favourable prognosis. But similar mature 
and benign-appearing rumour in adults is invariably associated with small hidden 
foci of immature elements so that their clinical course in adults is unpredictable. It 
is believed that all testicular teratomas in the adults are malignant. 
As mentioned above, dermoid cysts similar to those of the ovary are 
rare in the testis. 
2. Immature teratoma. Immature teratoma is composed of incom- 
pletely differentiated and primitive or embryonic tissues along with some ma- 
ture elements. Primitive or embryonic tissue commonly present are poorly- 
formed cartilage, mesenchyme, neural tissues, abortive eye, intestinal and 
respiratory tissue elements etc. Mitoses are usually frequent. 
3. Teratoma with malignant transformation. This is an extremely 
rare form of teratoma in which one or more of the tissue elements show malig- 
nant transformation. Such malignant change resembles morphologically with 
typical malignancies in other organs and tissues and commonly includes rhab- 
domyosarcoma, squamous cell carcinoma and adenocarcinoma. 
 
MIXED GERM CELL TUMOURS 
About 60% of germ cell rumours have more than one of the above his- 
tologic types (except spermatocytic seminoma) and are called mixed germ 




sion of more aggressive tumour component in a less malignant tumour. In- 
terestingly, metastases of the mixed germ cell tumours may not exactly re- 
produce the histologic types present in the primary tumour. 
The most common combinations of mixed germ cell tumours are: 
1. Teratoma, embryonal carcinoma, yolk sac tumour and syncytio- 
trophoblast; 
2. Embryonal carcinoma and teratoma (teratocarcinoma); and 
3. Seminoma and embryonal carcinoma. 
 
SEX CORD-STROMALTUMOURS 
Tumours arising from specialised gonadal stroma are classified on the ba- 
sis of histogenesis. The primitive mesenchyme which forms the specialised 
stroma of gonads in either sex gives rise to theca, granulosa and lutein cells in 
the female, and Sertoli and interstitial Leydig cells in the male. Since the cell of 
origin of primitive mesenchyme is identical, Sertoli and interstitial Leydig cell 
tumours may occur in the ovaries (in addition to theca cell, granulosa cell and 
lutein cell tumours). Likewise, the latter three tumours may occur in the testis 
(in addition to Sertoli cell and Leydig cell tumours). All these tumours secrete 
various hormones. The biologic behaviour of these tumours generally cannot be 
determined on histological grounds alone. 
LEYDIG (INTERSTITIAL) CELL TUMOUR 
Leydig cell tumours are quite uncommon. They may occur at any age but 
are more frequent in the age group of 20 to 50 years. Characteristically, these cells 
secrete androgen, or both androgen and oestrogen, and rarely corticosteroids. Bi- 
lateral tumours may occur typically in congenital adrenogenital syndrome. 
Pathologic changes. Grossly, the tumour appears as a small, well- 
demarcated and lobulated nodule. Cut surface is homogeneously yellowish or 
brown. 
Histologically, the tumour is composed of sheets and cords of normal- 
looking Leydig cells. These cells contain abundant eosinophilic cytoplasm 
and Reinke's crystals and a small central nucleus. 
Most of Leydig cell tumours are benign. Only about 10% may invade 
and metastasise. 
SERTOLI CELL TUMOURS (ANDROBLASTOMA) 
Sertoli cell tumours correspond to arrhenoblastoma of the ovary. They 
may occur at all ages but are more frequent in infants and children. These 
tumours may elaborate oestrogen or androgen and may account for gynaeco- 
mastia in an adult, or precocious sexual development in a child. 
Pathologic changes. Grossly, the tumour is fairly large, firm, round, 




grey. Microscopically, Sertoli cell tumour is composed of benign Sertoli cells 
arranged in well-defined tubules. 
Majority of Sertoli cell tumours are benign but about 10% may metas- 
tasise to regional lymph nodes. 
GRANULOSA CELL TUMOUR 
This is an extremely rare tumour in the testis and resembles morpho- 
logically with its ovarian counterpart. 
MIXED GERM CELL-SEX CORD STROMAL TUMOURS 
An example of combination of both germ cells and sex cord stromal 
components is gonadoblastoma. 
GONADOBLASTOMA 
Dysgenetic gonads and undescended testis are predisposed to develop 
such combined proliferations of germ cells and sex cord-stromal elements. The 
patients are commonly intersexuals, particularly phenotypic females. Most of 
the gonadoblastomas secrete androgen so as to produce virilisation in female 
phenotype. A few, however, secrete oestrogen. 
Pathologic changes. Grossly, the tumour is of variable size, yellowish- 
white and soft. Microscopically, gonadoblastoma is composed of 2 principal cell 
types – large germ cells resembling seminoma cells, and small cells resembling 
immature Sertoli, Leydig and granulosa cells. Call-Exner bodies of a granulosa 
cell tumour may be present. 
Prognosis largely depends upon the malignant potential of the type of 
germ cell components included. 
OTHER TUMOURS 
MALIGNANT LYMPHOMA 
Malignant lymphomas comprises 5% of testicular malignancies and is the 
most common testicular tumour in the elderly. Bilaterality is seen in half the cas- 
es. Most common are large cell non-Hodgkin's lymphoma of B cell type. 
RARE TUMOURS 
In addition to the testicular tumours described above, some other uncom- 
mon tumours in this location include: plasmacytoma, leukaemic infiltration, car- 
cinoid tumour, haemangioma, primary sarcomas and metastatic tumours. 
PENIS 
CONGENITAL ANOMALIES 
Some of the clinically significant congenital anomalies of the penis are 
phimosis, hypospadias and epispadias. 
PHIMOSIS is a condition in which the prepuce is too small to permit its 




phimosis is a developmental anomaly whereas acquired phimosis may result from 
inflammation, trauma or oedema leading to narrowing of preputial opening. In 
either case, phimosis interferes with cleanliness and predisposes to the develop- 
ment of secondary infection, preputial calculi and squamous cell carcinoma. 
PARAPHIMOSIS is a condition in which the phimotic prepuce is forcibly re- 
tracted resulting in constriction over the glans penis and subsequent swelling. 
HYPOSPADIA is a developmental defect of the urethra in which the ure- 
thral meatus fails to reach the end of the penis, but instead, opens on the ven- 
tral surface of the penis. Similar developmental defect with resultant urethral 
opening on the dorsal surface of the penis is termed epispadias. Hypospadias 
and epispadias may cause urethral constriction with consequent infection and 
may also interfere with normal ejaculation and insemination. Both these ure- 
thral anomalies are more frequently associated with cryptorchidism. 
INFLAMMATIONS 
Glans and prepuce are frequently involved in inflammation in a num- 
ber of specific and non-specific conditions. The specific inflammations in- 
clude various sexually-transmitted diseases such as hard chancre in syphilis, 
chancroid caused by Haemophilus ducreyi, gonorrhoea caused by gonococci, 
herpes progenitalis, granuloma inguinale (donovanosis), and lymphopathia 
venereum caused by Chlamydia trachomatis. Non-specific inflammations are 
designated as balanoposthitis. 
BALANOPOSTHITIS is the term used for nonspecific inflammation of 
the inner surface of the prepuce (balanitis) and adjacent surface of the glans 
(posthitis). It is caused by a variety of microorganisms such as staphylococci, 
streptococci,  coliform bacilli  and  gonococci. Balanoposthitis usually results 
from lack of cleanliness resulting in accumulation of secretions and smegma. It 
is a common accompaniment of phimosis. The type of inflammation may be 
acute or chronic, sometimes with ulceration on the mucosal surface of the glans. 
BALANITIS XEROTICA OBLITERANS is a white atrophic lesion on the 
glans penis and the prepuce and is a counterpart of the lichen sclerosus et 
atrophicus in the vulva. 
TUMOURS 
Benign and malignant tumours as well as certain premalignant lesions 




Condyloma acuminatum or venereal wart is a benign tumour caused by 




or there may be conglomerated papillomas. A more extensive, solitary, exo- 
phytic and cauliflower-like warty mass is termed giant condyloma or Busch- 
ke-Lowenstein tumour or verrucous carcinoma. 
Pathologic changes. The condyloma is commonly located on the cor- 
onal sulcus on the penis or the perineal area. 
Grossly, the tumour consists of solitary or multiple, warty, cauliflower- 
shaped lesions of variable size with exophytic growth pattern. Histologically, 
the lesions are essentially like common warts (verruca vulgaris). The features 
include formation of papillary villi composed of connective tissue stroma and 
covered by squamous epithelium which shows hyperkeratosis, parakeratosis, 
and hyperplasia of prickle cell layer. Many of the prickle cells show clear 
vacuolisation of the cytoplasm (koilocytosis) indicative of HPV infection. 
Giant condyloma shows upward as well as downward growth of the 
tumour but is otherwise histologically identical to condyloma acuminatum. 
Though histologically benign, clinically the giant condyloma is associated 
with recurrences and behaves as intermediate between truly benign condylo- 
ma acuminatum and squamous cell carcinoma. 
PREMALIGNANT LESIONS (CARCINOMA IN SITU) 
In the region of external male genitalia, three lesions display cytologi- 
cal changes of malignancy confined to epithelial layers only without evidence 
of invasion. These conditions are: Bowen's disease, erythroplasia of Queyrat 
and bowenoid papulosis. 
BOWEN'S DISEASE 
Bowen's disease is located on the shaft of the penis and the scrotum 
besides the sun-exposed areas of the skin. 
Grossly, it appears as a solitary, circumscribed plaque lesion with ul- 
ceration. 
Histologically, the changes are superficial to the dermo-epidermal bor- 
der. The epithelial cells of the epidermis show hyperplasia, hyperkeratosis, 
parakeratosis and scattered bizarre dyskeratotic cells. 
A fair proportion of cases of Bowen's disease are associated with inter- 
nal visceral cancers. 
ERYTHROPLASIA OF QUEyRAT 
It appears on the penile mucosa. 
Grossly, the lesions are pink, shiny and velvety soft. Histologically, the 
thickened and acanthotic epidermis shows variable degree of dysplasia. 
Unlike Bowen's disease, there is no relationship between erythroplasia 
of Queyrat and internal malignancy. 
BOWENOID PAPULOSIS 




Grossly, they are solitary or multiple, shiny, red-brown papular lesions. 
Histologically, there is orderly maturation of epithelial cells in hyper- 
plastic epidermis with scattered hyperchromatic nuclei and dysplastic cells. 
 
MALIGNANT TUMOURS SQUAMOUS CELL CARCINOMA 
The incidence of penile carcinoma shows wide variation in different 
populations. In the United States, the overall incidence of penile cancer is 
less than 2% of all cancers but it is 3-4 times more common in blacks than in 
whites. In China, its incidence is about 18%. Carcinoma of the penis is quite 
rare in Jews and Muslims who have a ritual of circumcision early in life. In 
India, cancer of the penis is rare in Muslims who practice circumcision as a 
rite in infancy, whereas Hindus who do not normally circumcise have higher 
incidence. Circumcision provides protection against penile cancer due to pre- 
vention of accumulation of smegma which is believed to be carcinogenic. 
The greatest incidence of penile cancer is between 45 and 60 years. 
Pathologic changes. Grossly, the tumour is located, in decreasing fre- 
quency, on frenum, prepuce, glans and coronal sulcus. The tumour may be 
cauliflower-like and papillary, or flat and ulcerating. 
Histologically, squamous cell carcinoma of both fungating and ulcerating 
type is generally well differentiated to moderately-differentiated type which re- 
sembles in morphology to similar cancer elsewhere in the body. 
The tumour metastasises via lymphatics to regional lymph nodes. Vis- 
ceral metastases by haematogenous route are uncommon and occur in ad- 




Prostate is involved in 3 important pathologic processes: prostatitis, 
nodular hyperplasia and carcinoma. 
 
PROSTATITIS 
Inflammation of the prostate i.e. prostatitis, may be acute, chronic and 
granulomatous types. 
ACUTE PROSTATITIS 
Acute focal or diffuse suppurative inflammation of the prostate is not 
uncommon. It occurs most commonly due to ascent of bacteria from the ure- 
thra, less often by descent from the upper urinary tract or bladder, and occa- 
sionally by lymphogenous or haematogenous spread from a distant focus of 
infection. The infection may occur spontaneously or may be a complication 
of urethral manipulation such as by catheterisation, cystoscopy, urethral dila- 
tation and surgical procedures on the prostate. The common pathogens are 




la, Proteus, Pseudomonas, Enterobacter, gonococci, staphylococci and strep- 
tococci. The diagnosis is made by culture of urine specimen. 
Pathologic changes. Grossly, the prostate is enlarged, swollen  and 
tense. Cut section shows multiple abscesses and foci of necrosis. Histologically, 
the prostatic acini are dilated and filled with neutrophilic exudate. There may be 
diffuse acute inflammatory infiltrate. Oedema, hyperaemia and foci of necrosis 
frequently accompany acute inflammatory involvement. 
CHRONIC PROSTATITIS 
Chronic Prostatitis is more common and foci of chronic inflammation 
are frequently present in the prostate of men above 40 years of age. Chronic 
prostatitis is usually asymptomatic but may cause allergic reactions, iritis, 
neuritis or arthritis. 
Chronic prostatitis is of 2 types – bacterial and abacterial. 
• Chronic bacterial prostatitis is caused in much the same way and by 
the same organisms as the acute prostatitis. It is generally a consequence of 
recurrent UTI. Diagnosis is made by detection of more than 10-12 leucocytes 
per high power field in expressed prostatic secretions, and by positive culture 
of urine specimen and prostatic secretions. This condition is more difficult to 
treat since antibiotics penetrate the prostate poorly. 
• Chronic abacterial prostatitis is more common these days. There is no 
history of recurrent UTI and culture of urine and prostatic secretions is al- 
ways negative, though leucocytosis is demonstrable in prostatic secretions. 
The pathogens implicated are Chlamydia trachomatis and Ureaplasma urea- 
lyticum. 
Pathologic changes. Pathologic changes in both bacterial and abacte- 
rial prostatitis are similar. Grossly, the prostate may be enlarged, fibrosed and 
shrunken. 
Histologically, the diagnosis of chronic prostatitis is made by foci of 
lymphocytes, plasma cells, macro-phages and neutrophils within the prostatic 
substance. Corpora amylacea, prostatic calculi and foci of squamous meta- 
plasia in the prostatic acini may accompany inflammatory changes. Seminal 
vesicles are invariably involved. 
GRANULOMATOUS PROSTATITIS 
Granulomatous prostatitis is a variety of chronic prostatitis, probably 
caused by leakage of prostatic secretions into the tissue, or could be of auto- 
immune origin. 
Pathologic changes. Grossly, the gland is firm to hard, giving the clin- 
ical impression of prostatic carcinoma on rectal examination. Histologically, 








Non-neoplasric tumour-like enlargement of the prostate, commonly 
termed benign nodular hyperplasia (BNH) or benign enlargement of prostate 
(BEP), is a very common condition in men and considered by some as nor- 
mal ageing process. 
Etiology. The cause of BEP has not been fully established. However, a 
few etiologic factors such as endocrinologic, racial, inflammation and arteri- 
osclerosis have been implicated but endocrine basis for hyperplasia has been 
more fully investigated and considered a strong possibility in its genesis. It 
has been found that both sexes elaborate androgen and oestrogen, though the 
level of androgen is high in males and that of oestrogen is high in females. 
With advancing age, there is decline in the level of androgen and a corre- 
sponding rise of oestrogen in the males. The periurethral inner prostate which 
is primarily involved in BEP is responsive to the rising level of oestrogen, 
whereas the outer prostate which is mainly involved in the carcinoma is re- 
sponsive to androgen. A plausible hypothesis suggested is that there is syner- 
gistic stimulation of the prostate by both hormones – the oestrogen acting to 
sensitise the prostatic tissue to the growth promoting effect of dihydroxy- 
testosterone derived from plasma testosterone. 
Pathologic changes. Grossly, the enlarged prostate is nodular, smooth 
and firm and weighs 2-4 times its normal weight i.e. may weigh up to 40-80 gm. 
The appearance on cut section varies depending upon whether the hyperplasia is 
predominantly of the glandular or fibromuscular tissue. In primarily glandular 
BEP the tissue is yellow-pink, soft, honeycombed, and milky fluid exudes, 
whereas in mainly fibromuscular BEP the cut surface is firm, homogeneous and 
does not exude milky fluid. The hyperplastic nodule forms a mass mainly in the 
inner periurethral prostatic gland so that the surrounding prostatic tissue fonns a 
false capsule which enables the surgeon to enucleate the nodular masses. The 
left-over peripheral prostatic tissue may sometimes undergo recurrent nodbaiar 
enlargement or may develop carcinoma later. Histologically, in every case, there 
is hyperplasia of aii there tissue elements in varying proportions – glandular, fi- 
brous and muscular: 
• Glandular hyperplasia predominates in most cases and is identified 
by exaggerated intra-acinar papillary infoldings with delicate fibrovascular 
cores. The lining epithelium is two-layered: the inner tall columnar mucus- 
secreting with poorly-defined borders, and the outer cuboidal to flattened epi- 




• Fibromuscular hyperplasia when present as dominant component 
appears as aggregates of spindle cells forming an appearance akin to fibro- 
myoma of the uterus. 
In addition to glandular and/or fibromuscular hyperplasia, other histolog- 
ic features frequently found include foci of lymphocytic aggregates, small areas 
of infarction, corpora amylacea and foci of squamous metaplasia. 
Clinically, the symptomatic cases develop symptoms due to complications such as 
urethral obstruction and secondary effects on the bladder (e.g. hypertrophy, cystitis), ureter 
(e.g. hydroureter) and kidneys (e.g. hydronephrosis). The presenting features include frequen- 
cy, nocturia, difficulty in micturition, pain, haematuria and sometimes, the patients present 
with acute retention of urine requiring immediate catheterisation. 
 
CARCINOMA OF PROSTATE 
Cancer of the prostate is the second most common form of cancer in 
males, followed in frequency by lung cancer. It is a disease of men above the 
age of 50 years and its prevalence increases with increasing age so that more 
than 50% of men 80 years old have asymptomatic (latent) carcinoma of the 
prostate. Many a times, carcinoma of the prostate is small and detected as 
microscopic foci in a prostate removed for BEP or found incidentally at au- 
topsy. Thus, it is common to classify carcinoma of the prostate into the fol- 
lowing 4 types: 
1. Latent carcinoma. This is found unexpectedly as a small focus of 
carcinoma in the prostate during autopsy studies in men dying of other caus- 
es. Its incidence in autopsies has been variously reported as 25-35%. 
2. Incidental carcinoma. About 15-20% of prostatectomies done for 
BEP reveal incidental carcinoma of the prostate. 
3. Occult carcinoma. This is the type in which the patient has no 
symptoms of prostatic carcinoma but shows evidence of metastases on clini- 
cal examination and investigations. 
4. Clinical carcinoma. Clinical prostatic carcinoma is the type detect- 
ed by rectal examination and other investigations and confirmed by patholog- 
ic examination of biopsy of the prostate. 
Etiology. The cause of prostatic cancer remains obscure. However, a 
few factors have been suspected. These are as under: 
1. Endocrinologic factors. Androgens are considered essential for de- 
velopment and maintenance of prostatic epithelium. But how androgens are 
responsible for causing malignant transformation is not yet clear. However, 
the etiologic role of androgens is supported by the following indirect evi- 
dences: 
i) Orchiectomy causes arrest of metastatic prostatic cancer disease (tes- 




ii) Administration of oestrogen causes regression of prostatic carcinoma. 
iii) Cancer of the prostate is extremely rare in eunuchs and in patients 
with Klinefelter's syndrome. 
iv) Cancer of the prostate begins at the stage of life when androgen 
levels are high. However, the cancer may remain latent with decline in an- 
drogen level with advancing age. 
2. Racial and geographic influences. There are some racial and geo- 
graphic differences in the incidence of prostatic cancer. It is uncommon in 
Japanese and Chinese, while the prevalence is high in Americans. American 
blacks have a markedly higher incidence as compared to whites. 
3. Environmental influences. It is possible that some common, as yet 
unidentified, environmental factors and carcinogens may play a role in the 
evolution of prostatic cancer. 
4. Nodular hyperplasia. Though nodular prostatic hyperplasia has been 
suggested by some as precursor for development of prostatic cancer, it is con- 
sidered unlikely. Most prostatic cancers develop in the periphery of the gland 
while BEP occurs in the periurethral part of the gland. Any concomitant occur- 
rence of the two diseases may be considered as aging process. Approximately 
15-20% of nodular hyperplastic prostates harbour carcinoma. 
5. Genetic factors. The possibility of genetic basis of prostatic cancer 
has been suggested by the observations of familial clustering and in first de- 
gree relatives. Recently prostatic cancer susceptibility gene has been identi- 
fied in familial cases. 
Histogenesis. Histogenesis of prostatic adenocarcinoma has been doc- 
umented recently as arising from premalignant stage of prostatic intraepithe- 
lial neoplasia (PIN), PIN refers to multiple foci of cytologically atypical lu- 
minal cells overlying diminished number of basal cells in prostatic ducts and 
is a forerunner of invasive prostatic carcinoma. Based on cytologic atypia, 
PIN may be low grade to high grade. PIN of high grades progresses to pros- 
tatic adenocarcinoma. 
Pathologic changes. Grossly, the prostate may be enlarged, normal in 
size or smaller than normal. In 95% of cases, prostatic carcinoma is located 
in the peripheral zone, especially in the posterior lobe. The malignant pros- 
tate is firm and fibrous. Cut section is homogeneous and contains irregular 
yellowish areas. 
Microscopically, 4 histologic types are described— adenocarcinoma, 
transitional cell carcinoma, squamous cell carcinoma and undifferentiated 
carcinoma. However, adenocarcinoma is the most common type found in 
96% of cases and is the one generally referred to as carcinoma of the pros- 
tate. The other three histologic types are rare and resemble in morphology 






The histologic characteristics of adenocarcinoma of the prostate are as 
 
1. Architectural disturbance: In contrast to convoluted appearance of 
the glands seen in normal and hyperplastic prostate, there is loss of intra- 
acinar papillary convolutions. The groups of acini are either closely packed in 
back-to-back arrangement without intervening stroma or are haphazardly dis- 
tributed. 
2. Stroma: Normally, fibromuscular sling surrounds the acini, whereas 
malignant acini have little or no stroma between them. The tumour cells may 
penetrate and replace the fibromuscular stroma. 
3. Gland pattern: Most frequently, the glands in well-differentiated 
prostatic adenocarcinoma are small or medium-sized, lined by a single layer 
of cuboidal or low columnar cells. Moderately-differentiated rumours have 
cribriform or fenestrated glandular appearance. Poorly-differentiated tumours 
have little or no glandular arrangement but instead show solid or trabecular 
pattern. 
4. Tumour cells: In many cases, the individual tumour cells in prostat- 
ic carcinoma do not show usual morphologic features of malignancy. The 
tumour cells may be clear, dark and eosinophilic cells. Clear cells have 
foamy cytoplasm, dark cells have homogeneous basophilic cytoplasm, and 
eosinophilic cells have granular cytoplasm. The cells may show varying de- 
gree of anaplasia and nuclear arypia but is generally slight. 
5. Invasion: One of the important diagnostic features of malignancy in 
prostate is the early and frequent occurrence of invasion of intra-prostatk per- 
ineumi spaces. Lymphatic and vascular invasion may be present but are diffi- 
cult to detect. 
Spread. The tumour spreads within the gland by direct extension, and 
to distant sites by metastases. 
Direct spread. Direct extension of the tumour occurs into the prostatic 
capsule and beyond. In late stage, the tumour may extend into the bladder 
neck, seminal vesicles, trigone and ureteral openings. 
Metastases. Distant spread occurs by both lymphatic and haematog- 
enous routes. The rich lymphatic network surrounding the prostate is the 
main mode of spread to the sacral, iliac and paraaortic lymph nodes. The ear- 
liest metastasis occur to the obturator lymph node. Haematogenous spread 
leads most often to osteoblastic osseous metastases, especially to pelvis, and 
lumbar spine; other sites are lungs, kidneys, breast and brain. The route of 
blood-borne metastases may be retrograde spread by prostatic venous plexus 
or via systemic circulation. 
Clinical features. By the time symptoms appear, the carcinoma of prostate is 




urinary obstruction with dysuria, frequency, retention of urine, haematuria, and in 10% of 
cases pain in the back due to skeletal metastases. Per-rectal examination shows a hard 
and nodular gland fixed to the surrounding tissues. 
Clinical classification of carcinoma prostate takes into account the following: 
• The tumour found incidentally or a clinically unsuspected cancer in prostate 
removed for benign disorder (Stage A). 
• The rumour palpable by rectal digital examination but confined to the prostate 
(Stage B). 
• The tumour has extended locally beyond the prostate into the surrounding tis- 
sues (Stage C). 
• The rumour is associated with distant metastases (Stage D). 
Such clinical staging has good correlation with histologic grading and, thus, has a 
prognostic significance. Gleason's microscopic grading system is based on the degree of 
glandular differentiation and the growth pattern of the tumour in relation to the stroma. 
These features are assessed by low-power examination of the prostatic tissue and is wide- 
ly followed and preferred to other grading system. More recently TNM staging system 
has been proposed which is considered international standard for prostate cancer staging. 
The diagnosis of prostatic carcinoma is made by cytologic, biochemi- 
cal, radiologic, ultrasonographic and pathologic methods. Two tumour mark- 
ers employed commonly for diagnosis and monitoring the prognosis of pros- 
tatic carcinoma are as under: 
• Prostatic acid phosphatase (PAP) is secreted by prostatic epithelium. 
Elevation of serum level of PAP is found in cases of prostatic cancer which 
have extended beyond the capsule or have metastasised. A reading of 3-5 KA 
units (normal 1-3 KA units) is highly suspicious but above 5 KA units is di- 
agnostic of prostatic carcinoma. PAP can also be demonstrated in the normal 
prostatic tissues. 
• Prostate-specific antigen (PSA) can be detected by immunohisto- 
chemical method in the malignant prostatic epithelium as well as in the se- 
rum. PSA assay is also useful in deciding whether the metastasis originated 
from the prostate or not. PSA assay is also helpful in distinguishing high 
grade prostatic cancer from urothelial carcinoma, colonic carcinoma, lym- 
phoma and prostatitis. PSA level is generally higher in low-grade tumours 
than in high-grade tumours. 
 
FEMAIL REPRODUCTIVE SYSTEM 
 
UTERINE CERVICAL ECTOPY 
Uterine cervical ectopy is the occurrence of single-layered secreting 
columnar epithelium (which usually covers the cervical canal, i.e. the en- 
docervix), beyond the external cervical orifice. Thus, the multilayered squa- 




This condition has many designations in medical terminology: ectropi- 
on, erythroplakia, macula rubra and erosion (pseudoerosion). 
Not all factors involved in the pathogenesis of cervical ectopy are known 
but there is an association with the action of estrogen. Ectopy is rare beyond the 
menopause and frequent at reproductive ages. It has higher prevalence during 
pregnancy and also among users of estrogen-based contraceptives. 
The natural history of ectopy is well established. After its develop- 
ment, a process of metaplasia occurs in the columnar epithelium, known as 
squamous metaplasia. 
There is a relationship between squamous metaplasia and induction of 
squamous cell carcinoma of the cervix. Cells undergoing metaplasia are more 
susceptible to carcinogens. Precancerous lesions often develop at the squamous- 
columnar junction, i.e. the area of transition between glandular and stratified 
epithelium, which is the location where metaplasia is most intense. 
 
CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN) 
It also known as cervical dysplasia and cervical interstitial neoplasia, is 
the potentially premalignant transformation and abnormal growth (dysplasia) 
of squamous cells on the surface of the cervix. 
The major cause of CIN is chronic infection of the cervix with the sex- 
ually transmitted human papillomavirus (HPV), especially the high-risk HPV 
types 16 or 18. 
Depending on several factors and the location of the infection, CIN can 
start in any of the three stage, and can either progress, or regress. 
CIN is classified in grades: 
CIN 1 (Grade I) - The least risky type, represents only mild dysplasia, 
or abnormal cell growth. It is confined to the basal 1/3 of the epithelium. This 
usually corresponds to infection with HPV, and may be cleared by immune 
response, though it can take several years to clear. 
CIN 2 (Grade II) - Moderate dysplasia confined to the basal 2/3 of the 
epithelium 
CIN 3 (Grade III) - Severe dysplasia that spans more than 2/3 of the 
epithelium, and may involve the full thickness. This lesion may sometimes 
also be referred to as cervical carcinoma in situ. 
 
ENDOMETRIAL HYPERPLASIA 
Endometrial hyperplasia involves the proliferation of endometrial 
glands that results in a greater than normal gland-to-stroma ratio. This results 




Like other hyperplastic disorders, endometrial hyperplasia initially rep- 
resents a physiological response of endometrial tissue to the growth- 
promoting actions of estrogen. However, the gland-forming cells of a hyper- 
plastic endometrium may also undergo changes over time which predispose 
them to cancerous transformation. 
The classification below is the most commonly used system and is 
used by the World Health Organization (WHO) and the International Society 
of Gynecologic Pathologists since 1994. This system characterizes the glan- 
dular architectural pattern as simple or complex and describes the presence or 
absence of nuclear atypia. 
 Simple hyperplasia - increased number of glands but regular glandu- 
lar architecture, 
 Complex hyperplasia - crowded irregular glands, 
 Simple hyperplasia with atypia - simple hyperplasia with presence of 
cytologic atypia (prominent nucleoli and nuclear pleomorphism), 
 Complex hyperplasia with atypia - complex hyperplasia with cyto- 
logic atypia. 
Endometrial hyperplasia results from continuous estrogen stimulation 
that is unopposed by progesterone. This can be due to endogenous estrogen 
or exogenous estrogenic sources. Endogenous estrogen may be caused by 
chronic anovulation associated with polycystic ovary syndrome. Obesity also 
contributes to unopposed estrogen exposure due to chronic high levels of es- 
tradiol that result from aromatization of androgens in adipose tissue and con- 
version of androstenedione to estrone. Endometrial hyperplasia and cancer 
can also result from estradiol-secreting ovarian tumors such as granulosa cell 
tumors. 
The most common clinical presentation of patients with endometrial 
hyperplasia is abnormal uterine bleeding, whether in the form of menorrha- 
gia, metrorrhagia, or postmenopausal bleeding. It can be associated with uter- 
ine hemorrhage, requiring emergent medical or surgical interventions, loss of 
fertility, and blood transfusion therapy. 
 
UTERINE CANCER 
Uterine cancer is defined as any invasive neoplasm of the uterine cor- 
pus. Invasive neoplasms of the female pelvic organs account for almost 15% 
of all cancers in women. The most common of these malignancies is uterine 
cancer. Endometrial adenocarcinoma is the most common gynecologic ma- 
lignancy. However, it has a favorable prognosis because the majority of pa- 












en. Uterine sarcomas comprise <9% of cancers of uterine corpus, however is 
associated with more aggressive behavior and a poorer prognosis. 
Endometrioid adenocarcinoma can be due to excess estrogen from vari- 
ous sources, either exogenous or endogenous. Endogenous estrogen sources in- 
clude obesity and polycystic ovary syndrome (PCOS) with anovulatory cycles, 
or estrogen-secreting tumors such as granulose cell tumors. Increasing body 
mass index has been associated with increasing risk of endometrial cancer. 
Endometrial cancers are divided into 2 classes, each with differing 
pathophysiology and prognosis. More than 80% of endometrial carcinomas 
are type I and are due to unopposed estrogen stimulation, resulting in a low- 
grade histology. It is often found in association with atypical endometrial hy- 
perplasia, which is thought to be a precursor lesion. Type II endometrial can- 
cers are thought to be estrogen independent, occurring in older women, with 
high-grade histologies such as uterine papillary serous or clear cell. 
Endometrial cancer may originate in a small area (e.g., within an en- 
dometrial polyp) or in a diffuse multifocal pattern. Early tumor growth is 
characterized by an exophytic and spreading pattern. This growth is charac- 
terized by friability and spontaneous bleeding, even at early stages. Later tu- 
mor growth is characterized by myometrial invasion and growth toward the 
cervix. Four routes of spread occur beyond the uterus: 
Direct/local  spread  accounts  for  most  local  extension  beyond  the 
uterus.  
Lymphatic spread accounts for spread to pelvic, para-aortic, and, rare- 
ly, inguinal lymph nodes. 
Hematologic spread is responsible for metastases to the lungs, liver, 
bone, and brain (rare). 
Peritoneal/transtubal spread results in intraperitoneal implants, partic- 
ularly with uterine papillary serous carcinoma, similar to the pattern observed 
in ovarian cancer. 
Endometrioid adenocarcinoma of the endometrium, the most common 
histology, is usually preceded by adenomatous hyperplasia with atypia. If left 
untreated, simple and complex endometrial hyperplasia with atypia progress 
to adenocarcinoma in 8% and 29% of cases, respectively. Without atypia, 
simple and complex hyperplasia progress to cancer in only 1% and 3% of 
cases, respectively. 
Endometrial adenocarcinoma is histologically characterized by cribri- 
form glands (or glandular crowding) with little, if any, stromal tissue between 
the glands. Nuclear atypia, variation in gland size, and increased mitoses are 
common in adenocarcinoma. Well-differentiated tumors may be confused 




entiated tumors might be confused with sarcomas histologically. All papillary 
serous and clear cell histologies are considered grade 3. The differentiation of 
endometrial cancers is one of the most important prognostic factors. The de- 
gree of histologic differentiation of adenocarcinoma of the endometrium as 
defined by the International Federation of Gynecology and Obstetrics (FIGO) 
is as follows: 
 FIGO grade 1 - 5% or less of solid/nonglandular areas 
 FIGO grade 2 - 6-50% of solid/nonglandular areas 
 FIGO grade 3 - More than 50% of solid/nonglandular areas 
Histological variants. The most common histologic subtype of endo- 
metrial cancer is endometrioid adenocarcinoma, accounting for about 75- 
80% of endometrial cancers. Less common histologies include adenosqua- 
mous and mucinous. 
Carcinosarcoma are typically comprised of a high grade epithelial carci- 
noma and stromal sarcoma. The sarcomatous portion of the tumor may exhibit 
an endometrial stromal sarcoma pattern, if differentiated. This tumor is charac- 
terized by early extrauterine spread and lymph node metastases. 
Endometrial Stromal Sarcomas (ESS) are a type of uterine cancer arising 
from the uterine mesenchymal tissue. ESS can be divided into 2 categories: low- 
grade ESS (LGESS) and high-grade (HGESS) or undifferentiated ESS. 
 
BENIGN BREAST LESIONS 
Fibrocystic breasts or fibrocystic breast disease or fibrocystic breast 
condition commonly referred to as "FBC" is a condition of breast tissue af- 
fecting an estimated 30-60% of women and at least 50% of women of 
childbearing age. It is characterized by noncancerous breast lumps which can 
sometimes cause discomfort, often periodically related to hormonal influ- 
ences from the menstrual cycle. 
In ICD-10 the condition is called diffuse cystic mastopathy, or, if there 
is epithelial proliferation, fibrosclerosis of breast. Other names for this condi- 
tion include chronic cystic mastitis, fibrocystic mastopathy and mammary 
dysplasia. 
The changes in fibrocystic breast disease are characterised by the ap- 
pearance of fibrous tissue and a lumpy, cobblestone texture in the breasts. 
These lumps are smooth with defined edges, and are usually free-moving in 
regard to adjacent structures. The bumps can sometimes be obscured by ir- 
regularities in the breast that are associated with the condition. The lumps are 
most often found in the upper, outer sections of the breast (nearest to the 




Women with fibrocystic changes may experience a persistent or inter- 
mittent breast aching or breast tenderness related to periodic swelling. 
Breasts and nipples may be tender or itchy. 
Symptoms follow a periodic trend tied closely to the menstrual cycle. 
The exact mechanism of the condition is not fully understood, though 
it is known to be tied to hormone levels, as the condition usually subsides af- 
ter menopause and is also related to the menstrual cycle. Post-menopausal 
women placed on hormone replacement therapy (HRT) have also reported 
symptoms of FBC indicating hormones may play a role. 
Fibrocystic breast changes is a cumulative process, caused partly by 
the normal hormonal variation during a woman's monthly cycle. The most 
important of these hormones are estrogen, progesterone and prolactin. 
These hormones directly affect the breast tissues by causing cells to grow 
and multiply. Many other hormones such as TSH, insulin, growth hormone and 
growth factors such as TGF-beta exert direct and indirect effects amplifying or 
regulating cell growth. Years of such fluctuations eventually produce small 
cysts and/or areas of dense or fibrotic tissue. Multiple small cysts and an in- 
creasing level of breast pain commonly develop when a woman hits her 30s. 
Larger cysts usually do not occur until after the age of 35. 
Several variants of fibrocystic breast changes may be distinguished and 
these may have different causes and genetic predispostions. Adenosis in- 
volves abnormal count and density of lobular units, while other lesions ap- 
pear to stem mainly from ductal epithelial origins. Histologically, a wide 
range of lesions are seen within fibrocystic changes, including epithelial met- 
aplasia, hyperplasia of benign or usual type, adenosis, cyst formation, 
inflammatory changes, and fibrosis. 
Sclerosing adenosis is a variant of breast proliferation. This is an im- 
portant entity to recognize, as clinically it is characterized by an irregular 
hard mass that is fixed to the adjacent structures, and by imaging, it also 
shows significant architectural distortion, rendering this indistinguishable 
from carcinoma. Histologically, there is proliferation of epithelial and my- 
oepithelial cells in the small ducts and ductules, and these are present within 
a densely fibrotic stroma. Other variants include blunt duct adenosis (colum- 
nar cell changes), microglandular adenosis, apocrine adenosis, and nodular 
adenosis. 
There are usually no adverse side effects to this condition. In almost all 
cases it subsides after menopause. Breast cancer risk is elevated for defined frac- 
tion of lesions. Except for patients with a strong family history of breast cancer, 




erative lesions also have approximately a 2-fold risk. In particular, atypical hy- 
perplasia is associated with an increased risk of developing breast cancer. 
Fibroadenomas are probably the most common benign breast tumor, 
presenting as solitary painless, mobile, and well-defined nodules. Multiple 
lesions are less frequent. Use of the immunosuppressant cyclosporine in 
transplant patients has resulted in an increased risk of fibroadenoma devel- 
opment. Macroscopically, fibroadenoma is ovoid, rubbery, and well circum- 
scribed; the cut surface is grayish and may be lobulated. Microscopically, it 
shows a mixed epithelial and stromal proliferation, giving rise to the pericana- 
licular and intracanalicular patterns, with the former formed by stromal prolifer- 
ation around the ducts and the latter formed by compression of the ductal ele- 
ments by the proliferating stromal component into slit-like spaces. These pat- 
terns have little prognostic significance. Occasionally stromal giant cells, myx- 
oid changes, dystrophic calcifications, and other mesenchymal metaplasia have 
been described. Complex fibroadenomas are those that show cysts larger than 3 
mm, sclerosing adenosis, epithelial calcifications, or papillary apocrine changes, 
and this group of fibroadenomas shows slightly higher (1.6×) cancer risk com- 
pared to the usual fibroadenomas. 
Gynecomastia is a benign enlargement of the male breast (usually bi- 
lateral but sometimes unilateral) resulting from a proliferation of the glandu- 
lar component of the breast. It is defined clinically by the presence of a rub- 
bery or firm mass extending concentrically from the nipples. Gynecomastia 
should be differentiated from pseudogynecomastia (lipomastia), which is 
characterized by fat deposition without glandular proliferation. 
Gynecomastia can be physiologic or pathologic. Physiologic gyneco- 
mastia is seen in newborn infants, pubescent adolescents, and elderly indi- 
viduals. 
Pathologic gynecomastia can be caused by an increase in the produc- 
tion and/or action of estrogen, by a decrease in the production and/or action 
of testosterone accompanied by increased aromatization and high estrogen, or 
by drug use. 
Certain health problems in men such as liver disease, kidney failure or 
low testosterone can cause breast growth in men. Medications such as metha- 
done, HIV medication, cancer chemotherapy, hormone treatment for prostate 
cancer, heartburn and ulcer medications, calcium channel blockers, antifun- 
gal medications such as ketoconazole, antibiotics such as metronidazole, tri- 
cyclic antidepressants such as amitriptyline, herbals such as lavender, tea tree 
oil, and dong quai are also known to cause gynecomastia. However, gyneco- 




Histologic findings. Characteristic findings include proliferation of 
ductules and stroma (consisting of connective-tissue elements such as fibro- 
blasts, collagen, and myofibroblasts) and occasional acini. Gynecomastia of 
short duration consists of a prominent ductular component with loose stroma. 
Long-standing gynecomastia consists of dense stroma with few ductules. 
BREAST CANCER 
Worldwide, breast cancer is the most frequently diagnosed life- 
threatening cancer in women. In less-developed countries, it is the leading 
cause of cancer death in women; in developed countries, however, it has been 
surpassed by lung cancer as a cause of cancer death in women. 
The current understanding of breast cancer etiopathogenesis is that in- 
vasive cancers arise through a series of molecular alterations at the cell level. 
These alterations result in breast epithelial cells with immortal features and 
uncontrolled growth. 
Genomic profiling has demonstrated the presence of discrete breast 
tumor subtypes with distinct natural histories and clinical behavior. The exact 
number of disease subtypes and molecular alterations from which these sub- 
types arise remains to be fully elucidated, but these generally align with the 
presence or absence of estrogen receptor (ER), progesterone receptor (PR), 
and human epidermal growth factor receptor 2 (HER2). 
Risk factors can be divided into two categories: 
     modifiable risk factors (things that people can change themselves, 
such as consumption of alcoholic beverages), and 
     fixed risk factors (things that cannot be changed, such as age and 
biological sex). 
The primary risk factors for breast cancer are female sex and older age. 
Other potential risk factors include: genetics, lack of childbearing or lack of 
breastfeeding, higher levels of certain hormones, certain dietary patterns, and 
obesity. Recent studies have indicated that exposure to light pollution is a 
risk factor for the development of breast cancer. 
The various types of breast cancers are listed below by percentage of 
cases: 
 Infiltrating ductal carcinoma is the most commonly diagnosed breast 
tumor and has a tendency to metastasize via lymphatics; this lesion accounts 
for 75% of breast cancers; 
 Over the past 25 years, the incidence of lobular carcinoma in situ 
(LCIS) has doubled, reaching a current level of 2.8 per 100,000 women; the 




 Infiltrating lobular carcinoma accounts for fewer than 15% of inva- 
sive breast cancers; 
 Medullary carcinoma accounts for about 5% of cases and generally 
occurs in younger women; 
 Mucinous (colloid) carcinoma is seen in fewer than 5% of invasive 
breast cancer cases; 
 Tubular carcinoma of the breast accounts for 1-2% of all breast cancers; 
 Papillary carcinoma is usually seen in women older than 60 years and 
accounts for approximately 1-2% of all breast cancers; 
 Metaplastic breast cancer accounts for fewer than 1% of breast cancer 
cases, tends to occur in older women (average age of onset in the sixth dec- 
ade), and has a higher incidence in blacks; 
 Mammary Paget disease accounts for 1-4% of all breast cancers and 
has a peak incidence in the sixth decade of life (mean age, 57 years). 
Histology. Breast cancers usually are epithelial tumors of ductal or 
lobular origin. The following features are all important in deciding on a 
course of treatment for any breast tumor: size, status of surgical margin, pres- 
ence or absence of estrogen receptor (ER) and progesterone receptor (PR), 
nuclear and histologic grade, proliferation, vascular invasion, tumor necrosis, 
quantity of intraductal component, HER2 status 
Breast cancer is usually classified primarily by its histological appear- 
ance. Most breast cancers are derived from the epithelium lining the ducts or 
lobules, and these cancers are classified as ductal or lobular carcinoma. Car- 
cinoma in situ is growth of low grade cancerous or precancerous cells within 
a particular tissue compartment such as the mammary duct without invasion 
of the surrounding tissue. In contrast, invasive carcinoma does not confine 
itself to the initial tissue compartment. 
Grade. Grading compares the appearance of the breast cancer cells to 
the appearance of normal breast tissue. Normal cells in an organ like the breast 
become differentiated, meaning that they take on specific shapes and forms that 
reflect their function as part of that organ. Cancerous cells lose that differentia- 
tion. In cancer, the cells that would normally line up in an orderly way to make 
up the milk ducts become disorganized. Cell division becomes uncontrolled. 
Cell nuclei become less uniform. Pathologists describe cells as well differentiat- 
ed (low grade), moderately differentiated (intermediate grade), and poorly dif- 
ferentiated (high grade) as the cells progressively lose the features seen in nor- 
mal breast cells. Poorly differentiated cancers (the ones whose tissue is least like 
normal breast tissue) have a worse prognosis. 
Histologic grade is the best predictor of disease prognosis in carcinoma 
in situ, but it is dependent on the grading system used, such as the Van Nuys 




grading of invasive carcinoma is also important as a prognostic indicator, 
with higher grades indicating a worse prognosis. 
Stage. Breast cancer staging using the TNM system is based on the 
size of the tumor (T), whether or not the tumor has spread to the lymph nodes 
(N) in the armpits, and whether the tumor has metastasized (M) (i.e. spread to 
a more distant part of the body). Larger size, nodal spread, and metastasis 
have a larger stage number and a worse prognosis. The main stages are: 
 Stage 0 is a pre-cancerous or marker condition, either ductal carcinoma 
in situ (DCIS) or lobular carcinoma in situ (LCIS). 
 Stages 1–3 are within the breast or regional lymph nodes. 
 Stage 4 is 'metastatic' cancer that has a less favorable prognosis since it 
has escaped into the blood stream. 
Ductal carcinoma in situ. Increased use of screening mammography 
has resulted in a dramatic increase in the detection of ductal carcinoma in 
situ. About 90% of DCIS cases are identified on mammography as suspicious 
calcifications: linear, clustered, segmental, focal, or mixed distribution. 
DCIS is broadly divided into 2 subtypes: comedo (i.e., cribriform, mi- 
cropapillary, and solid) and noncomedo. The likelihood of progression or lo- 
cal recurrence, as well as the prognosis, varies in accordance with the DCIS 
subtype present. 
Lobular carcinoma in situ arises from the terminal duct apparatus 
and shows a rather diffuse distribution throughout the breast, which explains 
its presentation as a nonpalpable mass in most cases. The peak incidence is in 
women aged 40-50 years. 
Infiltrating ductal carcinoma is the most commonly diagnosed breast 
tumor (accounting for 75% of breast cancers) and has a tendency to metasta- 
size via lymphatic vessels. This lesion has no specific histologic characteris- 
tics other than invasion through the basement membrane. DCIS is a frequent- 
ly associated finding on pathologic examination. 
Infiltrating lobular carcinoma has a much lower incidence than infil- 
trating ductal carcinoma, accounting for 15-20% of invasive breast cancers. 
Histologically, it is characterized by the "single-file" arrangement of small 
tumor cells. Like ductal carcinoma, infiltrating lobular carcinoma typically 
metastasizes to axillary lymph nodes first. However, it also has a tendency to 
be multifocal and have discontinuous areas of involvement. 
Medullary carcinoma is relatively uncommon (5%) and generally oc- 
curs in younger women. Most patients present with a bulky palpable mass 
and axillary lymphadenopathy. Diagnosis of this type of breast cancer de- 
pends on the following histologic triad: 
           Sheets of anaplastic tumor cells with scant stroma 




           Histologic circumscription or a pushing border 
DCIS may be observed in the surrounding normal tissues. Medullary 
carcinomas are typically high-grade lesions that are negative for ER, PR, and 
HER2 and that commonly demonstrate mutation of TP53. 
Mucinous carcinoma (colloid carcinoma) is another rare histologic 
type, seen in fewer than 5% of invasive breast cancer cases. It usually pre- 
sents during the seventh decade of life as a palpable mass or appears mam- 
mographically as a poorly defined tumor with rare calcifications. 
Mucin production is the histologic hallmark. There are 2 main types of le- 
sions, A and B, with AB lesions possessing features of both. Type A mucinous 
carcinoma represents the classic variety, with larger quantities of extracellular 
mucin, whereas type B is a distinct variant with endocrine differentiation. 
DCIS is not a frequent occurrence in this setting, though it may be 
found. Most cases are ER- and PR-positive, but HER2 overexpression is rare. 
Additionally, these carcinomas predominantly express glycoproteins MUC2 
and MUC6. 
Tubular carcinoma of the breast is an uncommon histologic type, ac- 
counting for only 1-2% of all breast cancers. Characteristic features of this 
type include a single layer of epithelial cells with low-grade nuclei and apical 
cytoplasmic snoutings arranged in well-formed tubules and glands. 
Tubular components make up more than 90% of pure tubular carcino- 
mas and at least 75% of mixed tubular carcinomas. This type of breast cancer 
has a low incidence of lymph node involvement and a very high overall sur- 
vival rate. Because of its favorable prognosis, patients are often treated with 
only breast-conserving surgery and local radiation therapy. 
Papillary carcinoma of the breast encompasses a spectrum of histo- 
logic subtypes. There are 2 common types: cystic (noninvasive form) and mi- 
cropapillary ductal carcinoma (invasive form). This form of breast cancer is 
usually seen in women older than 60 years and accounts for approximately 1- 
2% of all breast cancers. Papillary carcinomas are centrally located in the 
breast and can present as bloody nipple discharge. They are strongly ER- and 
PR-positive. 
Cystic papillary carcinoma has a low mitotic activity, which results in a 
more indolent course and a good prognosis. However, invasive micropapillary 
ductal carcinoma has a more aggressive phenotype similar to that of infiltrating 
ductal carcinoma, even though about 70% of cases are ER-positive. Additional- 
ly, lymph node metastasis is seen frequently in this subtype. 
Metaplastic breast cancer (MBC) accounts for fewer than 1% of breast 
cancer cases. It tends to occur in older women (average age of onset in the sixth 
decade) and has a higher incidence in blacks. It is characterized by a combina- 
tion of adenocarcinoma plus mesenchymal and epithelial components. 




 Spindle-cell carcinoma, 
 Carcinosarcoma, 
 Squamous cell carcinoma of ductal origin, 
 Adenosquamous carcinoma, 
 Carcinoma with pseudosarcomatous metaplasia, 
 Matrix-producing carcinoma. 
This diverse group of malignancies is identified as a single entity on 
the basis of a similarity in clinical behavior. Compared with infiltrating duc- 
tal carcinoma, MBC tumors are larger, faster-growing, commonly node- 
negative, and typically negative for ER, PR, and HER2. 
Mammary Paget disease is relatively rare, accounting for 1-4% of all 
breast cancers. The peak incidence is seen in the sixth decade of life. This ade- 
nocarcinoma is localized within the epidermis of the nipple-areola complex and 
is composed of the histologic hallmark Paget cells within the basement mem- 
brane. Paget cells are large, pale epithelial cells with hyperchromatic, atypical 
nuclei, dispersed between the keratinocytes singly or as a cluster of cells. 
Lesions are predominantly unilateral, developing insidiously as a scaly, 
fissured, oozing, or erythematous nipple-areola complex. Retraction or ulcer- 
ation of the nipple is often noted, along with symptoms of itching, tingling, 
burning, or pain. In situ or invasive breast cancer is found in approximately 
85% of patients with Paget disease. 
OVARIAN CANCER 
Malignant lesions of the ovaries include primary lesions arising from 
normal structures within the ovary and secondary lesions from cancers aris- 
ing elsewhere in the body. Primary lesions include epithelial ovarian carci- 
noma (70% of all ovarian malignancies), germ-cell tumors, sex-cord stromal 
tumors, and other more rare types. Metastases to the ovaries are relatively 
frequent, with the most common being from the endometrium, breast, colon, 
stomach, and cervix. 
The precise cause of ovarian cancer is unknown. However, several risk 
and contributing factors (including both reproductive and genetic factors) have 
been identified. Most of the risk for ovarian cancer is related to the amount of 
time spent in ovulation. Thus not having children is a risk factor for ovarian 
cancer, likely because ovulation is not suppressed via pregnancy. Both obesity 
and hormone replacement therapy also raise the risk. 
Things that halt ovulation: breast feeding, oral contraceptive use with 
estrogen/progesterone combination meds, multiple pregnancies, and pregnan- 
cy at an early age, all decrease risk of ovarian cancer. These conditions de- 
crease the overall time during one's lifetime spent ovulating. A positive fami- 




hereditary nonpolyposis colon  cancer  (Lynch  Syndrome),  and those  with 
BRCA-1 and BRCA-2 genetic abnormalities are at increased risk. 
Epithelial tumors represent the most common histology (90%) of ovarian 
tumors. Other histologies include the following: sex-cord stromal tumors, germ 
cell tumors, primary peritoneal carcinoma, metastatic tumors of the ovary. 
EPITHELIAL OVARIAN CANCER 
Epithelial ovarian cancer is thought to arise from epithelium covering 
the fimbria of the fallopian tubes, or the ovaries, both of which are derived 
from the coelomic epithelium in fetal development. This coelomic epithelium 
is also involved in formation of the müllerian ducts, from which the fallopian 
tubes, uterus, cervix, and upper vagina develop. 
Four main histologic subtypes, which are similar to carcinoma, arise in 
the epithelial lining of the cervix, uterus, and fallopian tube, as follows: 
 Serous (from fallopian tube), 
 Endometrioid (endometrium), 
 Mucinous (cervix), 
 Clear cell (mesonephros). 
Some variation is observed in the patterns of spread and disease distri- 
bution within the various histologic subtypes. 
Epithelial tumors are found as partially cystic lesions with solid compo- 
nents. The surface may be smooth or covered in papillary projections, and the 
cysts contain fluid ranging from straw-colored to opaque brown or hemorrhagic. 
Serous carcinoma 
Most people with epithelial ovarian carcinoma, about two-thirds, have a 
serous carcinoma, though this proportion is estimated as high as 80%. Low- 
grade serous carcinoma is less aggressive than high-grade serous carcinomas, 
though it does not typically respond well to chemotherapy or hormonal treat- 
ments. Serous carcinomas are thought to begin in the Fallopian tube. Histologi- 
cally, serous adenocarcinomas have psammoma bodies. Low-grade serous ade- 
nocarcinomas resemble Fallopian tube epithelium, whereas high-grade serous 
adenocarcinomas show anaplasia and nuclear atypia. 
50% of the time, serous carcinomas are bilateral, and in 85% of cases, 
they have spread beyond the ovary at the time of diagnosis. Most have a di- 
ameter over 15 cm. 
Endometrioid adenocarcinomas make up approximately 15-20% of 
epithelial ovarian cancers. Because they are typically low-grade, endometri- 
oid adenocarcinomas have a good prognosis. These tumors frequently co- 
occur with endometriosis or endometrial cancer. 
Mucinous tumors include mucinous adenocarcinoma and mucinous 
cystadenocarcinoma. Mucinous adenocarcinomas make up 5-10% of epithe- 




adenocarcinomas, and are often actually metastases of appendiceal or colon 
cancers. Advanced mucinous adenocarcinomas have a poor prognosis, gener- 
ally worse than serous tumors, and are often resistant to platinum chemother- 
apy, though they are rare. 
Clear-cell carcinoma 
Clear-cell ovarian carcinomas do not typically respond well to chemo- 
therapy and may be related to endometriosis. They represent approximately 
5% of all endometrial cancers. Japanese women develop clear-cell ovarian 
cancer more frequently than other groups of women. 
Clear-cell adenocarcinomas are histopathologically similar to other clear 
cell carcinomas, with clear cells and hobnail cells. They represent approximately 
5-10% of epithelial ovarian cancers and are associated with endometriosis in the 
pelvic cavity. They are typically early-stage and therefore curable by surgery, but 
advanced clear-cell adenocarcinomas (approximately 20%) have a poor prognosis 
and are often resistant to platinum chemotherapy. 
Small-cell carcinoma 
Small-cell ovarian carcinoma is rare and aggressive, with two main 
subtypes: hypercalcemic and pulmonary. It is typically fatal within 2 years of 
diagnosis. Hypercalcemic small cell ovarian carcinoma overwhelmingly af- 
fects those in their 20s, causes high blood calcium levels, and affects one 
ovary. Pulmonary small cell ovarian cancer usually affects both ovaries of 
older women and looks like oat-cell carcinoma of the lung. 
Malignant mixed müllerian tumor (carcinosarcoma) 
Mixed müllerian tumors make up less than 1% of ovarian cancer. They 
have epithelial and mesenchymal cells visible and tend to have a poor prognosis. 
Undifferentiated epithelial 
Undifferentiated cancers - those where the cell type cannot be deter- 
mined - make up about 10% of epithelial ovarian cancers and have a compar- 
atively poor prognosis. When examined under the microscope, these tumors 
have very abnormal cells that are arranged in clumps or sheets. Usually there 
are recognizable clumps of serous cells inside the tumor. 
Epithelial ovarian cancer most often spreads initially within the perito- 
neal cavity. Metastatic disease often is found on the peritoneal surfaces, par- 
ticularly on the undersurface of the diaphragms, the paracolic gutters, the 
bladder, and the cul-de-sac. Other common sites are as follows: surface of the 
liver; mesentery and serosa of the large and small bowel; omentum; uterus; 
para-aortic and pelvic lymph nodes. 
Outside the peritoneal cavity, epithelial ovarian cancer may spread to the 
pleural cavity, lungs, and groin lymph nodes. The presence of pleural effusion 
does not necessarily indicate disease in the chest, and malignancy can be diag- 
nosed only cytologically. Mucinous tumors tend to form large dominant masses, 




commonly bilateral. Endometrioid and clear-cell variants more commonly exhibit 
local invasion, retroperitoneal disease, and hepatic metastases. 
 
TUMORS OF LOW MALIGNANT POTENTIAL 
Tumors of low malignant potential (LMP), or borderline tumors, are a dis- 
tinct variety of epithelial ovarian cancer that behave in a much less aggressive 
fashion and have a very favorable prognosis. These tumors cause great anxiety to 
patients, and the concept of LMP sometimes is difficult to explain. They comprise 
approximately 20% of malignant ovarian tumors. The mean age of diagnosis is 
younger than for invasive epithelial ovarian cancer, at approximately 48 years, 
and no large peak of incidence is observed. 
LMP tumors can cause a range of symptoms similar to epithelial ovari- 
an cancer, including increasing abdominal girth, an abdominal mass, ab- 
dominal pain, abnormal uterine bleeding, urinary symptoms, and gastrointes- 
tinal symptoms. They may be asymptomatic and found on routine physical 
examination or ultrasound scan. 
MALIGNANT GERM CELL TUMORS 
Malignant germ cell tumors (GCTs), which include dysgerminoma, 
endodermal sinus tumor, malignant teratoma, embryonal carcinoma, and cho- 
riocarcinoma, are thought to derive from primitive germ cells in the embry- 
onic gonad. GCT of the ovary is much rarer than GCT of the testis in males, 
and much of the development of the management approach has been based 
on experience with male GCT. 
Common characteristics of these tumors include rapid growth, a predi- 
lection for lymphatic spread, frequent mixtures of tumor types, and a pre- 
dominantly unilateral pattern of ovarian involvement (except for dysger- 
minoma). GCT is much more common in young women but occasionally oc- 
curs in infants and older women. 
Many GCTs produce tumor markers that can be measured in the blood 
and then used to monitor response to treatment and for follow-up care. Endo- 
dermal sinus tumors secrete alpha-fetoprotein and choriocarcinoma, and dys- 
germinomas occasionally secrete beta human chorionic gonadotropin 
(bHCG). Dysgerminoma may secrete lactate dehydrogenase and placental al- 
kaline phosphatase. 
No factors have been established related to etiology, apart from an in- 
creased incidence associated with dysgenetic gonads. 
Although these tumors may be asymptomatic and present as a palpable 
mass, many patients present with abdominal pain. The mass may lead to 
acute pain due to torsion, rupture, or hemorrhage, or, patients may have ab- 
dominal distension, vaginal bleeding, or fever. 




Dysgerminoma. This is the most common malignant GCT and represents 
3-5% of all ovarian malignancies. Ninety percent occur in people younger than 
30 years, and 75% occur in the second and third decades, with a median age of 
22 years. 
Dysgerminomas are bilateral in 10-35% of cases. Five percent occur in 
phenotypic females with abnormal gonads. They may have a 46XY karyo- 
type with pure gonadal dysgenesis or androgen insensitivity syndrome, or, 
they may have a 45X, 46XY karyotype with mixed gonadal dysgenesis. Dys- 
germinomas may be large and usually are solid, with a smooth external sur- 
face and a fleshy pink-tan color inside. The majority are confined to the ova- 
ry at diagnosis, but approximately 25% of otherwise stage I dysgerminomas 
have lymph node metastasis. 
Cystic teratoma. Teratomas are germ cell tumors commonly composed 
of multiple cell types derived from one or more of the 3 germ layers. Incon- 
sistent nomenclature often confuses discussions of various subtypes of tera- 
tomas. The word is derived from the Greek teras, meaning monster, which 
Virchow coined in the first edition of his book on tumors published in 1863. 
Teratomas range from benign, well-differentiated (mature) cystic lesions to 
those that are solid and malignant (immature). Additionally, teratomas may 
be monodermal and highly specialized. Rarely, within some mature terato- 
mas certain elements (most commonly squamous components) undergo ma- 
lignant transformation. 
In 1831, Leblanc coined the term dermoid cyst in the veterinary litera- 
ture when he removed a lesion that resembled skin at the base of a horse's 
skull, which he called a ―kyste dermoid.‖ Both dermoid and teratoma, terms 
now more than a century old, remain in general use and often are used inter- 
changeably with various preferences among subspecialties. The earliest im- 
plications were that dermoids comprised elements similar to skin and its ap- 
pendages, whereas teratomas had no such limits. Dermoids now are recog- 
nized as often being trigeminal and containing practically any type of tissue. 
For those who continue to make a distinction, dermoids are tumors that 
maintain rather orderly arrangements, with  well-differentiated  ectodermal 
and mesodermal tissues surrounding endodermal components. Teratomas, 
specifically solid teratomas, are essentially devoid of organization; thus, the 
presence of some degree of organization, a high degree of cellular differentia- 
tion, and cystic structure differentiates dermoids from teratomas. 
Immature teratoma. 
This is the second most common GCT. It occurs mostly in females 
aged 10-20 years but may occur after menopause. The tumor spreads most 




OTHER GERM CELL TUMORS 
Endodermal sinus tumor occurs at a mean age of 18 years, and one 
third occur before puberty. Embryonal carcinoma and choriocarcinoma are 
extremely rare. 
SEX-CORD STROMAL TUMORS 
These include tumors arising from the sex cords; granulosa cells; Ser- 
toli cells; and the specialized stroma of the genital ridge, theca, and Leydig 
cells. They comprise fewer than 5% of all ovarian tumors. 
Although granulosa cell tumors are malignant and Sertoli-Leydig cell 
tumors less so, they behave in a much less malignant fashion than epithelial 
ovarian cancers. Benign tumors in the group include thecoma and fibroma. 
Granulosa cell tumors and pure Sertoli cell tumors commonly secrete estro- 
gen, while Leydig cell tumors and combined Sertoli-Leydig tumors often se- 
crete androgens. 
Granulosa cell tumor 
This is the most common malignant sex-cord stromal tumor. Ninety 
percent of granulosa cell tumors are stage I at the time of diagnosis. This tu- 
mor account for approximately 2% of all ovarian tumors and can be divided 
into adult (95%) and juvenile (5%) types based on histologic findings. Juve- 
nile granulosa cell tumor is a variant of granulosa cell tumor that is rarely 
malignant. It most often presents in young girls with isosexual precocious 
puberty. The tumor is usually unilateral and confined to the ovary and can be 
managed with surgery alone. 
Granulosa cell tumor can occur at any age, with a mean age of the early 
50s. Because of the secretion of estrogen, the presenting features depend on the 
patient's age. Prepubertal girls typically present with precocious sexual devel- 
opment, women of reproductive age have heavy or irregular periods, and post- 
menopausal women may have postmenopausal bleeding. At all ages, the tumor 
may present with acute abdominal pain due to rupture or hemorrhage. 
The tumors vary in size and may be solid or partially cystic. The cut 
surface may be gray-white or yellow, depending on lipid content. Necrosis 
and hemorrhage often are present, with cystic compartments filled with fluid 
or clotted blood. The microscopic features are granulosa cells in a wide varie- 
ty of patterns, and characteristic Call-Exner bodies may be present. 
Sertoli-Leydig cell tumor 
These tumors are rare. They are a form of low-grade malignancy that 
typically produces androgens and rarely estrogens. 
Metastatic tumors of the ovary arise from direct extension and spread 
within the bloodstream or lymphatic system or within the peritoneal cavity. 




such as breast, colon, and stomach. The classic Krukenberg tumor refers to 
bilateral enlargement of the ovaries from metastases from a signet-ring carci- 
noma of the stomach. 
Staging. Ovarian cancer is typically staged by means of the system 
formulated and updated by the International Federation of Obstetrics and Gy- 
necology (FIGO), as listed below. 
Ovarian cancer typically spreads to the peritoneal surfaces and omen- 
tum. Spread can occur by local extension, lymphatic invasion, intraperitoneal 
implantation, hematogenous dissemination, or transdiaphragmatic passage. 
Intraperitoneal dissemination is the most common and recognized character- 
istic of ovarian cancer. Malignant cells can implant anywhere in the peritone- 








PATHOLOGY OF PREGNANCY, FETUS AND INFANTS 
 
GESTATIONAL AND PLACENTAL DISORDERS 
 
GESTOSIS 
It is a pregnancy specific illness which manifests itself the definition 
of this disease has changed with increased blood pressure and/or egg-white 
excretions in the urine and/or water inclusions (edemas). 
Two forms of the gestosis are distinguished into dependence of the 
time of their occurrence: 
Early gestosis: in the first pregnancy third, 
Late gestation disorder: in the last pregnancy third. 
No gestoses appear in the second pregnancy third for common. One talks 
about the so-called tolerance stage. Most gestoses are late gestation disorders. 
The exact causes of the gestosis are unknown. Several pathological 
events apparently overlap. Being suspected: Lacking adaptation of the body 
to the pregnancy - particularly the womb, insufficient blood fluid increase, 
disturbances in the biochemical metabolism, acute nutrient deficiency. 
Risk groups. Gestoses appear in large numbers: women who are 
charged by high blood pressure illnesses familially, multiple pregnancies, 
very young or old first giving birth, existing vessel illnesses of the mother (by 
chronic kidney diseases, high blood pressure, diabetes, nicotine abuse), 
overweight pregnant women and women fed badly (protein deficiency). 
 
HYPEREMESIS GRAVIDARUM 
Hyperemesis gravidarum (HG) is a complication of pregnancy that is 
characterized by severe nausea and vomiting such that weight loss and dehy- 
dration occur. Signs and symptoms may include vomiting several times a day 
and feeling faint. It is more severe than morning sickness. Often symptoms 
get better after the 20th week of pregnancy but may last the entire pregnancy. 
The exact cause of hyperemesis gravidarum is not known. Risk factors 
include the first pregnancy, multiple pregnancy, obesity, prior or family his- 
tory of hyperemesis gravidarum, trophoblastic disorder, and a history of an 
eating disorder. The diagnosis is usually made based on the signs and symp- 
toms. It has been technically defined as more than three episodes of vomiting 
per day such that weight loss of 5% or three kilograms has occurred and ke- 
tones are present in the urine. Other potential causes of the symptoms should 
be excluded including urinary tract infection and high thyroid levels. 
Complications: 
Pregnant woman. If HG is inadequately treated, anemia, hypo- 




linolysis, coagulopathy, atrophy, Mallory-Weiss tears, hypoglycemia, jaun- 
dice, malnutrition, pneumomediastinum, rhabdomyolysis, deconditioning, 
deep vein thrombosis, pulmonary embolism, splenic avulsion, or vasospasms 
of cerebral arteries are possible consequences. 
Infant. The effects of HG on the fetus are mainly due to electrolyte im- 
balances caused by HG in the mother. Infants of women with severe hy- 
peremesis who gain less than 7 kg (15.4 lb) during pregnancy tend to be of 
lower birth weight, small for gestational age, and born before 37 weeks gesta- 
tion. In contrast, infants of women with hyperemesis who have a pregnancy 
weight gain of more than 7 kg appear similar to infants from uncomplicated 
pregnancies. 
HYPERTENSIVE STATES OF PREGNANCY 
GESTATIONAL HYPERTENSION 
Gestational hypertension is usually defined as having a blood pressure 
higher than 140/90 measured on two separate occasions, more than 6 hours 
apart, without the presence of protein in the urine and diagnosed after 20 
weeks of gestation. 
PRE-ECLAMPSIA 
Pre-eclampsia is gestational hypertension plus proteinuria (>300 mg of 
protein in a 24-hour urine sample). Severe preeclampsia involves a blood 
pressure greater than 160/110, with additional medical signs and symptoms. 
HELLP syndrome is a type of preeclampsia. It is a combination of three med- 
ical conditions: hemolytic anemia, elevated liver enzymes and low platelet 
count. 
ECLAMPSIA 
This is when tonic-clonic seizures appear in a pregnant woman with 
high blood pressure and proteinuria. 
Pathogenesis. The exact mechanisms leading to development of 
preeclampsia are still being investigated; however, it is clear that the placenta 
plays a central role in the pathogenesis of the syndrome, since the symptoms 
disappear rapidly after delivery of the placenta. The critical abnormalities in 
preeclampsia are diffuse endothelial dysfunction, vasoconstriction (leading to 
hypertension), and increased vascular permeability (resulting in proteinuria 
and edema). Recent work has demonstrated that these effects are most likely 
mediated by placenta derived factor(s) released into the maternal circulation. 
Although the release of these factors and the clinical syndrome develop late 
in gestation, the pathogenesis of the disease appears to be closely tied to the 
earliest events of pregnancy and placentation. The principal pathophysiologic 




Abnormal placental vasculature. The initial event in the pathogene- 
sis of preeclampsia is abnormal trophoblastic implantation and lack of devel- 
opment of physiologic alterations in the maternal vessels required for ade- 
quate perfusion of the placental bed. In normal pregnancy, fetal extravillous 
trophoblastic cells (trophoblastic cells not associated with chorionic villi) at 
the implantation site invade the maternal decidua and decidual vessels, de- 
stroy the vascular smooth muscle and replace the maternal endothelial cells 
with fetal trophoblastic cells (forming hybrid feto-maternal blood vessels). 
This process converts the decidual spiral arteries from small-caliber re- 
sistance vessels to large capacity uteroplacental vessels lacking a smooth 
muscle coat. In preeclampsia this remodeling fails to occur, leaving the pla- 
centa ill equipped to meet the increased circulatory demands of late gestation 
and setting the stage for the development of placental ischemia. 
Endothelial dysfunction and imbalance of angiogenic and anti- 
angiogenic factors. Although not formally proven, it is postulated that in re- 
sponse to hypoxia, the ischemic placenta releases factors into the maternal 
circulation that cause an imbalance in circulating angiogenic and anti- 
angiogenic factors; this in turn leads to systemic maternal endothelial dys- 
function and the clinical symptoms of the disease. In support of this, the 
blood levels of two placenta-derived anti-angiogenic factors, soluble Fms- 
like tyrosine kinase (sFltl) and endoglin, are several orders of magnitude 
higher in women with preeclampsia than in healthy controls. Placental hy- 
poxia causes overproduction of sFlt1 from the villous trophoblast; sFltl is a 
truncated soluble form of VEGF receptor that acts as a decoy receptor, bind- 
ing VEGF and placental growth factor in circulation and thereby neutralizing 
their pro-angiogenic activity. Similarly circulating endoglin, a soluble form 
of a TGF-β receptor, can bind TGF-β and inhibit signaling via cellular TGF-β 
receptors. Normally, in late gestation, levels of sFltl and soluble endoglin in 
the blood increase while placental growth factor and vascular endothelial 
growth factor decrease, leading to a reduction in angiogenic activity. In 
preeclampsia, high levels of sFlt1 and soluble endoglin bring about a de- 
crease in angiogenesis much earlier than in normal pregnancy. The result is 
defective vascular development in the placenta. 
Studies in animal models also implicate sFltl and soluble endoglin in 
the pathogenesis of endothelial dysfunction. When sFlt and endoglin are 
overexpressed together, rats develop nephrotic-range proteinuria, severe hy- 
pertension, and fetal growth restriction, the hallmarks of severe preeclampsia, 
as well as features of the HELLP syndrome, including elevated liver en- 
zymes, decreased platelet counts, and hemolysis. Thus, it seems that sFlt1 
and soluble endoglin are key mediators that link the placenta to the character- 




and endoglin appear to be related to their inhibition of VEGF and TGF-β- 
mediated production of endothelial-dependent nitric oxide (NO) and prosta- 
cyclin (PGI2). The capillary endothelium of the kidney is extremely sensitive 
to locally produced VEGF, which may explain why proteinuria and renal 
dysfunction are early markers of preeclampsia. 
Coagulation abnormalities. Preeclampsia is associated with a hyper- 
coaguable state; thrombosis of arterioles and capillaries may occur through- 
out the body, particularly in the liver, kidneys, brain, and pituitary. This hy- 
percoaguability is likely related to the reduced endothelial production of 
PGI2, a potent antithrombotic factor, and increased release of procoagulant 
factors. Production of PGI2 is stimulated by both VEGF and TGF-β, and 
women with preeclampsia have been shown to have decreased endothelial 
production of PGI2. 
Morphology. The placenta reveals various microscopic changes, most 
of which reflect malperfusion, ischemia, and vascular injury. These include: 
1) Placental infarcts small, peripheral ones that may occur in normal 
full-term placentasare larger and more numerous in preeclampsia. There is 
also an exaggeration of ischemic changes in the chorionic villi and tropho- 
blast. This includes increased syncytial knots and the appearance of acceler- 
ated villous maturity. 
2) There is increased frequency of retroplacental hematomas due to 
bleeding and instability of uteroplacental vessels. 
3) The most characteristic finding is in the decidual vessels, reflecting 
abnormal implantation. This can be in the form of thrombosis, lack of normal 
physiologic conversion (described earlier), fibrinoid necrosis, or intraintimal 
lipid deposition (acute atherosis). 
The liver lesions, when present, take the form of irregular, focal, subcap- 
sular, and intraparenchymal hemorrhages. On histologic examination there are 
fibrin thrombi in the portal capillaries and foci of hemorrhagic necrosis. 
The kidney lesions are variable. Glomerular lesions are diffuse, when 
assessed by electron microscopy. They consist of marked swelling of endo- 
thelial cells, the deposition of fibrinogen-derived amorphous dense deposits 
on the endothelial side of the basement membrane, and mesangial cell hyper- 
plasia. Immunofluorescent studies show an abundance of fibrin in glomeruli. 
In the better defined cases, fibrin thrombi are present in the glomeruli and ca- 
pillaries of the cortex. When the lesion is far advanced, it may produce com- 
plete destruction of the cortex in the pattern referred to as bilateral renal cor- 
tical necrosis. The brain may have gross or microscopic foci of hemorrhage 
along with small-vessel thromboses. Similar changes are often found in the 




Preeclampsia most commonly starts after 34 weeks of gestation but 
begins earlier in women with hydatidiform mole or preexisting kidney dis- 
ease, hypertension, or coagulopathies. The onset is typically insidious, char- 
acterized by hypertension and edema, with proteinuria following within sev- 
eral days. Headaches and visual disturbances are serious events and are in- 
dicative of severe preeclampsia, often requiring delivery. Eclampsia is her- 
alded by central nervous system involvement, including convulsions and 
eventual coma. Management of preeclampsia differs depending upon the ges- 
tational age and severity of disease. For term pregnancies, delivery is the 
treatment of choice regardless of disease severity. In preterm pregnancies, 
where delivery may not be in the best interest of the fetus, patients with mild 
disease can be managed expectantly with close monitoring of the mother and 
fetus. However, eclampsia, severe preeclampsia with maternal end-organ 
dysfunction, fetal compromise, or the HELLP syndrome are indications for 
delivery regardless of gestational age. Antihypertensive therapy does not af- 
fect the disease course or improve outcomes. Proteinuria and hypertension 
usually disappear within 1 to 2 weeks after delivery except when they predate 
the pregnancy. Although it is typically believed that preeclampsia has no last- 
ing sequelae, recent studies indicate that about 20% of women develop hy- 
pertension and microalbuminuria within 7 years of a pregnancy complicated 
by preeclampsia. There is also a two-fold increase in the long-term risk of 
vascular diseases of the heart and the brain. 
HELLP syndrome is a life-threatening obstetric complication usually 
considered to be a variant or complication of pre-eclampsia. Both conditions 
usually occur during the later stages of pregnancy, or sometimes after child- 
birth. "HELLP" is an abbreviation of the three main features of the syndrome: 
Hemolysis; Elevated Liver enzymes; Low Platelet count. 
HELLP usually begins during the third trimester; rare cases have been re- 
ported as early as 21 weeks gestation. Often, a woman who develops HELLP 
syndrome has already been followed up for pregnancy-induced hypertension 
(gestational hypertension), or is suspected to develop pre-eclampsia (high blood 
pressure and proteinuria). Up to 8% of all cases occur after delivery. 
Arterial hypertension is a diagnostic requirement, but may be mild. Rup- 
ture of the liver capsule and a resultant hematoma may occur. If a woman has a 
seizure or coma, the condition has progressed into full-blown eclampsia. 
Disseminated intravascular coagulation is also seen in about 20% of all 
women with HELLP syndrome, and in 84% when HELLP is complicated by 
acute renal failure. Pulmonary edema is found in 6% of all women with HELLP 
syndrome, and in 44% when HELLP is complicated by acute renal failure. 
Histologic Findings. Hepatic endothelial disruption and subsequent 




hepatocyte death, which can be segmental or apparent diffusely throughout 
the liver. Since HELLP tends to involve smaller terminal arterioles, charac- 
teristic histiologic features are periportal or focal parenchymal necrosis with 
hyaline deposits of fibrinlike material in the sinusoids. If larger-vessel vascu- 
lopathy occurs, hepatic infarction or subcapsular hematomas may result. 
 
SPONTANEOUS ABORTION 
Spontaneous abortion, or ―miscarriage,‖ is defined as pregnancy loss 
before 20 weeks of gestation. Most of these occur before 12 weeks. Ten to 
fifteen percent of clinically recognized pregnancies terminate in spontaneous 
abortion. However, using sensitive chorionic gonadotropin assays, it has been 
identified that an additional 22% of early pregnancies in otherwise healthy 
women terminate spontaneously. 
In the first trimester, embryonic causes of spontaneous abortion are the 
predominant etiology and account for 80-90% of miscarriages. 
Genetic abnormalities within the embryo (i.e., chromosomal abnormal- 
ities) are the most common cause of spontaneous abortion and account for 
50-65% of all miscarriages. Teratogenic and mutagenic factors may also play 
a role in spontaneous abortion, but quantification is difficult. Iatrogenic caus- 
es include Asherman syndrome. 
Maternal causes of spontaneous miscarriage include the following: ge- 
netic - maternal age is directly related to the aneuploidy risk (>30% in people 
aged 40 years). Couples with recurrent miscarriages have a 2-3% incidence 
of a parental chromosomal anomaly (i.e., balanced translocation). Structural 
abnormalities of the reproductive tract include the following: congenital uter- 
ine defects (particularly uterine septum), fibroids, cervical incompetence 
Acute maternal factors include the following: Corpus luteum deficien- 
cy; active infection (e.g., rubella virus, cytomegalovirus, Listeria infection, 
toxoplasmosis, malaria, brucellosis, human immunodeficiency virus (HIV), 
dengue fever, influenza, as well as vaginal infection with bacterial vaginosis) 
Chronic maternal health factors include the following: polycystic ovary 
syndrome; poorly controlled diabetes mellitus; renal disease; systemic lupus 
erythematosus (SLE); untreated thyroid disease; severe hypertension; an- 
tiphospholipid syndrome; exogenous factors include the following: tobacco, 
alcohol, cocaine, caffeine (high doses). 
Independent risk factors for a spontaneous miscarriage include the fol- 
lowing: advanced age, extremes of age, feeling stressed, advanced paternal age. 
 
STILLBIRTH 
Stillbirth is often defined as fetal death after 20 weeks of gestation, but 




al age and 350g, 400g, 500g, or 1000g birth weight may be considered still- 
born depending on local law. Once the fetus has died, the mother may or may 
not have contractions and undergo childbirth or in some cases, a Caesarean 
section. Most stillbirths occur in full-term pregnancies. 
The causes of a large percentage of human stillbirths remain unknown, 
even in cases where extensive testing and autopsy have been performed. Many 
stillbirths occur at full term to apparently healthy mothers, and a postmortem 
evaluation reveals a cause of death in only about 40% of autopsied cases. 
In cases where the cause is known, some possibilities of the cause of 
death are: bacterial infection, birth defects, especially pulmonary hypoplasia, 
chromosomal aberrations, growth retardation, Induced Fetal Demise, intrahepat- 
ic cholestasis of pregnancy, maternal diabetes, high blood pressure, including 
preeclampsia, maternal consumption of recreational drugs (such as alcohol, nic- 
otine, etc.) or pharmaceutical drugs contraindicated in pregnancy, postdate 
pregnancy, placental abruptions, physical trauma, radiation poisoning, Rh dis- 
ease, celiac disease, female genital mutilation, umbilical cord accidents. 
 
ECTOPIC PREGNANCY 
Ectopic pregnancy is the term applied to implantation of the fetus in 
any site other than a normal intrauterine location. The most common site is 
within the fallopian tubes (∼90%). Other sites include the ovary, the ab- 
dominal cavity, and the intrauterine portion of the fallopian tube (cornual 
pregnancy). Ectopic pregnancies occur about once in every 150 pregnancies. 
There are a number of risk factors for ectopic pregnancies. However, in 
as many as one third to one half no risk factors can be identified. Risk factors 
include: pelvic inflammatory disease, infertility, use of an intrauterine device, 
tubal surgery, intrauterine surgery, smoking, previous ectopic pregnancy, en- 
dometriosis, and tubal ligation. A previous induced abortion does not appear 
to increase the risk. 
Tubal pregnancy is when the egg is implanted in the Fallopian tubes. 
Hair-like cilia located on the internal surface of the Fallopian tubes carry the 
fertilized egg to the uterus. Fallopian cilia are sometimes seen in reduced 
numbers subsequent to an ectopic pregnancy, leading to a hypothesis that cil- 
ia damage in the Fallopian tubes is likely to lead to an ectopic pregnancy. 
Women who smoke have a higher chance of an ectopic pregnancy in the fal- 
lopian tubes. Smoking leads to risk factors of damaging and or killing cilia. 
As cilia degenerate the amount of time it takes for the fertilized egg to reach 
the uterus will increase. The fertilized egg, if it doesn't reach the uterus in 
time, will hatch from the non-adhesive zona pellucida and implant itself in- 




Women with pelvic inflammatory disease (PID) have a high occur- 
rence of ectopic pregnancy. This results from the build-up of scar tissue in 
the Fallopian tubes, causing damage to cilia. If however both tubes were 
completely blocked, so that sperm and egg were physically unable to meet, 
then fertilization of the egg would naturally be impossible, and neither nor- 
mal pregnancy nor ectopic pregnancy could occur. Intrauterine adhesions 
(IUA) present in Asherman's syndrome can cause ectopic cervical pregnancy 
or, if adhesions partially block access to the tubes via the ostia, ectopic tubal 
pregnancy. Asherman's syndrome usually occurs from intrauterine surgery. 
Endometrial/pelvic/genital tuberculosis, another cause of Asherman's syn- 
drome, can also lead to ectopic pregnancy as infection may lead to tubal ad- 
hesions in addition to intrauterine adhesions. 
Tubal ligation can predispose to ectopic pregnancy. Reversal of tubal 
sterilization (Tubal reversal) carries a risk for ectopic pregnancy. This is 
higher if more destructive methods of tubal ligation (tubal cautery, partial 
removal of the tubes) have been used than less destructive methods (tubal 
clipping). A history of a tubal pregnancy increases the risk of future occur- 
rences to about 10%. This risk is not reduced by removing the affected tube, 
even if the other tube appears normal. The best method for diagnosing this is 
to do an early ultrasound. 
Morphology. Tubal pregnancy is the most common cause of hema- 
tosalpinx (blood-filled fallopian tube) and should always be suspected when a 
tubal hematoma is present. Initially the embryonal sac, surrounded by placen- 
tal tissue composed of immature chorionic villi, implants in the lumen of the 
fallopian tube. With time trophoblastic cells and chorionic villi start to invade 
the fallopian tube wall as they do in the uterus during normal pregnancy. 
However, proper decidualization is lacking in the fallopian tube, and growth 
of the gestational sac distends the fallopian tube causing thinning and rupture. 
Fallopian tube rupture frequently results in massive intraperitoneal hemor- 
rhage. Less commonly the tubal pregnancy may undergo spontaneous regres- 
sion and resorption of the entire conceptus. Still less commonly, the tubal 
pregnancy is extruded through the fimbriated end into the abdominal cavity 
(tubal abortion). 
The clinical course of ectopic pregnancy is punctuated by the onset of 
severe abdominal pain, most commonly about 6 weeks after a previous nor- 
mal menstrual period, when rupture of the tube leads to pelvic hemorrhage. 
Rupture of a tubal pregnancy constitutes a medical emergency. In such cases 
the patient may rapidly develop hemorrhagic shock with signs of an acute 
abdomen, and early diagnosis is critical. Chorionic gonadotropin assays, ul- 
trasound studies, and laparoscopy may be helpful. Endometrial biopsy spec- 




ly rare dual pregnancy do not exhibit chorionic villi or evidence of an im- 
plantation site. 
The most common complication is rupture with internal bleeding 
which may lead to hypovolemic shock. Death from rupture is still the leading 
cause of death in the first trimester of the pregnancy. 
 
GESTATIONAL TROPHOBLASTIC DISEASE 
Gestational trophoblastic disease constitutes a spectrum of tumors and 
tumor-like conditions characterized by proliferation of placental tissue, either 
villous or trophoblastic. The lesions include hydatidiform mole (complete 
and partial), invasive mole, and malignant choriocarcinoma. 
Hydatidiform mole is characterized histologically by cystic swelling of 
the chorionic villi, accompanied by variable trophoblastic proliferation. The 
most important reason for the correct recognition of moles is that they are as- 
sociated with an increased risk of persistent trophoblastic disease (invasive 
mole) or choriocarcinoma. In the past, most patients presented in the fourth 
or fifth month of pregnancy with vaginal bleeding. Currently, hydatidiform 
moles are being diagnosed at earlier gestational ages (8.5 versus 17.0 weeks) 
due to routine ultrasound and close monitoring of early pregnancy. Molar 
pregnancy can develop at any age, but the risk is higher at the far ends of re- 
productive life: in teens and between the ages of 40 and 50 years. For poorly 
explained reasons, the incidence varies considerably in different regions of 
the world. Two types of benign, noninvasive moles complete and partial can 
be identified by cytogenetic and histologic studies. 
Complete mole results from fertilization of an egg that has lost its 
chromosomes, and the genetic material is completely paternally derived. 
Ninety percent have a 46,XX diploid pattern, all derived from duplication of 
the genetic material of one sperm (a phenomenon called androgenesis). The 
remaining 10% are from the fertilization of an empty egg by two sperm 
(46,XX and 46,XY). Histologically, in complete mole all or most of the villi 
are enlarged and edematous, and there is diffuse trophoblast hyperplasia. Alt- 
hough fetal vessels and fetal parts are extremely rare in complete moles since 
the embryo dies very early in development, they do occur. Patients have 
2.5% risk of subsequent choriocarcinoma. 
Partial moles result from fertilization of an egg with two sperm. In the- 
se moles the karyotype is triploid (e.g., 69,XXY) or even occasionally tetra- 
ploid (92,XXXY). Fetal parts are more commonly present than in complete 
moles. In partial moles some of the villi are edematous, and other villi show 
only minor changes; the trophoblastic proliferation is focal and less marked. 
Although partial moles have an increased risk of persistent molar disease, 




Morphology. The classic gross appearance is of a delicate, friable mass 
of thin-walled, translucent, cystic, grapelike structures consisting of swollen 
edematous (hydropic) villi. Fetal parts are frequently seen in partial moles. 
On histologic examination complete moles show abnormalities that involve 
all or most of the villous tissue. The chorionic villi are enlarged, scalloped in 
shape with central cavitation (cisterns), and lack adequately developed ves- 
sels. The most impressive abnormality is, however, an extensive trophoblast 
proliferation that involves the entire circumference of the villi, in addition to 
―extravillous‖ islands of trophoblast proliferation. The implantation site often 
displays atypia and an exuberant proliferation of implantation trophoblast. In 
contrast, partial moles demonstrate villous enlargement and architectural dis- 
turbances in only a proportion of villi. The trophoblastic proliferation is mod- 
erate but still may be circumferential. 
Histologic distinction of complete mole from partial molar gestations is 
important. In equivocal cases immunostaining for p57, a cell cycle inhibitor, 
may aid the diagnosis. The p57KIP2 gene is maternally transcribed but pater- 
nally imprinted, and shows expression in maternal decidual tissue as well as 
cytotrophoblast and stromal cells of the villi, when maternal genetic material 
is present in the conceptus. In contrast, since both the X chromosomes in 
complete moles are derived from the father, there is no expression of p57 
protein in the cytotrophoblast or stromal cells of the villi in complete moles. 
Most women with partial and early complete moles present with spon- 
taneous pregnancy loss or undergo curettage because of abnormalities in ul- 
trasound showing diffuse villous enlargement. In complete moles quantitative 
analysis of human chorionic gonadotropin (HCG) shows levels of hormone 
greatly exceeding those produced during a normal pregnancy of similar ges- 
tational age. Serial hormone determination indicates a rapidly mounting level 
that climbs faster than for the usual normal single or even multiple pregnan- 
cy. The vast majority of moles are removed by thorough curettage. Monitor- 
ing serum concentrations of HCG is necessary to determine the early devel- 
opment of persistent trophoblastic disease, since up to 10% of moles develop 
into persistent or invasive moles. In addition, 2.5% of complete moles evolve 
into gestational choriocarcinoma. Therefore, serum HCG levels are usually 
followed until they fall to and remain at zero for 6 months to a year. 
Invasive mole. This is defined as a mole that penetrates or even perfo- 
rates the uterine wall. There is invasion of the myometrium by hydropic cho- 
rionic villi, accompanied by proliferation of both cytotrophoblast and syn- 
cytiotrophoblast. The tumor is locally destructive and may invade parametrial 
tissue and blood vessels. Hydropic villi may embolize to distant sites, such as 
lungs and brain, but do not grow in these organs as true metastases, and even 




cally by vaginal bleeding and irregular uterine enlargement. It is always asso- 
ciated with a persistently elevated serum HCG and varying degrees of lutein- 
ization of the ovaries. The tumor responds well to chemotherapy but may re- 
sult in uterine rupture and necessitate hysterectomy. 
Choriocarcinoma. Gestational choriocarcinoma is a malignant neo- 
plasm of trophoblastic cells derived from a previously normal or abnormal 
pregnancy, which can even include extrauterine ectopic pregnancy. Chori- 
ocarcinoma is rapidly invasive and metastasizes widely. 
Morphology. Choriocarcinoma is classically a soft, fleshy, yellow- 
white tumor with a marked tendency to form large pale areas of ischemic ne- 
crosis, foci of cystic softening, and extensive hemorrhage. Histologically, it 
does not produce chorionic villi and consists entirely of a mixed proliferation 
of syncytiotrophoblasts and cytotrophoblasts. Mitoses are abundant and 
sometimes abnormal. The tumor invades the underlying myometrium, fre- 
quently penetrates blood vessels and lymphatics, and in some cases extends 
out onto the uterine serosa and into adjacent structures. Due to rapid growth it 
is subject to hemorrhage, ischemic necrosis, and secondary inflammation. In 
fatal cases metastases are found in the lungs, brain, bone marrow, liver, and 
other organs. On occasion, metastatic choriocarcinoma is discovered without 
a detectable primary in the uterus (or ovary), presumably because the primary 
has undergone complete necrosis. 
Uterine choriocarcinoma usually does not produce a large, bulky mass, 
but it manifests as irregular vaginal spotting of a bloody, brown fluid. This 
discharge may appear in the course of an apparently normal pregnancy, after 
a miscarriage, or after curettage. Sometimes the tumor does not appear until 
months after these events. Usually, by the time the tumor is discovered, radi- 
ographs of the chest and bones already disclose the presence of metastatic le- 
sions. The titers of HCG are elevated to levels above those encountered in 
hydatidiform moles. Occasionally, tumors produce little hormone, and some 
tumors become so necrotic as to become functionally inactive. Widespread 
metastases are characteristic. Frequent sites of involvement are the lungs 
(50%) and vagina (30% to 40%), followed in descending order of frequency 
by the brain, liver, and kidney. 
 
PUERPERAL INFECTIONS 
Puerperal infections, also known as postpartum infections, puerperal 
fever or childbed fever, is any bacterial infection of the female reproductive 
tract following childbirth or miscarriage. In addition to trauma sustained dur- 
ing the birth process or cesarean procedure, physiologic changes during 
pregnancy contribute to the development of postpartum infections. The typi- 




makes it difficult to discern postpartum infection from  postpartum  pain. 
Signs and symptoms usually include a fever greater than 38.0°C (100.4°F), 
chills, lower abdominal pain, and possibly bad-smelling vaginal discharge. It 
usually occurs after the first 24 hours and within the first ten days following 
delivery. 
After childbirth a woman's genital tract has a large bare surface, which 
is prone to infection. Infection may be limited to the cavity and wall of her 
uterus, or it may spread beyond to cause septicaemia (blood poisoning) or 
other illnesses, especially when her resistance has been lowered by a long la- 
bour or severe bleeding. Puerperal infection is most common on the raw sur- 
face of the interior of the uterus after separation of the placenta (afterbirth); 
but pathogenic organisms may also affect lacerations of any part of the geni- 
tal tract. By whatever portal, they can invade the bloodstream and lymph sys- 
tem to cause septicemia, cellulitis (inflammation of connective tissue), and 
pelvic or generalized peritonitis (inflammation of the abdominal lining). The 
severity of the illness depends on the virulence of the infecting organism, the 
resistance of the invaded tissues, and the general health of the woman. Or- 
ganisms commonly producing this infection are Streptococcus pyogenes; 
staphylococci (inhabitants of the skin and of pimples, carbuncles, and many 
other pustular eruptions); the anaerobic streptococci, which flourish in devi- 
talized tissues such as may be present after long and injurious labour and un- 
skilled instrumental delivery; Escherichia coli and Clostridium welchii (in- 
habitants of the lower bowel); and Clostridium tetani. 
Local spread of colonized bacteria is the most common etiology for 
postpartum infection following vaginal delivery. Endometritis is the most 
common infection in the postpartum period. Other postpartum infections in- 
clude (1) postsurgical wound infections, (2) perineal cellulitis, (3) mastitis, 
(4) respiratory complications from anesthesia, (5) retained products of con- 
ception, (6) urinary tract infections (UTIs), and (7) septic pelvic phlebitis. 
Wound infection is more common with cesarean delivery. 





Prenantal (antenatal) pathology includes pathologic processes of the 
human embryo, beginning with fertilization and ending with delivery. Prena- 
tal period lasts 280 days, or 40 weeks. The whole development from fertiliza- 
tion to delivery is called kinetogenesis which is preceded by progenesis – pe- 
riod of male and female sex cells (gametes) ripening before the fertilization. 
Kinetogenesis period is divided into three periods – blastogenesis, lasts from 




takes place and it ends up with embryo- and trophoblast elimination; embry- 
ogenesis – from the 16th to the 75th day of pregnancy when the main organ- 
ogenesis takes place amnion and chorion are formed; fetogenesis – lasts from 
the 76th to the 280th day of pregnancy when differentiation and ripening of 
the fetal tissue take place, placenta is formed, ends up with delivery. Feto- 
genesis period can be divided into early fetal (from the 76th to the 180th 
day), at the end of this period fetus becomes viable, and late fetal (from the 
181st to the 280th day), when the fetus becomes mature. Pathology which 
occurs during the kinetogenesis period is called kinetopathy and it is corre- 
spondingly divided into blastosis, embryopathy, early and late fetopathy. 
The reasons for kinetopathy according to the latest data: 20% deformi- 
ties (main kinetogenesis period pathology) are connected with gene mutations, 
10% – with chromosome aberration, 10% – with the exogenous factors influ- 
ence, 60% – of ambiguous etiology. German measles, rubeola, chickenpox, 
mononucleosis, parotitis, hepatitis, influenza, poliomyelitis, pale treponema, 
toxoplasmosis, tuberculosis microbacterium belong to the exogenous factors. 
Apart from infection agents kinetopathies can be caused by radiation 
energy, some pharmaceutical preparations (tolidomide, cytostatic drugs), 
hormones, vitamins, alcohol, drugs, hypoxia. 
Gametopathies. During protogenesis pathology of gametes may occur – 
gametopathies. They are manifested through nuclear substance and sex cells cy- 
toplasm pathology. Nucleus changes are characterized by hereditary apparatus 
of gamete pathology. Gene, chromosome and genomic mutations are distin- 
guished that are the cause of congenital maldevelopment (deformity). Deformi- 
ties are not viable and end up with spontaneous abortion. Gamete cytoplasm pa- 
thology as a rule results in sterility (infertility). 
Blastopathies. They are the most frequently caused by chromosome 
aberrations accompanied with environmental influence (mother‘s endocrine 
diseases, hypoxia, intoxications, etc.). To blastopathy belong: blastocyte im- 
plantation disturbance (extrauterine pregnancy), twin deformities, solitary de- 
formities, placenta and umbilical cord formation deformities. Twin deformi- 
ties are connected with appearance of two or more independent growing cen- 
tres during division. If centres of growth are in close location and have com- 
mon intermediate zone, than two conjoined twins develop. If the conjoined 
twins are identical, symmetrically developed, they are called  diplopagus 
(from Gr. diplos – double, pagus – to connect), if the twins are asymmetrical- 
ly developed, it is heteropagus. The twin lesser in size is called teratic para- 
site. Sometimes such twin is found in the body of the bigger one – ―fetus in 
fetu‖. In 1995 in the medical press was announced that a 43-year-old man 
had suddenly died in Nizhni Novgorod, in his thorax a dead fetus was found, 




ligneous density, yellow-red colour. Lungs and heart of the dead man were 
deformed, underdeveloped. The medical workers were surprised how this 
man had lived to the age of 43 with such deformation of thorax organs. A few 
years before it was reported that in China a fetus, extracted from the thorax of 
a 46-year-old man during the tumor ablation, began to grow. The doctors 
treated it as growth of the thorax tumor. 
The degree of twins conjugation can be different – from minor con- 
joined superficial tissues to such degree when only heads and limbs are sepa- 
rated. To determine the localization of twins conjugation a word pagus was 
added to the anatomic name of the site of conjugation – craniopagus, thora- 
copagus, ischiopagus, etc. 
Embryopathy is an embryonic period pathology from the 16th to the 
75th day of pregnancy, during which the main organogenesis is completed. 
To the embryopathies belong mostly congenital maldevelopment – deformi- 
ties. With the embryo‘s development the ability to react to different patho- 
genic influences with disturbance of morphogenesis is gradually developed. 
This ability is called dysontogenesis. It was found out that different terato- 
genic agents can cause the same deformity. Along with it the same teratogen- 
ic agent can cause different deformities of development influencing during 
different periods of embryogenesis. There is a certain period of time for each 
organ during which under the influence of a teratogenic agent hypoplasia of 
this organ occurs. This period of time is called teratogenic termination period 
(from Lat. teratos – deformity and terminus – boundary). So, it is a certain 
period of time during which anlage and formation of different organs is per- 
formed and the influence of teratogenic factors in this period causes the dis- 
turbance of this process which results in deformities. Morphogenesis of dif- 
ferent organs is carried out during different periods of embryogenesis and 
during this time the organs are the most susceptible to the teratogenic agent 
effect. Teratogenic agents are the viruses – bacteria, toxins, alcohol, medi- 
cine, hormones, vitamins, penetrating radiation, etc. 
Congenital maldevelopment is persistent morphologic changes of the 
organs which appeared as a result of the region‘s or organism‘s morphogene- 
sis disturbance and they are beyond the measures of normal variations. To the 
congenital maldevelopment belong: 
1) absence of any organ or region – agenesia, aplasia; 
2) underdevelopment of an organ – hypoplasia; 
3) excessive development – hyperplasia; 
4) change in forms: conjugated organs, arthrodesia or stenosis of aper- 
tures or canals, nonclosure of embryonic fissures – persistence, eversion – 
ectropion; 




6) persistence of embryonic (provisional) organs, more frequently of 
branchial arches or their remnants. 
Apart from the pathology of organs their can be congenital maldevel- 
opment with disturbance in differentiation of some tissues of: 
- skeletal muscles – congenital Oppenheim‘s myopathy; 
- connective tissue – Marphan‘s disease; 
- skin – ichthyosis congenita; 
- bones of cartilage genesis – congenital chondrodysplasia. 
Congenital maldevelopment can be simple – when one organ is in- 
volved, complicated – a few organs of one system and numerous – organs of 
few systems. 
Congenital heart defect (CHD), also known as a congenital heart 
anomaly or congenital heart disease, is a problem in the structure of the heart 
that is present at birth. Signs and symptoms depend on the specific type of 
problem. Symptoms can vary from none to life-threatening. When present 
they may include rapid breathing, bluish skin, poor weight gain, and feeling 
tired. It does not cause chest pain. Most congenital heart problems do not oc- 
cur with other diseases. Complications that can result from heart defects in- 
clude heart failure. 
The cause of a congenital heart defect is often unknown. Certain cases 
may be due to infections during pregnancy such as rubella, use of certain 
medications or drugs such as alcohol or tobacco, parents being closely relat- 
ed, or poor nutritional status or obesity in the mother. Having a parent with a 
congenital heart defect is also a risk factor. A number of genetic conditions 
are associated with heart defects including Down syndrome, Turner syn- 
drome, and Marfan syndrome. Congenital heart defects are divided into two 
main groups: cyanotic heart defects and non-cyanotic heart defects, depend- 
ing on whether the child has the potential to turn bluish in color. The prob- 
lems may involve the interior walls of the heart, the heart valves, or the large 
blood vessels that lead to and from the heart. 
A number of classification systems exist for congenital heart defects. 
In 2000 the International Congenital Heart Surgery Nomenclature was devel- 
oped to provide a generic classification system. 
Hypoplasia can affect the heart, typically resulting in the underdevel- 
opment of the right ventricle or the left ventricle. This causes only one side of 
the heart to be capable of pumping blood to the body and lungs effectively. 
Hypoplasia of the heart is rare but is the most serious form of CHD. It is 
called hypoplastic left heart syndrome when it affects the left side of the heart 
and hypoplastic right heart syndrome when it affects the right side of the 
heart. In both conditions, the presence of a patent ductus arteriosus (and, 




vital to the infant's ability to survive until emergency heart surgery can be 
performed, since without these pathways blood cannot circulate to the body 
(or lungs, depending on which side of the heart is defective). Hypoplasia of 
the heart is generally a cyanotic heart defect. 
Obstruction defects occur when heart valves, arteries, or veins are ab- 
normally narrow or blocked. Common defects include pulmonic stenosis, 
aortic stenosis, and coarctation of the aorta, with other types such as bicuspid 
aortic valve stenosis and subaortic stenosis being comparatively rare. Any 
narrowing or blockage can cause heart enlargement or hypertension. 
Septal defects. The septum is a wall of tissue which separates the left 
heart from the right heart. Defects in the interatrial septum or the interven- 
tricular septum allow blood to flow from the right side of the heart to the left, 
reducing the heart's efficiency. Ventricular septal defects are collectively the 
most common type of CHD, although approximately 30% of adults have a 
type of atrial septal defect called probe patent foramen ovale. 
Cyanotic defects. Cyanotic heart defects are called such because they 
result in cyanosis, a bluish-grey discoloration of the skin due to a lack of ox- 
ygen in the body. Such defects include persistent truncus arteriosus, total 
anomalous pulmonary venous connection, tetralogy of Fallot, transposition of 
the great vessels, and tricuspid atresia. 
Neural tube defects (NTDs) are a group of conditions in which an 
opening in the spinal cord or brain remains from early in human develop- 
ment. In the 3rd week of pregnancy called gastrulation, specialized cells on 
the dorsal side of the embryo begin to change shape and form the neural tube. 
When the neural tube does not close completely, an NTD develops. 
Specific types include: spina bifida which affects the spine, anenceph- 
aly which results in little to no brain, encephalocele which affects the skull, 
and iniencephaly which results in severe neck problems. 
Facial abnormalities number as the most frequent congenital anoma- 
lies (1:1000 newborns) and are often encountered in combined forms, occur- 
ring with other anomalies. Probably environmental factors as well as genetic 
factors play a role. 
Cheiloschisis is a disorder during the fusioning of the maxillary pro- 
cess with the prolabium (both globular processes of the medial nasolateral 
process). This disorder can occur unilaterally or bilaterally. 
In cheilognathoschisis, besides the soft tissue fusion disorder of the 
upper lip the fusing of the lateral edges of the primary palate with the two an- 
terior edges of the secondary palate is also disturbed. This disorder can also 




Cheilognathopalatoschisis (cleft lip, jaw and palate). In addition to 
the two previously mentioned disorders there is also a fusion disorder of the 
left and right portions of the secondary palatine lamina. 
Since it is not possible for such an infant to suck and thereby take in 
nourishment a surgical separation between the nasal and oral cavities must be 
undertaken as quickly as possible. 
Facial cleft. The disorders that affect the whole face are much more 
seldom. In an oblique facial cleft a fissure runs from the lower lid edge to the 
lower edge of the nasal opening. This results from a deficient fusion of the 
epithelium of the lacrimonasal duct. It can occur unilaterally or bilaterally or 
even combined with a cleft lip-jaw-palate. 
The middle cleft face can be understood mainly as a disorder of the 
bringing to the front of the nose and eyes. Thereby no flattening of the medial 
facial furrows occurs, e.g., between the two globular processes. It is supposed 
that this comes from an inhibition of tissue proliferation in this region. 
The transversal cleft face can only arise via a disorder of cheek for- 
mation and a survival of the early, primitive oral fissure (macrostomia) that 
extends into the anlage region of the ears (between the 1st and 2nd pharynge- 
al arches). 
Fetopathies are pathologies of the fetal period, from the 76th to the 
280th day of pregnancy, during which the basic tissue differentiation of the 
organs is carried out. Two types of manifestations are typical: blood- 
circulation disorders, dystrophy and necroses, mutated immune reactions and 
compensatory and time-serving processes. Disturbances of tissue morpho- 
genesis are typical of early fetopathies, reactive reactions – of the late ones. 
Fetus infection takes place in ascending way through genital organs and pla- 
centa and in a descending haematogenic way, mainly with either salpingitis 
or ovaritis. Morphologically infectional fetopathies manifest through general- 
ization of the inflammatory process with numerous foci of reactive necroses, 
granuloma formation, hemorrhagic syndrome resulted from vasculitis, hemo- 
lytic jaundice, retention of foci of extramedullar hematosis, accidental invo- 
lution (athrophy) of the retrosternal gland (thymus), general hypothrophy, 
prematurity. As a rule, such infants die during their first months of life. If 
they survive, persistent changes in the organs remain that cause disability. 
Noninfectious fetopathies can be early or late. To the early ones be- 
long: hypertrophic pylorostenosis, megacolon, megaurethra, agenesis, hypo- 
plasia or hyperplasia of bile ductules, polycystic lung disease, polycystic re- 
nal disease, etc., to the late ones – hemolytic disease of the infants, fetal mu- 




PATHOLOGIES OF THE INFANTS 
 
Perinatal period (period ―around delivery‖) lasts from the 154th day of 
the intrauterine life of fetus (22 weeks of pregnancy) to the first week of the 
extrauterine independent life. Infant is a neonate which has begun to breathe 
by itself. Stillborn is a fetus which doesn‘t breathe at the moment of birth and 
it could not be stimulated artificially although the heart beating can be ob- 
served during some time. Stillbirth and death of infants during the first seven 
days after delivery are called perinatal mortality. Perinatal period and corre- 
sponding pathology and mortality can be divided into antenatal (prenatal), 
intranatal (during the delivery), postnatal (postpartum) or neonatal. 
Features of prematurity: gestation duration is less than 38 weeks, the 
weight of fetus is less than 2500 g, height – less than 45 cm, long, lanugo hair 
on the face, shoulders, back, soft auricles, underdeveloped nails, the boys‘ 
testicles are not dropped into the gates and the girls‘ pudendal fissure gapes 
because of the maldevelopment of vulvar lips, cranial bones are soft, foci of 
bones in the long cortical bones are absent. 
Features of postmaturity: gestation duration is over 41 weeks, dryness, 
desquamation and partial maceration of skin, general hypothrophy, anemia, 
water, umbilical cord and membranes are imbued with meconium into bottle 
green because of hypoxia. 
To the pathology of infants belong asphyxia, pneumopathies, birth 
trauma, hemorrhagic and hemolytic disease of infants. 
BIRTH TRAUMA is a mechanic injury of tissues and organs of the fetus 
during delivery. The causes which determine it are divided into three groups. 
The first group is those laid in the condition of fetus itself: fragility of tissues 
at prematurity or postmaturity, congenital maldevelopments which are ac- 
companied by venous hyperemia, hemorrhagic syndrome, fetopathies, hypox- 
ia. The second group is determined by pathologies in the mother‘s maternal 
passages: rigidity of the maternal passages tissues, inclination of pelvis, con- 
tracted pelvis, tumors, olygoamnios, early pouring-out of the waters. The third 
group is those laid in the course of delivery – accelerated and prolonged labor. 
Morphology of the birth traumas. 
Cephalic tumor appears in the part of head that adjoins the pelvic out- 
let. It is determined by disorders of blood-circulation and lymphokinesis. The 
tissues of the latter become dropsy, swollen, can suppurate. 
Cephalohematoma is a hemorrhage under the cranial bones, it is al- 
ways restricted to the one bone site. External hematoma is the most frequent- 
ly found. It resolves slowly, undergoes organization and petrification. If there 
is a purulence, meningitis can develop. 
Hemorrhage into the meninges and brain. Epidural, subarachnoid and 




cephalohematoma) are always massive. They can take place when there are 
traumas of cranial bones and dura mater of brain. Subdural hemorrhages most 
frequently occur along with laceration of tentorium of cerebellum, of cres- 
cent, they are as a rule massive and located on the surface of celebrum. Sub- 
arachnoid hemorrhages are mostly determined by rupture of small veins. Un- 
like asphyctic, traumatic subarachnoid hemorrhages are always massive. 
Intracerbral hemorrhages are caused by rupture of terminal veins, can 
lead to development of hematomas. Intraventricular hemorrhages are most 
frequently observed among the premature infants. 
Spinal cord trauma is a result of injury of the spine mostly on the lev- 
el of the IV cervical vertebra and is accompanied by development of de- 
scending subdural hemorrhages. 
Among the skeleton bones clavicle is most frequently injured (fracture 
of clavicle). Paralyses of arms and diaphragm of the infants are determined 
by trauma of root of cervical plexus and brachial plexus. Rapture and hemor- 
rhage into the nodding muscle results in torticollis. Among the internals liver 
and adrenal glands are most frequently injured. 
 
HEMOLYTIC DISEASE of the infants develops with blood incompatibil- 
ity between the mother and the fetus (mother is Rh-negative and child is Rh- 
positive). From the mother‘s blood anti-Rh antibodies penetrate to the child‘s 
blood and attack red blood cells. It develops during the second and the fol- 
lowing gestations because immunization of the network (antibody titer) 
grows with gestation. Three main types of disease are distinguished – edema- 
tous, anemic and jaundice diseases. Manifestation of their certain forms de- 
pends on the period and amount of penetration of the mother‘s antibodies into 
the blood of fetus. 
When early massive penetration of the antibodies takes place, in some 
cases early fetopathy develops and antenatal death of the 5-7-month-old fe- 
tus, in the others – chronic fetopathy in the form of heavy edematous form of 
the hemolytic disease with maldevelopment of the tissue ripening. Patholo- 
goanatomic changes with the intrauterine fetal death manifest through macer- 
ation and autolysis. Maceration (from the lat. maceratio – maceration) is sof- 
tening of the tissues by the water. Along with it edema of face and peeling of 
the epidermic tissue in big layers. Autolysis (from the gr. autolis – by oneself, 
lisis – dissolution) is an autodigestion, disintegration of tissues of the organ- 
ism which takes place under aseptic conditions and effect of their own en- 
zymes. Organs and tissues disintefrate till the formation of the uniform mass 
of the murrey colour. If it is chronic edematous form, the skin of the infant is 
pale, half-transparent, glossy, partly macerated, with solitary petechial hem- 




sharply dropsical, in the body cavity is transsudate (hydrops factus universalis). 
Liver and spleen are greatly enlarged, retrosternal gland is atrophied. The heart 
is enlarged due to myocardium hyperplasia, lungs are diminished. With the help 
of the microscope foci of extramedullar hematosis with the dominance of eryth- 
roblasts (erythroblastosis) in the liver, spleen, lymph nodi, kidneys and petechial 
hemorrhages, dystrophic and necrobiotic changes in the internals. 
During the later and moderate penetration of the mother‘s antibodies 
into the blood of fetus anemic form of the hemolytic disease of the infants 
develops, it is more frequent observed with the premature infants. Paleness, 
slight pitting edemas are observed. There is no icteritiousness. The internals 
are anemic. Liver and spleen are slightly enlarged, they contain microscopic 
displays of marked erythroblastosis. 
Icteritous form seldom develops itrauterinally, because placenta is able 
to remove bilirubin from the organism of fetus. During the massive penetra- 
tion of the antibodies at delivery time a heavy postnatal icterous form of the 
hemolytic disease of the infants develops (icterus neonatorum gravis). Jaun- 
dice appears at the end of the first or on the second day after delivery and 
grows quickly. Penetration of the indirect toxic bilirubin into the brain causes 
the damage of ganglionic cells till their very necrosis – bilirubinic encepha- 
lopathy. 
The changes develop mostly in the subcortical sections – hypostones, 
nuclei of the bottom of the diamond-shaped fossa, inferior olives, pale nucle- 
us and nuclei of the cerebellum. Hypostones, nuclei of the bottom of the dia- 
mond-shaped fossa, inferior olives, pale nucleus and nuclei of the cerebellum 
are intensively coloured yellow – nuclear icterus. Erythroblastosis, hemo- 
siderosis, biliarystases and thrombi, sometimes even gallstones; in the kid- 
neys – bilirubinic infarctions are observed in the liver. Spleen is enlarged, 
dense. Microscopically hemosiderosis and erythroblastosis are found in it. 
The children who overcame hemolytic disease can have considerable 
defects in the development of the central nervous system (CNS) that results 






Infectious  diseases  -  the  diseases  which  are  caused  by  infectious 
agents – viruses, bacteria, fungi and others. 
Gate of infection is the site through which infectious agent penetrates the 
organism. In exogenous infections it may be intestine, skin, lungs. Endogenous 
infections develop when normal microflora microorganisms receives/get proper- 
ties by which they leads to disease. 
Common features of infectious diseases are: 
1) Infection spreads by lymph, blood, intracanalicularly and also along 
nerves; 
2) Each disease has its own causative agent; 
3) Each causative agent has proper gate to entry; 
4) There is development of focus of primary damage and inflammation 
of lymphatic vessels and nodes – lymphangitis, lymphadenitis. 
5) There is development of specific local changes in each infectious dis- 
ease;  
6) Infectious diseases correspond to general changes in organism (skin 
rash, lymphadenitis, splenomegaly), inflammatory processes in vessels (vascu- 
litis) and dystrophy of internal organs; 
7) Infectious diseases have incubation period – from moment of penetra- 
tion to appearance of primary symptoms; prodromal period of beginning of dis- 
ease appearance; and period of basic disease appearance. 
8) Outcomes of infectious diseases: 
A.Death, 
B. Recovery, 
C. Chronic course, 
D.Carriage, 
E. Development of complications. 
Classification of Infectious Diseases 
A. Under the biological sign: 
1. Antroponosis – which affect only human, 
2. Antropozoonosis – which affect both human and animals, 
3. Zoonosis – which affect only animals. 










C. Under the route of transmission: 
1. Fecal-oral – through intestine, 
2. Air-droplet – through respiratory tract, 
3. Blood transmissible – trough the blood, 
4. Contact infectious disease – through skin, 
5. Infectious through different ways. 
D. Under predominant damaged system: 
1. Respiratory infections, 
2. Infections of digestive tract, 
3. Infections of nervous system, 
4. Infections of cardiovascular system, 
5. Blood infectious, 
6. Urinary tract infections, 
 
DISEASES CAUSED BY VIRUSES 
 
Viral diseases are the most common cause of human illness. However, 
many of the viral infections remain asymptomatic while others produce viral 
disease. Another peculiar feature of viral infection is that a single etiologic 
agent may produce different diseases in the same host depending upon host 
immune response and age at infection (e.g. varicella-zoster virus is causative 
for chickenpox as well as herpes zoster). Viruses are essentially intracellular 
parasites. Depending upon their nucleic acid genomic composition, they may 
be single-stranded or double-stranded, RNA or DNA viruses. 
 
INFECTIOUS MONONUCLEOSIS 
Infectious mononucleosis (IM) or glandular fever is a benign, self- 
limiting lymphoproliferative disease caused by Epstein-Barr virus (EBV), 
one of the herpes viruses. Infection may occur from childhood to old age but 
the classical acute infection is more common in teenagers and young adults. 
The infection is transmitted by person-to-person contact such as by kissing 
with transfer of virally-contaminated saliva. Groups of cases occur particular- 
ly in young people living together in boarding schools, colleges, camps and 
military institutions. Primary infection in childhood is generally asymptomat- 
ic, while 50% of adults develop clinical manifestations. The condition is so 
common that by the age of 40, most people have been infected and developed 
antibodies. It may be mentioned here that EBV is oncogenic as well and is 
strongly implicated in the African (endemic) Burkitt's lymphoma and naso- 
pharyngeal carcinoma. 
Pathogenesis. EBV, the etiologic agent for IM, is a B lymphotropic 
herpesvirus. The disease is characterized by fever, generalized lymphade- 




cal 'mononucleosis cells'. The pathogenesis of these pathologic changes is 
outlined below: 
1. In a susceptible sero-negative host who lacks antibodies, the virus in 
the contaminated saliva invades and replicates within epithelial cells of the sali- 
vary gland and then enters B cells in the lymphoid tissues which possess recep- 
tors for EBV. The infection spreads throughout the body via the blood stream or 
by infected B cells. 
2. Viraemia and death of infected B cells causes an acute febrile illness 
and appearance of specific humoral antibodies which peak about 2 weeks after 
the infection and persist throughout life. The appearance of antibodies marks the 
disappearance of virus from the blood. 
3. Though the viral agent has disappeared from the blood, the EBV- 
infected B cells continue to be present in the circulation as latent infection. 
EBV-infected B cells undergo polyclonal activation and proliferation. These 
cells perform two important roles which are the characteristic diagnostic fea- 
tures of IM: 
i) They secrete antibodies — initially IgM but later IgG appear. IgM anti- 
body is the heterophile anti-sheep antibody used for diagnosis of Dvl while IgG 
antibody persists for life and provides immunity against reinfection. 
ii) They activate T lymphocytes of two types — CD8+ T lymphocytes 
and suppressor T cells. CD8+ T cells bring about killing of B cells while the 
suppressor T cells are pathognomonic atypical lymphocytes seen in blood in IM. 
4. The proliferation of these cells is responsible for generalized lymphad- 
enopathy and hepatosplenomegaly. 
5. The sore throat in IM may be caused by either necrosis of B cells or 
due to viral replication within the salivary epithelial cells in early stage. 
Clinicomorphological features. The incubation period is thought to be 
about 30 to 40 days. The disease incapacitates individuals for varying periods 
of time; some affected people are physically fit for normal activities within 
two or three weeks, while others remain ill for as long as two months, while 
children have shorter incubation period. A prodromal period of 3-5 days is 
followed by frank clinical features lasting for 1-3 weeks, and complete re- 
covery after 2 months. The usual clinical features are as under: 
1. During prodromal period (first 3-5 days), the symptoms are mild such 
as malaise, myalgia, headache and fatigue. 
2. Frank clinical features (next 7-21 days) commonly are fever, sore 
throat and bilateral cervical lymphadenopathy. Less commonly, splenomeg- 
aly (50% patients), hepatomegaly (10% cases), transient erythematous macu- 
lopapular eruption on the trunk and extremities, and neurologic manifesta- 




Complications. A common, but usually not serious, complication of 
IM is a mild inflammation of the liver, or hepatitis. The enlargement of the 
spleen that occurs with IM makes traumatic rupture of the spleen a possible 
complication. Swelling of the throat and tonsils can also lead to airway ob- 
struction when severe. Infection in the area of the tonsil can rarely be a seri- 
ous abscess referred to as a peritonsillar abscess. Another rare complication is 
swelling of the throat to an extent that breathing is obstructed. 
The rare severe complications include destruction of red blood cells 
(hemolytic anemia) and inflammation of the sac surrounding the heart 
(pericarditis), the heart muscle itself (myocarditis), and the brain 
(encephalitis). IM tends to be more aggressive in patients with abnormal im- 
mune systems, such as people with AIDS or those who are taking medica- 
tions that suppress immune function. 




Influenza (known as "flu") is one of the most common infectious diseas- 
es. It is a highly contagious airborne disease that occurs in seasonal epidemics 
and manifests as an acute febrile illness with variable degrees of systemic 
symptoms, ranging from mild fatigue to respiratory failure and death. Influen- 
za causes significant loss of workdays, human suffering, and mortality. 
Although the seasonal strains of influenza virus that circulate in the 
annual influenza cycle constitute a substantial public health concern, far more 
lethal influenza strains than these have emerged periodically. These deadly 
strains produced 3 global pandemics in the last century, the worst of which 
occurred in 1918. Called the Spanish flu, this pandemic killed an estimated 
20-50 million persons. 
Besides humans, influenza also infects a variety of animal species. Some 
of these influenza strains are species-specific, but new strains may spread from 
other animals to humans. The term avian influenza, in this context, refers to zo- 
onotic human infection with an influenza strain that primarily affects birds. 
Swine influenza refers to infections from strains derived from pigs. The 2009 
influenza pandemic was a recombinant influenza involving a mix of swine, avi- 
an, and human gene segments (H1N1 Influenza (Swine Flu)). 
Influenza viruses are encapsulated, negative-sense, single-stranded 
RNA viruses of the family Orthomyxoviridae. The core nucleoproteins are 
used to distinguish the 3 types of influenza viruses: A, B, and C. Influenza A 
viruses cause most human and all avian influenza infections. The RNA core 




(influenza B) proteins. Immunologically, the most significant surface proteins 
include hemagglutinin (H) and neuraminidase (N). 
Hemagglutinin and neuraminidase are critical for virulence, and they 
are major targets for the neutralizing antibodies of acquired immunity to in- 
fluenza. Hemagglutinin binds to respiratory epithelial cells, allowing cellular 
infection. Neuraminidase cleaves the bond that holds newly replicated virions 
to the cell surface, permitting the infection to spread. 
Influenza viruses spread from human to human via aerosols created 
when an infected individual coughs or sneezes. Infection occurs after an im- 
munologically susceptible person inhales the aerosol. If not neutralized by 
secretory antibodies, the virus invades airway and respiratory tract cells. 
Once the virus is within host cells, cellular dysfunction and degenera- 
tion occur, along with viral replication and release of viral progeny. As in 
other viral infections, systemic symptoms result from release of inflammatory 
mediators. 
Incubation period is 2-4 days. Virus penetrates the bronchial and al- 
veolar epithelium and leads to their necrosis and erosion. Then virus enters 
into blood and shows paralytic actions on vessels (causes congestion and sta- 
sis); and damages defense systems of organism that leads to development of 
secondary infection. 
Forms of influenza: 
1. Simple form – there is acute catarrhal inflammation of nasal epithe- 
lium, laryngeal and bronchial mucosa. Recovery occurs in 5-6 days. 
2. Moderate form – there is an inflammation in upper and lower respir- 
atory tract. Bronchioles and lung parenchyma are also affected. Hemorrhagic 
inflammation and necrosis zones appear in trachea and bronchi due to ob- 
struction of the bronchial lumen by desquamated epithelium. Acute emphy- 
sema and atelectasis of lungs may develop. Signs of pneumonia are accom- 
panied with appearance of viral particles in bronchial and alveolar epitheli- 
um. Recovery occurs in 3-4 weeks. 
3. Severe form – it may be of two variants: 
i) with general intoxication – there are serous-hemorrhagic inflamma- 
tion in trachea and bronchi, foci of pneumonia in lungs with possibility of 
hemorrhagic lung edema. Patients may develop hemorrhagic syndrome with 
the hemorrhages into brain, serous and mucous membranes, skin, that may 
causes death; 
ii) with pulmonary complications – develops due to association with 




hemorrhagic inflammation in the trachea, bronchopneumonia, formation of 
abscesses, hemorrhages and pleuritis. 
Dystrophic changes are observed in the internal organs. There are impair- 
ment in circulation and inflammatory processes; thrombi in vessels may arise. 
In children Influenza causes more severe changes and affects the nerv- 
ous system, respiratory system with pulmonary complications (edema of tra- 
cheal mucous membrane, asphyxia). 
 
PARAINFLUENZA 
It is caused by parainfluenza virus. Source and route of transmission is 
the same as in influenza. 
Human parainfluenza viruses (hPIVs) are a group of four distinct sero- 
types of enveloped single-stranded RNA viruses belonging to the paramyxo- 
virus family. These viruses are closely associated with both human and veter- 
inary disease. 
Clinical manifestation are like in influenza, but not so severe. There is 
damage of upper respiratory tract. Sometimes in children croup develops (it 
results from the spasm of laryngeal muscles and edema of the mucous mem- 
brane, that may cause an asphyxia). Mucous membrane usualy demonstrates 
moderate inflammatory infiltration and congestion. The most common com- 
plications are secondary bacterial infections, airway obstruction because of 
croup and bronchiolitis, bronchopneumonia, otitis. They are more dangerous 
for children. 
RESPIRATORY SYNCYTIAL VIRUS INFECTION 
Respiratory syncytial virus (RSV) is a virus that causes respiratory 
tract infection. It is a major cause of lower respiratory tract infections and 
hospital visits during infancy and childhood. 
RSV is a negative-sense, single-stranded RNA virus of the family 
Paramyxoviridae, which includes common respiratory viruses such as those 
causing measles and mumps. Its name comes from the fact that F proteins on 
the surface of the virus cause the cell membranes on nearby cells to merge, 
forming syncytia. 
In temperate climates there is an annual epidemic during the winter 
months. In tropical climates, infection is most common during the rainy season. 
The incubation time (from infection until symptoms arrive) is 4–5 
days. For adults, RSV produces mainly mild symptoms, often indistinguisha- 
ble from common colds and minor illnesses. The Centers for Disease Control 
consider RSV to be the "most common cause of bronchiolitis (inflammation 




age in the United States". For some children, RSV can cause bronchiolitis, 
leading to severe respiratory illness requiring hospitalization and, rarely, 
causing death. This is more likely to occur in patients that are immunocom- 
promised or infants born prematurely. Other RSV symptoms common among 
infants include listlessness, poor or diminished appetite, and a possible fever. 
However, it can cause serious problems in young babies, including 
pneumonia and severe breathing problems. There is damage of upper respira- 
tory tract and lungs with the development of laryngotracheitis, bronchitis, 
bronchopneumonia. 
Microscopicaly there is proliferation of epithelium in the form of nip- 
ples. That can lead to impairment in bronchial lumen and development of 
acute emphysema and atelectasis. 
Recurrent wheezing and asthma are more common among individuals 
who suffered severe RSV infection during the first few months of life than 
among controls; whether RSV infection sets up a process that leads to recur- 
rent wheezing or whether those already predisposed to asthma are more like- 
ly to become severely ill with RSV has yet to be determined. 
Death can occur from pneumonia and other pulmonary complications. 
 
ADENOVIRUS INFECTION 
It most commonly causes illness of the respiratory system; however, 
depending on the infecting serotype, they may also cause various other ill- 
nesses and presentations. 
Causative agent is DNA-containing viruses. Adenoviruses are a group 
of viruses that can infect the membranes (tissue linings) of the respiratory 
tract, conjunctiva, lymphoid tissue of pharynx, intestine and lymph nodes. 
Adenoviral infections affect babies and small children much more of- 
ten than adults. Adenovirus is highly contagious, so multiple cases are com- 
mon in close-contact settings like childcare centers, schools, hospitals, and 
summer camps. 
The illness often appears flu-like and can include symptoms of acute 
rhinolaryngotracheobronchitis, pharyngitis, rhinitis, cough, and swollen 
lymph nodes (cervical and submandibular). Sometimes the respiratory infec- 
tion leads to acute otitis media, an infection of the middle ear. Symptoms of 
conjunctivitis include red eyes, discharge, tearing, and the feeling that there's 
something in the eye. 
Severe form is characterized by the intestine, liver, kidney, pancreas 
and brain damage. Because of secondary infection association pus is formed. 
Complications include otitis, pneumonia, lymphadenitis, tonsillitis. Pa- 
tients with compromised immune systems are especially susceptible to severe 





It was an infectious disease caused by either of two virus variants, Va- 
riola major and Variola minor. The disease is also known by the Latin names 
Variola or Variola vera, derived from varius ("spotted") or varus ("pimple"). 
Infection with smallpox is focused in small blood vessels of the skin 
and in the mouth and throat before disseminating. In the skin it results in a 
characteristic maculopapular rash and, later, raised fluid-filled blisters. 
Classification. There were two clinical forms of smallpox. Variola ma- 
jor was the severe and most common form, with a more extensive rash and 
higher fever and had an overall mortality rate of 30–35 percent. 
V. minor caused a milder form of disease (also known as alastrim, cot- 
tonpox, milkpox, whitepox, and Cuban itch) which killed about 1 percent of 
its victims. It was a less common presentation, and a much less severe dis- 
ease, with historical death rates of 1 percent or less. 
Subclinical (asymptomatic) infections with variola virus were noted 
but were not common. In addition, a form called variola sine eruptione 
(smallpox without rash) was seen generally in vaccinated persons. This form 
was marked by a fever that occurred after the usual incubation period and 
could be confirmed only by antibody studies or, rarely, by virus isolation. 
Epidemiology. The most frequent mode of transmission is person to per- 
son. The virus spreads through direct deposit of infective droplets onto the nasal, 
oral, or pharyngeal mucosal membranes or the alveoli of the lungs. These droplets 
are acquired through face-to-face contact with the infectious person. Virus parti- 
cles can remain on such items as clothing, bedding, and surfaces for up to one 
week. Virus enters the blood after penetrating of the respiratory mucous mem- 
brane and spreads to the skin, intestines, lungs, kidneys, and brain. 
Pathogenesis. The incubation period between contraction and the first 
obvious symptoms of the disease is around 12 days. Once inhaled, variola 
major virus invades the oropharyngeal (mouth and throat) or the respiratory 
mucosa, migrates to regional lymph nodes, and begins to multiply. In the ini- 
tial growth phase the virus seems to move from cell to cell, but around the 
12th day, lysis of many infected cells occurs and the virus is found in the 
bloodstream in large numbers (this is called viremia), and a second wave of 
multiplication occurs in the spleen, bone marrow, and lymph nodes. The ini- 
tial or prodromal symptoms are similar to other viral diseases such as influ- 
enza and the common cold: fever of at least 38.3 °C (101 F), muscle pain, 
malaise, headache and prostration. As the digestive tract is commonly in- 
volved, nausea and vomiting and backache often occur. The prodrome, or 
preeruptive stage, usually lasts 2–4 days. By days 12–15 the first visible le- 
sions—small reddish spots called enanthem—appear on mucous membranes 




These lesions rapidly enlarge and rupture, releasing large amounts of virus 
into the saliva. 
Clinical picture. The eruptive stage is characterized by maculopapular 
rash that progresses to papules, then vesicles, and then pustules and scab lesions. 
A rash develops on the skin 24 to 48 hours after lesions on the mucous 
membranes appear. Typically the macules first appear on the forehead, then 
rapidly spread to the whole face, proximal portions of extremities, the trunk, 
and lastly to distal portions of extremities. The process takes no more than 24 
to 36 hours, after which no new lesions appear. 
According to the main skin symptoms there are 3 forms of small pox: 
1. Papulopustular form is characterized by appearance of pap- 
ulopastules on the face, neck, scalp, chest and back. Balloon dystrophy de- 
velops in epidermal cells which contain viral particles. These cells attach to 
each other and form vesicles which are separated by epithelial bridges. These 
papules then convert into vesicles and into pustules. Necrosis develops in the 
centre of pustule. On the 3rd week healing of pustule occurs and scars are 
formed at pustular places. 
2. Hemorrhagic form is a association of hemorrhage, edema and 
skin rach. Vesicles rupture with the formation of bleeding erosion – black 
chickenpox and it ends with death of patient. The hemorrhagic variety of va- 
riola has a much higher death rate (95%) than classic smallpox and leads to 
death more quickly. Infected people often die before the pustules form. This 
variety is recognizable by certain types of bleeding sores in mucous tissues. 
3. Varioloid form  is the simple form seen in vaccinated persons. 
Differentiated diagnosis. The most common disease that may be con- 
fused with smallpox is varicella, or chickenpox. In contrast to them, smallpox 
lesions appear on days 12 to 14, and the infection manifests with high fevers, 
malaise, and prostration with accompanying headache and backache. Small- 
pox lesions begin as a maculopapular rash, progress into vesicular lesions, 
and finally develop into pustules. 
Historically, smallpox has an overall fatality rate of about 30 percent; 
however, the malignant and hemorrhagic forms are usually fatal. Death may 
occur due to toxicosis or secondary infections. 
Smallpox pustular lesions persist for 8 to 9 days, the lesions then crust, 
and scabs form and separate, producing the characteristic pitted scarring 14 
days after they appear. 
CHICKENPOX 
It is caused by the varicella-zoster virus (VZV), a DNA virus belong- 
ing to the Herpesviridae family. Similar to smallpox, chickenpox is transmit- 




Chickenpox manifests with an abrupt onset of a pruritic rash, low- 
grade fever, and malaise. As chickenpox virus reaches the skin, it causes the 
characteristic rash, which appears in crops of lesions throughout the course of 
the infection. 
Chickenpox lesions appear predominately on the central and proximal 
upper extremities; fever and symptoms resolve in three to five days. Chick- 
enpox and smallpox are most often confused during the first two to three 
days of the rash. However, the lesions and clinical course of the two diseases 
aid in the ability to distinguish one from another. For example, all smallpox 
lesions develop at the same pace on all parts of the body (concentrated on the 
face and limbs and may appear on the palms or soles) and appear identical. 
Chickenpox lesions, which look like small red papules, appear in crops, are 
denser on the trunk, and are rarely found on the palms or soles. 
In chickenpox organs are damaged with the appearance of vesicles and 
pustules in mucous membrane of trachea and bronchi, oral cavity, oesopha- 
gus, intestine. Sometimes necrotic pneumonia and orchitis develop. There is 
damage of conjunctiva with loss of vision and damage of middle ear with 
hearing loss. Chickenpox that affects a healthy child is usually a self-limited 
disease. 




It is an acute infectious disease caused by the poliovirus (RNA – con- 
taining enterovirus). In about 0.5% of cases there is muscle weakness result- 
ing in an inability to move. Because of this it is often called polio or infantile 
paralysis. 
Poliomyelitis is highly contagious via the fecal-oral (intestinal source) 
and the oral-oral (oropharyngeal source) routes. It is seasonal in temperate 
climates, with peak transmission occurring in summer and autumn. These 
seasonal differences are far less pronounced in tropical areas. The time be- 
tween first exposure and first symptoms, known as the incubation period, is 
usually 6 to 20 days, with a maximum range of three to 35 days. Virus parti- 
cles are excreted in the feces for several weeks following initial infection. 
This group of RNA viruses colonize the gastrointestinal tract — specif- 
ically the oropharynx and the intestine. 
Few numbers of viruses enter the blood and go to other sites where the 
virus multiplies more extensively. Another round of viremia (presence of vi- 
rus in the blood) leads to invasion of the central nervous system (spinal cord 
and brain). In around 1% of infections, poliovirus spreads along certain nerve 




within the spinal cord, brain stem, or motor cortex. This leads to the devel- 
opment of paralytic poliomyelitis, the various forms of which (spinal, bulbar, 
and bulbospinal) vary only with the amount of neuronal damage and inflam- 
mation that occurs, and the region of the CNS affected. 
The destruction of neuronal cells produces lesions within the spinal 
ganglia; these may also occur in the reticular formation, vestibular nuclei, 
cerebellar vermis, and deep cerebellar nuclei. Inflammation associated with 
nerve cell destruction often alters the color and appearance of the gray matter 
in the spinal column, causing it to appear reddish and swollen. Other destruc- 
tive changes associated with paralytic disease occur in the forebrain region, 
specifically the hypothalamus and thalamus. The molecular mechanisms, by 
which poliovirus causes paralytic disease, are poorly understood. 
There are three clinic stages: acute, recovery and residual-paralysis 
stage.  
Acute stage. Poliovirus infections can be divided into minor and major 
forms. 
Minor illnesses. The minor associated illnesses occur 1–3 days before 
the onset of paralysis, with gastrointestinal complaints such as nausea and 
vomiting, abdominal cramps and pain, and diarrhea. There are also systemic 
manifestations, such as sore throat, fever, malaise, and headache. This stage 
lasts usually for 2–3 weeks but may extend for up to 2 months; the presence 
of any tenderness in the muscles is evidence that the acute stage is not over. 
Major illnesses. The major associated illnesses include all forms CNS 
disease caused by poliovirus, including aseptic meningitis (or nonparalytic 
polio), polio encephalitis, bulbar polio, and paralytic poliomyelitis, alone or 
in combination. 
The clinical findings associated with an attack of polio are as follows: 
 Fever, neck stiffness (nuchal rigidity), and a pleocytosis in the CSF, 
 Profound asymmetrical muscle weakness, 
The initial phase is typically followed by some recovery of muscle 
strength, but permanent weakness results from necrosis of anterior horn cells, 
 Rarely, a transverse myelitis with paraparesis, urinary retention, senso- 
ry symptoms and signs, autonomic dysfunction (including hyperhidrosis or 
hypohidrosis), and decreased limb temperature may occur. 
Recovery stage. In this stage, also known as the convalescent stage, the 
acute symptoms and muscle tenderness disappear and the paralyzed muscles 
begin to recover. This stage lasts for up to 2 years after the onset of the dis- 
ease. During this entire period, there is gradual recovery of the muscles; the 





Residual-paralysis stage. The period beyond 2 years after the onset of 
the disease is called the residual-paralysis stage. No recovery of muscle pow- 
er occurs in this stage. Deformities are liable to occur due to imbalance of 
muscle power and poor posture. There is also disuse atrophy of muscles and 
shortening of the leg due to interference with growth. In neglected cases, 
gross fixed deformities of the hip, knee, and foot occur with severe wasting 
of muscles. 
Death may occur due to damage of respiratory center and paralysis of 
respiratory muscles. 
In April 2012, the World Health Assembly declared the completion of 
polio eradication a programmatic emergency for global public health. But in 
2015, polio was believed to remain endemic in only two countries: Pakistan, 
and Afghanistan, although it continued to cause epidemics in other nearby 
countries due to hidden or reestablished transmission. 
MUMPS (EPIDEMIC PAROTITIS) 
Mumps is an acute, self-limited, systemic viral illness characterized by 
the swelling of one or more of the salivary glands, typically the parotid 
glands. 
Today, most reported mumps cases occur in school-aged children (age 5- 
14). The illness is caused by the RNA virus, Rubulavirus. Rubulavirus is within 
the genus Paramyxovirus and is a member of the family Paramyxoviridae. This 
virus contains a single-stranded, negative-sense RNA surrounded by a glycopro- 
tein envelope. Of 2 glycoproteins on the surface of the RNA viral envelope, one 
mediates neuraminidase and hemagglutination activity, whereas the other is re- 
sponsible for fusion to the lipid membrane of the host cell. 
Mumps occurs worldwide. Humans are the only known natural hosts. 
This Paramyxovirus is highly infectious to nonimmune individuals and is the 
only cause of epidemic parotitis. Although mumps cases occur at any time of 
year, an increase in case number is noted during late winter and early spring. 
Humans are the sole reservoir for the mumps virus. The transmission 
mode is person to person via respiratory droplets and saliva, direct contact, or 
fomites. The presence of maternal antibodies typically protects infants 
younger than 1 year from the disease. Infections can be a symptomatic in 20- 
30% of persons. Of those with symptomatic infection, adults tend to be more 
severely affected when compared to children. Lifelong immunity usually fol- 





Mumps has an incubation period of 16-18 days. After this period, pro- 
dromal symptoms (such as low-grade fever, malaise, myalgias, headache, and 
anorexia) occur; these symptoms can last 3-5 days. 
After the prodromal period (about 48 h), one or both parotid glands 
begin to enlarge which occurs in 30 to 40% of all patients and in 95% of 
those who are symptomatic. Parotitis is caused by the direct viral infection of 
the ductal epithelium and presents with localized gland inflammation. Ordi- 
narily, the parotid glands are not palpable; but in patients with mumps, parot- 
id swelling increases rapidly over several days. Edema over the parotid gland 
presents with non-discrete borders, pain with pressure, and obscures the angle 
of the mandible. Parotid swelling can last for 10 days. 
A patient is considered infectious from about 3 days before the onset of 
and up to 4 days after the start of active parotitis. 
Cell necrosis and inflammation with mononuclear cell infiltration is 
the tissue response. Salivary glands show edema and desquamation of necrot- 
ic epithelial cells lining the ducts. Focal hemorrhage and destruction of ger- 
minal epithelium may occur, leading to duct plugging. 
Permanent complications of mumps infection: aseptic meningi- 
tis/encephalitis, sensorineural hearing loss/deafness, pancreatitis, orchitis, 
oophoritis. Other rare complications include myocarditis, thyroiditis, mastitis, 
viral pneumonia nephritis, arthritis, and thrombocytopenia purpura. Death 
due to mumps is rare. 
Mumps infection in pregnant women increases the risk of embryonic 
loss, spontaneous fetal loss, and fetal death, especially during the first tri- 
mester of pregnancy (reported to be as high as 27%). 
 
MEASLES 
Measles is best known for causing a fever and rash in childhood, but 
measles can affect other parts of the body and sometimes occurs in adults. 
There are two types of measles, each caused by a different virus. 
1. The rubeola virus causes "red measles," also known as "hard mea- 
sles" or just "measles." Although most people recover without problems, ru- 
beola can lead to pneumonia or inflammation of the brain (encephalitis). 
2. The rubella virus causes "German measles," also known as "three- 
day measles." This is usually a milder disease than red measles. However, 
this virus can cause significant birth defects if an infected pregnant woman 
passes the virus to her unborn child. 
Both the rubeola and rubella viruses are spread through the respiratory 
route. In fact, the rubeola virus is one of the most contagious viruses known 




people carry the virus in their respiratory tract before they get sick, so they 
can spread the disease without being aware of it. 
Source of infection – sick person. 
Route of transmission: air-droplet. Viruses penetrate the mucous mem- 
brane of upper respiratory tract and conjunctiva, enter into the blood and 
causes skin rashes. Measles virus decreases immunity that usually leads to 
secondary infectious. 
Rubeola ("red measles" or "hard measles"). Symptoms appear about 
10-14 days after a person is infected with the rubeola virus. This is called the 
incubation period. During this period, the virus is multiplying. Symptoms oc- 
cur in two phases. 
The early phase begins with these symptoms: fever, run-down or le- 
thargic feeling, cough, red eyes (conjunctivitis), runny nose. 
The red measles rash develops from two to four days later. The rash usu- 
ally starts on the face, spreading to the trunk and then to the arms and legs. 
Catarrhal inflammation develops in fauces mucous membrane. It is 
characterized by congestion, edema, secretion of mucous and inflammatory 
infiltration. Sometimes necrosis croup and rashes appear on the mucous 
membrane (enanthema). Enanthema develops on internal surface of cheeks at 
the place of premolars (spots of Bilshow – Filatov-Kopilik) before appear- 
ance of skin rashes. After decrease of inflammation the necrotized epithelial 
layer is separated. There is enlargement of lymph nodes, spleen, tonsils with 
appearance of giant macrophages in them. 
Interstitial pneumonia with appearance of giant macrophages develops 
in lungs. In rare cases encephalitis occurs. 
Complications result from association with secondary infection and 
development of bronchitis, pneumonia, lung abscess. Patients die due to pul- 
monary complications and asphyxia in croup. 
Rubella ("German measles"). German measles causes milder symptoms 
than red measles. The incubation period between getting the virus and getting sick 
is 10 days to two weeks. 
Initially, some people experience fatigue, low-grade fever, headache, 
or red eyes several days before the rash appears. These symptoms are more 
common in adults than in children. 
Swollen, tender lymph nodes may occur in the back of the neck. 
The rash is light red to pink. It starts as individual spots that may 
merge together over time. The rash usually starts on the face and moves 
down to the trunk. The rash does not usually itch, but as it clears up, the skin 
may shed. 
Adult women who get rubella may get painful joints for days to weeks 




Symptoms may be so mild that they are not even noticed, especially in 
children. Most symptoms resolve in a few days, but swollen lymph nodes 
may persist for a few weeks. 
The most feared complication of rubella is "congenital rubella," which 
occurs when an infected pregnant woman passes the virus to her unborn 
child. Among other problems and birth defects, affected infants may have 
cataracts, heart defects, hearing impairment, and learning disabilities. The 
risk of transmission is highest early in pregnancy. The virus may also cause 
miscarriage or stillbirth. 
 
RABIES 
Rabies is a viral disease that affects the central nervous system. 
The fatal madness of rabies has been described throughout recorded 
history, and its association with rabid canines is well known. For centuries, 
dog bites were treated prophylactically with cautery, with predictable and un- 
fortunate results. In the 19th century, Pasteur developed a vaccine that suc- 
cessfully prevented rabies after inoculation and launched a new era of hope in 
the management of this uniformly fatal disease. 
The rabies virus is a bullet-shaped virion with a single-stranded RNA 
nucleocapsid core and lipoprotein envelope. Its nucleocapsid material con- 
sists of Negri bodies, which are observed as deeply eosinophilic inclusions in 
the cytoplasm of infected neurons. The virus is transmitted in saliva or in 
aerosolized secretions from infected animals, typically via a bite. The virus is 
not hardy and is quickly inactivated by drying, ultraviolet rays, x-rays, tryp- 
sin, detergents, and ether. 
Human rabies reflects the prevalence of animal infection and the extent 
of contact this population has with humans. Less than 5% of cases in devel- 
oped nations occur in domesticated dogs; however, unvaccinated dogs serve 
as the main reservoir worldwide. Undomesticated canines, such as coyotes, 
wolves, jackals, and foxes, are most prone to rabies and serve as reservoirs. 
Animal-control and vaccination strategies currently supersede postexposure 
prophylaxis in preventing the spread of rabies. 
Rabies is more prevalent in the developing world than in industrialized 
countries. The World Health Organization (WHO) estimates that rabies is re- 
sponsible for 35,000-50,000 deaths annually worldwide and that gross un- 
derreporting is likely. An estimated 10 million people receive postexposure 
prophylaxis each year after being exposed to animals with suspected rabies. 
Unvaccinated dogs are the major reservoir for rabies. Global reservoirs of ra- 
bies virus are as follows: Europe - foxes, bats; Middle East - wolves, dogs; 
Asia – dogs; Africa - dogs, mongooses, antelopes; North America - foxes, 




Rabies is a highly neurotropic virus that evades immune surveillance by 
its sequestration in the nervous system. Upon inoculation, it enters the peripheral 
nerves. A prolonged incubation follows, the length of which depends on the size 
of the inoculum and its proximity to the CNS. Amplification occurs until bare 
nucleocapsids spill into the myoneural junction and enter motor and sensory ax- 
ons. At this point, prophylactic therapy becomes futile, and rabies can be ex- 
pected to follow its fatal course, with a mortality rate of 100%. 
The rabies virus travels along these axons at a rate of 12-24 mm/d to 
enter the spinal ganglion. Its multiplication in the ganglion is heralded by the 
onset of pain or paresthesia at the site of the inoculum, which is the first clin- 
ical symptom and a hallmark finding. From here, the rabies virus spreads 
quickly, at a rate of 200-400 mm/d, into the CNS, and spread is marked by 
rapidly progressive encephalitis. Thereafter, the virus spreads to the periph- 
ery and salivary glands. 
Incubation period. The infected individual remains asymptomatic dur- 
ing this period. The average duration of incubation is 20-90 days. Rarely, in- 
cubation has been reported up to 7-19 years. In more than 90% of cases, in- 
cubation is less than 1 year. Patients may not recall exposure because of the 
prolonged incubation period. 
The incubation period is less than 50 days if the patient is bitten on the 
head or neck or if a heavy inoculum is transferred through multiple bites, 
deep wounds, or large wounds. A person with a scratch on the hand may take 
longer to develop symptoms of rabies than a person who receives a bite to the 
head. 
The rabies virus is segregated from the immune system during this pe- 
riod, and no antibody response is observed. 
Prodromal period. The virus enters the CNS. The duration of this peri- 
od is 2-10 days. Nonspecific symptoms and signs develop. Paresthesia, pain, 
or intense itching at the inoculation site is pathognomonic for rabies and oc- 
curs in 50% of cases during this phase; this may be the individual‘s only pre- 
senting sign. Symptoms may include the following: malaise, anorexia, head- 
aches, fever, chills, pharyngitis, nausea, emesis, diarrhea, anxiety, agitation, 
insomnia, depression. 
Acute neurologic period. This period is associated with objective signs 
of developing CNS disease. The duration is 2-7 days. Symptoms include 
muscle fasciculations, priapism, and focal or generalized convulsions. Pa- 
tients may die immediately or may progress to paralysis, which may be pre- 
sent only in the bitten limb at first but usually becomes diffuse. The form of 
rabies known as furious rabies may develop during this period. Patients de- 
velop agitation, hyperactivity, restlessness, thrashing, biting, confusion, or 




spersed with calm, cooperative, lucid periods. Furious episodes last less than 
5 minutes. Episodes may be triggered by visual, auditory, or tactile stimuli or 
may be spontaneous. Seizures may occur. This phase may end in cardi- 
orespiratory arrest or may progress to paralysis. 
Another form of rabies, paralytic rabies, is also known as dumb rabies 
or apathetic rabies, because the patient is relatively quiet compared with a 
person with the furious form. Twenty percent of patients do not develop the 
furious form. Paralysis occurs from the outset, and fever and headache are 
prominent. 
Coma. This begins within 10 days of onset, and the duration varies. With- 
out intensive supportive care, respiratory depression, arrest, and death occur 
shortly after coma. Death occurs from global neurologic and organ dysfunction. 
Histologic Findings. General findings on pathology include cerebral 
congestion and inflammation typical of encephalitis. Neuronal cell death is 
uncommon histopathologically. 
Immunohistochemical or fluorescent antibody staining of nervous tis- 
sue, usually of unfixed brain or skin biopsy specimens with sensory nerve 
endings, reveals deposition of virion in the cytoplasm. 
Negri bodies are observed in neurons on light microscopy and repre- 
sent round cytoplasmic inclusions of assembling nucleocapsid. Only 70% of 
brain biopsy tissue exhibits this finding in human rabies encephalitis. Elec- 
tron microscopy is more sensitive than light microscopy and reveals the char- 
acteristic bullet-shaped virion. 
 
HUMAN IMMUNODEFICIENCY VIRUS (HIV) 
HIV is the causative agent for AIDS. The most common type is known 
as HIV-1 and is the infectious agent that has led to the worldwide AIDS epi- 
demic. There is also an HIV-2 that is much less common and less virulent, 
but eventually produces clinical findings similar to HIV-1. The HIV-1 type 
itself has a number of subtypes (A through H and O) which have differing 
geographic distributions but all produce AIDS similarly. HIV is a retrovirus 
that contains only RNA. 
HIV is a sexually transmitted disease. Infection is aided by Langerhans 
cells in mucosal epithelial surfaces which can become infected. Infection is also 
aided by the presence of other sexually transmitted diseases that can produce 
mucosal ulceration and inflammation. The CD4+ T-lymphocytes have surface 
receptors to which HIV can attach to promote entry into the cell. The infection 
extends to lymphoid tissues which contain follicular dendritic cells that can be- 
come infected and provide a reservoir for continuing infection of CD4+ T- 
lymphocytes. HIV can also be spread via blood or blood products, most com- 




nous drug use. Mothers who are HIV infected can pass the virus on to their fe- 
tuses in utero or to infants via breast milk. 
When HIV infects a cell, it must use its reverse transcriptase enzyme to 
transcribe its RNA to host cell proviral DNA. It is this proviral DNA that directs 
the cell to produce additional HIV virions which are released. 
The genome of HIV contains only three major genes: env, gag, and pol. 
These genes direct the formation of the basic components of HIV. The env gene 
directs production of an enve-lope precursor protein gp160 which undergoes 
proteolytic cleavage to the outer envelope glycoprotein gp120, which is respon- 
sible for tropism to CD4+ receptors, and transmembrane glycoprotein gp41, 
which catalyzes fusion of HIV to the target cell's membrane. The gag gene di- 
rects formation of the proteins of the matrix p17, the "core" capsid p24, and the 
nucleocapsid p7. The pol gene directs synthesis of important enzymes including 
reverse transcriptase p51 and p66, integrase p32, and protease p11. 
In addition to the CD4 receptor, a coreceptor known as a chemokine is 
needed for HIV infection. Chemokines are cell surface fusion-mediating mole- 
cules. Such coreceptors include CXCR4 and CCR5. Their presence on cells can 
aid binding of the HIV envelope glycoprotein gp120, promoting infection. Ini- 
tial binding of HIV to the CD4 receptor is mediated by conformational changes 
in the gp120 subunit, but such conformational changes are not sufficient of fu- 
sion. The chemokine receptors produce a conformational change in the gp41 
subunit which allows fusion of HIV. The differences in chemokine coreceptors 
that are present on a cell also explains how different strains of HIV may infect 
cells selectively. There are strains of HIV known as T-tropic strains which selec- 
tively interact with the CXCR4 chemokine coreceptor to infect lymphocytes. 
The M-tropic strains of HIV interact with the CCR5 chemokine coreceptor to 
infect macrophages. Dual tropic HIV stains have been identified. The presence 
of a CCR5 mutation may explain the phenomenon of resistance to HIV infec- 
tion in some cases. Over time, mutations in HIV may increase the ability of the 
virus to infect cells via these routes. Infection with cytomegalovirus may serve 
to enhance HIV infection via this mechanism, because CMV encodes a chemo- 
kine receptor similar to human chemokine receptors. 
Acquired Immunodeficiency Syndrome (AIDS). When the CD4 lym- 
phocyte count drops below 200/microliter, then the stage of clinical AIDS has 
been reached. This is the point at which the characteristic opportunistic infec- 
tions and neoplasms of AIDS appear. Listed below are some of the more com- 
mon complications seen with AIDS with images that illustrate gross and micro- 
scopic pathologic findings. 
The organ involvement of infections with AIDS represents the typical 




makes treatment more difficult. The strategies employed in AIDS patients to 
meet this challenge consist of (1) preserving immune function as long as possi- 
ble with antiretroviral therapies, (2) using prophylactic pharmacologic therapies 
to prevent infections (such as Pneumocystis carinii pneumonia), and (3) diag- 
nosing and treating acute infections as soon as possible. 
Pneumocystis carinii. Pneumocystis carinii is the most frequent oppor- 
tunistic infection seen with AIDS. It produces a pulmonary infection, called 
Pneumocystis carinii pneumonia (PCP), but rarely disseminates outside of lung. 
The most common clinical findings in patients with PCP are acute onset of fe- 
ver, non-productive cough, and dyspnea. Chest radiograph may show perihilar 
infiltrates. Diagnosis is made histologically by finding the organisms in cytolog- 
ic (bronchoalveolar lavage) or biopsy (transbronchial biopsy) material from 
lung, typically via bronchoscopy. The cysts of P.carinii stain brown to black 
with the Gomori methenamine silver stain. With Giemsa or Dif-Quik stain on 
cytologic smears, the dot-like intracystic bodies are seen. 
Cytomegalovirus. Cytomegalovirus (CMV) is the most frequent dis- 
seminated opportunistic infection seen with AIDS. It causes the most serious 
disease as a pneumonia in the lung, but it can also cause serious disease in the 
brain and gastrointestinal tract. It is also a common cause for retinitis and 
blindness in persons with AIDS. CMV is identified by the presence of very 
large cytomegalic cells with enlarged nuclei that contain a violaceous intra- 
nuclear inclusion surrounded by a clear halo. Sometimes, basophilic stippling 
is present in the cytoplasm. 
Mycobacteria. Mycobacterial infections are frequently seen with AIDS. 
Mycobacterium tuberculosis has been increasing in frequency since the start of 
the AIDS epidemic. The appearance of M.tuberculosis with AIDS is similar to 
that of non-AIDS patients, with granulomatous pulmonary disease, though the 
infection may be more extensive or may be disseminated to other organs. My- 
cobacte-rium avium complex (MAC) infection is more unique to AIDS and is 
characterized by involvement mostly of the organs of the mononuclear phago- 
cyte system (lymph node, spleen, liver, marrow). MAC infections are less likely 
to produce visible granulomas, and the lesions often consist of clusters of mac- 
rophages filled with numerous mycobacteria. Definitive diagnosis of mycobac- 
terial disease is made by culture. 
Fungal Infections. There are many types of fungi that can complicate 
the course of AIDS. One of the most frequent (though uncommonly life- 




may presage the progression to AIDS. Candida can occasionally produce inva- 
sive infections in esophagus, upper respiratory tract, and lung. 
Infections with the dimorphic fungi Cryptococcus neoformans, Histo- 
plasma capsulatum, and Coccidioides immitis are more serious infections that 
are often widely disseminated. C.neoformans often produces pneumonia and 
meningitis. 
Toxoplasmosis. Toxoplasma gondii is a protozoan parasite that most of- 
ten leads to infection of the brain with AIDS. The lesions are usually multiple 
and have the appearance of abscesses. Less commonly, T gondii infection is dis- 
seminated to other organs. 
Herpes simplex 
Herpes simplex virus infection with AIDS is most likely to involve the 
gastrointestinal tract, mainly the esophagus and the perianal region. Herpes zos- 
ter infection of the skin can also occur prior to the onset of clinical AIDS. Her- 
pes infections are rarely life-threatening. 
Gastrointestinal Protozoal Infections. Cryptosporidium, Microsporidi- 
um, and Isospora are all capable of producing a voluminous watery diarrhea in 
patients with AIDS. Diagnosis can be made by examination of stool specimens 
and/or intestinal biopsy. 
Malignant Neoplasms. Kaposi's sarcoma (KS) produces reddish purple 
patches, plaques, or nodules over the skin and can be diagnosed with skin biop- 
sy. Visceral organ involvement eventually occurs in 3/4 of patients with KS. 
Malignant lymphomas seen with AIDS are typically of a high grade and extran- 
odal, often in the brain. They are very aggressive and respond poorly to therapy. 
Miscellaneous. Lymphoid interstitial pneumonitis (LIP) is a condition in- 
volving the lung that can be seen in AIDS in children. By chest radiograph, bilat- 
eral reticulonodular interstitial pulmonary infiltrates are seen. The earliest patho- 
logic finding is a hyperplasia of bronchial associated lymphoid tissue with aggre- 
gates of lymphocytes and plasma cells in a bronchovascular distribution. Later 
lesions demonstrate diffuse lung round cell infiltrates, and lymphoid aggregates 




Rickettsiae comprise a group of microorganisms that phylogenetically 
occupy a position between bacteria and viruses. The genus Rickettsia is in- 
cluded in the bacterial tribe Rickettsiae, family Rickettsiaceae, and order 
Rickettsiales. They are obligate intracellular gram-negative coccobacillary 
forms that multiply within eukaryotic cells. Rickettsiae do not stain well with 
Gram stain, but they take on a characteristic red color when stained by the 




lack flagella. Their genome is very small, composed of 1-1.5 million bases. A 
general characteristic of rickettsiae is that mammals and arthropods are natu- 
ral hosts. Rickettsioses are usually transmitted to humans by arthropods. 
 
EPIDEMIC TYPHUS 
It is an acute rickettsiosis with the damage of small vessels, brain and ap- 
pearance of generalized rash due to infection with a microorganism called Rick- 
ettsia prowazekii. 
Source of infection – sick person transmitted by body louses which 
spread rickettsiae with their faeces. Incubation period is 10-12 days. After 
that high fever develops. Vasculitis, thrombosis, vascular paresis develop in 
vessels, that causes the decrease of blood pressure. 
Damages of cerebral vessels lead to impairment in swallowing and 
respiration. If sympathetic nervous system is damaged the death of patient 
may occur due to impairment of heart activity. 
Rashes on skin has represented by red or brown color spots. Rash pre- 
sents mainly on the conjunctiva. 
Serous meningitis may develop. In blood vessels vascular destruction, 
endothelial erosion, thrombi formation (warty vasculitis), then endothelial 
proliferation (proliferative vasculitis) occur. Sometimes necrotic patches on 
vessel wall (necrotic vasculitis) appear. 
Inflammatory process in epidemic typhus has granulomatous character 
(epidemic typhus granuloma) except in liver, spleen, lymphnodes and bone 
marrow. There vessels are located in center and surrounded by proliferating 
glial cells (in brain) or by endothelium and adeventia of vessels, and by lym- 
phoid elements in skin. 
Complications result from impairment in blood circulation due to dam- 
aged vessels. That leads to trophism impairment in skin (bed sore develop- 
ment) and development of bronchitis and pneumonia. 
BRILL-ZINSSER DISEASE – relapsing epidemic typhus. The pathology 
is similar to that described for the spotted fever group of rickettsial diseases. 
However, the organisms appear to lie dormant, most likely in the cells of the 
reticuloendothelial system, until they are reactivated by an unknown stressor, 
multiply and cause another acute but milder infection. 
This reactivation event can then be transmitted to other individuals 
through fecal matter of the louse vector, and form the focus for a new epi- 
demic of typhus. 
 
DISEASES CAUSED BY BACTERIA 
 
In order to gain an upper hand in human host, bacteria must resist early 




ways such as by generation of toxins (e.g. gas-forming anaerobes), by form- 
ing a slippery capsule that resists attachment to macrophages (e.g. pneumo- 
cocci), by inhibition of fusion of phagocytic vacuoles with lysosomes (e.g. 
tubercle bacilli) etc. 
 
DIPHTHERIA 
Diphtheria is an infection caused by the bacterium Corynebacterium 
diphtheria. It is a potentially fatal, contagious disease that usually involves the 
nose, throat, and air passages but may also infect the skin. The name of the dis- 
ease is derived from the Greek ―diphtheria‖, meaning leather hide. The disease 
was described in the 5th century BCE by Hippocrates, and epidemics were de- 
scribed in the 6th century AD by Aetius. Its most striking feature is the for- 
mation of a grayish membrane covering the tonsils and upper part of the throat. 
Source of infection are bacilli-carriers and rarely sick person. Children 
are more frequently affected. 
Corynebacterium Diphtheriae multiplies in the place of invasion and 
releases exotoxin. Diphtheria toxin is produced by C. diphtheriae only when 
infected with a bacteriophage that integrates the toxin-encoding genetic ele- 
ments into the bacteria. Exotoxin depresses tissue metabolism and impairs 
catecholamine synthesis and causes epithelial necrosis, vascular dilation and 
formation of fibrinous layer on the mucous membrane surface. Local tissue 
destruction enables the toxin to be carried lymphatically and hematologically 
to other parts of the body. Elaboration of the diphtheria toxin may affect dis- 
tant organs such as the myocardium, nervous system, kidneys and adrenal 
glands. Sometimes it develops hyper toxic form due to hypersensitivity to 
exotoxin. 
Local changes are localized in mucous membrane of fauces, tonsils, 
upper respiratory tract, sometimes in conjunctiva and on sex organs in girls. 
Anterior Nasal Diphtheria 
The onset of anterior nasal diphtheria is indistinguishable from that of 
the common cold and is usually characterized by a mucopurulent nasal dis- 
charge (containing both mucus and pus) which may become blood-tinged. A 
white membrane usually appears on the nasal septum. The disease is usually 
fairly mild because of apparent poor systemic absorption of toxin in this loca- 
tion, and it can be terminated rapidly by diphtheria antitoxin and antibiotic 
therapy. 
Pharyngeal and Tonsillar Diphtheria 
The most common sites of diphtheria infection are the pharynx and the 
tonsils. Infection at these sites is usually associated with substantial systemic 




The onset of pharyngitis is insidious. Early symptoms include malaise, 
sore throat, anorexia, and low-grade fever. Within 2–3 days, a bluish-white 
membrane appears and extends, varying in size from covering a small patch 
on the tonsils to covering most of the soft palate. Often by the time a physi- 
cian is contacted, the membrane is greyish-green, or black if bleeding has oc- 
curred. There is a minimal amount of mucosal erythema surrounding the 
membrane. 
The pseudomembrane is firmly adherent to the tissue, and forcible at- 
tempts to remove it cause bleeding. Extensive pseudomembrane formation 
may result in respiratory obstruction. 
While some patients may recover at this point without treatment, oth- 
ers may develop severe disease. Fever is usually not high, even though the 
patient may appear quite toxic. Patients with severe disease may develop 
marked edema of the submandibular areas and the anterior neck along with 
lymphadenopathy, giving a characteristic ―bullneck‖ appearance. If enough 
toxin is absorbed, the patient may develop severe prostration, striking pallor, 
rapid pulse, stupor, and coma, and may even die within 6 to 10 days. 
Regional lymph nodes of neck are enlarged with necrotic patches. Car- 
diac toxicity typically occurs after 1-2 weeks of illness following improve- 
ment in the pharyngeal phase of the disease. It leads to death from cardiac in- 
sufficiency and this is known as early heart paralysis. If patients remain alive 
they finish with cardiosclerosis. 
Nerves and ganglions of the vegetative nervous system, mainly which 
are located near the fauces (n.glossopharyngeal, n.vagus, n.phrenic) are dam- 
aged that causes the late paralysis of the soft palate, diaphragm and heart. 
Necrosis and hemorrhage may appear in the adrenal medulla, and ne- 
crotic nephrosis - in the kidney. 
Laryngeal Diphtheria can be either an extension of the pharyngeal form or 
can involve only this site. Symptoms include fever, hoarseness, and a barking 
cough. The membrane can lead to airway obstruction, coma, and death. 
Fibrinous inflammation of larynx during diphtheria is known as croup. 
There is spread of process in to small branches of bronchial tree. Death may 
occur due to asphyxia or pneumonia. 
Skin (cutaneous) diphtheria affects the skin, causing the typical pain, 
redness and swelling associated with other bacterial skin infections. Ulcers 
covered by a gray membrane also may develop in cutaneous diphtheria. 
Although it's more common in tropical climates, cutaneous diphtheria 
also occurs in the United States, particularly among people with poor hygiene 
who live in crowded conditions. 






Scarlet fever (known as scarlatina in older literature references) is a 
syndrome characterized by exudative pharyngitis, fever, and scarlatiniform 
rash. It is caused by an infection with group A beta-hemolytic streptococci. 
The bacteria make a toxin that can cause the scarlet-colored rash from which 
this illness gets its name. The disease occurs mostly in children between the 
ages of 2 and 10 years. Rout of transmission is air-droplet, sometimes 
through direct contact. 
After entering into organism streptococci causes local inflammation at 
the portal of entry, then they spread along lymphatic way and causes regional 
lymphadenitis. Then streptococci enter into blood and causes intoxication. 
There is damage of C.N.S., internal organs and skin. This is first period of 
scarlet fever. 
Degradation of microbes in blood causes development of autoimmun- 
ization that leads to appearance of 2nd period of disease (from 3rd week). 
This period appear with allergic processes in skin, joints, kidney, and heart. 
There may be formation of septic patches. 
Local patches during scarlet are known as scarlet affect (located usual- 
ly in fauces and tonsils) and in association with regional lymphadenitis - 
known as primary complex. 
In 1st stage disease there is increased congestion of fauces and tonsils, 
oral mucosa, tongue and pharyngeal mucosa. Tonsils are enlarged, inflamed 
and then appears patches of necrosis. Necrosis may be present also in soft 
plate region, pharynx, and middle ear. Neck lymph nodes are enlarged with 
necrotic patches. 
General changes: 
1. Appearance of rash (appear on 2nd day of disease, small point 
like, red, covers whole body except nasolabial triangle) 
2. Dystrophy of liver, kidney, heart and cerebral neurons 
In severe toxic form death occur in 2-3 days. There is hyperemia in 
fauces. It involves esophagus. There is severe dystrophy of internal organs. 
In severe septic form there is development of purulent processes in or- 
gans: retropharyngeal abscess, otitis, osteomyelitis of temporal bone, phleg- 
mone in neck, abscesses of brain and meningitis. 
2nd period of disease is connected with autoimmune processes and de- 
velopment not always. It begins with catarrhal tonsillitis and accompany with 
gromerulonephritis. 
The microscopic findings of the eruption of scarlet fever are nonspecif- 
ic and have an appearance similar to that of other exanthematous eruptions. A 
sparse perivascular infiltrate is present, usually consisting primarily of lym- 




tosis may be present, which probably correlates with the sandpaperlike tex- 
ture of the skin. 
The complications of scarlet fever include septic complications due to 
spread of streptococci in blood, and immune-mediated complications due to 
an aberrant immune response. Complications due to the spread of the infec- 
tion can occur early in the infection and may include following: cervical 
lymphadenitis, otitis media and/or mastoiditis, ethmoiditis, peritonsillar ab- 
scess, sinusitis, bronchopneumonia, empyema thoracis, meningitis, brain ab- 
scess, intracranial venous sinus thrombosis, septicemia, osteomyelitis, and 
septic arthritis. Of these, otitis media, pneumonia, septicemia, osteomyelitis, 
rheumatic fever, and acute glomerulonephritis are the most common. Rare 
but lethal early toxin-mediated sequelae include myocarditis and toxic shock- 
like syndrome. 
Immune complications include acute glomerulonephritis, rheumatic 
fever, and erythema nodosum. The secondary scarlatinous disease, or sec- 
ondary malignant syndrome of scarlet fever, includes renewed fever, renewed 
angina, septic ear, nose, and throat complications, and kidney infection or 
rheumatic fever, and is seen around the 18th day of untreated scarlet fever. 
An association between scarlet fever and hepatitis has been recognized 
for several decades. The causal mechanism is unknown. 
 
MENINGOCOCCAL INFECTION 
Meningococcal disease describes infections caused by the bacterium 
Neisseria meningitidis (also termed meningococcus). It carries a high mor- 
tality rate if untreated but is a vaccine-preventable disease. While best known 
as a cause of meningitis, widespread blood infection can result in sepsis, 
which is a more damaging and dangerous condition. Meningitis and menin- 
gococcemia are major causes of illness, death, and disability in both devel- 
oped and under-developed countries. 
There are approximately 2,600 cases of bacterial meningitis per year in 
the United States, and on average 333,000 cases in developing countries. The 
case fatality rate ranges between 10 and 20 percent. The incidence of endem- 
ic meningococcal disease during the last 13 years ranges from 1 to 5 per 
100,000 in developed countries, and from 10 to 25 per 100,000 in developing 
countries. During epidemics the incidence of meningococcal disease ap- 
proaches 100 per 100,000. Meningococcal vaccines have sharply reduced the 
incidence of the disease in developed countries. 
The disease's pathogenesis is not fully understood. The pathogen colo- 
nises a large number of the general population harmlessly, but in some very 
small percentage of individuals it can invade the blood stream, and the entire 




years, experts have made an intensive effort to understand specific aspects of 
meningococcal biology and host interactions; however the development of 
improved treatments and effective vaccines is expected to depend on novel 
efforts by workers in many different fields. 
While meningococcal disease is not as contagious as the common cold 
(which is spread through casual contact), it can be transmitted through saliva and 
occasionally through close, prolonged general contact with an infected person. 
Some people have the bacteria living naturally in their nose and throat. 
In a small number of people, a dangerous strain of the bacteria can move 
through the lining of the throat, causing what is known as invasive meningo- 
coccal disease. 
The three common presentations of meningococcal infection are: 
1. Nasopharyngitis (inflammation of nasal and pharyngeal mucosa), 
2. Purulent meningitis, 
3. Meningococcemia. 
Mainly disease develops in children up to 5 years of age. 
Penetration of meningococci in nasopharyngeal mucosa causes naso- 
pharyngitis. The fundamental pathologic change is widespread vascular inju- 
ry characterized by endothelial necrosis, intraluminal thrombosis, and peri- 
vascular hemorrhage. Endotoxin, cytokines, and free radicals damage the 
vascular endothelium, producing platelet deposition and vasculitis. The dele- 
terious effects of cytokines play a major role in the pathogenesis of meningo- 
coccemia by causing severe hypotension, reduced cardiac output, and in- 
creased endothelial permeability. Then meningococci spread hematogenical- 
ly, crossing hematoencephalic barrier and causes purulent meningitis. It oc- 
curs presumably in children as they have weak hematoencephalic barrier. 
Sometimes meningococci may cause sepsis, so called meningococcemia. 
Meningococcal nasopharyngitis – there is inflammation of nasopha- 
ryngeal mucosa. Nasopharingitis is characterized by hyperemia of the phar- 
yngeal walls, edema of the epithelial cells, regional infiltration, hyperplasia 
and hypertrophy of lymphoid follicles. Signs of catarrhal inflammation are 
found in trachea and bronchi. 
Meningococcal meningitis there is congestion of pia matter during 
meningococcal meningitis and turbid exudates. 
The next stages may single out in pathogenesis of purulent meningitis: 
1. Penetration of the agent through hematoencephalic barrier, irritation 
of receptors of soft cerebral membrane of the brain and systems, forming cer- 
ebrospinal fluid. 
2. Hypersecretion of cerebrospinal fluid. 
3. Disorder of circulation of the blood in the vessels of the brain and 




4. Swelling-edema of the brain hyperirritation of the brain's mem- 
branes and radices of cerebrospinal nerves. 
Sometimes purulent process transfers from meninges to brain tissue 
and causes meningoencephalitis. On 3rd week exudates begins to resolve. 
This accompanies with spike formation in subarachnoid space and disturbs 
flow that leads to hydrocephaly and atrophy or brain. Death can occur from 
edema and swelling of brain, at last from cerebral cachexia due to hydro- 
cephaly, connected with block of CSF tract. 
Meningococcemia – there is damage of microcirculatory blood vessels. 
Multiple organ failure, shock, and death may ensue as a result of anoxia in 
vital organs and massive disseminated intravascular coagulation. 
Patients with fulminant meningococcemia develop thrombosis and 
hemorrhage in the skin, the mucous membranes, the serosal surfaces, the ad- 
renal sinusoids, and the renal glomeruli. Skin rash has hemorrhagic character, 
located on gluteal region and legs. Necrosis and hemorrhage in adrenal gland 
may cause acute adrenal insufficiency (Waterhouse-Frederickson syndrome). 
Thrombosis of the glomerular capillaries may cause renal cortical necrosis, 
the main characteristic of the generalized Schwartzman reaction. Thrombi 
containing numerous leukocytes are occasionally found in the lungs, and ex- 
tensive intra-alveolar hemorrhage can occur. Myocarditis has been observed 
in adults with fatal meningococcal infections. 
Microscopically, leukocytoclastic vasculitis, thrombosis, and organ- 
isms are often demonstrated in biopsy specimens from patients with acute 
meningococcemia. 
Cutaneous petechiae and purpura correspond to thrombi in the dermal 
vessels composed of neutrophils, platelets, and fibrin. Acute vasculitis with 
neutrophils and nuclear dust present within and around vessels leads to hem- 
orrhage into the surrounding tissue. Meningococci can often be seen in the 
luminal thrombi and vessel walls. Intraepidermal and subepidermal neutro- 
philic pustules also may be present. 
Perivascular lymphocytic infiltrate with few neutrophils characterize a 
chronic meningococcemia, although leukocytoclastic vasculitis may be seen 
in biopsies of petechiae. 
Chronic form of meningococcemia is rare. The duration of the disease 
is from some weeks till some years. One case was described with duration of 
meningococcemia during 25 years. The disease is accompanied by intermit- 
tent fever, polymorphic exudative erythema. During period of the remission 
rash becomes pale, it may disappear. The patient's state is improved. In 
chronic meningococcemia arthritis and polyarthritis are possible. Splenomeg- 




meningococcemia. It is possible the development of meningitis after some 
weeks or month from the onset of the disease. 
 
PERTUSSIS (WHOOPING COUGH) 
Pertussis, commonly known as whooping cough, is a respiratory tract 
infection characterized by a paroxysmal cough. Paroxysms of cough occur 
with characteristic 'whoop'. 
Whooping cough is a highly communicable acute bacterial disease of 
childhood caused by Bordetella pertussis. The use of DPT vaccination has 
reduced the prevalence of whooping cough in different populations. B. per- 
tussis spreads via aerosolized droplets produced by the cough of infected in- 
dividuals, attaching to and damaging ciliated respiratory epithelium. The 
causative organism, B. pertussis, has strong tropism for the brush border of 
the bronchial epithelium. The organisms proliferate here and stimulate the 
bronchial epithelium to produce abundant tenacious mucus. B. pertussis pro- 
duces a heat-labile toxin, a heat-stable endotoxin, and a lymphocytosis- 
producing factor called histamine-sensitising factor. 
Typically, the incubation period of pertussis ranges from 3-12 days. 
Pertussis is a 6-week disease divided into catarrhal, paroxysmal, and conva- 
lescent stages, each lasting from 1-2 weeks. 
Older children, adolescents, and adults may not exhibit distinct stages. 
Symptoms in these patients include uninterrupted coughing, feelings of suf- 
focation or strangulation, and headaches. Vaccinated adults usually develop 
only prolonged bronchitis without a whoop, whereas unvaccinated adults are 
more likely to have whooping and posttussive emesis. 
Pathologic changes. The initial (catarrhal) phase is indistinguishable 
from common upper respiratory infections. It includes nasal congestion, rhi- 
norrhea, and sneezing, variably accompanied by low-grade fever, tearing, and 
conjunctival suffusion. Pertussis is most infectious when patients are in the 
catarrhal phase, but pertussis may remain communicable for 3 or more weeks 
after the onset of cough. 
Patients in the second (paroxysmal) phase present with paroxysms of 
intense coughing lasting up to several minutes. In older infants and toddlers, 
the paroxysms of coughing occasionally are followed by a loud whoop as in- 
spired air goes through a still partially closed airway. Infants younger than 6 
months do not have the characteristic whoop but may have apneic episodes 
and are at risk for exhaustion. Posttussive vomiting and turning red with 
coughing are common in affected children. The condition is self-limiting but 
may cause death due to asphyxia in infants. 
Patients in the third (convalescent) stage have a chronic cough, which 




Microscopically, the lesions in the respiratory tract consist of necrotic 
bronchial epithelium covered by thick muco purulent exudate. In severe cas- 
es, there is mucosal erosion and hyperaemia. The peripheral blood shows 
marked lymphocytosis upto 90% and enlargement of lymphoid follicles in 
the bronchial mucosa and peribronchial lymph nodes. 
 
STAPHYLOCOCCAL INFECTIONS 
Staphylococci are gram positive cocci which are present everywhere 
in the skin, umbilicus, nasal vestibule, stool etc. Three species are pathogenic 
to human beings: Staph. aureus, Staph. epidermidis and Staph. saprophyticus. 
Most staphylococcal infections are caused by Staph. aureus. Staphylococcal 
infections are among the commonest antibiotic-resistant hospital-acquired in- 
fection in surgical wounds. 
A wide variety of suppurative diseases are caused by Staph. aureus 
which includes the following: 
1. Infections of skin. Staphylococcal infections of skin are quite com- 
mon. The infection begins from lodgement of cocci in the hair root due to 
poor hygiene and results in obstruction of sweat or sebaceous gland duct. 
This is termed folliculitis. Involvement of adjacent follicles results in larger 
lesions called furuncle. Further spread of infection horizontally under the 
skin and subcutaneous tissue causes carbuncle or cellulitis. Styes are staphy- 
lococcal infection of the sebaceous glands of Zeis, the glands of Moll and 
eyelash follicles. Impetigo is yet another staphylococcal skin infection com- 
mon in school children in which there are multiple pustular lesions on face 
forming honey-yellow crusts. Breast abscess may occur following delivery 
when Staphylococci are transmitted from infant having neonatal sepsis or due 
to stasis of milk. 
2. Infections of burns and surgical wounds. These are quite common 
due to contamination from the patient's own nasal secretions or from hospital 
staff. Elderly, malnourished, obese and neonates have increased susceptibility. 
3. Infections of the upper and lower respiratory tract. Small children 
under 2 years of age get staphylococcal infections of the respiratory tract 
commonly. These include pharyngitis, bronchopneumonia, staphylococcal 
pneumonia and its complications. Staphylococcal pneumonia predominantly 
affects people with underlying lung disease and can lead to abscess formation 
within the lungs. 
4. Bacterial arthritis. Septic arthritis in the elderly is caused by Staph. 
aureus. 
5. Infection of bone (Osteomyelitis). Young boys having history of 




6. Bacterial endocarditis. Acute and subacute bacterial endocarditis are 
complications of infection with Staph. aureus and Staph. Epidermidis. Its can 
lead to heart failure. 
7. Bacterial meningitis. Surgical procedures on central nervous system 
may lead to staphylococcal meningitis. 
8. Septicaemia. Staphylococcal septicaemia may occur in patients with 
lowered resistance or in patients having underlying staphylococcal infections. 
Patients present with features of bacteraemia such as shaking chills and fever. 
9. Toxic shock syndrome. Toxic shock syndrome is a serious complica- 
tion of staphylococcal infection characterized by fever, hypotension and ex- 
foliative skin rash. The condition affects young menstruating women who use 
tampons of some brands which when kept inside the vagina cause absorption 
of staphylococcal toxins from the vagina. 
 
STREPTOCOCCAL INFECTIONS 
Streptococcal infections are communicable diseases that develop when 
bacteria normally found on the skin or in the intestines, mouth, nose, repro- 
ductive tract, or urinary tract invade other parts of the body and contaminate 
blood or tissue. Streptococci are also gram-positive cocci but unlike staphy- 
lococci, they are more known for their nonsuppurative autoimmune compli- 
cations than suppurative inflammatory responses. Streptococcal infections 
occur throughout the world but their problems are greater in underprivileged 
populations where antibiotics are not instituted readily. 
The following groups and subtypes of streptococci have been identi- 
fied and implicated in different Streptococcal diseases: 
1. Group A or Streptococcus pyogenes, also called (β-haemolytic 
streptococci, are involved in causing upper respiratory tract infection and cu- 
taneous infections (erysipelas). Infection with this pathogen is also causally 
linked to 2 potentially serious nonsuppurative complications: acute rheumatic 
fever and acute glomerulonephritis. In addition, infection with S. pyogenes 
has reemerged as an important cause of toxic shock syndrome and of life- 
threatening skin and soft-tissue infections, especially necrotizingfasciitis. 
2. Group B Streptococcus, also known as Streptococcus agalactiae, is 
best known as a cause of postpartum infection and as the most common cause 
of neonatal sepsis. This organism is also causes infection in nonpregnant 
adults. Group B streptococcal infection in healthy adults is extremely un- 
common, except in young and middle-aged women, and is almost always as- 
sociated with underlying abnormalities, with diabetes most commonly asso- 
ciated with infection in some series. 
3. Group C is a common source of infection in animals. It rarely caus- 




4. Group D is a common cause of wound infections in hospital pa- 
tients. Streptococcus group D infections in humans are most often associated 
with bacteremia, with or without endocarditis. Other less-common infections 
involving group D streptococci include urinary tract infections, meningitis, 
neonatal sepsis, spontaneous bacterial peritonitis, septic arthritis and vertebral 
osteomyelitis. Traditionally, group D streptococcal infections have predomi- 
nantly been caused by Streptococcus bovis. This organism is well-established 
in the literature as a cause of bacteremia and endocarditis and has a well- 
known association with gastrointestinal malignancy. 
5. Group G. Normally present on the skin, in the mouth and throat, and 
in the intestines and genital tract, Group G strep is most likely to lead to in- 
fection in alcoholics and in people who have cancer, diabetes mellitus, rheu- 
matoid arthritis, and other conditions that suppress immune-system activity. 
It can cause a variety of infections, including: bacteria in the bloodstream (bac- 
teremia); inflammation of the connective tissue structure surrounding a joint 
(bursitis); endocarditis (a condition that affects the lining of the heart chambers 
and the heart valves); meningitis; inflammation of bone and bone marrow (oste- 
omyelitis); inflammation of the lining of the abdomen (peritonitis). 
6. Untypable α-haemolytic streptococci such as Streptococcus viridans 
constitute the normal flora of the mouth and may cause bacterial endocarditis. 
7. Pneumococci or Streptococcus pneumoniae are etiologic agents for 




Clostridia are gram-positive spore-forming anaerobic microorganisms 
found in the gastrointestinal tract of herbivorous animals and man. These or- 
ganisms may undergo vegetative division under anaerobic conditions, and spor- 
ulation under aerobic conditions. These spores are passed in faeces and can sur- 
vive in unfavourable conditions. On degeneration of these microorganisms, the 
plasmids are liberated which produce many toxins responsible for the following 
clostridial diseases depending upon the species: 
1. Gas gangrene by C. perfringens 
2. Tetanus by C. tetani 
3. Botulism by C. botulinum 
4. Clostridial food poisoning by C. perfringens 
5. Necrotising enterocolitis by C. perfringens. 
Gas gangrene is a rapidly progressive and fatal illness in which there 
is myonecrosis of previously healthy skeletal muscle due to elaboration of 
myotoxins by some species of clostridia. In majority of cases (80-90%), the 
source of myotoxins is C. perfringens Type A; others are C. novyi and C. 




by contamination with clostridia and become the site of myonecrosis. The in- 
cubation period is 2 to 4 days. The most common myotoxin produced by C. 
perfringens Type A is the alpha toxin which is a lecithinase. The prevention 
of gas gangrene lies in debridement of damaged tissue in which the clostridia 
thrive. The lesion has serosanguineous discharge with odour and contains gas 
bubbles. Infections are characterized by a very low level of host inflamma- 
tion in response to organism-associated exotoxins. Purulence is often absent. 
The process of myonecrosis can spread as fast as 2 cm/h. This results in sys- 
temic toxicity and shock that can be fatal within 12 hours. Overwhelming 
shock with accompanying renal failure usually leads to death. 
 
TETANUS 
Tetanus is characterized by an acute onset of hypertonia, painful mus- 
cular contractions (usually of the muscles of the jaw and neck), and general- 
ized muscle spasms without other apparent medical causes. Tetanus is a se- 
vere acute neurological syndrome of humans and other mammals caused by 
tetanus toxin an extremely potent neurotoxin elaborated by plasmids of 
Cl.tetani. 
Clostridium tetani is an obligate, anaerobic, motile, gram-positive ba- 
cillus. It is nonencapsulated and forms spores that are resistant to heat, desic- 
cation, and disinfectants. Since the colorless spores are located at one end of 
the bacillus. They are found in soil, house dust, animal intestines, and human 
feces. Spores can persist in normal tissue for months to years. The vegetative 
bacilli are found in the gastrointestinal tracts of herbivorous animals and hu- 
mans. Anaerobic condition promotes vegetative division, whereat aerobic 
ones lead to sporulation. 
To germinate, the spores require specific anaerobic conditions, such as 
wounds with low oxidation-reduction potential (eg, dead or devitalized tis- 
sue, foreign body, active infection). Under these conditions, upon germina- 
tion, they may release their toxin. Infection by C. tetani results in a benign 
appearance at the portal of entry because of the inability of the organism to 
evoke an inflammatory reaction 
When the proper anaerobic conditions are present, the spores germi- 
nate and produce the following 2 toxins: 
Tetanolysin – this substance is a hemolysin with no recognized patho- 
logic activity; 
Tetanospasmin – this toxin is responsible for the clinical manifesta- 
tions of tetanus. 
Tetanus remains a frequent and lethal disease in developing countries. 
More than 1 mln cases occur annually world-wide, most of which are fatal. 




horses and cattle), frequency of tetanus-prone wounds, abortion practices and 
immune status of population. Many deaths occur in newborns, owing to the 
custom of coating the umbilical stump with dirt or dung to prevent bleeding. 
In developed countries, tetanus is frequently associated with drug addiction. 
Pathogenesis. At the site of injury, necrotic tissue and suppuration con- 
tribute to the creation of an anaerobic environment, a condition that causes 
spores to revert to vegetative cells, although the clostridia infection remains 
localized, the potent neurotoxin (tetanospasmin) undergoes retrograde 
transport through the ventral roots of peripheral nerves to the anterior horn 
cells of the spinal cord, the toxin crosses the synapse and binds to ganglioside 
receptors on presynaptic terminals of motor neurons in the ventral horns. 
As a result the release of inhibitory neuro-transmitters is blocked, thereby 
permitting unopposed neural stimulation and sustained contraction of skeletal 
muscles (tetany). The block to release of inhibitory neuro-transmitters also in- 
cludes acceleration of the heart rate, hypertension and cardio-vascular instabil- 
ity. Tetanospaspin produces no specific histopathology. 
Clinical features. The incubation period of the disease is 1-3 weeks. 
Tetanus may be categorized into the following 4 clinical types: generalized, 
localized, cephalic and neonatal. 
Approximately 50-75% of patients with generalized tetanus present 
with trismus (―lockjaw‖), which is the inability to open the mouth secondary 
to masseter muscle spasm. Nuchal rigidity and dysphagia are also early com- 
plaints that cause risus sardonicus, the scornful smile of tetanus, resulting 
from facial muscle involvement. As the disease progresses, patients have 
generalized muscle rigidity with intermittent reflex spasms in response to 
stimuli (e.g. noise, touch). Tonic contractions cause opisthotonos (i.e., flexion 
and adduction of the arms, clenching of the fists, and extension of the lower 
extremities). During these episodes, patients have an intact sensorium and 
feel severe pain. The spasms can cause fractures, tendon ruptures, and acute 
respiratory failure. 
Patients with localized tetanus present with persistent rigidity in the 
muscle group close to the injury site. The muscular rigidity is caused by a 
dysfunction in the interneurons that inhibit the alpha motor neurons of the af- 
fected muscles. No further central nervous system involvement occurs in this 
form, and mortality is very low. 
Cephalic tetanus is uncommon and usually occurs after head trauma or 
otitis media. Patients with this form present with cranial nerve palsies. The 
infection may be localized or may become generalized. 
Neonatal tetanus is a major cause of infant mortality in underdeveloped 
countries. Infection results from umbilical cord contamination during unsanitary 




week of life, infected infants become irritable, feed poorly, and develop rigidity 
with spasms. Neonatal tetanus has a very poor prognosis. 
Although at present, tetanus is rare, it has not been eradicated, and early 
diagnosis and intervention are lifesaving. Prevention is the ultimate manage- 
ment strategy for tetanus. 
The outcome of tetanus depends on the age of the patient; the inoculums 
of toxin and the availability of medical support. 
Administration of antibody to bind unabsorbed toxin, antibiotics to 
eliminate infection and supportive care, including respiratory support are the 
mainstays of therapy. Infants and persons older than 50 years of age have the 
highest mortality. 
Complications of tetanus are pneumonia, rupture of muscles, compres- 
sive fracture of spinal column. 
 
BOTULISM 
It is characterized by symmetric paralysis of cranial nerves, limbs and 
trunk. The condition occurs following ingestion of food contaminated with 
neurotoxins of C. botulinum and less often by contamination of a penetrating 
wound. The spores of C. botulinum are capable of surviving in unfavourable 
conditions and contaminate vegetables and other foods, especially if improp- 
erly stored or canned. The symptoms of botulism begin to appear within 12 to 
36 hours of ingestion of food containing the neurotoxins (type A to type G). 
Toxins are absorbed from the stomach and small intestine, where they are not 
denatured by digestive enzymes. Subsequently, they are hematogenously dis- 
seminated and block neuromuscular transmission in cholinergic nerve fibers. 
The nervous, gastrointestinal, endocrine, and metabolic systems are predomi- 
nantly affected. Because the motor end plate responds to acetylcholine, botu- 
linum toxin ingestion results in hypotonia that manifests as descending sym- 
metric flaccid paralysis and is usually associated with gastrointestinal symp- 
toms of nausea, vomiting, and diarrhea. Cranial nerves are affected early in 
the disease course. Later complications include paralytic ileus, severe consti- 
pation, and urinary retention. 
 
CLOSTRIDIAL FOOD POISONING 
It is caused by enterotoxin elaborated by C. perfringens. Out of five 
serotypes of C. perfringens, type A and C produce α-enterotoxin that causes 
food poisoning. These serotypes of organism are omnipresent in the envi- 
ronment and thus clostridial poisoning occurs throughout the world. Food 
poisoning from C. perfringens is mostly from ingestion of meat and its prod- 
ucts which have been allowed to dry resulting in dehydration and anaerobic 




tains vegetative form of the organism and no preformed enterotoxin (unlike 
botulism where preformed neurotoxin of C. botulinum is ingested). On inges- 
tion of the contaminated meat, alpha-enterotoxin is produced in the intestine. 
The gastroenteritis starts about 6 to 24 hours after contaminated food is 
eaten. The most common symptoms are watery diarrhea and abdominal cramps. 
Although usually mild, the infection also can cause abdominal pain, abdominal 
expansion (distention) from gas, severe diarrhea, dehydration, and a severe de- 
crease in blood pressure (shock). Symptoms usually last about 24 hours. 
Necrotising enterocolitis or 'pig bel' is caused by beta-enterotoxin 
produced by C. perfringens Type C. The condition occurs especially in under- 
nourished children who suddenly indulge in overeating such as was first report- 
ed participation in pig feasts by poor children in New Guinea and hence the 
name 'pig bel'. Adults do not develop the condition due to good antibody re- 
sponse. Ingestion of contaminated pork by malnourished children who normally 
take protein-deficient vegetarian diet causes elaboration of beta-enterotoxin. The 
symptoms appear within 48 hours after ingestion of contaminated meat. These 
include: severe abdominal pain, distension, vomiting and passage of bloody 
stools. Milder form of disease runs a course similar to other forms of gastroen- 
teritis while fulminant 'pig bel' may result in death of the child. 
Grossly, the disease affects small intestine segmentally. The affected 
segment of bowel shows green, necrotic pseudomembrane covering the ne- 
crotic mucosa and there is associated peritonitis. Advanced cases may show 
perforation of the bowel wall. Microscopically, there is transmural infiltration 
by acute inflammatory cell infiltrate with changes of mucosal infarction, oe- 
dema and haemorrhage. The pseudomembrane consists of necrotic epitheli- 
um with entangled bacilli. 
 
PLAGUE 
Plague is caused by Yersinia (Pasteurella) pestis which is a small gram- 
negative coccobacillus that grows rapidly on most culture media. Direct identi- 
fication of the organism in tissues is possible by fluorescence antisera methods. 
Plague has been a great killer since 14th century and is known to have 
wiped out populations of cities. Unlike smallpox, the plague never will be eradi- 
cated. It lives in millions of animals and on billions of fleas that reside on them. It 
is a disease of the desert, the steppes, the mountains, and the forest. 
Although, the plague has been considered a disease of the Middle Ag- 
es, multiple outbreaks in India and Africa during the last 20 years have 
stoked fears of another global pandemic. One reason may be the climatic 
change brought about by global warming. This change is ideal for increasing 
the prevalence of Ypestis in the host population. Another reason may be the 




ever-increasing  contact  with  wildlife.  Lastly,  the  dramatic  population  in- 
crease will contribute to conditions of overcrowding and poor sanitation 
conditions ripe for plague hosts and vectors to flourish in. 
Plague is a zoonotic disease and spreads by rodents, primarily by rats, 
both wild and domestic; others being squirrels and rabbits. 
Once the flea bites a susceptible host, the bacilli migrate to the regional 
lymph nodes, are phagocytosed by polymorphonuclear and mononuclear phag- 
ocytes, and multiply intracellularly. Involved lymph nodes show dense concen- 
trations of plague bacilli, destruction of the normal architecture, and medullary 
necrosis. This occurs within 24-48 hours of infection and is accompanied by 
chills, fever, myalgia, nausea, vomiting and marked prostration. With subse- 
quent lysis of the phagocytes, bacteremia can occur and may lead to invasion of 
distant organs. If untreated, death occurs from disseminated intravascular coagu- 
lation (DIG) within 1 to 2 days with development of widespread petechiae and 
ecchymoses leading to gangrene and hence the name black death. In other cases, 
death results from multi-organ failure due to profound toxaemia. The patient 
and his fluids are highly infectious and can be transmitted by arthropods as well 
as person-to-person contact, giving rise to secondary cases. 
Virulence of the organism Y. pestis is attributed to the elaboration of 
plague toxins: pesticin and lipopoly-saccharide endotoxin. 
Pathologic changes. Three forms of the plague exist: bubonic plague 
the most common (60-80%), pneumonic plague (10-15%), and septicemic 
plague (10-15%). 
Bubonic plague. The bacillus invades nearby lymphoid tissue, produc- 
ing the bubo, an inflamed, necrotic, and hemorrhagic regional lymph node. 
Microscopically, the features are: 
• Effaced architecture of lymph nodes due to necrosis in and around the 
affected nodes. 
• Multiple necrotising granulomas. 
• Characteristic mononuclear inflammatory response. 
• Masses of proliferating bacilli in sinusoids of lymph nodes. 
• Cellulitis in the vicinity. 
Spread occurs along the lymphatic channels toward the thoracic duct, 
with eventual seeding of the vasculature. Bacteremia and septicemia ensue. The 
bacillus potentially seeds every organ, including the lungs, liver, spleen, kid- 
neys, and rarely even the meninges. 
The most virulent form, pneumonic plague, results from direct inhala- 
tion of the bacillus, which occurs from close contact of infected hosts or from 
aerosolized bacteria such as may occur if used as a biological weapon. A severe 
and rapidly progressive multilobar bronchopneumonia ensues with subsequent 




fected patient seeds his or her lungs and airways. Bronchopneumonia is character- 
ized by the following conspicuous microscopic features: 
• Necrosis of alveolar walls. 
• Intense hyperaemia and haemorrhages. 
• Numerous bacilli in the alveolar lumina. 
• Characteristic mononuclear inflammatory response with very scanty 
neutrophils. 
The third type of plague is a primary septicemic plague. This is hy- 
pothesized to occur when the bacillus is deposited in the vasculature, bypass- 
ing the lymphatics. Early dissemination with sepsis occurs but without the 
formation of a bubo. This usually is observed in bites to the oral, tonsillar, 
and pharyngeal area and is believed to occur because of the vascularity of the 
tissue and short lymphatic distance to the thoracic duct. 





Tularemia  is  an  acute,  febrile,  granulomatous,  infectious  zoonosis 
caused by Francisella tularensis, an aerobic, gram-negative, pleomorphic ba- 
cillus F tularensis is one of the most infectious bacterial species known, as it 
can cause illness in humans with exposure to as few as 10-50 organisms. 
Four major subspecies, or biovars, exist; they differ in virulence and geo- 
graphic range, with F tularensis biovar tularensis, found primarily in North 
America, being the most virulent. Worldwide, more than 100 species of ani- 
mals, including mammals, birds, amphibians, and arthropods, host F tularen- 
sis. The bacillus, which causes acute infectious illness in humans, may also 
be found in mud and water. 
Some authorities classify tularemia into 2 groups, which include the far 
more common ulceroglandular form (in which local or regional symptoms 
and signs predominate) and the more lethal typhoidal form (in which system- 
ic symptoms dominate the clinical picture). More commonly, however, tula- 
remia is divided into the following 6 forms: ulceroglandular, glandular, ocu- 
loglandular, oropharyngeal, pneumonic, and typhoidal. Each form reflects the 
mode of transmission. The organism gains access to the host by means of in- 
oculation into skin or mucous membrane or through inhalation or ingestion. 
A subcutaneous inoculum of 10 organisms is sufficient to induce dis- 
ease, whereas an inhalational exposure of 25 organisms may cause a severely 
debilitating or fatal disease. Over the first 3-5 days after cutaneous exposure, 




During the next 2-4 days, the site ulcerates. Organisms spread from the 
entry site to regional lymph nodes and may disseminate lympho- 
hematogenously to involve multiple organs. Pulmonary findings may be pri- 
mary after direct inhalation of aerosolized bacteria or may be present in up to 
half of all tularemia cases from hematogenous spread (secondary pneumo- 
nia). Patients are most likely bacteremic at this time, although this is not usu- 
ally detected. 
Infection produces an acute inflammatory response initially involving 
local macrophages, neutrophils, and fibrin. T lymphocytes, epithelioid cells, 
and giant cells then migrate into local necrotic tissue. As the area of necrosis 
expands, thrombosis of adjacent arteries and veins may occur. Granulomas 
develop, which may caseate and be mistaken for tuberculosis, and necrotic 
foci may coalesce to form abscesses. These changes occur in infected sites 
and have been demonstrated on autopsy in lymph nodes, the liver, the spleen, 
bone marrow, and the lungs. F tularensis may remain viable for prolonged 
periods. They may remain viable in the tissues, where they cause infection. 
The ability of F tularensis to impair phagocyte function and survive in in- 
fected cells is central to its virulence. 
The incubation period for tularemia depends on the size of the inocu- 
lum, but ranges from 1-21 days (average 2-6 days). Individuals with tulare- 
mia may be asymptomatic or acutely septic with rapid death. 
As with many other tick-borne diseases, tularemia may, early in its 
course, have a nonspecific presentation. Moreover, many individuals may not 
be aware of or recall having been bitten by a tick or fly. These factors illus- 
trate the importance of routinely including queries regarding travel, work, 
and animal and arthropod exposure in the history when presented with a pa- 
tient who potentially has tularemia. Delayed diagnosis and late administration 
of effective antibiotic therapy may result in increased morbidity and a greater 
risk of mortality in patients with the disease. Children infected with tularemia 
typically have a clinical presentation similar to that of adults. However, chil- 
dren have been reported to have fever, pharyngitis, hepatosplenomegaly, and 
constitutional symptoms more often than do adult patients. 
The following are common findings in the various clinical forms of tu- 
laremia: abrupt onset of fever and chills - these symptoms typically last for 
several days, remit for a brief interval, and then recur; pulse-temperature dis- 
association; headache; anorexia; malaise and fatigue or prostration; myalgias; 
cough; vomiting; pharyngitis; abdominal pain; secondary pneumonitis - may 
occur in 45-83% of patients with the typhoidal form. As many as 20% of pa- 
tients with tularemia have a rash, which may begin as blotchy, macular, or 
maculopapular and progress to pustular. Erythema nodosum and erythema 




Ulceroglandular tularemia. In this form of tularemia, F tularensis 
usually enters the body via a scratch or abrasion and then spreads lymphati- 
cally, typically causing painful regional lymphadenopathy and an ulcerated 
skin lesion. 
In most cases, 2-5 days following exposure to the disease bacterium 
(but with a range of 1-10 days) a small, erythematous, tender or pruritic pap- 
ule occurs at the site of inoculation; the papule enlarges and becomes ulcer- 
ated 2-3 days later. Gradually, the tender necrotic base develops with a black 
eschar, often concomitantly with tender regional adenopathy. 
The tick-borne form usually involves inguinal or femoral adenopathy, 
while the rabbit (animal)-associated form usually involves axillary or epi- 
trochlear adenopathy. Systemic adenopathy may also occur. Some patients 
will exhibit a sporotrichoid picture of ascending, tender subcutaneous nod- 
ules. Lymphadenopathy, lymphadenitis, or both may occur, with tender, sup- 
purative, local enlargement reflecting the site of entry. More than 20% of 
lymph nodes will suppurate if left untreated or treatment is delayed longer 
than 2 weeks. 
The ulcer, which has raised edges and a jagged floor, is located on a 
finger or hand in more than 90% of patients with rabbit-associated disease. In 
tick-borne tularemia, the ulcer is found on a lower extremity or the perineal 
area in 50% of patients, on the trunk in 30% of cases, and on the head in 5- 
10% of patients. 
Glandular tularemia. In the glandular form of tularemia, tender lym- 
phadenopathy occurs without evidence of local cutaneous lesions. The bacte- 
rium presumably gains entry via microscopic abrasions or potentially through 
intact skin. It then spreads lymphatically or via the bloodstream. 
Oculoglandular tularemia. In this form, F tularensis enters via the 
conjunctivae after the patient is either splashed with blood or rubs his or her 
eyes following contact with contaminated tissue fluids. Clinical manifesta- 
tions are usually unilateral; they include the following: unilateral conjunctivi- 
tis - painful, purulent conjunctivitis; some patients experience chemosis, pe- 
riorbital edema, and small, nodular or ulcerative lesions of the palpebral con- 
junctivae; corneal ulceration; lymphadenopathy - most commonly cervical, 
but preauricular and submandibular also observed; photophobia; lacrimation; 
lid edema; vision loss (rare) 
Oropharyngeal tularemia. This is a rare form that may occur after 
consumption of infected, undercooked meat or contaminated water. Manifes- 
tations of oropharyngeal tularemia include the following: stomatitis and exu- 
dative pharyngitis or tonsillitis - the patient may occasionally develop a yel- 
low-white pseudomembrane resembling diphtheria; abdominal pain (due to 




nopathy, including deep neck infection; diarrhea; gastrointestinal bleeding - 
occasionally; caused by intestinal ulcerations 
Pneumonic tularemia. Primary tularemia pneumonia, an uncommon 
condition, occurs after inhalation of F tularensis. Rarely acquired naturally, 
pneumonic tularemia may develop in laboratory workers. Patients with pneu- 
monic tularemia usually report a dry cough, dyspnea, and pleuritic-type chest 
pain. Chest radiography may reveal patchy, ill-defined infiltrates in 1 or more 
lobes. Frank lobar pneumonia may also develop, and bilateral hilar adenopathy 
may be present. Bloody pleural effusions are characteristic and demonstrate a 
mononuclear cellular response. ARDS develops in some patients. 
Typhoidal tularemia. This form of tularemia is particularly severe; it 
probably represents F tularensisbacteremia. Patients with this disease present 
with the following: fever; chills; myalgias; malaise; weight loss. Patients of- 
ten have pneumonia. Diagnosis is difficult because ulcers and lymphadenopa- 
thy are usually absent. 
Untreated tularemia has a mortality rate of 5-15%; if treated, the dis- 
ease carries a mortality rate of 1-3%. The mortality rate is 2-3 times higher in 
patients with typhoidal tularemia than in those with other forms. Other fac- 
tors associated with increased mortality include elevated creatine kinase lev- 
els, renal failure, and other serious comorbidities, as well as late diagnosis. 
The mortality rate also depends on the subspecies involved; F tularensis 
biovar tularensis is significantly more virulent than the others and is respon- 
sible for almost all reported deaths. 
Complications of tularemia include the following: pneumonia; lung 
abscess; respiratory failure, including possible acute respiratory distress syn- 
drome (ARDS); rhabdomyolysis; renal failure with possible hemodialysis; 
hemoptysis; meningitis; endocarditis; suppurative lymphadenitis; pericarditis; 




Brucellosis is a zoonotic infection caused by the bacterial genus Bru- 
cella. The bacteria are transmitted from animals to humans by ingestion 
through infected food products, direct contact with an infected animal, or in- 
halation of aerosols. The disease is an old one that has been known by vari- 
ous names, including Mediterranean fever, Malta fever, gastric remittent fe- 
ver, and undulant fever. Humans are accidental hosts, but brucellosis contin- 
ues to be a major public health concern worldwide and is the most common 
zoonotic infection. 
Brucella organisms, which are small aerobic intracellular coccobacilli, 




rility. They are shed in large numbers in the animal‘s urine, milk, placental 
fluid, and other fluids. To date, 8 species have been identified, named primar- 
ily for the source animal or features of infection. Of these, the following 4 
have moderate-to-significant human pathogenicity: 
 Brucella melitensis (from sheep; highest pathogenicity) 
 Brucella suis (from pigs; high pathogenicity) 
 Brucella abortus (from cattle; moderate pathogenicity) 
 Brucella canis (from dogs; moderate pathogenicity) 
Humans experience only limited risk from wild animals, mainly be- 
cause of lack of proximity or intimate contact and infrequent use of milk and 
meat products from these animals. Concerns have been voiced that interac- 
tion of wild animals with domesticated ones may lead to infection of agricul- 
tural herds, though supportive evidence is quite limited. 
The global burden of human brucellosis remains enormous: The infec- 
tion causes more than 500,000 infections per year worldwide. Interest in bru- 
cellosis has been increasing because of the growing phenomena of interna- 
tional tourism and migration, in addition to the potential use of Brucella as a 
biologic weapon. Familiarity with the manifestations of brucellosis and 
knowledge of the optimal laboratory studies are essential for the recognition of 
this reemerging zoonosis. B melitensis, B abortus, and B suis have been com- 
pletely sequenced, and these sequencing data will help improve our understand- 
ing of the pathogenesis and the manifestations of this complex disease. 
Brucellae are aerobic gram-negative coccobacilli that possess a unique 
ability to invade both phagocytic and nonphagocytic cells and to survive in 
the intracellular environment by finding ways to avoid the immune system. 
This ability helps explain why brucellosis is a systemic disease and can in- 
volve almost every organ system. 
Brucella can gain entry into the human body through breaks in the 
skin, mucous membranes, conjunctivae, and respiratory and gastrointestinal 
tracts. Sexual transmission has not been convincingly documented. Ingestion 
usually occurs by way of unpasteurized milk; meat products often have a low 
bacterial load. 
Once within the bloodstream, the organisms quickly become intracellu- 
lar pathogens contained within circulating polymorphonuclear cells and mac- 
rophages, making use of numerous mechanisms to avoid or suppress bacteri- 
cidal responses. Animal data suggest that the lipopolysaccharide coat 
(smooth in B melitensis, B abortus, and B suis; rough in B canis) is likely to 
play a role in intracellular survival, perhaps because of adenine and guanine 





In addition, Brucella species have relatively low virulence, toxicity, 
and pyrogenicity, making them poor inducers of some inflammatory cyto- 
kines, such as tumor necrosis factor and interferons. Furthermore, the bacte- 
ria do not activate the alternative complement system. Finally, they are 
thought to inhibit programmed cell death. 
After ingestion by phagocytes, about 15-30% of brucellae survive. 
Susceptibility to intracellular killing differs among species, with B abortus 
readily killed and B melitensis rarely affected; these differences might ex- 
plain the differences in pathogenicity and clinical manifestations in human 
cases of brucellosis. 
Brucellae that survive are transported into the lymphatic system and 
may replicate there locally; they also may replicate in the kidney, liver, 
spleen, breast tissue, or joints, causing both localized and systemic infection. 
Any organ system can be involved (eg, central nervous system [CNS], heart, 
joints, genitourinary system, pulmonary system, and skin); localization of the 
process may cause focal symptoms or findings. After replication in the endo- 
plasmic reticulum, the brucellae are released with the help of hemolysins and 
induced cell necrosis. 
Development of cell-mediated immunity is the principal mechanism of 
recovery. The host response to infection with B abortus is characterized by 
the development of tissue granulomas indistinguishable from those of sar- 
coidosis. In contrast, infection with the more virulent species (B melitensis 
and B suis) more commonly results in visceral microabscesses. 
Fever is the most common symptom and sign of brucellosis, occurring 
in 80-100% of cases. It is intermittent in 60% of patients with acute and 
chronic brucellosis and undulant in 60% of patients with subacute brucello- 
sis. Constitutional symptoms of brucellosis include anorexia, asthenia, fa- 
tigue, weakness, and malaise, and weight loss and are very common. 
Bone and joint symptoms include arthralgias, low back pain, spine and 
joint pain, and, rarely, joint swelling. Arthralgias may be diffuse or localized, 
with a predilection for bone ends and the sacroiliac joint. Acute monoarticu- 
lar arthritis is uncommon but may be part of the presentation. 
Neuropsychiatric symptoms of brucellosis are common despite the rare 
involvement of the nervous system. Headache, depression, and fatigue are the 
most frequently reported neuropsychiatric symptoms. In patients with advanced 
disease who have meningoencephalitis, these complaints may include changes 
in mental status, coma, neurologic deficit, nuchal rigidity, or seizures. 
A significant percentage (approximately 50%) of patients have gastro- 
intestinal) complaints, primarily dyspepsia, though abdominal pain from he- 
patic abscesses may occur. Hepatic abscesses should be suspected in patients 




abscess can serve as a source of bacteremic seeding. Spontaneous bacterial 
peritonitis secondary to brucellosis infection has been reported. Constipation, 
diarrhea, and vomiting may occur. 
Genitourinary infections with brucellae have been reported and include 
orchitis, urinary tract infection, and glomerulonephritis. Frank renal failure or 
sepsis is rare. 
Neurologic symptoms of brucellosis can include weakness, dizziness, 
unsteadiness of gait, and urinary retention. Symptoms associated with cranial 
nerve dysfunction may affect persons with chronic central nervous system 
involvement. 
Cough and dyspnea develop in up to 19% of persons with brucellosis; 
however, these symptoms are rarely associated with active pulmonary involve- 
ment. Pleuritic chest pain may affect patients with underlying empyema. 
Endocarditis from brucellae is reported, with septic embolization a 
common complication of this form of brucellosis. Other cardiac complica- 
tions, such as pulmonary edema or dysrhythmias, are rare. Brucella endocar- 
ditis is the form most commonly associated with fatalities. 
With the chronic form of brucellosis, in which the illness has lasted 
longer than 1 year (undiagnosed and untreated brucellosis), an afebrile pat- 
tern is typical, with a history of myalgia, fatigue, depression, and arthralgias 
(chronic fatigue syndrome is the most important disease in the differential di- 
agnosis). The chronic form is primarily caused by B melitensis and usually 
affects adults older than 30 years. The chronic form is rare in children. 
Traditionally, brucellosis has been classified as subclinical, acute, sub- 
acute, or chronic; localized and relapsing forms have also been described. 
This classification system, though commonly used, is subjective and of lim- 
ited clinical utility. 
Subclinical brucellosis. Disease is usually asymptomatic, and the di- 
agnosis is usually established incidentally after serologic screening of per- 
sons at high risk of exposure. Culture data are usually unrevealing. 
Acute and subacute brucellosis. Disease can be mild and self-limited 
(eg, B abortus) or fulminant with severe complications (eg, B melitensis). As- 
sociated symptoms can develop 2-3 months before diagnosis in mild cases 
and 3-12 months before diagnosis in severe cases. Usually, acute brucellosis 
occurs without focal abnormalities. Nonfocal weakness may be noted. Ten- 
derness, swelling, or effusion of joints may be evident. In some instances, or- 
chitis appears after a few days of illness. Testicular swelling and tenderness 
in the wake of chills and high fever thus resemble mumps orchitis. 
Some patients manifest constipation. Occasionally, abdominal tender- 
ness suggests an acute abdomen. In some more severe cases, tender enlarge- 




Murmurs, friction rubs, acute-onset blindness or visual field disturbance, 
tachycardia, oropharyngeal or conjunctival petechiae (some with pale centers), 
Roth spots, splinter hemorrhages of the nail beds, Osler nodes, Janeway lesions, 
or hepatosplenomegaly may develop as manifestations of bacterial endocarditis, 
a complication that is much rarer as an aspect of acute or subacute brucellosis 
than as an element of focal or diffuse chronic brucellosis. 
Rarely, disease of the lungs or pleura is a feature of acute brucellosis, 
manifestations of which could include rales, wheezes, abnormalities of per- 
cussion or egophony, or pleural friction rubs. 
Meningismus, papilledema, mental status changes, and long-tract signs 
are found in a small fraction of cases of acute brucellosis as manifestations of 
acute neurobrucellosis. 
Radicular sensory or motor changes may arise in individuals with bru- 
cellotic osteomyelitis with associated epidural abscess. Focal tenderness or 
pain in the perispinous region may precede fever and objective sensory or 
motor findings. Brucellotic cervical epidural abscess may produce tenderness 
and movement restriction without the classic triad (fever, neck pain, and 
radiculopathy) of streptococcal or other types of epidural abscess. However, 
such findings may eventually develop, prompting delayed consideration of 
this diagnostic entity. 
Chronic brucellosis. The diagnosis of chronic brucellosis is typically 
made after symptoms have persisted for 1 year or more. Low-grade fevers and 
neuropsychiatric symptoms predominate. Results of serologic studies and cul- 
tures are often negative; without confirmatory evidence, many authorities doubt 
the existence of chronic disease. Many patients have persistent disease caused 
by inadequate initial therapy, and underlying localized disease may be present. 
Localized and relapsing brucellosis. Localized complications of bru- 
cellosis are typically observed in patients with acute disease or chronic un- 
treated infection. Osteoarticular, genitourinary, and hepatosplenic involve- 
ment are most common. Cultures of involved tissue sites and serology can be 
diagnostic. 
Bone marrow aspiration and biopsy may be required to establish a di- 
agnosis in certain patients. Bone marrow examination may reveal erythro- 
phagocytosis. Microangiopathic hemolytic anemia, thrombocytopenic purpu- 
ra, and Coombs-positive hemolytic anemia have been reported in brucellosis. 
Percutaneous liver biopsy may be needed in the patient with liver granulomas 
to obtain a specimen for diagnosis. Analysis of liver biopsy specimens may 
reveal granulomatous hepatitis and hepatic microabscesses. Histologic find- 
ings in brucellosis usually include mixed inflammatory infiltrates with lym- 




The prognosis is generally excellent. Although initial symptoms of 
brucellosis may be debilitating, if they are treated appropriately and within 
the first few months of onset, the disease is easily curable, with a low risk of 
relapse or chronic disease. However, the prognosis is poor in persons who 
present with congestive heart failure due to endocarditis, in whom mortality 
approaches 85%. In some patients, brucellosis can cause chronic debilitating 
illness with extensive morbidity. 
In uncomplicated cases of acute brucellosis, fever, malaise, and many 
other manifestations improve rapidly with bed rest, whereas sustained physi- 
cal activity may prolong or worsen the degree of illness. Considerable im- 
provement from the symptoms of the acute phase of illness typically occurs 
within a few weeks, with or without treatment. In many cases, this is fol- 
lowed by complete remission within 2-6 months. Recovery tends to be more 
rapid with B abortus infection than with B melitensis or B suis infection. 
Overall mortality in recognizably symptomatic acute or chronic cases 
of brucellosis is very low, certainly less than 5% and probably less than 2%. 
It is usually the result of the rare instance of Brucella endocarditis or is the 
result of severe CNS involvement, often as a complication of endocarditis. 
Recurrence of symptoms of acute brucellosis is not uncommon. The 
recurrent disease may be systemic or localized. In some of these patients, the 
condition evolves into chronic brucellosis, which may be progressive if un- 
treated. Chronic brucellosis includes systemic and specific localized forms 
(including various types of neurobrucellosis). Chronic brucellosis may con- 
tinue to trouble patients for as long as 25 years, but such cases are quite rare. 
 
ANTHRAX 
Anthrax is a zoonotic infection caused by Bacillus anthracis. Most an- 
thrax is cutaneous (95%). The remaining cases of the disease are inhalational 
(5%) and gastrointestinal (< 1%). Cutaneous anthrax results from exposure to 
the spores of B anthracis while handling sick animals or contaminated wool, 
hair, or animal hides. Pulmonary anthrax results from inhaling anthrax spores. 
GI anthrax results from ingesting meat products that contain anthrax. Anthrax is 
present in areas where animals, particularly herbivores, graze. Anthrax caused 
by inhalation is usually fatal, and symptoms usually begin days after exposure. 
This delay makes the initial exposure to B anthracis difficult to track. 
Anthrax was described in the early literature of the Greeks, Romans, 
Egyptians, and Hindus. The term anthrakis means coal in Greek, and the dis- 
ease is named after the black appearance of its cutaneous form. A modern 
concern is use of anthrax as a biologic warfare agent. 
Anthrax is primarily a disease of herbivores (eg, cattle, sheep, goats, 




cats. Birds are usually naturally resistant to anthrax. Buzzards and vultures 
are naturally resistant to anthrax but may transmit the spores on their talons 
and beaks. 
Anthrax (B anthracis) is a large, spore-forming, gram-positive rod. Per- 
sistence of spores is aided by nitrogen and organic soil content, environmental 
pH greater than 6, and ambient temperature greater than 15°C. Spores can exist 
indefinitely in the environment. Optimal growth conditions result in a vegetative 
phase and bacterial multiplication. Drought or rainfall can trigger anthrax spore 
germination, while flies and vultures spread the spores.Virulence depends on the 
bacterial capsule and the toxin complex. The capsule is a poly-D-glutamic acid 
that protects against leukocytic phagocytosis and lysis. 
Anthrax toxins are composed of 3 entities: a protective antigen, a lethal 
factor, and an edema factor. The protective antigen is an 83-kd protein that 
binds to cell receptors within a target tissue. Once it is bound, a fragment is 
cleaved free to expose an additional binding site. The binding of edema fac- 
tor at this site results in the formation of edema toxin; the binding of lethal 
factor results in the formation of lethal toxin. 
Edema toxin acts by converting adenosine triphosphate to cyclic aden- 
osine monophosphate (cAMP). Cellular cAMP levels are increased, leading 
to cellular edema within the target tissue. Lethal factor is not well under- 
stood; it may inhibit neutrophil phagocytosis, lyse macrophages, and cause 
release of tumor necrosis factor and interleukin-1. Death from anthrax occurs 
as a result of the effects of lethal toxin. Near death or just after death, animals 
bleed from all body orifices. 
Cutaneous anthrax 
Humans are relatively resistant to cutaneous invasion by B anthracis, but 
the organisms may gain access through microscopic or gross breaks in the skin. 
In cutaneous anthrax, a malignant pustule develops at the infection site. Cutane- 
ous anthrax develops 1-7 days (usually 2-5 days) after skin exposure and pene- 
tration of B anthracis spores This pustule is a central area of coagulation necro- 
sis (ulcer) surrounded by a rim of vesicles filled with bloody or clear fluid. A 
black eschar forms at the ulcer site. Extensive edema surrounds the lesion. 
The organisms multiply locally and may spread to the bloodstream or 
other organs (eg, spleen) via the efferent lymphatics. B anthracis remains in 
the capillaries of invaded organs, and the local and fatal effects of the infec- 
tion are due, in large part, to the toxins elaborated by B anthracis. Dissemina- 
tion from the liver, spleen, and kidneys back into the bloodstream may result 
in bacteremia. Secondary hemorrhagic intestinal foci of anthrax result from B 
anthracis bacteremia. 
Intestinal anthrax is a rare form of infection. It occurs from eating in- 




anthrax 2-5 days following ingestion. Abdominal pain and fever occur first, 
followed by nausea, vomiting, malaise, anorexia, hematemesis, bloody diar- 
rhea, and, less often, watery diarrhea. Primary intestinal anthrax predomi- 
nantly affects the cecum and produces a local lesion similar to the lesion pro- 
duced in the cutaneous form. 
As spores are transported to mesenteric lymph nodes, replication and 
bacteremia begin. Ascites and ileus follow as the lymphatic system becomes 
occluded with the large number of bacilli. Peritoneal fluid is turbid with the 
presence of leukocytes and red blood cells from hemorrhagic adenitis. Vascu- 
lar stasis occurs, and the stomach and intestine become edematous. Shock 
may occur from interstitial and intraperitoneal volume losses. Anthrax toxin 
further causes intrinsic renal failure independent of prerenal azotemia. Death 
is rapid without antibiotic therapy and aggressive volume resuscitation. The 
mortality rate is 50%. 
Oropharyngeal anthrax is a more common form of GI anthrax and 
has occurred in epidemic settings. Ingestion of B anthracis spores may result 
in oropharyngeal anthrax 2-7 days after exposure. Typically, 2 days after in- 
gestion of contaminated meat, fever and neck swelling occur in the presence 
of an oral cavity lesion. The lesion starts as an edematous area that becomes 
necrotic and forms a pseudomembrane within 2 weeks. Sore throat, dyspha- 
gia, respiratory distress, and oral bleeding also occur. Soft-issue edema and 
dramatic cervical lymph node enlargement follow. Recovery usually takes 3 
weeks with antibiotic therapy. The reason the disease limits itself to the oro- 
pharyngeal area is unknown. 
Inhalational anthrax occurs after a person inhales spores into the 
lungs. Primate studies suggest that the minimum infective dose ranges from 
4000-8000 inhaled spores. Inhalational anthrax usually occurs in textile and 
tanning industries among workers handling contaminated animal wool, hair, 
and hides. Inhalational anthrax begins abruptly, usually 1-3 days (range, 1-60 
days) after inhaling anthrax spores. Inhaled spores are ingested by pulmonary 
macrophages and then carried to hilar and mediastinal lymph nodes. 
The spores undergo germination and multiplication and begin to elabo- 
rate toxins. Anthrax in the lungs does not cause pneumonia, but it does cause 
hemorrhagic mediastinitis and pulmonary edema. Hemorrhagic pleural effu- 
sions frequently accompany inhalational anthrax. After the lymph nodes be- 
come overwhelmed, bacteremia and death quickly ensue. Without treatment, 
the mortality rate of inhalational anthrax is approximately 95%. 
Bacteremic anthrax with hematogenous spread most commonly fol- 
lows inhalational anthrax. In bacteremic anthrax, hemorrhagic lesions may 




infection resulting from bloodstream invasion secondary to inhalation or in- 
testinal anthrax. 
Anthrax meningitis may complicate any form of anthrax, with bacte- 
remia and hematogenous spread to the CNS. It also has occurred without a 
primary focus. The meninges are characteristically hemorrhagic and edema- 
tous. The mortality rate is near 100%. 
Septicemic anthrax refers to overwhelming infection by anthrax ba- 
cilli. This form of anthrax may complicate inhalational anthrax. The anthrax 
bacilli multiply in the blood and proliferate to outnumber red blood cells. 
Another name for anthrax is black blood, which refers to the very dark color 
of the blood of animals or humans with overwhelming septicemic anthrax. 
Because humans are relatively resistant to invasion by B anthracis, 
most cases of septicemic anthrax occur following inhalational anthrax. The 
number of organisms released from the liver or spleen into the bloodstream 
overwhelms host defenses and produces massive amounts of lethal toxin that 
cause shock and death. 
Histologic Findings. The characteristic finding in anthrax is the pres- 
ence of the organisms in the capillaries at the infection site; therefore, if a pa- 
tient is infected, expect B anthracis in the capillaries of the skin, intestines, 
liver, spleen, lungs, or leptomeninges. Pathological findings are not in pro- 
portion to the numbers of bacilli present, which is best explained by the ef- 
fects of one or more of the toxins associated with B anthracis. Hemorrhage 
may be evident. 
Most cases of anthrax are the cutaneous type, are mild, and resolve with 
or without treatment. If treated early with appropriate antibiotics, the mortality 
rate of cutaneous anthrax is less than 1%. However, other forms of anthrax are 
potentially fatal, with inhalational anthrax carrying the worst prognosis. Inhala- 
tional anthrax and its subsequent systemic infection (eg, septicemia, hemorrhag- 
ic leptomeningitis) have a mortality rate approaching 100%. 
Oropharyngeal or intestinal anthrax carries a less favorable prognosis 
than cutaneous anthrax but a more favorable prognosis than inhalational an- 
thrax. Patients with oropharyngeal anthrax may develop airway obstruction 
(as may those with inhalational anthrax or cutaneous anthrax involving the 
neck). Intestinal anthrax is difficult to diagnose and is associated with higher 




As the name indicates, intestinal infections affect the gastrointestinal 
tract. Most intestinal infections are caused by bacteria, virus, protozoans, and 




food, water, or fecal matter. While other causes, such as contacting with pol- 
luted water and poor hygiene can also trigger intestinal infection. 
Pathogens. Intestinal infections are caused when pathogens enter your 
system and begin irritating the tissue in your digestive tract. The gastrointes- 
tinal tract can become inflamed and sore, which typically begins to cause ad- 
ditional symptoms of digestive distress. Pathogens which cause intestinal in- 
fections are ingested, typically from a contaminated food source. Spoiled 
dairy products, unpasteurized dairy products, spoiled meat, contaminated 
shellfish, or any food which was exposed to microbial pathogens and not 
sterilized properly with the cooking process can increase the risk of develop- 
ing an infection. 
Contaminated water. Coming into contact with contaminated water can 
also lead to an intestinal infection. Water from natural sources such as lakes 
should not be consumed unless it has been thoroughly boiled to sterilize it. 
Swimming pools can also become infested with microbes which can cause in- 
fection if they are not sanitized properly to accommodate the large population. 
Poor hygiene. This can also spread microbes that cause intestinal in- 
fections. Failing to wash your hands after visiting the restroom is a common 
way to contract an infection. Touching surfaces, silverware or food after fail- 
ing to wash your hands increases the risk that others will come into contact 
with these microbes, spreading the risk of disease further. 
Bacterial infection. Bacterial intestinal infections occur through con- 
sumption of food that is contaminated with the infection causing or pathogenic 
bacteria. Bacterial infections most commonly occur in cases wherein food is not 
prepared or handled hygienically. Typically, these kinds of infections are seen in 
places where food is prepared for masses such as cafeterias in schools, fairs, and 
so on. Bacterial intestinal infection is usually because of not cooking meat prod- 
ucts adequately as well as poor hygiene practices such as not washing hands be- 
fore handling foods, not boiling drinking water and so on. Listed below are 
some of common causes of intestinal bacterial infection. 
 Cholera, caused by the bacteria vibrio cholera 
 Typhoid (Salmonella enteritis) 
 Parathyroid infections. 
 Shigellosis (Shigella enteritis) 
 E. coli infections 
 Intestinal staph infection (Staphylococcus) 
 Botulism (Clostridium botulinum) 
 Enteritis (Campylobater enteritis) 
Viral infections. Viruses also cause a lot of stomach infections as 




and has a high death rate in children under the age of 5. The ill effects of viral 
intestinal infections are greater in developing nations where general sanita- 
tion is very poor. With transmission being through contact, viral intestinal in- 
fections can spread very quickly. Some of the common intestinal infections 
are caused by the following viruses. 
 Rotavirus infections 
 Norovirus infections 
 Adenovirus infections 
 Astrovirus infections 
Parasites and protozoans. Parasites and protozoans are another rea- 
son for intestinal infections. These however are usually not self-limiting and 
need medication to kill the pathogens. Some of the common intestinal infec- 
tions caused by parasites and protozoans are listed below. 
 Amoebiasis (Entamoeba hystolytica) 
 Balantidiasis 
 Giardiasis (Giardia lamblia) 
 Cryptosporidiosis (Cyrptosporidium) 
 Intestinal trichomoniasis. 
The most common symptoms of an intestinal infection are diarrhea, ab- 
dominal pain, cramps, nausea, and vomiting. 
 
TYPHOID FEVER 
Typhoid fever, also known as enteric fever, is a potentially fatal multi- 
systemic illness caused primarily by Salmonella typhi. Source of infection – 
sick person. 
S.typhi enters the host's system primarily through the distal ileum. S 
typhi has specialized fimbriae that adhere to the epithelium over clusters of 
lymphoid tissue in the ileum (Peyer patches), the main relay point for macro- 
phages traveling from the gut into the lymphatic system. After crossing lym- 
phatic barrier S.typhi enter into blood and leads to generalization of infec- 
tious process. The Typhoid fever, also known as enteric fever, is a potentially 
fatal multisystemic illness caused primarily by Salmonella typhi. Source of 
infection – a sick person. Microbes are present in urine, faeces, sweat. Route 
of transmission is a fecal-oral. 
Pathogenesis. The typhoid bacilli are ingested through contaminated 
food or water. During the initial asymptomatic incubation period of about 2 
weeks, the bacilli invade the lymphoid follicles and Peyer's patches of the 
small intestine and proliferate. Following this, the bacilli invade the blood 
stream causing bacteraemia, and the characteristic clinical features of the dis- 




served. Immunological reactions (Widal's test) begin after about 10 days and 
peak titres are seen by the end of the third week. Eventually, the bacilli are 
localised in the intestinal lymphoid tissue (producing typhoid intestinal le- 
sions), in the mesenteric lymph nodes (leading to haemorrhagic lymphadeni- 
tis), in the liver (causing foci of parenchymal necrosis), in the gall bladder 
(producing typhoid cholecystitis), and in the spleen (resulting in splenic reac- 
tive hyperplasia). 
S typhi enters the host's system primarily through the distal ileum. S 
typhi has specialized fimbriae that adhere to the epithelium over clusters of 
lymphoid tissue in the ileum (Peyer patches), the main relay point for macro- 
phages traveling from the gut into the lymphatic system. After crossing lym- 
phatic barrier S.typhi enter into blood and leads to generalization of infec- 
tious process. The bacteria then infect the gallbladder via either bacteremia or 
direct extension of S typhi –infected bile. The result is that the organism re- 
enters the gastrointestinal tract in the bile and reinfects Peyer`s patches and 
lymphatic nodules and causes necrosis of Payer‘s patches. After that mi- 
crobes excreted with urine faeces, bile, sweat, with milk in feeding mothers. 
In this period the patient is more infective and can cause infection of others. 
Pathologic changes. The lesions are observed in the intestines as well 
as in other organs. 
Intestina (local) changes develop in mucous membrane and lymphatic 
tissue of intestine. Macroscopically, terminal ileum is affected most often, 
but lesions may be seen in the jejunum and colon. The Peyer's patches show 
oval typhoid ulcers with their long axis along the length of the bowel. The 
base of the ulcers is black due to sloughed mucosa. The margins of the ulcers 
are slightly raised due to inflammatory oedema and cellular proliferation. 
There is never significant fibrosis and hence fibrous stenosis seldom occurs 
in healed typhoid lesions. The regional lymph nodes are invariably enlarged. 
Microscopically, there is hyperaemia, oedema and cellular proliferation 
consisting of phagocytic histiocytes (showing characteristic erythrophagocy- 
tosis), lymphocytes and plasma cells. Though enteric fever is an example of 
acute inflammation, neutrophils are invariably absent from the cellular infil- 
trate and this is reflected in the leucopenia with neutropenia and relative lym- 
phocytosis in the peripheral blood. 
So, 5 stages of intestinal lesion may be described: 
1. Stage of brain like swelling. 
2. Necrosis of enteric fever granulomas. 




4. Stage of pure ulcers. 
5. Ulcer healing and formation of scars. 
Other lesions. Typhoid red papular rash appears on 7-11th day at first on 
the abdomen. Besides the intestinal involvement, various other organs and tis- 
sues showing pathological changes in enteric fever are: 
i) Mesenteric lymph nodes — haemorrhagic lymphadenitis. 
ii) Liver — foci of parenchymal necrosis, 
iii) Gallbladder — typhoid cholecystitis, 
iv) Spleen — splenomegaly with reactive hyperplasia. 
v) Kidneys — nephritis. 
vi) Abdominal muscles — Zenker's degeneration, 
vii) Joints — arthritis, 
viii) Bones — osteitis, 
ix) Meninges — Meningitis. 
x) Testis — Orchitis. 
There is dystrophy in internal organs. 
Complications usually result from intestine damage (intestinal complica- 
tions)/ These are perforation of the ulcers and haemorrhage. Beside broncho 
pneumonia (due to association of secondary infection), osteomyelitis, sepsis 
may develop. 
Persistence of organism in the gallbladder or urinary tract may result in 
passage of organisms in the faeces or urine creating a 'carrier state' which is a 
source of infection to others. 
The prognosis among persons with typhoid fever depends primarily on 
the speed of diagnosis and initiation of correct treatment. Generally, untreated 
typhoid fever carries a mortality rate of 10%-20%. In properly treated disease, 
the mortality rate is less than 1%. 
 
SALMONELLOSIS 
It is a group of intestinal infections caused by salmonellae. They are 
seen in humans as weel as in animals – atropozoonosis. Most frequent causa- 
tive agents are Salmonella typhymurium, S.enteritidis, S.cholerae sues. 
The transmission of salmonella to a susceptible host usually occurs via 
consumption of contaminated foods. The most common sources of salmonella 
include beef, poultry, and eggs. Improperly prepared fruits, vegetables, dairy 
products, and shellfish have also been implicated as sources of Salmonella. 
Although the infectious dose varies among Salmonella strains, a large 
inoculum is thought to be necessary to overcome stomach acidity and to 
compete with normal intestinal flora. Large inocula are also associated with 




bacterial cells are needed to cause infection. Low gastric acidity, which is 
common in elderly persons and among individuals who use antacids, can de- 
crease the infective dose to 103 cells, while prior vaccination can increase the 
number to 109 cells. 
After ingestion, infection with salmonella is characterized by attach- 
ment of the bacteria by fimbriae or pili to cells lining the intestinal lumen. 
Salmonella selectively attach to specialized epithelial cells (M cells) of the 
Peyer patches. The bacteria are then internalized by receptor-mediated endo- 
cytosis and transported within phagosomes to the lamina propria, where they 
are released. Once there, salmonella induce an influx of macrophages (ty- 
phoidal strains) or neutrophils (nontyphoidal strains). 
The incubation period depends on the host and the inoculum is gener- 
ally 6-72 hours. In most cases, stools are loose and bloodless. In rare cases, 
Salmonella infections cause large-volume cholera like diarrhea or may be as- 
sociated with tenesmus. The diarrhea is typically self-limiting and resolves 
within 3-7 days. Fever, abdominal cramping, chills, headache, and myalgia 
are common. Fever usually resolves within 48 hours. 
There are 3 main clinical forms of salmonellosis: 
1. Intestinal – develops as acute gastritis with the dehydratation be- 
cause of vomiting and diarrhea, 
2. Septic – intestinal changes are not well marked but there is 
haematogenic spread of causative agent. Purulent inflammation in lungs and 
brain occur. 
3. Typhoid – it resembles enteric fever. The changes in intestine, 
lymph nodes and spleen appear as in enteric fever but are less marked. There 
is rare intestinal hemorrhage and perforation of intestinal wall. 
 
DYSENTERIES 
The term 'dysentery' is used to mean diarrhoea with abdominal cramps, 
tenesmus and passage of mucus in the stools, from any cause. There are 2 
main forms of dysenteries — bacillary and amoebic. 
1. Bacillary dysentery. Bacillary dysentery is the term used for infec- 
tion by shigella species: S. dysenteriae, S. flexneri, S. boydii and S. sonnei. 
Infection occurs by foecooral route and is seen with poor personal hygiene, in 
densely populated areas, and with contaminated food and water. The com- 
mon housefly plays a role in spread of infection. 
Large intestine (colon sigmoideum and rectum) is more frequently af- 
fected. Bacteria affect the large intestinal epithelium and lead to necrosis of 
mucous membrane. Bacterial endotoxin shows vasoneuroparalytic action that 
leads to increased exudation, necrotic changes in the intestinal wall and for- 




Microscopically, the lesions are mainly found in the colon and occa- 
sionally in the ileum. Superficial transverse ulcerations of the bowel wall 
mucosa occur in the area of lymphoid follicles but perforation is seldom seen. 
The intervening intact mucosa is hyperaemic and oedematous. Following re- 
covery from the acute attack, complete healing usually takes place. Micro- 
scopically, the mucosa overlying the lymphoid follicles is necrosed. The sur- 
rounding mucosa shows congestion, oedema and infiltration by neutrophils 
and lymphocytes. The mucosa may be covered by greyish-yellow 'pseudo- 
membrane' composed of fibrino-suppurative exudate. 
According to local changes, seen in large intestines, 4 stages may be 
diagnozed: 
1. Stage of catarrhal colitis – there are congestion and edema of in- 
testinal mucous membrane and small putches of necrosis. It continues for 2-3 
days. 
2. Stage of fibrinous colitis – there are necrosis and leukocyte infil- 
tration, appearance of fibrin layer on the mucous membrane and dystrophic 
changes in nerve plexus. It continues for 5-10 days. 
3. Ulceration stage – ulcers develop after the fibrinous layer and 
necrotic masses rejection. There may be complicated with intestinal hemor- 
rhage and perforation. 
4. Stage of ulcer healing – defect is filled with granulation tissue, 
which develops and converted into connective tissue scar. Large ulcers heal- 
ing may cause the deformation and stenosis of intestinal lumen. 
Sometimes there may be catarrhal colitis only. In children‘s it affects 
lymphoid tissue of intestines. If healing process is slow, chronic dysentery 
may develop. 
General changes are hyperplasia of spleen, liver dystrophy, dystrophy 
of the heart and kidney. 
Complication include perforation of intestine with development of per- 
itonitis, phlegmone of intestine, intestinal hemorrhage, stenosis of intestine, 
development of pneumonia, pyelonephritis, intoxication, polyarthritis and iri- 
docyclitis. 
2. Amoebic dysentery (Amoebiasis) 
Amoebiasis is caused by Entamoeba histolytica, named for its lyric ac- 
tion on tissues. It is the most important intestinal infection of man. The con- 
dition is particularly more common in tropical and subtropical areas with 
poor sanitation. 
The parasite occurs in 2 forms: a trophozoite form which is active adult 
form seen in the tissues and diarrhoeal stools, and a cystic form seen in 
formed stools but not in the tissues. The trophozoite form can be stained posi- 




nuclei can be identified in stools. The cysts are the infective stage of the par- 
asite and are found in contaminated water or food. Ingestion of E histolytica 
cysts from the environment is followed by excystation in the terminal ileum 
or colon to form highly motile trophozoites. Upon colonization of the colonic 
mucosa, the trophozoite may encyst and is then excreted in the feces, or it 
may invade the intestinal mucosal barrier and gain access to the bloodstream, 
whereby it is disseminated to the liver, lung, and other sites. Excreted cysts 
reach the environment to complete the cycle. 
Pathologic changes. The incubation period for E histolytica infection 
is commonly 2-4 weeks but may range from a few days to years. The clinical 
spectrum of amebiasis ranges from asymptomatic infection to fulminant coli- 
tis and peritonitis to extraintestinal amebiasis (liver abscess, pleuropulmonary 
disease, peritonitis, pericarditis, brain abscess, genitourinary disease),  the 
most common form of which is amebic liver abscess. 
Amoebic colitis, the most common type of amoebic infection begins as 
a small area of necrosis of mucosa which may ulcerate. These ulcerative le- 
sions may enlarge, develop undermining of margins of the ulcer due to lytic 
action of the trophozoite and have necrotic bed. Such chronic amoebic ulcers 
are described as flask-shaped ulcers due to their shape. The margin of the ul- 
cer shows inflammatory response consisting of admixture of poly- 
morphonuclear as well as mononuclear cells. Complications of amebic colitis 
include the following: fulminant or necrotizing colitis, toxic megacolon, 
ameboma, rectovaginal fistula. 
Amoebic liver abscess may be formed by invasion of the radicle of the 
portal vein by trophozoites. Amoebic liver abscess may be single or multiple. 
The amoebic abscess contains a yellowish-grey amorphous liquid material in 
which trophozoites are identified at the junction of the viable and necrotic tis- 
sue. Complications of amebic liver abscess include the following: intraperi- 
toneal, intrathoracic, or intrapericardial rupture, with or without secondary 
bacterial infection; direct extension to pleura or pericardium; dissemination 
and formation of brain abscess. 
Amoeboma a less common form of intestinal disease, arises from the 
formation of annular colonic granulation in response to the infecting organ- 
isms, which results in a large local lesion of the bowel. Microscopically, the 
lesion consists of inflammatory granulation tissue, fibrosis and clusters of 
trophozoites at the margin of necrotic with viable tissue. 
 
CHOLERA 
It is the infection which affects the stomach and small intestine. Causa- 
tive agent is Vibrio cholera. They multiplicate and secrete exotoxin – chol- 




water reabsorption. The hallmark of the disease is profuse secretory diarrhea. 
Although the disease may be asymptomatic or mild, severe cholera can cause 
dehydration and death within hours of onset. 
In the developed countries, because of advanced water and sanitation 
systems, cholera is not a major threat. Despite all the major advances in re- 
search, the condition still remains a challenge to the modern medical world. 
Cholera is transmitted by the fecal-oral route. Source of infection is a 
sick person. 
Cholera is typically transmitted to humans by either contaminated food 
or water. Most cholera cases in developed countries are a result of transmis- 
sion by food, while in the developing world it is more often water. Food 
transmission can occur when people harvest seafood such as oysters in waters 
infected with sewage, as Vibrio cholerae accumulates in planktonic crusta- 
ceans and the oysters eat the zooplankton. 
Cholera can be endemic, epidemic, or pandemic. 
When consumed, most bacteria do not survive the acidic conditions of 
the human stomach. The few surviving bacteria conserve their energy and 
stored nutrients during the passage through the stomach by shutting down 
much protein production. When the surviving bacteria exit the stomach and 
reach the small intestine, they must propel themselves through the thick mu- 
cus that lines the small intestine to reach the intestinal walls where they can 
attach and thrive. 
Once the cholera bacteria reach the intestinal wall they no longer need the 
flagella to move. The bacteria stop producing the protein flagellin to conserve 
energy and nutrients by changing the mix of proteins which they express in re- 
sponse to the changed chemical surroundings. On reaching the intestinal wall, 
V. cholerae start producing the toxic proteins that result in constitutive cAMP 
production, which in turn leads to secretion of H2O, Na+, K+, Cl−, and HCO3− 
into he lumen of the small intestine and rapid dehydration. 
Stages of cholera: 
1. Choleric enteritis – it has serous character. Mucous membrane is 
edematous, congested. There is increased formation of mucous and hemorrhages. 
2. Choleric gastroenteritis – there is necrosis of mucous membrane, 
damage of microvillus and dehydration 
3. Alhyde period – more expressive morphological changes. Mucous 
membrane has necrosis and sloughing of epithelium, expressive inflammatory 
infiltration and hemorrhages. 
In the intestinal lumen there is large amount of liquid which looks like 
rice water and contains vibrio. Diarrhea leads to dehydration and loss of min- 




cosity, oliguria, hypothermia. All these changes lead to choleric coma and pa- 
tient‘s death. 
Signs of dehydration seen in cadavers are dry skin, wrinkles, mainly on 
hands, dry serous and mucous membrane.In the liver, kidney and myocardi- 
um thare are severe dystrophic changes. 
Complications are choleric typhoid, fibrinous colitis, liver necrosis, 
subacute extracapillary glomerulonephritis or necrotic nephrosis with uremia 
development, postcholeric uremia, development of pneumonia, abscesses. 
Death occurs due to dehydration in alhyde period, coma, uremia. 
Before the development of effective regimens for restoration of fluid 
and electrolyte losses, the mortality in severe form of cholera was more than 
50%. Mortality is higher in pregnant women and children 
 
YERSINIOSIS 
Yersiniosis is a relatively uncommon infection contracted through the 
consumption of undercooked meat products (especially pork), unpasteurized 
milk, or contaminated water. Usually, someone with an infection caused by 
Yersinia bacteria recovers within a few days without medical treatment. 
Of the three main types of yersiniosis that affect people, Yersinia en- 
terocolitica (bacteria that thrive in cooler temperatures) are responsible for 
most infections. The infection seems to be more common in cooler climates. 
Yersinia enterocolitica is a pleomorphic, gram-negative bacillus that 
belongs to the family Enterobacteriaceae. As a human pathogen, 
Y.enterocolitica is most frequently associated with enterocolitis, acute diar- 
rhea, terminal ileitis, mesenteric lymphadenitis, and pseudoappendicitis, with the 
spectrum of disease ranging from asymptomatic to life-threatening sepsis, espe- 
cially in infants. The bacterium was first reported by Mclver and Picke, in 1934. 
Y.enterocolitica most commonly affects young individuals (approxi- 
mately 75% of patients with Y.enterocolitica infection are aged 5-15 years), 
but whether this represents an increased susceptibility or a greater likelihood 
of developing symptomatic illness is unclear. Most cases of Y.enterocolitica 
infection are sporadic, but reports have documented large outbreaks centered 
on a single contaminated source. 
Human yersiniosis is attributed to contaminated pork, milk, water, and 
tofu consumption, as well as to blood transfusion. Infected individuals may 
shed Y.enterocolitica in stools for 90 days after the symptom resolution, sug- 
gesting that early detection of Y.enterocolitica from diarrheal stool samples is 
critical in preventing its transmission and an eventual outbreak. 
As with other members of the genus Yersinia, Y.enterocolitica is an in- 




searchers have elucidated several potential pathogenic properties, including 
chromosomally mediated effects (eg, attachment to tissue culture, production 
of enterotoxin) and plasmid-mediated mechanisms (eg, production of Vw an- 
tigens, calcium dependency for growth, autoagglutination). 
As a foodborne pathogen, Y.enterocolitica can efficiently colonize and 
induce disease in the small intestine. Following ingestion, the bacteria colo- 
nize the lumen and invade the epithelial lining of the small intestine, resulting 
in the colonization of the underlying lymphoid tissues known as Peyer patch- 
es. A direct lymphatic link between the Peyer patches and mesenteric lymph 
nodes may result in bacterial dissemination to these sites, resulting in mesen- 
teric lymphadenitis or systemic infection. 
Dissemination to extraintestinal sites, such as the spleen, is hypothe- 
sized to occur via 2 main mechanisms: (1) colonization of the Peyer patches, 
which can then be used as a staging ground for spread into the blood and/or 
lymph, ultimately resulting in the appearance of bacteria in other tissues, and 
(2) bypass of the Peyer patches, with Y.enterocolitica going straight to sys- 
temic colonization. The possibilities of additional avenues for dissemination 
have yet to be excluded. 
The enterotoxin produced by Y.enterocolitica is similar to that pro- 
duced by the heat-stable Escherichia coli; however, it likely plays a minor 
role in causing disease, as diarrheal syndromes have been observed in the ab- 
sence of enterotoxin production. In addition, the toxin does not appear to be 
produced at temperatures higher than 30°C. The plasmid-mediated outer 
membrane antigens are associated with bacterial resistance to opsonization 
and neutrophil phagocytosis. 
One unique property of Y.enterocolitica is its inability to chelate iron, 
which is an essential growth factor for most bacteria and is obtained through 
the production of chelators known as siderophores. Y.enterocolitica does not 
produce siderophores but can utilize siderophores produced by other bacteria. 
The usual presentation of Y.enterocolitica infection includes diarrhea 
(the most common clinical manifestation of this infection), low-grade fever, 
and abdominal pain lasting 1-3 weeks. Diarrhea may be bloody in severe cas- 
es. Vomiting is present in approximately 15-40% of cases. The existence of 
extraintestinal symptoms after a gastrointestinal illness may also indicate the 
possibility of yersiniosis. 
Enterocolitis, the most common presentation of Y.enterocolitica, oc- 
curs primarily in young children, with a mean age of 24 months. The incuba- 
tion period is 4-6 days, typically with a range of 1-14 days. 
Prodromal symptoms of listlessness, anorexia, and headache may be pre- 
sent. Such symptoms are followed by watery, mucoid diarrhea; fever ; colicky 




generally has a duration of 1 day to 3 weeks. Most cases are self-limited. How- 
ever, concomitant bacteremia may occur in 20-30% of infants younger than 3 
months. 
Complications of enterocolitis include appendicitis, diffuse ulceration 
and inflammation of the small intestine and colon, peritonitis, meningitis, in- 
tussusception, and cholangitis. 
Histologic findings in Y.enterocolitica infection are consistent with 
acute and chronic inflammation. Yersiniosis does not produce unique histo- 
logic findings. Epithelial cell granulomas with suppuration of the centers of the 
granulomas (central microabscesses) have been reported. These granulomas 
were composed of numerous histiocytes with or without epithelioid cell fea- 
tures, along with scattered small T-lymphocytes and plasmacytoid monocytes 
 
GIARDIASIS 
Giardiasis is a major diarrheal disease found throughout the world. The 
flagellate protozoan Giardia intestinalis - (previously known as G. lamblia), its 
causative agent, is the most common protozoal intestinal parasite isolated 
worldwide. Infection is more common in children than in adults. 
G.intestinalis can cause asymptomatic colonization or acute or chronic 
diarrheal illness. The organism has been found in as many as 80% of raw wa- 
ter supplies from lakes, streams, and ponds and in as many as 15% of filtered 
water samples. It is a common cause of chronic diarrhea and growth retarda- 
tion in children in developing countries. 
Giardiasis usually represents a zoonosis with cross-infectivity between 
animals and humans. Giardia intestinalis has been isolated from the stools of 
beavers, dogs, cats, and primates. Beavers may be an important reservoir host 
for G.intestinalis. Other Giardia species include G .muris in rodents; G.agilis 
in amphibians; G.psittaci and G ardeae in birds; and G .microti in voles and 
muskrats. Although G. intestinalis was the first protozoan parasite described, 
its role as a pathogenic organism was not recognized until the 1970s, after 
community outbreaks and after the appearance of the disease in travelers re- 
turning from endemic regions. Prior to that time, the organism was thought to 
be a harmless commensal organism of the intestine. 
Giardia species are endemic in areas of the world that have poor sani- 
tation. In developing countries, the disease is an important cause of morbidi- 
ty. Water-borne and food-borne outbreaks are common. Because ingestion of 
as few as 10 Giardia cysts may be sufficient to cause infection, giardiasis is 
common in daycare center attendees and institutionalized patients in developed 
countries. G.intestinalis is a particularly significant pathogen for people with 




Infection with Giardia intestinalis most often results from fecal-oral 
transmission or ingestion of contaminated water. Contaminated food is a less 
common etiology. Person-to-person spread is common, with 25% of family 
members with infected children themselves becoming infected. 
Most infections are asymptomatic. The rate of symptomatic infection 
in the natural setting varies from 5-70%. Giardia is found in healthy people 
in endemic areas, and asymptomatic carriage with excretion of high numbers 
of cysts in stools is common. Predisposing factors to symptomatic infection 
include hypochlorhydria, various immune system deficiencies, blood group 
A, and malnutrition. The incubation period averages 1-2 weeks, with a mean of 
9 days. The average duration of symptoms in all ages ranges from 3-10 weeks. 
Giardia life cycle. Giardia has one of the simplest life cycles of all 
human parasites. The life cycle is composed of 2 stages: (1) the trophozoite, 
which exists freely in the human small intestine; and (2) the cyst, which is 
passed into the environment. No intermediate hosts are required. 
Upon ingestion of the cyst, contained in contaminated water or food, 
excystation occurs in the stomach and the duodenum in the presence of acid 
and pancreatic enzymes. The trophozoites pass into the small bowel where 
they multiply rapidly, with a doubling time of 9-12 hours. As trophozoites 
pass into the large bowel, encystation occurs in the presence of neutral pH 
and secondary bile salts. Cysts are passed into the environment, and the cycle 
is repeated. 
Mechanism of injury. The mechanisms by which Giardia causes diar- 
rhea and intestinal malabsorption are probably multifactorial and not yet fully 
elucidated. Postulated mechanisms include damage to the endothelial brush 
border, enterotoxins, immunologic reactions, and altered gut motility and flu- 
id hypersecretion via increased adenylate cyclase activity. 
Adhesion of trophozoites to the epithelium has been demonstrated to 
cause increased epithelial permeability. Giardia- induced loss of intestinal 
brush border surface area, villus flattening, inhibition of disaccharidase activ- 
ities, and eventual overgrowth of enteric bacterial flora appear to be involved 
in the pathophysiology of giardiasis but have yet to be causatively linked to 
the disease's clinical manifestations. 
Marked or moderate partial villous atrophy in the duodenum and jeju- 
num can be observed in histologic sections from asymptomatic individuals 
who are infected. In addition to disrupting the mucosal epithelium, effects in 
the intestinal lumen may contribute to malabsorption and the production of 
diarrhea. Nevertheless, diarrhea can occur in individuals in the absence of 
obvious light microscopic changes in small intestinal structure. 
Varying degrees of malabsorption of sugars (e.g., xylose, disaccha- 




to substantial weight loss. The histopathologic response to giardiasis varies 
and imperfectly correlates with the clinical symptoms. 
G.intestinalis may release cytopathic substances that damage the intes- 
tinal epithelium. Giardia species contain thiol-dependent and thiol- 
independent proteinases, which may find substrates in the microvillus mem- 
brane. In addition, the surface mannose-binding lectin of G.intestinalis may 
contribute to epithelial damage. Whatever the mechanism by which 
G.intestinalis damages villous epithelial cells, the result consistently appears 
to be an increase in crypt length and crypt cell proliferation. 
Enterocytic injury is mediated by activated host T lymphocytes. Patho- 
physiological activation of lymphocytes is secondary to Giardia -induced 
disruption of epithelial tight junctions, which, in turn, increases intestinal 
permeability. Loss of epithelial barrier function is a result of Giardia - 
induced enterocyte apoptosis. 
Epithelial barrier dysfunction in cases with chronic giardiasis is associ- 
ated with increased rates of enterocyte apoptosis. Consistent with these ob- 
servations, microarray analyses of the effects of G. intestinalis on human 
CaCo2 cells found that the parasite–host interactions lead to a pronounced 
up-regulation of genes implicated in the apoptotic cascade and the formation 
of reactive oxygen species. 
Giardia can also prevent the formation of nitric oxide, a compound 
known to inhibit giardial growth, by consuming local arginine, which effective- 
ly removes the substrate needed by enterocytes to produce nitric oxide. This 
mechanism may contribute to Giardia -induced enterocyte apoptosis because 
arginine starvation in these cells is known to cause programmed cell death. 
The prognosis for patients with giardiasis is generally excellent. Most 
patients are asymptomatic, and most infections are self-limited. Giardiasis is 
not associated with mortality except in rare cases of extreme dehydration, 
primarily in infants or malnourished children. Several antibiotic agents are 
available with good efficacy rates to shorten the disease course, although 
drug resistance has been observed in clinical experience. Untreated, giardia- 
sis can last for weeks. The parasite persists in the stool. Reinfection is possi- 
ble. Weight loss, disaccharidase deficiency, malabsorption, and growth retar- 
dation are possible complications. G. intestinalis has been implicated as the 
chief cause of growth retardation in infected children, even after other diar- 
rhea-causing agents are controlled. Some patients may experience persistent 
symptoms (e.g., chronic diarrhea/steatorrhea, malabsorption) despite appar- 
ently effective antibiotic treatment, although these usually subside over 
weeks to months. Patients reported bloating, diarrhea, and abdominal pain, 




Complications of giardiasis may include the following: development of 
chronic illness with weight loss; malabsorption syndrome in adults; failure to 
thrive in children; disaccharidase deficiency; zinc deficiency in schoolchil- 
dren; growth retardation; persistent gastrointestinal symptoms. 
The traditional basis of diagnosis is identification of Giardia intesti- 
nalis trophozoites or cysts in the stool of infected patients via a stool ova and 
parasite examination. Stool antigen enzyme-linked immunosorbent assays also 
are available. Standard treatment for giardiasis consists of antibiotic therapy. 
 
ESCHERICHIA COLI INFECTIONS 
Escherichia coli is one of the most frequent causes of many common 
bacterial infections, including cholecystitis, bacteremia, cholangitis, urinary 
tract infection, and traveler's diarrhea, and other clinical infections such as 
neonatal meningitis and pneumonia. 
Escherichia organisms are gram-negative bacilli that exist singly or in 
pairs. E. coli is facultative anaerobic with a type of metabolism that is both 
fermentative and respiratory. They are either non motile or motile by peritri- 
chous flagella. E. coli is a major facultative inhabitant of the large intestine. 
As a cause of enteric infections, 6 different mechanisms of action of 6 
different varieties of E. coli have been reported. Enterotoxigenic E coli 
(ETEC) is a cause of traveler's diarrhea. Enteropathogenic E. coli (EPEC) is 
a cause of childhood diarrhea. Enteroinvasive E. coli (EIEC) causes a Shigel- 
la-like dysentery. Enterohemorrhagic E. coli (EHEC) causes hemorrhagic co- 
litis or hemolytic-uremic syndrome. Enteroaggregative E. coli (EAggEC) is 
primarily associated with persistent diarrhea in children in developing coun- 
tries, and Enteroadherent E coli (EAEC) is a cause of childhood diarrhea and 
traveler's diarrhea in Mexico and North Africa. ETEC, EPEC, EAggEC, and 
EAEC colonize the small bowel, and EIEC and EHEC preferentially colonize 
the large bowel prior to causing diarrhea. 
Shiga toxin–producing E. coli (STEC) is among the most common 
causes of foodborne diseases. This organism is responsible for several gastro- 
intestinal illnesses, including nonbloody and bloody diarrhea. Patients with 
these diseases, especially children, may be affected by neurologic and renal 
complications, including hemolytic-uremic syndrome. 
 
BALANTIDIASIS 
Balantidiasis (also known as balantidiosis) is defined as large-intestinal 
infection with Balantidium coli, which is a ciliated protozoan (and the largest 
protozoan that infects humans). B. coli is known to parasitize the colon, and 
pigs may be its primary reservoir. Balantidiasis tends to be more common 




B. coli exists as a trophozoite and a cyst and usually affects the large 
intestine, from the caecum to the rectum. The trophozoites replicate by binary 
fission and conjugation, and they subsist on bacteria. Humans ingest infective 
cysts, which then migrate to the large intestine, cecum, and terminal ileum. 
The organisms primarily dwell in the lumen but can also penetrate the muco- 
sa and cause ulcers. B. coli produces hyaluronidase, potentially enhancing its 
ability to invade the mucosa. 
Patients with balantidiasis may present with abdominal tenderness, fe- 
ver, and prolonged diarrhea, which may result in signs of dehydration. 
Histologic  findings.  B  coli can  invade  the  mucosa  and  submucosa, 
causing ulceration and infiltration with polymorphonuclear cells, lympho- 
cytes, and eosinophils. Trophozoites can be observed at the invading edge of 
ulcers or at the periphery of submucosal abscesses. 
Complications. Intestinal perforation and extraintestinal spread to liver 
and mesenteric lymph nodes are rare. Pulmonary involvement has been re- 
ported and appears to be more common in patients with underlying illnesses 
such as diabetes, cancer, or impaired lymphocyte function. 
Most cases of balantidiasis in immunocompetent individuals are 






Rhinoscleroma is a chronic granulomatous bacterial disease of the nose 
and other parts of the upper respiratory tract, caused by Klebsiella rhinoscle- 
romatis. 
Rhinoscleroma is endemic to areas of Africa (Egypt, tropical areas), 
Southeast Asia, Mexico, Central and South America, and Central and Eastern 
Europe. It is rare in Western Europe. 
Rhinoscleroma develops due to direct inhalation of droplets or contam- 
inated material. The disease probably begins in areas of epithelial transition 
such as the vestibule of the nose, the subglottic area of the larynx, or the area 
between the nasopharynx and oropharynx. Cellular immunity is impaired in 
patients with rhinoscleroma; however, their humoral immunity is preserved. 
Rhinoscleroma usually affects the nasal cavity, but lesions associated 
with rhinoscleroma may also affect the larynx; nasopharynx; oral cavity; pa- 
ranasal sinuses; or soft tissues of the lips, nose, trachea, and bronchi. 
Classic  histopathologic  findings  include  large  vacuolated  Mikulicz 




large macrophage with clear cytoplasm that contains the bacilli; this cell is 
specific to the lesions in rhinoscleroma. 
 
TUBERCULOSIS 
Tuberculosis (TB), a multisystemic disease with myriad presentations and 
manifestations, is the most common cause of infectious disease–related mortali- 
ty worldwide. The World Health Organization (WHO) has estimated that 2 bil- 
lion people have latent TB and that globally, in 2009, the disease killed 1.7 mil- 
lion people. 
Despite great advances in immunology, microbiology, and drug devel- 
opment, TB remains among the great public health challenges. Poverty; lack of 
functioning public health infrastructure; lack of funding to support basic re- 
search aimed at developing new drugs, diagnostics, and vaccines; and the co- 
epidemic of HIV continue to fuel the ongoing epidemic of TB. 
The lungs are the most common site for the development of TB; 85% 
of patients with TB present with pulmonary complaints. Extrapulmonary TB 
can occur as part of a primary or late, generalized infection. 
Etiology. TB is caused by Mycobacterium tuberculosis (TBM), a slow- 
growing obligate aerobe and a facultative intracellular parasite. 
The first description of TBM is credited to Robert Whytt, on the basis 
of his 1768 monograph, Observations of Dropsy in the Brain. TBM first was 
described as a distinct pathological entity in 1836, and Robert Koch demon- 
strated that TB was caused by M.tuberculosis in 1882. 
M.tuberculosis is an aerobic gram-positive rod that stains poorly be- 
cause of its thick cell wall that contains lipids, peptidoglycans, and arabi- 
nomannans. 
Mycobacteria vary in appearance from spherical to short filaments, which 
may be branched. Although they appear as short to moderately long rods, they 
can be curved and frequently are seen in clumps. Individual bacilli generally are 
0.5-1 µm in diameter and 1.5-10 µm long. They are nonmotile and do not form 
spores. 
One of the distinct characteristics of mycobacteria is their ability to retain 
dyes within the bacilli that usually are removed from other microorganisms by 
alcohols and dilute solutions of strong mineral acids such as hydrochloric acid. 
This ability is attributed to a waxlike layer composed of long-chain fatty acids, 
the mycolic acids, in their cell wall. As a result, mycobacteria are termed acid- 
fast bacilli. 
The organism is spread primarily as an airborne aerosol from an indi- 
vidual who is in the infectious stage of TB. In immunocompetent individuals, 
exposure to M.tuberculosis usually results in a latent/dormant infection. Only 




tions in the host immune system that lead to decreased immune effectiveness 
can allow M.tuberculosis organisms to reactivate, with tubercular disease re- 
sulting from a combination of direct effects from the replicating infectious 
organism and from subsequent inappropriate host immune responses to tu- 
bercular antigens. 
Mycobacteria are highly antigenic, and they promote a vigorous, nonspe- 
cific immune response. Their antigenicity is due to multiple cell wall constitu- 
ents, including glycoproteins, phospholipids, and wax D, which activate Lang- 
erhans cells, lymphocytes, and polymorphonuclear leukocytes 
When a person is infected with M. tuberculosis, the infection can take 1 
of a variety of paths, most of which do not lead to actual TB. The infection may 
be cleared by the host immune system or suppressed into an inactive form called 
latent tuberculosis infection (LTBI), with resistant hosts controlling mycobacte- 
rial growth at distant foci before the development of active disease. Patients with 
LTBI cannot spread TB. 
Predisposing factors for the development of active TB include malnutri- 
tion, alcoholism, substance abuse, diabetes mellitus, corticosteroid use, malig- 
nancy, head trauma, and HIV infection. 
Homeless persons, people in correctional facilities, and residents of 
long-term care facilities also have a higher risk of developing active TB 
compared with the general population. 
Pathogenesis. The typical TB lesion is an epithelioid granuloma with 
central caseation necrosis. The most common site of the primary lesion is 
within alveolar macrophages in subpleural regions of the lung. Bacilli prolif- 
erate locally and spread through the lymphatics to a hilar node, forming the 
Ghon complex. 
Early tubercles are spherical, 0.5- to 3-mm nodules with 3 or 4 cellular 
zones demonstrating the following features: 
1. A central caseation necrosis, 
2. An inner cellular zone of epithelioid macrophages and Langhans 
giant cells admixed with lymphocytes, 
3. An outer cellular zone of lymphocytes, plasma cells, and immature 
macrophages, 
4. A rim of fibrosis (in healing lesions). 
Initial lesions may heal and the infection become latent before sympto- 
matic disease occurs. Smaller tubercles may resolve completely. Fibrosis occurs 
when hydrolytic enzymes dissolve tubercles and larger lesions are surrounded 
by a fibrous capsule. Such fibrocaseous nodules usually contain viable myco- 
bacteria and are potential lifelong foci for reactivation or cavitation. Some nod- 




Tissues within areas of caseation necrosis have high levels of fatty ac- 
ids, low pH, and low oxygen tension, all of which inhibit growth of the tu- 
bercle bacillus. 
If the host is unable to arrest the initial infection, the patient develops 
progressive, primary TB with tuberculous pneumonia in the lower and middle 
lobes of the lung. Purulent exudates with large numbers of acid-fast bacilli can 
be found in sputum and tissue. Subserosal granulomas may rupture into the 
pleural or pericardial spaces and create serous inflammation and effusions. 
With the onset of the host immune response, lesions that develop 
around mycobacterial foci can be either proliferative or exudative. Both types 
of lesions develop in the same host, since infective dose and local immunity 
vary from site to site. 
Proliferative lesions develop where the bacillary load is small and host 
cellular immune responses dominate. These tubercles are compact, with activat- 
ed macrophages admixed, and are surrounded by proliferating lymphocytes, 
plasma cells, and an outer rim of fibrosis. Intracellular killing of mycobacteria is 
effective, and the bacillary load remains low. 
Exudative lesions predominate when large numbers of bacilli are present 
and host defenses are weak. These loose aggregates of immature macrophages, 
neutrophils, fibrin, and caseation necrosis are sites of mycobacterial growth. 
Without treatment, these lesions progress and infection spreads. 
There are 3 main kinds of the clinicomorhologic forms of tuberculosis: 
primary, haematogenic and secondary. 
PRIMARY TUBERCULOSIS 
Primary tuberculosis develops due to primary contact of organism 
with M.tuberculosis. Mode of transmission – mostly air-droplet, rarely with 
food of direct contact. The way of infection spred – aerogenic; but alimentary 
way is possible too. More frequently the children are affected. 
To appearance of primary tuberculosis belongs primary TB complex. 
There are inflammatory patches in affected organ (primary focus on affect), in- 
flammation of lymphatic vessels (lymphagnitis) and regional lymph nodes 
(lymphadenitis). 
The most typical places of primary the focus localization in case aerogen- 
ic damage are the sub pleural segments of lungs (3,8,9,10). It consists of focus 
of exudative inflammation with the repid development of necrosis. The focus of 
caseous pneumonia, blundered by the zone of peritocal inflammation is formed. 
The sizes of affect are different: sometimes this is alveolitis, more frequently the 
damage of acinus or lobule, rarely – segment and hole lobe. 
The elastic fibres are kept long time in the caseous. Inflammatory process 




Specific inflammatory process speeds on the neighbor lymphatic vessels 
(the lymphangitis). Lymphostasis and the tuberculus formation along the lym- 
phatic vessels in perivascular tissue are observed. So, the way from the primary 
focus to hilus lymph nodes is formed. Then inflammatory process spreads father 
and involves the regional bronchopulmonary, bronchial, bifurcation lymph 
nodes, where the specific inflammatory process with the caseous necrosis ap- 
pears. It is total caseous the lymphadenitis. 
If M.tuberculosis penetrates with food, then there is formation of same 
primary complex in intestines. Tubercular tubercles are formed in the intes- 
tines with necrosis and ulcer formation, development of lymphangitis of 
mesenterial lymph vessels and caseous lymphadenitis. 
Thus primary tuberculosis is characterized by: 
1. Development of disease due to first meeting of organism and infection; 









3. Predominance of exudative-necrotic changes; 
4. Inclination to haematogenic and lymphogenic generalization; 
5. Para specific reactions such as vasculitis, arthritis, serositis and other. 
Variants of primary tuberculosis duration: 
1. Attenuation of primary tuberculosis and healing of primary com- 
 
2. Progressive primary tuberculosis with generalization of process, 
3. Chronic duration. 
I. Attenuation of primary tuberculosis  it begins from damaged 
patch of pulmonary tissue. Caseous necrosis patches – are surrounded by epi- 
thelioid and lymphoid cells, and then by fibrous capsule. Necrotic masses 
tear away. At their place forms fragments of bone tissue (ossification of pri- 
mary spot). Healed primary patch is known as Hon`s patch. There is sclerosis 
of lymph vessel with the formation of fibrous cord; healing process in lymph 
node occurs as well as in lungs, but slowly. M. tuberculosis then remains in 
these patches. This gives immunity and prevents from new attack. If steroids 
and immunosuppressants are given to these patients then these patches may 
be activated with development of tuberculosis infection. 
II. Progressive primary TB it is with generalization of process. It may 
have four forms: 
1. Haematogenic – causative agent enters into blood and spread  in 
whole organism that leads to formation of tuberculous patches of different size 
in different organs. 
2. Lymphoglandular – in this groups of lymph nodes are involved and 




3. Growth of primary affect – it is more severe progressive form. Case- 
ous necrotic patch increases continuously that leads to death of patient or cavity 
in lungs – primary pulmonary cavern. 
4. Mixed form – develops in weak patients from one of the previous 
forms. Necrotic patch is seen in lungs. There is damage of lymph nodes, tu- 
berculous patches are present in many organs. 
III. Chronic duration develops in prolonged inflammation process in 
lymph nodes. Periods of recurrence are alternated with remission periods. 
There is sensibilization of organism – increased sensitivity to different non- 
specific actions. This is confirmed by skin probes (Mont, perk). Paraspecific 
reactions develop – fibrinoid changes in CT, dystrophy in organs, amyloido- 
sis, hyperplasia of bone marrow. 
Peculiarities of primary chronic tuberculosis of lungs: 
1. Total caseous necrosis of lymph nodes; 
2. Inclination to generalization with metastatic foci of extra pulmonary tu- 
berculosis formation; 
3. Hematogenous generalization of infection is accompanied with tu- 
berculosis inflammation of serous coats (tuberculosis poliserositis – pleuritis, 
pericarditis) and activity of process in lymph nodes. 
Chronic primary tuberculosis arises in case of slowly progressive wavy 
course of specific process. It results in organism sensitization: increase of its 
sensitivity to nonspecific agents and development of paraspecific reactions 
(diffuse and nodular proliferation of lymphocytes and macrophagocytes, fi- 
brinoid changes in blood vessel wall, hyperplastic changes of hemopoietic 
tissue, disproteinosis, and sometime amyloidosis. 
HEMATOGENOUS TUBERCULOSIS 
Arises and develops in organism after primary infection and healing, but 
in patients secondary foci or not fully healed foci are kept in different organs 
and lymph nodes. Due to action of negative factors and hypersensitivity to tu- 
berculosis latent process exacerbation arises. 
Subvariants: 
1) generalized hematogenous tuberculosis; 
2) hematogenous tuberculosis with lungs lesion mainly; 
3) hematogenous tuberculosis with extrapulmonary lesions mainly. 
Generalized hematogenous tuberculosis is severe form of disease in 
which multiple tuberculosis tuberculum and necrotic foci appear. 
Depending on morphological substrate its 3 kinds are distinguished: 
I. Acute tuberculosis sepsis (necrotic type), 
II. Acute general miliary tuberculosis, 




Hematogenous tuberculosis with lungs lesion mainly – most frequent 
form of pulmonary tuberculosis. 
Variants: 
а) acute miliary lung tuberculosis; 
б) chronic miliary lung tuberculosis; 
в) chronic large focal tuberculosis of lungs. 
Chronic large focal tuberculosis of lungs is one of intermediate form 
of hematogenous tuberculosis with kept immunological features (appear in 
adult persons). 
Main morphological signs: 
1. Symmetric damage of both lungs; 
2. Mainly corticopleural localization of pathological process in lungs; 
3. Predominance of proliferative reactions; 
4. Development of diffuse net sclerosis; 
5. Development of emphysema; 
6. Hypertrophy of right heart; 
7. Absence of inclination to destruction; 
8. Formation of caverns in the borderline zones of lungs and their sym- 
metric localization; 
9. Presence of extrapulmonary metastatic foci. 
SECONDARY TUBERCULOSIS 
Secondary tuberculosis (reinfectious, after primary) develops in or- 
ganism of adult persons, who have suffered primary tuberculosis infection in 
childhood. It is characterized by lungs lesion. Progression of process is pos- 
sible by contact way or intracanalicular (in swallowing or aspiration of spu- 
tum), but not by the blood or lymph. 
Forms of secondary tuberculosis: 
1. Acute focal tuberculosis; 
2. Fibrous- focal tuberculosis; 
3. Infiltrative- pneumonic; 
4. Tuberculoma; 
5. Caseous pneumonia; 
6. Acute cavernous tuberculosis; 
7. Fibrous- cavernous tuberculosis; 
8. Cirrhotic tuberculosis. 
Complications: 
 In primary tuberculosis: tuberculosis meningitis, pleuritis, pericardi- 
tis, peritonitis. 




 In secondary tuberculosis complications are provided by caverns: 
hemorrhage, rupture of wall and spreading into pleural cavity (empyema and 
pneumothorax). 
 Amyloidosis (complication of chronic purulent processes). 
Causes of death: 
- progression of specific process, which is accompanied with severe in- 
toxication and dystrophy of parenchymatous organs, 
- brain edema in tuberculosis generalization and miliary tuberculosis with 
tuberculosis meningitis, hydrocephaly and fibrosis in pia mater encephali; 
- decompensation of renal failure with uremia in bilateral kidney tubercu- 
losis;  
- pulmonary bleedings from erosive blood vessels of cavern wall in pro- 
gression of pulmonary tuberculosis; 
- amyloid-lipoid nephrosis with progressing renal failure in general amy- 
loidosis; 
- chronic pulmonary-cardiac failure, which may result in the left type of 
acute pulmonary-cardiac failure. 
 
LEPROSY 
Leprosy is a chronic infection caused by the acid-fast, rod-shaped ba- 
cillus Mycobacterium leprae. Leprosy can be considered 2 connected diseas- 
es that primarily affect superficial tissues, especially the skin and peripheral 
nerves. Initially, a mycobacterial infection causes a wide array of cellular 
immune responses. These immunological events then elicit the second part of 
the disease, a peripheral neuropathy with potentially long-term consequences. 
In the 1990s, the World Health Organization (WHO) launched a cam- 
paign to eliminate leprosy as a public health problem by 2000. Elimination, 
as defined by the WHO, was defined as a reduction of patients with leprosy 
requiring multidrug therapy to fewer than 1 per 10,000 population. This goal 
was achieved in terms of global prevalence by 2002, but 15 of the 122 coun- 
tries where leprosy was endemic in 1985 still have prevalence rates of greater 
than 1 per 10,000 population 
According to WHO figures and as reported by 130 countries, the glob- 
al annual detection rates have declined from 2004-2010. Of the new cases, 
95% were detected worldwide during 2010 in the following countries: Ango- 
la, Bangladesh, Brazil, China, Democratic Republic of the Congo, India, 
Ethiopia, Indonesia, Madagascar, Mozambique, Myanmar, Nepal, Nigeria, 
Philippines, Sri Lanka, Sudan, and United Republic of Tanzania. These coun- 




M leprae was discovered as the causative agent in 1873. The acid fast, 
gram-positive bacillus is an obligate intracellular organism with a predilec- 
tion for Schwann cells and macrophages. 
The route of transmission has not been definitively established, alt- 
hough human-to-human aerosol spread of nasal secretions is thought to be 
the most likely mode of transmission in most cases. Leprosy is not spread by 
touch, since the mycobacteria are incapable of crossing intact skin. Living 
near people with leprosy is associated with increased transmission. Among 
household contacts, the relative risk for leprosy is increased 8- to 10-fold in 
multibacillary and 2- to 4-fold in paucibacillary forms. Animal reservoirs do 
exist (armadillos, certain nonhuman primates), and cases of suspected zoono- 
tic transmission have been reported. 
The incubation period of leprosy is long, ranging from a few months to 
20-50 years. The mean incubation time is estimated to be 10 years for lep- 
romatous leprosy and 4 years for tuberculoid leprosy. 
Leprosy can manifest in different forms, depending on the host re- 
sponse to the organism. 
Individuals who have a vigorous cellular immune response to  M. 
leprae have the tuberculoid form of the disease that usually involves the skin 
and peripheral nerves. The number of skin lesions is limited, and they tend to 
be dry and hypoesthetic. Nerve involvement is usually asymmetric. This form 
of the disease is also referred to as paucibacillary leprosy because of the low 
number of bacteria in the skin lesions (i.e., < 5 skin lesions, with absence of 
organisms on smear). 
Individuals with minimal cellular immune response have the leproma- 
tous form of the disease, which is characterized by extensive skin involve- 
ment. Skin lesions are often described as infiltrated nodules and plaques, and 
nerve involvement tends to be symmetric in distribution. The organism grows 
best at 27-30°C; therefore, skin lesions tend to develop in the cooler areas of 
the body, with sparing of the groin, axilla, and scalp. This form of the disease 
is also referred to as multibacillary leprosy because of the large number of 
bacteria found in the lesions (i.e., >6 lesions, with possible visualization of 
bacilli on smear). 
Leprosy is rarely fatal, and the primary consequence of infection is 
nerve impairment and debilitating sequelae. Although both lepromatous lep- 
rosy and tuberculoid leprosy involve the skin and peripheral nerves, tubercu- 
loid leprosy has more severe manifestations. Nerve involvement results in 
loss of sensory and motor function, which may lead to frequent trauma and 




Damage in the following nerves is associated with characteristic im- 
pairments in leprosy: 
 Ulnar and median - Clawed hand, 
 Posterior tibial - Plantar insensitivity and clawed toes, 
 Common peroneal -Foot drop, 
 Radial cutaneous, facial, and greater auricular nerves may also 
be involved. 
Infiltration by bacteria may lead to destruction of nasal cartilage (lep- 
romatous leprosy), ocular involvement, and diffuse thickening of the skin. 
Advanced cases of leprosy involve the loss of eyebrows and lashes, but these 
deformities are less common today. 
Histologic Findings. Findings vary but can include dermatitis, giant 
cells, infiltration of nerve bundles with mononuclear cells, and granulomas. 
Lepromatous lesions generally contain numerous acid-fast bacilli and fat- 
laden macrophages with a paucity of lymphocytes. 
In contrast, tuberculoid lesions contain few-to-no acid-fast bacilli but 
manifest granulomatous changes with epithelial cells and lymphocytes. 
GRANULOMA INGUINALE 
Granuloma inguinale is a chronic bacterial infection that frequently is as- 
sociated with other sexually transmitted diseases. Granuloma inguinale is char- 
acterized by intracellular inclusions in macrophages referred to as Donovan bod- 
ies. Granuloma inguinale usually affects the skin and mucous membranes in the 
genital region, where it results in nodular lesions that evolve into ulcers. 
The disease is common in tropical and subtropical countries such as New 
Guinea, Australia and India. The organism inhabits the intestinal tract. The in- 
fection is transmitted through vaginal or anal intercourse and by autoinocula- 
tion. The incubation period varies from 2 to 4 weeks. Initially, the lesion is in 
the form of a papule, a subcutaneous nodule or an ulcer. Within a few weeks, it 
develops into a raised, soft, painless, reddish ulcer with exuberant granulation 
tissue. Depending upon whether the individual is heterosexual or homosexual, 
the lesions are located on the penis, scrotum, genitocrural folds and inguinal 
folds, or in the perianal and anal area respectively. Regional lymphadenopathy 
generally does not occur. 
Microscopically, the margin of the ulcer shows epithelial hyperplasia. 
The ulcer bed shows neutrophilic abscesses. The dermis and subcutaneous tis- 
sues are infiltrated by numerous histiocytes containing many bacteria called 
Donovan bodies, and lymphocytes, plasma cells and neutrophils. These organ- 





Lymphogranuloma venereum (LGV) is a sexually-transmitted disease 
caused by Chlamydia trachomatis and is characterized by mucocutaneous le- 
sions and regional lymphadenopathy. C. trachomatis is an obligate intracellu- 
lar gram-negative bacteria. LGV is endemic in certain areas of Africa, South- 
east Asia, India, the Caribbean, and South America. 
Infection occurs after direct contact with the skin or mucous mem- 
branes of an infected partner. The organism does not penetrate intact skin. 
The organism then travels by lymphatics to regional lymph nodes, where it 
replicates within macrophages and causes systemic disease. 
Pathologic changes. LGV has three stages. In its primary stage, the 
disease is more likely to be detected in men; it may go unnoticed in women. 
After an incubation period of four to 30 days, a small painless ulcer or blister 
develops in the genital area. Second-stage LGV develops between one and six 
weeks later. In this stage, the infection spreads to the lymphatic system, forming 
buboes (swellings) in the lymph nodes of the groin area. The buboes often 
merge, soften, and rupture, forming sinuses and fistulas (hollow passages and 
ducts) that carry an infectious bloody discharge to the outside of the body. Pa- 
tients with second-stage LGV may also have fever, nausea, headaches, pains in 
their joints, skin rashes, and enlargement of the spleen or liver. Third-stage 
LGV, which is sometimes called anogenitorectal syndrome, develops in about 
25% of patients. Third-stage LGV is marked by rectal pain, constipation, a dis- 
charge containing pus or bloody mucus, and the development of strictures (nar- 
rowing or tightening of a body passage) in the rectum or vagina. 
LGV can have a number of serious complications. C. trachomatis in- 
fections of any subtype are associated with long-term fertility problems in 
women. Strictures in the rectum can completely close off the lower bowel, 
producing eventual rupture of the bowel and inflammation of the abdominal 
cavity. The patient can develop chronic abscesses or fistulae in the anal area 
or in the vagina in women. Long-term blockages in the lymph nodes can pro- 
duce elephantiasis, a condition in which the patient's upper legs and groin ar- 
ea become greatly enlarged. Patients with chronic LGV infection have a 
higher risk of developing cancer in the inflamed areas. 
Microscopically, the lymph nodes have characteristic stellate-shaped 
abscesses surrounded by a zone of epithelioid cells (granuloma). Healing 






Syphilis (lues) is a chronic, sexually transmitted, systemic infection 
caused by Treponema pallidum. The disease was first recognized in Europe in 
the 1490s and has been related to the return of Christopher Columbus and his 
seamen from the New World. Urbanization and mass movements of people 
caused by war contributed to its rapid spread. Originally, syphilis was an acute 
disease that caused destructive skin lesions and early death, but it has become 
milder, with a more protracted and insidious clinical course. 
Syphilis has a myriad of presentations and can mimic many other infec- 
tions and immune-mediated processes in advanced stages. Hence, it has earned 
the nickname ―the great impostor.‖ The complex and variable manifestations of 
the disease prompted Sir William Osler to remark, ―The physician who knows 
syphilis knows medicine.‖ Many famous personages throughout history are 
thought to have suffered from syphilis, including Bram Stoker, Henry VIII, and 
Vincent Van Gogh. Since the discovery of penicillin in the mid-20th century, 
the spread of this once very common disease has been largely controlled, but ef- 
forts to eradicate the disease entirely have been unsuccessful. 
The cause of syphilis is infection with the spirochete Treponema pal- 
lidum. Transmission of T.pallidum occurs via penetration of the spirochetes 
through mucosal membranes and abrasions on epithelial surfaces. It is pri- 
marily spread through sexual contact but can be spread by exposure to blood 
products and transferred in utero. T. pallidum is a labile organism that cannot 
survive drying or exposure to disinfectants; thus, fomite transmission (e.g., 
from toilet seats) is virtually impossible. 
T. pallidum is a thin, long spirochete, which cannot be grown in artifi- 
cial media. The organism is too thin to be seen by routine light microscopy, 
and techniques that amplify the width of the organism (e.g., dark-field mi- 
croscopy, silver impregnation stains) must be employed to demonstrate the 
organism in tissue of fluids. 
Epidemiology. Syphilis is a world wide disease, which is transmitted 
almost exclusively by sexual contact. The infection is also spread from an in- 
fected mother to her fetus (congenital syphilis). Blood transfusions, direct in- 
oculation, and nonsexual contact are only rare causes of syphilis. 
Risk factors of syphilis include the following: unprotected sex, promis- 
cuous sex, and intravenous drug use are the major risk factors. Health care 
workers are at occupational risk. 
Pathogenesis. Treponema pallidum is very fragile and is killed by 
soap, antiseptics, drying, and cold. Person-to-person transmission requires 
direct contact between a rich source of spirochetes (e.g., an open lesion) and 
mucous membranes or abraded skin of the genital organs, rectum, mouth, 




In acquired syphilis, T. pallidum rapidly penetrates intact mucous 
membranes or microscopic dermal abrasions and, within a few hours, enters 
the lymphatics and blood to produce systemic infection. Incubation time from 
exposure to development of primary lesions, which occur at the primary site 
of inoculation, averages 3 weeks but can range from 10-90 days. Studies in 
rabbits show that spirochetes can be found in the lymphatic system as early 
as 30 minutes after primary inoculation, suggesting that syphilis is a systemic 
disease from the outset. Although T.pallidum incites a vigorous inflammatory 
response, it persists and proliferates. Chronic infection and inflammation 
cause tissue destruction, sometimes for decades. 
Regardless of the stage of disease and location of lesions, histopathologic 
hallmarks of syphilis include endarteritis (which in some instances may be 
obliterative in nature) and a plasma cell–rich infiltrate. Endarteritis is caused by 
the binding of spirochetes to endothelial cells, mediated by host fibronectin 
molecules bound to the surface of the spirochetes. The resultant endarteritis can 
heal with scarring in some instances. 
The syphilitic infiltrate reflects a delayed-type hypersensitivity response 
to T.pallidum, and in certain individuals with tertiary syphilis, this response by 
sensitized T-lymphocytes and macrophages results in gummatous ulcerations 
and necrosis. Antigens of T.pallidum induce host production of treponemal anti- 
bodies and nonspecific reagin antibodies. Immunity to syphilis is incomplete. 
The course of syphilis is classically divided into three stages: 
1. Primary syphilis: the first lesion (a chancre) appears within sev- 
eral weeks of exposure at the inoculation site, where the number of organ- 
isms is initially greatest. 
2. Secondary syphilis: From the primary lesion, the spirochetes are 
disseminated throughout the body, producing systemic manifestations and 
widespread lesions 
3. Tertiary syphilis: The continued presence of spirochetes at some 
sites and the associated immunologic response produce chronic destructive 
lesions, which often manifest years after primary and secondary disease 
PRIMARY SYPHILIS 
The classic lesion of primary syphilis is the chancre; a characteristic ulcer 
located at the site of T. pallidum inoculation, usually the penis, vulva, anus, or 
mouth. It appears 1 week to 3 months after exposure, with an average incubation 
period of 3 weeks. The chancre tends to be solitary and has a firm, raised border. 
Unless secondarily infected, the chancre lacks a purulent exudate. Microscopi- 
cally, spirochetes may be anywhere in the chancre but tend to be concentrated in 
the walls of vessels and in the epidermis around the ulcer. Chancres, as well as 




litis," in which endothelial cells proliferate and swell and the walls of the vessels 
become thickened by lymphocytes and fibrous tissue. 
The chancre begins as a papule that quickly erodes to a characteristic 
ulcer. Chancres are painless and can go unnoticed in some locations, such as 
the uterine cervix, anal canal, and mouth. The chancre lasts from 3 to 12 
weeks and is frequently accompanied by inguinal lymphadenopathy. It heals 
without scarring. Penicillin remains effective therapy. 
SECONDARY SYPHILIS 
Secondary syphilis is characterized by lesions in a variety of organs, es- 
pecially the skin, mucous membranes, lymph nodes, meninges, stomach, and 
liver. This stage is the result of the systemic dissemination and proliferation of 
T. pallidum. Because almost any organ or combination of organs can be in- 
volved in secondary syphilis, this stage of the disease is enormously diverse in 
its clinical presentation, earning syphilis its nickname as "The Great Imitator." 
Histopathologically, the lesions of secondary syphilis show a chronic inflamma- 
tory infiltrate and endarteritis obliterans. 
• Skin: The most common presentation of secondary syphilis is a 
rash, accompanied by constitutional symptoms, which appears 2 weeks to 6 
months after the chancre heals. The rash is erythematous and maculopapular, 
involving the trunk and extremities and often including the palms and soles. 
There are a variety of other skin lesions in secondary syphilis, including con- 
dylomata lata (exudative plaques in the perineum, vulva, or scrotum, which 
abound in spirochetes; follicular syphilids (small popular lesions around hair 
follicles that cause loss of hair); and nummular syphilids (coinlike lesions in- 
volving the face and perineum). 
• Mucous membranes: lesions on mucosal surfaces of the mouth and 
genital organs, called ―mucous patches‖, teem with organisms and are highly 
infectious. The mucocutaneous lesions are accompanied by fever malaise, 
pharyngitis, weight loss and lymphadenopathy. 
• Lymph nodes: characteristic changes in lymph nodes include a 
thickened capsule, follicular hyperplasia, increased numbers of plasma cells 
and macrophages and luetic vasculitis. Numerous spirochetes are present in 
the lymph nodes of secondary syphilis. Swelling of the epitrochlear lymph 
nodes, uncommon in other diseases, has long been associated with syphilis. 
• Meninges: although the meninges are commonly seeded with T. 
Pallidum, this involvement is frequently asymptomatic. Occasionally patients 
complain of headache and stiff neck. 
The symptoms of secondary syphilis may begin before the chancre of 
primary syphilis has resolved and persist for varying periods of time ranging 





After the lesions of secondary syphilis have subsided, an asymptomatic 
period lasts for years or decades. However during this latent period, spirochetes 
continue to multiply, and the deep-seated lesions of tertiary syphilis gradually 
develop and expand. During this stage of apparent well-being, spirochetes may 
be passed in blood transfusions or across the placenta to the fetus. 
A third of untreated patients with syphilis develop tertiary lesions. 
Most of the pathologic processes associated with tertiary syphilis derive from 
focal ischemic necrosis secondary to obliterating endarteritis. T. Pallidum in- 
cites a mononuclear inflammatory infiltrate predominantly composed of lym- 
phocytes and plasma cells. These cells infiltrate small arteries and arterioles, 
producing a characteristic obstructive vascular lesion (endarteritis obliterans). 
The small arteries are inflamed and their endothelial cells are swollen. They 
are surrounded by concentric layers of proliferating fibroblasts, which confer 
an ―onion skin‖ appearance to the vascular lesions. 
Syphilitic aortitis: this lesion results from a slowly progressive endart- 
eritis obliterans of the vasa vasorum that eventually leads to necrosis of the 
aortic media, a gradual weakening and stretching of the aortic wall, and the 
formation of an aortic aneurysm. The syphilitic aneurysm is saccular and in- 
volves the ascending aorta, an unusual site for the much more common ath- 
erosclerotic aneurysms. On gross examination, the intima of the aorta appears 
rough and pitted (tree-bark appearance). The specialized arrangement of the 
aortic media, which includes a delicate and intimate weave elastica, smooth 
muscle and collagen, is gradually replaced by scar tissue. It is the specialized 
tissues of the media that gives the aorta its strength and resilience. When the- 
se are replaced by scar tissue, the aorta gradually stretches, becoming pro- 
gressively thinner to the point of rupture, massive hemorrhage, and sudden 
death. Damage to and scarring of the ascending aorta also commonly lead to 
dilatation of the aortic ring, separation of the valve cusps, and regurgitation 
of blood through the aortic valve (aortic insufficiency). 
Luetic vasculitis of the coronary arteries may narrow or occlude these 
vessels and cause myocardial infarction. 
• Neurosyphilis: The slowly progressive infection damages the menin- 
ges, cerebral cortex, spinal cord, cranial nerves, or eyes. Tertiary syphilis involv- 
ing the central nervous system is subclassified according to the predominant tis- 
sue affected. Thus, there are references to meningovascular syphilis (meninges), 
tabes dorsalis (spinal cord), and general paresis (cerebral cortex). 
• Gumma: A gumma is a characteristic lesion of tertiary syphilis, 
which may form in any organ or tissue. These granulomatous lesions are 
composed of a central area of coagulative necrosis, epithelioid histiocytes, 




monly found in the skin, bone, and joints, although lesions can occur at any 
body site. Gummas are usually localized lesions, which do not significantly 
damage the patient. 
CONGENITAL SYPHILIS 
Syphilis may be acquired in utero. The treponemes readily cross the 
placental barrier and infect the fetus, causing a high rate of spontaneous abor- 
tion and stillbirth. When T. pallidum is transmitted from an infected mother 
to the fetus, the organism disseminates in fetal tissues, which are injured by 
the proliferating organisms and accompanying inflammatory response. Fetal 
infection produces stillbirth, neonatal illness or death, or progressive postna- 
tal disease. 
Histopathologically, the lesions of congenital syphilis are identical to 
those of adult disease. Infected tissues show a chronic inflammatory infil- 
trate, composed of lymphocytes and plasma cells, and endarteritis obliterans. 
Virtually any tissue can be affected, but skin, bones, teeth, joints, liver, and 
central nervous systems are characteristically involved. 
The clinical features of congenital syphilis are highly variable, and in- 
fected newborns are often completely asymptomatic. Within the first 2 years 
of life, symptoms are similar to severe adult secondary syphilis with wide- 
spread condylomata lata and rash. ―Snuffles‖ describes the mucopurulent rhi- 
nitis caused by involvement of the nasal mucosae. Later manifestations of 
congenital syphilis include bone and teeth deformities, such as ―saddle nose‖ 
(due to destruction of the nasal septum), ―saber shins‖ (due to inflammation 
and bowing of the tibia), ―Clutton‘s joints‖ (due to inflammation of the knee 
joints), ―Hutchinson‘s teeth‖ (in which the upper incisors are widely spaced 
and notched), and ―mulberry molars‖ (in which the molars have too many 
cusps). Tabes dorsalis and general paresis may develop as in adults, with 8th 
cranial nerve deafness and optic nerve atrophy as well as a variety of other 
ophthalmologic involvement leading to blindness being additional features. 
 
DISEASES CAUSED BY FUNGI 
 
Of the large number of known fungi, only a few are infective to human 
beings. Many of the human fungal infections are opportunistic i.e. they occur in 
conditions with impaired host immune mechanisms. Such conditions include 
defective neutrophil function, administration of corticosteroids, immunosup- 
pressive therapy and immunodeficiency states (congenital and acquired). 
 
CANDIDIASIS 
Candidiasis is an opportunistic fungal infection caused most commonly 
by Candida albicans and occasionally by Candida tropicalis. In human be- 







cutaneous areas, intestines and vagina. The organism becomes pathogenic 
when the balance between the host and the organism is disturbed. Various 
predisposing factors are: impaired immunity, prolonged use of oral contra- 
ceptives, long-term antibiotic therapy, corticosteroid therapy, diabetes melli- 
tus, obesity, pregnancy etc. 
Pathologic changes. Candida produces superficial infections of the skin 
and mucous membranes, or may invade deeper tissues as described under: 
1. Oral thrush. This is the commonest form of muco-cutaneous candidia- 
sis seen especially in early life. Full-fledged lesions consist of creamy white 
pseudo-membrane composed of fungi covering the tongue, soft palate, and buc- 
cal mucosa. In severe cases, ulceration may be seen. 
2. Candidal vaginitis. Vaginal candidiasis or monilial vaginitis is charac- 
terised clinically by thick, yellow, curdy discharge. The lesions form pseudo- 
membrane of fungi on the vaginal mucosa. They are quite pruritic and may ex- 
tend to involve the vulva (vulvovaginitis) and the perineum. 
3. Cutaneous candidiasis. Candidal involvement of nail folds producing 
change in the shape of nail plate (paronychia) and colonisation in the intertrigi- 
nous areas of the skin, axilla, groin, infra- and intermammary, intergluteal folds 
and interdigital spaces are some of the common forms of cutaneous lesions 
caused by Candida albicans. 
4. Systemic candidiasis. Invasive candidiasis is rare and is usually a 
terminal event of an underlying disorder associated with impaired immune 
system. The organisms gain entry into the body through an ulcerative lesion 
on the skin and mucosa or may be introduced by iatrogenic means such as via 
intravenous infusion, peritoneal dialysis or urinary catheterisation. The le- 
sions of systemic candidiasis are most commonly encountered in kidneys as 
ascending pyelonephritis and in heart as candidal endocarditis. 
 
SUPERFICIAL MYCOSIS 
The superficial (cutaneous) mycoses are usually confined to the outer 
layers of skin, hair, and nails, and do not invade living tissues. The fungi are 
called dermatophytes. Dermatophytes, or more properly, keratinophilic fungi, 
produce extracellular enzymes (keratinases) which are capable of hydrolyzing 
keratin. Dermatophytes are the most important example of cutaneous mycosis 
caused by Microsporum, Trichophyton and Epidermophyton. These superficial 
fungi are spread by direct contact or by fomites and infect tissues. Examples of 
diseases pertaining to these tissues are as under: 
  Tinea capitis characterized by patchy alopecia affecting the scalp and 
eye brows. 
Tinea barbae is acute folliculitis of the beard. 










Tinea cruris - "jock itch". Infection of the groin, perineum or perianal 
 
Tinea pedis - "athlete's foot". Infection of toe webs and soles of feet. 
Tinea versicolor  -  сharacterized by a  blotchy discoloration of  skin 
which may itch. Up to 25% of the general population may have this lesion at 
any one time. Tinea versicolor is caused by Malassezia furfur. 
The diagnosis of dermatophytosis is made by light microscopic exami- 
nation of skin scrapings after addition of sodium or potassium hydroxide so- 
lution. Other methods include fungal culture and demonstration of fungus in 
tissue sections. 
Trichophyton species. These infect skin, hair and nails. They rarely 
cause subcutaneous infections, in immunocompromised individuals. Tri- 
chophyton species take 2 to 3 weeks to grow in culture. The conidia are large 
(macroconidia), smooth, thin-wall, septate (0-10 septa), and pencil-shaped; 
colonies are a loose aerial mycelium that grow in a variety of colors. Identifi- 
cation requires special biochemical and morphological techniques. It can 
rarely cause subcutaneous infections (kerion) in immunocompromized indi- 
viduals, particularly patients with chronic myelogenous leukemia. 
Microsporum species. These may infect skin and hair, rarely nails. The 
prevalence of infection has decreased significantly in recent years. When 
prevalent (15-20 years ago), this organism could be easily identified on the 
scalp because infected hairs fluoresce a bright green color when illuminated 
with a UV-emitting Wood's light. The loose, cottony mycelia produce macro- 
conidia which are thick-walled, spindle-shaped, multicellular, and echinulate 
(spiny). Microsporum canis is one of the most common dermatophyte species 
infecting humans. 
Epidermophyton floccosum. These infect skin and nails and rarely 
hair. They form yellow-colored, cottony cultures and are usually readily iden- 




Mycetoma is a chronic suppurative infection involving a limb, shoulder 
or other tissues and is characterized by draining sinuses. The material dis- 
charged from the sinuses is in the form of grains consisting of colonies of fungi 
or bacteria. Mycetomas are of 2 main types: 
• Mycetomas caused by actinomyces (higher bacteria) comprising 
about 60% of cases. This infection results in a granulomatous inflammatory 
response in the deep dermis and subcutaneous tissue, which can extend to the 
underlying bone. Mycetoma is characterized by the formation of grains con- 




the skin surface through multiple sinuses. The body parts affected most 
commonly in persons with mycetoma include the foot or lower leg, with in- 
fection of the dorsal aspect of the forefoot being typical. After several months 
of infection, the affected site, most commonly foot, is swollen and hence the 
name 'madura foot'. The lesions extend deeply into the subcutaneous tissues, 
along the fascia and eventually invade the bones. They drain through sinus 
tracts which discharge purulent material and grains. The surrounding tissue 
shows granulomatous reaction. The hand is the next most common location; 
however, mycetoma lesions can occur anywhere on the body. The causative 
organism enters through sites of local trauma. A neutrophilic response initial- 
ly occurs, which may be followed by a granulomatous reaction. Spread oc- 
curs through skin facial planes and can involve the bone. Hematogenous or 
lymphatic spread is uncommon. 
• Eumycetomas caused by true fungi comprising the remaining 40% of 
the cases. The disease is marked by progressive destruction of soft tissue and 
nearby anatomic structures. The foot is the most common site of infection, 
and 70% of all mycetomas affect the foot. Other reported sites of involve- 
ment include the upper extremities, trunk, buttocks, eyelids, lacrimal glands, 
paranasal sinuses, mandible, scalp, neck, perineum, and testes. The disease is 
initially limited to the skin and subcutaneous tissue but  may  eventually 
spread through the fascial planes to contiguous structures such as muscle, 
bone, blood and lymphatic vessels, and nerves. Rarely, the disease  may 
spread to the regional lymph nodes or viscera. 
Most common fungi causative for eumycetoma are Madurella mycetoma- 
tis or Madurella grisea, both causing black granules from discharging sinuses. 
Eumycetomas are particularly common in Northern and tropical Africa, South- 
ern Asia and tropical America. The organisms are inoculated directly from soil 
into bare feet, from carrying of contaminated sacks on the shoulders, and into 
the hands from infected vegetation. 
 
DISEASES CAUSED BY PARASITES 
 
Diseases caused by parasites (protozoa and helminths) are quite common 
and comprise a very large group of infestations and infections in human beings. 
Parasites may cause disease due to their presence in the lumen of the intestine, 
due to infiltration into the blood stream, or due to their presence inside the cells. 
AMOEBIASIS, BALANTIDIASIS 
See above (Intestinal infections) 
 
MALARIA 
Malaria is a protozoal disease caused by any one or combination of four 




ovale and Plasmodium malariae. While Plasmodium falciparum causes malig- 
nant malaria, the other three species produce benign form of illness. These para- 
sites are transmitted by bite of female Anopheles mosquito. The disease is en- 
demic in several parts of the world, especially in tropical Africa, parts of South 
and Central America, India and South-East Asia. 
P. falciparum differs from other forms of plasmodial species in 4 re- 
spects: 
I) It does not have exo-erythrocytic stage, 
II) Erythrocytes of any age are parasitised while other plasmodia para- 
sitize juvenile red cells, 
III) One red cell may contain more than one parasite, 
IV) The parasitized red cells are sticky causing obstruction of small 
blood vessels by thrombi, a feature which is responsible for extraordinary 
virulence of P. falciparum. 
The main clinical features of malaria are cyclic peaks of high fever ac- 
companied by chills, anaemia and splenomegaly. 
Pathologic changes. Parasitisation and destruction of erythrocytes are 
responsible for major pathologic changes as under: 
1. Malarial pigment liberated by destroyed red cells accumulates in the 
phagocytic cells of the reticuloendothelial system resulting in enlargement of the 
spleen and liver (hepatosplenomegaly). 
2. In falciparum malaria, there is massive absorption of haemoglobin by 
the renal tubules producing blackwater fever (haemoglobinuric nephrosis). 
3. At autopsy, cerebral malaria is characterized by congestion and pete- 
chiae on the white matter. 
4. Parasitized erythrocytes in falciparum malaria are sticky and get at- 
tached to endothelial cells resulting in obstruction of capillaries of deep or- 
gans such as of the brain leading to hypoxia and death. If the patient lives, 
microhaemorrhages and microinfarcts may be seen in the brain. 
Complications. Most complications are caused by P.falciparum. One 
of them is cerebral malaria, defined as coma, altered mental status, or multi- 
ple seizures with P.falciparum in the blood. The symptoms of cerebral malar- 
ia are similar to those of toxic encephalopathy. Other complications of 
P.falciparum infection include the following: 
 Seizures. Secondary to either hypoglycemia or cerebral malaria. 
 Renal failure. As many as 30% of nonimmune adults infected with 





 Hemoglobinuria (blackwater fever). It is the passage of dark urine, 
hemolysis, hemoglobinemia, and the subsequent hemoglobinuria and hemo- 
zoinuria cause this condition. 
 Noncardiogenic pulmonary edema. This affliction is most common in 
pregnant women and results in death in 80% of patients. 
 Hemolysis resulting in severe anemia and jaundice. 
 Bleeding (coagulopathy). 
The diagnosis of malaria is made by demonstration of malarial parasite in 
thin or thick blood films or sometimes in histologic sections. 
 
FILARIASIS 
Filariasis is a disease group affecting humans and animals, caused by 
filariae. Filarial parasites can be classified according to the habitat of the 
adult worms in the vertebral host, as follows: 
 Cutaneous group – includes Loa loa, Onchocerca volvulus, and Man- 
sonella streptocerca, 
 Lymphatic group – includes Wuchereria bancrofti, Brugia malayi, 
and Brugia timori, 
 Body-cavity group – includes Mansonella perstans and Mansonella 
ozzardi. 
Filariae have a specific geographic distribution. For example, 
W.bancrofti is found in sub-Saharan Africa, Southeast Asia, India, and the 
Pacific Islands. B.malayi is found in similar locations but not in sub-Saharan 
Africa. B.timori occurs on Timor Island, in Indonesia. 
Filarial infection generates significant inflammatory immune responses 
that participate in the development of symptomatic lymphatic obstruction. 
The lymphatic vessels inhabit the adult worm, especially in the lymph nodes, 
testis and epididymis. Microfilariae seen in the circulation are produced by 
the female worm. Majority of infected patients remain asymptomatic. Symp- 
tomatic cases may have two forms of disease an acute form and a chronic 
form. 
• Acute form of filariasis presents with fever, lymphangitis, lymphadeni- 
tis, epididymo-orchitis, urticaria, eosinophilia and microfilariaemia. 
• Chronic form of filariasis is characterized by lymphadenopathy, lym- 
phoedema, hydrocele and elephantiasis. 
The most commonly affected nodes are in the femoral and epitrochlear 
regions. Abscess formation may occur at the nodes or anywhere along the distal 
vessel. Cellular invasion with plasma cells, eosinophils, and macrophages, to- 
gether with hyperplasia of the lymphatic endothelium, occurs with repeated in- 




age of protein-rich lymph in the tissues, thickening and verrucous changes of the 
skin, and chronic streptococcal and fungal infections, which all contribute to the 
appearance of elephantiasis. (The skin of individuals with elephantiasis is char- 
acterized by hyperkeratosis, acanthosis, lymph and fatty tissue, loss of elastin 
fibers, and fibrosis.) Chylous ascites and chyluria may occur due to rupture of 
the abdominal lymphatics. 
 
CYSTICERCOSIS 
Cysticercosis is infection by the larval stage of Taenia solium, the pork 
tape-worm. The adult tape-worm resides in the human intestines. The eggs 
are passed in human faeces which are ingested by pigs or they infect vegeta- 
bles. These eggs then develop into larval stages in the host, spread by blood 
to any site in the body and form cystic larvae termed cysticercus cellulosae. 
Human beings may acquire infection by the larval stage by eating under- 
cooked pork ('measly pork'), by ingesting uncooked contaminated vegetables, 
and sometimes, by autoinfection. 
Pathologic changes. The cysticercus may be single or there may be 
multiple cysticerci in the different tissues of the body. The cysts may occur 
virtually anywhere in body and accordingly produce symptoms; most com- 
mon sites are brain, skeletal muscle and skin. The cysticercus consists of a 
round to oval white cyst, about 1 cm in diameter, contains milky fluid and in- 
vaginated scolex with birefringent booklets. The cysticercus may remain via- 
ble for a long time and incite no inflammation. But when the embryo dies, it 
produces granulomatous reaction with eosinophils. Later, the lesion may be- 





The original TORCH complex described similar congenital infections 
caused by Toxoplasma gondii, Rubella virus, Cytomegalovirus, and Herpes 
simplex virus. The letter «O» in TORCH refers to «other» organisms that cause 
perinatal infections such as Parvovirus B19, Varicella Zoster Virus, Syphilis, 
and HIV. 
TORCH infections are caused significant morbidity and mortality in neo- 
nates. It has been estimated that TORCH complex infections have an overall in- 
cidence of 1-5% of all live born children. These infections are acquired by the 
mother and passed either transplacentally or during the birth process. 
Common clinical manifestations that are suggestive of specific congenital 




























Table 7. Clinical Features Associated with TORCH Infections 
Infection Clinical Features 
 
Toxoplasmosis 
Intracranial calcifications in a diffuse pattern 
Hydrocephalus 
Chorioretinitis 




Cataracts, glaucoma, pigmented retinopathy 
Congenital heart disease (patent ductus arteriosus and 
peripheral pulmonary artery stenosis) 
Radiolucent bone disease 








Herpes Simplex Virus 
(HSV) 
Mucocutaneous vesicles or scarring 
CSFpleocytosis 
Thrombocytopenia 
Elevated liver transaminases 








Maculopapular rash (most notably on palms and soles or 
in diaper area) 
 
Since the symptoms produced by TORCH group of organisms are in- 
distinguishable from each other, it is a common practice in a suspected preg- 
nant mother or infant to test for all the four main TORCH agents. The fetal 
damage caused by TORCH complex infection is irreparable and, therefore, 
prevention is the best mode of therapy. 
 
CAT SCRATCH DISEASE 
Cat Scratch disease (CSD), also known as cat scratch fever or subacute 
regional lymphadenitis, is a bacterial infection affecting lymph nodes that 
drain the sites of inoculation. Bartonella henselae, a gram-negative rod, is 
considered the principal etiologic agent. B. henselae is organism linked to 
rickettsiae but unlike rickettsiae this organism can be grown in culture. 
The condition occurs more commonly in children (under 18 years of 
age). Patients with CSD usually have a history of sustaining a scratch or bite 
from a cat. The initial symptom is formation of a papule at the inoculation 
site, followed by solitary or regional lymphadenopathy within 1-2 weeks. In 
most patients, the disease resolves spontaneously within 2-4 months. A small 




other atypical manifestations. These may include oculoglandular syndrome, 
encephalitis, neuroretinitis, pneumonia, osteomyelitis, erythema nodosum, 
arthralgia, arthritis, and thrombocytopenic purpura. 
Lymph nodes. In general, lymph nodes become enlarged in the 1-2 
weeks after exposure. They are often tender and occasionally become fluctu- 
ant. Lymphoid hyperplasia with arteriolar proliferation and reticular cell hy- 
perplasia is seen early in the disease. As the disease progresses, granulomas 
appear, with central necrosis surrounded by lymphocytes. Histiocytes and 
multinucleated giant cells are often present. Finally, stellate microabscesses 
form, and nodes can become fluctuant. 
Central nervous system. Encephalopathy is the most common neuro- 
logic manifestation, occurring in 2-3% of patients. The onset is usually abrupt 
and occurs 1-6 weeks after the lymphadenopathy becomes apparent. Patients 
can become confused and disoriented, and their condition can deteriorate to co- 
ma. About 50% of patients have a fever. Focal findings of hemiparesis and re- 
flex abnormalities may be noted. Seizures, which occur in as many as 80% of 
patients with neurologic sequelae, are often prolonged and recurrent. 
Neuroretinitis. Patients with neuroretinitis generally present with 
painless, unilateral visual loss. Examination reveals decreased visual acuity, 
decreased color vision, and centrocecal scotoma. The optic disc appears 
edematous, and exudates frequently surround the macula. Neuroretinitis is 
possibly due to a subretinal angiomatous nodule similar to that seen in bacil- 
lary angiomatosis. 
Pulmonary. Six cases of CSD with pneumonia and 8 cases with pleu- 
ral thickening and/or effusion have been reported. In these cases, pulmonary 
features developed 1-5 weeks after lymphadenopathy occurred.  Systemic 
signs of infection, including fever, were present in 85%. One case in which a 
massive abscess involved the chest wall has been reported. 
Histopathologic findings of the lymph nodes depend on the stage of in- 
fection. Lymphoid hyperplasia with arteriolar proliferation, reticulum cell 
hyperplasia, and widening of arteriolar walls are seen early in the disease. 
Progression of the disease is manifested by granulomas. The centers of these 
granulomas are acellular and necrotic with surrounding histiocytes and lym- 
phocytes. Microabscesses may develop as the granulomas and areas of necro- 
sis coalesce. The organism is extracellular and can be identified by silver 
stains. 
The prognosis for immunocompetent patients with CSD is excellent. 
Complete recovery without sequelae occurs in nearly all patients. Significant 
morbidity occurs in 5-10% of cases, usually because of involvement of the cen- 
tral or peripheral nervous system or because of multisystem disseminated dis- 




logic sequelae within weeks to months can be expected. Death caused by CSD 




Sepsis is life-threatening organ dysfunction caused by a dysregulated host 
response to infection. Sepsis and septic shock are major healthcare problems, 
affecting millions of people around the world each year, and killing as many as 
one in four (and often more). Similar to polytrauma, acute myocardial infarc- 
tion, or stroke, early identification and appropriate management in the initial 
hours after sepsis develops improves outcomes. 
Sepsis is now defined as a ‗life-threatening organ dysfunction due to a 
dysregulated host response to infection‘. In this new definition the concept of 
the non-homeostatic host response to infection is strongly stressed while the 
SIRS criteria have been removed. The SIRS criteria are considered overly non- 
specific and of poor clinical utility: i.e. they may be present in simple, non- 
complicated infection, or in response to non infectious-triggers (i.e. trauma, 
pancreatitis, post-cardiac arrest syndrome), or may even be absent in critically ill 
patients with obvious evidence of a life-threatening infection. While recognition 
and treatment of the infectious trigger obviously remain important, the attention 
with sepsis is now more focused on the pathobiology of the host response and 
the related organ dysfunction. The inflammatory response accompanying infec- 
tion (pyrexia, neutrophilia, etc.) often represent an appropriate host response to 
any infection, and this may not necessarily be life-threatening. 
The key element of sepsis-induced organ dysfunction is defined by ‗an 
acute change in total SOFA score ≥ 2 points consequent to infection, reflecting 
an overall mortality rate of approximately 10%‘. The baseline Sepsis-related 
Organ Failure Assessment (SOFA) score may be taken as zero unless the patient 
is known to have previous comorbidity (e.g. head injury, chronic kidney disease, 
etc.). In light of this, the current definition of 'severe sepsis' becomes obsolete, 
as does the term. 
The Sepsis-related Organ Failure Assessment (SOFA) score is widely 
used in the critical care setting and is a reliable tool to clinical characterise septic 
patients, but it requires some laboratory investigations and may be less useful 
for a quick screening patients in settings outside of the ICU. A simple bedside 
score (‗qSOFA‘, for quick SOFA) has been proposed, which incorporates hypo- 
tension (systolic blood pressure ≤100mmHg), altered mental status and tachyp- 
nea (respiratory rate > 22/min): the presence of at least two of these criteria 
strongly predicts the likelihood of poor outcome in out-of-ICU patients with 
clinical suspicion of sepsis. 
Septic shock is now defined as a ‗subset of sepsis where underlying circu- 




increase mortality‘. Clinical criteria identifying such condition include the need 
for vasopressors to obtain a MAP≥ 65mmHg and an increase in lactate concen- 
tration > 2 mmol/L, despite adequate fluid resuscitation. This new definition is 
mainly focused on the importance to both distinguish septic shock from other 
forms of circulatory shock and underline the detrimental clinical impact of sep- 
sis-induced cellular metabolism abnormalities. 
Given the urgent need to widely spread education campaigns and better in- 
form the public about the clinical and economic implications of such condition, a 
lay definition of sepsis as ‗a life-threatening condition that arises when the body‘s 
response to infection injures its own tissue‘ has been also endorsed. Finally, all 
these new definitions are recommended for coding and research purposes. 
Despite the unavoidable limits affecting any definition of syndromes that 
do not have any specific diagnostic clinical, imaging, laboratory or biochemical 
marker, this new classification includes the most recent deep understanding of 
sepsis biology and stresses the clinical relevance of organ dysfunction. In addi- 
tion, similarly to software updates, the Sepsis-3 definition has been established 
with the aim of fostering future updates. 
Pathomorphological characteristics are based on 3 factors: 
1. Etiology; 
2. Entrance gate; 
3. Clinico-morphological appearances. 
According to entrance gate there are therapeutic (parainfectious), ton- 
sillogenic, surgical, uterine, otogenic, odontogenic, umbilical, cryptogenic 
forms of sepsis. 
Morhologicaly, sepsis can be in the form of septicaemia, seticopyemia, 
septic endocarditis. 
Septicaemia means presence of rapidly multiplying, highly pathogenic 
bacteria in the blood e.g. pyogenic cocci (more frequently streptococci), bacilli 
of plague etc. It is generally accompanied by systemic effects like toxaemia, 
multiple small haemorrhages, neutrophilic leucocytosis and disseminated intra- 
vascular coagulation (DIC). Main features of septicemia are: 1) rapid course, 
severe toxicosis; 2) absence of purulent focus (or it is very small), purulent me- 
tastasis; 3) is accompanied with severe hyperergic reaction; 4) more frequently it 
results from streptococci infection. 
Pathological anatomy: 
1. Absence of purulent focus; 
2. Hemolytic jaundice, skin and sclera are yellowish with hemorrhag- 
ic rush (hemorrhagic syndrome); 
3. Hyperplasia of red bone marrow (changes in myelogramma), lym- 




4. Interstitial inflammation in parenchymatous organs (liver, kidney, 
heart); 
5. Allergic vasculitis. 
Septicopyemia is characterized: 
1. Purulent processes in infectious gate and in different organs and 
tissues (metastatic foci of inflammation); 
2. Hyperergic reaction is moderate, and due to this there is no rapid 
course; 
3. Is caused by staphylococci and haemophilus influenzae; 
4. Intoxication is week more frequently; 
5. Results in chronic sepsis. 
Pathological anatomy: 
1. The dissemination of small septic thrombi in the blood which cause 
their effects at the site where they are lodged. This can result in pyaemic ab- 
scesses or septic infarcts. 
3. Hyperplastic processes are more week as in septicaemya. In red 
bone marrow there is no leukemoid reaction (in myelogramma). May be 
―septic spleen‖, but lymphatic nodes may be normal. 
4. Interstitial inflammation in parenchymatous organs (liver, kidney, 
heart) is moderate or week; 
5. Allergic vasculitis. 
It is characterized by presence of purulent focus with changes in lymph 
vessels (lymphangitis), lymph nodes (lymphadenitis), changes in blood ves- 
sels (purulent trombophlebitis). 
In case of systemic circulation in veins first metastatic purulent foci 
appear in pulmonary veins, then in organs: liver, kidney, skin fat tissue, bone 
marrow, synovial coats and heart valves (acute septic polipous- ulcerative 
endocarditis. 
Septic endocarditis is characterized by septic damage of the valvular 
and mural endocardium (heart valves) with typical infected and friable vege- 
tations. It appears more frequently in males. It may be caused by different 
forms of bacteria (Streptococci, Staphylococci, Enterococci). 
Acute bacterial endocarditis (ABE) is the fulminant and destructive 
acute infection of the endocardium by highly virulent bacteria in a previously 
normal heart and almost invariably runs a rapidly fatal course in a period of 
2-6 weeks. 
Subacute bacterial endocarditis (SABE) or endocarditis lenta (lenta = 
slow) is caused by less virulent bacteria in a previously diseased heart and 





Predisposing factors of both forms of bacterial endocarditis develop- 
ment are: 
1. Conditions initiating transient bacteraemia, septicemia and pyaemia; 
2. Underlying heart disease; and 
3. Impaired host defenses. 
Pathologic changes are characterized by presence of typical vegeta- 
tions or verrucae on the valve cusps or leaflets, and less often, on mural en- 
docardium. 
Macroscopically, the lesions are found commonly on the valves of the 
left heart, most frequently on the mitral, followed in descending frequency, 
by the aortic, simultaneous involvement of both mitral and aortic valves, and 
quite rarely on the valves of the right heart. The vegetations of bacterial en- 
docarditis vary in size from a few millimeters to several centimeters, grey- 
tawny to greenish, irregular, single or multiple, and typically friable. They 
may appear flat, filiform, fungating or polypoid. The vegetations in ABE tend 
to be bulkier and globular than those of SABE and are located more often on 
previously normal valves, may cause ulceration or perforation of the underly- 
ing valve leaflet, or may produce myocardial abscesses. 
Microscopically, the vegetations of bacterial endocarditis consist of 3 
zones:  
1. The outer layer or cap consists of eosinophilic material composed of 
fibrin and platelets, 
2. Underneath this layer is the basophilic zone containing colonies of 
bacteria. However, bacterial component of the vegetations may be lacking in 
treated cases. 
3. The deeper zone consists of non-specific inflammatory reaction in 
the cusp itself, and in the case of SABE there may be evidence of repair. 
Its peripheral signs are: 
1. Test of Konchalovsky (appearance of petechia in the places of skin 
compression). 
2. Petechiae in the inferior eyelid conjunctive of medial angle. 
3. Osler`s nodules (features of septic vasculitis) – painful nodules on 
the manus palmar surfaces. 
4. Thickness of the falanges – due to vegetation of periosteum. 
5. Hemorrhages in the skin (spots of Jenuay). 
6. Jaundice (hemolytic). 
7. Very often thromboembolic complications (sometimes thromboem- 
bolic syndrome). 
Complications of BE: 
Cardiac complications. 




ii) Perforation, rupture and aneurysm of valve leaflets, 
iii) Abscesses in the valve ring, 
iv) Myocardial abscesses, 
v) Suppurative pericarditis, 
vi) Cardiac failure from one or more of the foregoing complications. 
Extra-cardiac complications: 
i) Emboli originating from the left side of the heart and entering the 
systemic circulation affect organs like the spleen, kidneys and brain causing 
infarcts, abscesses and mycotic aneurysms. 
ii) Emboli arising from right heart enter the pulmonary circulation and 
produce pulmonary abscesses. 
iii) Petechiae may be seen in the skin and conjunctiva due to either 
emboli or toxic damage to the capillaries. 
iv) Painful, tender nodules on the finger tips of hands and feet called 
Osler's nodes, while in ABE there is appearance of painless, non-tender sub- 
cutaneous maculopapular lesions on the pulp of the fingers called Janeway's 
spots. In either case, their origin is due to toxic or allergic inflammation of 
the vessel wall. 
v) Focal necrotising glomerulonephritis is seen more commonly in 
SABE than in ABE. Occasionally diffuse glomerulonephritis may occur. 






A man in the era of scientific and technical revolution is exposed by 
powerful, long, various influences of aggressive factors of the environment, 
that affect on the integration systems of maintenance of the homeostasis, in- 
terrelation of the human body with microorganisms and medical products. 
There are previously unknown features of the course of various diseases, new 
diseases, new syndromes, thus the phenomena of pathomorphosis develops. 
Pathomorphosis (from Greek pathos - suffering, disease and morphe - 
kind, shape) - essential and steady changes of character of the disease, causes of 
death and properties of various diseases under the influence of various factors. 
The term "pathomorphosis" has been used for the first time in the 30 
years of the twentieth century in the foreign literature as the amendment to the 
presentation accepted in the pathology about stability of nosological forms. W. 
Hellpach meant first of all changes of clinical and morphological forms of syph- 
ilis under the influence of active chemotherapy. 
In 1956 W. Doerr specified such forms of pathomorphosis, as natural 
pathomorphosis (spontaneous changes in the course of the disease arising from 
changes of external and internal causes of the disease) and induced or therapeu- 
tic pathomorphosis (changes in the disease caused by therapeutic effects). 
In literature the term "pathomorphosis" was introduced by Ya.L. 
Rapoport only in 1962. Professor Ya.L. Rapoport singled out one important fea- 
ture - induced pathomorphosis was not fixed genetically, therefore are possible 
the reversal of the disease, returning to its classical forms and manifestations af- 
ter removal of the therapeutic factor. 
V.V. Serov gave the following definition of pathomorphosis: ‖Pathomor- 
phosis is nosomorphosis as in wide ("panorama" of diseases) and narrow (some 
disease) sense‖. 
At the present stage scientists identify two forms of pathomorphosis: 
spontaneous (idiopathic, natural) and induced (therapeutic). Spontaneous 
pathomorphosis are transformations in the course of nosological forms which 
are caused by changes of external causes of disease, influence of factors of envi- 
ronment (ecology), action of the internal causes (the constitution, features of the 
reactivity of the organism), changes of properties of the pathogenic organism. 
Manifestations of induced pathomorphosis arise in relatively short periods of 
time under the influence of treatment by new drugs, radiation therapy and other. 
 
IATROGENIC REACTIONS AND DISEASES 
From the Greek words ―iatros‖ meaning "medical" and ―genea‖ meaning 
"origin", ―iatrogenic‖ means the occurrence of negative effects caused by a 
medical procedure. According to The ICD-10, iatrogenic diseases are any unde- 




procedures which lead to the infringement of functions of the body, limiting of 
usual activity, disablement or even death; complications of medical interven- 
tions which may arise as a result of false and correct actions of doctors. 
It is frequently thought that iatrogenic means "error" or "neglect", but 
iatrogenic effects and medical errors are opposite terms, not synonymous 
ones. An error is a mistake or the result of ignorance and, thus, opposes the 
concept of medical attitude, whereas an iatrogenic effect is the consequence 
of an accurate action based on a correct orders, indication and adequate crite- 
ria and can be predicted by the physician. When, in trying to heal, relieve or 
treat a patient, the physician (like any other health care worker) generates 
psychological, functional or organic illness that takes the from of pain, dis- 
ease or disturbance, he is being iatrogenic. The diagnosis may be difficult, 
delayed or initially missed as iatrogenic illness can be generated directly 
from the doctor-patient relationship or by means of agents used in the diag- 
nostic search, or as a consequence of a therapeutic, instrumental (technical) 
or drug-related measure. 
Iatrogenic disease is a serious problem with a great social impact. The 
world literature shows that the incidence of iatrogenic events in the hospitalized 
population varies widely, ranging from 6 to 65%. It occurs very frequently, is ex- 
pensive and is potentially responsible for high morbidity and mortality. In the 
U.S., it is estimated that iatrogenic causes are responsible for 225,000 deaths each 
year, thus being the third leading cause of death after heart disease and cancer. 
Causes of iatrogenesis include: 
1. Side effects of possible drug interactions, 
2. Complications arising from a procedure or treatment, 
3. Medical error, 
4. Negligence, 
5. Unexamined instrument design, 
6. Anxiety or annoyance in the physician or treatment provider in re- 
lation to medical procedures or treatments, 
7. Unnecessary treatment for profit. 
Professionals who may cause harm to patients include physicians, 
pharmacists, nurses, dentists, psychologists, psychiatrists, medical laboratory 
scientists and therapists. Iatrogenesis can also result from complementary and 
alternative medicine treatments. 
Among the causes of iatrogenic diseases objective and subjective fac- 
tors are distinguished. The objective factors are the imperfection of medicine, 
the incurability of some pathology, the necessity of the realization of invasive 
procedures for confirmation or refutation of the diagnosis. The subjective 
factors of the beginning of iatrogenic diseases are connected with the indi- 




skills, the inability to collect correctly the information about the disease of 
the patient, disinterest in the estimation of the condition of the patient). 
Iatrogenic reactions and diseases are divided into 4 groups: 
1. Connected with diagnostic procedures: instrumental damage of or- 
gans by endoscopes and other diagnostic appliances, radiation damage of a 
patient during X- ray and radiological examination, allergic and toxic reac- 
tions to contrast substances. 
2. Connected with therapeutic actions: drug disease due to drug intox- 
ication; allergic reactions to drugs; radiation damage during radiation thera- 
py; puncture, injection, infusion damages of organs and tissues; operational 
stress and mechanical damage of organs. 
3. Connected with preventive measures: reaction to vaccination; in- 
fectious and inflammatory damages due to injections. 
4. Information: reaction to words of medical workers; effects of mod- 
ern literature, medical books, articles; self-treatment under the influence of 
newspapers, appeals to witch doctors. 
The risk factors for the occurrence of iatrogenesis during hospitalization are: 
age, number of comorbidities, complexity of the diseases, use of multiple drugs, 
length of hospital stay, severity of illness at admission and functional status. 
Patients 65 years and older suffer twice as many diagnostic complica- 
tions, two and one half times as many medication reactions, four times as many 
therapeutic mishaps, and nine times as many falls as those younger patients. 
Age-related factors that predispose the older patient to iatrogenesis include: 
1. Diminished physiologic reserve. 
2. Impaired compensatory mechanisms. 
3. Atypical presentation of illness, which complicates accurate diag- 
nosis and treatment. 
4. More co-morbid, chronic medical conditions that require more di- 
agnostic procedures and medications. 
5. Polypharmacy - The prescription, administration or use of more 
medications than clinically indicated. 
6. Increased cognitive and functional impairment. 
7. Other risk factors for iatrogenic complications include: 
a. Increased severity of illness and complexity of care, 
b. Greater numbers of prescribed medications, 
c. Admission from nursing home or other acute care facility, 
d. Longer length or stay, 
e. Lack of attention to functional impairment by physicians upon admis- 
sion.  
The role of the pathologist in the investigation of dead bodies is central 
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